data_2l18_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l18 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt . . . . . 0 N--CA 1.465 0.312 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.7 mttt -100.28 123.14 44.14 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.8 p -102.93 144.74 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 122.058 0.932 . . . . 0.0 110.51 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 29.6 tpp -124.24 142.69 51.04 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 125.042 1.337 . . . . 0.0 108.629 176.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -124.22 124.34 42.23 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 171.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.7 t -127.61 121.6 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 120.483 1.492 . . . . 0.0 109.073 -172.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.8 t -118.64 165.75 13.59 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.954 0.797 . . . . 0.0 109.687 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -56.32 -20.99 21.42 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.977 0.911 . . . . 0.0 112.455 170.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -139.51 -2.74 1.56 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 60.27 -47.15 0.1 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 128.53 2.732 . . . . 0.0 115.499 -169.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.7 p -43.96 -25.61 0.22 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 119.707 3.225 . . . . 0.0 119.707 -168.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 45.2 m -126.91 -72.47 0.64 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.909 0.777 . . . . 0.0 109.818 -169.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -63.98 -49.56 72.0 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -169.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.16 -42.08 72.97 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 117.76 0.254 . . . . 0.0 111.11 -177.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -60.09 -45.51 92.7 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.007 0.523 . . . . 0.0 111.166 -175.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 46.9 mtm -64.16 -44.35 92.38 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 121.235 -0.186 . . . . 0.0 110.853 175.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.16 -37.76 75.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 119.363 -0.351 . . . . 0.0 111.116 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -65.5 -45.06 85.08 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.946 0.339 . . . . 0.0 110.52 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.84 -44.14 97.33 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -67.03 -50.56 61.64 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 118.629 1.214 . . . . 0.0 109.412 176.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.36 -42.55 82.29 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 119.477 1.035 . . . . 0.0 112.432 -173.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -69.65 -36.88 76.46 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.46 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.9 m -66.79 -43.1 84.84 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 119.65 -1.906 . . . . 0.0 110.571 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.5 mt -73.02 -39.37 66.05 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.539 1.536 . . . . 0.0 110.79 -174.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.874 0 CA-C-O 116.747 -2.14 . . . . 0.0 118.296 -169.509 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.6 pt . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -120.16 130.5 54.62 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 170.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 p -113.08 151.24 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 124.169 0.988 . . . . 0.0 111.381 -176.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.7 m -147.81 135.9 21.28 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 167.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.3 p -102.45 156.63 17.47 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 121.083 -1.011 . . . . 0.0 108.335 169.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.4 m -148.53 -175.3 4.87 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 125.848 1.659 . . . . 0.0 106.759 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.93 154.7 25.85 Favored Glycine 0 CA--C 1.497 -1.051 0 N-CA-C 108.301 -1.919 . . . . 0.0 108.301 169.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 68.7 tp -49.03 -34.41 13.27 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.877 1.271 . . . . 0.0 109.74 169.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -146.47 148.38 32.18 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 168.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 p -83.03 162.84 21.29 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.81 0.844 . . . . 0.0 111.548 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 69.3 m -160.03 160.28 33.06 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.392 2.277 . . . . 0.0 106.551 169.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.88 138.14 30.51 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 117.813 -1.089 . . . . 0.0 110.386 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.6 p -57.76 130.09 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 120.083 1.311 . . . . 0.0 107.846 170.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -74.29 142.76 78.94 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.083 -169.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.51 -42.29 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.341 1.361 . . . . 0.0 112.25 -169.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.432 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 26.3 m -62.77 -24.95 67.98 Favored 'General case' 0 CA--C 1.535 0.365 0 O-C-N 120.484 -1.385 . . . . 0.0 111.414 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.69 -40.2 59.68 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.462 0.705 . . . . 0.0 111.536 173.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.1 mt -55.68 -46.08 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.38 -38.83 91.18 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 124.439 1.096 . . . . 0.0 110.144 -171.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 8.7 mmm -68.64 -44.01 75.08 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 122.791 1.281 . . . . 0.0 110.557 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 9.7 mtp -65.64 -35.48 80.93 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.327 -0.858 . . . . 0.0 109.867 175.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -62.72 -26.53 68.73 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.657 0.662 . . . . 0.0 111.501 173.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -65.7 -39.87 91.68 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.823 0.738 . . . . 0.0 109.876 173.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 88.7 t -76.67 -25.37 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.617 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.45 25.86 5.61 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.034 1.302 . . . . 0.0 111.718 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.9 mt -122.89 178.79 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 C-N-CA 125.255 1.422 . . . . 0.0 107.378 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -143.1 156.1 44.74 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.315 1.446 . . . . 0.0 109.276 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -128.08 -15.6 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 123.881 0.872 . . . . 0.0 112.351 169.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -45.75 -38.09 6.65 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.687 1.195 . . . . 0.0 112.859 172.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.77 -6.59 85.37 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.557 1.075 . . . . 0.0 114.217 -173.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -125.15 169.59 12.05 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 119.01 1.405 . . . . 0.0 111.036 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.3 p -127.05 169.91 12.88 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.75 1.22 . . . . 0.0 110.819 -172.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.7 p -92.69 160.15 15.11 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.576 1.15 . . . . 0.0 111.284 178.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -154.81 138.7 11.14 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 118.364 -0.827 . . . . 0.0 109.474 -169.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -80.94 152.88 19.15 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.663 2.242 . . . . 0.0 111.703 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.0 tt -52.43 -34.86 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.763 1.225 . . . . 0.0 111.552 173.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -57.78 -23.64 53.26 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.128 1.771 . . . . 0.0 112.371 -175.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -83.37 -6.71 59.55 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.856 0.863 . . . . 0.0 112.79 -175.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -128.57 -176.89 3.97 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.465 1.029 . . . . 0.0 111.269 -176.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.56 132.53 37.31 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 126.672 1.989 . . . . 0.0 108.344 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.32 -30.01 69.24 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.732 1.213 . . . . 0.0 112.702 -176.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -61.29 -21.21 63.73 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.08 0.952 . . . . 0.0 112.496 -174.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -85.86 -15.26 42.4 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.3 0.64 . . . . 0.0 110.778 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -107.8 121.97 45.83 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 124.775 1.23 . . . . 0.0 109.309 -172.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -71.83 -38.33 70.17 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.312 0.245 . . . . 0.0 111.039 177.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.1 p -131.5 133.17 62.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -170.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.7 t -124.23 123.13 65.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 122.526 1.155 . . . . 0.0 108.404 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 35.5 mm -113.41 97.09 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.5 m -72.65 156.51 38.89 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 168.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.05 54.72 0.65 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 176.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.8 m . . . . . 0 CA--C 1.53 0.194 0 C-N-CA 124.193 0.997 . . . . 0.0 109.796 176.546 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 . . . . . 0 N--CA 1.466 0.332 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -57.51 -24.9 58.59 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 121.17 -0.956 . . . . 0.0 111.994 174.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.1 p -87.3 -9.97 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 119.65 1.114 . . . . 0.0 110.541 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 49.5 p -113.44 19.88 16.54 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.916 0.886 . . . . 0.0 112.549 -169.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -81.67 175.72 10.23 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.609 0.764 . . . . 0.0 109.663 171.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -57.77 -32.67 67.72 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.905 1.282 . . . . 0.0 113.588 -169.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.0 mt -135.17 139.08 47.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -141.93 137.83 31.57 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 124.276 1.03 . . . . 0.0 108.506 172.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -146.68 158.75 43.97 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.802 1.641 . . . . 0.0 107.421 168.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -121.92 101.4 7.54 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.015 1.326 . . . . 0.0 108.045 168.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.411 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 43.5 m0 -75.44 95.83 3.34 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.539 1.136 . . . . 0.0 108.955 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -59.91 118.55 6.36 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 169.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 38.3 mt -153.43 146.24 24.36 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.846 1.658 . . . . 0.0 107.204 -169.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -83.77 72.8 10.34 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.25 1.42 . . . . 0.0 110.946 -173.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -23.55 100.93 0.08 OUTLIER Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 128.007 2.523 . . . . 0.0 113.075 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -60.97 -2.65 2.32 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 124.236 3.29 . . . . 0.0 116.925 -172.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -52.28 100.49 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.239 1.381 . . . . 0.0 112.157 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.75 20.47 59.69 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.341 1.924 . . . . 0.0 113.561 171.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -96.95 179.23 5.01 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.752 1.276 . . . . 0.0 113.052 -169.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.1 m -76.44 154.93 34.33 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.497 1.519 . . . . 0.0 109.877 175.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.8 mt -58.63 -31.77 68.42 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 122.053 -0.404 . . . . 0.0 111.461 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -63.39 -41.08 98.76 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.075 0.398 . . . . 0.0 110.889 177.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 88.9 t -65.63 -46.75 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.432 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 8.0 m-85 -54.59 -53.83 49.38 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.344 0.658 . . . . 0.0 110.732 176.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 31.2 mtt180 -59.75 -41.99 92.21 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 123.947 0.899 . . . . 0.0 111.463 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 93.9 m -61.46 -54.41 43.76 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.2 t -62.97 -43.21 98.91 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 CA-C-O 118.799 -0.62 . . . . 0.0 110.648 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -57.73 -43.81 85.58 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 119.328 0.967 . . . . 0.0 110.139 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.29 -50.2 61.36 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.015 -0.88 . . . . 0.0 111.166 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -58.02 -51.43 69.68 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.243 1.022 . . . . 0.0 110.912 -176.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.6 t -50.83 -55.89 5.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 126.841 2.057 . . . . 0.0 109.934 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -59.34 -46.91 87.31 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 119.405 1.002 . . . . 0.0 110.185 -173.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.07 -42.06 79.95 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.318 1.047 . . . . 0.0 110.547 177.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.411 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 45.4 mtt85 -72.23 -40.97 67.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 117.684 -1.15 . . . . 0.0 110.888 -177.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 99.2 t -54.5 -46.15 71.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 120.653 1.569 . . . . 0.0 109.763 169.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -62.21 -40.9 97.63 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.222 0.919 . . . . 0.0 110.861 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -62.61 -44.24 96.81 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 122.911 0.485 . . . . 0.0 110.542 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.32 -47.59 78.82 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 118.293 -0.86 . . . . 0.0 109.768 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 67.3 mt -54.31 -41.46 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.787 0.835 . . . . 0.0 109.452 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.66 -31.53 72.42 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.84 1.2 . . . . 0.0 111.543 -173.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -66.15 -45.91 79.32 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.413 1.085 . . . . 0.0 110.814 176.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.2 pt -89.19 -27.03 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.813 1.245 . . . . 0.0 114.299 -169.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 63.4 m . . . . . 0 C--O 1.248 1.0 0 C-N-CA 125.882 1.673 . . . . 0.0 111.17 -179.231 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.7 mttm . . . . . 0 C--O 1.23 0.061 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.477 ' HE2' ' CE1' ' A' ' 73' ' ' TYR . 32.5 mtpt -96.15 129.14 43.53 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 118.508 -0.758 . . . . 0.0 109.593 175.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.6 p -105.31 140.26 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 118.673 0.67 . . . . 0.0 109.456 171.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.7 tpp -115.58 141.78 47.61 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 169.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -117.62 135.67 53.83 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 169.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -138.28 118.42 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 120.38 1.446 . . . . 0.0 109.382 -170.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.0 t -115.12 163.68 15.28 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.367 0.985 . . . . 0.0 109.723 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -61.45 -21.37 64.08 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 118.129 -0.939 . . . . 0.0 112.821 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -131.77 -0.97 3.83 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 62.32 -48.48 0.17 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 127.595 2.358 . . . . 0.0 115.105 -169.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.7 m -31.11 -40.59 0.03 OUTLIER 'General case' 0 C--O 1.235 0.313 0 N-CA-C 119.542 3.164 . . . . 0.0 119.542 -168.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.7 m -127.45 -63.86 1.02 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.66 1.118 . . . . 0.0 111.405 -169.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -58.13 -50.73 72.49 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.254 0.933 . . . . 0.0 109.787 -171.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 m -69.07 -41.17 77.91 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 117.85 0.296 . . . . 0.0 110.854 -174.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -70.3 -41.27 73.57 Favored 'General case' 0 N--CA 1.463 0.175 0 O-C-N 121.599 -0.688 . . . . 0.0 110.881 -169.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 66.2 mtm -62.06 -41.85 98.58 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 118.082 0.401 . . . . 0.0 110.893 171.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.34 -33.65 69.77 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 118.931 -0.557 . . . . 0.0 110.951 175.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -59.21 -65.06 0.73 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.77 -39.5 77.06 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.015 -0.881 . . . . 0.0 112.549 -175.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -67.18 -45.01 78.23 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 119.274 1.537 . . . . 0.0 109.579 177.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.55 -43.6 93.43 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 120.372 1.442 . . . . 0.0 112.555 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.4 ptmt -69.18 -9.73 54.33 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.941 1.246 . . . . 0.0 113.1 175.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.4 m -92.81 -49.3 6.13 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 119.97 1.259 . . . . 0.0 110.618 170.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.4 mt -79.07 -39.91 32.61 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.352 1.461 . . . . 0.0 112.318 -169.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.343 0 CA-C-O 117.935 -1.481 . . . . 0.0 114.428 -169.058 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.3 pt . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 121.246 0.545 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -128.18 138.5 52.51 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 168.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -113.13 152.17 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-O 122.26 1.029 . . . . 0.0 113.412 -169.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.4 m -139.72 147.63 41.17 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 127.315 2.246 . . . . 0.0 105.123 167.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.3 m -132.21 146.71 52.2 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.831 1.252 . . . . 0.0 108.568 169.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 23.9 p -156.36 -161.79 1.17 Allowed 'General case' 0 C--O 1.242 0.666 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -176.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -151.66 156.96 26.97 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 169.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.3 tp -46.52 -36.87 7.19 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.979 1.712 . . . . 0.0 109.391 169.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -147.03 148.26 31.5 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 102.205 -3.257 . . . . 0.0 102.205 167.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.6 m -125.04 144.16 50.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.199 0.523 . . . . 0.0 112.284 -173.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.0 m -137.64 164.59 28.42 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.403 2.281 . . . . 0.0 107.551 173.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.93 145.62 1.44 Allowed 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.149 1.38 . . . . 0.0 113.232 -169.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.9 p -61.05 132.07 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 169.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -76.72 145.96 75.66 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.692 -172.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.17 -40.72 0.78 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 121.393 1.396 . . . . 0.0 112.534 -169.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.496 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 24.0 m -66.12 -17.07 64.48 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 120.044 -1.66 . . . . 0.0 111.864 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.68 -40.74 76.11 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 123.984 0.914 . . . . 0.0 110.836 170.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.0 mt -55.14 -52.19 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.18 -38.93 81.01 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 123.741 0.65 . . . . 0.0 111.917 -173.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.6 mmt -59.42 -49.84 76.26 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 122.403 1.097 . . . . 0.0 111.697 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.4 mtp -67.33 -36.15 80.86 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.164 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -61.75 -30.17 70.61 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.315 1.046 . . . . 0.0 111.295 174.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -64.13 -40.78 96.91 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.83 0.741 . . . . 0.0 110.336 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.1 t -75.2 -20.23 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.498 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.63 25.47 9.91 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.697 1.141 . . . . 0.0 111.332 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.4 mt -121.62 -178.33 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -146.51 151.73 37.83 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 120.457 -1.402 . . . . 0.0 109.694 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.6 pt -132.68 -3.96 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.405 1.082 . . . . 0.0 112.824 169.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 95.3 p -55.87 -30.62 61.82 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 120.187 1.358 . . . . 0.0 112.146 169.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.05 -7.43 87.6 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 118.729 -1.039 . . . . 0.0 114.087 -176.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.56 172.4 7.87 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.448 1.499 . . . . 0.0 111.16 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 16.8 p -129.46 157.62 41.48 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.368 1.067 . . . . 0.0 111.071 -170.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.6 p -68.21 156.67 37.09 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.717 1.207 . . . . 0.0 110.04 169.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -156.07 143.54 13.91 Favored Pre-proline 0 N--CA 1.469 0.5 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.038 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -81.32 150.4 17.37 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.835 2.357 . . . . 0.0 111.226 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.6 tt -55.27 -33.21 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.272 0.629 . . . . 0.0 111.362 173.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -56.92 -22.11 35.09 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.548 1.939 . . . . 0.0 112.418 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -79.46 -4.64 52.15 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.209 1.004 . . . . 0.0 112.85 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -128.13 177.91 6.59 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.768 1.167 . . . . 0.0 111.753 -175.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.03 140.14 52.84 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 127.183 2.193 . . . . 0.0 106.859 170.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.54 -23.0 60.93 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.115 0.966 . . . . 0.0 112.002 -177.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.86 -24.25 66.79 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.176 0.99 . . . . 0.0 112.472 -173.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -89.82 -15.16 32.9 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.033 0.933 . . . . 0.0 110.505 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.477 ' CE1' ' HE2' ' A' ' 3' ' ' LYS . 83.5 m-85 -86.69 141.62 28.79 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.901 1.281 . . . . 0.0 110.061 178.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -89.98 -34.84 15.85 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.151 0.98 . . . . 0.0 110.64 173.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -140.36 137.67 36.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -172.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.2 m -127.48 108.79 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 123.167 1.461 . . . . 0.0 109.39 -173.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.2 mm -104.26 96.67 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.3 t -71.17 157.0 38.91 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 167.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.21 52.37 0.43 Allowed 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 103.52 -2.77 . . . . 0.0 103.52 174.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 95.4 m . . . . . 0 C--O 1.232 0.147 0 C-N-CA 124.432 1.093 . . . . 0.0 110.153 176.628 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 CA--C 1.532 0.271 0 N-CA-C 114.703 1.372 . . . . 0.0 114.703 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -60.64 10.28 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.792 2.837 . . . . 0.0 114.427 172.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.2 p -128.02 18.61 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 124.623 1.169 . . . . 0.0 112.015 173.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 48.8 p -124.63 18.27 8.77 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -170.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -94.5 -174.9 3.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.52 1.528 . . . . 0.0 109.452 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -66.77 -34.98 79.02 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.57 -0.706 . . . . 0.0 112.506 -174.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.0 mt -134.71 136.58 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -174.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -137.61 138.14 39.22 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 169.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -146.92 159.98 42.88 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.659 1.583 . . . . 0.0 107.388 168.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -123.17 104.52 9.22 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.954 1.302 . . . . 0.0 108.744 169.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 41.9 m0 -80.71 88.72 5.76 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.996 0.918 . . . . 0.0 108.873 -177.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -62.71 104.49 0.54 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.47 1.108 . . . . 0.0 109.644 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -136.92 172.16 13.43 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 126.217 1.807 . . . . 0.0 108.511 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -70.78 158.89 35.55 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 166.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -112.48 109.28 53.74 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 169.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -53.31 1.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 1 C-N-CA 126.652 4.901 . . . . 0.0 119.514 -169.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -51.53 98.93 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.844 1.202 . . . . 0.0 112.094 174.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.23 18.23 63.11 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 126.197 1.856 . . . . 0.0 113.111 171.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -95.18 178.22 5.6 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.811 1.305 . . . . 0.0 111.876 -169.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.9 m -74.09 153.89 39.41 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.236 1.414 . . . . 0.0 109.96 176.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 82.2 mt -60.14 -28.75 68.14 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.762 -0.586 . . . . 0.0 111.843 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.42 -38.8 92.55 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.087 0.403 . . . . 0.0 110.789 174.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 86.7 t -68.49 -46.29 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.496 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 16.3 m-85 -52.98 -54.55 33.45 Favored 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 122.704 0.401 . . . . 0.0 110.561 175.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -59.66 -40.67 88.5 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.175 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.8 m -62.55 -52.29 64.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.432 1.014 . . . . 0.0 109.668 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.86 -45.83 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-O 118.181 -0.914 . . . . 0.0 109.475 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -55.85 -49.61 72.84 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.448 1.022 . . . . 0.0 109.303 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.64 -49.1 82.34 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-O 118.368 -1.24 . . . . 0.0 110.482 -176.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -60.71 -53.49 56.82 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-N 118.371 1.085 . . . . 0.0 110.812 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 68.5 t -52.88 -46.13 51.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 124.355 1.062 . . . . 0.0 110.2 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -63.54 -49.9 71.63 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 119.724 1.147 . . . . 0.0 110.523 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.09 -43.44 70.36 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.338 1.055 . . . . 0.0 110.526 175.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 81.5 mtt-85 -72.24 -41.25 67.04 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 117.74 -1.124 . . . . 0.0 110.074 -175.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.7 t -54.3 -49.0 66.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 120.629 1.559 . . . . 0.0 108.811 169.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -60.17 -39.85 87.88 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.29 0.95 . . . . 0.0 110.883 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -63.65 -45.48 89.98 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.309 1.043 . . . . 0.0 110.257 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -46.09 89.31 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 123.829 0.852 . . . . 0.0 109.645 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 64.1 mt -60.07 -38.07 75.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.672 1.189 . . . . 0.0 110.921 175.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.69 -31.72 71.88 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 120.139 1.336 . . . . 0.0 111.295 -174.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -69.7 -20.46 63.54 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.596 1.558 . . . . 0.0 113.023 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.7 pt -125.01 -21.21 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -168.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 C--O 1.251 1.134 0 C-N-CA 126.391 1.876 . . . . 0.0 111.124 173.746 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.467 0.386 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -93.08 128.22 38.9 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 169.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.4 p -113.0 136.74 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 123.477 0.711 . . . . 0.0 109.565 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 35.9 tpp -112.93 141.34 46.88 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 170.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -117.47 136.0 53.52 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 169.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.1 t -138.87 131.03 37.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -174.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.23 165.9 18.09 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 120.116 1.325 . . . . 0.0 109.971 169.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -62.74 -10.81 14.05 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.6 ptm85 -153.93 114.27 3.95 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 103.168 -2.901 . . . . 0.0 103.168 169.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -51.83 -25.6 8.13 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.327 1.851 . . . . 0.0 113.25 -176.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.4 p -40.05 -36.87 0.53 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 118.42 2.748 . . . . 0.0 118.42 -168.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.0 p -137.55 -54.52 0.68 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 -169.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -64.59 -51.93 60.16 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 122.221 2.282 . . . . 0.0 108.863 -169.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 82.2 p -70.31 -39.04 75.06 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -170.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -55.89 -50.57 70.3 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.184 0.993 . . . . 0.0 111.096 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 60.0 mtm -64.18 -46.21 84.96 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 117.489 0.132 . . . . 0.0 110.709 178.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.78 -39.49 71.32 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 119.524 -0.274 . . . . 0.0 110.508 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -65.55 -45.35 83.73 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 119.434 -0.317 . . . . 0.0 111.137 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.38 -41.79 99.74 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -65.39 -49.05 70.76 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 117.997 0.899 . . . . 0.0 109.107 174.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.32 -43.15 88.08 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.169 0.895 . . . . 0.0 112.391 -172.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -69.37 -36.56 76.96 Favored 'General case' 0 C--O 1.219 -0.546 0 C-N-CA 118.991 -1.083 . . . . 0.0 110.946 175.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 52.2 m -67.19 -42.48 84.11 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 120.762 1.619 . . . . 0.0 110.495 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.3 mt -77.16 -37.63 53.45 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.38 1.472 . . . . 0.0 111.423 -174.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.702 0 CA-C-O 116.578 -2.234 . . . . 0.0 117.441 -169.116 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.2 pt . . . . . 0 C--O 1.234 0.269 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.73 127.84 53.22 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 105.472 -2.048 . . . . 0.0 105.472 169.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 p -112.17 150.87 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -173.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.1 m -141.03 144.28 34.9 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 126.012 1.725 . . . . 0.0 107.452 168.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.8 p -117.11 152.73 34.1 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.816 1.646 . . . . 0.0 109.003 168.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 32.1 p -158.14 -165.01 1.61 Allowed 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 176.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.47 160.05 28.31 Favored Glycine 0 CA--C 1.503 -0.68 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 169.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.3 tp -47.51 -35.66 9.15 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.369 1.468 . . . . 0.0 109.758 169.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -142.07 144.14 33.43 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 168.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.2 p -73.75 155.74 38.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.75 0.786 . . . . 0.0 110.885 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 67.5 m -159.19 150.57 20.26 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.513 1.925 . . . . 0.0 106.018 169.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.7 ttt-85 -49.08 146.94 3.16 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.876 1.271 . . . . 0.0 110.831 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.6 t -57.32 129.34 19.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.519 -1.659 . . . . 0.0 106.519 169.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -71.66 137.32 83.06 Favored Pre-proline 0 N--CA 1.444 -0.747 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -72.95 -38.64 2.77 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.04 1.16 . . . . 0.0 111.66 -169.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.423 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 20.6 m -64.4 -24.69 67.72 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.737 -1.227 . . . . 0.0 111.571 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.04 -39.38 66.13 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 121.574 -0.704 . . . . 0.0 111.193 175.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.5 mt -55.86 -46.03 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.26 -40.22 93.67 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 123.99 0.916 . . . . 0.0 110.065 -170.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.9 mmm -67.14 -43.0 83.48 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 122.672 1.225 . . . . 0.0 110.685 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.407 ' SD ' HG12 ' A' ' 57' ' ' ILE . 9.4 mtp -65.42 -34.92 79.43 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.375 -0.828 . . . . 0.0 109.863 174.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.65 -30.53 68.8 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.717 0.69 . . . . 0.0 111.217 173.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -66.69 -38.1 86.08 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.192 0.451 . . . . 0.0 109.879 176.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 64.3 t -77.28 -24.66 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.612 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.13 26.03 5.89 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.161 1.362 . . . . 0.0 111.75 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.7 mt -124.79 178.34 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 125.091 1.357 . . . . 0.0 107.476 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -142.23 156.43 45.3 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.514 1.526 . . . . 0.0 109.301 -177.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.407 HG12 ' SD ' ' A' ' 50' ' ' MET . 0.1 OUTLIER -129.06 -15.2 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.041 0.936 . . . . 0.0 112.634 170.505 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -44.62 -37.39 3.6 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.785 1.234 . . . . 0.0 112.715 172.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.95 -7.7 84.22 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.664 1.126 . . . . 0.0 114.384 -174.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -125.77 168.39 13.87 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.244 1.522 . . . . 0.0 110.667 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.0 p -129.36 169.37 14.97 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.207 1.003 . . . . 0.0 111.374 -169.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 54.7 m -89.61 159.66 17.04 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.17 0.988 . . . . 0.0 111.044 174.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -157.91 140.38 10.47 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.954 1.301 . . . . 0.0 108.875 -172.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.52 148.05 32.84 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.562 1.508 . . . . 0.0 110.417 -177.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.7 tt -52.15 -35.03 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 123.878 0.871 . . . . 0.0 111.559 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -58.05 -22.21 49.09 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.455 1.902 . . . . 0.0 112.316 -175.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -80.43 -7.01 58.97 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.343 1.057 . . . . 0.0 112.835 -177.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -125.02 179.86 4.85 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.575 1.08 . . . . 0.0 111.06 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.44 139.62 52.26 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 127.085 2.154 . . . . 0.0 107.254 171.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.62 -24.09 66.26 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.97 1.308 . . . . 0.0 111.891 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -60.18 -23.88 64.32 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.008 0.923 . . . . 0.0 112.45 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -83.54 -13.11 55.24 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.036 0.934 . . . . 0.0 110.785 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -107.23 128.0 54.03 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 125.743 1.617 . . . . 0.0 109.208 -174.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -77.17 -34.8 56.29 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.1 p -132.55 137.65 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 123.385 0.674 . . . . 0.0 109.524 -175.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.88 129.04 60.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 122.548 1.166 . . . . 0.0 109.94 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.5 mm -124.06 101.3 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -170.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.7 m -73.74 154.17 39.72 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 168.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.62 45.36 1.03 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 177.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 99.1 m . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 117.744 -1.122 . . . . 0.0 112.046 -169.535 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -61.63 1.11 0.26 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.122 1.769 . . . . 0.0 113.572 170.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.9 p -121.6 6.23 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.494 1.118 . . . . 0.0 112.019 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 82.8 p -127.48 22.38 6.47 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.355 0.98 . . . . 0.0 112.718 -172.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -89.28 -177.33 5.36 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.432 0.693 . . . . 0.0 109.922 173.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -64.0 -31.79 73.11 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.131 0.573 . . . . 0.0 112.525 -171.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.3 mt -135.84 134.36 51.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -141.04 138.12 33.4 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 169.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -145.26 157.19 44.12 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.03 1.332 . . . . 0.0 107.968 168.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -120.94 102.92 8.67 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.1 1.36 . . . . 0.0 109.177 169.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 39.8 m0 -78.88 93.79 5.08 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.877 1.671 . . . . 0.0 108.927 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -65.99 107.22 1.81 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -129.41 157.67 41.31 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 125.712 1.605 . . . . 0.0 109.906 -175.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -82.48 61.09 5.46 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.419 1.488 . . . . 0.0 112.126 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 53.1 t0 4.11 83.27 0.04 OUTLIER Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 129.603 3.161 . . . . 0.0 113.424 169.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -60.06 -5.93 4.4 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 123.174 2.583 . . . . 0.0 117.491 -169.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -60.23 90.78 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.728 1.211 . . . . 0.0 111.86 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.89 15.08 27.43 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 126.283 1.896 . . . . 0.0 113.376 173.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -91.94 179.05 5.71 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.013 1.407 . . . . 0.0 112.866 -169.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 41.5 m -75.54 155.7 35.81 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.563 1.545 . . . . 0.0 109.988 175.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.77 -33.39 70.24 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.944 -0.473 . . . . 0.0 111.563 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.28 -39.18 93.4 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.577 0.351 . . . . 0.0 110.764 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 99.2 t -66.08 -47.55 84.53 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 175.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.423 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 7.2 m-85 -54.76 -51.38 65.86 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.006 0.522 . . . . 0.0 111.026 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 24.0 mtt180 -60.29 -42.77 96.15 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.473 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 88.9 m -62.18 -55.16 31.43 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.4 t -61.01 -43.08 95.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 118.855 -0.593 . . . . 0.0 110.312 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.76 -45.19 93.01 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 119.396 0.998 . . . . 0.0 110.374 -177.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.42 -46.5 90.31 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -63.85 -46.39 85.24 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.988 0.915 . . . . 0.0 111.186 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.0 t -56.77 -51.71 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 125.65 1.58 . . . . 0.0 110.228 171.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -58.4 -45.35 88.53 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.114 0.87 . . . . 0.0 110.366 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -55.67 -45.88 77.67 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.9 0.88 . . . . 0.0 109.254 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.4 mtt85 -70.38 -39.05 74.79 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-O 118.086 -0.959 . . . . 0.0 110.782 -174.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.5 t -54.81 -48.56 73.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 120.373 1.442 . . . . 0.0 109.594 169.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -60.85 -40.33 92.48 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 119.625 1.102 . . . . 0.0 110.858 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -61.21 -46.46 90.36 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.259 1.424 . . . . 0.0 109.945 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.32 -48.43 73.08 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 124.011 0.925 . . . . 0.0 110.08 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 45.8 mt -55.31 -38.99 50.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.751 1.22 . . . . 0.0 110.631 174.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.37 -30.73 70.72 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.772 1.169 . . . . 0.0 111.237 -173.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -72.78 -20.79 61.1 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.691 1.596 . . . . 0.0 112.638 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.0 pt -123.37 -22.36 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -168.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 C--O 1.251 1.159 0 C-N-CA 126.181 1.792 . . . . 0.0 111.194 175.854 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt . . . . . 0 N--CA 1.464 0.261 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.4 mttt -95.33 136.28 35.88 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 121.7 -0.625 . . . . 0.0 109.491 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.5 t -121.2 127.22 75.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -173.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 42.2 tpp -110.89 141.01 44.87 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 169.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -109.85 130.52 55.51 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 169.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.4 t -132.23 119.0 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 120.447 1.476 . . . . 0.0 109.141 -169.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.1 t -124.7 159.27 31.24 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.969 1.258 . . . . 0.0 110.704 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.2 mttm -58.49 -12.81 4.34 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.189 0.995 . . . . 0.0 113.115 169.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -138.6 -12.13 1.34 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 173.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 64.52 -43.82 0.3 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.744 2.418 . . . . 0.0 114.599 -169.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.0 m -40.25 -23.58 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 121.028 3.714 . . . . 0.0 121.028 -168.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 23.6 m -140.99 -62.84 0.47 Allowed 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 120.443 1.474 . . . . 0.0 111.174 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -59.79 -50.36 74.13 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.669 0.668 . . . . 0.0 109.583 -169.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.43 -43.81 69.17 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.389 0.276 . . . . 0.0 111.178 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -59.89 -46.4 89.44 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.69 0.796 . . . . 0.0 111.359 -174.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 56.6 mtm -67.71 -45.63 74.52 Favored 'General case' 0 C--O 1.231 0.114 0 O-C-N 122.276 -0.265 . . . . 0.0 110.551 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.48 -38.29 71.52 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 122.281 0.232 . . . . 0.0 111.053 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -64.91 -55.87 16.71 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 118.448 -0.787 . . . . 0.0 110.372 178.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -52.04 -40.25 50.75 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 119.481 -0.622 . . . . 0.0 112.149 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -64.9 -51.12 63.65 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 118.717 1.258 . . . . 0.0 110.266 173.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.6 -44.78 89.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 119.708 1.14 . . . . 0.0 112.88 -174.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -70.19 -9.69 56.53 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 119.732 1.151 . . . . 0.0 113.281 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.5 m -92.57 -48.2 6.73 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 119.892 1.224 . . . . 0.0 110.423 169.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.0 mt -77.49 -43.55 31.82 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.881 1.672 . . . . 0.0 112.073 -169.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.353 0 CA-C-O 118.038 -1.423 . . . . 0.0 114.923 -169.089 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.7 pt . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 121.564 0.697 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -123.63 133.24 53.96 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 104.381 -2.452 . . . . 0.0 104.381 169.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.4 p -118.45 155.28 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-O 121.88 0.848 . . . . 0.0 112.541 -169.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.8 m -148.26 152.72 37.63 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.915 1.686 . . . . 0.0 107.216 167.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.3 p -118.35 153.35 34.16 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.53 1.132 . . . . 0.0 108.535 168.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 23.4 p -152.43 -169.99 3.51 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 173.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.92 163.12 30.79 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 169.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.7 mt -58.5 -32.24 68.62 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.971 0.508 . . . . 0.0 110.601 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -142.45 132.76 24.86 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 103.623 -2.732 . . . . 0.0 103.623 168.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.3 p -76.24 149.97 37.09 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.951 0.5 . . . . 0.0 111.084 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.1 m -147.52 158.45 44.0 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.081 2.152 . . . . 0.0 106.513 169.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.04 144.8 11.32 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.922 0.889 . . . . 0.0 110.905 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.6 p -65.11 138.42 23.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 169.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -83.38 149.48 58.14 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 123.479 0.711 . . . . 0.0 109.607 -174.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -81.86 -38.76 0.2 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 121.562 1.508 . . . . 0.0 112.907 -169.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.418 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 28.5 m -62.76 -27.23 69.14 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.297 1.408 . . . . 0.0 111.24 -177.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.28 -44.24 22.99 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.019 0.928 . . . . 0.0 111.175 171.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 52.3 mt -55.93 -45.52 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 C-N-CA 124.287 1.035 . . . . 0.0 108.291 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.47 -34.25 77.77 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.28 1.032 . . . . 0.0 110.104 -172.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 8.1 mmm -70.66 -41.49 72.02 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-O 122.547 1.165 . . . . 0.0 110.386 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.405 ' HG3' ' CG1' ' A' ' 57' ' ' ILE . 87.2 mmm -62.9 -41.13 99.33 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -61.63 -25.66 67.5 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.291 0.636 . . . . 0.0 111.096 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -65.61 -42.24 91.84 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 118.652 0.66 . . . . 0.0 110.094 171.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.3 t -76.22 -25.78 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.78 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.66 23.2 6.33 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.454 1.502 . . . . 0.0 111.958 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.4 mt -121.42 177.44 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 125.742 1.617 . . . . 0.0 107.693 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -143.9 157.51 44.31 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.484 1.513 . . . . 0.0 109.957 -176.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.405 ' CG1' ' HG3' ' A' ' 50' ' ' MET . 0.6 OUTLIER -130.45 -17.78 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.153 0.981 . . . . 0.0 111.983 169.607 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -42.58 -38.18 1.9 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.959 1.304 . . . . 0.0 113.292 173.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.0 -10.75 68.94 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 118.551 -1.138 . . . . 0.0 114.033 -175.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -123.99 168.75 12.41 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 119.181 1.491 . . . . 0.0 112.641 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.2 p -127.37 -176.05 3.62 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 126.526 1.931 . . . . 0.0 109.679 -174.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.7 p -113.56 158.95 20.12 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.284 1.433 . . . . 0.0 110.908 -175.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -151.22 149.9 25.84 Favored Pre-proline 0 N--CA 1.467 0.409 0 C-N-CA 124.218 1.007 . . . . 0.0 109.827 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.47 150.87 19.64 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.977 2.451 . . . . 0.0 110.617 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.2 tt -52.24 -36.22 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.766 1.226 . . . . 0.0 110.756 172.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -58.17 -25.55 61.64 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.838 1.655 . . . . 0.0 112.884 -171.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.81 -9.74 45.34 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -176.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -98.97 -174.45 2.77 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.371 0.987 . . . . 0.0 110.127 175.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.6 128.41 20.49 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 126.841 2.056 . . . . 0.0 106.941 175.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.92 -27.24 66.58 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.898 0.879 . . . . 0.0 111.969 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -60.28 -23.55 64.24 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.237 1.015 . . . . 0.0 112.644 -175.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -84.65 -16.55 41.55 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.101 0.56 . . . . 0.0 110.761 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -109.1 112.89 25.31 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 125.354 1.462 . . . . 0.0 108.323 -172.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -76.44 -21.6 55.71 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.328 0.585 . . . . 0.0 109.673 -176.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.1 t -133.98 134.83 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 125.803 1.641 . . . . 0.0 107.229 -172.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -137.36 119.39 19.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 123.023 1.392 . . . . 0.0 109.726 -176.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.2 mm -112.74 94.13 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 66.9 m -72.4 157.34 37.83 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 167.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.87 50.61 0.67 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 74.7 m . . . . . 0 N--CA 1.452 -0.334 0 C-N-CA 124.431 1.092 . . . . 0.0 108.89 171.964 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 . . . . . 0 N--CA 1.472 0.632 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -61.87 0.05 0.42 Allowed 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 126.024 1.73 . . . . 0.0 112.378 169.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.6 m -114.33 5.17 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 120.376 1.444 . . . . 0.0 112.46 170.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.8 p -120.98 21.99 11.18 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.979 0.911 . . . . 0.0 111.716 -177.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -90.52 -178.99 5.46 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.375 1.07 . . . . 0.0 109.382 171.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.56 -36.42 82.61 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.719 0.808 . . . . 0.0 112.922 -169.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.9 mt -133.16 134.77 57.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -141.63 136.92 31.45 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.355 1.062 . . . . 0.0 108.835 172.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -146.47 159.51 43.31 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.822 1.649 . . . . 0.0 107.68 168.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -124.55 92.47 3.66 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.182 1.393 . . . . 0.0 109.045 169.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -66.01 141.54 58.14 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.746 0.819 . . . . 0.0 110.891 -176.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -110.71 92.03 3.89 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.845 1.258 . . . . 0.0 107.689 -170.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -131.1 149.68 52.49 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.679 1.592 . . . . 0.0 109.107 -170.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -84.47 56.81 3.98 Favored 'General case' 0 C--O 1.228 -0.072 0 C-N-CA 126.37 1.868 . . . . 0.0 112.05 -172.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.3 t0 5.94 82.35 0.04 OUTLIER Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 129.903 3.281 . . . . 0.0 113.977 169.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -54.5 -13.86 6.2 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 125.271 3.981 . . . . 0.0 118.633 -169.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.29 90.17 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 120.3 1.409 . . . . 0.0 111.925 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.85 6.69 26.25 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 126.282 1.896 . . . . 0.0 113.164 174.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -89.67 -178.5 5.55 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.81 1.305 . . . . 0.0 112.056 -169.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.0 m -78.98 156.96 28.24 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.971 1.308 . . . . 0.0 109.909 173.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 70.4 mt -59.79 -32.9 71.05 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 122.086 -0.384 . . . . 0.0 111.498 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -61.21 -39.9 91.96 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.376 0.534 . . . . 0.0 110.622 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.7 t -67.25 -46.57 83.72 Favored 'Isoleucine or valine' 0 C--N 1.338 0.086 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.418 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 11.7 m-85 -53.98 -52.57 60.29 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 122.608 0.363 . . . . 0.0 110.729 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.1 mtp180 -64.18 -40.91 97.1 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 118.511 -0.756 . . . . 0.0 111.09 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.5 m -63.37 -52.53 61.32 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.75 -42.74 95.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.216 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.79 -44.3 90.71 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-N 120.277 1.399 . . . . 0.0 110.365 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.84 -49.35 76.76 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -61.56 -44.9 96.19 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.266 1.033 . . . . 0.0 111.869 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.5 t -58.59 -50.05 80.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 125.606 1.562 . . . . 0.0 109.806 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -58.49 -45.78 88.02 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 119.478 1.035 . . . . 0.0 110.119 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.59 -43.6 80.24 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.307 1.043 . . . . 0.0 110.345 176.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 46.3 mtt85 -71.61 -40.9 69.52 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-O 117.965 -1.017 . . . . 0.0 111.088 -177.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.0 t -54.47 -48.22 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 120.505 1.502 . . . . 0.0 109.499 169.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -60.05 -40.13 88.34 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.4 1.0 . . . . 0.0 110.615 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -62.2 -45.74 92.02 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.244 1.018 . . . . 0.0 110.347 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.1 -47.45 82.79 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.012 0.925 . . . . 0.0 109.834 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 61.5 mt -58.88 -37.88 69.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 124.607 1.163 . . . . 0.0 110.491 176.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.79 -29.67 69.59 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.941 1.246 . . . . 0.0 111.486 -174.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 41.7 mttm -73.52 -19.57 60.88 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.974 1.71 . . . . 0.0 112.93 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.2 pt -125.95 -20.27 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.895 1.678 . . . . 0.0 114.941 -168.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.9 m . . . . . 0 C--O 1.251 1.16 0 C-N-CA 126.457 1.903 . . . . 0.0 110.886 169.883 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.467 0.392 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -102.46 117.99 35.91 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 72.9 t -97.37 137.94 23.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 125.517 1.527 . . . . 0.0 108.128 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 35.5 tpp -126.01 143.64 51.02 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 169.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -114.02 133.23 55.64 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 169.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.3 t -136.26 122.15 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 120.065 1.302 . . . . 0.0 108.551 -169.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.0 t -129.9 163.6 26.0 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.146 0.885 . . . . 0.0 111.288 -173.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -59.49 -21.96 60.89 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 118.202 -0.904 . . . . 0.0 112.303 169.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -138.01 -9.68 1.55 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 116.18 1.918 . . . . 0.0 116.18 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 61.99 -43.1 0.16 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 128.346 2.659 . . . . 0.0 115.872 -174.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.7 p -35.16 -38.99 0.1 Allowed 'General case' 0 C--O 1.233 0.228 0 C-N-CA 129.596 3.159 . . . . 0.0 118.499 -168.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.4 p -133.13 -59.94 0.87 Allowed 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 118.757 -0.639 . . . . 0.0 111.129 -169.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.0 mtm180 -58.32 -56.73 18.27 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -171.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.6 -42.64 77.87 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.516 0.327 . . . . 0.0 111.063 -177.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -60.37 -45.86 92.02 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.65 0.78 . . . . 0.0 111.423 -174.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 49.4 mtm -62.3 -46.41 88.87 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 110.494 -0.187 . . . . 0.0 110.494 175.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.16 -39.15 78.1 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 119.742 -0.17 . . . . 0.0 111.062 -178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -63.69 -45.88 88.02 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.47 0.708 . . . . 0.0 110.422 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.24 -44.55 97.54 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -65.55 -47.33 76.23 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 118.624 1.212 . . . . 0.0 108.75 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.81 -43.18 85.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 119.366 0.985 . . . . 0.0 112.372 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -76.25 -2.35 30.98 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 119.047 0.84 . . . . 0.0 113.159 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.0 m -96.9 -45.64 6.54 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 121.301 -0.874 . . . . 0.0 109.445 169.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 91.8 mt -74.05 -41.03 62.38 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.96 1.704 . . . . 0.0 111.151 -171.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.84 0 CA-C-O 117.971 -1.46 . . . . 0.0 115.631 -169.818 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.8 pt . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -118.3 134.71 54.8 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 169.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.5 p -123.64 152.55 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-O 121.439 0.637 . . . . 0.0 112.061 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.3 m -144.35 161.88 37.87 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.944 1.298 . . . . 0.0 108.131 169.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 94.1 p -126.71 155.95 41.87 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 124.901 1.28 . . . . 0.0 109.107 168.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.3 p -154.51 -165.87 2.19 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 174.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.55 163.75 33.68 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 169.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.1 mt -52.08 -31.76 31.83 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.267 1.027 . . . . 0.0 110.237 174.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -148.01 145.67 28.61 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 168.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.5 p -79.03 161.68 26.43 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.579 0.704 . . . . 0.0 111.313 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.6 m -157.0 166.06 34.42 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.417 1.887 . . . . 0.0 107.284 169.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.1 ptt-85 -51.96 143.35 13.83 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.653 1.181 . . . . 0.0 110.728 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 56.0 t -63.4 130.34 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 168.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -70.63 138.78 86.0 Favored Pre-proline 0 N--CA 1.448 -0.555 0 CA-C-O 118.771 -0.633 . . . . 0.0 109.615 -174.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.18 -40.12 1.84 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 121.074 1.183 . . . . 0.0 111.471 -172.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.482 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 11.2 m -67.67 -18.08 64.82 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 120.488 -1.382 . . . . 0.0 111.916 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.21 -39.43 78.99 Favored 'General case' 0 C--N 1.339 0.116 0 O-C-N 121.275 -0.89 . . . . 0.0 110.63 171.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.4 mt -57.8 -46.15 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.54 -40.97 96.6 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.531 0.732 . . . . 0.0 112.036 -176.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.5 mmt -58.5 -49.15 78.42 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 122.558 1.17 . . . . 0.0 111.302 177.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.1 mtp -68.82 -36.26 77.99 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.651 -1.158 . . . . 0.0 108.899 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -62.46 -28.96 70.18 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.18 0.592 . . . . 0.0 111.514 173.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -64.25 -39.67 94.42 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.02 0.827 . . . . 0.0 110.176 173.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.0 t -78.58 -23.98 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 119.743 -0.17 . . . . 0.0 110.766 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.46 24.95 6.52 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.913 1.245 . . . . 0.0 111.882 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.1 mt -122.72 -178.23 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 C-N-CA 125.938 1.695 . . . . 0.0 106.821 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -147.93 156.12 42.32 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 120.438 -1.414 . . . . 0.0 109.909 -176.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.79 -16.38 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.277 1.031 . . . . 0.0 112.227 169.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.7 p -51.86 -31.39 27.74 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.707 1.139 . . . . 0.0 112.451 177.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.84 -6.28 88.59 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.814 1.197 . . . . 0.0 114.366 -177.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -125.77 168.65 13.51 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.369 1.584 . . . . 0.0 110.824 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.7 p -128.0 170.92 12.34 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.063 0.945 . . . . 0.0 111.372 -171.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.6 p -85.62 162.99 18.59 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.188 1.395 . . . . 0.0 111.06 175.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -157.89 145.15 13.44 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 123.775 0.83 . . . . 0.0 109.345 -178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -81.32 153.71 18.53 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.26 1.973 . . . . 0.0 110.936 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.4 tt -55.04 -34.03 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 123.706 0.802 . . . . 0.0 111.123 175.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -57.52 -23.22 49.0 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.369 1.867 . . . . 0.0 112.402 -174.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -85.17 -3.65 58.88 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.864 0.866 . . . . 0.0 112.819 -175.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -124.95 -174.25 2.99 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.426 1.09 . . . . 0.0 110.833 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.39 128.17 20.42 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.849 2.059 . . . . 0.0 107.63 175.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.84 -26.86 64.57 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.08 0.952 . . . . 0.0 112.554 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -59.42 -23.39 62.6 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.088 0.955 . . . . 0.0 112.488 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -83.67 -14.76 51.06 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.39 0.676 . . . . 0.0 110.799 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -108.32 120.36 42.15 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 125.704 1.602 . . . . 0.0 109.079 -172.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -75.25 -30.81 60.62 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.374 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.52 130.13 62.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -173.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.0 m -127.73 115.29 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 123.618 1.675 . . . . 0.0 109.855 -174.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.0 mm -110.22 101.78 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -175.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.7 t -72.7 155.41 40.01 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 168.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.18 50.8 0.72 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 171.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 85.4 m . . . . . 0 CA--C 1.534 0.346 0 C-N-CA 123.45 0.7 . . . . 0.0 110.947 174.601 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -63.65 6.28 0.16 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 126.324 1.85 . . . . 0.0 112.593 169.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 p -117.85 2.18 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 125.23 1.412 . . . . 0.0 111.505 172.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.8 p -127.72 24.05 6.17 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.124 -0.985 . . . . 0.0 112.292 -172.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -90.55 -176.73 4.84 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.324 0.65 . . . . 0.0 109.26 169.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -66.13 -32.14 73.42 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -169.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.0 mt -134.11 132.38 55.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -177.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -140.1 138.21 35.11 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.143 0.977 . . . . 0.0 108.856 174.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -146.65 159.44 43.46 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.152 1.381 . . . . 0.0 107.762 168.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -122.05 113.43 19.53 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.879 1.272 . . . . 0.0 108.622 168.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 40.0 m0 -87.4 97.1 10.63 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -62.03 118.88 7.89 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 169.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 60.0 mt -150.21 150.57 31.77 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.236 1.415 . . . . 0.0 107.794 -169.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.8 mp0 -83.12 57.32 3.88 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.819 1.648 . . . . 0.0 111.999 -173.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.9 t70 2.76 85.53 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 129.377 3.071 . . . . 0.0 114.486 173.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -60.13 -8.01 7.47 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.523 2.815 . . . . 0.0 117.411 -169.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -55.36 100.72 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 120.528 1.513 . . . . 0.0 111.811 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.24 18.32 43.13 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 126.482 1.991 . . . . 0.0 113.382 171.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -98.31 177.01 5.51 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.012 1.406 . . . . 0.0 113.234 -169.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 37.7 m -75.77 154.77 36.09 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.987 1.715 . . . . 0.0 110.081 175.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 71.1 mt -59.14 -31.34 68.87 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 121.812 -0.555 . . . . 0.0 111.899 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.7 mp0 -62.3 -41.07 98.21 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.417 0.687 . . . . 0.0 110.387 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.63 -43.4 86.87 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.482 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 14.3 m-85 -55.68 -52.44 63.84 Favored 'General case' 0 N--CA 1.458 -0.069 0 CA-C-O 118.683 -0.675 . . . . 0.0 110.752 175.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 72.9 mtp85 -59.54 -41.5 90.19 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.248 0.931 . . . . 0.0 111.758 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.9 m -61.04 -46.7 89.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 118.682 0.674 . . . . 0.0 110.039 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.4 t -70.46 -42.97 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 117.79 -1.1 . . . . 0.0 110.257 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.9 ttp180 -56.34 -44.85 80.43 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 119.923 1.238 . . . . 0.0 109.48 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.04 -48.8 84.32 Favored Glycine 0 CA--C 1.521 0.426 0 CA-C-O 118.702 -1.055 . . . . 0.0 110.69 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -59.8 -55.55 32.83 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 118.113 0.956 . . . . 0.0 110.182 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.7 t -48.17 -53.91 5.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.698 1.599 . . . . 0.0 110.234 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -63.55 -47.51 81.28 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 119.412 1.006 . . . . 0.0 110.221 -172.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -53.98 -45.27 71.35 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.654 0.781 . . . . 0.0 109.8 174.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 78.0 mtt-85 -71.46 -37.61 71.36 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.173 -173.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 96.2 t -56.44 -48.37 80.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 120.726 1.603 . . . . 0.0 109.242 168.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -60.54 -35.29 75.64 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.259 0.936 . . . . 0.0 110.598 177.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -65.2 -45.16 85.86 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.445 1.498 . . . . 0.0 110.414 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.24 -44.47 88.06 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 123.204 0.602 . . . . 0.0 110.372 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 86.4 mt -56.6 -36.9 49.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 124.286 1.034 . . . . 0.0 109.861 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.27 -35.46 77.92 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 120.363 1.438 . . . . 0.0 111.094 -177.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -59.03 -52.44 65.74 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.604 0.762 . . . . 0.0 110.37 174.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pt -80.1 -39.01 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.657 1.183 . . . . 0.0 112.517 -171.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . 0.259 6.0 p . . . . . 0 C--O 1.25 1.084 0 C-N-CA 130.744 3.617 . . . . 0.0 114.003 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -106.37 106.7 17.34 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 123.974 0.91 . . . . 0.0 109.725 178.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 57.2 t -85.41 139.7 17.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 125.934 1.694 . . . . 0.0 109.218 176.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 20.1 tpp -127.13 145.96 50.55 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.242 0.617 . . . . 0.0 109.59 169.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -120.47 120.77 36.86 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.825 1.65 . . . . 0.0 108.492 171.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.6 t -128.4 141.79 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.939 1.296 . . . . 0.0 109.263 -169.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 28.4 p -152.65 -170.61 3.68 Favored 'General case' 0 C--O 1.222 -0.354 0 O-C-N 120.976 -1.078 . . . . 0.0 112.869 -169.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -80.87 -24.96 37.99 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.321 1.048 . . . . 0.0 112.915 169.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -159.83 108.77 1.78 Allowed 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 -173.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -54.07 -17.51 2.76 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.525 1.53 . . . . 0.0 113.567 -173.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -38.93 -47.18 1.41 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 127.859 2.464 . . . . 0.0 117.177 -169.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.0 p -132.32 -77.32 0.5 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 116.009 -1.948 . . . . 0.0 114.561 -168.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.2 -49.14 33.92 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 121.601 2.0 . . . . 0.0 111.246 -168.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.77 -48.61 71.24 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.825 1.65 . . . . 0.0 110.709 -174.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -64.97 -42.02 94.94 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 124.541 1.136 . . . . 0.0 111.338 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 63.2 mtp -60.71 -48.78 80.24 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.27 1.028 . . . . 0.0 108.913 175.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.06 -41.04 87.0 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 122.968 0.507 . . . . 0.0 111.132 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -62.4 -45.23 94.07 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.505 0.722 . . . . 0.0 110.016 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.01 -45.2 97.1 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.448 -0.64 . . . . 0.0 111.645 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -65.26 -52.13 56.34 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 118.661 1.23 . . . . 0.0 108.58 175.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.01 -42.76 76.91 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.416 1.086 . . . . 0.0 112.508 -173.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -70.23 -35.54 73.91 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 118.791 0.723 . . . . 0.0 110.111 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.9 m -67.17 -43.27 82.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 119.521 -1.987 . . . . 0.0 110.504 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.6 mt -71.52 -39.94 70.43 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.071 1.748 . . . . 0.0 110.78 -174.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.844 0 CA-C-O 116.725 -2.153 . . . . 0.0 118.284 -169.479 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.5 pt . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.99 139.67 50.39 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 169.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 p -131.59 148.64 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.2 0.524 . . . . 0.0 111.871 -175.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 m -142.14 160.69 39.74 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.069 170.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 91.7 p -129.23 157.39 41.98 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.067 1.347 . . . . 0.0 108.265 168.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.4 p -153.04 -164.82 2.02 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.93 159.63 29.15 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 169.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 75.0 mt -52.5 -28.87 22.22 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.241 1.417 . . . . 0.0 110.556 172.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -144.57 146.58 32.41 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 168.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.1 p -72.1 159.25 34.46 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.94 0.896 . . . . 0.0 111.439 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.2 p -153.85 165.3 36.5 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.582 1.953 . . . . 0.0 106.904 170.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -66.09 154.16 40.35 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 120.896 -1.127 . . . . 0.0 109.556 172.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.4 t -62.46 132.75 28.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 169.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -74.14 140.4 76.7 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -75.3 -41.32 0.63 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.277 1.318 . . . . 0.0 112.124 -169.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.439 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 27.7 m -63.41 -25.34 68.23 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.536 -1.352 . . . . 0.0 111.576 -178.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.95 -39.44 59.24 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.467 0.707 . . . . 0.0 111.541 173.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.6 mt -56.2 -45.78 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.68 -38.25 88.75 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.265 1.026 . . . . 0.0 110.09 -170.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.3 mmm -69.84 -44.1 70.59 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 122.751 1.263 . . . . 0.0 110.569 -177.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.3 mtp -65.03 -36.15 83.45 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.482 -0.761 . . . . 0.0 109.683 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -63.25 -25.99 68.58 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.243 0.617 . . . . 0.0 111.417 174.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -66.26 -39.63 89.59 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.873 0.76 . . . . 0.0 109.817 173.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.3 t -76.96 -24.93 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.636 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.82 26.44 5.81 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.008 1.29 . . . . 0.0 111.67 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.2 mt -122.67 177.32 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 125.194 1.398 . . . . 0.0 107.252 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -142.16 156.43 45.35 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.107 1.363 . . . . 0.0 109.421 -177.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.48 -16.96 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 123.781 0.832 . . . . 0.0 112.27 169.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -45.2 -39.08 5.89 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.679 1.192 . . . . 0.0 112.791 173.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.55 -4.56 89.27 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.625 1.107 . . . . 0.0 114.266 -172.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -126.78 165.47 19.23 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.125 1.462 . . . . 0.0 110.705 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 25.7 p -128.01 170.79 12.49 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.972 0.909 . . . . 0.0 111.361 -170.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.8 p -87.48 169.33 12.31 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.434 1.494 . . . . 0.0 112.034 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.24 135.07 6.64 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 123.966 0.907 . . . . 0.0 108.698 -174.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.36 154.29 31.8 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.767 2.311 . . . . 0.0 111.4 176.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.2 tt -55.9 -34.45 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 123.764 0.825 . . . . 0.0 111.33 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -60.1 -22.0 62.23 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.823 1.649 . . . . 0.0 112.205 -173.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -80.82 -2.5 47.5 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.179 0.992 . . . . 0.0 112.569 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -130.65 -179.87 5.55 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.586 1.085 . . . . 0.0 111.984 -174.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.08 139.43 45.96 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 127.812 2.445 . . . . 0.0 106.547 169.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.4 -24.89 66.55 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.549 1.14 . . . . 0.0 111.593 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -60.86 -24.56 66.01 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.022 0.929 . . . . 0.0 112.497 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -82.96 -17.92 41.81 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.909 0.884 . . . . 0.0 110.53 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -97.82 122.4 40.89 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 125.623 1.569 . . . . 0.0 108.546 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -73.11 -29.4 62.88 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 175.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.47 134.34 43.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 C-N-CA 122.507 0.323 . . . . 0.0 110.317 -170.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.5 m -127.03 128.98 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 122.135 0.969 . . . . 0.0 110.115 -175.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 49.9 mm -116.36 135.15 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.3 m -104.18 146.52 28.64 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 123.92 0.762 . . . . 0.0 109.233 169.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.97 53.92 0.35 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.047 1.739 . . . . 0.0 107.741 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 83.2 m . . . . . 0 CA--C 1.531 0.244 0 C-N-CA 123.802 0.841 . . . . 0.0 110.959 172.168 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -63.29 5.78 0.15 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.318 1.847 . . . . 0.0 113.756 170.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.4 p -126.44 5.17 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.338 1.055 . . . . 0.0 112.388 171.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.0 p -120.36 21.22 11.75 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.642 1.11 . . . . 0.0 112.61 -171.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -90.81 -176.78 4.79 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.624 0.769 . . . . 0.0 109.543 173.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -65.65 -31.56 72.65 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -170.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.7 mt -134.39 137.24 51.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -137.03 136.34 38.35 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 169.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -143.11 155.6 44.63 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.286 1.434 . . . . 0.0 107.853 169.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -120.63 132.53 55.17 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.147 1.379 . . . . 0.0 108.884 169.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.407 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 39.7 m0 -116.52 96.41 5.5 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.829 1.652 . . . . 0.0 107.472 -172.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -72.92 83.59 1.23 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.517 1.527 . . . . 0.0 109.721 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.32 154.0 23.12 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 125.208 1.403 . . . . 0.0 109.844 -175.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -78.25 65.85 3.7 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.204 1.402 . . . . 0.0 111.819 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -13.41 92.17 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 129.036 2.935 . . . . 0.0 114.308 178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -61.71 -6.91 8.13 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.927 3.085 . . . . 0.0 116.769 -169.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -60.42 88.62 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 120.214 1.37 . . . . 0.0 111.3 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.16 14.86 23.33 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 126.604 2.049 . . . . 0.0 113.874 175.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -93.82 179.75 5.25 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.51 1.655 . . . . 0.0 113.522 -169.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.9 m -77.74 156.48 30.56 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.769 1.628 . . . . 0.0 110.138 175.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 93.5 mt -58.14 -34.48 70.31 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.908 0.483 . . . . 0.0 111.462 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -66.81 -36.87 83.37 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.072 0.396 . . . . 0.0 110.695 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.0 t -65.87 -46.08 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.439 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 7.9 m-85 -56.4 -49.08 75.51 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.962 0.505 . . . . 0.0 111.078 176.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 16.4 mtp85 -59.08 -45.03 91.87 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.897 0.879 . . . . 0.0 111.05 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 92.9 m -60.94 -53.01 62.55 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 74.4 t -64.58 -40.47 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-O 118.506 -0.759 . . . . 0.0 110.5 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.84 -43.43 94.62 Favored 'General case' 0 CA--C 1.523 -0.071 0 CA-C-N 120.215 1.37 . . . . 0.0 110.446 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.43 -50.02 65.58 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-O 118.929 -0.928 . . . . 0.0 111.057 174.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -56.43 -50.3 72.06 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.27 1.035 . . . . 0.0 110.991 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 48.9 t -55.77 -54.92 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 126.32 1.848 . . . . 0.0 109.341 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -59.93 -45.53 92.31 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 119.336 0.971 . . . . 0.0 110.065 -173.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.18 -45.19 79.85 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.784 0.833 . . . . 0.0 110.248 176.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.407 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 45.2 mtt85 -70.32 -42.38 72.04 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 117.869 -1.062 . . . . 0.0 110.744 -176.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.5 t -52.82 -49.71 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 120.321 1.418 . . . . 0.0 110.293 169.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -60.77 -41.65 95.91 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.262 0.937 . . . . 0.0 110.599 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -61.38 -44.32 97.36 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.228 1.011 . . . . 0.0 110.176 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . 0.262 0.2 OUTLIER -67.97 -46.47 71.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.809 -179.375 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.8 mt -51.52 -42.81 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 119.373 0.988 . . . . 0.0 109.245 172.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.44 -30.1 70.37 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.68 1.127 . . . . 0.0 111.532 -172.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 47.1 mttt -71.98 -45.75 59.87 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.272 1.429 . . . . 0.0 110.863 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.2 pt -86.11 -27.56 6.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.684 1.193 . . . . 0.0 113.875 -171.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 C--O 1.248 1.012 0 C-N-CA 126.194 1.798 . . . . 0.0 111.009 176.588 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.8 mmtt . . . . . 0 N--CA 1.465 0.318 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.8 mttt -101.96 120.06 39.79 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 118.753 -0.642 . . . . 0.0 109.568 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.9 p -99.75 140.26 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 121.469 0.652 . . . . 0.0 110.438 175.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 33.9 tpp -121.37 140.61 51.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.596 -1.184 . . . . 0.0 108.202 169.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -112.5 127.11 55.96 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 169.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.5 t -128.92 126.5 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 120.088 1.313 . . . . 0.0 108.446 -169.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.7 t -134.68 156.49 48.68 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 119.106 0.867 . . . . 0.0 112.658 -174.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -56.94 -23.0 42.11 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.225 1.01 . . . . 0.0 111.405 169.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.6 ptt-85 -148.82 107.81 3.88 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 169.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -47.46 -36.49 10.15 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.225 1.01 . . . . 0.0 112.0 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.3 m -43.7 -24.5 0.12 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 130.931 3.693 . . . . 0.0 118.717 -169.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.0 p -130.92 -79.84 0.53 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 120.018 1.281 . . . . 0.0 112.44 -169.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -56.79 -52.18 66.06 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.358 1.063 . . . . 0.0 109.664 -169.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.13 -46.69 79.93 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 126.37 1.868 . . . . 0.0 111.558 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -62.22 -41.02 98.01 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.096 0.407 . . . . 0.0 111.14 -174.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 44.1 mtm -62.69 -47.89 81.67 Favored 'General case' 0 CA--C 1.529 0.15 0 O-C-N 122.3 -0.25 . . . . 0.0 111.127 172.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.32 -38.94 78.11 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 117.887 0.312 . . . . 0.0 111.227 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -62.49 -51.05 68.99 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.345 1.458 . . . . 0.0 109.445 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.46 -42.52 99.05 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 119.501 -0.61 . . . . 0.0 112.248 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -67.14 -49.47 64.7 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 119.006 1.403 . . . . 0.0 108.971 177.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.27 -36.84 76.27 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 119.303 0.956 . . . . 0.0 112.415 -176.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -72.17 -35.95 69.15 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 119.383 0.992 . . . . 0.0 110.633 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.0 m -66.99 -42.14 85.55 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 119.98 -1.7 . . . . 0.0 110.476 177.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.4 mt -75.83 -31.47 59.37 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.887 1.675 . . . . 0.0 111.512 -173.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.928 0 CA-C-O 117.212 -1.882 . . . . 0.0 117.539 -170.349 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.9 pt . . . . . 0 C--O 1.235 0.316 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.68 123.74 50.01 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 170.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.27 143.9 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 C-N-CA 126.441 1.896 . . . . 0.0 109.516 -169.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 86.7 m -152.04 160.41 43.46 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.841 1.656 . . . . 0.0 106.78 169.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.1 p -130.48 161.26 31.83 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.745 0.818 . . . . 0.0 109.688 168.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.2 p -153.77 -168.85 3.1 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 176.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.36 166.91 34.91 Favored Glycine 0 N--CA 1.448 -0.522 0 O-C-N 121.283 -0.885 . . . . 0.0 111.59 170.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.2 mp -52.15 -36.86 52.68 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.742 1.217 . . . . 0.0 110.014 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -142.89 144.65 32.54 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 169.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 p -84.0 155.72 22.62 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.674 0.749 . . . . 0.0 110.935 174.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.9 m -163.23 151.48 13.78 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 128.033 2.533 . . . . 0.0 105.203 169.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -55.45 156.41 4.55 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.028 0.831 . . . . 0.0 111.959 -170.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.2 t -60.92 135.17 25.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -72.66 143.02 84.33 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 123.614 0.766 . . . . 0.0 109.07 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.43 -42.07 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 121.426 1.417 . . . . 0.0 113.11 -169.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.493 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 21.5 m -66.66 -17.02 64.62 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.172 -1.58 . . . . 0.0 111.956 -176.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.37 -39.32 72.72 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.292 -0.88 . . . . 0.0 110.935 169.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 62.5 mt -56.66 -48.09 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.65 -40.71 93.03 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 123.967 0.907 . . . . 0.0 111.489 -173.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.2 mmt -59.54 -48.18 82.66 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 122.934 1.349 . . . . 0.0 111.517 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.0 mtp -68.17 -35.93 78.81 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.886 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -61.31 -30.15 70.31 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 118.783 -0.627 . . . . 0.0 111.64 172.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -65.13 -36.31 83.85 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.057 0.844 . . . . 0.0 110.435 175.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.1 t -80.99 -25.45 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 117.606 0.184 . . . . 0.0 111.058 176.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.91 27.81 5.26 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.692 1.139 . . . . 0.0 111.741 -177.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.7 mt -123.32 -178.74 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 126.222 1.809 . . . . 0.0 106.874 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -147.22 156.45 42.96 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.156 1.382 . . . . 0.0 109.483 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.49 -14.25 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.99 0.916 . . . . 0.0 112.341 169.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -46.83 -38.18 9.87 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.647 1.179 . . . . 0.0 112.678 173.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.65 -4.99 85.88 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 118.604 -1.109 . . . . 0.0 113.988 -172.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -128.64 167.06 17.73 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.135 1.467 . . . . 0.0 111.393 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.9 p -126.24 166.14 17.65 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.487 1.115 . . . . 0.0 111.566 -169.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.0 m -81.51 162.7 23.12 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.188 0.995 . . . . 0.0 111.252 175.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -153.56 144.12 15.81 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-O 118.47 -0.776 . . . . 0.0 109.973 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.77 152.74 17.2 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.423 2.082 . . . . 0.0 111.229 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.3 tt -55.88 -33.92 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 123.562 0.745 . . . . 0.0 111.202 174.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -57.94 -22.98 51.6 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.165 1.786 . . . . 0.0 112.39 -175.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -80.98 -5.65 57.81 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.988 0.915 . . . . 0.0 112.818 -176.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -126.13 -179.93 4.95 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.552 1.069 . . . . 0.0 111.805 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.01 139.31 51.05 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 127.558 2.343 . . . . 0.0 106.983 169.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.16 -22.39 62.97 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.207 1.003 . . . . 0.0 112.231 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -61.77 -22.35 65.35 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.284 1.034 . . . . 0.0 112.507 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -83.8 -16.01 46.24 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.851 0.86 . . . . 0.0 110.491 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -103.77 130.09 51.26 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 125.176 1.39 . . . . 0.0 109.493 -172.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -78.81 -36.52 42.52 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 122.728 0.411 . . . . 0.0 111.166 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.4 p -133.39 132.95 57.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -171.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.5 m -125.67 108.06 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-O 123.124 1.44 . . . . 0.0 109.042 -173.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.7 mm -103.13 96.78 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.4 m -73.38 157.68 36.48 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 167.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.96 26.37 1.88 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 174.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 74.9 m . . . . . 0 CA--C 1.531 0.217 0 C-N-CA 125.648 1.579 . . . . 0.0 111.75 -171.486 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.421 ' C ' ' H ' ' A' ' 91' ' ' VAL . 9.5 pt-20 . . . . . 0 N--CA 1.466 0.373 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -62.55 11.23 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 128.732 2.813 . . . . 0.0 113.857 176.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.421 ' H ' ' C ' ' A' ' 89' ' ' GLU . 3.7 p -119.38 15.21 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 124.824 1.25 . . . . 0.0 111.609 174.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.5 p -130.23 17.44 5.5 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -171.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -91.37 179.12 5.77 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.36 1.464 . . . . 0.0 109.464 178.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -61.57 -33.63 74.2 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.636 1.174 . . . . 0.0 113.551 -171.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.8 mt -137.7 134.0 45.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -137.35 138.63 40.15 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 171.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -146.53 158.84 43.96 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.016 1.727 . . . . 0.0 107.362 169.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -123.16 100.06 6.67 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.869 1.267 . . . . 0.0 108.612 168.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.418 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 43.8 m0 -73.02 102.16 3.43 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.268 1.027 . . . . 0.0 108.832 -177.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -68.89 93.16 0.54 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.659 1.184 . . . . 0.0 109.259 176.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.5 153.36 35.45 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 125.481 1.512 . . . . 0.0 109.974 -172.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -85.66 53.36 2.74 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.432 1.493 . . . . 0.0 111.829 -171.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.8 t70 5.62 87.07 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 129.287 3.035 . . . . 0.0 114.106 169.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -61.64 -4.85 4.91 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.864 3.042 . . . . 0.0 116.805 -172.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -54.5 93.03 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.988 1.267 . . . . 0.0 112.686 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.08 17.75 39.36 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 126.329 1.918 . . . . 0.0 113.419 172.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -95.0 178.25 5.62 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.987 1.393 . . . . 0.0 113.055 -169.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.6 m -77.45 156.13 31.3 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.994 1.718 . . . . 0.0 110.139 175.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 99.8 mt -59.14 -32.48 69.91 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.785 -0.572 . . . . 0.0 111.817 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.67 -39.14 93.0 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.656 0.382 . . . . 0.0 110.622 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 90.6 t -67.82 -45.07 84.98 Favored 'Isoleucine or valine' 0 C--N 1.338 0.083 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.493 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 17.4 m-85 -56.9 -50.38 72.71 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 119.023 -0.513 . . . . 0.0 111.043 176.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 -58.82 -41.76 87.57 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.024 0.829 . . . . 0.0 111.663 176.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.7 m -60.89 -49.75 76.22 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 118.836 0.744 . . . . 0.0 109.489 177.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.7 t -65.26 -39.21 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-O 117.748 -1.12 . . . . 0.0 110.654 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.6 ttp-105 -55.35 -48.59 73.99 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 120.354 1.434 . . . . 0.0 108.898 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.05 -47.76 89.56 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-O 118.326 -1.263 . . . . 0.0 110.196 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -56.27 -56.08 25.42 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.518 1.159 . . . . 0.0 110.151 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.6 t -55.82 -54.2 29.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 126.746 2.018 . . . . 0.0 110.851 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -63.01 -47.63 82.25 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 119.645 1.111 . . . . 0.0 110.158 -169.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -41.69 72.38 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 123.781 0.833 . . . . 0.0 110.995 174.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.418 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 45.7 mtt85 -71.45 -42.71 67.84 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.676 -177.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 71.5 t -53.02 -47.81 53.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 120.732 1.605 . . . . 0.0 109.769 169.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -61.48 -41.04 96.65 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 118.894 0.77 . . . . 0.0 110.767 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -62.19 -46.36 89.27 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 123.099 0.56 . . . . 0.0 110.264 175.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.18 -46.32 89.47 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 118.249 -0.881 . . . . 0.0 109.793 -177.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 71.7 mt -57.0 -40.14 70.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.791 0.836 . . . . 0.0 109.596 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.62 -31.3 72.45 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 120.147 1.34 . . . . 0.0 111.593 -175.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -64.08 -36.24 83.37 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.28 1.032 . . . . 0.0 111.827 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 pt -104.14 -25.28 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -169.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.7 m . . . . . 0 C--O 1.248 0.996 0 C-N-CA 125.785 1.634 . . . . 0.0 111.143 179.489 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? . . . . . 0 N--CA 1.465 0.28 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -93.9 110.7 22.36 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 170.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 85.5 t -93.06 136.97 23.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 125.582 1.553 . . . . 0.0 107.966 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 39.6 tpp -119.06 143.06 47.33 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.458 1.103 . . . . 0.0 108.63 172.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -121.09 122.64 40.49 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.958 1.303 . . . . 0.0 108.114 170.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.8 t -127.45 123.91 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 120.771 1.623 . . . . 0.0 109.498 -174.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.4 t -118.39 165.11 14.27 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.872 0.76 . . . . 0.0 109.756 176.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -65.7 -11.54 46.13 Favored 'General case' 0 CA--C 1.548 0.893 0 O-C-N 121.82 -0.55 . . . . 0.0 111.548 169.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -154.47 107.53 2.85 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 128.238 2.615 . . . . 0.0 105.307 169.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -47.16 -38.42 11.77 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.927 1.291 . . . . 0.0 113.014 -178.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.9 p -38.77 -33.05 0.1 Allowed 'General case' 0 C--O 1.236 0.362 0 C-N-CA 129.507 3.123 . . . . 0.0 117.852 -169.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.8 m -122.62 -76.21 0.59 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.659 0.663 . . . . 0.0 111.791 -169.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -58.99 -51.11 71.5 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.264 0.484 . . . . 0.0 109.751 -169.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.76 -42.51 81.63 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.34 0.656 . . . . 0.0 111.271 -173.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -59.65 -45.05 93.2 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.547 0.739 . . . . 0.0 111.1 -175.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 53.5 mtm -65.66 -45.82 81.49 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 117.563 0.165 . . . . 0.0 111.07 176.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.43 -39.09 75.5 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 117.592 0.178 . . . . 0.0 110.859 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -65.41 -54.56 26.9 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.484 -0.77 . . . . 0.0 110.682 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.71 -41.38 50.39 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-O 119.271 -0.739 . . . . 0.0 112.456 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -68.02 -46.94 69.81 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 118.938 1.369 . . . . 0.0 109.457 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.04 -46.29 85.6 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 120.188 1.358 . . . . 0.0 112.894 -176.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -69.54 -5.77 26.47 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.523 1.056 . . . . 0.0 113.57 175.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.0 m -97.7 -47.99 5.39 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 119.927 1.239 . . . . 0.0 110.255 170.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 97.0 mt -77.45 -41.35 39.98 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.608 1.563 . . . . 0.0 111.86 -169.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.374 0 CA-C-O 117.86 -1.522 . . . . 0.0 114.877 -169.157 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.5 pt . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 121.313 0.578 . . . . 0.0 111.722 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -121.94 131.97 54.3 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 104.191 -2.522 . . . . 0.0 104.191 168.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 p -117.67 151.68 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -169.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.6 m -144.49 144.03 31.16 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 167.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.5 p -112.37 153.05 27.88 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 168.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.9 m -151.08 -170.13 3.58 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.39 160.56 29.94 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 169.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.1 mt -53.69 -30.65 44.63 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.369 0.668 . . . . 0.0 110.788 173.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -143.82 146.75 33.3 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 168.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.6 p -75.15 165.91 24.48 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.01 0.909 . . . . 0.0 111.756 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.7 p -151.59 -148.01 0.25 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.565 1.946 . . . . 0.0 106.322 173.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -133.13 155.65 48.89 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 173.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.4 t -63.21 128.71 25.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -173.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -70.96 137.85 85.05 Favored Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -70.58 -38.09 6.42 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 121.974 1.782 . . . . 0.0 112.428 -169.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.469 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 10.4 m -67.65 -18.86 65.1 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.407 -0.808 . . . . 0.0 111.878 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.48 -40.96 84.18 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 121.646 -0.659 . . . . 0.0 110.1 171.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.6 mp -61.99 -43.79 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.24 -37.67 81.09 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -176.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.4 mmt -62.31 -47.61 83.5 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 122.823 1.297 . . . . 0.0 111.441 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.2 mtp -69.0 -34.17 74.85 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.12 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -62.29 -29.83 70.7 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.584 0.754 . . . . 0.0 111.361 172.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -63.75 -39.31 93.97 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.872 0.76 . . . . 0.0 110.247 173.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.7 t -78.96 -25.33 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 121.219 -0.192 . . . . 0.0 110.97 178.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.61 24.89 5.94 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.104 1.335 . . . . 0.0 112.032 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.8 mt -123.21 179.29 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 125.768 1.627 . . . . 0.0 107.249 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -144.61 157.95 43.99 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.745 1.618 . . . . 0.0 108.942 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -128.86 -16.95 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.888 0.875 . . . . 0.0 112.701 170.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 61.4 p -54.1 -28.58 40.3 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 120.076 1.307 . . . . 0.0 112.498 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.38 -11.22 71.44 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.706 1.146 . . . . 0.0 114.146 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -123.21 173.05 8.15 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.291 1.545 . . . . 0.0 111.163 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.4 p -128.53 164.79 22.04 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.458 1.103 . . . . 0.0 111.416 -169.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 73.6 m -80.6 158.62 25.65 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.904 0.882 . . . . 0.0 110.859 170.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -158.0 145.9 13.85 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.0 0.92 . . . . 0.0 109.663 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -82.85 150.83 14.33 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.606 2.204 . . . . 0.0 111.258 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.1 tt -55.55 -33.29 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.392 0.677 . . . . 0.0 111.807 175.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -58.75 -21.68 56.01 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.986 1.714 . . . . 0.0 112.35 -176.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -78.92 -6.94 57.46 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.953 0.901 . . . . 0.0 112.855 -176.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -127.97 -179.84 5.19 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.619 1.1 . . . . 0.0 111.433 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -127.24 127.39 44.34 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.789 2.036 . . . . 0.0 107.886 175.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.26 -24.07 67.05 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 -174.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -64.03 -21.03 66.34 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.775 0.43 . . . . 0.0 112.111 -177.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -81.41 -18.36 45.69 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.459 0.703 . . . . 0.0 110.19 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -97.11 130.26 44.41 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 125.45 1.5 . . . . 0.0 109.062 -177.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -89.65 -22.1 22.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.53 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.99 135.9 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -175.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.2 t -127.94 127.45 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 123.307 1.527 . . . . 0.0 109.566 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 35.4 mm -113.49 98.67 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.3 m -72.4 155.54 40.02 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 167.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.7 49.17 0.87 Allowed 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 102.878 -3.008 . . . . 0.0 102.878 172.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.5 m . . . . . 0 CA--C 1.532 0.26 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 170.727 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 . . . . . 0 CA--C 1.54 0.581 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -62.96 9.05 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.949 2.1 . . . . 0.0 113.01 169.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.3 p -132.15 7.3 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 124.204 1.002 . . . . 0.0 112.509 173.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 82.8 p -116.23 33.18 5.68 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 120.044 1.293 . . . . 0.0 112.852 -169.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -122.01 -172.03 2.36 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.527 1.531 . . . . 0.0 110.222 174.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -59.43 -36.37 75.76 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -168.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.7 mm -133.05 138.52 51.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -173.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -142.94 129.8 20.51 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.226 1.411 . . . . 0.0 107.402 169.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -141.79 158.76 43.41 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 168.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -122.5 101.66 7.62 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.021 1.328 . . . . 0.0 109.46 169.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 39.5 m0 -78.8 92.73 4.87 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.199 0.999 . . . . 0.0 109.656 -177.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -62.1 120.49 10.97 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 169.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 47.6 mt -151.72 152.96 33.43 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.147 1.779 . . . . 0.0 107.585 -169.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -82.13 71.7 9.18 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.461 1.105 . . . . 0.0 111.448 -176.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -22.38 97.88 0.06 OUTLIER Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 128.678 2.791 . . . . 0.0 112.7 -177.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -59.79 -2.9 1.78 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.292 3.328 . . . . 0.0 117.221 -169.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -50.86 95.85 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.843 1.257 . . . . 0.0 112.656 173.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.36 21.9 46.59 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.29 1.9 . . . . 0.0 113.153 171.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -98.73 176.68 5.54 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.952 1.376 . . . . 0.0 112.755 -169.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 44.2 m -74.4 154.69 38.68 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.804 1.641 . . . . 0.0 110.166 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 91.9 mt -58.38 -31.12 67.35 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.796 -0.565 . . . . 0.0 111.658 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -72.31 -33.66 67.54 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.296 0.498 . . . . 0.0 111.155 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 80.8 t -65.43 -46.22 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 171.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.469 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 11.1 m-85 -55.46 -50.38 70.03 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 118.876 -0.583 . . . . 0.0 110.351 175.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -59.37 -43.16 92.91 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.877 0.871 . . . . 0.0 112.207 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 100.0 m -60.96 -51.06 70.85 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 119.01 0.823 . . . . 0.0 109.151 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.0 t -63.69 -45.35 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 117.875 -1.059 . . . . 0.0 110.039 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -55.78 -47.2 77.47 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 119.818 1.19 . . . . 0.0 109.392 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.88 -49.02 83.29 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-O 118.383 -1.231 . . . . 0.0 110.417 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -59.72 -56.83 16.92 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 118.359 1.079 . . . . 0.0 110.398 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.8 t -46.26 -51.32 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 125.888 1.675 . . . . 0.0 110.483 177.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -63.62 -48.71 76.2 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.449 1.022 . . . . 0.0 110.192 -175.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.56 -40.56 72.09 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.377 1.071 . . . . 0.0 111.155 175.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 82.8 mtt-85 -73.1 -43.26 62.01 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.921 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 69.5 t -54.35 -46.74 69.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 120.417 1.462 . . . . 0.0 108.843 169.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -61.2 -39.54 90.61 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.051 0.841 . . . . 0.0 110.831 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -63.47 -47.43 81.81 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 123.196 0.598 . . . . 0.0 110.308 176.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . 0.251 0.2 OUTLIER -60.52 -44.31 96.16 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 118.858 -0.592 . . . . 0.0 109.724 -178.666 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.1 mt -60.79 -38.05 77.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.514 1.126 . . . . 0.0 110.764 173.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.37 -31.42 72.57 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 120.287 1.403 . . . . 0.0 111.223 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -66.78 -20.49 65.96 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.014 1.325 . . . . 0.0 113.169 177.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.5 pt -127.53 -20.95 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 116.382 1.993 . . . . 0.0 116.382 -167.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 C--O 1.249 1.033 0 C-N-CA 126.371 1.868 . . . . 0.0 111.118 174.501 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? . . . . . 0 N--CA 1.466 0.36 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -83.29 136.07 34.51 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 169.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.9 p -119.64 146.56 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-O 121.928 0.871 . . . . 0.0 109.526 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 33.3 tpp -127.17 142.51 51.48 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.308 -1.315 . . . . 0.0 108.423 -177.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -124.0 121.99 36.71 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 117.66 -1.162 . . . . 0.0 108.113 172.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.6 t -126.19 118.78 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 121.111 1.778 . . . . 0.0 110.055 -170.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.5 t -116.19 162.25 17.74 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.424 1.011 . . . . 0.0 112.081 -178.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.8 mttm -60.81 -17.88 52.25 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.767 0.827 . . . . 0.0 111.649 169.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.1 ptm85 -154.15 112.96 3.65 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 169.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -47.87 -30.57 4.22 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.025 0.93 . . . . 0.0 112.797 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.4 m -35.29 -35.86 0.05 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 130.085 3.354 . . . . 0.0 119.879 -171.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.8 p -137.68 -68.85 0.46 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 120.576 1.534 . . . . 0.0 113.51 -169.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -55.09 -51.1 67.45 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.045 0.838 . . . . 0.0 109.527 -169.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -49.14 68.09 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.955 2.102 . . . . 0.0 111.806 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -60.26 -43.12 96.42 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.502 0.721 . . . . 0.0 110.847 -175.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 65.9 mtm -66.66 -47.14 73.47 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-O 119.569 -0.253 . . . . 0.0 110.991 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.99 -39.31 71.66 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 117.743 0.247 . . . . 0.0 110.773 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -64.95 -55.22 20.49 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 118.485 -0.769 . . . . 0.0 110.938 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.5 -40.45 47.02 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-O 119.346 -0.697 . . . . 0.0 112.516 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -68.08 -47.01 69.44 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 119.008 1.404 . . . . 0.0 109.523 175.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.91 -45.49 90.21 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 120.187 1.358 . . . . 0.0 112.907 -176.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt -69.41 -9.45 53.63 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.685 1.129 . . . . 0.0 113.294 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.3 m -93.55 -48.59 6.29 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 119.852 1.206 . . . . 0.0 110.611 170.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 98.3 mt -77.23 -41.45 41.14 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.808 1.643 . . . . 0.0 111.92 -169.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.38 0 CA-C-O 117.759 -1.578 . . . . 0.0 114.962 -169.113 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.0 pt . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 121.29 0.567 . . . . 0.0 111.845 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -125.79 132.35 52.29 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 169.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 p -117.08 153.26 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -169.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.5 m -145.65 145.01 30.76 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 167.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.2 p -113.53 157.5 21.95 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 120.896 -1.128 . . . . 0.0 109.008 168.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.5 m -151.37 -175.95 5.38 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.714 1.606 . . . . 0.0 107.035 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -152.4 163.13 30.18 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 169.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.4 mt -53.24 -34.74 58.43 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 124.245 0.614 . . . . 0.0 110.265 174.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -141.9 145.58 34.74 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 104.659 -2.349 . . . . 0.0 104.659 169.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.2 p -75.75 147.4 39.32 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.098 0.475 . . . . 0.0 110.44 174.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 59.5 m -150.51 149.22 29.67 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.145 2.178 . . . . 0.0 105.542 169.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.64 155.56 9.68 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.858 0.863 . . . . 0.0 111.966 -172.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.6 t -65.63 131.07 31.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -73.74 138.97 76.91 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.35 -35.95 4.49 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 121.974 1.782 . . . . 0.0 112.494 -169.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.499 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 4.8 m -67.84 -18.57 64.87 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.093 -1.004 . . . . 0.0 111.945 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.32 -41.44 76.03 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.698 -0.626 . . . . 0.0 110.184 170.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.8 mp -62.78 -41.31 91.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -178.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.7 -36.99 82.5 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 118.341 0.519 . . . . 0.0 112.043 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 24.5 mmt -62.51 -47.69 82.84 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 122.763 1.268 . . . . 0.0 111.463 175.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 10.6 mtp -68.27 -34.0 75.38 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.433 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -63.03 -28.77 70.32 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.128 0.971 . . . . 0.0 111.077 173.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -65.39 -38.72 90.85 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.788 0.722 . . . . 0.0 110.162 172.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.9 t -78.22 -25.09 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 121.256 -0.178 . . . . 0.0 110.809 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.77 25.65 6.14 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.161 1.363 . . . . 0.0 111.953 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.5 mt -124.2 175.97 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 125.584 1.554 . . . . 0.0 107.348 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -140.81 158.06 44.5 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.507 1.523 . . . . 0.0 109.154 -178.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -129.34 -18.59 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 118.186 -0.911 . . . . 0.0 112.816 171.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.7 m -51.58 -30.16 19.99 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 120.393 1.451 . . . . 0.0 112.274 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.69 -11.56 69.17 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.81 1.195 . . . . 0.0 114.093 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -123.99 168.62 12.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.432 1.493 . . . . 0.0 110.876 176.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.8 p -126.92 172.08 10.74 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.443 1.097 . . . . 0.0 110.85 -173.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.2 m -76.89 165.05 25.21 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.45 0.7 . . . . 0.0 112.173 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.29 142.86 15.33 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 124.349 1.06 . . . . 0.0 108.73 177.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -85.18 153.15 10.9 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.903 2.402 . . . . 0.0 110.095 169.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.1 tt -54.29 -33.28 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 123.524 0.73 . . . . 0.0 111.135 173.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -56.04 -26.25 48.28 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.411 1.884 . . . . 0.0 112.676 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -81.06 -5.44 57.63 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -175.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -130.11 -176.67 4.01 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.151 0.98 . . . . 0.0 111.181 -176.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.67 131.04 33.06 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 126.595 1.958 . . . . 0.0 108.399 -177.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.33 -29.4 67.62 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.599 1.16 . . . . 0.0 113.191 -176.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -60.23 -22.15 62.68 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.976 0.91 . . . . 0.0 112.336 -176.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -85.23 -14.8 45.63 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.545 0.738 . . . . 0.0 110.777 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -109.31 137.31 47.37 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.945 1.298 . . . . 0.0 110.276 -172.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -93.48 -33.78 13.66 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.519 0.727 . . . . 0.0 110.238 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.06 136.45 53.53 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 CA-C-N 118.578 0.626 . . . . 0.0 109.415 -175.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.9 t -128.49 115.96 39.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 122.929 1.347 . . . . 0.0 108.531 -175.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.9 mm -107.79 93.91 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.3 m -71.24 157.29 38.38 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 117.759 -1.576 . . . . 0.0 106.857 168.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.82 46.88 0.94 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 177.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 86.2 m . . . . . 0 N--CA 1.454 -0.259 0 C-N-CA 123.553 0.741 . . . . 0.0 109.323 177.258 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -55.51 -25.74 38.94 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.826 -1.171 . . . . 0.0 111.871 171.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.7 p -84.8 -18.3 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 119.637 1.108 . . . . 0.0 110.347 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 56.8 p -100.42 18.51 18.82 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.591 0.756 . . . . 0.0 112.683 -169.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -83.98 -172.71 4.31 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.896 0.879 . . . . 0.0 109.72 173.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -63.44 -34.62 78.15 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.426 0.691 . . . . 0.0 112.344 -169.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.0 mt -140.73 140.13 33.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 -174.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -140.1 137.87 34.85 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.623 1.169 . . . . 0.0 108.228 170.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -146.5 160.17 42.46 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.695 1.598 . . . . 0.0 107.726 168.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -122.53 95.73 4.75 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.117 1.367 . . . . 0.0 108.533 169.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -68.45 101.4 1.24 Allowed 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.418 1.087 . . . . 0.0 109.432 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -61.21 120.59 10.65 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 169.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.7 mt -157.78 146.77 19.55 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.161 1.385 . . . . 0.0 107.993 -169.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.9 mp0 -86.61 60.25 6.12 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.375 1.87 . . . . 0.0 111.925 -169.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -1.59 85.67 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 129.672 3.189 . . . . 0.0 113.852 174.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -59.64 -11.13 13.32 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.963 3.109 . . . . 0.0 117.85 -169.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.3 96.18 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 120.46 1.482 . . . . 0.0 111.495 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.4 13.11 29.25 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 126.402 1.953 . . . . 0.0 113.232 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -98.72 178.12 5.08 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.182 1.491 . . . . 0.0 112.765 -169.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.9 m -76.35 154.98 34.53 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.975 1.71 . . . . 0.0 110.059 175.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.9 mt -59.3 -30.96 68.71 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.708 -0.62 . . . . 0.0 111.889 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -62.11 -40.11 94.8 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.134 0.574 . . . . 0.0 110.521 175.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.7 t -68.9 -43.8 82.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.499 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 13.3 m-85 -55.44 -52.07 64.82 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.538 175.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -60.1 -41.54 92.76 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.413 0.685 . . . . 0.0 111.772 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 56.3 m -61.0 -46.19 91.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.78 0.718 . . . . 0.0 110.0 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.7 t -69.07 -43.84 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-O 117.853 -1.07 . . . . 0.0 110.265 177.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -56.45 -44.79 80.82 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 119.828 1.195 . . . . 0.0 109.438 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.16 -50.25 69.27 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-O 118.33 -1.261 . . . . 0.0 110.576 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -57.52 -57.05 14.38 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 118.311 1.055 . . . . 0.0 110.098 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.6 t -48.91 -52.95 8.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.937 1.695 . . . . 0.0 110.619 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -64.68 -48.89 73.05 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 119.159 0.891 . . . . 0.0 109.795 -171.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.62 -44.33 69.41 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.924 0.89 . . . . 0.0 110.46 174.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -72.45 -39.37 67.84 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 117.484 -1.246 . . . . 0.0 110.764 -175.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 72.5 t -55.26 -48.68 76.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 121.046 1.748 . . . . 0.0 108.724 169.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -60.42 -38.81 85.25 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.226 0.921 . . . . 0.0 110.778 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -64.71 -45.19 87.6 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.508 1.123 . . . . 0.0 110.352 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.58 -46.97 85.9 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 124.102 0.961 . . . . 0.0 109.434 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.7 mt -59.16 -38.04 71.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.607 1.163 . . . . 0.0 110.861 175.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.77 -30.08 70.56 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 120.011 1.278 . . . . 0.0 111.413 -173.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -71.61 -19.56 62.1 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.833 1.653 . . . . 0.0 112.976 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.4 pt -126.26 -20.35 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 126.018 1.727 . . . . 0.0 115.269 -168.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.5 m . . . . . 0 C--O 1.248 0.99 0 C-N-CA 126.471 1.908 . . . . 0.0 111.019 171.018 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt . . . . . 0 N--CA 1.464 0.244 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -97.25 133.62 41.64 Favored 'General case' 0 CA--C 1.511 -0.547 0 O-C-N 121.48 -0.762 . . . . 0.0 109.234 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.9 p -114.77 140.9 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 123.293 0.637 . . . . 0.0 109.662 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 44.2 tpp -119.94 143.8 47.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.973 169.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -117.9 135.62 54.0 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.972 1.309 . . . . 0.0 107.717 169.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.1 t -141.4 123.88 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 120.017 1.281 . . . . 0.0 109.274 -173.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.4 p -127.59 174.69 8.85 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.805 1.184 . . . . 0.0 111.019 173.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -66.04 -16.44 63.92 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.227 0.611 . . . . 0.0 112.415 173.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -152.14 101.79 2.74 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 170.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -40.02 -36.67 0.5 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.255 1.822 . . . . 0.0 113.252 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.6 m -37.21 -32.12 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 129.421 3.088 . . . . 0.0 116.936 -178.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 71.5 m -119.87 -84.96 0.66 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.172 0.896 . . . . 0.0 112.4 -169.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.02 -51.9 67.69 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.501 1.046 . . . . 0.0 110.069 -169.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -56.34 -50.19 72.21 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.247 1.019 . . . . 0.0 110.519 -173.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -61.64 -45.07 95.63 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.434 0.694 . . . . 0.0 111.344 -173.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 65.7 mtm -64.22 -47.04 81.21 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 119.446 -0.311 . . . . 0.0 110.927 175.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.69 -40.04 71.82 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 122.451 0.3 . . . . 0.0 110.681 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -64.54 -55.03 23.2 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.414 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.42 -38.09 68.41 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 119.457 -0.635 . . . . 0.0 111.702 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.419 ' CD1' ' HE3' ' A' ' 50' ' ' MET . 22.2 m-85 -67.73 -47.76 68.37 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 118.753 1.276 . . . . 0.0 108.775 175.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.64 -44.82 93.38 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.931 1.241 . . . . 0.0 113.312 -175.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 ptmt -68.98 -9.0 50.05 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 119.736 1.153 . . . . 0.0 113.145 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.6 m -93.51 -47.52 6.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 119.783 1.174 . . . . 0.0 110.459 169.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.2 mt -76.39 -40.77 50.04 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 126.04 1.736 . . . . 0.0 112.076 -169.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.36 0 CA-C-O 117.879 -1.512 . . . . 0.0 115.296 -169.217 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.8 pt . . . . . 0 N--CA 1.452 -0.375 0 CA-C-O 121.523 0.678 . . . . 0.0 112.01 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -122.77 132.42 54.22 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 169.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -117.39 150.83 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 C-N-CA 124.02 0.928 . . . . 0.0 112.06 -170.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.4 m -144.23 152.55 40.99 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 167.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.9 p -131.2 156.97 44.44 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 167.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.1 p -155.73 -159.99 0.97 Allowed 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.97 163.95 32.06 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 169.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 67.2 mt -52.93 -34.0 53.28 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.59 0.756 . . . . 0.0 109.622 172.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -142.6 146.22 34.33 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 103.199 -2.889 . . . . 0.0 103.199 168.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.3 m -124.51 148.6 47.64 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.287 0.565 . . . . 0.0 111.456 -178.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.3 m -143.86 168.59 19.6 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.997 2.519 . . . . 0.0 106.303 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.0 ptt85 -54.22 158.97 2.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.979 0.809 . . . . 0.0 112.478 -172.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.9 t -62.62 136.15 26.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -73.85 143.27 81.07 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.96 -40.98 0.57 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.307 1.338 . . . . 0.0 112.79 -169.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.504 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 11.5 m -67.3 -16.92 64.54 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.368 -1.458 . . . . 0.0 111.898 -177.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.52 -40.07 71.33 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.698 0.799 . . . . 0.0 110.503 169.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 59.4 mt -57.74 -48.39 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.97 -37.6 85.37 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 123.654 0.782 . . . . 0.0 111.828 -174.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 20.2 mmt -61.28 -47.58 85.34 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 122.858 1.313 . . . . 0.0 111.31 175.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.419 ' HE3' ' CD1' ' A' ' 21' ' ' PHE . 9.3 mtp -69.39 -33.11 72.54 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.516 -177.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -61.89 -29.01 69.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.858 -0.592 . . . . 0.0 111.588 170.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -65.59 -36.32 83.4 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.18 0.9 . . . . 0.0 110.446 173.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.67 -25.71 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 117.474 0.124 . . . . 0.0 110.769 176.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.43 28.26 7.23 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.546 1.069 . . . . 0.0 111.461 -174.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.6 mt -122.93 -177.53 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -146.45 157.02 43.7 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.364 1.466 . . . . 0.0 109.158 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -127.47 -16.48 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.703 0.801 . . . . 0.0 112.339 169.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -45.29 -38.18 5.42 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.693 1.197 . . . . 0.0 112.768 173.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.88 -5.46 88.72 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 118.517 -1.157 . . . . 0.0 114.335 -173.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -125.86 168.19 14.19 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.319 1.56 . . . . 0.0 110.875 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.8 p -127.84 168.61 14.94 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.016 0.926 . . . . 0.0 111.542 -169.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.2 m -82.16 163.36 22.0 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.401 1.08 . . . . 0.0 111.426 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -156.8 141.34 12.0 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.495 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -81.88 151.72 16.64 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.826 2.351 . . . . 0.0 111.173 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.1 tt -57.33 -31.13 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 121.725 -0.609 . . . . 0.0 111.833 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -56.76 -22.3 34.72 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.704 2.001 . . . . 0.0 112.111 -177.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -82.04 -7.99 59.64 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.56 1.144 . . . . 0.0 113.096 -176.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -128.57 -178.5 4.61 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 120.025 1.284 . . . . 0.0 111.607 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -127.66 141.86 51.5 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 127.247 2.219 . . . . 0.0 107.57 169.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.09 -22.99 65.8 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.889 1.276 . . . . 0.0 111.985 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -60.21 -23.14 63.78 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.054 0.942 . . . . 0.0 112.352 -176.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -83.07 -12.25 57.3 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.875 0.87 . . . . 0.0 110.728 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -111.3 126.93 55.42 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 125.644 1.578 . . . . 0.0 109.368 -170.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -72.61 -42.13 64.82 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 175.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.4 p -128.02 134.06 65.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 C-N-CA 122.942 0.497 . . . . 0.0 110.123 -169.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.4 m -127.91 108.26 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-O 123.341 1.543 . . . . 0.0 109.141 -172.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.4 mm -104.12 100.34 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 114.22 -1.355 . . . . 0.0 107.388 -175.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.4 t -74.01 157.14 36.68 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 167.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.13 51.38 0.6 Allowed 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 175.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.7 p . . . . . 0 CA--C 1.534 0.334 0 O-C-N 120.712 -1.243 . . . . 0.0 110.907 -169.998 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 61.2 m95 -66.28 8.3 0.24 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 126.7 2.0 . . . . 0.0 113.152 171.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.1 p -118.06 2.68 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 124.891 1.277 . . . . 0.0 111.512 171.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.1 p -128.5 26.43 5.65 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.111 0.964 . . . . 0.0 112.131 -172.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -92.57 -173.1 3.26 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.548 0.739 . . . . 0.0 109.558 170.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -65.72 -33.44 75.88 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -169.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.2 mt -137.25 132.62 46.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -138.48 140.46 39.21 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -147.58 159.07 44.17 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.276 1.43 . . . . 0.0 107.34 168.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -122.22 110.7 16.05 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.718 1.207 . . . . 0.0 108.934 168.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 37.1 m0 -87.39 84.68 7.15 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.28 1.032 . . . . 0.0 108.461 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -56.95 120.85 8.66 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 170.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 25.1 mt -151.03 153.05 34.38 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.986 1.314 . . . . 0.0 108.602 -169.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -78.16 74.83 4.7 Favored 'General case' 0 CA--C 1.523 -0.092 0 C-N-CA 125.105 1.362 . . . . 0.0 111.525 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -28.68 102.77 0.16 Allowed Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 127.432 2.293 . . . . 0.0 113.668 -175.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -63.68 -0.37 2.47 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.966 3.111 . . . . 0.0 117.425 -169.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -56.04 102.93 0.08 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 119.964 1.256 . . . . 0.0 111.702 178.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.34 22.06 59.4 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 126.201 1.857 . . . . 0.0 113.134 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -97.68 177.37 5.51 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.703 1.251 . . . . 0.0 112.554 -169.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.8 m -74.37 154.97 38.6 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.431 1.493 . . . . 0.0 109.814 176.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 91.5 mt -59.3 -30.58 68.44 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 122.001 -0.437 . . . . 0.0 111.656 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -62.77 -39.25 93.59 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.405 0.548 . . . . 0.0 110.918 176.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 89.0 t -67.9 -46.07 82.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.504 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 14.7 m-85 -55.34 -50.46 69.59 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.896 175.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 -59.85 -42.6 94.0 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.959 0.904 . . . . 0.0 111.74 177.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.7 m -60.78 -50.54 73.05 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 118.935 0.789 . . . . 0.0 109.363 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.6 t -66.1 -44.47 91.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 117.626 -1.178 . . . . 0.0 110.316 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 48.0 ttp85 -53.08 -47.36 68.6 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 120.093 1.315 . . . . 0.0 108.988 176.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.98 -47.9 81.18 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-O 118.481 -1.177 . . . . 0.0 110.598 -175.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -61.21 -56.7 17.64 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 118.292 1.046 . . . . 0.0 110.37 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 82.4 t -50.09 -49.95 20.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 125.132 1.373 . . . . 0.0 110.386 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -62.03 -48.43 80.33 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 120.207 1.367 . . . . 0.0 110.445 -176.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -53.91 -45.81 71.26 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 123.681 0.793 . . . . 0.0 109.751 174.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 76.6 mtt-85 -70.82 -39.54 72.98 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 118.257 -0.878 . . . . 0.0 109.925 -173.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 75.4 t -55.6 -48.8 77.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 120.437 1.471 . . . . 0.0 109.189 169.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -60.94 -38.87 87.35 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.659 1.118 . . . . 0.0 110.754 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -62.04 -46.73 87.85 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.806 1.642 . . . . 0.0 109.832 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.28 -45.76 83.16 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 123.75 0.82 . . . . 0.0 110.106 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 60.1 mt -57.44 -38.32 62.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.574 1.149 . . . . 0.0 110.468 175.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.26 -29.19 69.7 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.873 1.215 . . . . 0.0 111.447 -173.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -73.75 -19.14 60.87 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.079 1.752 . . . . 0.0 112.802 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 pt -126.51 -20.08 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 126.21 1.804 . . . . 0.0 114.966 -168.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 C--O 1.25 1.124 0 C-N-CA 126.504 1.922 . . . . 0.0 110.9 170.11 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt . . . . . 0 C--O 1.231 0.12 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.7 mttt -106.48 124.74 50.05 Favored 'General case' 0 CA--C 1.508 -0.657 0 C-N-CA 122.885 0.474 . . . . 0.0 109.936 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.6 p -105.16 140.67 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 O-C-N 123.626 0.579 . . . . 0.0 110.656 175.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 39.7 tpp -119.07 142.39 47.91 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 169.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -116.08 134.53 54.84 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 169.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.3 t -136.9 123.05 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 119.641 1.11 . . . . 0.0 108.643 -171.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.4 t -123.23 157.12 33.79 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.066 0.848 . . . . 0.0 109.691 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.319 20.9 pttp -67.52 -2.48 6.59 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 175.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -139.17 -5.12 1.46 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 168.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 63.86 -44.13 0.26 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 127.332 2.253 . . . . 0.0 114.571 -172.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.3 m -34.03 -37.95 0.05 Allowed 'General case' 0 C--O 1.232 0.132 0 N-CA-C 119.684 3.216 . . . . 0.0 119.684 -168.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.9 p -136.12 -60.07 0.73 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-N 120.0 1.273 . . . . 0.0 112.202 -169.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -60.32 -50.12 74.89 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.001 0.819 . . . . 0.0 109.956 -171.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.04 -40.87 82.78 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 117.909 0.322 . . . . 0.0 110.579 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -61.75 -47.21 86.25 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.278 0.631 . . . . 0.0 111.131 -173.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 46.5 mtm -64.46 -43.05 95.45 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 119.837 -0.125 . . . . 0.0 110.745 176.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.85 -37.52 74.03 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.048 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -65.73 -46.96 76.96 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 119.181 -0.438 . . . . 0.0 110.641 177.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.83 -42.76 98.24 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -67.48 -49.09 65.11 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 118.619 1.209 . . . . 0.0 109.624 176.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.1 -43.09 86.91 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 119.98 1.264 . . . . 0.0 112.092 -176.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.2 pttt -76.22 -2.46 31.44 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.4 m -98.62 -45.12 6.18 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 120.867 -1.145 . . . . 0.0 109.322 169.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.4 mt -72.15 -40.31 68.11 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.774 1.629 . . . . 0.0 110.79 -172.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.812 0 CA-C-O 117.403 -1.776 . . . . 0.0 116.612 -169.765 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.9 pt . . . . . 0 C--O 1.236 0.343 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.78 133.94 55.42 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 169.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -114.95 153.18 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 C-N-CA 124.074 0.95 . . . . 0.0 111.513 -175.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.9 m -144.01 148.19 34.91 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 167.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 63.2 p -121.92 148.67 44.46 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.33 1.452 . . . . 0.0 108.826 169.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 29.6 p -155.51 -165.11 1.9 Allowed 'General case' 0 C--O 1.241 0.63 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.22 168.48 33.07 Favored Glycine 0 N--CA 1.446 -0.698 0 O-C-N 121.541 -0.724 . . . . 0.0 111.976 169.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.2 mp -49.46 -39.85 34.91 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.044 0.937 . . . . 0.0 109.875 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -146.04 143.48 29.45 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 103.789 -2.671 . . . . 0.0 103.789 168.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.1 p -75.65 156.11 35.15 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 122.121 0.962 . . . . 0.0 111.503 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 63.5 m -158.39 153.92 26.1 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 127.72 2.408 . . . . 0.0 105.143 169.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -54.09 146.64 14.35 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 122.938 0.495 . . . . 0.0 110.894 -171.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 p -60.8 135.82 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 169.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -78.94 143.55 62.05 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 123.587 0.755 . . . . 0.0 109.858 -171.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.1 -41.63 0.28 Allowed 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 121.495 1.463 . . . . 0.0 112.409 -169.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.454 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 25.3 m -62.73 -24.57 67.75 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 120.422 -1.424 . . . . 0.0 111.292 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.36 -40.07 58.42 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.718 0.807 . . . . 0.0 111.663 173.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 62.9 mt -55.6 -46.0 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.12 -38.91 89.36 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 124.425 1.09 . . . . 0.0 110.161 -170.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.2 mmm -68.19 -44.19 76.44 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.744 1.259 . . . . 0.0 110.63 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.0 mtp -65.22 -35.87 82.39 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.221 -0.924 . . . . 0.0 109.963 175.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -63.89 -24.86 67.91 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.359 0.664 . . . . 0.0 111.489 173.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -65.82 -40.01 91.43 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 118.848 0.749 . . . . 0.0 109.746 172.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 92.7 t -76.78 -25.41 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.602 176.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.25 25.66 5.47 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.152 1.358 . . . . 0.0 111.727 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.5 mt -123.37 178.85 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 125.128 1.371 . . . . 0.0 107.379 -178.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -142.84 155.26 44.75 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.219 1.408 . . . . 0.0 109.557 -176.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -127.94 -13.88 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 123.955 0.902 . . . . 0.0 112.562 169.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -46.74 -37.17 8.07 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.53 1.132 . . . . 0.0 112.75 172.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.16 -6.23 85.96 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 118.697 -1.057 . . . . 0.0 114.248 -173.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -126.81 170.03 12.61 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.077 1.439 . . . . 0.0 111.204 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.6 p -129.2 166.57 19.12 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.645 1.178 . . . . 0.0 111.184 -170.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.2 m -92.08 155.78 17.83 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.798 1.239 . . . . 0.0 110.034 173.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -156.9 144.23 13.78 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 124.299 1.039 . . . . 0.0 110.07 -169.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.56 148.99 23.63 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 121.735 1.624 . . . . 0.0 111.158 -176.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.2 tt -52.01 -34.1 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.306 1.042 . . . . 0.0 111.761 173.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -58.44 -23.16 56.77 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.119 1.768 . . . . 0.0 112.404 -175.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -82.13 -6.83 59.48 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.916 0.886 . . . . 0.0 112.814 -175.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -125.39 -174.73 3.13 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.254 1.022 . . . . 0.0 110.356 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.47 130.71 30.82 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 126.399 1.88 . . . . 0.0 108.449 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.4 -28.39 66.87 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.633 1.173 . . . . 0.0 112.829 -176.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -60.49 -22.55 63.66 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.06 0.944 . . . . 0.0 112.452 -176.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -84.76 -13.2 51.96 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.428 0.691 . . . . 0.0 110.7 -178.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -108.77 127.37 53.95 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.972 1.309 . . . . 0.0 109.593 -172.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -74.17 -40.07 62.79 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.156 0.583 . . . . 0.0 109.967 175.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.97 136.38 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 122.823 0.449 . . . . 0.0 110.411 -169.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.7 m -129.15 110.53 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-O 122.839 1.304 . . . . 0.0 109.55 -170.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.7 mm -109.47 97.41 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -174.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.0 m -73.49 156.09 38.55 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 168.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.41 66.31 0.63 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 77.4 m . . . . . 0 N--CA 1.456 -0.146 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.391 -169.821 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -66.77 11.79 0.09 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.408 1.483 . . . . 0.0 112.624 169.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.7 p -124.01 3.24 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 125.563 1.545 . . . . 0.0 111.508 170.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 52.7 p -127.38 19.5 6.86 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.352 0.978 . . . . 0.0 112.649 -173.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -85.86 -173.64 4.71 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.223 0.609 . . . . 0.0 109.536 171.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -65.91 -32.5 74.04 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -169.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.2 mt -136.3 136.28 49.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -137.33 139.58 40.93 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 170.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -146.75 159.63 43.25 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.436 1.494 . . . . 0.0 107.441 168.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -123.35 96.39 4.97 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.488 1.515 . . . . 0.0 108.955 169.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -73.9 92.81 2.11 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.066 1.346 . . . . 0.0 109.54 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -65.81 97.37 0.34 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.889 1.276 . . . . 0.0 109.532 174.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -125.56 156.2 39.46 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.616 1.566 . . . . 0.0 109.906 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -78.7 66.35 4.18 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.518 1.927 . . . . 0.0 111.701 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -8.87 92.74 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 129.528 3.131 . . . . 0.0 113.553 169.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -60.14 -4.38 2.99 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 124.707 3.605 . . . . 0.0 117.611 -169.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -54.64 98.85 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 120.244 1.384 . . . . 0.0 111.611 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.46 16.89 54.45 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.115 1.817 . . . . 0.0 113.522 170.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -94.95 179.59 5.17 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.792 1.296 . . . . 0.0 112.626 -169.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.2 m -76.35 155.43 34.15 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.254 1.422 . . . . 0.0 109.926 175.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.9 mt -58.89 -31.67 68.82 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.957 -0.464 . . . . 0.0 111.559 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -63.96 -40.53 96.63 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.088 0.404 . . . . 0.0 110.894 177.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.4 t -65.8 -47.44 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 176.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.454 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 8.1 m-85 -53.8 -54.24 41.06 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.225 0.61 . . . . 0.0 110.822 177.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 33.6 mtt180 -59.78 -42.06 92.48 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.707 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.5 m -61.67 -52.72 63.16 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 118.828 0.74 . . . . 0.0 109.222 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.3 t -64.04 -44.42 97.76 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.02 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -57.64 -45.5 85.39 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 119.728 1.149 . . . . 0.0 110.189 -177.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.46 -49.28 66.08 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-O 118.684 -1.064 . . . . 0.0 111.153 177.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -59.9 -50.06 75.25 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 118.661 1.231 . . . . 0.0 111.058 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.6 t -54.18 -48.13 66.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 124.634 1.174 . . . . 0.0 109.921 178.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -60.13 -46.94 87.96 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 120.071 1.305 . . . . 0.0 110.586 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -42.04 86.07 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.304 1.042 . . . . 0.0 110.68 178.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.6 mtt-85 -71.2 -41.88 69.71 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 117.821 -1.085 . . . . 0.0 109.863 -177.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.1 t -54.47 -46.06 70.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 120.461 1.482 . . . . 0.0 109.976 169.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -61.94 -40.21 94.74 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.465 1.03 . . . . 0.0 111.075 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -63.11 -44.62 95.14 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.048 0.539 . . . . 0.0 110.321 176.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.02 -46.79 82.92 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 118.447 -0.787 . . . . 0.0 109.951 -178.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.1 mt -52.86 -41.91 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 124.052 0.941 . . . . 0.0 109.423 173.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.31 -31.01 72.05 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.713 1.142 . . . . 0.0 111.571 -175.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -69.65 -39.25 77.18 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.497 1.119 . . . . 0.0 111.504 176.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.0 pt -95.81 -28.7 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -169.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.5 m . . . . . 0 C--O 1.25 1.132 0 C-N-CA 126.079 1.752 . . . . 0.0 111.22 -179.177 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? . . . . . 0 N--CA 1.466 0.366 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.7 mttt -102.72 104.13 14.43 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 123.515 0.726 . . . . 0.0 109.453 175.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 36.4 t -79.0 141.03 15.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 125.259 1.424 . . . . 0.0 108.837 175.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 30.6 tpp -127.18 142.41 51.5 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.707 1.203 . . . . 0.0 108.368 173.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -124.47 133.49 53.34 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.135 0.974 . . . . 0.0 108.893 173.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.3 t -144.19 122.81 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 120.259 1.39 . . . . 0.0 110.027 -169.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.2 p -132.4 179.9 5.84 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 120.058 1.299 . . . . 0.0 111.181 175.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.8 mttm -62.55 -10.57 12.46 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.789 1.236 . . . . 0.0 114.001 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -143.85 -10.45 0.69 Allowed 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 116.026 1.861 . . . . 0.0 116.026 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 63.2 -40.95 0.19 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 128.312 2.645 . . . . 0.0 114.291 -169.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.5 m -34.84 -39.14 0.09 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 129.252 3.021 . . . . 0.0 118.573 -169.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.7 p -132.64 -72.27 0.52 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 118.124 -0.941 . . . . 0.0 109.594 -169.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 -50.62 -52.58 38.12 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.928 0.785 . . . . 0.0 110.387 -169.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.65 -45.02 63.27 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.361 0.664 . . . . 0.0 111.349 -176.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -59.78 -44.01 94.11 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.204 1.002 . . . . 0.0 111.409 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 53.5 mtp -64.57 -48.29 75.52 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.877 1.271 . . . . 0.0 109.295 178.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.8 -40.14 79.22 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.363 0.265 . . . . 0.0 111.149 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -62.56 -46.95 85.97 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.761 0.425 . . . . 0.0 110.556 177.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.35 -43.43 95.68 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 119.443 -0.643 . . . . 0.0 111.875 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -67.24 -48.92 66.34 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 119.025 1.413 . . . . 0.0 109.159 176.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.71 -42.71 79.63 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 119.599 1.091 . . . . 0.0 112.395 -176.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.3 pttt -75.7 -2.41 29.41 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.9 m -99.16 -45.57 5.86 Favored 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 120.917 -1.114 . . . . 0.0 109.437 169.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 91.9 mt -71.25 -40.34 71.07 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.183 1.793 . . . . 0.0 110.945 -173.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.845 0 CA-C-O 117.444 -1.753 . . . . 0.0 116.8 -169.791 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.1 pt . . . . . 0 N--CA 1.451 -0.377 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -120.37 144.39 47.92 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 169.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.92 153.67 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 123.442 0.697 . . . . 0.0 112.631 -174.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.3 m -151.02 144.9 25.17 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.579 1.552 . . . . 0.0 106.873 168.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 97.6 p -112.01 157.74 20.38 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.35 -0.844 . . . . 0.0 109.665 168.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.7 p -152.02 -164.17 1.91 Allowed 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 171.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.32 161.8 35.18 Favored Glycine 0 CA--C 1.519 0.297 0 O-C-N 121.276 -0.89 . . . . 0.0 111.092 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 66.0 mt -54.75 -32.02 59.28 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.407 1.083 . . . . 0.0 111.123 -173.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -146.85 144.54 29.38 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 168.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.6 p -73.5 153.46 40.31 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.741 0.781 . . . . 0.0 111.296 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.3 m -160.21 154.07 22.86 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.502 2.321 . . . . 0.0 105.869 169.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -57.13 156.12 7.59 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.62 0.645 . . . . 0.0 111.408 -174.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.9 t -63.23 132.34 29.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 172.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -73.84 139.8 77.24 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -75.12 -41.59 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.358 1.372 . . . . 0.0 112.614 -169.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.482 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 25.5 m -64.65 -23.02 67.12 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 120.556 -1.34 . . . . 0.0 111.48 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.62 -40.55 60.11 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 123.622 0.769 . . . . 0.0 111.402 171.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 61.7 mt -56.2 -45.38 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.88 -40.17 91.36 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 124.249 1.02 . . . . 0.0 110.056 -171.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.8 mmm -64.47 -44.86 89.7 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 122.145 0.974 . . . . 0.0 110.16 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.1 mtp -66.94 -36.7 82.83 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.721 177.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -61.04 -29.92 70.01 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.306 0.643 . . . . 0.0 111.272 173.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -64.25 -39.81 94.72 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 118.884 0.766 . . . . 0.0 110.213 173.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 62.1 t -77.79 -17.06 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.027 177.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.92 25.44 10.54 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.787 1.184 . . . . 0.0 111.933 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.9 mt -121.28 179.68 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 125.405 1.482 . . . . 0.0 107.279 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -144.9 156.0 43.75 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.228 1.411 . . . . 0.0 109.351 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -127.74 -16.85 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.831 0.852 . . . . 0.0 112.443 169.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -44.18 -38.71 3.89 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.692 1.197 . . . . 0.0 112.968 172.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.29 -6.45 86.37 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-O 118.582 -1.121 . . . . 0.0 114.268 -173.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -126.61 164.74 20.58 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.156 1.478 . . . . 0.0 110.732 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.5 p -129.88 167.26 18.44 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.017 0.927 . . . . 0.0 111.74 -169.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.1 m -77.45 164.64 25.26 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.573 1.149 . . . . 0.0 111.761 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -157.63 141.58 11.49 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-O 118.411 -0.804 . . . . 0.0 109.471 174.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -78.09 153.37 28.49 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.557 2.171 . . . . 0.0 111.232 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.1 tt -53.82 -33.86 24.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.798 1.239 . . . . 0.0 112.471 177.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -66.07 -20.98 66.34 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.251 1.42 . . . . 0.0 112.074 -169.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -83.33 -0.98 52.17 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.108 0.963 . . . . 0.0 112.561 -173.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -115.85 -173.12 2.29 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.847 0.859 . . . . 0.0 112.462 -170.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.463 ' HA ' ' CH2' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -142.91 131.39 22.32 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 127.284 2.234 . . . . 0.0 107.846 173.433 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.468 ' HB1' ' CE3' ' A' ' 90' ' ' TRP . . . -62.28 -29.16 70.22 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 119.142 -0.456 . . . . 0.0 112.208 178.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -61.73 -20.36 63.42 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.381 0.672 . . . . 0.0 112.372 -170.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -88.73 -22.84 23.13 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.601 0.76 . . . . 0.0 110.955 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -99.08 113.1 25.14 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.972 1.309 . . . . 0.0 108.832 -176.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -72.31 -28.91 63.38 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 122.315 -0.24 . . . . 0.0 110.875 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.18 135.13 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.081 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -172.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.7 t -131.74 129.63 61.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 122.786 1.279 . . . . 0.0 109.253 -173.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.3 mm -120.32 101.77 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -177.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.5 t -72.42 155.39 40.18 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 105.496 -2.039 . . . . 0.0 105.496 168.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.45 36.3 0.89 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 172.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 90.4 m . . . . . 0 CA--C 1.533 0.313 0 O-C-N 121.08 -1.013 . . . . 0.0 112.15 -173.913 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 122.075 0.94 . . . . 0.0 113.271 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.468 ' CE3' ' HB1' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -49.14 -27.52 3.56 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 128.209 2.604 . . . . 0.0 111.65 169.646 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.21 -2.14 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.811 0.844 . . . . 0.0 110.589 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 56.7 p -120.68 18.96 11.93 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.978 0.911 . . . . 0.0 113.151 -169.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -86.95 179.87 6.63 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.306 1.042 . . . . 0.0 110.339 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -57.3 -34.02 68.27 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.714 1.206 . . . . 0.0 113.082 -169.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.4 mt -132.8 139.15 50.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 174.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -140.61 132.92 28.28 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 169.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -142.27 159.13 42.85 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.292 1.437 . . . . 0.0 108.622 169.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -121.14 111.28 17.22 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.764 1.226 . . . . 0.0 109.428 168.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -85.33 93.83 8.8 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.566 1.146 . . . . 0.0 108.741 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -59.77 116.51 4.12 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 169.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.3 mt -149.68 149.32 30.43 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.565 1.546 . . . . 0.0 107.506 -169.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -84.61 63.23 7.8 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 125.023 1.329 . . . . 0.0 111.137 -175.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -0.99 88.0 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 129.021 2.929 . . . . 0.0 112.918 169.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -58.68 -4.93 2.14 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 124.262 3.308 . . . . 0.0 117.33 -169.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -54.91 99.7 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.392 0.996 . . . . 0.0 111.738 176.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.17 18.06 54.35 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 126.16 1.838 . . . . 0.0 113.324 171.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -95.9 178.16 5.52 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.661 1.23 . . . . 0.0 112.562 -169.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.3 m -74.94 154.74 38.01 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.498 1.519 . . . . 0.0 110.048 174.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.9 mt -58.58 -32.67 69.16 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.786 -0.571 . . . . 0.0 111.574 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -63.31 -39.93 95.93 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 122.679 0.392 . . . . 0.0 110.664 177.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.7 t -66.39 -45.77 88.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 176.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.482 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 10.7 m-85 -55.4 -52.06 64.81 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.823 0.449 . . . . 0.0 110.803 177.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 34.8 mtt180 -61.76 -40.09 93.91 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.509 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.3 m -62.0 -51.49 67.82 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.393 0.997 . . . . 0.0 109.708 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 49.0 t -63.66 -45.1 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.958 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 -56.31 -45.83 80.11 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-N 119.705 1.139 . . . . 0.0 109.499 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.17 -50.34 68.75 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-O 118.176 -1.347 . . . . 0.0 110.408 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -59.36 -54.46 46.47 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 118.535 1.168 . . . . 0.0 110.512 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 65.1 t -47.32 -54.57 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 125.541 1.536 . . . . 0.0 110.297 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -62.99 -44.85 94.9 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 120.112 1.324 . . . . 0.0 110.626 -175.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -57.96 -42.19 84.47 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.727 1.211 . . . . 0.0 109.655 177.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 80.5 mtt-85 -74.61 -41.58 60.15 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 117.186 -1.388 . . . . 0.0 109.979 -175.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.6 t -53.15 -45.71 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 121.216 1.825 . . . . 0.0 109.564 169.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -62.29 -42.02 98.99 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.044 0.838 . . . . 0.0 111.218 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -60.91 -46.01 92.34 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 175.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.03 -48.97 76.44 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.252 -0.88 . . . . 0.0 109.561 -176.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 55.9 mt -52.35 -42.14 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 124.234 1.014 . . . . 0.0 109.443 173.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.26 -30.74 71.82 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.638 1.108 . . . . 0.0 111.58 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 44.7 mttt -70.38 -38.0 74.64 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.719 1.208 . . . . 0.0 111.537 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.7 pt -97.61 -27.12 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -169.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.8 m . . . . . 0 C--O 1.25 1.111 0 C-N-CA 126.125 1.77 . . . . 0.0 110.915 176.481 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.464 0.243 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -96.14 117.77 31.39 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 170.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 98.2 t -101.7 135.63 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 125.469 1.508 . . . . 0.0 107.673 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 51.9 ttm -118.86 138.28 52.84 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 168.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -108.68 130.22 55.34 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 169.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.9 t -129.17 113.23 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 120.326 1.421 . . . . 0.0 109.296 -170.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.6 t -111.59 162.63 14.95 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.97 0.805 . . . . 0.0 111.571 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.4 mttm -65.51 -13.01 57.95 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.824 -1.173 . . . . 0.0 112.383 171.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.6 ptt180 -153.81 114.33 3.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 104.149 -2.537 . . . . 0.0 104.149 169.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -69.56 52.92 0.11 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.795 1.238 . . . . 0.0 112.415 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.5 p -126.76 -23.3 3.72 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.842 1.257 . . . . 0.0 112.668 -170.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.455 ' HG ' ' N ' ' A' ' 105' ' ' ASP . 78.6 m -133.99 -87.82 0.4 Allowed 'General case' 0 C--N 1.343 0.3 0 CA-C-O 118.379 -0.82 . . . . 0.0 111.185 -171.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -50.33 -50.6 50.46 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.016 0.825 . . . . 0.0 110.922 -169.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.1 p -70.25 -44.67 68.02 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 125.26 1.424 . . . . 0.0 110.974 -174.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -58.93 -46.39 88.09 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.649 1.18 . . . . 0.0 110.436 -177.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 52.2 mtp -63.76 -46.63 84.41 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.586 1.154 . . . . 0.0 109.598 177.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.74 -37.75 74.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 119.104 -0.474 . . . . 0.0 111.425 178.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -62.29 -53.31 56.98 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-O 118.464 -0.779 . . . . 0.0 109.855 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.91 -41.17 75.62 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -66.38 -49.79 65.68 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 118.271 1.036 . . . . 0.0 109.676 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.0 -46.43 88.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 120.09 1.314 . . . . 0.0 113.082 -174.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -71.14 -8.77 55.74 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 119.7 1.136 . . . . 0.0 113.201 176.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 38.0 m -92.77 -48.7 6.44 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 119.965 1.257 . . . . 0.0 110.552 169.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.2 mt -78.92 -41.55 29.25 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.998 1.719 . . . . 0.0 112.135 -169.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 CA-C-O 117.904 -1.498 . . . . 0.0 114.604 -169.066 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.8 pt . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 121.47 0.652 . . . . 0.0 112.124 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -123.74 134.11 53.74 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 168.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 p -119.45 151.35 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -170.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.2 m -141.71 131.71 24.58 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.132 1.373 . . . . 0.0 108.614 168.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.6 p -98.21 141.4 31.17 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.026 -1.046 . . . . 0.0 108.517 169.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.6 m -154.0 -177.28 6.3 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.413 1.885 . . . . 0.0 106.087 -169.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.53 170.77 43.3 Favored Glycine 0 N--CA 1.439 -1.11 0 O-C-N 121.377 -0.827 . . . . 0.0 111.522 175.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -53.62 -33.58 55.55 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 125.176 1.163 . . . . 0.0 110.048 174.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -143.57 146.23 33.15 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.986 1.714 . . . . 0.0 106.67 169.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 p -70.53 157.66 37.49 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.294 0.569 . . . . 0.0 109.612 169.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.6 m -162.16 148.56 13.39 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.199 1.8 . . . . 0.0 106.795 170.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -54.4 151.96 7.03 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.562 0.619 . . . . 0.0 110.907 -175.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.9 t -57.44 126.19 14.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 172.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -70.46 140.85 87.59 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -72.84 -41.68 1.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.265 1.31 . . . . 0.0 113.192 -169.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.481 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 29.8 m -65.01 -25.19 67.75 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.664 -1.272 . . . . 0.0 111.298 -177.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.46 -40.87 60.33 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.723 0.809 . . . . 0.0 111.335 173.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.8 mt -56.45 -45.88 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.12 -38.37 88.01 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.507 1.123 . . . . 0.0 110.578 -172.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.9 mmm -68.41 -44.02 75.93 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 122.915 1.34 . . . . 0.0 110.434 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.2 mtp -66.88 -34.29 77.46 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 121.124 -0.985 . . . . 0.0 110.005 175.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -62.48 -26.4 68.51 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.998 0.817 . . . . 0.0 111.423 172.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -65.55 -39.84 92.19 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 118.905 0.775 . . . . 0.0 109.768 173.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 63.9 t -78.46 -22.28 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 120.159 -0.617 . . . . 0.0 110.852 177.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.93 25.09 6.63 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.054 1.311 . . . . 0.0 111.948 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.7 mt -122.68 179.03 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 125.227 1.411 . . . . 0.0 107.45 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -144.28 155.96 44.06 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.863 1.665 . . . . 0.0 108.822 -176.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -130.85 -13.04 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.981 0.913 . . . . 0.0 113.365 174.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.7 m -43.1 -34.24 1.03 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.993 1.717 . . . . 0.0 114.637 -176.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -102.82 1.93 48.52 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 117.853 -1.526 . . . . 0.0 114.576 -174.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -71.92 -26.78 62.44 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 120.528 2.164 . . . . 0.0 113.081 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.9 p 60.49 -161.06 0.29 Allowed 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.314 1.046 . . . . 0.0 110.264 -174.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.4 t -134.19 163.0 30.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.798 0.809 . . . . 0.0 111.406 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -161.21 133.9 4.48 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 126.304 1.842 . . . . 0.0 106.373 -171.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -85.0 158.51 11.57 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.875 2.384 . . . . 0.0 110.934 176.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.4 tt -54.28 -35.15 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 123.476 0.711 . . . . 0.0 111.02 172.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -57.22 -24.12 52.47 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.11 1.764 . . . . 0.0 112.66 -175.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -83.3 -2.34 55.44 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.569 0.748 . . . . 0.0 112.547 -176.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -128.88 -176.87 3.99 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.253 1.021 . . . . 0.0 111.005 -177.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.18 129.28 31.46 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 126.602 1.961 . . . . 0.0 108.274 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.31 -29.82 66.18 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.548 1.139 . . . . 0.0 112.939 -175.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -60.73 -22.7 64.27 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.036 0.934 . . . . 0.0 112.475 -176.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -84.31 -18.02 37.67 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.272 0.629 . . . . 0.0 110.605 -177.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -101.89 122.74 44.58 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 125.168 1.387 . . . . 0.0 108.959 -175.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -76.22 -32.34 58.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.841 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.9 138.01 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 123.518 0.727 . . . . 0.0 109.059 -171.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.0 128.01 45.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 122.97 1.367 . . . . 0.0 109.869 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.0 mm -120.33 96.16 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 -175.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.7 m -70.04 156.01 39.78 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 168.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.74 56.07 0.91 Allowed 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 102.753 -3.055 . . . . 0.0 102.753 173.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.4 m . . . . . 0 N--CA 1.452 -0.352 0 C-N-CA 123.834 0.854 . . . . 0.0 110.14 -178.042 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -64.65 8.7 0.11 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.115 1.766 . . . . 0.0 113.03 170.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.7 p -122.1 2.87 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 124.845 1.258 . . . . 0.0 111.652 172.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.9 p -128.05 23.48 6.09 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.212 1.005 . . . . 0.0 112.149 -173.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -88.58 179.87 6.19 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.621 0.768 . . . . 0.0 109.313 170.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -59.69 -33.6 71.79 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.23 1.012 . . . . 0.0 113.246 -171.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.9 mt -134.76 135.67 53.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 177.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -140.43 133.69 29.7 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 169.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -144.81 157.91 43.99 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.001 1.32 . . . . 0.0 107.573 168.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -119.48 117.54 28.71 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.7 1.2 . . . . 0.0 108.496 168.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -93.92 108.65 20.43 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.218 1.407 . . . . 0.0 109.543 -173.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -72.54 105.57 4.25 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.727 1.211 . . . . 0.0 108.511 178.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -135.76 151.94 50.62 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 125.038 1.335 . . . . 0.0 108.855 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -82.98 75.91 9.84 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.735 1.214 . . . . 0.0 110.657 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -21.92 98.86 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 128.096 2.558 . . . . 0.0 112.466 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -60.81 -4.5 3.62 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 124.44 3.427 . . . . 0.0 116.785 -169.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.455 ' N ' ' HG ' ' A' ' 13' ' ' CYS . 12.6 t70 -56.47 101.07 0.05 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.182 1.355 . . . . 0.0 111.485 177.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.37 18.24 55.66 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 126.096 1.808 . . . . 0.0 113.389 170.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -94.41 178.34 5.65 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.652 1.226 . . . . 0.0 112.763 -169.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.2 m -75.18 154.79 37.49 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.477 1.511 . . . . 0.0 109.955 175.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 93.5 mt -57.47 -32.6 67.13 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.017 -0.427 . . . . 0.0 111.479 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.98 -40.29 94.75 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.858 0.463 . . . . 0.0 110.874 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 88.6 t -65.26 -48.31 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 175.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.481 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 6.4 m-85 -53.94 -52.43 60.65 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.281 0.632 . . . . 0.0 110.954 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -60.97 -43.79 98.28 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.74 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.1 m -61.5 -50.78 71.36 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 118.867 0.758 . . . . 0.0 109.183 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 66.3 t -66.71 -43.67 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-O 118.349 -0.834 . . . . 0.0 110.153 -178.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.62 -43.38 89.64 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 119.966 1.257 . . . . 0.0 110.242 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.66 -49.03 71.97 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-O 118.595 -1.114 . . . . 0.0 111.244 176.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -59.96 -51.87 67.82 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 118.701 1.251 . . . . 0.0 110.884 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 64.4 t -52.78 -48.51 49.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 124.804 1.242 . . . . 0.0 109.959 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -60.02 -47.38 86.08 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.86 1.209 . . . . 0.0 110.399 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.04 -42.76 81.06 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.943 0.897 . . . . 0.0 110.341 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -70.6 -43.43 69.38 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 118.19 -0.909 . . . . 0.0 109.961 -176.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 74.6 t -53.83 -48.19 62.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 120.282 1.401 . . . . 0.0 109.661 169.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -59.48 -40.37 86.76 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.449 1.022 . . . . 0.0 110.559 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -62.54 -46.07 90.07 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.307 1.043 . . . . 0.0 110.316 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.38 -49.56 76.42 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 124.099 0.96 . . . . 0.0 109.488 178.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.88 -37.49 67.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.679 1.191 . . . . 0.0 110.795 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.52 -31.12 71.12 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.889 1.222 . . . . 0.0 111.328 -174.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -70.8 -20.15 62.62 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.689 1.595 . . . . 0.0 112.872 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.9 pt -125.28 -21.04 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -168.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 C--O 1.249 1.028 0 C-N-CA 126.186 1.795 . . . . 0.0 111.174 173.684 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 49.0 mmtt . . . . . 0 N--CA 1.463 0.224 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -92.06 137.71 32.14 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.3 p -122.47 143.83 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 121.866 0.841 . . . . 0.0 109.457 -178.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 31.2 tpp -124.38 141.88 51.73 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.368 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -121.67 125.01 45.64 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 170.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.7 t -128.69 129.53 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 120.402 1.456 . . . . 0.0 109.351 -169.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.8 t -137.84 161.05 37.61 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 119.528 1.058 . . . . 0.0 112.473 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.8 mttt -58.76 -21.42 55.58 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.854 1.262 . . . . 0.0 110.884 168.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.4 ptp85 -147.94 101.23 3.28 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 126.096 1.759 . . . . 0.0 107.05 169.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -44.65 -42.46 7.52 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.013 1.325 . . . . 0.0 112.2 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.7 p -45.21 -20.91 0.06 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 129.599 3.159 . . . . 0.0 118.266 -169.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.4 p -130.65 -74.73 0.53 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.953 1.251 . . . . 0.0 110.647 -171.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -61.22 -52.08 66.29 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -169.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.41 -42.94 78.26 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.425 0.29 . . . . 0.0 111.125 -178.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -59.3 -45.66 90.68 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.603 0.761 . . . . 0.0 111.579 -174.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 44.2 mtm -63.97 -46.6 83.91 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 117.78 0.264 . . . . 0.0 110.903 175.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.8 -39.04 76.61 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 117.606 0.185 . . . . 0.0 110.925 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -63.43 -45.44 90.93 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 122.549 0.34 . . . . 0.0 111.163 178.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.24 -40.07 96.45 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -175.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -66.66 -46.44 75.68 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 118.146 0.973 . . . . 0.0 108.923 174.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.49 -44.04 84.62 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 119.338 0.972 . . . . 0.0 112.591 -173.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -67.93 -38.4 82.83 Favored 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 119.246 -0.982 . . . . 0.0 111.049 174.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.1 m -66.89 -43.4 83.54 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 120.478 1.49 . . . . 0.0 110.504 -177.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.1 -37.7 53.77 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.076 1.35 . . . . 0.0 111.184 -173.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.605 0 CA-C-O 116.55 -2.25 . . . . 0.0 117.582 -169.216 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.5 pt . . . . . 0 N--CA 1.449 -0.483 0 CA-C-O 121.361 0.6 . . . . 0.0 111.295 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -126.1 130.8 51.79 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 169.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 p -117.76 152.28 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 C-N-CA 123.331 0.652 . . . . 0.0 111.582 -171.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.4 m -151.69 135.4 16.31 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 167.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 89.0 p -97.43 161.82 13.61 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 121.207 -0.933 . . . . 0.0 109.795 169.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.8 p -151.85 -165.77 2.32 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 169.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.63 165.78 37.0 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 169.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 61.5 mt -54.99 -30.58 59.67 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.825 0.85 . . . . 0.0 110.5 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -148.82 145.96 27.77 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 168.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.2 p -89.55 152.56 21.35 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.593 0.757 . . . . 0.0 111.16 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.8 m -147.52 154.89 41.31 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.748 2.019 . . . . 0.0 106.276 170.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -57.89 148.49 25.36 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.933 0.788 . . . . 0.0 109.702 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 26.9 t -57.95 130.47 21.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -176.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -66.21 136.4 95.28 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -177.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.46 -40.24 6.05 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.273 1.982 . . . . 0.0 113.409 -168.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.493 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 6.1 m -68.0 -17.84 64.54 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.366 -0.834 . . . . 0.0 111.826 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.06 -41.27 87.52 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 121.679 -0.638 . . . . 0.0 110.026 171.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.08 -42.37 94.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.44 -38.92 85.65 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -177.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 21.9 mmt -61.85 -47.49 84.8 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 122.813 1.292 . . . . 0.0 111.326 176.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.0 mtp -69.41 -33.58 73.2 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.368 -178.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -61.95 -29.84 70.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.863 0.865 . . . . 0.0 111.128 172.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -64.98 -39.31 93.28 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.734 0.697 . . . . 0.0 110.328 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 62.1 t -78.67 -23.38 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.935 178.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.95 25.97 5.7 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.109 1.338 . . . . 0.0 112.034 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.3 mt -124.64 176.84 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 125.688 1.595 . . . . 0.0 107.662 -176.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -140.65 157.87 44.81 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.137 1.775 . . . . 0.0 108.605 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -128.21 -20.18 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.649 0.78 . . . . 0.0 113.009 171.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 55.3 p -51.84 -33.36 35.72 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.198 0.908 . . . . 0.0 112.441 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.92 -24.75 59.33 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-O 118.024 -1.431 . . . . 0.0 114.324 -176.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -86.95 -27.41 23.33 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 120.122 1.961 . . . . 0.0 114.953 -169.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 29.2 p 65.87 176.6 0.22 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.719 1.608 . . . . 0.0 113.459 173.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.2 m -102.13 162.13 13.15 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.45 1.1 . . . . 0.0 112.202 -169.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -156.3 134.42 7.18 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-O 118.273 -0.87 . . . . 0.0 109.071 -174.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -80.07 156.24 23.12 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.973 2.448 . . . . 0.0 111.771 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.7 tt -56.7 -33.88 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 123.773 0.829 . . . . 0.0 111.419 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -58.28 -23.13 55.23 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.2 1.8 . . . . 0.0 112.222 -174.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -82.45 -3.17 55.25 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.094 0.958 . . . . 0.0 112.693 -176.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -129.51 177.27 7.32 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 119.916 1.235 . . . . 0.0 112.556 -173.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.43 141.63 50.53 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 128.05 2.54 . . . . 0.0 106.493 170.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.35 -23.9 62.0 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.084 0.954 . . . . 0.0 111.91 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -60.48 -23.09 64.21 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.012 0.925 . . . . 0.0 112.412 -175.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -81.59 -15.85 53.44 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.032 0.933 . . . . 0.0 110.894 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -107.84 128.0 54.22 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.698 1.599 . . . . 0.0 109.65 -172.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -72.44 -40.36 67.13 Favored 'General case' 0 C--O 1.232 0.152 0 O-C-N 121.954 -0.467 . . . . 0.0 110.331 174.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -130.28 135.4 60.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 122.908 0.483 . . . . 0.0 109.927 -170.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.7 t -122.62 119.05 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 122.413 1.101 . . . . 0.0 108.916 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 35.9 mm -108.45 96.7 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.3 t -70.18 156.39 39.29 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 168.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.19 40.32 0.78 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 172.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 85.6 m . . . . . 0 CA--C 1.534 0.34 0 C-N-CA 124.028 0.931 . . . . 0.0 111.55 179.762 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 CA--C 1.54 0.566 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -59.52 -3.96 0.54 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.074 2.15 . . . . 0.0 114.467 171.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.9 p -119.82 -5.62 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 119.545 1.066 . . . . 0.0 112.754 171.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.2 p -102.94 18.12 22.37 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.623 1.101 . . . . 0.0 111.919 -172.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -87.51 -176.96 5.78 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.487 1.115 . . . . 0.0 109.304 172.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -68.22 -32.66 73.02 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -169.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.2 mt -136.61 140.14 43.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -176.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -142.4 139.45 31.67 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.691 1.196 . . . . 0.0 108.661 171.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -147.07 159.68 43.31 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.935 1.694 . . . . 0.0 107.942 168.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -121.72 105.6 10.55 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.06 1.344 . . . . 0.0 108.728 168.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 43.1 m0 -78.38 93.16 4.66 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.067 0.947 . . . . 0.0 109.315 -178.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -60.67 119.93 9.06 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 169.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.8 mt -150.05 152.15 34.37 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.541 1.536 . . . . 0.0 107.529 -169.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -82.47 64.15 6.98 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 125.073 1.349 . . . . 0.0 111.142 -176.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -10.34 94.85 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 128.762 2.825 . . . . 0.0 113.804 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -58.66 -9.95 8.31 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 124.081 3.187 . . . . 0.0 116.549 -173.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -54.81 101.99 0.06 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 120.262 1.392 . . . . 0.0 111.804 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.87 21.63 42.11 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.279 1.895 . . . . 0.0 113.433 172.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -102.07 178.12 4.7 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.839 1.319 . . . . 0.0 113.67 -169.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.2 m -78.73 156.07 29.08 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.204 1.802 . . . . 0.0 110.19 175.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 96.5 mt -60.3 -30.19 69.32 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.772 -0.58 . . . . 0.0 111.951 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.51 -39.07 93.1 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.326 0.512 . . . . 0.0 110.777 176.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 95.3 t -67.46 -45.9 84.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.493 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 12.1 m-85 -55.55 -51.8 65.86 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 118.902 -0.571 . . . . 0.0 110.547 176.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -59.19 -42.11 90.09 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.913 0.779 . . . . 0.0 111.919 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.8 m -61.52 -51.1 70.01 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.052 0.842 . . . . 0.0 109.627 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.7 t -65.46 -43.87 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 117.87 -1.062 . . . . 0.0 110.234 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -55.18 -45.01 75.78 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 119.821 1.191 . . . . 0.0 109.214 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.42 -49.9 72.34 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-O 118.214 -1.326 . . . . 0.0 110.409 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -60.07 -56.43 21.72 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 118.574 1.187 . . . . 0.0 110.423 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.9 t -46.62 -52.46 3.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 125.694 1.597 . . . . 0.0 110.444 176.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -63.61 -46.55 85.23 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 119.708 1.14 . . . . 0.0 110.114 -175.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -43.14 85.04 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.272 0.629 . . . . 0.0 110.197 178.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.6 mtt-85 -69.87 -42.74 73.1 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.894 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 72.9 t -54.12 -49.18 63.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 120.393 1.451 . . . . 0.0 109.516 169.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -59.78 -39.85 86.27 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 119.448 1.022 . . . . 0.0 110.625 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -63.42 -45.9 88.83 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.328 1.051 . . . . 0.0 110.224 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -47.93 80.06 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 124.082 0.953 . . . . 0.0 109.815 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 61.8 mt -57.3 -38.49 62.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 124.703 1.201 . . . . 0.0 110.562 176.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.2 -28.94 69.51 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.776 1.171 . . . . 0.0 111.488 -173.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -73.66 -19.51 60.81 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.879 1.672 . . . . 0.0 112.731 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 pt -125.67 -20.1 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 126.151 1.78 . . . . 0.0 114.921 -168.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.3 m . . . . . 0 C--O 1.251 1.138 0 C-N-CA 126.432 1.893 . . . . 0.0 110.907 170.015 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 51.3 mmtt . . . . . 0 N--CA 1.465 0.297 0 N-CA-C 107.354 -1.351 . . . . 0.0 107.354 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.7 mttt -94.51 135.86 35.46 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.2 p -121.68 144.55 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-O 121.885 0.85 . . . . 0.0 109.548 -176.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 29.6 tpp -124.23 142.2 51.44 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.493 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -123.41 111.37 16.27 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.4 t -111.65 117.06 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 119.611 1.096 . . . . 0.0 108.546 -173.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.9 t -108.05 165.19 11.65 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.713 0.768 . . . . 0.0 110.824 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -59.03 -16.22 17.41 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.701 0.8 . . . . 0.0 111.875 169.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -158.62 115.69 2.81 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 128.241 2.616 . . . . 0.0 103.975 178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -65.02 40.27 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.751 1.62 . . . . 0.0 113.063 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.5 p -122.75 -20.37 5.93 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 119.839 -1.788 . . . . 0.0 113.559 -169.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 82.5 m -132.71 -89.06 0.42 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.595 0.634 . . . . 0.0 111.438 -169.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -56.3 -46.84 79.62 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 118.881 0.764 . . . . 0.0 110.555 -169.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.3 p -68.87 -37.53 79.11 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.584 1.153 . . . . 0.0 111.583 -174.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -66.08 -47.71 73.35 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.704 0.802 . . . . 0.0 109.927 -174.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 69.1 mtm -63.77 -46.16 86.51 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 119.434 -0.317 . . . . 0.0 110.645 176.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.85 -42.4 71.94 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 123.043 0.215 . . . . 0.0 110.822 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -65.29 -47.1 77.83 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 123.02 0.2 . . . . 0.0 110.807 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.63 -38.08 95.72 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -175.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.415 ' CD1' ' HE1' ' A' ' 50' ' ' MET . 18.8 m-85 -65.19 -49.75 68.55 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 174.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.09 -43.39 82.15 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 124.228 1.011 . . . . 0.0 113.079 -172.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -67.47 -37.79 83.46 Favored 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 118.926 -1.109 . . . . 0.0 111.048 174.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.4 m -68.1 -42.16 80.72 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 120.404 1.456 . . . . 0.0 110.481 -177.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.0 mt -75.44 -38.41 59.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.733 1.613 . . . . 0.0 111.555 -175.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.658 0 CA-C-O 116.732 -2.149 . . . . 0.0 117.98 -169.076 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.2 pt . . . . . 0 N--CA 1.451 -0.42 0 CA-C-O 121.406 0.622 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -125.34 131.23 53.04 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 169.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -117.29 152.78 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 123.32 0.648 . . . . 0.0 111.806 -170.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.9 m -148.5 134.42 19.07 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 167.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.4 p -96.99 159.31 14.98 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 120.692 -1.255 . . . . 0.0 107.949 168.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.1 m -153.22 -170.3 3.57 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 176.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.78 164.96 33.91 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 169.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.4 mt -52.32 -30.1 26.71 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 124.627 0.84 . . . . 0.0 110.348 170.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -143.0 148.51 36.9 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 169.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 p -72.46 154.74 40.7 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.25 0.62 . . . . 0.0 109.552 169.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.9 m -159.78 147.1 16.67 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 169.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -58.64 147.66 31.8 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.471 0.578 . . . . 0.0 109.856 -177.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -60.19 129.58 22.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -70.27 139.85 87.46 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.63 -38.83 5.42 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.238 1.959 . . . . 0.0 113.315 -168.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.509 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 8.2 m -68.04 -17.16 64.32 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.315 -0.866 . . . . 0.0 111.647 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.04 -40.62 85.61 Favored 'General case' 0 C--N 1.341 0.229 0 O-C-N 121.456 -0.778 . . . . 0.0 110.26 171.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.9 mp -62.97 -42.15 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -178.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.34 -37.39 83.14 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 20.5 mmt -62.13 -47.02 86.44 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 122.921 1.343 . . . . 0.0 111.197 175.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.415 ' HE1' ' CD1' ' A' ' 21' ' ' PHE . 9.3 mtp -70.09 -31.81 69.56 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.61 -177.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -61.57 -29.13 69.82 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.495 0.718 . . . . 0.0 111.36 169.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -65.83 -35.98 82.2 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.083 0.856 . . . . 0.0 110.475 173.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.4 t -78.96 -26.02 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 117.512 0.142 . . . . 0.0 110.916 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.48 28.19 6.48 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.723 1.154 . . . . 0.0 111.818 -175.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.5 mt -125.66 -177.57 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 126.018 1.727 . . . . 0.0 107.163 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -147.03 158.38 43.91 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.589 1.955 . . . . 0.0 108.355 -178.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -130.57 -13.2 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 173.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.5 p -51.22 -29.31 13.84 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.534 1.061 . . . . 0.0 113.43 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.24 -13.94 65.05 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 118.121 -1.377 . . . . 0.0 114.249 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -74.51 -29.9 61.59 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 120.281 2.041 . . . . 0.0 113.137 -173.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.7 p 59.74 -163.49 0.23 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.482 0.713 . . . . 0.0 109.689 -169.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.5 m -138.07 156.15 48.07 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.937 -173.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -153.44 135.87 9.38 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.319 1.048 . . . . 0.0 109.106 -169.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.89 153.64 22.62 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.466 2.11 . . . . 0.0 111.272 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.6 tt -53.54 -34.09 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.831 0.852 . . . . 0.0 111.486 174.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -57.51 -23.55 50.85 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.079 1.752 . . . . 0.0 112.503 -176.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -86.15 -7.43 58.57 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.736 0.814 . . . . 0.0 112.872 -174.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -121.77 -176.38 3.31 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.459 1.027 . . . . 0.0 110.523 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -133.96 130.58 37.86 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 126.26 1.824 . . . . 0.0 108.439 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.27 -30.43 68.29 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.708 1.203 . . . . 0.0 112.742 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.63 -21.73 63.05 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.066 0.947 . . . . 0.0 112.571 -175.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -85.52 -13.83 47.8 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.452 0.701 . . . . 0.0 111.012 -177.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -109.22 125.17 51.96 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.735 1.214 . . . . 0.0 109.852 -172.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -72.14 -41.38 67.22 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 122.474 0.31 . . . . 0.0 110.229 175.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.65 134.61 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 122.959 0.504 . . . . 0.0 109.898 -169.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.8 t -125.56 111.18 26.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 123.091 1.424 . . . . 0.0 108.64 -177.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.9 mm -100.25 99.26 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 177.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.8 t -72.31 156.81 38.71 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 167.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.57 54.78 0.68 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 103.394 -2.817 . . . . 0.0 103.394 173.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 83.5 m . . . . . 0 N--CA 1.451 -0.389 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.111 173.38 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 . . . . . 0 N--CA 1.472 0.656 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -57.0 -25.76 59.04 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.31 1.044 . . . . 0.0 112.039 173.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.6 p -83.63 -16.18 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 119.625 1.102 . . . . 0.0 110.179 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.7 p -106.51 17.92 22.65 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.917 0.887 . . . . 0.0 112.266 -170.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -78.81 179.12 7.42 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.593 0.757 . . . . 0.0 109.764 171.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -63.61 -31.96 73.28 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -169.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.6 mt -135.64 137.49 49.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -142.21 139.15 31.93 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.228 1.011 . . . . 0.0 108.448 171.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -146.93 161.78 40.06 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.663 1.585 . . . . 0.0 108.003 168.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -122.53 100.77 7.1 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.742 1.617 . . . . 0.0 108.653 168.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.412 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 40.2 m0 -76.27 91.15 3.19 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.558 1.143 . . . . 0.0 108.594 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -64.99 100.65 0.44 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.768 1.227 . . . . 0.0 109.734 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -129.83 155.34 46.15 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.006 1.323 . . . . 0.0 110.856 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -78.06 80.77 4.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.061 1.744 . . . . 0.0 110.125 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -35.69 108.76 0.38 Allowed Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 126.318 1.847 . . . . 0.0 112.652 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -60.26 -2.53 1.87 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 125.13 3.887 . . . . 0.0 117.579 -171.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -53.57 98.4 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 120.495 1.498 . . . . 0.0 112.435 175.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.6 18.73 56.24 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 126.406 1.955 . . . . 0.0 112.963 171.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -95.33 177.21 5.92 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.69 1.245 . . . . 0.0 112.601 -169.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.9 m -74.93 154.91 37.95 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.48 1.512 . . . . 0.0 109.798 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.6 mt -59.5 -29.8 68.11 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.861 -0.524 . . . . 0.0 111.717 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.61 -39.0 92.39 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.226 0.466 . . . . 0.0 110.876 175.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 82.3 t -68.13 -46.55 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 176.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.509 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 17.8 m-85 -55.07 -50.65 68.62 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 119.283 -0.389 . . . . 0.0 110.89 176.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -60.54 -42.13 95.9 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.931 0.893 . . . . 0.0 111.972 177.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 93.6 m -60.82 -51.73 68.08 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 119.156 0.889 . . . . 0.0 109.147 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 74.6 t -61.61 -47.09 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-O 117.891 -1.052 . . . . 0.0 109.81 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 38.6 ttp85 -53.57 -51.41 63.04 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 119.661 1.118 . . . . 0.0 108.967 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.55 -48.48 72.82 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -173.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -60.91 -52.6 64.34 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.856 0.862 . . . . 0.0 110.402 -177.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.0 t -57.98 -49.59 80.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 125.369 1.467 . . . . 0.0 110.325 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -58.25 -48.05 81.65 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 121.034 1.743 . . . . 0.0 110.623 -178.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.98 -45.26 71.35 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.207 1.003 . . . . 0.0 110.505 174.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.412 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 49.9 mtt85 -70.59 -39.87 73.58 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 117.869 -1.062 . . . . 0.0 111.024 -177.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 80.9 t -54.47 -49.14 67.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 120.515 1.507 . . . . 0.0 109.349 169.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -60.47 -39.64 88.34 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.349 0.977 . . . . 0.0 110.58 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -62.81 -45.92 90.36 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.335 1.054 . . . . 0.0 110.464 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.69 -47.95 79.1 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 124.342 1.057 . . . . 0.0 109.714 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.4 mt -57.07 -38.48 60.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.544 1.137 . . . . 0.0 110.591 175.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.28 -28.93 69.54 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.875 1.216 . . . . 0.0 111.5 -173.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -73.64 -19.68 60.78 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.969 1.708 . . . . 0.0 112.79 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.4 pt -125.43 -20.21 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 126.175 1.79 . . . . 0.0 114.826 -168.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 C--O 1.248 1.013 0 C-N-CA 126.571 1.948 . . . . 0.0 110.857 170.005 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -97.17 118.77 34.35 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 172.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.9 p -101.37 138.38 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 O-C-N 123.688 0.617 . . . . 0.0 110.716 173.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 37.9 tpp -116.2 143.72 45.14 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 169.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -115.96 140.71 48.99 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.274 1.43 . . . . 0.0 108.149 169.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.7 t -146.4 129.87 9.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -170.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -133.83 172.16 13.17 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.098 0.863 . . . . 0.0 109.817 169.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -66.31 -12.11 54.64 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.42 -0.8 . . . . 0.0 112.946 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.1 ptm85 -155.23 106.17 2.57 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 171.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -46.99 -28.08 1.52 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.464 1.905 . . . . 0.0 114.135 -177.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -30.12 -42.39 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 129.81 3.244 . . . . 0.0 118.183 -169.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.7 p -136.25 -68.37 0.5 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 117.686 -1.149 . . . . 0.0 113.919 -169.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.5 ptt-85 -56.62 -48.7 76.91 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.507 1.503 . . . . 0.0 110.76 -172.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.83 -51.44 70.0 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.67 0.788 . . . . 0.0 110.121 176.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 -62.55 -44.88 95.26 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.68 0.792 . . . . 0.0 111.769 -173.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 51.4 mtm -62.87 -45.72 91.23 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.916 0.486 . . . . 0.0 110.384 175.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.99 -37.99 75.29 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 119.434 -0.317 . . . . 0.0 110.393 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -61.13 -50.03 74.88 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.4 0.68 . . . . 0.0 110.258 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.57 -44.69 94.71 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 119.348 -0.695 . . . . 0.0 111.866 -177.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -65.84 -46.98 76.54 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 118.773 1.286 . . . . 0.0 108.646 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.16 -43.3 87.32 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 119.779 1.172 . . . . 0.0 112.54 -175.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -68.26 -35.59 78.12 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.786 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.3 m -67.74 -42.43 81.86 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 120.047 -1.658 . . . . 0.0 110.758 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.9 mt -73.05 -40.1 65.39 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.031 1.732 . . . . 0.0 111.036 -174.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.799 0 CA-C-O 116.749 -2.14 . . . . 0.0 117.964 -169.506 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.3 pt . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.72 130.3 56.64 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 169.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.7 p -113.94 151.83 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-O 121.882 0.848 . . . . 0.0 111.911 -175.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.1 m -144.15 152.59 41.12 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 126.214 1.806 . . . . 0.0 106.206 167.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.0 p -129.26 157.07 42.9 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.135 0.974 . . . . 0.0 108.803 168.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.6 p -158.53 -161.39 0.98 Allowed 'General case' 0 C--O 1.241 0.642 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.66 163.96 33.35 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 169.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 65.3 mt -53.36 -31.79 46.23 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.37 1.068 . . . . 0.0 110.727 177.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -143.14 145.04 32.47 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 168.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.9 p -75.66 165.65 24.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.911 0.863 . . . . 0.0 111.567 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.5 p -150.03 -132.27 0.05 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.542 1.537 . . . . 0.0 106.957 177.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -144.55 157.73 44.09 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 171.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.5 t -65.24 131.6 31.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -177.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -71.99 138.54 82.22 Favored Pre-proline 0 N--CA 1.446 -0.65 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.96 -38.17 5.47 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 CA-C-N 120.423 1.187 . . . . 0.0 111.694 -169.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.48 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 8.6 m -67.59 -19.12 65.21 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.56 -1.338 . . . . 0.0 112.094 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.15 -39.2 78.17 Favored 'General case' 0 C--O 1.231 0.084 0 O-C-N 121.502 -0.749 . . . . 0.0 110.494 172.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.6 mt -58.37 -47.73 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.51 -40.33 91.04 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.808 0.843 . . . . 0.0 111.837 -175.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.2 mmt -60.26 -48.61 81.03 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.517 1.151 . . . . 0.0 111.21 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 9.3 mtp -69.04 -35.34 76.48 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.914 -178.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -61.18 -30.51 70.45 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.824 0.738 . . . . 0.0 111.55 172.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -63.22 -39.58 95.03 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.026 0.83 . . . . 0.0 110.384 173.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.1 t -79.76 -18.65 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-O 119.888 -0.101 . . . . 0.0 111.098 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.13 26.35 8.91 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.552 1.073 . . . . 0.0 111.816 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.7 mt -122.09 -176.13 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 126.078 1.751 . . . . 0.0 106.505 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -149.68 155.58 40.44 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 120.406 -1.434 . . . . 0.0 109.632 -177.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.49 -13.61 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.061 0.945 . . . . 0.0 112.538 169.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 99.7 p -52.99 -30.83 37.43 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.659 1.118 . . . . 0.0 112.432 176.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.14 -7.11 87.76 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 118.526 -1.152 . . . . 0.0 114.366 -176.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -125.3 169.9 11.84 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.37 1.585 . . . . 0.0 110.93 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 19.2 p -127.58 164.47 21.93 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.231 1.012 . . . . 0.0 112.365 -169.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.4 m -78.98 156.91 28.25 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.567 1.147 . . . . 0.0 110.953 171.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -155.42 145.14 15.46 Favored Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 123.935 0.894 . . . . 0.0 109.542 -177.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -80.32 151.94 20.56 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.246 1.964 . . . . 0.0 111.113 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.1 tt -54.25 -34.92 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.658 0.783 . . . . 0.0 111.442 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -60.59 -21.58 62.78 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.689 1.595 . . . . 0.0 112.471 -174.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -79.77 -5.54 55.52 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.564 0.746 . . . . 0.0 112.562 -177.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -124.76 -175.83 3.38 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.539 1.136 . . . . 0.0 110.651 -178.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.49 127.19 25.34 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 126.563 1.945 . . . . 0.0 107.583 176.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.79 -27.74 63.37 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.604 1.162 . . . . 0.0 112.447 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -59.82 -23.47 63.37 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.33 1.052 . . . . 0.0 112.739 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -85.0 -14.18 48.26 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.421 0.689 . . . . 0.0 110.72 -177.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -104.54 126.21 51.42 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 125.222 1.409 . . . . 0.0 109.012 -174.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.94 -42.63 76.45 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.8 p -130.99 136.08 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 C-N-CA 122.9 0.48 . . . . 0.0 109.918 -169.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.5 m -127.66 120.3 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-O 122.363 1.078 . . . . 0.0 108.651 -172.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.6 mm -116.72 102.84 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-N 115.006 -0.997 . . . . 0.0 108.389 -169.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.9 t -74.37 153.68 39.16 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 168.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.79 36.48 0.4 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 171.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 77.4 m . . . . . 0 C--N 1.339 0.128 0 O-C-N 120.92 -1.113 . . . . 0.0 112.151 -169.962 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 . . . . . 0 N--CA 1.471 0.609 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 56.1 m95 -67.44 11.29 0.13 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.628 1.971 . . . . 0.0 112.725 171.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.0 p -121.95 4.04 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 125.229 1.412 . . . . 0.0 111.651 169.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 36.3 p -131.71 25.9 4.7 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.17 -0.956 . . . . 0.0 112.602 -172.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -91.54 -170.72 2.69 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 170.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -64.55 -32.06 73.54 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.295 0.638 . . . . 0.0 112.235 -170.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.3 mt -137.9 138.3 44.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -134.61 134.88 41.73 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 169.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -141.25 152.06 44.23 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 169.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -119.95 124.74 46.72 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.448 1.099 . . . . 0.0 109.143 169.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -107.76 86.64 2.33 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -54.82 125.11 18.79 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 169.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 25.0 mt -149.06 156.12 41.76 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.618 1.567 . . . . 0.0 107.4 -169.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -82.4 60.93 5.33 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.725 1.21 . . . . 0.0 111.151 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.3 t0 4.53 85.97 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.469 0 C-N-CA 129.348 3.059 . . . . 0.0 112.141 169.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -61.56 -8.14 10.35 Favored 'Trans proline' 0 C--N 1.352 0.748 0 N-CA-C 116.71 1.773 . . . . 0.0 116.71 -169.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -61.04 95.98 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.848 1.204 . . . . 0.0 111.27 -177.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.5 16.1 25.55 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.243 1.878 . . . . 0.0 113.361 172.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -95.76 178.12 5.56 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.925 1.362 . . . . 0.0 113.167 -169.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.4 m -76.55 155.73 33.43 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.985 1.714 . . . . 0.0 110.143 174.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 97.0 mt -58.53 -32.5 68.92 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.853 -0.529 . . . . 0.0 111.621 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -71.15 -33.82 70.42 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.126 0.421 . . . . 0.0 110.852 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 72.1 t -65.82 -45.75 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 172.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.48 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 13.6 m-85 -57.38 -49.8 75.03 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 118.609 -0.71 . . . . 0.0 110.52 176.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 60.9 mtt180 -57.6 -43.35 84.61 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.425 1.011 . . . . 0.0 111.808 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 89.4 m -61.15 -53.58 55.24 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 50.4 t -63.58 -41.62 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.558 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -56.64 -48.36 77.7 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 120.205 1.366 . . . . 0.0 109.225 177.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.66 -45.31 96.54 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -59.31 -60.83 3.23 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 123.756 0.823 . . . . 0.0 109.017 177.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.4 t -45.29 -51.62 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 126.752 2.021 . . . . 0.0 110.974 177.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -63.54 -46.54 85.5 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 120.008 1.276 . . . . 0.0 110.38 -175.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.26 -42.12 85.75 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.708 0.803 . . . . 0.0 110.237 176.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -69.33 -43.13 74.34 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.292 1.037 . . . . 0.0 109.914 -175.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 71.5 t -54.79 -48.97 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 119.427 1.012 . . . . 0.0 110.068 168.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -60.67 -38.96 86.66 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 120.017 1.281 . . . . 0.0 111.197 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -63.66 -44.38 93.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.439 1.096 . . . . 0.0 110.201 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.11 -40.8 67.91 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.101 -179.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.7 mt -51.88 -43.23 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 124.004 0.921 . . . . 0.0 108.697 169.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.15 -29.81 70.61 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.674 1.125 . . . . 0.0 111.494 -173.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -71.8 -44.8 63.33 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.121 1.368 . . . . 0.0 110.761 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 pt -85.02 -29.07 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.895 1.278 . . . . 0.0 113.89 -173.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.5 m . . . . . 0 C--O 1.249 1.053 0 C-N-CA 126.161 1.785 . . . . 0.0 111.102 179.693 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.4 mptt . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -88.93 116.96 27.6 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 170.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 98.3 t -99.04 138.3 23.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 125.286 1.435 . . . . 0.0 107.19 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 31.0 tpp -121.5 140.72 51.82 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.792 1.237 . . . . 0.0 108.889 175.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -122.19 134.85 54.71 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 170.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.7 t -140.35 133.89 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 119.42 1.009 . . . . 0.0 109.182 -170.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 p -139.71 167.76 21.38 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 119.897 1.226 . . . . 0.0 111.813 169.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -62.08 -18.16 59.85 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -146.83 102.93 3.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 169.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -44.56 -36.75 3.16 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 127.112 2.165 . . . . 0.0 113.355 -177.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.2 m -45.68 -13.5 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 129.519 3.128 . . . . 0.0 119.237 -168.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.5 p -128.97 -89.14 0.51 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 120.279 1.4 . . . . 0.0 111.17 -171.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -57.8 -48.28 80.16 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.555 0.616 . . . . 0.0 110.758 -169.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.4 m -57.74 -44.43 86.04 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.462 0.705 . . . . 0.0 110.104 -175.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -76.25 -32.73 59.02 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 119.075 -0.488 . . . . 0.0 111.773 -173.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 65.4 mtm -65.55 -47.15 76.85 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.691 0.678 . . . . 0.0 109.986 169.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.22 -36.08 70.46 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.842 0.457 . . . . 0.0 110.831 177.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -59.08 -62.04 2.18 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.79 -39.66 68.61 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 119.144 -0.809 . . . . 0.0 111.883 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.405 ' CZ ' ' SD ' ' A' ' 50' ' ' MET . 40.5 m-85 -66.53 -50.25 63.8 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 119.038 1.419 . . . . 0.0 110.594 174.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.32 -43.47 98.76 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 120.233 1.378 . . . . 0.0 112.45 -172.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 ptmt -70.48 -9.04 55.52 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.626 1.103 . . . . 0.0 113.24 175.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.7 m -92.67 -49.4 6.11 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 119.982 1.265 . . . . 0.0 110.544 169.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.5 mt -78.32 -41.4 33.8 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 125.642 1.577 . . . . 0.0 112.205 -169.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.338 0 CA-C-O 118.034 -1.426 . . . . 0.0 114.75 -169.142 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.9 pt . . . . . 0 C--O 1.233 0.211 0 CA-C-O 121.342 0.591 . . . . 0.0 111.635 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.7 127.92 53.31 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 168.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.0 p -109.07 150.69 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-O 121.55 0.691 . . . . 0.0 111.654 -176.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.7 m -148.95 137.51 21.13 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 167.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.3 m -124.02 152.46 42.57 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 121.752 -0.593 . . . . 0.0 110.291 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 19.3 p -157.56 -163.62 1.39 Allowed 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -171.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.65 168.77 41.82 Favored Glycine 0 N--CA 1.448 -0.504 0 O-C-N 121.318 -0.864 . . . . 0.0 111.098 174.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 65.6 mt -56.42 -32.3 64.73 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.085 0.554 . . . . 0.0 111.061 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -141.57 149.39 40.7 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 169.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.8 p -91.1 157.93 16.94 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.276 1.031 . . . . 0.0 110.599 170.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 28.5 m -164.88 158.23 17.05 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.826 2.85 . . . . 0.0 104.912 169.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 96.5 mtt-85 -50.93 136.73 22.28 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.643 1.111 . . . . 0.0 110.449 -172.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.7 p -58.17 131.72 22.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -70.33 142.83 90.0 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-O 118.851 -0.595 . . . . 0.0 109.872 -169.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.68 -39.7 0.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.53 1.486 . . . . 0.0 112.583 -169.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.45 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 29.3 m -62.44 -25.8 68.16 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.643 -1.286 . . . . 0.0 111.529 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.75 -43.98 38.11 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.61 0.764 . . . . 0.0 110.928 172.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.9 mt -54.99 -46.52 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 C-N-CA 124.257 1.023 . . . . 0.0 108.345 -178.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.4 -34.89 79.22 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 123.996 0.918 . . . . 0.0 110.051 -171.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.9 mmm -70.09 -41.94 73.39 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.062 0.934 . . . . 0.0 110.549 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.423 ' HG3' ' CG1' ' A' ' 57' ' ' ILE . 87.8 mmm -62.82 -41.23 99.24 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 174.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -61.79 -26.27 67.99 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.079 0.552 . . . . 0.0 111.129 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -66.25 -40.27 90.07 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 118.478 0.581 . . . . 0.0 110.025 172.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.5 t -77.96 -26.22 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.816 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.98 24.29 6.09 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 125.354 1.455 . . . . 0.0 112.009 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.8 mt -121.81 177.63 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 125.643 1.577 . . . . 0.0 107.576 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -143.37 159.0 43.16 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.495 1.518 . . . . 0.0 109.746 -177.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.423 ' CG1' ' HG3' ' A' ' 50' ' ' MET . 0.7 OUTLIER -131.3 -18.64 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.244 1.017 . . . . 0.0 111.776 169.62 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -42.64 -38.32 1.99 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.155 1.382 . . . . 0.0 113.345 174.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.13 -11.28 63.62 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.529 1.061 . . . . 0.0 113.899 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -128.13 172.8 10.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.413 1.485 . . . . 0.0 112.442 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.2 p -125.09 164.28 20.55 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.709 1.604 . . . . 0.0 110.348 -176.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.26 166.95 21.4 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.512 1.525 . . . . 0.0 111.539 174.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -154.91 142.67 14.09 Favored Pre-proline 0 N--CA 1.472 0.643 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.535 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -84.49 151.85 11.86 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.028 2.485 . . . . 0.0 111.868 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.2 tt -58.19 -32.75 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 123.951 0.9 . . . . 0.0 111.647 175.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -57.24 -21.6 35.2 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.255 1.822 . . . . 0.0 112.1 -176.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -74.72 -9.61 58.73 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.662 1.185 . . . . 0.0 112.855 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -134.1 179.7 6.09 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 120.24 1.382 . . . . 0.0 112.711 -175.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.42 143.08 51.15 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 127.901 2.48 . . . . 0.0 107.384 169.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.62 -25.31 62.98 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.194 0.998 . . . . 0.0 112.439 -176.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -60.88 -23.12 64.94 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.753 0.821 . . . . 0.0 112.325 -174.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -80.71 -16.44 53.94 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.122 0.969 . . . . 0.0 110.597 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -102.77 124.37 48.18 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 125.394 1.477 . . . . 0.0 109.083 -173.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -72.16 -36.43 69.3 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 176.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.73 132.32 56.9 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -170.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.1 t -124.04 132.52 71.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 122.188 0.994 . . . . 0.0 108.894 178.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.9 mm -121.87 102.74 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -178.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.3 m -73.95 155.08 39.03 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 168.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.27 26.71 0.96 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.633 1.573 . . . . 0.0 108.156 175.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 86.4 m . . . . . 0 C--N 1.339 0.138 0 C-N-CA 124.863 1.265 . . . . 0.0 113.276 -169.877 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -55.58 -28.47 55.22 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 124.821 1.248 . . . . 0.0 112.193 173.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.5 p -87.39 -2.63 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 118.935 0.789 . . . . 0.0 110.26 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.7 p -123.35 22.66 9.26 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.144 0.978 . . . . 0.0 112.716 -169.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -82.07 178.14 8.44 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.479 0.712 . . . . 0.0 110.7 174.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.72 -33.87 72.18 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.454 1.101 . . . . 0.0 112.224 -169.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.5 mt -129.2 138.58 54.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 172.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -141.94 134.49 28.23 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 170.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -141.15 153.9 45.6 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 168.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -120.08 104.9 10.51 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.715 1.206 . . . . 0.0 110.069 169.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 37.9 m0 -80.59 79.48 7.2 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.381 1.872 . . . . 0.0 108.564 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -55.02 118.67 4.51 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 171.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 30.6 mt -147.07 154.7 41.48 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.534 1.534 . . . . 0.0 107.785 -169.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -82.8 59.35 4.75 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.963 1.305 . . . . 0.0 111.982 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 47.8 t0 5.79 82.23 0.04 OUTLIER Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 129.925 3.29 . . . . 0.0 113.135 169.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -59.49 -13.67 22.01 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.997 3.131 . . . . 0.0 118.691 -168.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -62.98 98.24 0.13 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.623 1.556 . . . . 0.0 110.217 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 106.24 10.94 28.71 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.22 1.867 . . . . 0.0 113.559 173.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -95.7 179.38 5.14 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.152 1.476 . . . . 0.0 113.29 -169.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.3 m -76.9 155.51 32.78 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.653 1.581 . . . . 0.0 110.123 175.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 57.3 mt -59.42 -32.2 69.97 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.879 -0.513 . . . . 0.0 111.686 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.36 -41.2 98.41 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.245 0.475 . . . . 0.0 110.765 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 97.3 t -66.28 -45.92 88.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.45 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 11.1 m-85 -55.69 -50.88 69.11 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.86 177.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 53.8 mtp85 -62.58 -40.49 97.05 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 118.31 -0.853 . . . . 0.0 111.486 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 93.9 m -62.08 -52.37 64.2 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 118.57 0.623 . . . . 0.0 109.334 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.9 t -66.37 -45.59 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 118.128 -0.939 . . . . 0.0 110.324 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -40.91 88.78 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 120.054 1.297 . . . . 0.0 110.298 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.48 -50.12 69.93 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-O 118.479 -1.178 . . . . 0.0 110.942 175.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -60.41 -53.72 54.26 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 118.652 1.226 . . . . 0.0 110.631 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.6 t -47.01 -51.92 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 125.212 1.405 . . . . 0.0 109.965 175.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -62.12 -48.35 80.52 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.604 1.093 . . . . 0.0 110.803 -177.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.36 -43.74 75.37 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.295 1.038 . . . . 0.0 110.257 177.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 81.7 mtt-85 -72.12 -40.85 67.84 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 117.833 -1.079 . . . . 0.0 110.094 -175.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 71.4 t -55.05 -48.74 75.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 120.71 1.595 . . . . 0.0 109.057 169.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.33 -39.8 88.34 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.34 0.973 . . . . 0.0 110.698 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -63.13 -46.01 89.3 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.201 1.0 . . . . 0.0 110.326 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.9 -44.14 90.56 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 123.148 0.579 . . . . 0.0 110.085 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.9 mt -58.56 -36.62 60.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.161 0.984 . . . . 0.0 110.775 174.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.96 -30.73 71.8 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.91 1.232 . . . . 0.0 111.34 -174.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -65.94 -24.87 66.91 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.285 1.434 . . . . 0.0 113.422 177.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.0 pt -123.23 -20.08 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 -167.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.3 m . . . . . 0 C--O 1.248 1.026 0 C-N-CA 126.074 1.75 . . . . 0.0 111.05 173.232 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.9 mptt . . . . . 0 N--CA 1.466 0.34 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -90.64 135.63 33.59 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 121.494 -0.754 . . . . 0.0 109.013 170.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.4 p -115.37 140.37 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 123.659 0.784 . . . . 0.0 109.483 173.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 45.2 tpp -118.59 143.26 46.91 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 171.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -118.38 127.28 53.53 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 169.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 53.4 t -126.69 114.12 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 119.999 1.272 . . . . 0.0 108.871 -171.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.2 t -110.94 160.35 16.88 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.766 0.712 . . . . 0.0 111.071 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -59.13 -18.13 33.05 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 121.321 -0.862 . . . . 0.0 112.637 174.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.11 -2.39 2.07 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -174.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.489 ' ND2' ' H ' ' A' ' 63' ' ' ASP . 37.0 t-20 37.71 35.73 0.08 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.314 1.846 . . . . 0.0 115.211 -169.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.7 p -107.88 -35.08 6.74 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 120.523 -1.361 . . . . 0.0 112.306 -171.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 20.4 m -134.75 -68.36 0.54 Allowed 'General case' 0 C--N 1.342 0.27 0 CA-C-O 117.948 -1.025 . . . . 0.0 111.727 -169.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -56.13 -53.51 56.25 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.46 1.027 . . . . 0.0 110.262 -170.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.9 p -68.45 -43.06 77.89 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.675 1.19 . . . . 0.0 110.467 -174.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -59.94 -47.51 85.51 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.773 1.229 . . . . 0.0 110.626 -177.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 44.7 mtm -65.75 -44.98 84.28 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 119.272 -0.394 . . . . 0.0 110.77 175.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.89 -40.16 66.36 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.818 0.281 . . . . 0.0 110.945 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -63.6 -55.08 26.52 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 118.676 -0.678 . . . . 0.0 110.009 177.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -53.15 -40.17 59.07 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 119.077 -0.846 . . . . 0.0 111.974 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.429 ' CD1' ' HE3' ' A' ' 50' ' ' MET . 13.3 m-85 -66.29 -49.13 68.15 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 119.11 1.455 . . . . 0.0 108.525 176.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.58 -46.05 90.07 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 124.183 0.993 . . . . 0.0 112.942 -173.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.5 ptmt -68.54 -8.81 44.84 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 119.337 0.971 . . . . 0.0 113.173 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.1 m -94.48 -47.59 6.49 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 119.984 1.266 . . . . 0.0 110.72 169.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.1 mt -76.34 -42.66 44.15 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.885 1.674 . . . . 0.0 111.956 -169.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 CA-C-O 117.741 -1.588 . . . . 0.0 114.935 -169.084 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.1 pt . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -122.84 133.57 54.43 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 168.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -116.8 157.56 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -169.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 m -148.3 145.55 28.21 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 126.306 1.842 . . . . 0.0 107.678 168.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.7 p -115.85 141.21 48.4 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.492 1.517 . . . . 0.0 108.608 168.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.8 m -150.73 -177.68 6.13 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.059 1.744 . . . . 0.0 106.616 -171.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.13 168.87 39.46 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.114 -1.041 . . . . 0.0 112.953 173.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.0 mp -56.2 -36.45 68.43 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 125.305 1.238 . . . . 0.0 110.607 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -150.24 150.41 31.51 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 169.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 65.8 m -83.64 146.5 28.22 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.567 0.699 . . . . 0.0 112.223 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.4 m -144.12 158.1 43.92 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 128.444 2.697 . . . . 0.0 104.505 168.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.5 ptt-85 -57.52 146.2 30.78 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.403 1.001 . . . . 0.0 110.392 -175.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 p -62.91 133.91 28.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 169.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -78.48 145.15 67.12 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.295 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.44 -41.11 0.36 Allowed 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.44 1.426 . . . . 0.0 112.814 -169.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.448 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 38.6 m -63.09 -24.86 68.1 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.422 -1.424 . . . . 0.0 111.314 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.67 -40.59 53.97 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.882 0.873 . . . . 0.0 111.514 172.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 55.5 mt -56.42 -44.23 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 124.304 1.042 . . . . 0.0 108.248 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.01 -37.67 81.69 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 125.069 1.347 . . . . 0.0 110.29 -172.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.0 mmm -68.66 -41.92 78.66 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 123.088 1.423 . . . . 0.0 110.427 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.429 ' HE3' ' CD1' ' A' ' 21' ' ' PHE . 4.6 mtp -66.62 -34.3 77.57 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 120.689 -1.257 . . . . 0.0 109.948 175.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -61.3 -28.83 69.48 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.844 -0.598 . . . . 0.0 111.654 170.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -61.24 -40.85 95.57 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.23 0.923 . . . . 0.0 110.529 173.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.7 m -92.58 7.3 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 178.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.99 25.34 49.53 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.137 0.875 . . . . 0.0 112.6 170.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.416 HG23 ' H ' ' A' ' 56' ' ' ASP . 9.9 mt -123.84 -174.82 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 125.404 1.482 . . . . 0.0 107.159 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.416 ' H ' HG23 ' A' ' 55' ' ' ILE . 8.0 t70 -148.85 155.84 41.47 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.612 1.565 . . . . 0.0 109.349 -176.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.49 -15.44 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 124.148 0.979 . . . . 0.0 112.38 169.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.6 p -52.6 -30.82 33.28 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.544 1.065 . . . . 0.0 112.621 176.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.79 -7.48 86.13 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.729 1.157 . . . . 0.0 114.187 -177.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -123.65 173.7 7.93 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 119.3 1.55 . . . . 0.0 111.165 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.5 p -128.72 174.02 9.81 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.11 1.364 . . . . 0.0 110.749 -173.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.8 p -96.92 151.74 19.4 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.355 1.062 . . . . 0.0 110.1 172.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.489 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 3.5 t70 -150.11 148.79 25.65 Favored Pre-proline 0 C--O 1.239 0.543 0 C-N-CA 125.415 1.486 . . . . 0.0 109.258 -171.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -84.04 151.72 12.55 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.957 1.772 . . . . 0.0 110.898 -177.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.8 tt -54.86 -31.45 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 123.309 0.644 . . . . 0.0 111.271 171.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -50.78 -28.93 10.28 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.243 2.617 . . . . 0.0 112.274 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -83.98 -4.82 59.0 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.269 1.028 . . . . 0.0 112.917 -172.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -129.58 -176.84 4.03 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.643 1.111 . . . . 0.0 110.998 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.83 139.49 50.17 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 127.113 2.165 . . . . 0.0 107.427 173.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.62 -26.58 65.43 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.427 1.091 . . . . 0.0 111.791 -178.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -59.91 -24.54 64.41 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.105 0.962 . . . . 0.0 112.317 -171.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -89.85 -13.04 37.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.766 0.827 . . . . 0.0 111.08 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -94.2 133.05 38.12 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 125.307 1.443 . . . . 0.0 109.798 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -75.48 -42.47 52.91 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.3 p -132.75 137.24 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 123.02 0.528 . . . . 0.0 110.454 -169.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.3 m -129.51 104.61 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-O 123.5 1.619 . . . . 0.0 109.336 -171.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.7 mm -101.65 99.11 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 -177.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.8 t -73.19 155.77 39.26 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 168.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.08 53.49 0.57 Allowed 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 173.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 90.2 m . . . . . 0 C--N 1.339 0.118 0 C-N-CA 123.835 0.854 . . . . 0.0 109.546 173.525 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -66.1 8.99 0.17 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 126.58 1.952 . . . . 0.0 113.396 171.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.9 p -119.95 1.43 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.836 1.255 . . . . 0.0 111.705 171.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.1 p -125.49 25.38 7.05 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.989 0.915 . . . . 0.0 112.156 -172.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -91.54 -172.75 3.34 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.464 0.705 . . . . 0.0 109.444 170.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -66.08 -33.98 77.02 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -169.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.6 mt -136.84 134.46 48.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -139.27 140.23 37.59 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.263 1.025 . . . . 0.0 108.61 173.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -148.91 160.54 43.17 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.372 1.469 . . . . 0.0 107.93 168.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -121.95 102.44 8.18 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.274 1.43 . . . . 0.0 108.743 168.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -77.91 98.62 5.7 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.131 0.972 . . . . 0.0 109.596 -176.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -69.25 104.39 2.2 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.799 1.239 . . . . 0.0 109.229 174.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -137.69 168.71 19.12 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 126.679 1.992 . . . . 0.0 108.033 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -67.53 162.4 23.42 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 166.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -117.1 105.32 49.3 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 171.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -54.7 -1.88 0.17 Allowed 'Trans proline' 0 CA--C 1.537 0.64 1 C-N-CA 125.882 4.388 . . . . 0.0 118.652 -169.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -50.67 91.64 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.365 1.866 . . . . 0.0 112.616 172.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.64 16.71 51.49 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 126.121 1.819 . . . . 0.0 113.244 171.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -94.38 -179.96 5.09 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.843 1.322 . . . . 0.0 112.075 -169.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.5 m -77.46 155.67 31.59 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.089 1.356 . . . . 0.0 109.937 175.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.3 mt -58.61 -32.08 68.68 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 122.032 -0.418 . . . . 0.0 111.546 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -61.96 -39.27 91.56 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.145 0.429 . . . . 0.0 110.731 176.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 89.1 t -67.65 -46.78 82.15 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.448 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 14.0 m-85 -54.04 -52.58 60.41 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.885 0.474 . . . . 0.0 110.898 176.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 28.9 mtt180 -59.29 -42.14 90.57 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.371 1.069 . . . . 0.0 111.621 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 95.4 m -60.86 -52.71 63.9 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 95.8 t -64.41 -42.88 96.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 118.803 -0.618 . . . . 0.0 110.094 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -55.26 -46.71 76.09 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.346 0.976 . . . . 0.0 109.738 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -69.38 -49.35 39.28 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-O 119.211 -0.772 . . . . 0.0 111.866 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -63.79 -45.09 91.28 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.657 1.228 . . . . 0.0 111.866 -174.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.4 t -64.07 -43.42 97.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 117.874 -1.06 . . . . 0.0 109.37 176.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -58.56 -46.37 87.02 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.472 1.487 . . . . 0.0 110.512 178.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.09 -44.13 78.73 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.587 1.155 . . . . 0.0 110.138 176.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.3 mtt85 -71.25 -39.64 71.5 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 117.953 -1.023 . . . . 0.0 111.042 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 88.4 t -54.94 -48.02 75.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 120.514 1.506 . . . . 0.0 109.784 169.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -60.08 -39.6 86.64 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.459 1.027 . . . . 0.0 110.614 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -62.28 -45.51 92.96 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.211 1.004 . . . . 0.0 110.485 178.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.38 -47.62 78.57 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 124.033 0.933 . . . . 0.0 110.06 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 63.7 mt -56.62 -38.37 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.394 1.078 . . . . 0.0 110.329 175.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.98 -28.87 69.32 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.72 1.145 . . . . 0.0 111.44 -174.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -75.16 -19.59 59.79 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.806 1.643 . . . . 0.0 112.731 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.4 pt -125.11 -20.56 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 125.707 1.603 . . . . 0.0 115.29 -168.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 C--O 1.251 1.137 0 C-N-CA 126.573 1.949 . . . . 0.0 110.935 172.311 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? . . . . . 0 N--CA 1.467 0.382 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -92.36 126.21 37.35 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 169.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.7 p -115.88 135.5 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 O-C-N 123.721 0.638 . . . . 0.0 110.962 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 55.1 tpp -107.5 153.05 23.41 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.237 1.015 . . . . 0.0 109.204 170.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -130.03 104.48 7.37 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.985 1.714 . . . . 0.0 106.686 169.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.97 127.28 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 120.057 1.298 . . . . 0.0 109.158 -176.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.2 t -116.17 163.11 16.45 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.791 1.178 . . . . 0.0 112.34 176.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -58.99 -21.81 59.49 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.584 -0.697 . . . . 0.0 111.654 171.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.4 ptm85 -153.48 116.07 4.45 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 169.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -48.8 -29.29 4.41 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.214 1.006 . . . . 0.0 113.166 -175.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.2 m -40.38 -34.33 0.33 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 119.235 3.05 . . . . 0.0 119.235 -169.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.7 p -135.63 -71.68 0.47 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 121.006 1.73 . . . . 0.0 113.942 -169.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -55.14 -50.92 68.05 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.21 0.914 . . . . 0.0 109.886 -169.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.413 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 0.1 OUTLIER -63.65 -48.49 77.0 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.992 2.117 . . . . 0.0 111.787 -179.233 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -63.34 -42.95 98.99 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.317 0.647 . . . . 0.0 110.785 -175.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 67.5 mtm -64.82 -46.23 82.83 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 119.05 -0.5 . . . . 0.0 111.036 174.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.86 -41.55 70.93 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 118.233 0.47 . . . . 0.0 110.805 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.63 -46.25 79.98 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 122.843 0.457 . . . . 0.0 111.054 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.39 -40.4 97.52 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -66.63 -52.14 48.41 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 118.506 1.153 . . . . 0.0 108.009 176.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.27 -42.98 78.32 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.824 1.25 . . . . 0.0 113.052 -174.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.3 pttt -68.56 -35.74 77.81 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-N 119.169 0.895 . . . . 0.0 110.265 175.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.6 m -68.1 -41.77 81.32 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 119.555 -1.966 . . . . 0.0 110.569 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.8 mt -73.23 -37.3 66.44 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.086 1.754 . . . . 0.0 111.202 -175.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.909 0 CA-C-O 117.01 -1.995 . . . . 0.0 117.875 -169.768 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.9 pt . . . . . 0 C--O 1.234 0.261 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -110.89 114.65 28.15 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 170.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 p -102.33 151.66 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-O 121.797 0.808 . . . . 0.0 111.723 -176.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.0 m -145.91 151.32 37.66 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 126.182 1.793 . . . . 0.0 106.195 167.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.413 ' HB2' ' HB2' ' A' ' 15' ' ' SER . 58.5 p -122.92 158.11 31.12 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 121.043 -1.036 . . . . 0.0 108.673 168.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.8 m -152.18 -173.66 4.62 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.491 1.516 . . . . 0.0 107.525 -174.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.89 162.59 31.35 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 169.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.2 mp -50.2 -36.87 32.51 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.656 1.183 . . . . 0.0 110.075 174.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -141.11 150.06 42.36 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 169.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.0 p -78.02 157.96 29.41 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.988 0.899 . . . . 0.0 110.694 173.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.2 m -164.86 157.86 16.71 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 128.126 2.57 . . . . 0.0 105.231 169.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -56.47 154.18 8.89 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.027 0.83 . . . . 0.0 111.322 -175.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.8 t -62.96 129.71 26.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 172.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -69.37 141.37 91.0 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -176.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.63 -40.42 2.07 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.182 1.255 . . . . 0.0 111.759 -169.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.494 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 6.2 m -67.95 -17.06 64.33 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.453 -1.404 . . . . 0.0 111.868 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.71 -40.28 83.24 Favored 'General case' 0 C--N 1.34 0.168 0 O-C-N 121.338 -0.851 . . . . 0.0 110.459 171.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.2 mt -57.26 -45.48 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.01 99.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.321 0.649 . . . . 0.0 111.791 -175.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 21.4 mmt -57.81 -47.37 82.8 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 122.85 1.31 . . . . 0.0 111.227 176.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 6.7 mtp -69.81 -31.86 69.99 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.376 -177.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.12 -31.82 70.42 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.47 0.708 . . . . 0.0 111.278 170.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -64.98 -35.11 80.12 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 118.669 0.668 . . . . 0.0 110.368 175.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.0 t -79.44 -25.87 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 119.906 -0.093 . . . . 0.0 110.908 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.14 28.81 6.67 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.718 1.151 . . . . 0.0 111.682 -174.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.7 mt -125.29 -178.81 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 125.942 1.697 . . . . 0.0 106.927 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -145.92 155.97 43.22 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.979 1.711 . . . . 0.0 108.883 -178.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.24 -15.61 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.108 0.963 . . . . 0.0 113.331 172.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.4 p -50.39 -32.03 16.45 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.647 1.179 . . . . 0.0 113.615 -174.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.46 -15.82 36.53 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 117.852 -1.526 . . . . 0.0 114.425 -172.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -85.8 -25.63 26.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.262 2.031 . . . . 0.0 114.507 -171.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 38.1 p 68.02 168.65 0.26 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.604 1.961 . . . . 0.0 114.116 170.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.8 m -85.14 166.7 16.39 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.718 -171.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.98 139.34 12.59 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 124.137 0.975 . . . . 0.0 109.041 174.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.45 153.58 13.84 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.067 2.512 . . . . 0.0 110.632 169.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.1 tt -53.62 -34.85 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 123.725 0.81 . . . . 0.0 111.355 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -58.82 -22.81 59.43 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.757 1.623 . . . . 0.0 112.528 -176.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -80.42 -5.13 56.04 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.198 0.599 . . . . 0.0 112.541 -177.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -133.41 -176.24 4.08 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.487 1.039 . . . . 0.0 111.336 -176.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -139.68 131.93 28.25 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 126.889 2.076 . . . . 0.0 108.209 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.84 -28.48 67.52 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.475 1.11 . . . . 0.0 112.856 -175.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -60.26 -24.17 64.69 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.849 0.86 . . . . 0.0 112.334 -176.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -83.62 -15.87 47.35 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.247 0.619 . . . . 0.0 110.618 -177.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -102.44 127.06 49.64 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 125.465 1.506 . . . . 0.0 108.701 -175.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -85.4 -25.84 26.78 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.342 0.592 . . . . 0.0 109.688 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.0 t -131.0 135.81 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 -173.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.3 p -135.34 102.71 3.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 123.198 1.475 . . . . 0.0 110.137 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.5 mm -84.7 144.59 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 104.799 -2.296 . . . . 0.0 104.799 168.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.4 m -132.72 158.23 42.89 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 168.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.83 63.57 0.99 Allowed 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 102.515 -3.142 . . . . 0.0 102.515 -171.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 76.2 m . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -177.564 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 . . . . . 0 CA--C 1.538 0.507 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -64.96 10.42 0.07 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.278 1.831 . . . . 0.0 112.496 169.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.1 p -126.12 5.13 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 125.039 1.336 . . . . 0.0 112.03 172.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.6 p -129.41 25.7 5.43 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.895 -1.128 . . . . 0.0 112.89 -170.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -94.31 -177.09 4.16 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.403 0.681 . . . . 0.0 109.682 173.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -57.36 -35.26 69.72 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.372 1.069 . . . . 0.0 112.994 -174.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.8 mt -135.84 138.39 47.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -139.25 137.0 35.54 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 169.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -146.36 151.86 38.17 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.132 1.373 . . . . 0.0 108.21 169.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -115.73 126.67 54.37 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.798 1.239 . . . . 0.0 109.624 169.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 40.0 m0 -107.09 91.61 3.73 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.412 1.485 . . . . 0.0 108.124 -173.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -69.9 103.69 2.29 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.951 1.3 . . . . 0.0 109.28 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -136.57 161.5 35.72 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.675 1.59 . . . . 0.0 110.517 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -81.65 66.74 7.34 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.02 1.728 . . . . 0.0 111.283 -178.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -9.99 91.93 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 129.731 3.212 . . . . 0.0 112.318 169.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -57.43 -8.36 3.8 Favored 'Trans proline' 0 N--CA 1.459 -0.553 1 C-N-CA 125.409 4.073 . . . . 0.0 117.946 -169.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -57.43 95.14 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 120.32 1.418 . . . . 0.0 111.832 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 98.63 13.86 39.55 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 126.428 1.966 . . . . 0.0 113.241 172.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -93.31 177.99 5.86 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.039 1.42 . . . . 0.0 112.575 -169.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.8 m -74.6 154.72 38.43 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.407 1.483 . . . . 0.0 109.931 175.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.1 mt -60.07 -30.31 69.13 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.737 -0.602 . . . . 0.0 111.784 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -62.68 -39.87 95.32 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.106 0.412 . . . . 0.0 110.877 174.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.4 t -67.15 -45.2 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.057 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.494 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 16.2 m-85 -54.66 -52.98 60.63 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.322 0.51 . . . . 0.0 110.829 175.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 75.2 mtp85 -59.11 -42.07 89.67 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 118.434 -0.793 . . . . 0.0 111.956 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 91.1 m -62.16 -53.26 57.8 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 119.038 0.836 . . . . 0.0 109.059 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.2 t -62.36 -42.86 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-O 117.802 -1.094 . . . . 0.0 110.183 -178.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.3 ttp85 -53.41 -52.76 58.33 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 119.813 1.188 . . . . 0.0 108.88 176.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.31 -46.02 91.86 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -172.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -62.74 -49.65 74.19 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.918 0.887 . . . . 0.0 111.054 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.8 t -62.05 -48.15 89.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 125.731 1.612 . . . . 0.0 110.42 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -58.84 -47.35 85.17 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 120.625 1.557 . . . . 0.0 110.424 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -53.64 -46.59 70.6 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 123.792 0.837 . . . . 0.0 109.446 174.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 61.7 mtt85 -69.1 -38.22 78.84 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 117.604 -1.189 . . . . 0.0 110.946 -174.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.6 t -55.49 -49.64 71.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 120.803 1.638 . . . . 0.0 109.626 169.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -61.12 -39.94 91.9 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.519 1.054 . . . . 0.0 110.689 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -61.81 -46.38 89.75 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.486 1.514 . . . . 0.0 109.922 178.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.1 -52.71 62.79 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.477 1.111 . . . . 0.0 109.387 178.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 72.7 mt -52.14 -40.29 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 123.934 0.894 . . . . 0.0 109.67 177.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.19 -30.84 71.35 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.65 1.113 . . . . 0.0 111.622 -174.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 51.9 mttt -70.52 -37.23 74.09 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.985 1.314 . . . . 0.0 111.493 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.0 pt -99.99 -25.59 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -169.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 64.5 m . . . . . 0 C--O 1.248 1.005 0 C-N-CA 126.165 1.786 . . . . 0.0 111.249 179.612 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt . . . . . 0 N--CA 1.466 0.361 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -103.52 125.18 49.92 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -176.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.4 t -108.47 138.6 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 124.415 1.086 . . . . 0.0 108.16 -172.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 32.1 tpp -125.99 140.45 52.6 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.858 1.263 . . . . 0.0 108.803 178.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -122.22 132.98 54.71 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 118.098 -0.953 . . . . 0.0 108.538 170.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.8 t -134.04 116.52 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 121.041 1.746 . . . . 0.0 109.926 -171.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.9 t -115.71 163.08 16.34 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.653 1.115 . . . . 0.0 111.093 -177.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -55.54 -22.54 22.09 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.294 1.438 . . . . 0.0 112.67 172.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -135.21 -1.81 2.58 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 62.32 -52.85 0.15 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 127.589 2.356 . . . . 0.0 113.99 -168.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.9 m -41.43 -19.05 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 120.97 3.693 . . . . 0.0 120.97 -169.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.2 p -131.0 -80.6 0.53 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 120.152 1.342 . . . . 0.0 111.085 -169.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -55.12 -50.91 68.02 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.612 0.765 . . . . 0.0 109.002 -170.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.02 -40.99 74.87 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.221 0.608 . . . . 0.0 111.96 -173.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.8 mm100 -69.39 -40.28 77.47 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.579 -0.701 . . . . 0.0 110.678 -170.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 63.1 mtm -62.47 -44.83 95.45 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 119.58 -0.248 . . . . 0.0 110.393 171.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.37 -37.45 70.09 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 119.361 -0.352 . . . . 0.0 111.152 177.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -62.15 -52.15 65.0 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.172 0.589 . . . . 0.0 109.956 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.01 -41.04 99.65 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.341 -0.699 . . . . 0.0 111.503 -177.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.427 ' CD1' ' HE2' ' A' ' 50' ' ' MET . 25.0 m-85 -66.87 -51.3 57.09 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 118.733 1.266 . . . . 0.0 107.947 177.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.93 -42.77 80.63 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 124.2 1.0 . . . . 0.0 112.666 -174.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -68.41 -35.51 77.74 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 119.771 1.169 . . . . 0.0 110.962 175.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.5 m -67.06 -43.16 83.36 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 120.738 1.608 . . . . 0.0 110.404 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.5 mt -74.57 -36.83 63.06 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.051 1.34 . . . . 0.0 111.209 -173.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.835 0 CA-C-O 116.621 -2.211 . . . . 0.0 118.009 -169.162 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.5 pt . . . . . 0 N--CA 1.452 -0.367 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -121.05 133.62 55.25 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 169.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.14 149.84 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-O 121.331 0.586 . . . . 0.0 111.986 -173.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.8 m -142.35 150.82 41.24 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 167.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.4 m -124.75 153.17 42.82 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.951 0.9 . . . . 0.0 109.858 169.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 32.8 m -150.4 -171.46 3.92 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 126.482 1.913 . . . . 0.0 107.463 -170.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.05 169.1 39.52 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 169.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 67.7 mt -53.94 -35.87 62.2 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 124.63 0.841 . . . . 0.0 110.777 178.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -149.69 150.31 31.92 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 169.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.0 p -86.58 165.92 15.81 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 122.081 0.943 . . . . 0.0 111.85 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.1 m -161.68 172.38 16.35 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 128.796 2.838 . . . . 0.0 105.469 169.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.71 151.57 29.0 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.5 -1.375 . . . . 0.0 109.671 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.1 t -57.6 132.91 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 171.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 37.5 t60 -67.92 139.8 93.43 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-O 118.772 -0.632 . . . . 0.0 109.392 177.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.6 -42.29 0.36 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.207 1.938 . . . . 0.0 113.456 -171.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.451 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 5.6 m -62.61 -18.6 62.53 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 119.701 -1.874 . . . . 0.0 112.452 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.7 -38.95 73.01 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.01 0.924 . . . . 0.0 110.291 171.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 62.5 mt -56.49 -48.3 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.04 -40.4 93.47 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 123.972 0.909 . . . . 0.0 111.484 -174.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.5 mmt -59.72 -47.95 83.64 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 122.656 1.217 . . . . 0.0 111.358 176.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.427 ' HE2' ' CD1' ' A' ' 21' ' ' PHE . 8.2 mtp -68.31 -34.72 76.64 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.207 -178.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -61.81 -29.22 70.01 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.243 0.617 . . . . 0.0 111.657 171.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -65.31 -35.84 82.25 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.196 0.907 . . . . 0.0 110.489 173.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 t -78.61 -25.96 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 117.64 0.2 . . . . 0.0 111.0 175.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.25 28.05 7.0 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.522 1.058 . . . . 0.0 111.702 -174.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.8 mt -121.88 -177.71 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 125.94 1.696 . . . . 0.0 106.731 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -146.9 157.67 43.71 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.37 1.468 . . . . 0.0 109.383 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.45 -17.13 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.993 0.917 . . . . 0.0 112.314 169.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -45.0 -38.05 4.48 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.834 1.254 . . . . 0.0 112.783 173.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.86 -5.09 88.71 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.735 1.16 . . . . 0.0 113.972 -173.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -128.27 171.68 11.76 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.324 1.45 . . . . 0.0 110.82 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.3 p -123.86 164.59 18.93 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 122.016 0.913 . . . . 0.0 111.279 -171.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.3 p -74.47 168.25 20.09 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.983 1.713 . . . . 0.0 110.887 173.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -154.45 144.29 15.47 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.524 0.73 . . . . 0.0 109.744 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -86.27 153.11 9.39 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.063 2.508 . . . . 0.0 110.27 169.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.9 tt -54.09 -33.21 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.542 0.737 . . . . 0.0 111.469 173.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -58.28 -24.37 59.25 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.675 1.59 . . . . 0.0 112.552 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -80.11 -6.45 57.72 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -175.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -130.59 -176.51 4.0 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.377 0.99 . . . . 0.0 111.515 -175.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.67 134.17 38.91 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 126.8 2.04 . . . . 0.0 108.348 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.86 -30.87 70.38 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.842 1.257 . . . . 0.0 112.788 -176.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -60.89 -21.78 63.66 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.151 0.98 . . . . 0.0 112.286 -173.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -83.0 -19.47 36.94 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.521 0.729 . . . . 0.0 110.595 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -104.72 124.94 50.28 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.356 1.062 . . . . 0.0 110.282 -169.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -72.86 -38.45 67.04 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 175.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.0 p -132.26 131.67 60.81 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -170.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.2 t -124.41 109.29 22.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 123.219 1.485 . . . . 0.0 108.699 -176.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.2 mm -99.44 94.3 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 177.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.4 m -70.68 157.76 37.42 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 117.351 -1.74 . . . . 0.0 106.461 167.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.81 50.66 0.68 Allowed 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 103.742 -2.688 . . . . 0.0 103.742 176.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 64.9 m . . . . . 0 CA--C 1.533 0.29 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 169.358 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -55.8 -26.74 47.72 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 121.002 -1.061 . . . . 0.0 112.035 172.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.6 p -84.12 -16.33 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 119.579 1.081 . . . . 0.0 110.337 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.7 p -105.12 16.39 25.9 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.683 0.793 . . . . 0.0 112.477 -169.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -79.13 173.91 12.1 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.608 0.763 . . . . 0.0 109.241 170.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.6 mp0 -58.96 -33.77 71.01 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.343 1.057 . . . . 0.0 113.41 -169.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.2 mt -134.92 136.72 51.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -177.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -143.15 138.76 30.01 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.501 1.12 . . . . 0.0 108.833 175.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -147.23 162.27 39.26 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.367 1.467 . . . . 0.0 107.986 168.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -122.61 97.5 5.48 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.78 1.632 . . . . 0.0 108.805 169.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -74.05 97.81 2.95 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.778 0.831 . . . . 0.0 109.619 -178.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -63.05 119.16 8.96 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 169.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 47.6 mt -151.72 151.48 31.48 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.865 1.666 . . . . 0.0 107.581 -169.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -84.08 73.54 10.38 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.153 0.981 . . . . 0.0 111.002 -176.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -19.36 97.39 0.05 OUTLIER Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 128.765 2.826 . . . . 0.0 111.427 177.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -63.7 -7.43 12.84 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.965 2.443 . . . . 0.0 116.708 -169.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -61.62 90.86 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 120.849 1.658 . . . . 0.0 113.501 -172.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.61 12.48 28.35 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.955 1.741 . . . . 0.0 113.387 175.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -91.34 -179.64 5.45 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.035 1.417 . . . . 0.0 112.128 -171.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.6 m -76.14 155.44 34.63 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.43 1.492 . . . . 0.0 109.973 174.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.6 -31.62 68.22 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.793 -0.567 . . . . 0.0 111.748 -178.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.62 -34.61 76.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 118.418 0.554 . . . . 0.0 111.169 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 95.3 t -66.25 -45.78 89.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 172.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.451 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 18.8 m-85 -56.83 -49.46 75.33 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 119.066 -0.493 . . . . 0.0 110.489 175.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -57.84 -43.38 85.81 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.591 1.157 . . . . 0.0 111.799 176.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.7 m -61.03 -49.49 77.18 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 118.875 0.761 . . . . 0.0 109.406 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.57 -44.66 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 117.742 -1.123 . . . . 0.0 110.377 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 44.3 ttp85 -52.81 -47.11 67.88 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 119.984 1.266 . . . . 0.0 109.137 175.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.89 -49.79 65.45 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-O 118.341 -1.255 . . . . 0.0 110.398 -176.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -59.81 -56.5 21.02 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 118.36 1.08 . . . . 0.0 110.269 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 80.3 t -49.46 -53.28 9.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 125.285 1.434 . . . . 0.0 109.897 177.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -60.82 -46.9 88.73 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 121.049 1.75 . . . . 0.0 110.463 -175.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.15 -44.8 88.06 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.996 0.519 . . . . 0.0 110.269 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -69.08 -40.97 78.14 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.152 -0.927 . . . . 0.0 110.175 -176.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 70.5 t -55.08 -49.05 74.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 120.446 1.476 . . . . 0.0 109.604 169.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -60.35 -39.0 85.57 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.389 0.995 . . . . 0.0 110.45 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -63.54 -45.85 88.68 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.318 1.047 . . . . 0.0 110.427 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.57 -47.12 79.91 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 123.963 0.905 . . . . 0.0 109.779 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.1 mt -53.88 -42.69 54.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 124.715 1.206 . . . . 0.0 109.968 174.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.15 -28.45 67.93 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.399 1.0 . . . . 0.0 111.67 -171.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -73.29 -20.44 60.82 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.91 1.684 . . . . 0.0 112.465 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.3 pt -124.64 -22.29 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 -168.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.9 m . . . . . 0 C--O 1.251 1.174 0 C-N-CA 125.591 1.557 . . . . 0.0 111.283 170.528 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.9 ttm . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 120.95 0.405 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -123.52 142.37 51.08 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 172.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.7 mttt -100.28 123.14 44.14 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.8 p -102.93 144.74 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 122.058 0.932 . . . . 0.0 110.51 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 29.6 tpp -124.24 142.69 51.04 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 125.042 1.337 . . . . 0.0 108.629 176.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -124.22 124.34 42.23 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 171.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.7 t -127.61 121.6 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 120.483 1.492 . . . . 0.0 109.073 -172.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.8 t -118.64 165.75 13.59 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.954 0.797 . . . . 0.0 109.687 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -56.32 -20.99 21.42 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.977 0.911 . . . . 0.0 112.455 170.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -139.51 -2.74 1.56 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 60.27 -47.15 0.1 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 128.53 2.732 . . . . 0.0 115.499 -169.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.7 p -43.96 -25.61 0.22 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 119.707 3.225 . . . . 0.0 119.707 -168.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 45.2 m -126.91 -72.47 0.64 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.909 0.777 . . . . 0.0 109.818 -169.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -63.98 -49.56 72.0 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -169.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.16 -42.08 72.97 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 117.76 0.254 . . . . 0.0 111.11 -177.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -60.09 -45.51 92.7 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.007 0.523 . . . . 0.0 111.166 -175.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 46.9 mtm -64.16 -44.35 92.38 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 121.235 -0.186 . . . . 0.0 110.853 175.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.16 -37.76 75.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 119.363 -0.351 . . . . 0.0 111.116 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -65.5 -45.06 85.08 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.946 0.339 . . . . 0.0 110.52 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.84 -44.14 97.33 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -67.03 -50.56 61.64 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 118.629 1.214 . . . . 0.0 109.412 176.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.36 -42.55 82.29 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 119.477 1.035 . . . . 0.0 112.432 -173.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -69.65 -36.88 76.46 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.46 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.9 m -66.79 -43.1 84.84 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 119.65 -1.906 . . . . 0.0 110.571 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.5 mt -73.02 -39.37 66.05 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.539 1.536 . . . . 0.0 110.79 -174.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -133.77 3.48 4.6 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 116.747 -2.14 . . . . 0.0 118.296 -169.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.85 112.54 1.06 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 121.433 2.616 . . . . 0.0 109.011 170.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.71 -24.22 5.53 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.671 1.129 . . . . 0.0 111.741 -175.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.48 -19.28 3.08 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.402 1.101 . . . . 0.0 111.844 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.6 pt -131.7 156.29 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 168.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -120.16 130.5 54.62 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 170.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 p -113.08 151.24 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 124.169 0.988 . . . . 0.0 111.381 -176.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.7 m -147.81 135.9 21.28 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 167.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.3 p -102.45 156.63 17.47 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 121.083 -1.011 . . . . 0.0 108.335 169.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.4 m -148.53 -175.3 4.87 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 125.848 1.659 . . . . 0.0 106.759 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.93 154.7 25.85 Favored Glycine 0 CA--C 1.497 -1.051 0 N-CA-C 108.301 -1.919 . . . . 0.0 108.301 169.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 68.7 tp -49.03 -34.41 13.27 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.877 1.271 . . . . 0.0 109.74 169.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -146.47 148.38 32.18 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 168.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 p -83.03 162.84 21.29 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.81 0.844 . . . . 0.0 111.548 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 69.3 m -160.03 160.28 33.06 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.392 2.277 . . . . 0.0 106.551 169.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.88 138.14 30.51 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 117.813 -1.089 . . . . 0.0 110.386 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.6 p -57.76 130.09 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 120.083 1.311 . . . . 0.0 107.846 170.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -74.29 142.76 78.94 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.083 -169.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.51 -42.29 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.341 1.361 . . . . 0.0 112.25 -169.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.432 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 26.3 m -62.77 -24.95 67.98 Favored 'General case' 0 CA--C 1.535 0.365 0 O-C-N 120.484 -1.385 . . . . 0.0 111.414 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.69 -40.2 59.68 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.462 0.705 . . . . 0.0 111.536 173.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.1 mt -55.68 -46.08 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.38 -38.83 91.18 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 124.439 1.096 . . . . 0.0 110.144 -171.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 8.7 mmm -68.64 -44.01 75.08 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 122.791 1.281 . . . . 0.0 110.557 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 9.7 mtp -65.64 -35.48 80.93 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.327 -0.858 . . . . 0.0 109.867 175.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -62.72 -26.53 68.73 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.657 0.662 . . . . 0.0 111.501 173.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -65.7 -39.87 91.68 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.823 0.738 . . . . 0.0 109.876 173.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 88.7 t -76.67 -25.37 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.617 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.45 25.86 5.61 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.034 1.302 . . . . 0.0 111.718 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.9 mt -122.89 178.79 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 C-N-CA 125.255 1.422 . . . . 0.0 107.378 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -143.1 156.1 44.74 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.315 1.446 . . . . 0.0 109.276 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -128.08 -15.6 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 123.881 0.872 . . . . 0.0 112.351 169.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -45.75 -38.09 6.65 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.687 1.195 . . . . 0.0 112.859 172.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.77 -6.59 85.37 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.557 1.075 . . . . 0.0 114.217 -173.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -125.15 169.59 12.05 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 119.01 1.405 . . . . 0.0 111.036 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.3 p -127.05 169.91 12.88 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.75 1.22 . . . . 0.0 110.819 -172.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.7 p -92.69 160.15 15.11 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.576 1.15 . . . . 0.0 111.284 178.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -154.81 138.7 11.14 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 118.364 -0.827 . . . . 0.0 109.474 -169.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -80.94 152.88 19.15 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.663 2.242 . . . . 0.0 111.703 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.0 tt -52.43 -34.86 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.763 1.225 . . . . 0.0 111.552 173.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -57.78 -23.64 53.26 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.128 1.771 . . . . 0.0 112.371 -175.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -83.37 -6.71 59.55 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.856 0.863 . . . . 0.0 112.79 -175.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -128.57 -176.89 3.97 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.465 1.029 . . . . 0.0 111.269 -176.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.56 132.53 37.31 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 126.672 1.989 . . . . 0.0 108.344 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.32 -30.01 69.24 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.732 1.213 . . . . 0.0 112.702 -176.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -61.29 -21.21 63.73 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.08 0.952 . . . . 0.0 112.496 -174.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -85.86 -15.26 42.4 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.3 0.64 . . . . 0.0 110.778 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -107.8 121.97 45.83 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 124.775 1.23 . . . . 0.0 109.309 -172.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -71.83 -38.33 70.17 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.312 0.245 . . . . 0.0 111.039 177.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.1 p -131.5 133.17 62.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -170.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.7 t -124.23 123.13 65.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 122.526 1.155 . . . . 0.0 108.404 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 35.5 mm -113.41 97.09 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.5 m -72.65 156.51 38.89 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 168.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.05 54.72 0.65 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 176.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.8 m -82.95 -34.19 26.56 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.193 0.997 . . . . 0.0 109.796 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.32 169.51 40.6 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 98.8 m 39.13 33.34 0.09 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.226 2.21 . . . . 0.0 114.639 -175.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.24 22.84 51.48 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.533 1.54 . . . . 0.0 114.59 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.6 t -62.33 144.59 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 169.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -141.03 178.81 7.11 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.004 0.922 . . . . 0.0 110.444 -169.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.8 mt -114.31 111.23 47.22 Favored Pre-proline 0 N--CA 1.453 -0.308 0 C-N-CA 126.305 1.842 . . . . 0.0 106.973 -170.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -50.61 -41.18 54.24 Favored 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 122.571 2.181 . . . . 0.0 115.355 169.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.35 -179.7 5.02 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.797 1.665 . . . . 0.0 114.1 -174.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -52.19 -16.58 0.84 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 129.307 3.043 . . . . 0.0 114.222 -174.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -57.51 -24.9 58.59 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 121.17 -0.956 . . . . 0.0 111.994 174.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.1 p -87.3 -9.97 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 119.65 1.114 . . . . 0.0 110.541 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 49.5 p -113.44 19.88 16.54 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.916 0.886 . . . . 0.0 112.549 -169.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -81.67 175.72 10.23 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.609 0.764 . . . . 0.0 109.663 171.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -57.77 -32.67 67.72 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.905 1.282 . . . . 0.0 113.588 -169.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.0 mt -135.17 139.08 47.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -141.93 137.83 31.57 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 124.276 1.03 . . . . 0.0 108.506 172.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -146.68 158.75 43.97 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.802 1.641 . . . . 0.0 107.421 168.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -121.92 101.4 7.54 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.015 1.326 . . . . 0.0 108.045 168.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.411 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 43.5 m0 -75.44 95.83 3.34 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.539 1.136 . . . . 0.0 108.955 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -59.91 118.55 6.36 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 169.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 38.3 mt -153.43 146.24 24.36 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.846 1.658 . . . . 0.0 107.204 -169.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -83.77 72.8 10.34 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.25 1.42 . . . . 0.0 110.946 -173.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -23.55 100.93 0.08 OUTLIER Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 128.007 2.523 . . . . 0.0 113.075 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -60.97 -2.65 2.32 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 124.236 3.29 . . . . 0.0 116.925 -172.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -52.28 100.49 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.239 1.381 . . . . 0.0 112.157 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.75 20.47 59.69 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.341 1.924 . . . . 0.0 113.561 171.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -96.95 179.23 5.01 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.752 1.276 . . . . 0.0 113.052 -169.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.1 m -76.44 154.93 34.33 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.497 1.519 . . . . 0.0 109.877 175.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.8 mt -58.63 -31.77 68.42 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 122.053 -0.404 . . . . 0.0 111.461 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -63.39 -41.08 98.76 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.075 0.398 . . . . 0.0 110.889 177.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 88.9 t -65.63 -46.75 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.432 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 8.0 m-85 -54.59 -53.83 49.38 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.344 0.658 . . . . 0.0 110.732 176.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 31.2 mtt180 -59.75 -41.99 92.21 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 123.947 0.899 . . . . 0.0 111.463 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 93.9 m -61.46 -54.41 43.76 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.2 t -62.97 -43.21 98.91 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 CA-C-O 118.799 -0.62 . . . . 0.0 110.648 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -57.73 -43.81 85.58 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 119.328 0.967 . . . . 0.0 110.139 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.29 -50.2 61.36 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.015 -0.88 . . . . 0.0 111.166 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -58.02 -51.43 69.68 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.243 1.022 . . . . 0.0 110.912 -176.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.6 t -50.83 -55.89 5.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 126.841 2.057 . . . . 0.0 109.934 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -59.34 -46.91 87.31 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 119.405 1.002 . . . . 0.0 110.185 -173.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.07 -42.06 79.95 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.318 1.047 . . . . 0.0 110.547 177.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.411 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 45.4 mtt85 -72.23 -40.97 67.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 117.684 -1.15 . . . . 0.0 110.888 -177.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 99.2 t -54.5 -46.15 71.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 120.653 1.569 . . . . 0.0 109.763 169.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -62.21 -40.9 97.63 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.222 0.919 . . . . 0.0 110.861 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -62.61 -44.24 96.81 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 122.911 0.485 . . . . 0.0 110.542 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.32 -47.59 78.82 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 118.293 -0.86 . . . . 0.0 109.768 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 67.3 mt -54.31 -41.46 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.787 0.835 . . . . 0.0 109.452 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.66 -31.53 72.42 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.84 1.2 . . . . 0.0 111.543 -173.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -66.15 -45.91 79.32 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.413 1.085 . . . . 0.0 110.814 176.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.2 pt -89.19 -27.03 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.813 1.245 . . . . 0.0 114.299 -169.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 63.4 m . . . . . 0 C--O 1.248 1.0 0 C-N-CA 125.882 1.673 . . . . 0.0 111.17 -179.231 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.9 ttm . . . . . 0 N--CA 1.484 1.254 0 CA-C-O 121.474 0.654 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -76.8 127.09 32.1 Favored 'General case' 0 C--O 1.23 0.061 0 C-N-CA 123.536 0.734 . . . . 0.0 109.238 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.477 ' HE2' ' CE1' ' A' ' 73' ' ' TYR . 32.5 mtpt -96.15 129.14 43.53 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 118.508 -0.758 . . . . 0.0 109.593 175.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.6 p -105.31 140.26 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 118.673 0.67 . . . . 0.0 109.456 171.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.7 tpp -115.58 141.78 47.61 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 169.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -117.62 135.67 53.83 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 169.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -138.28 118.42 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 120.38 1.446 . . . . 0.0 109.382 -170.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.0 t -115.12 163.68 15.28 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.367 0.985 . . . . 0.0 109.723 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -61.45 -21.37 64.08 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 118.129 -0.939 . . . . 0.0 112.821 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -131.77 -0.97 3.83 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 62.32 -48.48 0.17 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 127.595 2.358 . . . . 0.0 115.105 -169.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.7 m -31.11 -40.59 0.03 OUTLIER 'General case' 0 C--O 1.235 0.313 0 N-CA-C 119.542 3.164 . . . . 0.0 119.542 -168.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.7 m -127.45 -63.86 1.02 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.66 1.118 . . . . 0.0 111.405 -169.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -58.13 -50.73 72.49 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.254 0.933 . . . . 0.0 109.787 -171.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 m -69.07 -41.17 77.91 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 117.85 0.296 . . . . 0.0 110.854 -174.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -70.3 -41.27 73.57 Favored 'General case' 0 N--CA 1.463 0.175 0 O-C-N 121.599 -0.688 . . . . 0.0 110.881 -169.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 66.2 mtm -62.06 -41.85 98.58 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 118.082 0.401 . . . . 0.0 110.893 171.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.34 -33.65 69.77 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 118.931 -0.557 . . . . 0.0 110.951 175.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -59.21 -65.06 0.73 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.77 -39.5 77.06 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.015 -0.881 . . . . 0.0 112.549 -175.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -67.18 -45.01 78.23 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 119.274 1.537 . . . . 0.0 109.579 177.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.55 -43.6 93.43 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 120.372 1.442 . . . . 0.0 112.555 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.4 ptmt -69.18 -9.73 54.33 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.941 1.246 . . . . 0.0 113.1 175.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.4 m -92.81 -49.3 6.13 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 119.97 1.259 . . . . 0.0 110.618 170.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.4 mt -79.07 -39.91 32.61 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.352 1.461 . . . . 0.0 112.318 -169.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.18 -10.41 15.68 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-O 117.935 -1.481 . . . . 0.0 114.428 -169.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.89 108.94 0.4 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.31 1.555 . . . . 0.0 109.18 169.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 137.36 -29.24 2.71 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.871 1.224 . . . . 0.0 111.541 -169.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.18 -23.95 2.13 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.402 1.081 . . . . 0.0 111.844 173.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.3 pt -128.37 162.13 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 123.344 0.658 . . . . 0.0 111.088 175.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -128.18 138.5 52.51 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 168.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -113.13 152.17 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-O 122.26 1.029 . . . . 0.0 113.412 -169.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.4 m -139.72 147.63 41.17 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 127.315 2.246 . . . . 0.0 105.123 167.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.3 m -132.21 146.71 52.2 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.831 1.252 . . . . 0.0 108.568 169.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 23.9 p -156.36 -161.79 1.17 Allowed 'General case' 0 C--O 1.242 0.666 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -176.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -151.66 156.96 26.97 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 169.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.3 tp -46.52 -36.87 7.19 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.979 1.712 . . . . 0.0 109.391 169.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -147.03 148.26 31.5 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 102.205 -3.257 . . . . 0.0 102.205 167.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.6 m -125.04 144.16 50.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.199 0.523 . . . . 0.0 112.284 -173.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.0 m -137.64 164.59 28.42 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.403 2.281 . . . . 0.0 107.551 173.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.93 145.62 1.44 Allowed 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.149 1.38 . . . . 0.0 113.232 -169.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.9 p -61.05 132.07 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 169.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -76.72 145.96 75.66 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.692 -172.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.17 -40.72 0.78 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 121.393 1.396 . . . . 0.0 112.534 -169.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.496 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 24.0 m -66.12 -17.07 64.48 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 120.044 -1.66 . . . . 0.0 111.864 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.68 -40.74 76.11 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 123.984 0.914 . . . . 0.0 110.836 170.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.0 mt -55.14 -52.19 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.18 -38.93 81.01 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 123.741 0.65 . . . . 0.0 111.917 -173.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.6 mmt -59.42 -49.84 76.26 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 122.403 1.097 . . . . 0.0 111.697 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.4 mtp -67.33 -36.15 80.86 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.164 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -61.75 -30.17 70.61 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.315 1.046 . . . . 0.0 111.295 174.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -64.13 -40.78 96.91 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.83 0.741 . . . . 0.0 110.336 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.1 t -75.2 -20.23 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.498 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.63 25.47 9.91 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.697 1.141 . . . . 0.0 111.332 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.4 mt -121.62 -178.33 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -146.51 151.73 37.83 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 120.457 -1.402 . . . . 0.0 109.694 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.6 pt -132.68 -3.96 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.405 1.082 . . . . 0.0 112.824 169.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 95.3 p -55.87 -30.62 61.82 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 120.187 1.358 . . . . 0.0 112.146 169.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.05 -7.43 87.6 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 118.729 -1.039 . . . . 0.0 114.087 -176.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.56 172.4 7.87 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.448 1.499 . . . . 0.0 111.16 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 16.8 p -129.46 157.62 41.48 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.368 1.067 . . . . 0.0 111.071 -170.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.6 p -68.21 156.67 37.09 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.717 1.207 . . . . 0.0 110.04 169.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -156.07 143.54 13.91 Favored Pre-proline 0 N--CA 1.469 0.5 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.038 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -81.32 150.4 17.37 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.835 2.357 . . . . 0.0 111.226 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.6 tt -55.27 -33.21 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.272 0.629 . . . . 0.0 111.362 173.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -56.92 -22.11 35.09 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.548 1.939 . . . . 0.0 112.418 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -79.46 -4.64 52.15 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.209 1.004 . . . . 0.0 112.85 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -128.13 177.91 6.59 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.768 1.167 . . . . 0.0 111.753 -175.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.03 140.14 52.84 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 127.183 2.193 . . . . 0.0 106.859 170.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.54 -23.0 60.93 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.115 0.966 . . . . 0.0 112.002 -177.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.86 -24.25 66.79 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.176 0.99 . . . . 0.0 112.472 -173.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -89.82 -15.16 32.9 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.033 0.933 . . . . 0.0 110.505 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.477 ' CE1' ' HE2' ' A' ' 3' ' ' LYS . 83.5 m-85 -86.69 141.62 28.79 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.901 1.281 . . . . 0.0 110.061 178.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -89.98 -34.84 15.85 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.151 0.98 . . . . 0.0 110.64 173.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -140.36 137.67 36.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -172.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.2 m -127.48 108.79 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 123.167 1.461 . . . . 0.0 109.39 -173.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.2 mm -104.26 96.67 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.3 t -71.17 157.0 38.91 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 167.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.21 52.37 0.43 Allowed 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 103.52 -2.77 . . . . 0.0 103.52 174.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 95.4 m -77.27 -34.67 55.64 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.432 1.093 . . . . 0.0 110.153 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.25 169.77 29.37 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -176.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 88.8 m 38.06 32.88 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.431 2.293 . . . . 0.0 115.318 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.08 25.54 59.91 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.057 1.313 . . . . 0.0 113.878 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.2 t -61.74 158.03 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.789 1.236 . . . . 0.0 107.959 169.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -139.24 -179.59 5.96 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.149 1.38 . . . . 0.0 108.937 -171.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 49.6 mt -119.85 92.23 46.31 Favored Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 126.763 2.025 . . . . 0.0 105.859 -171.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -47.12 -35.34 19.23 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 123.205 2.603 . . . . 0.0 116.667 175.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -68.37 -173.7 0.58 Allowed 'Trans proline' 0 C--N 1.356 0.928 0 CA-C-N 122.127 1.795 . . . . 0.0 113.983 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -45.16 -21.28 0.07 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 128.157 2.583 . . . . 0.0 114.703 171.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -60.64 10.28 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.792 2.837 . . . . 0.0 114.427 172.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.2 p -128.02 18.61 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 124.623 1.169 . . . . 0.0 112.015 173.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 48.8 p -124.63 18.27 8.77 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -170.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -94.5 -174.9 3.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.52 1.528 . . . . 0.0 109.452 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -66.77 -34.98 79.02 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.57 -0.706 . . . . 0.0 112.506 -174.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.0 mt -134.71 136.58 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -174.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -137.61 138.14 39.22 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 169.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -146.92 159.98 42.88 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.659 1.583 . . . . 0.0 107.388 168.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -123.17 104.52 9.22 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.954 1.302 . . . . 0.0 108.744 169.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 41.9 m0 -80.71 88.72 5.76 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.996 0.918 . . . . 0.0 108.873 -177.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -62.71 104.49 0.54 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.47 1.108 . . . . 0.0 109.644 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -136.92 172.16 13.43 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 126.217 1.807 . . . . 0.0 108.511 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -70.78 158.89 35.55 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 166.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -112.48 109.28 53.74 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 169.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -53.31 1.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 1 C-N-CA 126.652 4.901 . . . . 0.0 119.514 -169.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -51.53 98.93 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.844 1.202 . . . . 0.0 112.094 174.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.23 18.23 63.11 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 126.197 1.856 . . . . 0.0 113.111 171.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -95.18 178.22 5.6 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.811 1.305 . . . . 0.0 111.876 -169.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.9 m -74.09 153.89 39.41 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.236 1.414 . . . . 0.0 109.96 176.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 82.2 mt -60.14 -28.75 68.14 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.762 -0.586 . . . . 0.0 111.843 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.42 -38.8 92.55 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.087 0.403 . . . . 0.0 110.789 174.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 86.7 t -68.49 -46.29 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.496 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 16.3 m-85 -52.98 -54.55 33.45 Favored 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 122.704 0.401 . . . . 0.0 110.561 175.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -59.66 -40.67 88.5 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.175 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.8 m -62.55 -52.29 64.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.432 1.014 . . . . 0.0 109.668 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.86 -45.83 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-O 118.181 -0.914 . . . . 0.0 109.475 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -55.85 -49.61 72.84 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.448 1.022 . . . . 0.0 109.303 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.64 -49.1 82.34 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-O 118.368 -1.24 . . . . 0.0 110.482 -176.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -60.71 -53.49 56.82 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-N 118.371 1.085 . . . . 0.0 110.812 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 68.5 t -52.88 -46.13 51.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 124.355 1.062 . . . . 0.0 110.2 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -63.54 -49.9 71.63 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 119.724 1.147 . . . . 0.0 110.523 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.09 -43.44 70.36 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.338 1.055 . . . . 0.0 110.526 175.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 81.5 mtt-85 -72.24 -41.25 67.04 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 117.74 -1.124 . . . . 0.0 110.074 -175.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.7 t -54.3 -49.0 66.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 120.629 1.559 . . . . 0.0 108.811 169.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -60.17 -39.85 87.88 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.29 0.95 . . . . 0.0 110.883 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -63.65 -45.48 89.98 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.309 1.043 . . . . 0.0 110.257 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -46.09 89.31 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 123.829 0.852 . . . . 0.0 109.645 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 64.1 mt -60.07 -38.07 75.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.672 1.189 . . . . 0.0 110.921 175.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.69 -31.72 71.88 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 120.139 1.336 . . . . 0.0 111.295 -174.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -69.7 -20.46 63.54 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.596 1.558 . . . . 0.0 113.023 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.7 pt -125.01 -21.21 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -168.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 C--O 1.251 1.134 0 C-N-CA 126.391 1.876 . . . . 0.0 111.124 173.746 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.9 ttm . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.611 0.243 . . . . 0.0 110.457 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.69 141.91 43.31 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.582 0.753 . . . . 0.0 109.409 171.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -93.08 128.22 38.9 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 169.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.4 p -113.0 136.74 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 123.477 0.711 . . . . 0.0 109.565 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 35.9 tpp -112.93 141.34 46.88 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 170.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -117.47 136.0 53.52 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 169.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.1 t -138.87 131.03 37.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -174.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.23 165.9 18.09 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 120.116 1.325 . . . . 0.0 109.971 169.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -62.74 -10.81 14.05 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.6 ptm85 -153.93 114.27 3.95 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 103.168 -2.901 . . . . 0.0 103.168 169.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -51.83 -25.6 8.13 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.327 1.851 . . . . 0.0 113.25 -176.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.4 p -40.05 -36.87 0.53 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 118.42 2.748 . . . . 0.0 118.42 -168.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.0 p -137.55 -54.52 0.68 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 -169.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -64.59 -51.93 60.16 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 122.221 2.282 . . . . 0.0 108.863 -169.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 82.2 p -70.31 -39.04 75.06 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -170.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -55.89 -50.57 70.3 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.184 0.993 . . . . 0.0 111.096 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 60.0 mtm -64.18 -46.21 84.96 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 117.489 0.132 . . . . 0.0 110.709 178.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.78 -39.49 71.32 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 119.524 -0.274 . . . . 0.0 110.508 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -65.55 -45.35 83.73 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 119.434 -0.317 . . . . 0.0 111.137 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.38 -41.79 99.74 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -65.39 -49.05 70.76 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 117.997 0.899 . . . . 0.0 109.107 174.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.32 -43.15 88.08 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.169 0.895 . . . . 0.0 112.391 -172.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -69.37 -36.56 76.96 Favored 'General case' 0 C--O 1.219 -0.546 0 C-N-CA 118.991 -1.083 . . . . 0.0 110.946 175.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 52.2 m -67.19 -42.48 84.11 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 120.762 1.619 . . . . 0.0 110.495 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.3 mt -77.16 -37.63 53.45 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.38 1.472 . . . . 0.0 111.423 -174.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.3 -1.13 5.32 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 116.578 -2.234 . . . . 0.0 117.441 -169.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.55 108.75 0.52 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 121.935 2.868 . . . . 0.0 108.86 169.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.53 -29.26 2.8 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.846 1.212 . . . . 0.0 111.65 -170.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -134.21 -11.85 2.5 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.259 1.024 . . . . 0.0 113.216 171.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.2 pt -130.09 155.22 41.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 119.063 0.847 . . . . 0.0 109.306 168.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.73 127.84 53.22 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 105.472 -2.048 . . . . 0.0 105.472 169.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 p -112.17 150.87 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -173.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.1 m -141.03 144.28 34.9 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 126.012 1.725 . . . . 0.0 107.452 168.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.8 p -117.11 152.73 34.1 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.816 1.646 . . . . 0.0 109.003 168.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 32.1 p -158.14 -165.01 1.61 Allowed 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 176.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.47 160.05 28.31 Favored Glycine 0 CA--C 1.503 -0.68 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 169.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.3 tp -47.51 -35.66 9.15 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.369 1.468 . . . . 0.0 109.758 169.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -142.07 144.14 33.43 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 168.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.2 p -73.75 155.74 38.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.75 0.786 . . . . 0.0 110.885 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 67.5 m -159.19 150.57 20.26 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.513 1.925 . . . . 0.0 106.018 169.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.7 ttt-85 -49.08 146.94 3.16 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.876 1.271 . . . . 0.0 110.831 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.6 t -57.32 129.34 19.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.519 -1.659 . . . . 0.0 106.519 169.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -71.66 137.32 83.06 Favored Pre-proline 0 N--CA 1.444 -0.747 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -72.95 -38.64 2.77 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.04 1.16 . . . . 0.0 111.66 -169.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.423 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 20.6 m -64.4 -24.69 67.72 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.737 -1.227 . . . . 0.0 111.571 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.04 -39.38 66.13 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 121.574 -0.704 . . . . 0.0 111.193 175.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.5 mt -55.86 -46.03 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.26 -40.22 93.67 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 123.99 0.916 . . . . 0.0 110.065 -170.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.9 mmm -67.14 -43.0 83.48 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 122.672 1.225 . . . . 0.0 110.685 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.407 ' SD ' HG12 ' A' ' 57' ' ' ILE . 9.4 mtp -65.42 -34.92 79.43 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.375 -0.828 . . . . 0.0 109.863 174.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.65 -30.53 68.8 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.717 0.69 . . . . 0.0 111.217 173.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -66.69 -38.1 86.08 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.192 0.451 . . . . 0.0 109.879 176.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 64.3 t -77.28 -24.66 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.612 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.13 26.03 5.89 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.161 1.362 . . . . 0.0 111.75 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.7 mt -124.79 178.34 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 125.091 1.357 . . . . 0.0 107.476 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -142.23 156.43 45.3 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.514 1.526 . . . . 0.0 109.301 -177.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.407 HG12 ' SD ' ' A' ' 50' ' ' MET . 0.1 OUTLIER -129.06 -15.2 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.041 0.936 . . . . 0.0 112.634 170.505 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -44.62 -37.39 3.6 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.785 1.234 . . . . 0.0 112.715 172.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.95 -7.7 84.22 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.664 1.126 . . . . 0.0 114.384 -174.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -125.77 168.39 13.87 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.244 1.522 . . . . 0.0 110.667 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.0 p -129.36 169.37 14.97 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.207 1.003 . . . . 0.0 111.374 -169.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 54.7 m -89.61 159.66 17.04 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.17 0.988 . . . . 0.0 111.044 174.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -157.91 140.38 10.47 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.954 1.301 . . . . 0.0 108.875 -172.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.52 148.05 32.84 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.562 1.508 . . . . 0.0 110.417 -177.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.7 tt -52.15 -35.03 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 123.878 0.871 . . . . 0.0 111.559 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -58.05 -22.21 49.09 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.455 1.902 . . . . 0.0 112.316 -175.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -80.43 -7.01 58.97 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.343 1.057 . . . . 0.0 112.835 -177.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -125.02 179.86 4.85 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.575 1.08 . . . . 0.0 111.06 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.44 139.62 52.26 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 127.085 2.154 . . . . 0.0 107.254 171.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.62 -24.09 66.26 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.97 1.308 . . . . 0.0 111.891 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -60.18 -23.88 64.32 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.008 0.923 . . . . 0.0 112.45 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -83.54 -13.11 55.24 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.036 0.934 . . . . 0.0 110.785 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -107.23 128.0 54.03 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 125.743 1.617 . . . . 0.0 109.208 -174.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -77.17 -34.8 56.29 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.1 p -132.55 137.65 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 123.385 0.674 . . . . 0.0 109.524 -175.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.88 129.04 60.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 122.548 1.166 . . . . 0.0 109.94 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.5 mm -124.06 101.3 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -170.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.7 m -73.74 154.17 39.72 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 168.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.62 45.36 1.03 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 177.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 99.1 m -65.02 -59.39 4.2 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 117.744 -1.122 . . . . 0.0 112.046 -169.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 117.64 -22.94 9.81 Favored Glycine 0 N--CA 1.47 0.947 0 CA-C-N 119.873 1.215 . . . . 0.0 114.758 169.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 43.7 m -131.9 27.34 4.59 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.943 0.897 . . . . 0.0 111.867 -176.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.52 -1.68 65.41 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.813 1.196 . . . . 0.0 114.318 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.61 134.66 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 169.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -143.92 178.57 7.75 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.456 1.102 . . . . 0.0 110.103 -169.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 53.4 mt -117.69 99.33 52.26 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 124.36 1.064 . . . . 0.0 109.604 -169.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -52.26 -36.95 69.66 Favored 'Trans proline' 0 CA--C 1.549 1.249 0 C-N-CA 123.08 2.52 . . . . 0.0 116.915 169.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -67.65 -175.14 0.66 Allowed 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 122.267 1.978 . . . . 0.0 114.779 -173.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -45.39 -20.01 0.05 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.396 2.678 . . . . 0.0 115.492 171.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -61.63 1.11 0.26 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.122 1.769 . . . . 0.0 113.572 170.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.9 p -121.6 6.23 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.494 1.118 . . . . 0.0 112.019 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 82.8 p -127.48 22.38 6.47 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.355 0.98 . . . . 0.0 112.718 -172.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -89.28 -177.33 5.36 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.432 0.693 . . . . 0.0 109.922 173.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -64.0 -31.79 73.11 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.131 0.573 . . . . 0.0 112.525 -171.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.3 mt -135.84 134.36 51.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -141.04 138.12 33.4 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 169.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -145.26 157.19 44.12 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.03 1.332 . . . . 0.0 107.968 168.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -120.94 102.92 8.67 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.1 1.36 . . . . 0.0 109.177 169.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 39.8 m0 -78.88 93.79 5.08 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.877 1.671 . . . . 0.0 108.927 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -65.99 107.22 1.81 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -129.41 157.67 41.31 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 125.712 1.605 . . . . 0.0 109.906 -175.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -82.48 61.09 5.46 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.419 1.488 . . . . 0.0 112.126 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 53.1 t0 4.11 83.27 0.04 OUTLIER Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 129.603 3.161 . . . . 0.0 113.424 169.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -60.06 -5.93 4.4 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 123.174 2.583 . . . . 0.0 117.491 -169.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -60.23 90.78 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.728 1.211 . . . . 0.0 111.86 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.89 15.08 27.43 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 126.283 1.896 . . . . 0.0 113.376 173.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -91.94 179.05 5.71 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.013 1.407 . . . . 0.0 112.866 -169.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 41.5 m -75.54 155.7 35.81 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.563 1.545 . . . . 0.0 109.988 175.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.77 -33.39 70.24 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.944 -0.473 . . . . 0.0 111.563 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.28 -39.18 93.4 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.577 0.351 . . . . 0.0 110.764 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 99.2 t -66.08 -47.55 84.53 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 175.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.423 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 7.2 m-85 -54.76 -51.38 65.86 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.006 0.522 . . . . 0.0 111.026 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 24.0 mtt180 -60.29 -42.77 96.15 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.473 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 88.9 m -62.18 -55.16 31.43 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.4 t -61.01 -43.08 95.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 118.855 -0.593 . . . . 0.0 110.312 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.76 -45.19 93.01 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 119.396 0.998 . . . . 0.0 110.374 -177.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.42 -46.5 90.31 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -63.85 -46.39 85.24 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.988 0.915 . . . . 0.0 111.186 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.0 t -56.77 -51.71 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 125.65 1.58 . . . . 0.0 110.228 171.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -58.4 -45.35 88.53 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.114 0.87 . . . . 0.0 110.366 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -55.67 -45.88 77.67 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.9 0.88 . . . . 0.0 109.254 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.4 mtt85 -70.38 -39.05 74.79 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-O 118.086 -0.959 . . . . 0.0 110.782 -174.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.5 t -54.81 -48.56 73.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 120.373 1.442 . . . . 0.0 109.594 169.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -60.85 -40.33 92.48 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 119.625 1.102 . . . . 0.0 110.858 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -61.21 -46.46 90.36 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.259 1.424 . . . . 0.0 109.945 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.32 -48.43 73.08 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 124.011 0.925 . . . . 0.0 110.08 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 45.8 mt -55.31 -38.99 50.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.751 1.22 . . . . 0.0 110.631 174.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.37 -30.73 70.72 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.772 1.169 . . . . 0.0 111.237 -173.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -72.78 -20.79 61.1 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.691 1.596 . . . . 0.0 112.638 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.0 pt -123.37 -22.36 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -168.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 C--O 1.251 1.159 0 C-N-CA 126.181 1.792 . . . . 0.0 111.194 175.854 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.6 ttm . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 120.755 0.312 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -120.32 136.32 54.73 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.4 mttt -95.33 136.28 35.88 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 121.7 -0.625 . . . . 0.0 109.491 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.5 t -121.2 127.22 75.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -173.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 42.2 tpp -110.89 141.01 44.87 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 169.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -109.85 130.52 55.51 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 169.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.4 t -132.23 119.0 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 120.447 1.476 . . . . 0.0 109.141 -169.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.1 t -124.7 159.27 31.24 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.969 1.258 . . . . 0.0 110.704 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.2 mttm -58.49 -12.81 4.34 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.189 0.995 . . . . 0.0 113.115 169.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -138.6 -12.13 1.34 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 173.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 64.52 -43.82 0.3 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.744 2.418 . . . . 0.0 114.599 -169.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.0 m -40.25 -23.58 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 121.028 3.714 . . . . 0.0 121.028 -168.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 23.6 m -140.99 -62.84 0.47 Allowed 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 120.443 1.474 . . . . 0.0 111.174 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -59.79 -50.36 74.13 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.669 0.668 . . . . 0.0 109.583 -169.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.43 -43.81 69.17 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.389 0.276 . . . . 0.0 111.178 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -59.89 -46.4 89.44 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.69 0.796 . . . . 0.0 111.359 -174.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 56.6 mtm -67.71 -45.63 74.52 Favored 'General case' 0 C--O 1.231 0.114 0 O-C-N 122.276 -0.265 . . . . 0.0 110.551 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.48 -38.29 71.52 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 122.281 0.232 . . . . 0.0 111.053 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -64.91 -55.87 16.71 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 118.448 -0.787 . . . . 0.0 110.372 178.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -52.04 -40.25 50.75 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 119.481 -0.622 . . . . 0.0 112.149 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -64.9 -51.12 63.65 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 118.717 1.258 . . . . 0.0 110.266 173.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.6 -44.78 89.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 119.708 1.14 . . . . 0.0 112.88 -174.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -70.19 -9.69 56.53 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 119.732 1.151 . . . . 0.0 113.281 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.5 m -92.57 -48.2 6.73 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 119.892 1.224 . . . . 0.0 110.423 169.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.0 mt -77.49 -43.55 31.82 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.881 1.672 . . . . 0.0 112.073 -169.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.35 -6.11 18.33 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-O 118.038 -1.423 . . . . 0.0 114.923 -169.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.41 110.0 0.57 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.61 1.705 . . . . 0.0 108.891 169.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.38 -29.94 2.75 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.981 1.276 . . . . 0.0 111.444 -169.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.63 -22.6 3.27 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.811 1.244 . . . . 0.0 111.896 172.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.7 pt -125.83 158.69 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-O 121.564 0.697 . . . . 0.0 111.903 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -123.63 133.24 53.96 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 104.381 -2.452 . . . . 0.0 104.381 169.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.4 p -118.45 155.28 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-O 121.88 0.848 . . . . 0.0 112.541 -169.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.8 m -148.26 152.72 37.63 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.915 1.686 . . . . 0.0 107.216 167.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.3 p -118.35 153.35 34.16 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.53 1.132 . . . . 0.0 108.535 168.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 23.4 p -152.43 -169.99 3.51 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 173.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.92 163.12 30.79 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 169.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.7 mt -58.5 -32.24 68.62 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.971 0.508 . . . . 0.0 110.601 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -142.45 132.76 24.86 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 103.623 -2.732 . . . . 0.0 103.623 168.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.3 p -76.24 149.97 37.09 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.951 0.5 . . . . 0.0 111.084 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.1 m -147.52 158.45 44.0 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.081 2.152 . . . . 0.0 106.513 169.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.04 144.8 11.32 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.922 0.889 . . . . 0.0 110.905 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.6 p -65.11 138.42 23.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 169.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -83.38 149.48 58.14 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 123.479 0.711 . . . . 0.0 109.607 -174.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -81.86 -38.76 0.2 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 121.562 1.508 . . . . 0.0 112.907 -169.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.418 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 28.5 m -62.76 -27.23 69.14 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.297 1.408 . . . . 0.0 111.24 -177.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.28 -44.24 22.99 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.019 0.928 . . . . 0.0 111.175 171.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 52.3 mt -55.93 -45.52 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 C-N-CA 124.287 1.035 . . . . 0.0 108.291 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.47 -34.25 77.77 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.28 1.032 . . . . 0.0 110.104 -172.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 8.1 mmm -70.66 -41.49 72.02 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-O 122.547 1.165 . . . . 0.0 110.386 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.405 ' HG3' ' CG1' ' A' ' 57' ' ' ILE . 87.2 mmm -62.9 -41.13 99.33 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -61.63 -25.66 67.5 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.291 0.636 . . . . 0.0 111.096 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -65.61 -42.24 91.84 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 118.652 0.66 . . . . 0.0 110.094 171.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.3 t -76.22 -25.78 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.78 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.66 23.2 6.33 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.454 1.502 . . . . 0.0 111.958 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.4 mt -121.42 177.44 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 125.742 1.617 . . . . 0.0 107.693 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -143.9 157.51 44.31 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.484 1.513 . . . . 0.0 109.957 -176.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.405 ' CG1' ' HG3' ' A' ' 50' ' ' MET . 0.6 OUTLIER -130.45 -17.78 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.153 0.981 . . . . 0.0 111.983 169.607 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -42.58 -38.18 1.9 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.959 1.304 . . . . 0.0 113.292 173.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.0 -10.75 68.94 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 118.551 -1.138 . . . . 0.0 114.033 -175.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -123.99 168.75 12.41 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 119.181 1.491 . . . . 0.0 112.641 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.2 p -127.37 -176.05 3.62 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 126.526 1.931 . . . . 0.0 109.679 -174.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.7 p -113.56 158.95 20.12 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.284 1.433 . . . . 0.0 110.908 -175.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -151.22 149.9 25.84 Favored Pre-proline 0 N--CA 1.467 0.409 0 C-N-CA 124.218 1.007 . . . . 0.0 109.827 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.47 150.87 19.64 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.977 2.451 . . . . 0.0 110.617 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.2 tt -52.24 -36.22 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.766 1.226 . . . . 0.0 110.756 172.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -58.17 -25.55 61.64 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.838 1.655 . . . . 0.0 112.884 -171.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.81 -9.74 45.34 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -176.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -98.97 -174.45 2.77 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.371 0.987 . . . . 0.0 110.127 175.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.6 128.41 20.49 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 126.841 2.056 . . . . 0.0 106.941 175.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.92 -27.24 66.58 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.898 0.879 . . . . 0.0 111.969 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -60.28 -23.55 64.24 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.237 1.015 . . . . 0.0 112.644 -175.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -84.65 -16.55 41.55 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.101 0.56 . . . . 0.0 110.761 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -109.1 112.89 25.31 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 125.354 1.462 . . . . 0.0 108.323 -172.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -76.44 -21.6 55.71 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.328 0.585 . . . . 0.0 109.673 -176.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.1 t -133.98 134.83 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 125.803 1.641 . . . . 0.0 107.229 -172.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -137.36 119.39 19.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 123.023 1.392 . . . . 0.0 109.726 -176.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.2 mm -112.74 94.13 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 66.9 m -72.4 157.34 37.83 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 167.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.87 50.61 0.67 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 74.7 m -73.62 -42.02 62.02 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.431 1.092 . . . . 0.0 108.89 171.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.95 -56.58 0.74 Allowed Glycine 0 C--N 1.334 0.456 0 C-N-CA 124.459 1.028 . . . . 0.0 112.834 168.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 35.4 m -80.03 30.16 0.27 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -169.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.54 32.19 72.69 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.198 0.904 . . . . 0.0 110.868 -171.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.3 t -63.35 141.41 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 124.638 1.175 . . . . 0.0 108.783 -174.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -124.1 104.93 9.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.343 -172.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.1 mt -58.78 121.38 53.71 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 125.421 1.489 . . . . 0.0 108.659 -172.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -48.83 -40.1 39.42 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.444 2.096 . . . . 0.0 114.658 169.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.31 173.5 14.1 Favored 'Trans proline' 0 C--N 1.355 0.894 0 CA-C-N 121.623 1.615 . . . . 0.0 113.114 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -54.99 -6.93 0.14 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 129.235 3.014 . . . . 0.0 115.893 -176.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -61.87 0.05 0.42 Allowed 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 126.024 1.73 . . . . 0.0 112.378 169.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.6 m -114.33 5.17 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 120.376 1.444 . . . . 0.0 112.46 170.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.8 p -120.98 21.99 11.18 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.979 0.911 . . . . 0.0 111.716 -177.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -90.52 -178.99 5.46 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.375 1.07 . . . . 0.0 109.382 171.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.56 -36.42 82.61 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.719 0.808 . . . . 0.0 112.922 -169.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.9 mt -133.16 134.77 57.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -141.63 136.92 31.45 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.355 1.062 . . . . 0.0 108.835 172.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -146.47 159.51 43.31 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.822 1.649 . . . . 0.0 107.68 168.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -124.55 92.47 3.66 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.182 1.393 . . . . 0.0 109.045 169.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -66.01 141.54 58.14 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.746 0.819 . . . . 0.0 110.891 -176.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -110.71 92.03 3.89 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.845 1.258 . . . . 0.0 107.689 -170.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -131.1 149.68 52.49 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.679 1.592 . . . . 0.0 109.107 -170.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -84.47 56.81 3.98 Favored 'General case' 0 C--O 1.228 -0.072 0 C-N-CA 126.37 1.868 . . . . 0.0 112.05 -172.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.3 t0 5.94 82.35 0.04 OUTLIER Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 129.903 3.281 . . . . 0.0 113.977 169.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -54.5 -13.86 6.2 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 125.271 3.981 . . . . 0.0 118.633 -169.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.29 90.17 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 120.3 1.409 . . . . 0.0 111.925 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.85 6.69 26.25 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 126.282 1.896 . . . . 0.0 113.164 174.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -89.67 -178.5 5.55 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.81 1.305 . . . . 0.0 112.056 -169.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.0 m -78.98 156.96 28.24 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.971 1.308 . . . . 0.0 109.909 173.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 70.4 mt -59.79 -32.9 71.05 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 122.086 -0.384 . . . . 0.0 111.498 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -61.21 -39.9 91.96 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.376 0.534 . . . . 0.0 110.622 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.7 t -67.25 -46.57 83.72 Favored 'Isoleucine or valine' 0 C--N 1.338 0.086 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.418 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 11.7 m-85 -53.98 -52.57 60.29 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 122.608 0.363 . . . . 0.0 110.729 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.1 mtp180 -64.18 -40.91 97.1 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 118.511 -0.756 . . . . 0.0 111.09 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.5 m -63.37 -52.53 61.32 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.75 -42.74 95.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.216 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.79 -44.3 90.71 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-N 120.277 1.399 . . . . 0.0 110.365 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.84 -49.35 76.76 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -61.56 -44.9 96.19 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.266 1.033 . . . . 0.0 111.869 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.5 t -58.59 -50.05 80.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 125.606 1.562 . . . . 0.0 109.806 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -58.49 -45.78 88.02 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 119.478 1.035 . . . . 0.0 110.119 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.59 -43.6 80.24 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.307 1.043 . . . . 0.0 110.345 176.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 46.3 mtt85 -71.61 -40.9 69.52 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-O 117.965 -1.017 . . . . 0.0 111.088 -177.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.0 t -54.47 -48.22 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 120.505 1.502 . . . . 0.0 109.499 169.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -60.05 -40.13 88.34 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.4 1.0 . . . . 0.0 110.615 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -62.2 -45.74 92.02 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.244 1.018 . . . . 0.0 110.347 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.1 -47.45 82.79 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.012 0.925 . . . . 0.0 109.834 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 61.5 mt -58.88 -37.88 69.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 124.607 1.163 . . . . 0.0 110.491 176.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.79 -29.67 69.59 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.941 1.246 . . . . 0.0 111.486 -174.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 41.7 mttm -73.52 -19.57 60.88 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.974 1.71 . . . . 0.0 112.93 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.2 pt -125.95 -20.27 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.895 1.678 . . . . 0.0 114.941 -168.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.9 m . . . . . 0 C--O 1.251 1.16 0 C-N-CA 126.457 1.903 . . . . 0.0 110.886 169.883 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.5 ttm . . . . . 0 N--CA 1.484 1.264 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.5 147.28 42.9 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.788 0.835 . . . . 0.0 109.392 170.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -102.46 117.99 35.91 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 72.9 t -97.37 137.94 23.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 125.517 1.527 . . . . 0.0 108.128 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 35.5 tpp -126.01 143.64 51.02 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 169.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -114.02 133.23 55.64 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 169.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.3 t -136.26 122.15 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 120.065 1.302 . . . . 0.0 108.551 -169.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.0 t -129.9 163.6 26.0 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.146 0.885 . . . . 0.0 111.288 -173.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -59.49 -21.96 60.89 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 118.202 -0.904 . . . . 0.0 112.303 169.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -138.01 -9.68 1.55 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 116.18 1.918 . . . . 0.0 116.18 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 61.99 -43.1 0.16 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 128.346 2.659 . . . . 0.0 115.872 -174.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.7 p -35.16 -38.99 0.1 Allowed 'General case' 0 C--O 1.233 0.228 0 C-N-CA 129.596 3.159 . . . . 0.0 118.499 -168.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.4 p -133.13 -59.94 0.87 Allowed 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 118.757 -0.639 . . . . 0.0 111.129 -169.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.0 mtm180 -58.32 -56.73 18.27 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -171.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.6 -42.64 77.87 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.516 0.327 . . . . 0.0 111.063 -177.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -60.37 -45.86 92.02 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.65 0.78 . . . . 0.0 111.423 -174.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 49.4 mtm -62.3 -46.41 88.87 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 110.494 -0.187 . . . . 0.0 110.494 175.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.16 -39.15 78.1 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 119.742 -0.17 . . . . 0.0 111.062 -178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -63.69 -45.88 88.02 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.47 0.708 . . . . 0.0 110.422 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.24 -44.55 97.54 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -65.55 -47.33 76.23 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 118.624 1.212 . . . . 0.0 108.75 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.81 -43.18 85.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 119.366 0.985 . . . . 0.0 112.372 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -76.25 -2.35 30.98 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 119.047 0.84 . . . . 0.0 113.159 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.0 m -96.9 -45.64 6.54 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 121.301 -0.874 . . . . 0.0 109.445 169.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 91.8 mt -74.05 -41.03 62.38 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.96 1.704 . . . . 0.0 111.151 -171.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.63 -6.14 4.73 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-O 117.971 -1.46 . . . . 0.0 115.631 -169.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.75 121.95 9.66 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 120.237 2.019 . . . . 0.0 109.406 174.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.15 -31.61 4.21 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.733 1.158 . . . . 0.0 110.607 -172.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.2 -13.58 5.58 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.503 1.121 . . . . 0.0 112.021 174.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.8 pt -130.5 156.56 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 168.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -118.3 134.71 54.8 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 169.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.5 p -123.64 152.55 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-O 121.439 0.637 . . . . 0.0 112.061 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.3 m -144.35 161.88 37.87 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.944 1.298 . . . . 0.0 108.131 169.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 94.1 p -126.71 155.95 41.87 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 124.901 1.28 . . . . 0.0 109.107 168.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.3 p -154.51 -165.87 2.19 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 174.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.55 163.75 33.68 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 169.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.1 mt -52.08 -31.76 31.83 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.267 1.027 . . . . 0.0 110.237 174.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -148.01 145.67 28.61 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 168.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.5 p -79.03 161.68 26.43 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.579 0.704 . . . . 0.0 111.313 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.6 m -157.0 166.06 34.42 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.417 1.887 . . . . 0.0 107.284 169.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.1 ptt-85 -51.96 143.35 13.83 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.653 1.181 . . . . 0.0 110.728 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 56.0 t -63.4 130.34 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 168.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -70.63 138.78 86.0 Favored Pre-proline 0 N--CA 1.448 -0.555 0 CA-C-O 118.771 -0.633 . . . . 0.0 109.615 -174.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.18 -40.12 1.84 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 121.074 1.183 . . . . 0.0 111.471 -172.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.482 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 11.2 m -67.67 -18.08 64.82 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 120.488 -1.382 . . . . 0.0 111.916 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.21 -39.43 78.99 Favored 'General case' 0 C--N 1.339 0.116 0 O-C-N 121.275 -0.89 . . . . 0.0 110.63 171.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.4 mt -57.8 -46.15 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.54 -40.97 96.6 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.531 0.732 . . . . 0.0 112.036 -176.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.5 mmt -58.5 -49.15 78.42 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 122.558 1.17 . . . . 0.0 111.302 177.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.1 mtp -68.82 -36.26 77.99 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.651 -1.158 . . . . 0.0 108.899 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -62.46 -28.96 70.18 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.18 0.592 . . . . 0.0 111.514 173.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -64.25 -39.67 94.42 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.02 0.827 . . . . 0.0 110.176 173.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.0 t -78.58 -23.98 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 119.743 -0.17 . . . . 0.0 110.766 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.46 24.95 6.52 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.913 1.245 . . . . 0.0 111.882 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.1 mt -122.72 -178.23 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 C-N-CA 125.938 1.695 . . . . 0.0 106.821 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -147.93 156.12 42.32 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 120.438 -1.414 . . . . 0.0 109.909 -176.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.79 -16.38 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.277 1.031 . . . . 0.0 112.227 169.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.7 p -51.86 -31.39 27.74 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.707 1.139 . . . . 0.0 112.451 177.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.84 -6.28 88.59 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.814 1.197 . . . . 0.0 114.366 -177.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -125.77 168.65 13.51 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.369 1.584 . . . . 0.0 110.824 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.7 p -128.0 170.92 12.34 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.063 0.945 . . . . 0.0 111.372 -171.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.6 p -85.62 162.99 18.59 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.188 1.395 . . . . 0.0 111.06 175.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -157.89 145.15 13.44 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 123.775 0.83 . . . . 0.0 109.345 -178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -81.32 153.71 18.53 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.26 1.973 . . . . 0.0 110.936 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.4 tt -55.04 -34.03 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 123.706 0.802 . . . . 0.0 111.123 175.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -57.52 -23.22 49.0 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.369 1.867 . . . . 0.0 112.402 -174.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -85.17 -3.65 58.88 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.864 0.866 . . . . 0.0 112.819 -175.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -124.95 -174.25 2.99 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.426 1.09 . . . . 0.0 110.833 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.39 128.17 20.42 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.849 2.059 . . . . 0.0 107.63 175.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.84 -26.86 64.57 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.08 0.952 . . . . 0.0 112.554 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -59.42 -23.39 62.6 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.088 0.955 . . . . 0.0 112.488 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -83.67 -14.76 51.06 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.39 0.676 . . . . 0.0 110.799 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -108.32 120.36 42.15 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 125.704 1.602 . . . . 0.0 109.079 -172.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -75.25 -30.81 60.62 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.374 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.52 130.13 62.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -173.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.0 m -127.73 115.29 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 123.618 1.675 . . . . 0.0 109.855 -174.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.0 mm -110.22 101.78 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -175.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.7 t -72.7 155.41 40.01 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 168.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.18 50.8 0.72 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 171.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 85.4 m -65.42 -18.96 65.72 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.45 0.7 . . . . 0.0 110.947 174.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.24 -64.18 3.31 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 125.159 1.362 . . . . 0.0 110.266 169.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 37.9 m -75.85 22.45 0.14 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.336 1.054 . . . . 0.0 113.681 -174.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 65.51 16.94 63.8 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.994 1.759 . . . . 0.0 113.54 -177.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 95.9 t -70.86 161.97 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 169.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -136.36 167.68 20.86 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.34 1.056 . . . . 0.0 109.235 -174.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.2 mt -90.37 112.54 53.41 Favored Pre-proline 0 N--CA 1.45 -0.437 0 C-N-CA 126.196 1.799 . . . . 0.0 107.031 -173.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -60.12 -36.25 89.59 Favored 'Trans proline' 0 CA--C 1.547 1.171 0 CA-C-O 116.581 -1.508 . . . . 0.0 114.756 171.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.12 179.4 6.16 Favored 'Trans proline' 0 C--N 1.355 0.912 0 CA-C-N 122.732 2.011 . . . . 0.0 113.163 -178.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -53.97 -10.67 0.35 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 128.589 2.756 . . . . 0.0 115.746 -176.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -63.65 6.28 0.16 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 126.324 1.85 . . . . 0.0 112.593 169.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 p -117.85 2.18 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 125.23 1.412 . . . . 0.0 111.505 172.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.8 p -127.72 24.05 6.17 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.124 -0.985 . . . . 0.0 112.292 -172.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -90.55 -176.73 4.84 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.324 0.65 . . . . 0.0 109.26 169.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -66.13 -32.14 73.42 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -169.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.0 mt -134.11 132.38 55.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -177.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -140.1 138.21 35.11 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.143 0.977 . . . . 0.0 108.856 174.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -146.65 159.44 43.46 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.152 1.381 . . . . 0.0 107.762 168.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -122.05 113.43 19.53 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.879 1.272 . . . . 0.0 108.622 168.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 40.0 m0 -87.4 97.1 10.63 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -62.03 118.88 7.89 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 169.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 60.0 mt -150.21 150.57 31.77 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.236 1.415 . . . . 0.0 107.794 -169.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.8 mp0 -83.12 57.32 3.88 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.819 1.648 . . . . 0.0 111.999 -173.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.9 t70 2.76 85.53 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 129.377 3.071 . . . . 0.0 114.486 173.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -60.13 -8.01 7.47 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.523 2.815 . . . . 0.0 117.411 -169.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -55.36 100.72 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 120.528 1.513 . . . . 0.0 111.811 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.24 18.32 43.13 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 126.482 1.991 . . . . 0.0 113.382 171.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -98.31 177.01 5.51 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.012 1.406 . . . . 0.0 113.234 -169.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 37.7 m -75.77 154.77 36.09 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.987 1.715 . . . . 0.0 110.081 175.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 71.1 mt -59.14 -31.34 68.87 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 121.812 -0.555 . . . . 0.0 111.899 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.7 mp0 -62.3 -41.07 98.21 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.417 0.687 . . . . 0.0 110.387 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.63 -43.4 86.87 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.482 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 14.3 m-85 -55.68 -52.44 63.84 Favored 'General case' 0 N--CA 1.458 -0.069 0 CA-C-O 118.683 -0.675 . . . . 0.0 110.752 175.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 72.9 mtp85 -59.54 -41.5 90.19 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.248 0.931 . . . . 0.0 111.758 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.9 m -61.04 -46.7 89.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 118.682 0.674 . . . . 0.0 110.039 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.4 t -70.46 -42.97 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 117.79 -1.1 . . . . 0.0 110.257 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.9 ttp180 -56.34 -44.85 80.43 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 119.923 1.238 . . . . 0.0 109.48 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.04 -48.8 84.32 Favored Glycine 0 CA--C 1.521 0.426 0 CA-C-O 118.702 -1.055 . . . . 0.0 110.69 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -59.8 -55.55 32.83 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 118.113 0.956 . . . . 0.0 110.182 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.7 t -48.17 -53.91 5.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.698 1.599 . . . . 0.0 110.234 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -63.55 -47.51 81.28 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 119.412 1.006 . . . . 0.0 110.221 -172.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -53.98 -45.27 71.35 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.654 0.781 . . . . 0.0 109.8 174.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 78.0 mtt-85 -71.46 -37.61 71.36 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.173 -173.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 96.2 t -56.44 -48.37 80.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 120.726 1.603 . . . . 0.0 109.242 168.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -60.54 -35.29 75.64 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.259 0.936 . . . . 0.0 110.598 177.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -65.2 -45.16 85.86 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.445 1.498 . . . . 0.0 110.414 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.24 -44.47 88.06 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 123.204 0.602 . . . . 0.0 110.372 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 86.4 mt -56.6 -36.9 49.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 124.286 1.034 . . . . 0.0 109.861 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.27 -35.46 77.92 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 120.363 1.438 . . . . 0.0 111.094 -177.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -59.03 -52.44 65.74 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.604 0.762 . . . . 0.0 110.37 174.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pt -80.1 -39.01 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.657 1.183 . . . . 0.0 112.517 -171.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . 0.259 6.0 p . . . . . 0 C--O 1.25 1.084 0 C-N-CA 130.744 3.617 . . . . 0.0 114.003 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.1 ttm . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -121.04 150.49 41.08 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.052 0.941 . . . . 0.0 109.582 171.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -106.37 106.7 17.34 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 123.974 0.91 . . . . 0.0 109.725 178.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 57.2 t -85.41 139.7 17.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 125.934 1.694 . . . . 0.0 109.218 176.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 20.1 tpp -127.13 145.96 50.55 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.242 0.617 . . . . 0.0 109.59 169.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -120.47 120.77 36.86 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.825 1.65 . . . . 0.0 108.492 171.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.6 t -128.4 141.79 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.939 1.296 . . . . 0.0 109.263 -169.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 28.4 p -152.65 -170.61 3.68 Favored 'General case' 0 C--O 1.222 -0.354 0 O-C-N 120.976 -1.078 . . . . 0.0 112.869 -169.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -80.87 -24.96 37.99 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.321 1.048 . . . . 0.0 112.915 169.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -159.83 108.77 1.78 Allowed 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 -173.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -54.07 -17.51 2.76 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.525 1.53 . . . . 0.0 113.567 -173.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -38.93 -47.18 1.41 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 127.859 2.464 . . . . 0.0 117.177 -169.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.0 p -132.32 -77.32 0.5 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 116.009 -1.948 . . . . 0.0 114.561 -168.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.2 -49.14 33.92 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 121.601 2.0 . . . . 0.0 111.246 -168.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.77 -48.61 71.24 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.825 1.65 . . . . 0.0 110.709 -174.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -64.97 -42.02 94.94 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 124.541 1.136 . . . . 0.0 111.338 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 63.2 mtp -60.71 -48.78 80.24 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.27 1.028 . . . . 0.0 108.913 175.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.06 -41.04 87.0 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 122.968 0.507 . . . . 0.0 111.132 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -62.4 -45.23 94.07 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.505 0.722 . . . . 0.0 110.016 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.01 -45.2 97.1 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.448 -0.64 . . . . 0.0 111.645 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -65.26 -52.13 56.34 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 118.661 1.23 . . . . 0.0 108.58 175.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.01 -42.76 76.91 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.416 1.086 . . . . 0.0 112.508 -173.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -70.23 -35.54 73.91 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 118.791 0.723 . . . . 0.0 110.111 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.9 m -67.17 -43.27 82.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 119.521 -1.987 . . . . 0.0 110.504 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.6 mt -71.52 -39.94 70.43 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.071 1.748 . . . . 0.0 110.78 -174.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.19 4.19 4.13 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 116.725 -2.153 . . . . 0.0 118.284 -169.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.87 114.71 1.67 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 121.588 2.694 . . . . 0.0 109.041 169.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 124.01 -24.11 6.4 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.63 1.109 . . . . 0.0 111.548 -175.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.66 -20.19 3.26 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 118.327 1.063 . . . . 0.0 111.684 178.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.5 pt -132.07 156.87 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 168.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.99 139.67 50.39 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 169.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 p -131.59 148.64 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.2 0.524 . . . . 0.0 111.871 -175.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 m -142.14 160.69 39.74 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.069 170.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 91.7 p -129.23 157.39 41.98 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.067 1.347 . . . . 0.0 108.265 168.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.4 p -153.04 -164.82 2.02 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.93 159.63 29.15 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 169.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 75.0 mt -52.5 -28.87 22.22 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.241 1.417 . . . . 0.0 110.556 172.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -144.57 146.58 32.41 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 168.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.1 p -72.1 159.25 34.46 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.94 0.896 . . . . 0.0 111.439 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.2 p -153.85 165.3 36.5 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.582 1.953 . . . . 0.0 106.904 170.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -66.09 154.16 40.35 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 120.896 -1.127 . . . . 0.0 109.556 172.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.4 t -62.46 132.75 28.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 169.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -74.14 140.4 76.7 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -75.3 -41.32 0.63 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.277 1.318 . . . . 0.0 112.124 -169.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.439 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 27.7 m -63.41 -25.34 68.23 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.536 -1.352 . . . . 0.0 111.576 -178.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.95 -39.44 59.24 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.467 0.707 . . . . 0.0 111.541 173.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.6 mt -56.2 -45.78 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.68 -38.25 88.75 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.265 1.026 . . . . 0.0 110.09 -170.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.3 mmm -69.84 -44.1 70.59 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 122.751 1.263 . . . . 0.0 110.569 -177.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.3 mtp -65.03 -36.15 83.45 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.482 -0.761 . . . . 0.0 109.683 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -63.25 -25.99 68.58 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.243 0.617 . . . . 0.0 111.417 174.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -66.26 -39.63 89.59 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.873 0.76 . . . . 0.0 109.817 173.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.3 t -76.96 -24.93 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.636 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.82 26.44 5.81 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.008 1.29 . . . . 0.0 111.67 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.2 mt -122.67 177.32 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 125.194 1.398 . . . . 0.0 107.252 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -142.16 156.43 45.35 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.107 1.363 . . . . 0.0 109.421 -177.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.48 -16.96 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 123.781 0.832 . . . . 0.0 112.27 169.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -45.2 -39.08 5.89 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.679 1.192 . . . . 0.0 112.791 173.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.55 -4.56 89.27 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.625 1.107 . . . . 0.0 114.266 -172.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -126.78 165.47 19.23 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.125 1.462 . . . . 0.0 110.705 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 25.7 p -128.01 170.79 12.49 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.972 0.909 . . . . 0.0 111.361 -170.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.8 p -87.48 169.33 12.31 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.434 1.494 . . . . 0.0 112.034 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.24 135.07 6.64 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 123.966 0.907 . . . . 0.0 108.698 -174.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.36 154.29 31.8 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.767 2.311 . . . . 0.0 111.4 176.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.2 tt -55.9 -34.45 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 123.764 0.825 . . . . 0.0 111.33 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -60.1 -22.0 62.23 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.823 1.649 . . . . 0.0 112.205 -173.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -80.82 -2.5 47.5 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.179 0.992 . . . . 0.0 112.569 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -130.65 -179.87 5.55 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.586 1.085 . . . . 0.0 111.984 -174.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.08 139.43 45.96 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 127.812 2.445 . . . . 0.0 106.547 169.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.4 -24.89 66.55 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.549 1.14 . . . . 0.0 111.593 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -60.86 -24.56 66.01 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.022 0.929 . . . . 0.0 112.497 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -82.96 -17.92 41.81 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.909 0.884 . . . . 0.0 110.53 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -97.82 122.4 40.89 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 125.623 1.569 . . . . 0.0 108.546 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -73.11 -29.4 62.88 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 175.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.47 134.34 43.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 C-N-CA 122.507 0.323 . . . . 0.0 110.317 -170.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.5 m -127.03 128.98 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 122.135 0.969 . . . . 0.0 110.115 -175.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 49.9 mm -116.36 135.15 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.3 m -104.18 146.52 28.64 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 123.92 0.762 . . . . 0.0 109.233 169.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.97 53.92 0.35 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.047 1.739 . . . . 0.0 107.741 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 83.2 m -61.66 -41.38 97.46 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.802 0.841 . . . . 0.0 110.959 172.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.91 -71.53 0.49 Allowed Glycine 0 CA--C 1.508 -0.36 0 N-CA-C 104.964 -3.254 . . . . 0.0 104.964 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 84.2 m -70.2 163.61 26.03 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 167.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.58 37.87 1.65 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 123.675 0.655 . . . . 0.0 113.378 -173.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 96.9 t -65.71 154.31 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 124.876 1.271 . . . . 0.0 107.976 171.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -132.82 -178.5 4.98 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.96 1.304 . . . . 0.0 109.862 -173.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.3 mt -122.49 95.23 47.06 Favored Pre-proline 0 CA--C 1.532 0.253 0 C-N-CA 125.693 1.597 . . . . 0.0 107.572 -169.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -48.45 -37.62 33.5 Favored 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 122.825 2.35 . . . . 0.0 116.239 172.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.39 -174.06 0.77 Allowed 'Trans proline' 0 C--N 1.356 0.936 0 CA-C-N 122.059 1.771 . . . . 0.0 114.523 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -46.56 -18.7 0.07 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 128.244 2.618 . . . . 0.0 115.468 172.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -63.29 5.78 0.15 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.318 1.847 . . . . 0.0 113.756 170.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.4 p -126.44 5.17 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.338 1.055 . . . . 0.0 112.388 171.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.0 p -120.36 21.22 11.75 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.642 1.11 . . . . 0.0 112.61 -171.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -90.81 -176.78 4.79 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.624 0.769 . . . . 0.0 109.543 173.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -65.65 -31.56 72.65 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -170.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.7 mt -134.39 137.24 51.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -137.03 136.34 38.35 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 169.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -143.11 155.6 44.63 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.286 1.434 . . . . 0.0 107.853 169.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -120.63 132.53 55.17 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.147 1.379 . . . . 0.0 108.884 169.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.407 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 39.7 m0 -116.52 96.41 5.5 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.829 1.652 . . . . 0.0 107.472 -172.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -72.92 83.59 1.23 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.517 1.527 . . . . 0.0 109.721 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.32 154.0 23.12 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 125.208 1.403 . . . . 0.0 109.844 -175.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -78.25 65.85 3.7 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.204 1.402 . . . . 0.0 111.819 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -13.41 92.17 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 129.036 2.935 . . . . 0.0 114.308 178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -61.71 -6.91 8.13 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.927 3.085 . . . . 0.0 116.769 -169.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -60.42 88.62 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 120.214 1.37 . . . . 0.0 111.3 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.16 14.86 23.33 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 126.604 2.049 . . . . 0.0 113.874 175.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -93.82 179.75 5.25 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.51 1.655 . . . . 0.0 113.522 -169.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.9 m -77.74 156.48 30.56 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.769 1.628 . . . . 0.0 110.138 175.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 93.5 mt -58.14 -34.48 70.31 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.908 0.483 . . . . 0.0 111.462 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -66.81 -36.87 83.37 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.072 0.396 . . . . 0.0 110.695 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.0 t -65.87 -46.08 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.439 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 7.9 m-85 -56.4 -49.08 75.51 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.962 0.505 . . . . 0.0 111.078 176.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 16.4 mtp85 -59.08 -45.03 91.87 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.897 0.879 . . . . 0.0 111.05 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 92.9 m -60.94 -53.01 62.55 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 74.4 t -64.58 -40.47 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-O 118.506 -0.759 . . . . 0.0 110.5 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.84 -43.43 94.62 Favored 'General case' 0 CA--C 1.523 -0.071 0 CA-C-N 120.215 1.37 . . . . 0.0 110.446 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.43 -50.02 65.58 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-O 118.929 -0.928 . . . . 0.0 111.057 174.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -56.43 -50.3 72.06 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.27 1.035 . . . . 0.0 110.991 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 48.9 t -55.77 -54.92 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 126.32 1.848 . . . . 0.0 109.341 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -59.93 -45.53 92.31 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 119.336 0.971 . . . . 0.0 110.065 -173.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.18 -45.19 79.85 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.784 0.833 . . . . 0.0 110.248 176.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.407 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 45.2 mtt85 -70.32 -42.38 72.04 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 117.869 -1.062 . . . . 0.0 110.744 -176.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.5 t -52.82 -49.71 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 120.321 1.418 . . . . 0.0 110.293 169.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -60.77 -41.65 95.91 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.262 0.937 . . . . 0.0 110.599 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -61.38 -44.32 97.36 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.228 1.011 . . . . 0.0 110.176 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . 0.262 0.2 OUTLIER -67.97 -46.47 71.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.809 -179.375 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.8 mt -51.52 -42.81 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 119.373 0.988 . . . . 0.0 109.245 172.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.44 -30.1 70.37 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.68 1.127 . . . . 0.0 111.532 -172.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 47.1 mttt -71.98 -45.75 59.87 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.272 1.429 . . . . 0.0 110.863 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.2 pt -86.11 -27.56 6.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.684 1.193 . . . . 0.0 113.875 -171.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 C--O 1.248 1.012 0 C-N-CA 126.194 1.798 . . . . 0.0 111.009 176.588 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.0 ttm . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.961 0.41 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.8 mmtt -125.77 144.33 50.68 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.299 1.44 . . . . 0.0 107.144 174.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.8 mttt -101.96 120.06 39.79 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 118.753 -0.642 . . . . 0.0 109.568 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.9 p -99.75 140.26 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 121.469 0.652 . . . . 0.0 110.438 175.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 33.9 tpp -121.37 140.61 51.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.596 -1.184 . . . . 0.0 108.202 169.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -112.5 127.11 55.96 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 169.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.5 t -128.92 126.5 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 120.088 1.313 . . . . 0.0 108.446 -169.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.7 t -134.68 156.49 48.68 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 119.106 0.867 . . . . 0.0 112.658 -174.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -56.94 -23.0 42.11 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.225 1.01 . . . . 0.0 111.405 169.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.6 ptt-85 -148.82 107.81 3.88 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 169.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -47.46 -36.49 10.15 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.225 1.01 . . . . 0.0 112.0 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.3 m -43.7 -24.5 0.12 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 130.931 3.693 . . . . 0.0 118.717 -169.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.0 p -130.92 -79.84 0.53 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 120.018 1.281 . . . . 0.0 112.44 -169.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -56.79 -52.18 66.06 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.358 1.063 . . . . 0.0 109.664 -169.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.13 -46.69 79.93 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 126.37 1.868 . . . . 0.0 111.558 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -62.22 -41.02 98.01 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.096 0.407 . . . . 0.0 111.14 -174.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 44.1 mtm -62.69 -47.89 81.67 Favored 'General case' 0 CA--C 1.529 0.15 0 O-C-N 122.3 -0.25 . . . . 0.0 111.127 172.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.32 -38.94 78.11 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 117.887 0.312 . . . . 0.0 111.227 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -62.49 -51.05 68.99 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.345 1.458 . . . . 0.0 109.445 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.46 -42.52 99.05 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 119.501 -0.61 . . . . 0.0 112.248 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -67.14 -49.47 64.7 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 119.006 1.403 . . . . 0.0 108.971 177.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.27 -36.84 76.27 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 119.303 0.956 . . . . 0.0 112.415 -176.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -72.17 -35.95 69.15 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 119.383 0.992 . . . . 0.0 110.633 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.0 m -66.99 -42.14 85.55 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 119.98 -1.7 . . . . 0.0 110.476 177.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.4 mt -75.83 -31.47 59.37 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.887 1.675 . . . . 0.0 111.512 -173.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -141.33 4.45 2.28 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 117.212 -1.882 . . . . 0.0 117.539 -170.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.12 113.56 1.59 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 120.989 2.394 . . . . 0.0 108.829 171.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.07 -24.34 5.7 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.64 1.114 . . . . 0.0 111.644 -175.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.94 -18.2 3.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.408 1.104 . . . . 0.0 112.24 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.9 pt -130.62 150.11 34.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 168.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.68 123.74 50.01 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 170.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.27 143.9 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 C-N-CA 126.441 1.896 . . . . 0.0 109.516 -169.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 86.7 m -152.04 160.41 43.46 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.841 1.656 . . . . 0.0 106.78 169.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.1 p -130.48 161.26 31.83 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.745 0.818 . . . . 0.0 109.688 168.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.2 p -153.77 -168.85 3.1 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 176.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.36 166.91 34.91 Favored Glycine 0 N--CA 1.448 -0.522 0 O-C-N 121.283 -0.885 . . . . 0.0 111.59 170.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.2 mp -52.15 -36.86 52.68 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.742 1.217 . . . . 0.0 110.014 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -142.89 144.65 32.54 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 169.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 p -84.0 155.72 22.62 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.674 0.749 . . . . 0.0 110.935 174.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.9 m -163.23 151.48 13.78 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 128.033 2.533 . . . . 0.0 105.203 169.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -55.45 156.41 4.55 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.028 0.831 . . . . 0.0 111.959 -170.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.2 t -60.92 135.17 25.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -72.66 143.02 84.33 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 123.614 0.766 . . . . 0.0 109.07 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.43 -42.07 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 121.426 1.417 . . . . 0.0 113.11 -169.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.493 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 21.5 m -66.66 -17.02 64.62 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.172 -1.58 . . . . 0.0 111.956 -176.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.37 -39.32 72.72 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.292 -0.88 . . . . 0.0 110.935 169.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 62.5 mt -56.66 -48.09 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.65 -40.71 93.03 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 123.967 0.907 . . . . 0.0 111.489 -173.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.2 mmt -59.54 -48.18 82.66 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 122.934 1.349 . . . . 0.0 111.517 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.0 mtp -68.17 -35.93 78.81 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.886 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -61.31 -30.15 70.31 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 118.783 -0.627 . . . . 0.0 111.64 172.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -65.13 -36.31 83.85 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.057 0.844 . . . . 0.0 110.435 175.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.1 t -80.99 -25.45 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 117.606 0.184 . . . . 0.0 111.058 176.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.91 27.81 5.26 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.692 1.139 . . . . 0.0 111.741 -177.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.7 mt -123.32 -178.74 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 126.222 1.809 . . . . 0.0 106.874 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -147.22 156.45 42.96 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.156 1.382 . . . . 0.0 109.483 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.49 -14.25 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.99 0.916 . . . . 0.0 112.341 169.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -46.83 -38.18 9.87 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.647 1.179 . . . . 0.0 112.678 173.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.65 -4.99 85.88 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 118.604 -1.109 . . . . 0.0 113.988 -172.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -128.64 167.06 17.73 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.135 1.467 . . . . 0.0 111.393 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.9 p -126.24 166.14 17.65 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.487 1.115 . . . . 0.0 111.566 -169.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.0 m -81.51 162.7 23.12 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.188 0.995 . . . . 0.0 111.252 175.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -153.56 144.12 15.81 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-O 118.47 -0.776 . . . . 0.0 109.973 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.77 152.74 17.2 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.423 2.082 . . . . 0.0 111.229 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.3 tt -55.88 -33.92 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 123.562 0.745 . . . . 0.0 111.202 174.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -57.94 -22.98 51.6 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.165 1.786 . . . . 0.0 112.39 -175.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -80.98 -5.65 57.81 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.988 0.915 . . . . 0.0 112.818 -176.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -126.13 -179.93 4.95 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.552 1.069 . . . . 0.0 111.805 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.01 139.31 51.05 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 127.558 2.343 . . . . 0.0 106.983 169.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.16 -22.39 62.97 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.207 1.003 . . . . 0.0 112.231 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -61.77 -22.35 65.35 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.284 1.034 . . . . 0.0 112.507 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -83.8 -16.01 46.24 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.851 0.86 . . . . 0.0 110.491 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -103.77 130.09 51.26 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 125.176 1.39 . . . . 0.0 109.493 -172.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -78.81 -36.52 42.52 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 122.728 0.411 . . . . 0.0 111.166 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.4 p -133.39 132.95 57.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -171.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.5 m -125.67 108.06 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-O 123.124 1.44 . . . . 0.0 109.042 -173.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.7 mm -103.13 96.78 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.4 m -73.38 157.68 36.48 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 167.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.96 26.37 1.88 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 174.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 74.9 m -57.9 -33.57 68.9 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.648 1.579 . . . . 0.0 111.75 -171.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.47 -66.91 0.5 Allowed Glycine 0 C--N 1.334 0.442 0 C-N-CA 124.294 0.949 . . . . 0.0 112.022 168.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 85.6 m -83.76 33.4 0.48 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 117.668 0.734 . . . . 0.0 112.526 -169.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.24 24.45 72.02 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.397 0.998 . . . . 0.0 112.265 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.8 t -74.31 104.26 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 124.366 1.066 . . . . 0.0 108.616 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -75.97 156.99 33.63 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 122.211 1.005 . . . . 0.0 108.343 168.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.9 mt -77.56 123.3 86.7 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 114.092 -1.413 . . . . 0.0 107.356 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.94 -40.78 83.94 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.101 1.867 . . . . 0.0 113.632 169.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -77.36 -176.74 3.37 Favored 'Trans proline' 0 C--N 1.356 0.945 0 CA-C-N 121.533 1.583 . . . . 0.0 113.196 -174.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.421 ' C ' ' H ' ' A' ' 91' ' ' VAL . 9.5 pt-20 -45.64 -23.31 0.23 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 129.599 3.16 . . . . 0.0 114.921 -178.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -62.55 11.23 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 128.732 2.813 . . . . 0.0 113.857 176.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.421 ' H ' ' C ' ' A' ' 89' ' ' GLU . 3.7 p -119.38 15.21 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 124.824 1.25 . . . . 0.0 111.609 174.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.5 p -130.23 17.44 5.5 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -171.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -91.37 179.12 5.77 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.36 1.464 . . . . 0.0 109.464 178.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -61.57 -33.63 74.2 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.636 1.174 . . . . 0.0 113.551 -171.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.8 mt -137.7 134.0 45.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -137.35 138.63 40.15 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 171.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -146.53 158.84 43.96 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.016 1.727 . . . . 0.0 107.362 169.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -123.16 100.06 6.67 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.869 1.267 . . . . 0.0 108.612 168.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.418 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 43.8 m0 -73.02 102.16 3.43 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.268 1.027 . . . . 0.0 108.832 -177.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -68.89 93.16 0.54 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.659 1.184 . . . . 0.0 109.259 176.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.5 153.36 35.45 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 125.481 1.512 . . . . 0.0 109.974 -172.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -85.66 53.36 2.74 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.432 1.493 . . . . 0.0 111.829 -171.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.8 t70 5.62 87.07 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 129.287 3.035 . . . . 0.0 114.106 169.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -61.64 -4.85 4.91 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.864 3.042 . . . . 0.0 116.805 -172.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -54.5 93.03 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.988 1.267 . . . . 0.0 112.686 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.08 17.75 39.36 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 126.329 1.918 . . . . 0.0 113.419 172.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -95.0 178.25 5.62 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.987 1.393 . . . . 0.0 113.055 -169.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.6 m -77.45 156.13 31.3 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.994 1.718 . . . . 0.0 110.139 175.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 99.8 mt -59.14 -32.48 69.91 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.785 -0.572 . . . . 0.0 111.817 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.67 -39.14 93.0 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.656 0.382 . . . . 0.0 110.622 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 90.6 t -67.82 -45.07 84.98 Favored 'Isoleucine or valine' 0 C--N 1.338 0.083 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.493 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 17.4 m-85 -56.9 -50.38 72.71 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 119.023 -0.513 . . . . 0.0 111.043 176.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 -58.82 -41.76 87.57 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.024 0.829 . . . . 0.0 111.663 176.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.7 m -60.89 -49.75 76.22 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 118.836 0.744 . . . . 0.0 109.489 177.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.7 t -65.26 -39.21 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-O 117.748 -1.12 . . . . 0.0 110.654 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.6 ttp-105 -55.35 -48.59 73.99 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 120.354 1.434 . . . . 0.0 108.898 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.05 -47.76 89.56 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-O 118.326 -1.263 . . . . 0.0 110.196 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -56.27 -56.08 25.42 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.518 1.159 . . . . 0.0 110.151 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.6 t -55.82 -54.2 29.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 126.746 2.018 . . . . 0.0 110.851 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -63.01 -47.63 82.25 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 119.645 1.111 . . . . 0.0 110.158 -169.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -41.69 72.38 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 123.781 0.833 . . . . 0.0 110.995 174.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.418 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 45.7 mtt85 -71.45 -42.71 67.84 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.676 -177.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 71.5 t -53.02 -47.81 53.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 120.732 1.605 . . . . 0.0 109.769 169.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -61.48 -41.04 96.65 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 118.894 0.77 . . . . 0.0 110.767 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -62.19 -46.36 89.27 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 123.099 0.56 . . . . 0.0 110.264 175.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.18 -46.32 89.47 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 118.249 -0.881 . . . . 0.0 109.793 -177.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 71.7 mt -57.0 -40.14 70.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.791 0.836 . . . . 0.0 109.596 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.62 -31.3 72.45 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 120.147 1.34 . . . . 0.0 111.593 -175.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -64.08 -36.24 83.37 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.28 1.032 . . . . 0.0 111.827 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 pt -104.14 -25.28 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -169.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.7 m . . . . . 0 C--O 1.248 0.996 0 C-N-CA 125.785 1.634 . . . . 0.0 111.143 179.489 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.4 ttm . . . . . 0 N--CA 1.484 1.274 0 CA-C-O 121.094 0.473 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -96.64 138.72 33.79 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.547 0.739 . . . . 0.0 109.26 176.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -93.9 110.7 22.36 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 170.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 85.5 t -93.06 136.97 23.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 125.582 1.553 . . . . 0.0 107.966 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 39.6 tpp -119.06 143.06 47.33 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.458 1.103 . . . . 0.0 108.63 172.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -121.09 122.64 40.49 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.958 1.303 . . . . 0.0 108.114 170.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.8 t -127.45 123.91 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 120.771 1.623 . . . . 0.0 109.498 -174.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.4 t -118.39 165.11 14.27 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.872 0.76 . . . . 0.0 109.756 176.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -65.7 -11.54 46.13 Favored 'General case' 0 CA--C 1.548 0.893 0 O-C-N 121.82 -0.55 . . . . 0.0 111.548 169.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -154.47 107.53 2.85 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 128.238 2.615 . . . . 0.0 105.307 169.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -47.16 -38.42 11.77 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.927 1.291 . . . . 0.0 113.014 -178.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.9 p -38.77 -33.05 0.1 Allowed 'General case' 0 C--O 1.236 0.362 0 C-N-CA 129.507 3.123 . . . . 0.0 117.852 -169.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.8 m -122.62 -76.21 0.59 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.659 0.663 . . . . 0.0 111.791 -169.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -58.99 -51.11 71.5 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.264 0.484 . . . . 0.0 109.751 -169.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.76 -42.51 81.63 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.34 0.656 . . . . 0.0 111.271 -173.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -59.65 -45.05 93.2 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.547 0.739 . . . . 0.0 111.1 -175.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 53.5 mtm -65.66 -45.82 81.49 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 117.563 0.165 . . . . 0.0 111.07 176.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.43 -39.09 75.5 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 117.592 0.178 . . . . 0.0 110.859 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -65.41 -54.56 26.9 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.484 -0.77 . . . . 0.0 110.682 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.71 -41.38 50.39 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-O 119.271 -0.739 . . . . 0.0 112.456 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -68.02 -46.94 69.81 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 118.938 1.369 . . . . 0.0 109.457 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.04 -46.29 85.6 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 120.188 1.358 . . . . 0.0 112.894 -176.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -69.54 -5.77 26.47 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.523 1.056 . . . . 0.0 113.57 175.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.0 m -97.7 -47.99 5.39 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 119.927 1.239 . . . . 0.0 110.255 170.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 97.0 mt -77.45 -41.35 39.98 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.608 1.563 . . . . 0.0 111.86 -169.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -119.74 -5.22 11.16 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-O 117.86 -1.522 . . . . 0.0 114.877 -169.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.94 108.2 0.34 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.621 1.71 . . . . 0.0 108.825 169.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 137.69 -28.97 2.71 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.94 1.257 . . . . 0.0 111.643 -169.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.47 -22.32 3.36 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.569 1.148 . . . . 0.0 111.676 171.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.5 pt -123.82 156.04 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 121.313 0.578 . . . . 0.0 111.722 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -121.94 131.97 54.3 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 104.191 -2.522 . . . . 0.0 104.191 168.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 p -117.67 151.68 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -169.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.6 m -144.49 144.03 31.16 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 167.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.5 p -112.37 153.05 27.88 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 168.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.9 m -151.08 -170.13 3.58 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.39 160.56 29.94 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 169.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.1 mt -53.69 -30.65 44.63 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.369 0.668 . . . . 0.0 110.788 173.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -143.82 146.75 33.3 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 168.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.6 p -75.15 165.91 24.48 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.01 0.909 . . . . 0.0 111.756 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.7 p -151.59 -148.01 0.25 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.565 1.946 . . . . 0.0 106.322 173.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -133.13 155.65 48.89 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 173.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.4 t -63.21 128.71 25.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -173.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -70.96 137.85 85.05 Favored Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -70.58 -38.09 6.42 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 121.974 1.782 . . . . 0.0 112.428 -169.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.469 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 10.4 m -67.65 -18.86 65.1 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.407 -0.808 . . . . 0.0 111.878 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.48 -40.96 84.18 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 121.646 -0.659 . . . . 0.0 110.1 171.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.6 mp -61.99 -43.79 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.24 -37.67 81.09 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -176.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.4 mmt -62.31 -47.61 83.5 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 122.823 1.297 . . . . 0.0 111.441 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.2 mtp -69.0 -34.17 74.85 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.12 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -62.29 -29.83 70.7 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.584 0.754 . . . . 0.0 111.361 172.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -63.75 -39.31 93.97 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.872 0.76 . . . . 0.0 110.247 173.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.7 t -78.96 -25.33 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 121.219 -0.192 . . . . 0.0 110.97 178.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.61 24.89 5.94 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.104 1.335 . . . . 0.0 112.032 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.8 mt -123.21 179.29 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 125.768 1.627 . . . . 0.0 107.249 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -144.61 157.95 43.99 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.745 1.618 . . . . 0.0 108.942 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -128.86 -16.95 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.888 0.875 . . . . 0.0 112.701 170.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 61.4 p -54.1 -28.58 40.3 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 120.076 1.307 . . . . 0.0 112.498 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.38 -11.22 71.44 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.706 1.146 . . . . 0.0 114.146 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -123.21 173.05 8.15 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.291 1.545 . . . . 0.0 111.163 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.4 p -128.53 164.79 22.04 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.458 1.103 . . . . 0.0 111.416 -169.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 73.6 m -80.6 158.62 25.65 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.904 0.882 . . . . 0.0 110.859 170.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -158.0 145.9 13.85 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.0 0.92 . . . . 0.0 109.663 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -82.85 150.83 14.33 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.606 2.204 . . . . 0.0 111.258 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.1 tt -55.55 -33.29 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.392 0.677 . . . . 0.0 111.807 175.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -58.75 -21.68 56.01 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.986 1.714 . . . . 0.0 112.35 -176.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -78.92 -6.94 57.46 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.953 0.901 . . . . 0.0 112.855 -176.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -127.97 -179.84 5.19 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.619 1.1 . . . . 0.0 111.433 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -127.24 127.39 44.34 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.789 2.036 . . . . 0.0 107.886 175.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.26 -24.07 67.05 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 -174.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -64.03 -21.03 66.34 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.775 0.43 . . . . 0.0 112.111 -177.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -81.41 -18.36 45.69 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.459 0.703 . . . . 0.0 110.19 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -97.11 130.26 44.41 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 125.45 1.5 . . . . 0.0 109.062 -177.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -89.65 -22.1 22.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.53 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.99 135.9 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -175.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.2 t -127.94 127.45 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 123.307 1.527 . . . . 0.0 109.566 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 35.4 mm -113.49 98.67 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.3 m -72.4 155.54 40.02 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 167.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.7 49.17 0.87 Allowed 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 102.878 -3.008 . . . . 0.0 102.878 172.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.5 m -75.49 -36.28 60.63 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 170.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' A' ' 83' ' ' GLY . . . 76.1 -42.15 1.6 Allowed Glycine 0 CA--C 1.52 0.402 0 C-N-CA 125.824 1.678 . . . . 0.0 115.622 167.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 40.0 m -74.15 25.68 0.08 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.126 1.463 . . . . 0.0 112.444 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 81' ' ' GLY . . . 60.34 13.79 30.89 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 127.479 2.466 . . . . 0.0 114.014 -169.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.7 t -69.55 146.83 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 169.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -141.16 -177.85 5.31 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.291 1.036 . . . . 0.0 109.403 -171.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.7 mt -120.98 91.47 47.85 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 124.9 1.28 . . . . 0.0 108.064 -171.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.52 -37.08 41.6 Favored 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 123.289 2.659 . . . . 0.0 116.874 171.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -67.06 -176.78 0.84 Allowed 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.159 1.906 . . . . 0.0 113.911 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -51.15 -11.37 0.1 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.562 2.345 . . . . 0.0 115.155 173.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -62.96 9.05 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.949 2.1 . . . . 0.0 113.01 169.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.3 p -132.15 7.3 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 124.204 1.002 . . . . 0.0 112.509 173.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 82.8 p -116.23 33.18 5.68 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 120.044 1.293 . . . . 0.0 112.852 -169.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -122.01 -172.03 2.36 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.527 1.531 . . . . 0.0 110.222 174.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -59.43 -36.37 75.76 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -168.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.7 mm -133.05 138.52 51.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -173.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -142.94 129.8 20.51 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.226 1.411 . . . . 0.0 107.402 169.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -141.79 158.76 43.41 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 168.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -122.5 101.66 7.62 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.021 1.328 . . . . 0.0 109.46 169.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 39.5 m0 -78.8 92.73 4.87 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.199 0.999 . . . . 0.0 109.656 -177.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -62.1 120.49 10.97 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 169.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 47.6 mt -151.72 152.96 33.43 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.147 1.779 . . . . 0.0 107.585 -169.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -82.13 71.7 9.18 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.461 1.105 . . . . 0.0 111.448 -176.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -22.38 97.88 0.06 OUTLIER Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 128.678 2.791 . . . . 0.0 112.7 -177.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -59.79 -2.9 1.78 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.292 3.328 . . . . 0.0 117.221 -169.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -50.86 95.85 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.843 1.257 . . . . 0.0 112.656 173.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.36 21.9 46.59 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.29 1.9 . . . . 0.0 113.153 171.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -98.73 176.68 5.54 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.952 1.376 . . . . 0.0 112.755 -169.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 44.2 m -74.4 154.69 38.68 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.804 1.641 . . . . 0.0 110.166 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 91.9 mt -58.38 -31.12 67.35 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.796 -0.565 . . . . 0.0 111.658 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -72.31 -33.66 67.54 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.296 0.498 . . . . 0.0 111.155 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 80.8 t -65.43 -46.22 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 171.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.469 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 11.1 m-85 -55.46 -50.38 70.03 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 118.876 -0.583 . . . . 0.0 110.351 175.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -59.37 -43.16 92.91 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.877 0.871 . . . . 0.0 112.207 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 100.0 m -60.96 -51.06 70.85 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 119.01 0.823 . . . . 0.0 109.151 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.0 t -63.69 -45.35 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 117.875 -1.059 . . . . 0.0 110.039 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -55.78 -47.2 77.47 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 119.818 1.19 . . . . 0.0 109.392 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.88 -49.02 83.29 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-O 118.383 -1.231 . . . . 0.0 110.417 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -59.72 -56.83 16.92 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 118.359 1.079 . . . . 0.0 110.398 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.8 t -46.26 -51.32 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 125.888 1.675 . . . . 0.0 110.483 177.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -63.62 -48.71 76.2 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.449 1.022 . . . . 0.0 110.192 -175.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.56 -40.56 72.09 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.377 1.071 . . . . 0.0 111.155 175.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 82.8 mtt-85 -73.1 -43.26 62.01 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.921 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 69.5 t -54.35 -46.74 69.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 120.417 1.462 . . . . 0.0 108.843 169.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -61.2 -39.54 90.61 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.051 0.841 . . . . 0.0 110.831 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -63.47 -47.43 81.81 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 123.196 0.598 . . . . 0.0 110.308 176.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . 0.251 0.2 OUTLIER -60.52 -44.31 96.16 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 118.858 -0.592 . . . . 0.0 109.724 -178.666 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.1 mt -60.79 -38.05 77.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.514 1.126 . . . . 0.0 110.764 173.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.37 -31.42 72.57 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 120.287 1.403 . . . . 0.0 111.223 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -66.78 -20.49 65.96 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.014 1.325 . . . . 0.0 113.169 177.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.5 pt -127.53 -20.95 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 116.382 1.993 . . . . 0.0 116.382 -167.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 C--O 1.249 1.033 0 C-N-CA 126.371 1.868 . . . . 0.0 111.118 174.501 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.1 ttm . . . . . 0 N--CA 1.485 1.282 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -111.03 135.41 51.58 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 170.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -83.29 136.07 34.51 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 169.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.9 p -119.64 146.56 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-O 121.928 0.871 . . . . 0.0 109.526 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 33.3 tpp -127.17 142.51 51.48 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.308 -1.315 . . . . 0.0 108.423 -177.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -124.0 121.99 36.71 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 117.66 -1.162 . . . . 0.0 108.113 172.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.6 t -126.19 118.78 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 121.111 1.778 . . . . 0.0 110.055 -170.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.5 t -116.19 162.25 17.74 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.424 1.011 . . . . 0.0 112.081 -178.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.8 mttm -60.81 -17.88 52.25 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.767 0.827 . . . . 0.0 111.649 169.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.1 ptm85 -154.15 112.96 3.65 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 169.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -47.87 -30.57 4.22 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.025 0.93 . . . . 0.0 112.797 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.4 m -35.29 -35.86 0.05 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 130.085 3.354 . . . . 0.0 119.879 -171.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.8 p -137.68 -68.85 0.46 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 120.576 1.534 . . . . 0.0 113.51 -169.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -55.09 -51.1 67.45 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.045 0.838 . . . . 0.0 109.527 -169.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -49.14 68.09 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.955 2.102 . . . . 0.0 111.806 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -60.26 -43.12 96.42 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.502 0.721 . . . . 0.0 110.847 -175.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 65.9 mtm -66.66 -47.14 73.47 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-O 119.569 -0.253 . . . . 0.0 110.991 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.99 -39.31 71.66 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 117.743 0.247 . . . . 0.0 110.773 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -64.95 -55.22 20.49 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 118.485 -0.769 . . . . 0.0 110.938 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.5 -40.45 47.02 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-O 119.346 -0.697 . . . . 0.0 112.516 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -68.08 -47.01 69.44 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 119.008 1.404 . . . . 0.0 109.523 175.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.91 -45.49 90.21 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 120.187 1.358 . . . . 0.0 112.907 -176.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt -69.41 -9.45 53.63 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.685 1.129 . . . . 0.0 113.294 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.3 m -93.55 -48.59 6.29 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 119.852 1.206 . . . . 0.0 110.611 170.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 98.3 mt -77.23 -41.45 41.14 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.808 1.643 . . . . 0.0 111.92 -169.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -118.02 -5.75 13.15 Favored Glycine 0 C--N 1.333 0.38 0 CA-C-O 117.759 -1.578 . . . . 0.0 114.962 -169.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.4 109.11 0.4 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.702 1.751 . . . . 0.0 109.097 169.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.42 -28.88 2.85 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.974 1.273 . . . . 0.0 111.684 -169.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.82 -21.14 3.09 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.918 1.287 . . . . 0.0 111.677 172.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.0 pt -127.43 158.45 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.29 0.567 . . . . 0.0 111.845 174.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -125.79 132.35 52.29 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 169.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 p -117.08 153.26 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -169.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.5 m -145.65 145.01 30.76 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 167.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.2 p -113.53 157.5 21.95 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 120.896 -1.128 . . . . 0.0 109.008 168.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.5 m -151.37 -175.95 5.38 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.714 1.606 . . . . 0.0 107.035 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -152.4 163.13 30.18 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 169.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.4 mt -53.24 -34.74 58.43 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 124.245 0.614 . . . . 0.0 110.265 174.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -141.9 145.58 34.74 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 104.659 -2.349 . . . . 0.0 104.659 169.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.2 p -75.75 147.4 39.32 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.098 0.475 . . . . 0.0 110.44 174.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 59.5 m -150.51 149.22 29.67 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.145 2.178 . . . . 0.0 105.542 169.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.64 155.56 9.68 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.858 0.863 . . . . 0.0 111.966 -172.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.6 t -65.63 131.07 31.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -73.74 138.97 76.91 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.35 -35.95 4.49 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 121.974 1.782 . . . . 0.0 112.494 -169.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.499 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 4.8 m -67.84 -18.57 64.87 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.093 -1.004 . . . . 0.0 111.945 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.32 -41.44 76.03 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.698 -0.626 . . . . 0.0 110.184 170.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.8 mp -62.78 -41.31 91.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -178.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.7 -36.99 82.5 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 118.341 0.519 . . . . 0.0 112.043 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 24.5 mmt -62.51 -47.69 82.84 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 122.763 1.268 . . . . 0.0 111.463 175.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 10.6 mtp -68.27 -34.0 75.38 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.433 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -63.03 -28.77 70.32 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.128 0.971 . . . . 0.0 111.077 173.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -65.39 -38.72 90.85 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.788 0.722 . . . . 0.0 110.162 172.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.9 t -78.22 -25.09 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 121.256 -0.178 . . . . 0.0 110.809 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.77 25.65 6.14 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.161 1.363 . . . . 0.0 111.953 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.5 mt -124.2 175.97 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 125.584 1.554 . . . . 0.0 107.348 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -140.81 158.06 44.5 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.507 1.523 . . . . 0.0 109.154 -178.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -129.34 -18.59 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 118.186 -0.911 . . . . 0.0 112.816 171.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.7 m -51.58 -30.16 19.99 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 120.393 1.451 . . . . 0.0 112.274 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.69 -11.56 69.17 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.81 1.195 . . . . 0.0 114.093 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -123.99 168.62 12.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.432 1.493 . . . . 0.0 110.876 176.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.8 p -126.92 172.08 10.74 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.443 1.097 . . . . 0.0 110.85 -173.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.2 m -76.89 165.05 25.21 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.45 0.7 . . . . 0.0 112.173 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.29 142.86 15.33 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 124.349 1.06 . . . . 0.0 108.73 177.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -85.18 153.15 10.9 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.903 2.402 . . . . 0.0 110.095 169.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.1 tt -54.29 -33.28 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 123.524 0.73 . . . . 0.0 111.135 173.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -56.04 -26.25 48.28 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.411 1.884 . . . . 0.0 112.676 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -81.06 -5.44 57.63 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -175.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -130.11 -176.67 4.01 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.151 0.98 . . . . 0.0 111.181 -176.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.67 131.04 33.06 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 126.595 1.958 . . . . 0.0 108.399 -177.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.33 -29.4 67.62 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.599 1.16 . . . . 0.0 113.191 -176.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -60.23 -22.15 62.68 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.976 0.91 . . . . 0.0 112.336 -176.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -85.23 -14.8 45.63 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.545 0.738 . . . . 0.0 110.777 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -109.31 137.31 47.37 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.945 1.298 . . . . 0.0 110.276 -172.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -93.48 -33.78 13.66 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.519 0.727 . . . . 0.0 110.238 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.06 136.45 53.53 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 CA-C-N 118.578 0.626 . . . . 0.0 109.415 -175.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.9 t -128.49 115.96 39.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 122.929 1.347 . . . . 0.0 108.531 -175.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.9 mm -107.79 93.91 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.3 m -71.24 157.29 38.38 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 117.759 -1.576 . . . . 0.0 106.857 168.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.82 46.88 0.94 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 177.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 86.2 m -72.86 -41.86 64.3 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.553 0.741 . . . . 0.0 109.323 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.56 -62.47 0.64 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 123.81 0.719 . . . . 0.0 113.135 168.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 38.1 m -80.69 31.26 0.3 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -169.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 61.93 30.49 75.48 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -170.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 t -66.66 156.73 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.285 1.034 . . . . 0.0 108.295 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -135.58 156.01 49.55 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 124.211 1.004 . . . . 0.0 110.218 -169.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.5 mt -103.3 113.39 65.77 Favored Pre-proline 0 CA--C 1.53 0.206 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -172.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -50.89 -41.77 54.33 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 122.371 2.047 . . . . 0.0 114.798 169.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.73 176.49 9.74 Favored 'Trans proline' 0 C--N 1.356 0.95 0 CA-C-N 121.687 1.638 . . . . 0.0 113.753 -174.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -57.28 -12.19 2.23 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.248 2.219 . . . . 0.0 113.737 -173.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -55.51 -25.74 38.94 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.826 -1.171 . . . . 0.0 111.871 171.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.7 p -84.8 -18.3 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 119.637 1.108 . . . . 0.0 110.347 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 56.8 p -100.42 18.51 18.82 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.591 0.756 . . . . 0.0 112.683 -169.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -83.98 -172.71 4.31 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.896 0.879 . . . . 0.0 109.72 173.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -63.44 -34.62 78.15 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.426 0.691 . . . . 0.0 112.344 -169.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.0 mt -140.73 140.13 33.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 -174.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -140.1 137.87 34.85 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.623 1.169 . . . . 0.0 108.228 170.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -146.5 160.17 42.46 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.695 1.598 . . . . 0.0 107.726 168.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -122.53 95.73 4.75 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.117 1.367 . . . . 0.0 108.533 169.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -68.45 101.4 1.24 Allowed 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.418 1.087 . . . . 0.0 109.432 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -61.21 120.59 10.65 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 169.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.7 mt -157.78 146.77 19.55 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.161 1.385 . . . . 0.0 107.993 -169.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.9 mp0 -86.61 60.25 6.12 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.375 1.87 . . . . 0.0 111.925 -169.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -1.59 85.67 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 129.672 3.189 . . . . 0.0 113.852 174.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -59.64 -11.13 13.32 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.963 3.109 . . . . 0.0 117.85 -169.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.3 96.18 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 120.46 1.482 . . . . 0.0 111.495 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.4 13.11 29.25 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 126.402 1.953 . . . . 0.0 113.232 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -98.72 178.12 5.08 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.182 1.491 . . . . 0.0 112.765 -169.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.9 m -76.35 154.98 34.53 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.975 1.71 . . . . 0.0 110.059 175.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.9 mt -59.3 -30.96 68.71 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.708 -0.62 . . . . 0.0 111.889 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -62.11 -40.11 94.8 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.134 0.574 . . . . 0.0 110.521 175.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.7 t -68.9 -43.8 82.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.499 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 13.3 m-85 -55.44 -52.07 64.82 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.538 175.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -60.1 -41.54 92.76 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.413 0.685 . . . . 0.0 111.772 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 56.3 m -61.0 -46.19 91.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.78 0.718 . . . . 0.0 110.0 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.7 t -69.07 -43.84 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-O 117.853 -1.07 . . . . 0.0 110.265 177.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -56.45 -44.79 80.82 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 119.828 1.195 . . . . 0.0 109.438 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.16 -50.25 69.27 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-O 118.33 -1.261 . . . . 0.0 110.576 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -57.52 -57.05 14.38 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 118.311 1.055 . . . . 0.0 110.098 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.6 t -48.91 -52.95 8.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.937 1.695 . . . . 0.0 110.619 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -64.68 -48.89 73.05 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 119.159 0.891 . . . . 0.0 109.795 -171.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.62 -44.33 69.41 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.924 0.89 . . . . 0.0 110.46 174.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -72.45 -39.37 67.84 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 117.484 -1.246 . . . . 0.0 110.764 -175.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 72.5 t -55.26 -48.68 76.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 121.046 1.748 . . . . 0.0 108.724 169.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -60.42 -38.81 85.25 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.226 0.921 . . . . 0.0 110.778 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -64.71 -45.19 87.6 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.508 1.123 . . . . 0.0 110.352 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.58 -46.97 85.9 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 124.102 0.961 . . . . 0.0 109.434 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.7 mt -59.16 -38.04 71.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.607 1.163 . . . . 0.0 110.861 175.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.77 -30.08 70.56 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 120.011 1.278 . . . . 0.0 111.413 -173.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -71.61 -19.56 62.1 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.833 1.653 . . . . 0.0 112.976 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.4 pt -126.26 -20.35 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 126.018 1.727 . . . . 0.0 115.269 -168.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.5 m . . . . . 0 C--O 1.248 0.99 0 C-N-CA 126.471 1.908 . . . . 0.0 111.019 171.018 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.4 ttm . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 120.848 0.356 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -119.53 138.15 53.36 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.719 1.208 . . . . 0.0 107.758 176.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -97.25 133.62 41.64 Favored 'General case' 0 CA--C 1.511 -0.547 0 O-C-N 121.48 -0.762 . . . . 0.0 109.234 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.9 p -114.77 140.9 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 123.293 0.637 . . . . 0.0 109.662 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 44.2 tpp -119.94 143.8 47.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.973 169.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -117.9 135.62 54.0 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.972 1.309 . . . . 0.0 107.717 169.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.1 t -141.4 123.88 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 120.017 1.281 . . . . 0.0 109.274 -173.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.4 p -127.59 174.69 8.85 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.805 1.184 . . . . 0.0 111.019 173.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -66.04 -16.44 63.92 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.227 0.611 . . . . 0.0 112.415 173.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -152.14 101.79 2.74 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 170.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -40.02 -36.67 0.5 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.255 1.822 . . . . 0.0 113.252 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.6 m -37.21 -32.12 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 129.421 3.088 . . . . 0.0 116.936 -178.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 71.5 m -119.87 -84.96 0.66 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.172 0.896 . . . . 0.0 112.4 -169.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.02 -51.9 67.69 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.501 1.046 . . . . 0.0 110.069 -169.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -56.34 -50.19 72.21 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.247 1.019 . . . . 0.0 110.519 -173.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -61.64 -45.07 95.63 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.434 0.694 . . . . 0.0 111.344 -173.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 65.7 mtm -64.22 -47.04 81.21 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 119.446 -0.311 . . . . 0.0 110.927 175.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.69 -40.04 71.82 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 122.451 0.3 . . . . 0.0 110.681 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -64.54 -55.03 23.2 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.414 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.42 -38.09 68.41 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 119.457 -0.635 . . . . 0.0 111.702 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.419 ' CD1' ' HE3' ' A' ' 50' ' ' MET . 22.2 m-85 -67.73 -47.76 68.37 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 118.753 1.276 . . . . 0.0 108.775 175.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.64 -44.82 93.38 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.931 1.241 . . . . 0.0 113.312 -175.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 ptmt -68.98 -9.0 50.05 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 119.736 1.153 . . . . 0.0 113.145 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.6 m -93.51 -47.52 6.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 119.783 1.174 . . . . 0.0 110.459 169.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.2 mt -76.39 -40.77 50.04 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 126.04 1.736 . . . . 0.0 112.076 -169.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -121.93 -4.37 9.49 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-O 117.879 -1.512 . . . . 0.0 115.296 -169.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.27 110.08 0.57 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.763 1.781 . . . . 0.0 108.906 169.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.64 -30.43 2.68 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.931 1.253 . . . . 0.0 111.409 -169.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.07 -22.76 3.42 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.67 1.188 . . . . 0.0 111.892 172.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.8 pt -125.22 157.39 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-O 121.523 0.678 . . . . 0.0 112.01 176.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -122.77 132.42 54.22 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 169.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -117.39 150.83 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 C-N-CA 124.02 0.928 . . . . 0.0 112.06 -170.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.4 m -144.23 152.55 40.99 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 167.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.9 p -131.2 156.97 44.44 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 167.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.1 p -155.73 -159.99 0.97 Allowed 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.97 163.95 32.06 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 169.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 67.2 mt -52.93 -34.0 53.28 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.59 0.756 . . . . 0.0 109.622 172.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -142.6 146.22 34.33 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 103.199 -2.889 . . . . 0.0 103.199 168.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.3 m -124.51 148.6 47.64 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.287 0.565 . . . . 0.0 111.456 -178.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.3 m -143.86 168.59 19.6 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.997 2.519 . . . . 0.0 106.303 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.0 ptt85 -54.22 158.97 2.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.979 0.809 . . . . 0.0 112.478 -172.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.9 t -62.62 136.15 26.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -73.85 143.27 81.07 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.96 -40.98 0.57 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.307 1.338 . . . . 0.0 112.79 -169.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.504 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 11.5 m -67.3 -16.92 64.54 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.368 -1.458 . . . . 0.0 111.898 -177.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.52 -40.07 71.33 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.698 0.799 . . . . 0.0 110.503 169.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 59.4 mt -57.74 -48.39 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.97 -37.6 85.37 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 123.654 0.782 . . . . 0.0 111.828 -174.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 20.2 mmt -61.28 -47.58 85.34 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 122.858 1.313 . . . . 0.0 111.31 175.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.419 ' HE3' ' CD1' ' A' ' 21' ' ' PHE . 9.3 mtp -69.39 -33.11 72.54 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.516 -177.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -61.89 -29.01 69.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.858 -0.592 . . . . 0.0 111.588 170.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -65.59 -36.32 83.4 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.18 0.9 . . . . 0.0 110.446 173.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.67 -25.71 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 117.474 0.124 . . . . 0.0 110.769 176.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.43 28.26 7.23 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.546 1.069 . . . . 0.0 111.461 -174.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.6 mt -122.93 -177.53 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -146.45 157.02 43.7 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.364 1.466 . . . . 0.0 109.158 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -127.47 -16.48 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.703 0.801 . . . . 0.0 112.339 169.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -45.29 -38.18 5.42 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.693 1.197 . . . . 0.0 112.768 173.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.88 -5.46 88.72 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 118.517 -1.157 . . . . 0.0 114.335 -173.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -125.86 168.19 14.19 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.319 1.56 . . . . 0.0 110.875 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.8 p -127.84 168.61 14.94 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.016 0.926 . . . . 0.0 111.542 -169.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.2 m -82.16 163.36 22.0 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.401 1.08 . . . . 0.0 111.426 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -156.8 141.34 12.0 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.495 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -81.88 151.72 16.64 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.826 2.351 . . . . 0.0 111.173 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.1 tt -57.33 -31.13 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 121.725 -0.609 . . . . 0.0 111.833 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -56.76 -22.3 34.72 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.704 2.001 . . . . 0.0 112.111 -177.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -82.04 -7.99 59.64 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.56 1.144 . . . . 0.0 113.096 -176.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -128.57 -178.5 4.61 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 120.025 1.284 . . . . 0.0 111.607 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -127.66 141.86 51.5 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 127.247 2.219 . . . . 0.0 107.57 169.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.09 -22.99 65.8 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.889 1.276 . . . . 0.0 111.985 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -60.21 -23.14 63.78 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.054 0.942 . . . . 0.0 112.352 -176.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -83.07 -12.25 57.3 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.875 0.87 . . . . 0.0 110.728 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -111.3 126.93 55.42 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 125.644 1.578 . . . . 0.0 109.368 -170.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -72.61 -42.13 64.82 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 175.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.4 p -128.02 134.06 65.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 C-N-CA 122.942 0.497 . . . . 0.0 110.123 -169.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.4 m -127.91 108.26 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-O 123.341 1.543 . . . . 0.0 109.141 -172.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.4 mm -104.12 100.34 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 114.22 -1.355 . . . . 0.0 107.388 -175.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.4 t -74.01 157.14 36.68 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 167.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.13 51.38 0.6 Allowed 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 175.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.7 p -55.87 -52.47 63.94 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.712 -1.243 . . . . 0.0 110.907 -169.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.01 -27.71 2.88 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.282 1.42 . . . . 0.0 112.186 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 51.8 m -131.64 26.8 4.71 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.097 0.949 . . . . 0.0 113.482 -169.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.47 16.31 69.32 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.276 0.941 . . . . 0.0 114.489 176.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.7 t -68.91 175.44 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 126.052 1.741 . . . . 0.0 108.24 169.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.77 158.33 44.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.16 0.984 . . . . 0.0 108.347 169.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 37.6 mt -62.42 121.41 66.75 Favored Pre-proline 0 C--N 1.327 -0.377 0 C-N-CA 125.867 1.667 . . . . 0.0 107.468 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -56.73 -41.35 76.58 Favored 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 122.063 1.842 . . . . 0.0 114.014 169.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.49 -177.05 3.56 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.709 1.606 . . . . 0.0 113.386 -172.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -47.71 -17.23 0.09 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 129.461 3.104 . . . . 0.0 115.632 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 61.2 m95 -66.28 8.3 0.24 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 126.7 2.0 . . . . 0.0 113.152 171.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.1 p -118.06 2.68 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 124.891 1.277 . . . . 0.0 111.512 171.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.1 p -128.5 26.43 5.65 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.111 0.964 . . . . 0.0 112.131 -172.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -92.57 -173.1 3.26 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.548 0.739 . . . . 0.0 109.558 170.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -65.72 -33.44 75.88 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -169.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.2 mt -137.25 132.62 46.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -138.48 140.46 39.21 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -147.58 159.07 44.17 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.276 1.43 . . . . 0.0 107.34 168.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -122.22 110.7 16.05 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.718 1.207 . . . . 0.0 108.934 168.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 37.1 m0 -87.39 84.68 7.15 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.28 1.032 . . . . 0.0 108.461 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -56.95 120.85 8.66 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 170.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 25.1 mt -151.03 153.05 34.38 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.986 1.314 . . . . 0.0 108.602 -169.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -78.16 74.83 4.7 Favored 'General case' 0 CA--C 1.523 -0.092 0 C-N-CA 125.105 1.362 . . . . 0.0 111.525 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -28.68 102.77 0.16 Allowed Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 127.432 2.293 . . . . 0.0 113.668 -175.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -63.68 -0.37 2.47 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.966 3.111 . . . . 0.0 117.425 -169.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -56.04 102.93 0.08 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 119.964 1.256 . . . . 0.0 111.702 178.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.34 22.06 59.4 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 126.201 1.857 . . . . 0.0 113.134 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -97.68 177.37 5.51 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.703 1.251 . . . . 0.0 112.554 -169.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.8 m -74.37 154.97 38.6 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.431 1.493 . . . . 0.0 109.814 176.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 91.5 mt -59.3 -30.58 68.44 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 122.001 -0.437 . . . . 0.0 111.656 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -62.77 -39.25 93.59 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.405 0.548 . . . . 0.0 110.918 176.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 89.0 t -67.9 -46.07 82.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.504 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 14.7 m-85 -55.34 -50.46 69.59 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.896 175.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 -59.85 -42.6 94.0 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.959 0.904 . . . . 0.0 111.74 177.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.7 m -60.78 -50.54 73.05 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 118.935 0.789 . . . . 0.0 109.363 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.6 t -66.1 -44.47 91.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 117.626 -1.178 . . . . 0.0 110.316 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 48.0 ttp85 -53.08 -47.36 68.6 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 120.093 1.315 . . . . 0.0 108.988 176.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.98 -47.9 81.18 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-O 118.481 -1.177 . . . . 0.0 110.598 -175.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -61.21 -56.7 17.64 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 118.292 1.046 . . . . 0.0 110.37 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 82.4 t -50.09 -49.95 20.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 125.132 1.373 . . . . 0.0 110.386 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -62.03 -48.43 80.33 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 120.207 1.367 . . . . 0.0 110.445 -176.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -53.91 -45.81 71.26 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 123.681 0.793 . . . . 0.0 109.751 174.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 76.6 mtt-85 -70.82 -39.54 72.98 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 118.257 -0.878 . . . . 0.0 109.925 -173.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 75.4 t -55.6 -48.8 77.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 120.437 1.471 . . . . 0.0 109.189 169.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -60.94 -38.87 87.35 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.659 1.118 . . . . 0.0 110.754 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -62.04 -46.73 87.85 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.806 1.642 . . . . 0.0 109.832 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.28 -45.76 83.16 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 123.75 0.82 . . . . 0.0 110.106 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 60.1 mt -57.44 -38.32 62.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.574 1.149 . . . . 0.0 110.468 175.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.26 -29.19 69.7 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.873 1.215 . . . . 0.0 111.447 -173.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -73.75 -19.14 60.87 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.079 1.752 . . . . 0.0 112.802 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 pt -126.51 -20.08 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 126.21 1.804 . . . . 0.0 114.966 -168.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 C--O 1.25 1.124 0 C-N-CA 126.504 1.922 . . . . 0.0 110.9 170.11 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.9 ttm . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 121.439 0.638 . . . . 0.0 110.392 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -78.45 124.23 27.9 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 175.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.7 mttt -106.48 124.74 50.05 Favored 'General case' 0 CA--C 1.508 -0.657 0 C-N-CA 122.885 0.474 . . . . 0.0 109.936 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.6 p -105.16 140.67 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 O-C-N 123.626 0.579 . . . . 0.0 110.656 175.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 39.7 tpp -119.07 142.39 47.91 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 169.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -116.08 134.53 54.84 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 169.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.3 t -136.9 123.05 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 119.641 1.11 . . . . 0.0 108.643 -171.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.4 t -123.23 157.12 33.79 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.066 0.848 . . . . 0.0 109.691 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.319 20.9 pttp -67.52 -2.48 6.59 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 175.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -139.17 -5.12 1.46 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 168.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 63.86 -44.13 0.26 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 127.332 2.253 . . . . 0.0 114.571 -172.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.3 m -34.03 -37.95 0.05 Allowed 'General case' 0 C--O 1.232 0.132 0 N-CA-C 119.684 3.216 . . . . 0.0 119.684 -168.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.9 p -136.12 -60.07 0.73 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-N 120.0 1.273 . . . . 0.0 112.202 -169.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -60.32 -50.12 74.89 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.001 0.819 . . . . 0.0 109.956 -171.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.04 -40.87 82.78 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 117.909 0.322 . . . . 0.0 110.579 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -61.75 -47.21 86.25 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.278 0.631 . . . . 0.0 111.131 -173.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 46.5 mtm -64.46 -43.05 95.45 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 119.837 -0.125 . . . . 0.0 110.745 176.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.85 -37.52 74.03 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.048 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -65.73 -46.96 76.96 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 119.181 -0.438 . . . . 0.0 110.641 177.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.83 -42.76 98.24 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -67.48 -49.09 65.11 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 118.619 1.209 . . . . 0.0 109.624 176.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.1 -43.09 86.91 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 119.98 1.264 . . . . 0.0 112.092 -176.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.2 pttt -76.22 -2.46 31.44 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.4 m -98.62 -45.12 6.18 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 120.867 -1.145 . . . . 0.0 109.322 169.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.4 mt -72.15 -40.31 68.11 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.774 1.629 . . . . 0.0 110.79 -172.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.33 2.62 3.89 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 117.403 -1.776 . . . . 0.0 116.612 -169.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.44 116.07 2.45 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 120.607 2.204 . . . . 0.0 109.0 170.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.82 -24.19 6.45 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.599 1.095 . . . . 0.0 111.595 -175.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.35 -17.35 3.79 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.427 1.091 . . . . 0.0 111.912 176.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.9 pt -132.26 156.77 42.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 169.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.78 133.94 55.42 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 169.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -114.95 153.18 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 C-N-CA 124.074 0.95 . . . . 0.0 111.513 -175.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.9 m -144.01 148.19 34.91 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 167.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 63.2 p -121.92 148.67 44.46 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.33 1.452 . . . . 0.0 108.826 169.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 29.6 p -155.51 -165.11 1.9 Allowed 'General case' 0 C--O 1.241 0.63 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.22 168.48 33.07 Favored Glycine 0 N--CA 1.446 -0.698 0 O-C-N 121.541 -0.724 . . . . 0.0 111.976 169.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.2 mp -49.46 -39.85 34.91 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.044 0.937 . . . . 0.0 109.875 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -146.04 143.48 29.45 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 103.789 -2.671 . . . . 0.0 103.789 168.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.1 p -75.65 156.11 35.15 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 122.121 0.962 . . . . 0.0 111.503 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 63.5 m -158.39 153.92 26.1 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 127.72 2.408 . . . . 0.0 105.143 169.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -54.09 146.64 14.35 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 122.938 0.495 . . . . 0.0 110.894 -171.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 p -60.8 135.82 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 169.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -78.94 143.55 62.05 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 123.587 0.755 . . . . 0.0 109.858 -171.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.1 -41.63 0.28 Allowed 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 121.495 1.463 . . . . 0.0 112.409 -169.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.454 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 25.3 m -62.73 -24.57 67.75 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 120.422 -1.424 . . . . 0.0 111.292 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.36 -40.07 58.42 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.718 0.807 . . . . 0.0 111.663 173.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 62.9 mt -55.6 -46.0 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.12 -38.91 89.36 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 124.425 1.09 . . . . 0.0 110.161 -170.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.2 mmm -68.19 -44.19 76.44 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.744 1.259 . . . . 0.0 110.63 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.0 mtp -65.22 -35.87 82.39 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.221 -0.924 . . . . 0.0 109.963 175.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -63.89 -24.86 67.91 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.359 0.664 . . . . 0.0 111.489 173.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -65.82 -40.01 91.43 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 118.848 0.749 . . . . 0.0 109.746 172.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 92.7 t -76.78 -25.41 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.602 176.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.25 25.66 5.47 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.152 1.358 . . . . 0.0 111.727 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.5 mt -123.37 178.85 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 125.128 1.371 . . . . 0.0 107.379 -178.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -142.84 155.26 44.75 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.219 1.408 . . . . 0.0 109.557 -176.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -127.94 -13.88 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 123.955 0.902 . . . . 0.0 112.562 169.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -46.74 -37.17 8.07 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.53 1.132 . . . . 0.0 112.75 172.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.16 -6.23 85.96 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 118.697 -1.057 . . . . 0.0 114.248 -173.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -126.81 170.03 12.61 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.077 1.439 . . . . 0.0 111.204 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.6 p -129.2 166.57 19.12 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.645 1.178 . . . . 0.0 111.184 -170.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.2 m -92.08 155.78 17.83 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.798 1.239 . . . . 0.0 110.034 173.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -156.9 144.23 13.78 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 124.299 1.039 . . . . 0.0 110.07 -169.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.56 148.99 23.63 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 121.735 1.624 . . . . 0.0 111.158 -176.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.2 tt -52.01 -34.1 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.306 1.042 . . . . 0.0 111.761 173.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -58.44 -23.16 56.77 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.119 1.768 . . . . 0.0 112.404 -175.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -82.13 -6.83 59.48 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.916 0.886 . . . . 0.0 112.814 -175.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -125.39 -174.73 3.13 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.254 1.022 . . . . 0.0 110.356 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.47 130.71 30.82 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 126.399 1.88 . . . . 0.0 108.449 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.4 -28.39 66.87 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.633 1.173 . . . . 0.0 112.829 -176.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -60.49 -22.55 63.66 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.06 0.944 . . . . 0.0 112.452 -176.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -84.76 -13.2 51.96 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.428 0.691 . . . . 0.0 110.7 -178.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -108.77 127.37 53.95 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.972 1.309 . . . . 0.0 109.593 -172.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -74.17 -40.07 62.79 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.156 0.583 . . . . 0.0 109.967 175.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.97 136.38 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 122.823 0.449 . . . . 0.0 110.411 -169.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.7 m -129.15 110.53 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-O 122.839 1.304 . . . . 0.0 109.55 -170.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.7 mm -109.47 97.41 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -174.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.0 m -73.49 156.09 38.55 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 168.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.41 66.31 0.63 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 77.4 m -105.32 -43.84 4.89 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.391 -169.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.57 -96.78 0.24 Allowed Glycine 0 N--CA 1.465 0.574 0 CA-C-N 119.603 1.092 . . . . 0.0 112.905 168.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 56.2 m -76.94 39.19 0.22 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.614 1.566 . . . . 0.0 112.902 -169.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.12 14.66 78.85 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.455 1.026 . . . . 0.0 112.658 -172.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.5 t -58.74 126.06 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 169.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -137.94 -178.13 5.12 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.831 1.253 . . . . 0.0 109.531 -169.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.1 mt -113.16 108.21 53.15 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 123.981 0.912 . . . . 0.0 109.553 -169.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.19 -41.82 69.43 Favored 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 122.71 2.273 . . . . 0.0 115.078 169.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.63 -178.91 3.31 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.211 1.941 . . . . 0.0 113.432 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -59.1 -7.74 1.25 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.752 2.021 . . . . 0.0 114.151 -172.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -66.77 11.79 0.09 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.408 1.483 . . . . 0.0 112.624 169.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.7 p -124.01 3.24 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 125.563 1.545 . . . . 0.0 111.508 170.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 52.7 p -127.38 19.5 6.86 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.352 0.978 . . . . 0.0 112.649 -173.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -85.86 -173.64 4.71 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.223 0.609 . . . . 0.0 109.536 171.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -65.91 -32.5 74.04 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -169.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.2 mt -136.3 136.28 49.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -137.33 139.58 40.93 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 170.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -146.75 159.63 43.25 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.436 1.494 . . . . 0.0 107.441 168.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -123.35 96.39 4.97 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.488 1.515 . . . . 0.0 108.955 169.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -73.9 92.81 2.11 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.066 1.346 . . . . 0.0 109.54 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -65.81 97.37 0.34 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.889 1.276 . . . . 0.0 109.532 174.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -125.56 156.2 39.46 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.616 1.566 . . . . 0.0 109.906 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -78.7 66.35 4.18 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.518 1.927 . . . . 0.0 111.701 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -8.87 92.74 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 129.528 3.131 . . . . 0.0 113.553 169.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -60.14 -4.38 2.99 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 124.707 3.605 . . . . 0.0 117.611 -169.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -54.64 98.85 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 120.244 1.384 . . . . 0.0 111.611 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.46 16.89 54.45 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.115 1.817 . . . . 0.0 113.522 170.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -94.95 179.59 5.17 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.792 1.296 . . . . 0.0 112.626 -169.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.2 m -76.35 155.43 34.15 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.254 1.422 . . . . 0.0 109.926 175.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.9 mt -58.89 -31.67 68.82 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.957 -0.464 . . . . 0.0 111.559 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -63.96 -40.53 96.63 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.088 0.404 . . . . 0.0 110.894 177.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.4 t -65.8 -47.44 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 176.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.454 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 8.1 m-85 -53.8 -54.24 41.06 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.225 0.61 . . . . 0.0 110.822 177.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 33.6 mtt180 -59.78 -42.06 92.48 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.707 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.5 m -61.67 -52.72 63.16 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 118.828 0.74 . . . . 0.0 109.222 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.3 t -64.04 -44.42 97.76 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.02 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -57.64 -45.5 85.39 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 119.728 1.149 . . . . 0.0 110.189 -177.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.46 -49.28 66.08 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-O 118.684 -1.064 . . . . 0.0 111.153 177.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -59.9 -50.06 75.25 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 118.661 1.231 . . . . 0.0 111.058 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.6 t -54.18 -48.13 66.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 124.634 1.174 . . . . 0.0 109.921 178.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -60.13 -46.94 87.96 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 120.071 1.305 . . . . 0.0 110.586 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -42.04 86.07 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.304 1.042 . . . . 0.0 110.68 178.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.6 mtt-85 -71.2 -41.88 69.71 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 117.821 -1.085 . . . . 0.0 109.863 -177.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.1 t -54.47 -46.06 70.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 120.461 1.482 . . . . 0.0 109.976 169.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -61.94 -40.21 94.74 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.465 1.03 . . . . 0.0 111.075 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -63.11 -44.62 95.14 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.048 0.539 . . . . 0.0 110.321 176.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.02 -46.79 82.92 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 118.447 -0.787 . . . . 0.0 109.951 -178.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.1 mt -52.86 -41.91 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 124.052 0.941 . . . . 0.0 109.423 173.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.31 -31.01 72.05 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.713 1.142 . . . . 0.0 111.571 -175.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -69.65 -39.25 77.18 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.497 1.119 . . . . 0.0 111.504 176.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.0 pt -95.81 -28.7 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -169.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.5 m . . . . . 0 C--O 1.25 1.132 0 C-N-CA 126.079 1.752 . . . . 0.0 111.22 -179.177 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.6 ttm . . . . . 0 N--CA 1.484 1.274 0 CA-C-O 120.752 0.31 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -119.94 147.73 44.38 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.629 1.172 . . . . 0.0 108.496 171.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.7 mttt -102.72 104.13 14.43 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 123.515 0.726 . . . . 0.0 109.453 175.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 36.4 t -79.0 141.03 15.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 125.259 1.424 . . . . 0.0 108.837 175.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 30.6 tpp -127.18 142.41 51.5 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.707 1.203 . . . . 0.0 108.368 173.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -124.47 133.49 53.34 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.135 0.974 . . . . 0.0 108.893 173.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.3 t -144.19 122.81 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 120.259 1.39 . . . . 0.0 110.027 -169.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.2 p -132.4 179.9 5.84 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 120.058 1.299 . . . . 0.0 111.181 175.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.8 mttm -62.55 -10.57 12.46 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.789 1.236 . . . . 0.0 114.001 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -143.85 -10.45 0.69 Allowed 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 116.026 1.861 . . . . 0.0 116.026 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 63.2 -40.95 0.19 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 128.312 2.645 . . . . 0.0 114.291 -169.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.5 m -34.84 -39.14 0.09 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 129.252 3.021 . . . . 0.0 118.573 -169.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.7 p -132.64 -72.27 0.52 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 118.124 -0.941 . . . . 0.0 109.594 -169.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 -50.62 -52.58 38.12 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.928 0.785 . . . . 0.0 110.387 -169.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.65 -45.02 63.27 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.361 0.664 . . . . 0.0 111.349 -176.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -59.78 -44.01 94.11 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.204 1.002 . . . . 0.0 111.409 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 53.5 mtp -64.57 -48.29 75.52 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.877 1.271 . . . . 0.0 109.295 178.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.8 -40.14 79.22 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.363 0.265 . . . . 0.0 111.149 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -62.56 -46.95 85.97 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.761 0.425 . . . . 0.0 110.556 177.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.35 -43.43 95.68 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 119.443 -0.643 . . . . 0.0 111.875 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -67.24 -48.92 66.34 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 119.025 1.413 . . . . 0.0 109.159 176.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.71 -42.71 79.63 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 119.599 1.091 . . . . 0.0 112.395 -176.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.3 pttt -75.7 -2.41 29.41 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.9 m -99.16 -45.57 5.86 Favored 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 120.917 -1.114 . . . . 0.0 109.437 169.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 91.9 mt -71.25 -40.34 71.07 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.183 1.793 . . . . 0.0 110.945 -173.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -133.87 0.15 4.04 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 117.444 -1.753 . . . . 0.0 116.8 -169.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.35 116.87 2.87 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 120.512 2.156 . . . . 0.0 109.35 172.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.29 -24.24 6.62 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.642 1.115 . . . . 0.0 111.514 -176.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.29 -18.75 4.0 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.455 1.102 . . . . 0.0 111.654 177.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.1 pt -131.0 158.45 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 168.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -120.37 144.39 47.92 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 169.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.92 153.67 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 123.442 0.697 . . . . 0.0 112.631 -174.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.3 m -151.02 144.9 25.17 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.579 1.552 . . . . 0.0 106.873 168.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 97.6 p -112.01 157.74 20.38 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.35 -0.844 . . . . 0.0 109.665 168.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.7 p -152.02 -164.17 1.91 Allowed 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 171.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.32 161.8 35.18 Favored Glycine 0 CA--C 1.519 0.297 0 O-C-N 121.276 -0.89 . . . . 0.0 111.092 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 66.0 mt -54.75 -32.02 59.28 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.407 1.083 . . . . 0.0 111.123 -173.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -146.85 144.54 29.38 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 168.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.6 p -73.5 153.46 40.31 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.741 0.781 . . . . 0.0 111.296 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.3 m -160.21 154.07 22.86 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.502 2.321 . . . . 0.0 105.869 169.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -57.13 156.12 7.59 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.62 0.645 . . . . 0.0 111.408 -174.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.9 t -63.23 132.34 29.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 172.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -73.84 139.8 77.24 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -75.12 -41.59 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.358 1.372 . . . . 0.0 112.614 -169.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.482 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 25.5 m -64.65 -23.02 67.12 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 120.556 -1.34 . . . . 0.0 111.48 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.62 -40.55 60.11 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 123.622 0.769 . . . . 0.0 111.402 171.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 61.7 mt -56.2 -45.38 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.88 -40.17 91.36 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 124.249 1.02 . . . . 0.0 110.056 -171.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.8 mmm -64.47 -44.86 89.7 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 122.145 0.974 . . . . 0.0 110.16 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.1 mtp -66.94 -36.7 82.83 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.721 177.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -61.04 -29.92 70.01 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.306 0.643 . . . . 0.0 111.272 173.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -64.25 -39.81 94.72 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 118.884 0.766 . . . . 0.0 110.213 173.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 62.1 t -77.79 -17.06 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.027 177.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.92 25.44 10.54 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.787 1.184 . . . . 0.0 111.933 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.9 mt -121.28 179.68 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 125.405 1.482 . . . . 0.0 107.279 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -144.9 156.0 43.75 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.228 1.411 . . . . 0.0 109.351 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -127.74 -16.85 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.831 0.852 . . . . 0.0 112.443 169.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -44.18 -38.71 3.89 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.692 1.197 . . . . 0.0 112.968 172.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.29 -6.45 86.37 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-O 118.582 -1.121 . . . . 0.0 114.268 -173.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -126.61 164.74 20.58 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.156 1.478 . . . . 0.0 110.732 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.5 p -129.88 167.26 18.44 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.017 0.927 . . . . 0.0 111.74 -169.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.1 m -77.45 164.64 25.26 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.573 1.149 . . . . 0.0 111.761 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -157.63 141.58 11.49 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-O 118.411 -0.804 . . . . 0.0 109.471 174.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -78.09 153.37 28.49 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.557 2.171 . . . . 0.0 111.232 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.1 tt -53.82 -33.86 24.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.798 1.239 . . . . 0.0 112.471 177.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -66.07 -20.98 66.34 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.251 1.42 . . . . 0.0 112.074 -169.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -83.33 -0.98 52.17 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.108 0.963 . . . . 0.0 112.561 -173.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -115.85 -173.12 2.29 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.847 0.859 . . . . 0.0 112.462 -170.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.463 ' HA ' ' CH2' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -142.91 131.39 22.32 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 127.284 2.234 . . . . 0.0 107.846 173.433 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.468 ' HB1' ' CE3' ' A' ' 90' ' ' TRP . . . -62.28 -29.16 70.22 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 119.142 -0.456 . . . . 0.0 112.208 178.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -61.73 -20.36 63.42 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.381 0.672 . . . . 0.0 112.372 -170.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -88.73 -22.84 23.13 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.601 0.76 . . . . 0.0 110.955 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -99.08 113.1 25.14 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.972 1.309 . . . . 0.0 108.832 -176.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -72.31 -28.91 63.38 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 122.315 -0.24 . . . . 0.0 110.875 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.18 135.13 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.081 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -172.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.7 t -131.74 129.63 61.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 122.786 1.279 . . . . 0.0 109.253 -173.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.3 mm -120.32 101.77 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -177.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.5 t -72.42 155.39 40.18 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 105.496 -2.039 . . . . 0.0 105.496 168.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.45 36.3 0.89 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 172.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 90.4 m -60.35 -21.49 62.15 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.08 -1.013 . . . . 0.0 112.15 -173.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.52 -63.74 0.8 Allowed Glycine 0 CA--C 1.518 0.238 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 169.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 37.9 m -76.34 24.21 0.14 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -173.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.34 15.23 63.18 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.758 1.647 . . . . 0.0 113.57 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.22 156.07 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.442 1.497 . . . . 0.0 107.609 169.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -127.44 158.36 37.57 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.924 1.29 . . . . 0.0 108.126 174.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.0 mt -65.56 123.96 85.96 Favored Pre-proline 0 C--N 1.327 -0.398 0 C-N-CA 125.065 1.346 . . . . 0.0 108.472 -177.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -56.85 -41.26 77.29 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 122.037 1.825 . . . . 0.0 113.77 169.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.448 ' HB2' ' CE3' ' A' ' 90' ' ' TRP . 71.2 Cg_endo -75.91 172.37 16.42 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 121.724 1.652 . . . . 0.0 113.217 -170.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -54.24 -13.12 0.77 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 127.205 2.202 . . . . 0.0 113.271 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.468 ' CE3' ' HB1' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -49.14 -27.52 3.56 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 128.209 2.604 . . . . 0.0 111.65 169.646 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.21 -2.14 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.811 0.844 . . . . 0.0 110.589 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 56.7 p -120.68 18.96 11.93 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.978 0.911 . . . . 0.0 113.151 -169.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -86.95 179.87 6.63 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.306 1.042 . . . . 0.0 110.339 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -57.3 -34.02 68.27 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.714 1.206 . . . . 0.0 113.082 -169.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.4 mt -132.8 139.15 50.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 174.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -140.61 132.92 28.28 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 169.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -142.27 159.13 42.85 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.292 1.437 . . . . 0.0 108.622 169.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -121.14 111.28 17.22 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.764 1.226 . . . . 0.0 109.428 168.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -85.33 93.83 8.8 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.566 1.146 . . . . 0.0 108.741 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -59.77 116.51 4.12 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 169.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.3 mt -149.68 149.32 30.43 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.565 1.546 . . . . 0.0 107.506 -169.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -84.61 63.23 7.8 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 125.023 1.329 . . . . 0.0 111.137 -175.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -0.99 88.0 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 129.021 2.929 . . . . 0.0 112.918 169.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -58.68 -4.93 2.14 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 124.262 3.308 . . . . 0.0 117.33 -169.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -54.91 99.7 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.392 0.996 . . . . 0.0 111.738 176.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.17 18.06 54.35 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 126.16 1.838 . . . . 0.0 113.324 171.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -95.9 178.16 5.52 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.661 1.23 . . . . 0.0 112.562 -169.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.3 m -74.94 154.74 38.01 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.498 1.519 . . . . 0.0 110.048 174.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.9 mt -58.58 -32.67 69.16 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.786 -0.571 . . . . 0.0 111.574 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -63.31 -39.93 95.93 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 122.679 0.392 . . . . 0.0 110.664 177.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.7 t -66.39 -45.77 88.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 176.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.482 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 10.7 m-85 -55.4 -52.06 64.81 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.823 0.449 . . . . 0.0 110.803 177.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 34.8 mtt180 -61.76 -40.09 93.91 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.509 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.3 m -62.0 -51.49 67.82 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.393 0.997 . . . . 0.0 109.708 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 49.0 t -63.66 -45.1 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.958 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 -56.31 -45.83 80.11 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-N 119.705 1.139 . . . . 0.0 109.499 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.17 -50.34 68.75 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-O 118.176 -1.347 . . . . 0.0 110.408 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -59.36 -54.46 46.47 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 118.535 1.168 . . . . 0.0 110.512 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 65.1 t -47.32 -54.57 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 125.541 1.536 . . . . 0.0 110.297 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -62.99 -44.85 94.9 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 120.112 1.324 . . . . 0.0 110.626 -175.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -57.96 -42.19 84.47 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.727 1.211 . . . . 0.0 109.655 177.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 80.5 mtt-85 -74.61 -41.58 60.15 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 117.186 -1.388 . . . . 0.0 109.979 -175.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.6 t -53.15 -45.71 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 121.216 1.825 . . . . 0.0 109.564 169.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -62.29 -42.02 98.99 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.044 0.838 . . . . 0.0 111.218 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -60.91 -46.01 92.34 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 175.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.03 -48.97 76.44 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.252 -0.88 . . . . 0.0 109.561 -176.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 55.9 mt -52.35 -42.14 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 124.234 1.014 . . . . 0.0 109.443 173.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.26 -30.74 71.82 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.638 1.108 . . . . 0.0 111.58 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 44.7 mttt -70.38 -38.0 74.64 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.719 1.208 . . . . 0.0 111.537 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.7 pt -97.61 -27.12 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -169.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.8 m . . . . . 0 C--O 1.25 1.111 0 C-N-CA 126.125 1.77 . . . . 0.0 110.915 176.481 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.8 ttm . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 120.819 0.342 . . . . 0.0 110.44 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.09 141.98 35.27 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.676 0.79 . . . . 0.0 109.711 173.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -96.14 117.77 31.39 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 170.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 98.2 t -101.7 135.63 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 125.469 1.508 . . . . 0.0 107.673 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 51.9 ttm -118.86 138.28 52.84 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 168.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -108.68 130.22 55.34 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 169.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.9 t -129.17 113.23 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 120.326 1.421 . . . . 0.0 109.296 -170.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.6 t -111.59 162.63 14.95 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.97 0.805 . . . . 0.0 111.571 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.4 mttm -65.51 -13.01 57.95 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.824 -1.173 . . . . 0.0 112.383 171.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.6 ptt180 -153.81 114.33 3.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 104.149 -2.537 . . . . 0.0 104.149 169.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -69.56 52.92 0.11 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.795 1.238 . . . . 0.0 112.415 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.5 p -126.76 -23.3 3.72 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.842 1.257 . . . . 0.0 112.668 -170.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.455 ' HG ' ' N ' ' A' ' 105' ' ' ASP . 78.6 m -133.99 -87.82 0.4 Allowed 'General case' 0 C--N 1.343 0.3 0 CA-C-O 118.379 -0.82 . . . . 0.0 111.185 -171.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -50.33 -50.6 50.46 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.016 0.825 . . . . 0.0 110.922 -169.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.1 p -70.25 -44.67 68.02 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 125.26 1.424 . . . . 0.0 110.974 -174.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -58.93 -46.39 88.09 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.649 1.18 . . . . 0.0 110.436 -177.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 52.2 mtp -63.76 -46.63 84.41 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.586 1.154 . . . . 0.0 109.598 177.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.74 -37.75 74.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 119.104 -0.474 . . . . 0.0 111.425 178.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -62.29 -53.31 56.98 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-O 118.464 -0.779 . . . . 0.0 109.855 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.91 -41.17 75.62 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -66.38 -49.79 65.68 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 118.271 1.036 . . . . 0.0 109.676 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.0 -46.43 88.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 120.09 1.314 . . . . 0.0 113.082 -174.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -71.14 -8.77 55.74 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 119.7 1.136 . . . . 0.0 113.201 176.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 38.0 m -92.77 -48.7 6.44 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 119.965 1.257 . . . . 0.0 110.552 169.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.2 mt -78.92 -41.55 29.25 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.998 1.719 . . . . 0.0 112.135 -169.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.21 -7.32 16.95 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-O 117.904 -1.498 . . . . 0.0 114.604 -169.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.08 109.34 0.46 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.632 1.716 . . . . 0.0 108.897 169.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.09 -28.87 2.88 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.917 1.246 . . . . 0.0 111.622 -169.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.67 -21.38 2.78 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.619 1.168 . . . . 0.0 111.812 172.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.8 pt -126.77 158.87 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-O 121.47 0.652 . . . . 0.0 112.124 174.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -123.74 134.11 53.74 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 168.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 p -119.45 151.35 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -170.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.2 m -141.71 131.71 24.58 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.132 1.373 . . . . 0.0 108.614 168.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.6 p -98.21 141.4 31.17 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.026 -1.046 . . . . 0.0 108.517 169.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.6 m -154.0 -177.28 6.3 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.413 1.885 . . . . 0.0 106.087 -169.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.53 170.77 43.3 Favored Glycine 0 N--CA 1.439 -1.11 0 O-C-N 121.377 -0.827 . . . . 0.0 111.522 175.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -53.62 -33.58 55.55 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 125.176 1.163 . . . . 0.0 110.048 174.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -143.57 146.23 33.15 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.986 1.714 . . . . 0.0 106.67 169.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 p -70.53 157.66 37.49 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.294 0.569 . . . . 0.0 109.612 169.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.6 m -162.16 148.56 13.39 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.199 1.8 . . . . 0.0 106.795 170.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -54.4 151.96 7.03 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.562 0.619 . . . . 0.0 110.907 -175.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.9 t -57.44 126.19 14.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 172.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -70.46 140.85 87.59 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -72.84 -41.68 1.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.265 1.31 . . . . 0.0 113.192 -169.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.481 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 29.8 m -65.01 -25.19 67.75 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.664 -1.272 . . . . 0.0 111.298 -177.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.46 -40.87 60.33 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.723 0.809 . . . . 0.0 111.335 173.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.8 mt -56.45 -45.88 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.12 -38.37 88.01 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.507 1.123 . . . . 0.0 110.578 -172.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.9 mmm -68.41 -44.02 75.93 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 122.915 1.34 . . . . 0.0 110.434 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.2 mtp -66.88 -34.29 77.46 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 121.124 -0.985 . . . . 0.0 110.005 175.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -62.48 -26.4 68.51 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.998 0.817 . . . . 0.0 111.423 172.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -65.55 -39.84 92.19 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 118.905 0.775 . . . . 0.0 109.768 173.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 63.9 t -78.46 -22.28 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 120.159 -0.617 . . . . 0.0 110.852 177.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.93 25.09 6.63 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.054 1.311 . . . . 0.0 111.948 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.7 mt -122.68 179.03 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 125.227 1.411 . . . . 0.0 107.45 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -144.28 155.96 44.06 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.863 1.665 . . . . 0.0 108.822 -176.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -130.85 -13.04 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.981 0.913 . . . . 0.0 113.365 174.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.7 m -43.1 -34.24 1.03 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.993 1.717 . . . . 0.0 114.637 -176.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -102.82 1.93 48.52 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 117.853 -1.526 . . . . 0.0 114.576 -174.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -71.92 -26.78 62.44 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 120.528 2.164 . . . . 0.0 113.081 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.9 p 60.49 -161.06 0.29 Allowed 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.314 1.046 . . . . 0.0 110.264 -174.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.4 t -134.19 163.0 30.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.798 0.809 . . . . 0.0 111.406 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -161.21 133.9 4.48 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 126.304 1.842 . . . . 0.0 106.373 -171.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -85.0 158.51 11.57 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.875 2.384 . . . . 0.0 110.934 176.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.4 tt -54.28 -35.15 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 123.476 0.711 . . . . 0.0 111.02 172.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -57.22 -24.12 52.47 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.11 1.764 . . . . 0.0 112.66 -175.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -83.3 -2.34 55.44 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.569 0.748 . . . . 0.0 112.547 -176.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -128.88 -176.87 3.99 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.253 1.021 . . . . 0.0 111.005 -177.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.18 129.28 31.46 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 126.602 1.961 . . . . 0.0 108.274 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.31 -29.82 66.18 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.548 1.139 . . . . 0.0 112.939 -175.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -60.73 -22.7 64.27 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.036 0.934 . . . . 0.0 112.475 -176.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -84.31 -18.02 37.67 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.272 0.629 . . . . 0.0 110.605 -177.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -101.89 122.74 44.58 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 125.168 1.387 . . . . 0.0 108.959 -175.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -76.22 -32.34 58.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.841 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.9 138.01 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 123.518 0.727 . . . . 0.0 109.059 -171.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.0 128.01 45.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 122.97 1.367 . . . . 0.0 109.869 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.0 mm -120.33 96.16 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 -175.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.7 m -70.04 156.01 39.78 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 168.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.74 56.07 0.91 Allowed 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 102.753 -3.055 . . . . 0.0 102.753 173.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.4 m -76.51 -34.15 58.6 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.834 0.854 . . . . 0.0 110.14 -178.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.53 176.13 47.19 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -170.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 91.4 m 37.48 32.15 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.594 2.357 . . . . 0.0 114.791 -172.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 53.36 26.43 29.75 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.493 1.52 . . . . 0.0 114.503 -175.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.1 t -64.13 156.26 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 125.19 1.396 . . . . 0.0 108.692 174.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -141.1 173.93 11.01 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 125.343 1.457 . . . . 0.0 109.485 174.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 68.2 mt -101.18 117.69 61.72 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 124.741 1.216 . . . . 0.0 108.953 -169.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.21 -40.52 69.29 Favored 'Trans proline' 0 CA--C 1.548 1.224 0 C-N-CA 122.367 2.045 . . . . 0.0 114.88 169.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.58 -178.98 4.07 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 121.879 1.72 . . . . 0.0 114.073 -175.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -52.94 -14.48 0.58 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 128.427 2.691 . . . . 0.0 114.055 -178.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -64.65 8.7 0.11 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.115 1.766 . . . . 0.0 113.03 170.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.7 p -122.1 2.87 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 124.845 1.258 . . . . 0.0 111.652 172.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.9 p -128.05 23.48 6.09 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.212 1.005 . . . . 0.0 112.149 -173.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -88.58 179.87 6.19 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.621 0.768 . . . . 0.0 109.313 170.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -59.69 -33.6 71.79 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.23 1.012 . . . . 0.0 113.246 -171.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.9 mt -134.76 135.67 53.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 177.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -140.43 133.69 29.7 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 169.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -144.81 157.91 43.99 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.001 1.32 . . . . 0.0 107.573 168.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -119.48 117.54 28.71 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.7 1.2 . . . . 0.0 108.496 168.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -93.92 108.65 20.43 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.218 1.407 . . . . 0.0 109.543 -173.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -72.54 105.57 4.25 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.727 1.211 . . . . 0.0 108.511 178.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -135.76 151.94 50.62 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 125.038 1.335 . . . . 0.0 108.855 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -82.98 75.91 9.84 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.735 1.214 . . . . 0.0 110.657 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -21.92 98.86 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 128.096 2.558 . . . . 0.0 112.466 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -60.81 -4.5 3.62 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 124.44 3.427 . . . . 0.0 116.785 -169.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.455 ' N ' ' HG ' ' A' ' 13' ' ' CYS . 12.6 t70 -56.47 101.07 0.05 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.182 1.355 . . . . 0.0 111.485 177.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.37 18.24 55.66 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 126.096 1.808 . . . . 0.0 113.389 170.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -94.41 178.34 5.65 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.652 1.226 . . . . 0.0 112.763 -169.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.2 m -75.18 154.79 37.49 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.477 1.511 . . . . 0.0 109.955 175.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 93.5 mt -57.47 -32.6 67.13 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.017 -0.427 . . . . 0.0 111.479 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.98 -40.29 94.75 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.858 0.463 . . . . 0.0 110.874 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 88.6 t -65.26 -48.31 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 175.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.481 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 6.4 m-85 -53.94 -52.43 60.65 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.281 0.632 . . . . 0.0 110.954 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -60.97 -43.79 98.28 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.74 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.1 m -61.5 -50.78 71.36 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 118.867 0.758 . . . . 0.0 109.183 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 66.3 t -66.71 -43.67 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-O 118.349 -0.834 . . . . 0.0 110.153 -178.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.62 -43.38 89.64 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 119.966 1.257 . . . . 0.0 110.242 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.66 -49.03 71.97 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-O 118.595 -1.114 . . . . 0.0 111.244 176.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -59.96 -51.87 67.82 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 118.701 1.251 . . . . 0.0 110.884 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 64.4 t -52.78 -48.51 49.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 124.804 1.242 . . . . 0.0 109.959 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -60.02 -47.38 86.08 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.86 1.209 . . . . 0.0 110.399 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.04 -42.76 81.06 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.943 0.897 . . . . 0.0 110.341 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -70.6 -43.43 69.38 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 118.19 -0.909 . . . . 0.0 109.961 -176.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 74.6 t -53.83 -48.19 62.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 120.282 1.401 . . . . 0.0 109.661 169.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -59.48 -40.37 86.76 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.449 1.022 . . . . 0.0 110.559 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -62.54 -46.07 90.07 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.307 1.043 . . . . 0.0 110.316 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.38 -49.56 76.42 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 124.099 0.96 . . . . 0.0 109.488 178.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.88 -37.49 67.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.679 1.191 . . . . 0.0 110.795 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.52 -31.12 71.12 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.889 1.222 . . . . 0.0 111.328 -174.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -70.8 -20.15 62.62 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.689 1.595 . . . . 0.0 112.872 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.9 pt -125.28 -21.04 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -168.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 C--O 1.249 1.028 0 C-N-CA 126.186 1.795 . . . . 0.0 111.174 173.684 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.4 ttm . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.855 0.359 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 49.0 mmtt -118.26 132.59 56.29 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 175.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -92.06 137.71 32.14 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.3 p -122.47 143.83 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 121.866 0.841 . . . . 0.0 109.457 -178.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 31.2 tpp -124.38 141.88 51.73 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.368 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -121.67 125.01 45.64 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 170.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.7 t -128.69 129.53 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 120.402 1.456 . . . . 0.0 109.351 -169.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.8 t -137.84 161.05 37.61 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 119.528 1.058 . . . . 0.0 112.473 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.8 mttt -58.76 -21.42 55.58 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.854 1.262 . . . . 0.0 110.884 168.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.4 ptp85 -147.94 101.23 3.28 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 126.096 1.759 . . . . 0.0 107.05 169.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -44.65 -42.46 7.52 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.013 1.325 . . . . 0.0 112.2 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.7 p -45.21 -20.91 0.06 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 129.599 3.159 . . . . 0.0 118.266 -169.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.4 p -130.65 -74.73 0.53 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.953 1.251 . . . . 0.0 110.647 -171.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -61.22 -52.08 66.29 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -169.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.41 -42.94 78.26 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.425 0.29 . . . . 0.0 111.125 -178.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -59.3 -45.66 90.68 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.603 0.761 . . . . 0.0 111.579 -174.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 44.2 mtm -63.97 -46.6 83.91 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 117.78 0.264 . . . . 0.0 110.903 175.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.8 -39.04 76.61 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 117.606 0.185 . . . . 0.0 110.925 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -63.43 -45.44 90.93 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 122.549 0.34 . . . . 0.0 111.163 178.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.24 -40.07 96.45 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -175.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -66.66 -46.44 75.68 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 118.146 0.973 . . . . 0.0 108.923 174.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.49 -44.04 84.62 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 119.338 0.972 . . . . 0.0 112.591 -173.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -67.93 -38.4 82.83 Favored 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 119.246 -0.982 . . . . 0.0 111.049 174.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.1 m -66.89 -43.4 83.54 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 120.478 1.49 . . . . 0.0 110.504 -177.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.1 -37.7 53.77 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.076 1.35 . . . . 0.0 111.184 -173.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -129.57 -0.3 5.77 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-O 116.55 -2.25 . . . . 0.0 117.582 -169.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.75 105.93 0.25 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 121.582 2.691 . . . . 0.0 108.549 169.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 140.98 -30.29 2.27 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.025 1.298 . . . . 0.0 111.358 -169.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.26 -24.63 4.62 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.486 1.114 . . . . 0.0 111.409 169.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.5 pt -125.71 159.0 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 123.464 0.706 . . . . 0.0 111.295 176.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -126.1 130.8 51.79 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 169.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 p -117.76 152.28 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 C-N-CA 123.331 0.652 . . . . 0.0 111.582 -171.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.4 m -151.69 135.4 16.31 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 167.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 89.0 p -97.43 161.82 13.61 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 121.207 -0.933 . . . . 0.0 109.795 169.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.8 p -151.85 -165.77 2.32 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 169.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.63 165.78 37.0 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 169.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 61.5 mt -54.99 -30.58 59.67 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.825 0.85 . . . . 0.0 110.5 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -148.82 145.96 27.77 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 168.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.2 p -89.55 152.56 21.35 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.593 0.757 . . . . 0.0 111.16 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.8 m -147.52 154.89 41.31 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.748 2.019 . . . . 0.0 106.276 170.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -57.89 148.49 25.36 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.933 0.788 . . . . 0.0 109.702 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 26.9 t -57.95 130.47 21.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -176.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -66.21 136.4 95.28 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -177.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.46 -40.24 6.05 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.273 1.982 . . . . 0.0 113.409 -168.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.493 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 6.1 m -68.0 -17.84 64.54 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.366 -0.834 . . . . 0.0 111.826 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.06 -41.27 87.52 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 121.679 -0.638 . . . . 0.0 110.026 171.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.08 -42.37 94.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.44 -38.92 85.65 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -177.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 21.9 mmt -61.85 -47.49 84.8 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 122.813 1.292 . . . . 0.0 111.326 176.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.0 mtp -69.41 -33.58 73.2 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.368 -178.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -61.95 -29.84 70.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.863 0.865 . . . . 0.0 111.128 172.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -64.98 -39.31 93.28 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.734 0.697 . . . . 0.0 110.328 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 62.1 t -78.67 -23.38 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.935 178.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.95 25.97 5.7 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.109 1.338 . . . . 0.0 112.034 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.3 mt -124.64 176.84 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 125.688 1.595 . . . . 0.0 107.662 -176.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -140.65 157.87 44.81 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.137 1.775 . . . . 0.0 108.605 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -128.21 -20.18 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.649 0.78 . . . . 0.0 113.009 171.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 55.3 p -51.84 -33.36 35.72 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.198 0.908 . . . . 0.0 112.441 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.92 -24.75 59.33 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-O 118.024 -1.431 . . . . 0.0 114.324 -176.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -86.95 -27.41 23.33 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 120.122 1.961 . . . . 0.0 114.953 -169.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 29.2 p 65.87 176.6 0.22 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.719 1.608 . . . . 0.0 113.459 173.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.2 m -102.13 162.13 13.15 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.45 1.1 . . . . 0.0 112.202 -169.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -156.3 134.42 7.18 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-O 118.273 -0.87 . . . . 0.0 109.071 -174.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -80.07 156.24 23.12 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.973 2.448 . . . . 0.0 111.771 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.7 tt -56.7 -33.88 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 123.773 0.829 . . . . 0.0 111.419 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -58.28 -23.13 55.23 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.2 1.8 . . . . 0.0 112.222 -174.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -82.45 -3.17 55.25 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.094 0.958 . . . . 0.0 112.693 -176.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -129.51 177.27 7.32 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 119.916 1.235 . . . . 0.0 112.556 -173.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.43 141.63 50.53 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 128.05 2.54 . . . . 0.0 106.493 170.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.35 -23.9 62.0 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.084 0.954 . . . . 0.0 111.91 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -60.48 -23.09 64.21 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.012 0.925 . . . . 0.0 112.412 -175.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -81.59 -15.85 53.44 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.032 0.933 . . . . 0.0 110.894 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -107.84 128.0 54.22 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.698 1.599 . . . . 0.0 109.65 -172.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -72.44 -40.36 67.13 Favored 'General case' 0 C--O 1.232 0.152 0 O-C-N 121.954 -0.467 . . . . 0.0 110.331 174.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -130.28 135.4 60.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 122.908 0.483 . . . . 0.0 109.927 -170.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.7 t -122.62 119.05 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 122.413 1.101 . . . . 0.0 108.916 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 35.9 mm -108.45 96.7 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.3 t -70.18 156.39 39.29 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 168.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.19 40.32 0.78 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 172.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 85.6 m -63.31 -20.31 65.37 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.028 0.931 . . . . 0.0 111.55 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.5 -59.86 0.45 Allowed Glycine 0 C--N 1.332 0.309 0 C-N-CA 125.289 1.423 . . . . 0.0 111.322 168.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 74.2 m -81.03 30.14 0.33 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 117.703 0.751 . . . . 0.0 113.006 -172.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.93 28.57 68.83 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.6 1.095 . . . . 0.0 111.964 -175.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.4 t -68.72 169.07 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.769 1.228 . . . . 0.0 108.999 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -135.7 172.49 12.94 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.878 1.271 . . . . 0.0 110.092 -175.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.6 mt -124.34 83.87 56.77 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 -170.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -45.41 -33.13 8.67 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.422 2.748 . . . . 0.0 117.103 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -64.6 -173.2 0.22 Allowed 'Trans proline' 0 C--N 1.356 0.928 0 CA-C-N 122.177 1.813 . . . . 0.0 114.296 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -47.69 -19.45 0.21 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.613 1.965 . . . . 0.0 114.745 170.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -59.52 -3.96 0.54 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.074 2.15 . . . . 0.0 114.467 171.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.9 p -119.82 -5.62 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 119.545 1.066 . . . . 0.0 112.754 171.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.2 p -102.94 18.12 22.37 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.623 1.101 . . . . 0.0 111.919 -172.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -87.51 -176.96 5.78 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.487 1.115 . . . . 0.0 109.304 172.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -68.22 -32.66 73.02 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -169.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.2 mt -136.61 140.14 43.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -176.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -142.4 139.45 31.67 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.691 1.196 . . . . 0.0 108.661 171.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -147.07 159.68 43.31 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.935 1.694 . . . . 0.0 107.942 168.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -121.72 105.6 10.55 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.06 1.344 . . . . 0.0 108.728 168.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 43.1 m0 -78.38 93.16 4.66 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.067 0.947 . . . . 0.0 109.315 -178.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -60.67 119.93 9.06 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 169.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.8 mt -150.05 152.15 34.37 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.541 1.536 . . . . 0.0 107.529 -169.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -82.47 64.15 6.98 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 125.073 1.349 . . . . 0.0 111.142 -176.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -10.34 94.85 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 128.762 2.825 . . . . 0.0 113.804 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -58.66 -9.95 8.31 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 124.081 3.187 . . . . 0.0 116.549 -173.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -54.81 101.99 0.06 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 120.262 1.392 . . . . 0.0 111.804 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.87 21.63 42.11 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.279 1.895 . . . . 0.0 113.433 172.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -102.07 178.12 4.7 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.839 1.319 . . . . 0.0 113.67 -169.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.2 m -78.73 156.07 29.08 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.204 1.802 . . . . 0.0 110.19 175.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 96.5 mt -60.3 -30.19 69.32 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.772 -0.58 . . . . 0.0 111.951 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.51 -39.07 93.1 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.326 0.512 . . . . 0.0 110.777 176.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 95.3 t -67.46 -45.9 84.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.493 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 12.1 m-85 -55.55 -51.8 65.86 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 118.902 -0.571 . . . . 0.0 110.547 176.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -59.19 -42.11 90.09 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.913 0.779 . . . . 0.0 111.919 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.8 m -61.52 -51.1 70.01 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.052 0.842 . . . . 0.0 109.627 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.7 t -65.46 -43.87 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 117.87 -1.062 . . . . 0.0 110.234 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -55.18 -45.01 75.78 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 119.821 1.191 . . . . 0.0 109.214 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.42 -49.9 72.34 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-O 118.214 -1.326 . . . . 0.0 110.409 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -60.07 -56.43 21.72 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 118.574 1.187 . . . . 0.0 110.423 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.9 t -46.62 -52.46 3.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 125.694 1.597 . . . . 0.0 110.444 176.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -63.61 -46.55 85.23 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 119.708 1.14 . . . . 0.0 110.114 -175.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -43.14 85.04 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.272 0.629 . . . . 0.0 110.197 178.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.6 mtt-85 -69.87 -42.74 73.1 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.894 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 72.9 t -54.12 -49.18 63.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 120.393 1.451 . . . . 0.0 109.516 169.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -59.78 -39.85 86.27 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 119.448 1.022 . . . . 0.0 110.625 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -63.42 -45.9 88.83 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.328 1.051 . . . . 0.0 110.224 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -47.93 80.06 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 124.082 0.953 . . . . 0.0 109.815 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 61.8 mt -57.3 -38.49 62.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 124.703 1.201 . . . . 0.0 110.562 176.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.2 -28.94 69.51 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.776 1.171 . . . . 0.0 111.488 -173.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -73.66 -19.51 60.81 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.879 1.672 . . . . 0.0 112.731 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 pt -125.67 -20.1 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 126.151 1.78 . . . . 0.0 114.921 -168.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.3 m . . . . . 0 C--O 1.251 1.138 0 C-N-CA 126.432 1.893 . . . . 0.0 110.907 170.015 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.4 ttm . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 120.919 0.39 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 51.3 mmtt -119.99 134.64 55.19 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 107.354 -1.351 . . . . 0.0 107.354 175.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.7 mttt -94.51 135.86 35.46 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.2 p -121.68 144.55 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-O 121.885 0.85 . . . . 0.0 109.548 -176.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 29.6 tpp -124.23 142.2 51.44 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.493 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -123.41 111.37 16.27 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.4 t -111.65 117.06 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 119.611 1.096 . . . . 0.0 108.546 -173.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.9 t -108.05 165.19 11.65 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.713 0.768 . . . . 0.0 110.824 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -59.03 -16.22 17.41 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.701 0.8 . . . . 0.0 111.875 169.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -158.62 115.69 2.81 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 128.241 2.616 . . . . 0.0 103.975 178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -65.02 40.27 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.751 1.62 . . . . 0.0 113.063 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.5 p -122.75 -20.37 5.93 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 119.839 -1.788 . . . . 0.0 113.559 -169.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 82.5 m -132.71 -89.06 0.42 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.595 0.634 . . . . 0.0 111.438 -169.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -56.3 -46.84 79.62 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 118.881 0.764 . . . . 0.0 110.555 -169.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.3 p -68.87 -37.53 79.11 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.584 1.153 . . . . 0.0 111.583 -174.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -66.08 -47.71 73.35 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.704 0.802 . . . . 0.0 109.927 -174.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 69.1 mtm -63.77 -46.16 86.51 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 119.434 -0.317 . . . . 0.0 110.645 176.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.85 -42.4 71.94 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 123.043 0.215 . . . . 0.0 110.822 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -65.29 -47.1 77.83 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 123.02 0.2 . . . . 0.0 110.807 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.63 -38.08 95.72 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -175.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.415 ' CD1' ' HE1' ' A' ' 50' ' ' MET . 18.8 m-85 -65.19 -49.75 68.55 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 174.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.09 -43.39 82.15 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 124.228 1.011 . . . . 0.0 113.079 -172.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -67.47 -37.79 83.46 Favored 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 118.926 -1.109 . . . . 0.0 111.048 174.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.4 m -68.1 -42.16 80.72 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 120.404 1.456 . . . . 0.0 110.481 -177.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.0 mt -75.44 -38.41 59.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.733 1.613 . . . . 0.0 111.555 -175.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -131.17 0.32 5.22 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-O 116.732 -2.149 . . . . 0.0 117.98 -169.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.58 107.29 0.37 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 121.421 2.61 . . . . 0.0 108.629 169.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 140.06 -30.59 2.34 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.953 1.263 . . . . 0.0 111.349 -169.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.31 -24.47 4.64 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.454 1.101 . . . . 0.0 111.51 170.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.2 pt -125.55 158.01 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 123.298 0.639 . . . . 0.0 111.247 176.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -125.34 131.23 53.04 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 169.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -117.29 152.78 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 123.32 0.648 . . . . 0.0 111.806 -170.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.9 m -148.5 134.42 19.07 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 167.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.4 p -96.99 159.31 14.98 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 120.692 -1.255 . . . . 0.0 107.949 168.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.1 m -153.22 -170.3 3.57 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 176.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.78 164.96 33.91 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 169.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.4 mt -52.32 -30.1 26.71 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 124.627 0.84 . . . . 0.0 110.348 170.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -143.0 148.51 36.9 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 169.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 p -72.46 154.74 40.7 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.25 0.62 . . . . 0.0 109.552 169.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.9 m -159.78 147.1 16.67 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 169.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -58.64 147.66 31.8 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.471 0.578 . . . . 0.0 109.856 -177.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -60.19 129.58 22.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -70.27 139.85 87.46 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.63 -38.83 5.42 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.238 1.959 . . . . 0.0 113.315 -168.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.509 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 8.2 m -68.04 -17.16 64.32 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.315 -0.866 . . . . 0.0 111.647 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.04 -40.62 85.61 Favored 'General case' 0 C--N 1.341 0.229 0 O-C-N 121.456 -0.778 . . . . 0.0 110.26 171.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.9 mp -62.97 -42.15 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -178.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.34 -37.39 83.14 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 20.5 mmt -62.13 -47.02 86.44 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 122.921 1.343 . . . . 0.0 111.197 175.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.415 ' HE1' ' CD1' ' A' ' 21' ' ' PHE . 9.3 mtp -70.09 -31.81 69.56 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.61 -177.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -61.57 -29.13 69.82 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.495 0.718 . . . . 0.0 111.36 169.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -65.83 -35.98 82.2 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.083 0.856 . . . . 0.0 110.475 173.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.4 t -78.96 -26.02 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 117.512 0.142 . . . . 0.0 110.916 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.48 28.19 6.48 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.723 1.154 . . . . 0.0 111.818 -175.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.5 mt -125.66 -177.57 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 126.018 1.727 . . . . 0.0 107.163 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -147.03 158.38 43.91 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.589 1.955 . . . . 0.0 108.355 -178.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -130.57 -13.2 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 173.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.5 p -51.22 -29.31 13.84 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.534 1.061 . . . . 0.0 113.43 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.24 -13.94 65.05 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 118.121 -1.377 . . . . 0.0 114.249 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -74.51 -29.9 61.59 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 120.281 2.041 . . . . 0.0 113.137 -173.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.7 p 59.74 -163.49 0.23 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.482 0.713 . . . . 0.0 109.689 -169.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.5 m -138.07 156.15 48.07 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.937 -173.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -153.44 135.87 9.38 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.319 1.048 . . . . 0.0 109.106 -169.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.89 153.64 22.62 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.466 2.11 . . . . 0.0 111.272 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.6 tt -53.54 -34.09 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.831 0.852 . . . . 0.0 111.486 174.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -57.51 -23.55 50.85 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.079 1.752 . . . . 0.0 112.503 -176.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -86.15 -7.43 58.57 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.736 0.814 . . . . 0.0 112.872 -174.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -121.77 -176.38 3.31 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.459 1.027 . . . . 0.0 110.523 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -133.96 130.58 37.86 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 126.26 1.824 . . . . 0.0 108.439 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.27 -30.43 68.29 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.708 1.203 . . . . 0.0 112.742 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.63 -21.73 63.05 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.066 0.947 . . . . 0.0 112.571 -175.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -85.52 -13.83 47.8 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.452 0.701 . . . . 0.0 111.012 -177.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -109.22 125.17 51.96 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.735 1.214 . . . . 0.0 109.852 -172.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -72.14 -41.38 67.22 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 122.474 0.31 . . . . 0.0 110.229 175.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.65 134.61 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 122.959 0.504 . . . . 0.0 109.898 -169.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.8 t -125.56 111.18 26.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 123.091 1.424 . . . . 0.0 108.64 -177.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.9 mm -100.25 99.26 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 177.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.8 t -72.31 156.81 38.71 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 167.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.57 54.78 0.68 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 103.394 -2.817 . . . . 0.0 103.394 173.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 83.5 m -85.55 -34.81 21.41 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.111 173.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.58 174.2 50.22 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 94.0 m 39.78 32.55 0.11 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.954 2.102 . . . . 0.0 114.009 -170.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.1 22.15 54.77 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.808 1.67 . . . . 0.0 114.599 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 79.2 t -62.67 141.42 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 169.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -135.62 -179.47 5.67 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.304 1.042 . . . . 0.0 109.699 -169.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 49.1 mt -113.46 108.38 52.23 Favored Pre-proline 0 N--CA 1.453 -0.286 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -170.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -50.22 -42.31 47.42 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 122.494 2.129 . . . . 0.0 115.097 169.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.22 179.65 5.93 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 121.834 1.69 . . . . 0.0 113.873 -174.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -56.46 -13.02 1.97 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 127.713 2.405 . . . . 0.0 113.826 -172.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -57.0 -25.76 59.04 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.31 1.044 . . . . 0.0 112.039 173.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.6 p -83.63 -16.18 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 119.625 1.102 . . . . 0.0 110.179 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.7 p -106.51 17.92 22.65 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.917 0.887 . . . . 0.0 112.266 -170.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -78.81 179.12 7.42 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.593 0.757 . . . . 0.0 109.764 171.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -63.61 -31.96 73.28 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -169.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.6 mt -135.64 137.49 49.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -142.21 139.15 31.93 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.228 1.011 . . . . 0.0 108.448 171.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -146.93 161.78 40.06 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.663 1.585 . . . . 0.0 108.003 168.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -122.53 100.77 7.1 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.742 1.617 . . . . 0.0 108.653 168.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.412 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 40.2 m0 -76.27 91.15 3.19 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.558 1.143 . . . . 0.0 108.594 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -64.99 100.65 0.44 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.768 1.227 . . . . 0.0 109.734 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -129.83 155.34 46.15 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.006 1.323 . . . . 0.0 110.856 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -78.06 80.77 4.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.061 1.744 . . . . 0.0 110.125 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -35.69 108.76 0.38 Allowed Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 126.318 1.847 . . . . 0.0 112.652 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -60.26 -2.53 1.87 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 125.13 3.887 . . . . 0.0 117.579 -171.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -53.57 98.4 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 120.495 1.498 . . . . 0.0 112.435 175.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.6 18.73 56.24 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 126.406 1.955 . . . . 0.0 112.963 171.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -95.33 177.21 5.92 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.69 1.245 . . . . 0.0 112.601 -169.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.9 m -74.93 154.91 37.95 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.48 1.512 . . . . 0.0 109.798 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.6 mt -59.5 -29.8 68.11 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.861 -0.524 . . . . 0.0 111.717 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.61 -39.0 92.39 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.226 0.466 . . . . 0.0 110.876 175.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 82.3 t -68.13 -46.55 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 176.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.509 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 17.8 m-85 -55.07 -50.65 68.62 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 119.283 -0.389 . . . . 0.0 110.89 176.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -60.54 -42.13 95.9 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.931 0.893 . . . . 0.0 111.972 177.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 93.6 m -60.82 -51.73 68.08 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 119.156 0.889 . . . . 0.0 109.147 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 74.6 t -61.61 -47.09 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-O 117.891 -1.052 . . . . 0.0 109.81 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 38.6 ttp85 -53.57 -51.41 63.04 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 119.661 1.118 . . . . 0.0 108.967 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.55 -48.48 72.82 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -173.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -60.91 -52.6 64.34 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.856 0.862 . . . . 0.0 110.402 -177.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.0 t -57.98 -49.59 80.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 125.369 1.467 . . . . 0.0 110.325 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -58.25 -48.05 81.65 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 121.034 1.743 . . . . 0.0 110.623 -178.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.98 -45.26 71.35 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.207 1.003 . . . . 0.0 110.505 174.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.412 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 49.9 mtt85 -70.59 -39.87 73.58 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 117.869 -1.062 . . . . 0.0 111.024 -177.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 80.9 t -54.47 -49.14 67.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 120.515 1.507 . . . . 0.0 109.349 169.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -60.47 -39.64 88.34 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.349 0.977 . . . . 0.0 110.58 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -62.81 -45.92 90.36 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.335 1.054 . . . . 0.0 110.464 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.69 -47.95 79.1 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 124.342 1.057 . . . . 0.0 109.714 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.4 mt -57.07 -38.48 60.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.544 1.137 . . . . 0.0 110.591 175.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.28 -28.93 69.54 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.875 1.216 . . . . 0.0 111.5 -173.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -73.64 -19.68 60.78 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.969 1.708 . . . . 0.0 112.79 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.4 pt -125.43 -20.21 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 126.175 1.79 . . . . 0.0 114.826 -168.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 C--O 1.248 1.013 0 C-N-CA 126.571 1.948 . . . . 0.0 110.857 170.005 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.1 ttm . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 120.564 0.221 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -115.68 145.61 42.59 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.972 0.909 . . . . 0.0 109.18 170.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -97.17 118.77 34.35 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 172.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.9 p -101.37 138.38 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 O-C-N 123.688 0.617 . . . . 0.0 110.716 173.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 37.9 tpp -116.2 143.72 45.14 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 169.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -115.96 140.71 48.99 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.274 1.43 . . . . 0.0 108.149 169.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.7 t -146.4 129.87 9.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -170.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -133.83 172.16 13.17 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.098 0.863 . . . . 0.0 109.817 169.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -66.31 -12.11 54.64 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.42 -0.8 . . . . 0.0 112.946 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.1 ptm85 -155.23 106.17 2.57 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 171.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -46.99 -28.08 1.52 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.464 1.905 . . . . 0.0 114.135 -177.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -30.12 -42.39 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 129.81 3.244 . . . . 0.0 118.183 -169.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.7 p -136.25 -68.37 0.5 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 117.686 -1.149 . . . . 0.0 113.919 -169.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.5 ptt-85 -56.62 -48.7 76.91 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.507 1.503 . . . . 0.0 110.76 -172.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.83 -51.44 70.0 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.67 0.788 . . . . 0.0 110.121 176.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 -62.55 -44.88 95.26 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.68 0.792 . . . . 0.0 111.769 -173.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 51.4 mtm -62.87 -45.72 91.23 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.916 0.486 . . . . 0.0 110.384 175.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.99 -37.99 75.29 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 119.434 -0.317 . . . . 0.0 110.393 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -61.13 -50.03 74.88 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.4 0.68 . . . . 0.0 110.258 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.57 -44.69 94.71 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 119.348 -0.695 . . . . 0.0 111.866 -177.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -65.84 -46.98 76.54 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 118.773 1.286 . . . . 0.0 108.646 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.16 -43.3 87.32 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 119.779 1.172 . . . . 0.0 112.54 -175.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -68.26 -35.59 78.12 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.786 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.3 m -67.74 -42.43 81.86 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 120.047 -1.658 . . . . 0.0 110.758 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.9 mt -73.05 -40.1 65.39 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.031 1.732 . . . . 0.0 111.036 -174.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -136.26 4.92 3.84 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 116.749 -2.14 . . . . 0.0 117.964 -169.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.46 115.68 2.65 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 121.643 2.721 . . . . 0.0 108.974 171.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 124.84 -24.9 5.96 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.59 1.09 . . . . 0.0 111.56 -173.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.21 -19.89 3.84 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.365 1.066 . . . . 0.0 111.456 176.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.3 pt -130.88 155.27 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 168.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.72 130.3 56.64 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 169.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.7 p -113.94 151.83 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-O 121.882 0.848 . . . . 0.0 111.911 -175.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.1 m -144.15 152.59 41.12 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 126.214 1.806 . . . . 0.0 106.206 167.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.0 p -129.26 157.07 42.9 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.135 0.974 . . . . 0.0 108.803 168.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.6 p -158.53 -161.39 0.98 Allowed 'General case' 0 C--O 1.241 0.642 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.66 163.96 33.35 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 169.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 65.3 mt -53.36 -31.79 46.23 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.37 1.068 . . . . 0.0 110.727 177.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -143.14 145.04 32.47 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 168.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.9 p -75.66 165.65 24.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.911 0.863 . . . . 0.0 111.567 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.5 p -150.03 -132.27 0.05 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.542 1.537 . . . . 0.0 106.957 177.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -144.55 157.73 44.09 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 171.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.5 t -65.24 131.6 31.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -177.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -71.99 138.54 82.22 Favored Pre-proline 0 N--CA 1.446 -0.65 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.96 -38.17 5.47 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 CA-C-N 120.423 1.187 . . . . 0.0 111.694 -169.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.48 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 8.6 m -67.59 -19.12 65.21 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.56 -1.338 . . . . 0.0 112.094 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.15 -39.2 78.17 Favored 'General case' 0 C--O 1.231 0.084 0 O-C-N 121.502 -0.749 . . . . 0.0 110.494 172.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.6 mt -58.37 -47.73 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.51 -40.33 91.04 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.808 0.843 . . . . 0.0 111.837 -175.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.2 mmt -60.26 -48.61 81.03 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.517 1.151 . . . . 0.0 111.21 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 9.3 mtp -69.04 -35.34 76.48 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.914 -178.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -61.18 -30.51 70.45 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.824 0.738 . . . . 0.0 111.55 172.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -63.22 -39.58 95.03 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.026 0.83 . . . . 0.0 110.384 173.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.1 t -79.76 -18.65 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-O 119.888 -0.101 . . . . 0.0 111.098 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.13 26.35 8.91 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.552 1.073 . . . . 0.0 111.816 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.7 mt -122.09 -176.13 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 126.078 1.751 . . . . 0.0 106.505 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -149.68 155.58 40.44 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 120.406 -1.434 . . . . 0.0 109.632 -177.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.49 -13.61 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.061 0.945 . . . . 0.0 112.538 169.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 99.7 p -52.99 -30.83 37.43 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.659 1.118 . . . . 0.0 112.432 176.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.14 -7.11 87.76 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 118.526 -1.152 . . . . 0.0 114.366 -176.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -125.3 169.9 11.84 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.37 1.585 . . . . 0.0 110.93 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 19.2 p -127.58 164.47 21.93 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.231 1.012 . . . . 0.0 112.365 -169.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.4 m -78.98 156.91 28.25 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.567 1.147 . . . . 0.0 110.953 171.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -155.42 145.14 15.46 Favored Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 123.935 0.894 . . . . 0.0 109.542 -177.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -80.32 151.94 20.56 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.246 1.964 . . . . 0.0 111.113 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.1 tt -54.25 -34.92 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.658 0.783 . . . . 0.0 111.442 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -60.59 -21.58 62.78 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.689 1.595 . . . . 0.0 112.471 -174.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -79.77 -5.54 55.52 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.564 0.746 . . . . 0.0 112.562 -177.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -124.76 -175.83 3.38 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.539 1.136 . . . . 0.0 110.651 -178.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.49 127.19 25.34 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 126.563 1.945 . . . . 0.0 107.583 176.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.79 -27.74 63.37 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.604 1.162 . . . . 0.0 112.447 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -59.82 -23.47 63.37 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.33 1.052 . . . . 0.0 112.739 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -85.0 -14.18 48.26 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.421 0.689 . . . . 0.0 110.72 -177.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -104.54 126.21 51.42 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 125.222 1.409 . . . . 0.0 109.012 -174.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.94 -42.63 76.45 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.8 p -130.99 136.08 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 C-N-CA 122.9 0.48 . . . . 0.0 109.918 -169.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.5 m -127.66 120.3 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-O 122.363 1.078 . . . . 0.0 108.651 -172.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.6 mm -116.72 102.84 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-N 115.006 -0.997 . . . . 0.0 108.389 -169.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.9 t -74.37 153.68 39.16 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 168.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.79 36.48 0.4 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 171.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 77.4 m -56.48 -43.98 80.18 Favored 'General case' 0 C--N 1.339 0.128 0 O-C-N 120.92 -1.113 . . . . 0.0 112.151 -169.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.43 165.96 36.4 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 -173.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 13.0 p 36.33 34.1 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.927 2.091 . . . . 0.0 115.42 -171.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.4 15.91 68.69 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.177 0.894 . . . . 0.0 114.867 176.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.0 t -67.13 156.17 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 169.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -143.55 -172.85 3.8 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.574 1.55 . . . . 0.0 109.076 -173.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 53.3 mt -117.51 100.04 52.6 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 125.255 1.422 . . . . 0.0 107.965 -169.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.82 -43.11 58.72 Favored 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 122.814 2.342 . . . . 0.0 115.828 172.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -75.51 -175.39 2.41 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.061 1.841 . . . . 0.0 113.131 -174.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -53.28 -12.89 0.45 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 128.706 2.802 . . . . 0.0 114.551 -175.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 56.1 m95 -67.44 11.29 0.13 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.628 1.971 . . . . 0.0 112.725 171.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.0 p -121.95 4.04 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 125.229 1.412 . . . . 0.0 111.651 169.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 36.3 p -131.71 25.9 4.7 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.17 -0.956 . . . . 0.0 112.602 -172.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -91.54 -170.72 2.69 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 170.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -64.55 -32.06 73.54 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.295 0.638 . . . . 0.0 112.235 -170.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.3 mt -137.9 138.3 44.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -134.61 134.88 41.73 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 169.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -141.25 152.06 44.23 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 169.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -119.95 124.74 46.72 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.448 1.099 . . . . 0.0 109.143 169.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -107.76 86.64 2.33 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -54.82 125.11 18.79 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 169.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 25.0 mt -149.06 156.12 41.76 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.618 1.567 . . . . 0.0 107.4 -169.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -82.4 60.93 5.33 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.725 1.21 . . . . 0.0 111.151 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.3 t0 4.53 85.97 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.469 0 C-N-CA 129.348 3.059 . . . . 0.0 112.141 169.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -61.56 -8.14 10.35 Favored 'Trans proline' 0 C--N 1.352 0.748 0 N-CA-C 116.71 1.773 . . . . 0.0 116.71 -169.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -61.04 95.98 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.848 1.204 . . . . 0.0 111.27 -177.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.5 16.1 25.55 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.243 1.878 . . . . 0.0 113.361 172.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -95.76 178.12 5.56 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.925 1.362 . . . . 0.0 113.167 -169.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.4 m -76.55 155.73 33.43 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.985 1.714 . . . . 0.0 110.143 174.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 97.0 mt -58.53 -32.5 68.92 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.853 -0.529 . . . . 0.0 111.621 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -71.15 -33.82 70.42 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.126 0.421 . . . . 0.0 110.852 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 72.1 t -65.82 -45.75 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 172.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.48 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 13.6 m-85 -57.38 -49.8 75.03 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 118.609 -0.71 . . . . 0.0 110.52 176.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 60.9 mtt180 -57.6 -43.35 84.61 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.425 1.011 . . . . 0.0 111.808 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 89.4 m -61.15 -53.58 55.24 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 50.4 t -63.58 -41.62 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.558 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -56.64 -48.36 77.7 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 120.205 1.366 . . . . 0.0 109.225 177.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.66 -45.31 96.54 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -59.31 -60.83 3.23 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 123.756 0.823 . . . . 0.0 109.017 177.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.4 t -45.29 -51.62 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 126.752 2.021 . . . . 0.0 110.974 177.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -63.54 -46.54 85.5 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 120.008 1.276 . . . . 0.0 110.38 -175.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.26 -42.12 85.75 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.708 0.803 . . . . 0.0 110.237 176.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -69.33 -43.13 74.34 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.292 1.037 . . . . 0.0 109.914 -175.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 71.5 t -54.79 -48.97 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 119.427 1.012 . . . . 0.0 110.068 168.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -60.67 -38.96 86.66 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 120.017 1.281 . . . . 0.0 111.197 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -63.66 -44.38 93.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.439 1.096 . . . . 0.0 110.201 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.11 -40.8 67.91 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.101 -179.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.7 mt -51.88 -43.23 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 124.004 0.921 . . . . 0.0 108.697 169.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.15 -29.81 70.61 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.674 1.125 . . . . 0.0 111.494 -173.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -71.8 -44.8 63.33 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.121 1.368 . . . . 0.0 110.761 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 pt -85.02 -29.07 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.895 1.278 . . . . 0.0 113.89 -173.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.5 m . . . . . 0 C--O 1.249 1.053 0 C-N-CA 126.161 1.785 . . . . 0.0 111.102 179.693 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.8 ttm . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.54 0.209 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -108.4 140.92 41.01 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 173.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -88.93 116.96 27.6 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 170.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 98.3 t -99.04 138.3 23.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 125.286 1.435 . . . . 0.0 107.19 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 31.0 tpp -121.5 140.72 51.82 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.792 1.237 . . . . 0.0 108.889 175.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -122.19 134.85 54.71 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 170.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.7 t -140.35 133.89 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 119.42 1.009 . . . . 0.0 109.182 -170.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 p -139.71 167.76 21.38 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 119.897 1.226 . . . . 0.0 111.813 169.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -62.08 -18.16 59.85 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -146.83 102.93 3.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 169.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -44.56 -36.75 3.16 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 127.112 2.165 . . . . 0.0 113.355 -177.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.2 m -45.68 -13.5 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 129.519 3.128 . . . . 0.0 119.237 -168.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.5 p -128.97 -89.14 0.51 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 120.279 1.4 . . . . 0.0 111.17 -171.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -57.8 -48.28 80.16 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.555 0.616 . . . . 0.0 110.758 -169.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.4 m -57.74 -44.43 86.04 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.462 0.705 . . . . 0.0 110.104 -175.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -76.25 -32.73 59.02 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 119.075 -0.488 . . . . 0.0 111.773 -173.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 65.4 mtm -65.55 -47.15 76.85 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.691 0.678 . . . . 0.0 109.986 169.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.22 -36.08 70.46 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.842 0.457 . . . . 0.0 110.831 177.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -59.08 -62.04 2.18 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.79 -39.66 68.61 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 119.144 -0.809 . . . . 0.0 111.883 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.405 ' CZ ' ' SD ' ' A' ' 50' ' ' MET . 40.5 m-85 -66.53 -50.25 63.8 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 119.038 1.419 . . . . 0.0 110.594 174.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.32 -43.47 98.76 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 120.233 1.378 . . . . 0.0 112.45 -172.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 ptmt -70.48 -9.04 55.52 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.626 1.103 . . . . 0.0 113.24 175.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.7 m -92.67 -49.4 6.11 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 119.982 1.265 . . . . 0.0 110.544 169.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.5 mt -78.32 -41.4 33.8 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 125.642 1.577 . . . . 0.0 112.205 -169.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.26 -7.65 16.23 Favored Glycine 0 C--N 1.332 0.338 0 CA-C-O 118.034 -1.426 . . . . 0.0 114.75 -169.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.98 109.79 0.51 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.477 1.639 . . . . 0.0 108.971 169.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.09 -29.4 2.83 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.838 1.209 . . . . 0.0 111.585 -169.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.27 -21.7 2.57 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.561 1.145 . . . . 0.0 111.848 173.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.9 pt -126.95 157.55 38.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 121.342 0.591 . . . . 0.0 111.635 174.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.7 127.92 53.31 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 168.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.0 p -109.07 150.69 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-O 121.55 0.691 . . . . 0.0 111.654 -176.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.7 m -148.95 137.51 21.13 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 167.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.3 m -124.02 152.46 42.57 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 121.752 -0.593 . . . . 0.0 110.291 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 19.3 p -157.56 -163.62 1.39 Allowed 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -171.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.65 168.77 41.82 Favored Glycine 0 N--CA 1.448 -0.504 0 O-C-N 121.318 -0.864 . . . . 0.0 111.098 174.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 65.6 mt -56.42 -32.3 64.73 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.085 0.554 . . . . 0.0 111.061 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -141.57 149.39 40.7 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 169.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.8 p -91.1 157.93 16.94 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.276 1.031 . . . . 0.0 110.599 170.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 28.5 m -164.88 158.23 17.05 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.826 2.85 . . . . 0.0 104.912 169.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 96.5 mtt-85 -50.93 136.73 22.28 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.643 1.111 . . . . 0.0 110.449 -172.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.7 p -58.17 131.72 22.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -70.33 142.83 90.0 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-O 118.851 -0.595 . . . . 0.0 109.872 -169.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.68 -39.7 0.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.53 1.486 . . . . 0.0 112.583 -169.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.45 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 29.3 m -62.44 -25.8 68.16 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.643 -1.286 . . . . 0.0 111.529 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.75 -43.98 38.11 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.61 0.764 . . . . 0.0 110.928 172.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.9 mt -54.99 -46.52 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 C-N-CA 124.257 1.023 . . . . 0.0 108.345 -178.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.4 -34.89 79.22 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 123.996 0.918 . . . . 0.0 110.051 -171.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.9 mmm -70.09 -41.94 73.39 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.062 0.934 . . . . 0.0 110.549 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.423 ' HG3' ' CG1' ' A' ' 57' ' ' ILE . 87.8 mmm -62.82 -41.23 99.24 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 174.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -61.79 -26.27 67.99 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.079 0.552 . . . . 0.0 111.129 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -66.25 -40.27 90.07 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 118.478 0.581 . . . . 0.0 110.025 172.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.5 t -77.96 -26.22 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.816 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.98 24.29 6.09 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 125.354 1.455 . . . . 0.0 112.009 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.8 mt -121.81 177.63 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 125.643 1.577 . . . . 0.0 107.576 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -143.37 159.0 43.16 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.495 1.518 . . . . 0.0 109.746 -177.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.423 ' CG1' ' HG3' ' A' ' 50' ' ' MET . 0.7 OUTLIER -131.3 -18.64 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.244 1.017 . . . . 0.0 111.776 169.62 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -42.64 -38.32 1.99 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.155 1.382 . . . . 0.0 113.345 174.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.13 -11.28 63.62 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.529 1.061 . . . . 0.0 113.899 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -128.13 172.8 10.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.413 1.485 . . . . 0.0 112.442 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.2 p -125.09 164.28 20.55 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.709 1.604 . . . . 0.0 110.348 -176.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.26 166.95 21.4 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.512 1.525 . . . . 0.0 111.539 174.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -154.91 142.67 14.09 Favored Pre-proline 0 N--CA 1.472 0.643 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.535 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -84.49 151.85 11.86 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.028 2.485 . . . . 0.0 111.868 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.2 tt -58.19 -32.75 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 123.951 0.9 . . . . 0.0 111.647 175.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -57.24 -21.6 35.2 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.255 1.822 . . . . 0.0 112.1 -176.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -74.72 -9.61 58.73 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.662 1.185 . . . . 0.0 112.855 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -134.1 179.7 6.09 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 120.24 1.382 . . . . 0.0 112.711 -175.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.42 143.08 51.15 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 127.901 2.48 . . . . 0.0 107.384 169.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.62 -25.31 62.98 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.194 0.998 . . . . 0.0 112.439 -176.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -60.88 -23.12 64.94 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.753 0.821 . . . . 0.0 112.325 -174.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -80.71 -16.44 53.94 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.122 0.969 . . . . 0.0 110.597 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -102.77 124.37 48.18 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 125.394 1.477 . . . . 0.0 109.083 -173.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -72.16 -36.43 69.3 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 176.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.73 132.32 56.9 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -170.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.1 t -124.04 132.52 71.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 122.188 0.994 . . . . 0.0 108.894 178.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.9 mm -121.87 102.74 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -178.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.3 m -73.95 155.08 39.03 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 168.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.27 26.71 0.96 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.633 1.573 . . . . 0.0 108.156 175.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 86.4 m -54.92 -36.38 65.17 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 124.863 1.265 . . . . 0.0 113.276 -169.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.87 166.22 38.84 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 88.8 m 39.58 33.8 0.13 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.679 1.992 . . . . 0.0 114.413 -173.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 61.34 19.26 57.29 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.887 1.708 . . . . 0.0 115.211 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 97.2 t -68.3 155.15 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 169.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -154.45 -175.43 5.4 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.057 0.943 . . . . 0.0 110.379 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.0 mt -114.33 110.69 47.58 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 125.439 1.496 . . . . 0.0 108.71 -169.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -55.51 -42.76 64.66 Favored 'Trans proline' 0 CA--C 1.55 1.311 0 C-N-CA 122.36 2.04 . . . . 0.0 114.876 169.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.43 -179.94 5.58 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 121.934 1.756 . . . . 0.0 114.592 -170.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -47.02 -19.41 0.11 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 130.512 3.525 . . . . 0.0 115.863 -177.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -55.58 -28.47 55.22 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 124.821 1.248 . . . . 0.0 112.193 173.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.5 p -87.39 -2.63 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 118.935 0.789 . . . . 0.0 110.26 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.7 p -123.35 22.66 9.26 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.144 0.978 . . . . 0.0 112.716 -169.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -82.07 178.14 8.44 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.479 0.712 . . . . 0.0 110.7 174.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.72 -33.87 72.18 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.454 1.101 . . . . 0.0 112.224 -169.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.5 mt -129.2 138.58 54.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 172.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -141.94 134.49 28.23 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 170.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -141.15 153.9 45.6 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 168.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -120.08 104.9 10.51 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.715 1.206 . . . . 0.0 110.069 169.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 37.9 m0 -80.59 79.48 7.2 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.381 1.872 . . . . 0.0 108.564 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -55.02 118.67 4.51 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 171.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 30.6 mt -147.07 154.7 41.48 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.534 1.534 . . . . 0.0 107.785 -169.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -82.8 59.35 4.75 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.963 1.305 . . . . 0.0 111.982 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 47.8 t0 5.79 82.23 0.04 OUTLIER Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 129.925 3.29 . . . . 0.0 113.135 169.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -59.49 -13.67 22.01 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.997 3.131 . . . . 0.0 118.691 -168.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -62.98 98.24 0.13 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.623 1.556 . . . . 0.0 110.217 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 106.24 10.94 28.71 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.22 1.867 . . . . 0.0 113.559 173.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -95.7 179.38 5.14 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.152 1.476 . . . . 0.0 113.29 -169.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.3 m -76.9 155.51 32.78 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.653 1.581 . . . . 0.0 110.123 175.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 57.3 mt -59.42 -32.2 69.97 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.879 -0.513 . . . . 0.0 111.686 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.36 -41.2 98.41 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.245 0.475 . . . . 0.0 110.765 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 97.3 t -66.28 -45.92 88.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.45 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 11.1 m-85 -55.69 -50.88 69.11 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.86 177.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 53.8 mtp85 -62.58 -40.49 97.05 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 118.31 -0.853 . . . . 0.0 111.486 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 93.9 m -62.08 -52.37 64.2 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 118.57 0.623 . . . . 0.0 109.334 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.9 t -66.37 -45.59 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 118.128 -0.939 . . . . 0.0 110.324 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -40.91 88.78 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 120.054 1.297 . . . . 0.0 110.298 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.48 -50.12 69.93 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-O 118.479 -1.178 . . . . 0.0 110.942 175.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -60.41 -53.72 54.26 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 118.652 1.226 . . . . 0.0 110.631 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.6 t -47.01 -51.92 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 125.212 1.405 . . . . 0.0 109.965 175.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -62.12 -48.35 80.52 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.604 1.093 . . . . 0.0 110.803 -177.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.36 -43.74 75.37 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.295 1.038 . . . . 0.0 110.257 177.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 81.7 mtt-85 -72.12 -40.85 67.84 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 117.833 -1.079 . . . . 0.0 110.094 -175.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 71.4 t -55.05 -48.74 75.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 120.71 1.595 . . . . 0.0 109.057 169.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.33 -39.8 88.34 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.34 0.973 . . . . 0.0 110.698 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -63.13 -46.01 89.3 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.201 1.0 . . . . 0.0 110.326 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.9 -44.14 90.56 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 123.148 0.579 . . . . 0.0 110.085 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.9 mt -58.56 -36.62 60.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.161 0.984 . . . . 0.0 110.775 174.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.96 -30.73 71.8 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.91 1.232 . . . . 0.0 111.34 -174.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -65.94 -24.87 66.91 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.285 1.434 . . . . 0.0 113.422 177.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.0 pt -123.23 -20.08 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 -167.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.3 m . . . . . 0 C--O 1.248 1.026 0 C-N-CA 126.074 1.75 . . . . 0.0 111.05 173.232 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.9 ttm . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.871 0.367 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -102.63 140.73 36.53 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -90.64 135.63 33.59 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 121.494 -0.754 . . . . 0.0 109.013 170.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.4 p -115.37 140.37 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 123.659 0.784 . . . . 0.0 109.483 173.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 45.2 tpp -118.59 143.26 46.91 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 171.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -118.38 127.28 53.53 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 169.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 53.4 t -126.69 114.12 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 119.999 1.272 . . . . 0.0 108.871 -171.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.2 t -110.94 160.35 16.88 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.766 0.712 . . . . 0.0 111.071 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -59.13 -18.13 33.05 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 121.321 -0.862 . . . . 0.0 112.637 174.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.11 -2.39 2.07 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -174.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.489 ' ND2' ' H ' ' A' ' 63' ' ' ASP . 37.0 t-20 37.71 35.73 0.08 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.314 1.846 . . . . 0.0 115.211 -169.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.7 p -107.88 -35.08 6.74 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 120.523 -1.361 . . . . 0.0 112.306 -171.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 20.4 m -134.75 -68.36 0.54 Allowed 'General case' 0 C--N 1.342 0.27 0 CA-C-O 117.948 -1.025 . . . . 0.0 111.727 -169.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -56.13 -53.51 56.25 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.46 1.027 . . . . 0.0 110.262 -170.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.9 p -68.45 -43.06 77.89 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.675 1.19 . . . . 0.0 110.467 -174.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -59.94 -47.51 85.51 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.773 1.229 . . . . 0.0 110.626 -177.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 44.7 mtm -65.75 -44.98 84.28 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 119.272 -0.394 . . . . 0.0 110.77 175.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.89 -40.16 66.36 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.818 0.281 . . . . 0.0 110.945 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -63.6 -55.08 26.52 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 118.676 -0.678 . . . . 0.0 110.009 177.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -53.15 -40.17 59.07 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 119.077 -0.846 . . . . 0.0 111.974 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.429 ' CD1' ' HE3' ' A' ' 50' ' ' MET . 13.3 m-85 -66.29 -49.13 68.15 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 119.11 1.455 . . . . 0.0 108.525 176.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.58 -46.05 90.07 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 124.183 0.993 . . . . 0.0 112.942 -173.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.5 ptmt -68.54 -8.81 44.84 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 119.337 0.971 . . . . 0.0 113.173 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.1 m -94.48 -47.59 6.49 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 119.984 1.266 . . . . 0.0 110.72 169.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.1 mt -76.34 -42.66 44.15 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.885 1.674 . . . . 0.0 111.956 -169.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -119.27 -5.25 11.62 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-O 117.741 -1.588 . . . . 0.0 114.935 -169.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.33 109.58 0.45 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.833 1.816 . . . . 0.0 108.852 169.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.57 -29.93 2.73 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.988 1.28 . . . . 0.0 111.355 -169.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.05 -22.15 3.84 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.672 1.189 . . . . 0.0 111.741 170.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.1 pt -125.72 156.92 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -122.84 133.57 54.43 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 168.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -116.8 157.56 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -169.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 m -148.3 145.55 28.21 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 126.306 1.842 . . . . 0.0 107.678 168.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.7 p -115.85 141.21 48.4 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.492 1.517 . . . . 0.0 108.608 168.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.8 m -150.73 -177.68 6.13 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.059 1.744 . . . . 0.0 106.616 -171.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.13 168.87 39.46 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.114 -1.041 . . . . 0.0 112.953 173.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.0 mp -56.2 -36.45 68.43 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 125.305 1.238 . . . . 0.0 110.607 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -150.24 150.41 31.51 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 169.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 65.8 m -83.64 146.5 28.22 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.567 0.699 . . . . 0.0 112.223 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.4 m -144.12 158.1 43.92 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 128.444 2.697 . . . . 0.0 104.505 168.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.5 ptt-85 -57.52 146.2 30.78 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.403 1.001 . . . . 0.0 110.392 -175.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 p -62.91 133.91 28.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 169.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -78.48 145.15 67.12 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.295 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.44 -41.11 0.36 Allowed 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.44 1.426 . . . . 0.0 112.814 -169.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.448 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 38.6 m -63.09 -24.86 68.1 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.422 -1.424 . . . . 0.0 111.314 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.67 -40.59 53.97 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.882 0.873 . . . . 0.0 111.514 172.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 55.5 mt -56.42 -44.23 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 124.304 1.042 . . . . 0.0 108.248 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.01 -37.67 81.69 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 125.069 1.347 . . . . 0.0 110.29 -172.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.0 mmm -68.66 -41.92 78.66 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 123.088 1.423 . . . . 0.0 110.427 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.429 ' HE3' ' CD1' ' A' ' 21' ' ' PHE . 4.6 mtp -66.62 -34.3 77.57 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 120.689 -1.257 . . . . 0.0 109.948 175.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -61.3 -28.83 69.48 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.844 -0.598 . . . . 0.0 111.654 170.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -61.24 -40.85 95.57 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.23 0.923 . . . . 0.0 110.529 173.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.7 m -92.58 7.3 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 178.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.99 25.34 49.53 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.137 0.875 . . . . 0.0 112.6 170.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.416 HG23 ' H ' ' A' ' 56' ' ' ASP . 9.9 mt -123.84 -174.82 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 125.404 1.482 . . . . 0.0 107.159 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.416 ' H ' HG23 ' A' ' 55' ' ' ILE . 8.0 t70 -148.85 155.84 41.47 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.612 1.565 . . . . 0.0 109.349 -176.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.49 -15.44 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 124.148 0.979 . . . . 0.0 112.38 169.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.6 p -52.6 -30.82 33.28 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.544 1.065 . . . . 0.0 112.621 176.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.79 -7.48 86.13 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.729 1.157 . . . . 0.0 114.187 -177.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -123.65 173.7 7.93 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 119.3 1.55 . . . . 0.0 111.165 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.5 p -128.72 174.02 9.81 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.11 1.364 . . . . 0.0 110.749 -173.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.8 p -96.92 151.74 19.4 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.355 1.062 . . . . 0.0 110.1 172.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.489 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 3.5 t70 -150.11 148.79 25.65 Favored Pre-proline 0 C--O 1.239 0.543 0 C-N-CA 125.415 1.486 . . . . 0.0 109.258 -171.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -84.04 151.72 12.55 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.957 1.772 . . . . 0.0 110.898 -177.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.8 tt -54.86 -31.45 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 123.309 0.644 . . . . 0.0 111.271 171.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -50.78 -28.93 10.28 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.243 2.617 . . . . 0.0 112.274 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -83.98 -4.82 59.0 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.269 1.028 . . . . 0.0 112.917 -172.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -129.58 -176.84 4.03 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.643 1.111 . . . . 0.0 110.998 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.83 139.49 50.17 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 127.113 2.165 . . . . 0.0 107.427 173.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.62 -26.58 65.43 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.427 1.091 . . . . 0.0 111.791 -178.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -59.91 -24.54 64.41 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.105 0.962 . . . . 0.0 112.317 -171.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -89.85 -13.04 37.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.766 0.827 . . . . 0.0 111.08 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -94.2 133.05 38.12 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 125.307 1.443 . . . . 0.0 109.798 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -75.48 -42.47 52.91 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.3 p -132.75 137.24 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 123.02 0.528 . . . . 0.0 110.454 -169.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.3 m -129.51 104.61 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-O 123.5 1.619 . . . . 0.0 109.336 -171.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.7 mm -101.65 99.11 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 -177.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.8 t -73.19 155.77 39.26 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 168.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.08 53.49 0.57 Allowed 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 173.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 90.2 m -71.58 -36.75 70.98 Favored 'General case' 0 C--N 1.339 0.118 0 C-N-CA 123.835 0.854 . . . . 0.0 109.546 173.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.92 -61.67 0.49 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 124.999 1.285 . . . . 0.0 111.295 169.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 56.2 m -80.3 27.54 0.33 Allowed 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -169.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.61 14.78 65.4 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 125.026 1.298 . . . . 0.0 113.21 -175.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 78.8 t -70.08 110.77 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 175.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -79.0 156.82 28.26 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 169.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.4 mt -70.18 121.84 84.39 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -54.98 -40.84 83.84 Favored 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 122.044 1.829 . . . . 0.0 114.067 169.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -77.23 -176.97 3.49 Favored 'Trans proline' 0 C--N 1.356 0.933 0 CA-C-N 121.49 1.568 . . . . 0.0 113.504 -173.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -47.47 -17.5 0.09 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 129.28 3.032 . . . . 0.0 115.574 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -66.1 8.99 0.17 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 126.58 1.952 . . . . 0.0 113.396 171.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.9 p -119.95 1.43 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.836 1.255 . . . . 0.0 111.705 171.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.1 p -125.49 25.38 7.05 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.989 0.915 . . . . 0.0 112.156 -172.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -91.54 -172.75 3.34 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.464 0.705 . . . . 0.0 109.444 170.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -66.08 -33.98 77.02 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -169.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.6 mt -136.84 134.46 48.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -139.27 140.23 37.59 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.263 1.025 . . . . 0.0 108.61 173.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -148.91 160.54 43.17 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.372 1.469 . . . . 0.0 107.93 168.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -121.95 102.44 8.18 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.274 1.43 . . . . 0.0 108.743 168.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -77.91 98.62 5.7 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.131 0.972 . . . . 0.0 109.596 -176.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -69.25 104.39 2.2 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.799 1.239 . . . . 0.0 109.229 174.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -137.69 168.71 19.12 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 126.679 1.992 . . . . 0.0 108.033 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -67.53 162.4 23.42 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 166.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -117.1 105.32 49.3 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 171.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -54.7 -1.88 0.17 Allowed 'Trans proline' 0 CA--C 1.537 0.64 1 C-N-CA 125.882 4.388 . . . . 0.0 118.652 -169.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -50.67 91.64 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.365 1.866 . . . . 0.0 112.616 172.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.64 16.71 51.49 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 126.121 1.819 . . . . 0.0 113.244 171.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -94.38 -179.96 5.09 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.843 1.322 . . . . 0.0 112.075 -169.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.5 m -77.46 155.67 31.59 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.089 1.356 . . . . 0.0 109.937 175.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.3 mt -58.61 -32.08 68.68 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 122.032 -0.418 . . . . 0.0 111.546 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -61.96 -39.27 91.56 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.145 0.429 . . . . 0.0 110.731 176.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 89.1 t -67.65 -46.78 82.15 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.448 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 14.0 m-85 -54.04 -52.58 60.41 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.885 0.474 . . . . 0.0 110.898 176.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 28.9 mtt180 -59.29 -42.14 90.57 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.371 1.069 . . . . 0.0 111.621 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 95.4 m -60.86 -52.71 63.9 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 95.8 t -64.41 -42.88 96.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 118.803 -0.618 . . . . 0.0 110.094 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -55.26 -46.71 76.09 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.346 0.976 . . . . 0.0 109.738 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -69.38 -49.35 39.28 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-O 119.211 -0.772 . . . . 0.0 111.866 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -63.79 -45.09 91.28 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.657 1.228 . . . . 0.0 111.866 -174.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.4 t -64.07 -43.42 97.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 117.874 -1.06 . . . . 0.0 109.37 176.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -58.56 -46.37 87.02 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.472 1.487 . . . . 0.0 110.512 178.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.09 -44.13 78.73 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.587 1.155 . . . . 0.0 110.138 176.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.3 mtt85 -71.25 -39.64 71.5 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 117.953 -1.023 . . . . 0.0 111.042 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 88.4 t -54.94 -48.02 75.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 120.514 1.506 . . . . 0.0 109.784 169.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -60.08 -39.6 86.64 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.459 1.027 . . . . 0.0 110.614 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -62.28 -45.51 92.96 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.211 1.004 . . . . 0.0 110.485 178.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.38 -47.62 78.57 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 124.033 0.933 . . . . 0.0 110.06 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 63.7 mt -56.62 -38.37 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.394 1.078 . . . . 0.0 110.329 175.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.98 -28.87 69.32 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.72 1.145 . . . . 0.0 111.44 -174.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -75.16 -19.59 59.79 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.806 1.643 . . . . 0.0 112.731 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.4 pt -125.11 -20.56 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 125.707 1.603 . . . . 0.0 115.29 -168.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 C--O 1.251 1.137 0 C-N-CA 126.573 1.949 . . . . 0.0 110.935 172.311 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.7 ttm . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 120.791 0.329 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -112.96 141.13 47.15 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.15 0.98 . . . . 0.0 108.412 170.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -92.36 126.21 37.35 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 169.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.7 p -115.88 135.5 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 O-C-N 123.721 0.638 . . . . 0.0 110.962 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 55.1 tpp -107.5 153.05 23.41 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.237 1.015 . . . . 0.0 109.204 170.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -130.03 104.48 7.37 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.985 1.714 . . . . 0.0 106.686 169.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.97 127.28 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 120.057 1.298 . . . . 0.0 109.158 -176.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.2 t -116.17 163.11 16.45 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.791 1.178 . . . . 0.0 112.34 176.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -58.99 -21.81 59.49 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.584 -0.697 . . . . 0.0 111.654 171.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.4 ptm85 -153.48 116.07 4.45 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 169.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -48.8 -29.29 4.41 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.214 1.006 . . . . 0.0 113.166 -175.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.2 m -40.38 -34.33 0.33 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 119.235 3.05 . . . . 0.0 119.235 -169.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.7 p -135.63 -71.68 0.47 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 121.006 1.73 . . . . 0.0 113.942 -169.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -55.14 -50.92 68.05 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.21 0.914 . . . . 0.0 109.886 -169.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.413 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 0.1 OUTLIER -63.65 -48.49 77.0 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.992 2.117 . . . . 0.0 111.787 -179.233 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -63.34 -42.95 98.99 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.317 0.647 . . . . 0.0 110.785 -175.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 67.5 mtm -64.82 -46.23 82.83 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 119.05 -0.5 . . . . 0.0 111.036 174.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.86 -41.55 70.93 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 118.233 0.47 . . . . 0.0 110.805 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.63 -46.25 79.98 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 122.843 0.457 . . . . 0.0 111.054 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.39 -40.4 97.52 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -66.63 -52.14 48.41 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 118.506 1.153 . . . . 0.0 108.009 176.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.27 -42.98 78.32 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.824 1.25 . . . . 0.0 113.052 -174.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.3 pttt -68.56 -35.74 77.81 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-N 119.169 0.895 . . . . 0.0 110.265 175.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.6 m -68.1 -41.77 81.32 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 119.555 -1.966 . . . . 0.0 110.569 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.8 mt -73.23 -37.3 66.44 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.086 1.754 . . . . 0.0 111.202 -175.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -139.48 7.68 3.1 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 117.01 -1.995 . . . . 0.0 117.875 -169.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.01 114.34 1.71 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 121.317 2.558 . . . . 0.0 108.59 169.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 124.55 -23.02 6.43 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.525 1.059 . . . . 0.0 111.888 -174.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.96 -17.56 2.76 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.505 1.152 . . . . 0.0 112.135 177.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.9 pt -129.97 147.64 33.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 168.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -110.89 114.65 28.15 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 170.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 p -102.33 151.66 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-O 121.797 0.808 . . . . 0.0 111.723 -176.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.0 m -145.91 151.32 37.66 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 126.182 1.793 . . . . 0.0 106.195 167.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.413 ' HB2' ' HB2' ' A' ' 15' ' ' SER . 58.5 p -122.92 158.11 31.12 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 121.043 -1.036 . . . . 0.0 108.673 168.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.8 m -152.18 -173.66 4.62 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.491 1.516 . . . . 0.0 107.525 -174.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.89 162.59 31.35 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 169.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.2 mp -50.2 -36.87 32.51 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.656 1.183 . . . . 0.0 110.075 174.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -141.11 150.06 42.36 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 169.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.0 p -78.02 157.96 29.41 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.988 0.899 . . . . 0.0 110.694 173.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.2 m -164.86 157.86 16.71 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 128.126 2.57 . . . . 0.0 105.231 169.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -56.47 154.18 8.89 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.027 0.83 . . . . 0.0 111.322 -175.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.8 t -62.96 129.71 26.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 172.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -69.37 141.37 91.0 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -176.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.63 -40.42 2.07 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.182 1.255 . . . . 0.0 111.759 -169.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.494 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 6.2 m -67.95 -17.06 64.33 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.453 -1.404 . . . . 0.0 111.868 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.71 -40.28 83.24 Favored 'General case' 0 C--N 1.34 0.168 0 O-C-N 121.338 -0.851 . . . . 0.0 110.459 171.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.2 mt -57.26 -45.48 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.01 99.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.321 0.649 . . . . 0.0 111.791 -175.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 21.4 mmt -57.81 -47.37 82.8 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 122.85 1.31 . . . . 0.0 111.227 176.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 6.7 mtp -69.81 -31.86 69.99 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.376 -177.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.12 -31.82 70.42 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.47 0.708 . . . . 0.0 111.278 170.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -64.98 -35.11 80.12 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 118.669 0.668 . . . . 0.0 110.368 175.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.0 t -79.44 -25.87 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 119.906 -0.093 . . . . 0.0 110.908 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.14 28.81 6.67 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.718 1.151 . . . . 0.0 111.682 -174.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.7 mt -125.29 -178.81 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 125.942 1.697 . . . . 0.0 106.927 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -145.92 155.97 43.22 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.979 1.711 . . . . 0.0 108.883 -178.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.24 -15.61 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.108 0.963 . . . . 0.0 113.331 172.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.4 p -50.39 -32.03 16.45 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.647 1.179 . . . . 0.0 113.615 -174.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.46 -15.82 36.53 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 117.852 -1.526 . . . . 0.0 114.425 -172.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -85.8 -25.63 26.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.262 2.031 . . . . 0.0 114.507 -171.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 38.1 p 68.02 168.65 0.26 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.604 1.961 . . . . 0.0 114.116 170.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.8 m -85.14 166.7 16.39 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.718 -171.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.98 139.34 12.59 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 124.137 0.975 . . . . 0.0 109.041 174.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.45 153.58 13.84 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.067 2.512 . . . . 0.0 110.632 169.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.1 tt -53.62 -34.85 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 123.725 0.81 . . . . 0.0 111.355 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -58.82 -22.81 59.43 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.757 1.623 . . . . 0.0 112.528 -176.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -80.42 -5.13 56.04 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.198 0.599 . . . . 0.0 112.541 -177.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -133.41 -176.24 4.08 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.487 1.039 . . . . 0.0 111.336 -176.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -139.68 131.93 28.25 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 126.889 2.076 . . . . 0.0 108.209 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.84 -28.48 67.52 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.475 1.11 . . . . 0.0 112.856 -175.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -60.26 -24.17 64.69 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.849 0.86 . . . . 0.0 112.334 -176.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -83.62 -15.87 47.35 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.247 0.619 . . . . 0.0 110.618 -177.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -102.44 127.06 49.64 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 125.465 1.506 . . . . 0.0 108.701 -175.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -85.4 -25.84 26.78 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.342 0.592 . . . . 0.0 109.688 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.0 t -131.0 135.81 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 -173.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.3 p -135.34 102.71 3.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 123.198 1.475 . . . . 0.0 110.137 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.5 mm -84.7 144.59 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 104.799 -2.296 . . . . 0.0 104.799 168.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.4 m -132.72 158.23 42.89 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 168.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.83 63.57 0.99 Allowed 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 102.515 -3.142 . . . . 0.0 102.515 -171.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 76.2 m -83.48 -39.0 21.08 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -177.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.01 169.81 45.52 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -175.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 95.4 m 38.85 32.86 0.06 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.401 2.28 . . . . 0.0 114.834 -175.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 56.28 24.1 43.53 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.68 1.609 . . . . 0.0 114.637 -176.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.1 t -64.8 151.33 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 169.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -138.49 -171.21 3.0 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.75 1.22 . . . . 0.0 110.071 -171.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 mp -131.15 105.54 14.93 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -169.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -49.92 -41.73 46.86 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 122.868 2.379 . . . . 0.0 115.483 170.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.34 -178.31 3.87 Favored 'Trans proline' 0 C--N 1.356 0.935 0 CA-C-N 121.794 1.677 . . . . 0.0 113.893 -175.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -59.77 -7.34 1.56 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.318 2.247 . . . . 0.0 114.116 -171.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -64.96 10.42 0.07 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.278 1.831 . . . . 0.0 112.496 169.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.1 p -126.12 5.13 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 125.039 1.336 . . . . 0.0 112.03 172.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.6 p -129.41 25.7 5.43 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.895 -1.128 . . . . 0.0 112.89 -170.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -94.31 -177.09 4.16 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.403 0.681 . . . . 0.0 109.682 173.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -57.36 -35.26 69.72 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.372 1.069 . . . . 0.0 112.994 -174.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.8 mt -135.84 138.39 47.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -139.25 137.0 35.54 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 169.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -146.36 151.86 38.17 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.132 1.373 . . . . 0.0 108.21 169.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -115.73 126.67 54.37 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.798 1.239 . . . . 0.0 109.624 169.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 40.0 m0 -107.09 91.61 3.73 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.412 1.485 . . . . 0.0 108.124 -173.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -69.9 103.69 2.29 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.951 1.3 . . . . 0.0 109.28 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -136.57 161.5 35.72 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.675 1.59 . . . . 0.0 110.517 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -81.65 66.74 7.34 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.02 1.728 . . . . 0.0 111.283 -178.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -9.99 91.93 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 129.731 3.212 . . . . 0.0 112.318 169.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -57.43 -8.36 3.8 Favored 'Trans proline' 0 N--CA 1.459 -0.553 1 C-N-CA 125.409 4.073 . . . . 0.0 117.946 -169.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -57.43 95.14 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 120.32 1.418 . . . . 0.0 111.832 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 98.63 13.86 39.55 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 126.428 1.966 . . . . 0.0 113.241 172.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -93.31 177.99 5.86 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.039 1.42 . . . . 0.0 112.575 -169.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.8 m -74.6 154.72 38.43 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.407 1.483 . . . . 0.0 109.931 175.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.1 mt -60.07 -30.31 69.13 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.737 -0.602 . . . . 0.0 111.784 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -62.68 -39.87 95.32 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.106 0.412 . . . . 0.0 110.877 174.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.4 t -67.15 -45.2 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.057 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.494 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 16.2 m-85 -54.66 -52.98 60.63 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.322 0.51 . . . . 0.0 110.829 175.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 75.2 mtp85 -59.11 -42.07 89.67 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 118.434 -0.793 . . . . 0.0 111.956 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 91.1 m -62.16 -53.26 57.8 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 119.038 0.836 . . . . 0.0 109.059 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.2 t -62.36 -42.86 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-O 117.802 -1.094 . . . . 0.0 110.183 -178.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.3 ttp85 -53.41 -52.76 58.33 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 119.813 1.188 . . . . 0.0 108.88 176.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.31 -46.02 91.86 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -172.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -62.74 -49.65 74.19 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.918 0.887 . . . . 0.0 111.054 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.8 t -62.05 -48.15 89.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 125.731 1.612 . . . . 0.0 110.42 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -58.84 -47.35 85.17 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 120.625 1.557 . . . . 0.0 110.424 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -53.64 -46.59 70.6 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 123.792 0.837 . . . . 0.0 109.446 174.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 61.7 mtt85 -69.1 -38.22 78.84 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 117.604 -1.189 . . . . 0.0 110.946 -174.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.6 t -55.49 -49.64 71.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 120.803 1.638 . . . . 0.0 109.626 169.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -61.12 -39.94 91.9 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.519 1.054 . . . . 0.0 110.689 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -61.81 -46.38 89.75 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.486 1.514 . . . . 0.0 109.922 178.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.1 -52.71 62.79 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.477 1.111 . . . . 0.0 109.387 178.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 72.7 mt -52.14 -40.29 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 123.934 0.894 . . . . 0.0 109.67 177.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.19 -30.84 71.35 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.65 1.113 . . . . 0.0 111.622 -174.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 51.9 mttt -70.52 -37.23 74.09 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.985 1.314 . . . . 0.0 111.493 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.0 pt -99.99 -25.59 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -169.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 64.5 m . . . . . 0 C--O 1.248 1.005 0 C-N-CA 126.165 1.786 . . . . 0.0 111.249 179.612 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.0 ttm . . . . . 0 N--CA 1.484 1.255 0 CA-C-O 120.655 0.264 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt -121.51 143.5 49.24 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.579 1.151 . . . . 0.0 108.213 175.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -103.52 125.18 49.92 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -176.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.4 t -108.47 138.6 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 124.415 1.086 . . . . 0.0 108.16 -172.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 32.1 tpp -125.99 140.45 52.6 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.858 1.263 . . . . 0.0 108.803 178.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -122.22 132.98 54.71 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 118.098 -0.953 . . . . 0.0 108.538 170.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.8 t -134.04 116.52 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 121.041 1.746 . . . . 0.0 109.926 -171.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.9 t -115.71 163.08 16.34 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.653 1.115 . . . . 0.0 111.093 -177.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -55.54 -22.54 22.09 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.294 1.438 . . . . 0.0 112.67 172.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -135.21 -1.81 2.58 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 62.32 -52.85 0.15 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 127.589 2.356 . . . . 0.0 113.99 -168.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.9 m -41.43 -19.05 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 120.97 3.693 . . . . 0.0 120.97 -169.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.2 p -131.0 -80.6 0.53 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 120.152 1.342 . . . . 0.0 111.085 -169.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -55.12 -50.91 68.02 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.612 0.765 . . . . 0.0 109.002 -170.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.02 -40.99 74.87 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.221 0.608 . . . . 0.0 111.96 -173.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.8 mm100 -69.39 -40.28 77.47 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.579 -0.701 . . . . 0.0 110.678 -170.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 63.1 mtm -62.47 -44.83 95.45 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 119.58 -0.248 . . . . 0.0 110.393 171.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.37 -37.45 70.09 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 119.361 -0.352 . . . . 0.0 111.152 177.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -62.15 -52.15 65.0 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.172 0.589 . . . . 0.0 109.956 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.01 -41.04 99.65 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.341 -0.699 . . . . 0.0 111.503 -177.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.427 ' CD1' ' HE2' ' A' ' 50' ' ' MET . 25.0 m-85 -66.87 -51.3 57.09 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 118.733 1.266 . . . . 0.0 107.947 177.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.93 -42.77 80.63 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 124.2 1.0 . . . . 0.0 112.666 -174.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -68.41 -35.51 77.74 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 119.771 1.169 . . . . 0.0 110.962 175.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.5 m -67.06 -43.16 83.36 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 120.738 1.608 . . . . 0.0 110.404 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.5 mt -74.57 -36.83 63.06 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.051 1.34 . . . . 0.0 111.209 -173.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -131.69 -3.04 4.24 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 116.621 -2.211 . . . . 0.0 118.009 -169.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.79 109.25 0.6 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 121.901 2.85 . . . . 0.0 109.047 171.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.6 -29.32 2.78 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.813 1.197 . . . . 0.0 111.758 -170.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -133.45 -13.32 2.66 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.391 1.077 . . . . 0.0 112.824 171.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.5 pt -129.5 157.24 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 168.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -121.05 133.62 55.25 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 169.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.14 149.84 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-O 121.331 0.586 . . . . 0.0 111.986 -173.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.8 m -142.35 150.82 41.24 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 167.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.4 m -124.75 153.17 42.82 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.951 0.9 . . . . 0.0 109.858 169.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 32.8 m -150.4 -171.46 3.92 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 126.482 1.913 . . . . 0.0 107.463 -170.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.05 169.1 39.52 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 169.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 67.7 mt -53.94 -35.87 62.2 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 124.63 0.841 . . . . 0.0 110.777 178.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -149.69 150.31 31.92 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 169.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.0 p -86.58 165.92 15.81 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 122.081 0.943 . . . . 0.0 111.85 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.1 m -161.68 172.38 16.35 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 128.796 2.838 . . . . 0.0 105.469 169.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.71 151.57 29.0 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.5 -1.375 . . . . 0.0 109.671 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.1 t -57.6 132.91 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 171.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 37.5 t60 -67.92 139.8 93.43 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-O 118.772 -0.632 . . . . 0.0 109.392 177.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.6 -42.29 0.36 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.207 1.938 . . . . 0.0 113.456 -171.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.451 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 5.6 m -62.61 -18.6 62.53 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 119.701 -1.874 . . . . 0.0 112.452 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.7 -38.95 73.01 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.01 0.924 . . . . 0.0 110.291 171.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 62.5 mt -56.49 -48.3 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.04 -40.4 93.47 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 123.972 0.909 . . . . 0.0 111.484 -174.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.5 mmt -59.72 -47.95 83.64 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 122.656 1.217 . . . . 0.0 111.358 176.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.427 ' HE2' ' CD1' ' A' ' 21' ' ' PHE . 8.2 mtp -68.31 -34.72 76.64 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.207 -178.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -61.81 -29.22 70.01 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.243 0.617 . . . . 0.0 111.657 171.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -65.31 -35.84 82.25 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.196 0.907 . . . . 0.0 110.489 173.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 t -78.61 -25.96 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 117.64 0.2 . . . . 0.0 111.0 175.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.25 28.05 7.0 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.522 1.058 . . . . 0.0 111.702 -174.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.8 mt -121.88 -177.71 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 125.94 1.696 . . . . 0.0 106.731 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -146.9 157.67 43.71 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.37 1.468 . . . . 0.0 109.383 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.45 -17.13 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.993 0.917 . . . . 0.0 112.314 169.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -45.0 -38.05 4.48 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.834 1.254 . . . . 0.0 112.783 173.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.86 -5.09 88.71 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.735 1.16 . . . . 0.0 113.972 -173.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -128.27 171.68 11.76 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.324 1.45 . . . . 0.0 110.82 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.3 p -123.86 164.59 18.93 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 122.016 0.913 . . . . 0.0 111.279 -171.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.3 p -74.47 168.25 20.09 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.983 1.713 . . . . 0.0 110.887 173.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -154.45 144.29 15.47 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.524 0.73 . . . . 0.0 109.744 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -86.27 153.11 9.39 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.063 2.508 . . . . 0.0 110.27 169.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.9 tt -54.09 -33.21 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.542 0.737 . . . . 0.0 111.469 173.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -58.28 -24.37 59.25 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.675 1.59 . . . . 0.0 112.552 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -80.11 -6.45 57.72 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -175.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -130.59 -176.51 4.0 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.377 0.99 . . . . 0.0 111.515 -175.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.67 134.17 38.91 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 126.8 2.04 . . . . 0.0 108.348 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.86 -30.87 70.38 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.842 1.257 . . . . 0.0 112.788 -176.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -60.89 -21.78 63.66 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.151 0.98 . . . . 0.0 112.286 -173.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -83.0 -19.47 36.94 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.521 0.729 . . . . 0.0 110.595 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -104.72 124.94 50.28 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.356 1.062 . . . . 0.0 110.282 -169.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -72.86 -38.45 67.04 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 175.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.0 p -132.26 131.67 60.81 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -170.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.2 t -124.41 109.29 22.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 123.219 1.485 . . . . 0.0 108.699 -176.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.2 mm -99.44 94.3 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 177.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.4 m -70.68 157.76 37.42 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 117.351 -1.74 . . . . 0.0 106.461 167.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.81 50.66 0.68 Allowed 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 103.742 -2.688 . . . . 0.0 103.742 176.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 64.9 m -72.21 -32.72 67.02 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 169.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 83' ' ' GLY . . . 82.58 -42.94 2.98 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 125.664 1.602 . . . . 0.0 114.24 168.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 34.8 m -74.57 23.74 0.09 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.523 1.162 . . . . 0.0 112.905 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 81' ' ' GLY . . . 59.94 17.36 43.4 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.686 2.089 . . . . 0.0 113.515 -170.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.3 t -69.68 152.72 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 169.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -141.51 178.87 7.15 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.931 1.292 . . . . 0.0 108.662 -173.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.7 mt -110.11 109.63 58.84 Favored Pre-proline 0 N--CA 1.453 -0.309 0 C-N-CA 124.981 1.313 . . . . 0.0 107.811 -170.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.69 -42.09 58.39 Favored 'Trans proline' 0 CA--C 1.546 1.094 0 C-N-CA 122.353 2.035 . . . . 0.0 114.844 169.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.58 179.25 6.12 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 121.796 1.664 . . . . 0.0 113.824 -175.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -56.41 -13.0 1.92 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 127.714 2.406 . . . . 0.0 113.799 -172.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -55.8 -26.74 47.72 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 121.002 -1.061 . . . . 0.0 112.035 172.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.6 p -84.12 -16.33 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 119.579 1.081 . . . . 0.0 110.337 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.7 p -105.12 16.39 25.9 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.683 0.793 . . . . 0.0 112.477 -169.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -79.13 173.91 12.1 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.608 0.763 . . . . 0.0 109.241 170.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.6 mp0 -58.96 -33.77 71.01 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.343 1.057 . . . . 0.0 113.41 -169.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.2 mt -134.92 136.72 51.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -177.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -143.15 138.76 30.01 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.501 1.12 . . . . 0.0 108.833 175.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -147.23 162.27 39.26 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.367 1.467 . . . . 0.0 107.986 168.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -122.61 97.5 5.48 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.78 1.632 . . . . 0.0 108.805 169.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -74.05 97.81 2.95 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.778 0.831 . . . . 0.0 109.619 -178.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -63.05 119.16 8.96 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 169.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 47.6 mt -151.72 151.48 31.48 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.865 1.666 . . . . 0.0 107.581 -169.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -84.08 73.54 10.38 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.153 0.981 . . . . 0.0 111.002 -176.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -19.36 97.39 0.05 OUTLIER Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 128.765 2.826 . . . . 0.0 111.427 177.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -63.7 -7.43 12.84 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.965 2.443 . . . . 0.0 116.708 -169.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -61.62 90.86 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 120.849 1.658 . . . . 0.0 113.501 -172.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.61 12.48 28.35 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.955 1.741 . . . . 0.0 113.387 175.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -91.34 -179.64 5.45 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.035 1.417 . . . . 0.0 112.128 -171.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.6 m -76.14 155.44 34.63 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.43 1.492 . . . . 0.0 109.973 174.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.6 -31.62 68.22 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.793 -0.567 . . . . 0.0 111.748 -178.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.62 -34.61 76.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 118.418 0.554 . . . . 0.0 111.169 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 95.3 t -66.25 -45.78 89.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 172.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.451 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 18.8 m-85 -56.83 -49.46 75.33 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 119.066 -0.493 . . . . 0.0 110.489 175.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -57.84 -43.38 85.81 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.591 1.157 . . . . 0.0 111.799 176.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.7 m -61.03 -49.49 77.18 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 118.875 0.761 . . . . 0.0 109.406 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.57 -44.66 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 117.742 -1.123 . . . . 0.0 110.377 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 44.3 ttp85 -52.81 -47.11 67.88 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 119.984 1.266 . . . . 0.0 109.137 175.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.89 -49.79 65.45 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-O 118.341 -1.255 . . . . 0.0 110.398 -176.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -59.81 -56.5 21.02 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 118.36 1.08 . . . . 0.0 110.269 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 80.3 t -49.46 -53.28 9.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 125.285 1.434 . . . . 0.0 109.897 177.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -60.82 -46.9 88.73 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 121.049 1.75 . . . . 0.0 110.463 -175.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.15 -44.8 88.06 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.996 0.519 . . . . 0.0 110.269 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -69.08 -40.97 78.14 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.152 -0.927 . . . . 0.0 110.175 -176.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 70.5 t -55.08 -49.05 74.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 120.446 1.476 . . . . 0.0 109.604 169.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -60.35 -39.0 85.57 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.389 0.995 . . . . 0.0 110.45 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -63.54 -45.85 88.68 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.318 1.047 . . . . 0.0 110.427 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.57 -47.12 79.91 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 123.963 0.905 . . . . 0.0 109.779 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.1 mt -53.88 -42.69 54.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 124.715 1.206 . . . . 0.0 109.968 174.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.15 -28.45 67.93 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.399 1.0 . . . . 0.0 111.67 -171.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -73.29 -20.44 60.82 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.91 1.684 . . . . 0.0 112.465 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.3 pt -124.64 -22.29 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 -168.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.9 m . . . . . 0 C--O 1.251 1.174 0 C-N-CA 125.591 1.557 . . . . 0.0 111.283 170.528 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt . . . . . 0 N--CA 1.465 0.312 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.7 mttt -100.28 123.14 44.14 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.436 ' HA ' HG13 ' A' ' 75' ' ' VAL . 14.8 p -102.93 144.74 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 122.058 0.932 . . . . 0.0 110.51 177.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 29.6 tpp -124.24 142.69 51.04 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 125.042 1.337 . . . . 0.0 108.629 176.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -124.22 124.34 42.23 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 171.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.7 t -127.61 121.6 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 120.483 1.492 . . . . 0.0 109.073 -172.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.8 t -118.64 165.75 13.59 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.954 0.797 . . . . 0.0 109.687 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -56.32 -20.99 21.42 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.977 0.911 . . . . 0.0 112.455 170.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -139.51 -2.74 1.56 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 60.27 -47.15 0.1 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 128.53 2.732 . . . . 0.0 115.499 -169.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.7 p -43.96 -25.61 0.22 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 119.707 3.225 . . . . 0.0 119.707 -168.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 45.2 m -126.91 -72.47 0.64 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.909 0.777 . . . . 0.0 109.818 -169.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -63.98 -49.56 72.0 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -169.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.16 -42.08 72.97 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 117.76 0.254 . . . . 0.0 111.11 -177.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -60.09 -45.51 92.7 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.007 0.523 . . . . 0.0 111.166 -175.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.42 ' HG2' HD11 ' A' ' 57' ' ' ILE . 46.9 mtm -64.16 -44.35 92.38 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 121.235 -0.186 . . . . 0.0 110.853 175.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.16 -37.76 75.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 119.363 -0.351 . . . . 0.0 111.116 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -65.5 -45.06 85.08 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.946 0.339 . . . . 0.0 110.52 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.84 -44.14 97.33 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -67.03 -50.56 61.64 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 118.629 1.214 . . . . 0.0 109.412 176.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.36 -42.55 82.29 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 119.477 1.035 . . . . 0.0 112.432 -173.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -69.65 -36.88 76.46 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.46 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.9 m -66.79 -43.1 84.84 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 119.65 -1.906 . . . . 0.0 110.571 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.5 mt -73.02 -39.37 66.05 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.539 1.536 . . . . 0.0 110.79 -174.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.874 0 CA-C-O 116.747 -2.14 . . . . 0.0 118.296 -169.509 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.6 pt . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -120.16 130.5 54.62 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 170.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 p -113.08 151.24 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 124.169 0.988 . . . . 0.0 111.381 -176.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.7 m -147.81 135.9 21.28 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 167.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.3 p -102.45 156.63 17.47 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 121.083 -1.011 . . . . 0.0 108.335 169.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.4 m -148.53 -175.3 4.87 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 125.848 1.659 . . . . 0.0 106.759 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.93 154.7 25.85 Favored Glycine 0 CA--C 1.497 -1.051 0 N-CA-C 108.301 -1.919 . . . . 0.0 108.301 169.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 68.7 tp -49.03 -34.41 13.27 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.877 1.271 . . . . 0.0 109.74 169.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -146.47 148.38 32.18 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 168.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 p -83.03 162.84 21.29 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.81 0.844 . . . . 0.0 111.548 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 69.3 m -160.03 160.28 33.06 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.392 2.277 . . . . 0.0 106.551 169.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.88 138.14 30.51 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 117.813 -1.089 . . . . 0.0 110.386 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.6 p -57.76 130.09 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 120.083 1.311 . . . . 0.0 107.846 170.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -74.29 142.76 78.94 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.083 -169.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.51 -42.29 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.341 1.361 . . . . 0.0 112.25 -169.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.455 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 26.3 m -62.77 -24.95 67.98 Favored 'General case' 0 CA--C 1.535 0.365 0 O-C-N 120.484 -1.385 . . . . 0.0 111.414 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.69 -40.2 59.68 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.462 0.705 . . . . 0.0 111.536 173.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.1 mt -55.68 -46.08 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.38 -38.83 91.18 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 124.439 1.096 . . . . 0.0 110.144 -171.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 8.7 mmm -68.64 -44.01 75.08 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 122.791 1.281 . . . . 0.0 110.557 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 9.7 mtp -65.64 -35.48 80.93 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.327 -0.858 . . . . 0.0 109.867 175.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -62.72 -26.53 68.73 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.657 0.662 . . . . 0.0 111.501 173.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -65.7 -39.87 91.68 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.823 0.738 . . . . 0.0 109.876 173.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 88.7 t -76.67 -25.37 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.617 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.45 25.86 5.61 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.034 1.302 . . . . 0.0 111.718 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.503 HG22 ' H ' ' A' ' 56' ' ' ASP . 12.9 mt -122.89 178.79 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 C-N-CA 125.255 1.422 . . . . 0.0 107.378 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.503 ' H ' HG22 ' A' ' 55' ' ' ILE . 13.3 t70 -143.1 156.1 44.74 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.315 1.446 . . . . 0.0 109.276 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.42 HD11 ' HG2' ' A' ' 17' ' ' MET . 0.4 OUTLIER -128.08 -15.6 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 123.881 0.872 . . . . 0.0 112.351 169.937 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -45.75 -38.09 6.65 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.687 1.195 . . . . 0.0 112.859 172.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.77 -6.59 85.37 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.557 1.075 . . . . 0.0 114.217 -173.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -125.15 169.59 12.05 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 119.01 1.405 . . . . 0.0 111.036 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.3 p -127.05 169.91 12.88 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.75 1.22 . . . . 0.0 110.819 -172.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.7 p -92.69 160.15 15.11 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.576 1.15 . . . . 0.0 111.284 178.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -154.81 138.7 11.14 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 118.364 -0.827 . . . . 0.0 109.474 -169.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -80.94 152.88 19.15 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.663 2.242 . . . . 0.0 111.703 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.0 tt -52.43 -34.86 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.763 1.225 . . . . 0.0 111.552 173.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -57.78 -23.64 53.26 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.128 1.771 . . . . 0.0 112.371 -175.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -83.37 -6.71 59.55 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.856 0.863 . . . . 0.0 112.79 -175.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -128.57 -176.89 3.97 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.465 1.029 . . . . 0.0 111.269 -176.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.56 132.53 37.31 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 126.672 1.989 . . . . 0.0 108.344 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.32 -30.01 69.24 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.732 1.213 . . . . 0.0 112.702 -176.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -61.29 -21.21 63.73 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.08 0.952 . . . . 0.0 112.496 -174.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -85.86 -15.26 42.4 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.3 0.64 . . . . 0.0 110.778 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -107.8 121.97 45.83 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 124.775 1.23 . . . . 0.0 109.309 -172.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -71.83 -38.33 70.17 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.312 0.245 . . . . 0.0 111.039 177.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.436 HG13 ' HA ' ' A' ' 4' ' ' VAL . 1.1 p -131.5 133.17 62.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -170.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.7 t -124.23 123.13 65.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 122.526 1.155 . . . . 0.0 108.404 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 35.5 mm -113.41 97.09 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.5 m -72.65 156.51 38.89 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 168.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.05 54.72 0.65 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 176.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.8 m . . . . . 0 CA--C 1.53 0.194 0 C-N-CA 124.193 0.997 . . . . 0.0 109.796 176.546 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 . . . . . 0 N--CA 1.466 0.332 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -57.51 -24.9 58.59 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 121.17 -0.956 . . . . 0.0 111.994 174.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.1 p -87.3 -9.97 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 119.65 1.114 . . . . 0.0 110.541 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 49.5 p -113.44 19.88 16.54 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.916 0.886 . . . . 0.0 112.549 -169.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -81.67 175.72 10.23 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.609 0.764 . . . . 0.0 109.663 171.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -57.77 -32.67 67.72 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.905 1.282 . . . . 0.0 113.588 -169.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.0 mt -135.17 139.08 47.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -141.93 137.83 31.57 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 124.276 1.03 . . . . 0.0 108.506 172.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -146.68 158.75 43.97 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.802 1.641 . . . . 0.0 107.421 168.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -121.92 101.4 7.54 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.015 1.326 . . . . 0.0 108.045 168.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.463 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 43.5 m0 -75.44 95.83 3.34 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.539 1.136 . . . . 0.0 108.955 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -59.91 118.55 6.36 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 169.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 38.3 mt -153.43 146.24 24.36 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.846 1.658 . . . . 0.0 107.204 -169.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -83.77 72.8 10.34 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.25 1.42 . . . . 0.0 110.946 -173.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -23.55 100.93 0.08 OUTLIER Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 128.007 2.523 . . . . 0.0 113.075 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.456 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 68.4 Cg_exo -60.97 -2.65 2.32 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 124.236 3.29 . . . . 0.0 116.925 -172.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -52.28 100.49 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.239 1.381 . . . . 0.0 112.157 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.75 20.47 59.69 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.341 1.924 . . . . 0.0 113.561 171.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.456 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 21.2 mm-40 -96.95 179.23 5.01 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.752 1.276 . . . . 0.0 113.052 -169.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.1 m -76.44 154.93 34.33 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.497 1.519 . . . . 0.0 109.877 175.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.8 mt -58.63 -31.77 68.42 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 122.053 -0.404 . . . . 0.0 111.461 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -63.39 -41.08 98.76 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.075 0.398 . . . . 0.0 110.889 177.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 88.9 t -65.63 -46.75 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.455 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 8.0 m-85 -54.59 -53.83 49.38 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.344 0.658 . . . . 0.0 110.732 176.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 31.2 mtt180 -59.75 -41.99 92.21 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 123.947 0.899 . . . . 0.0 111.463 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 93.9 m -61.46 -54.41 43.76 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.2 t -62.97 -43.21 98.91 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 CA-C-O 118.799 -0.62 . . . . 0.0 110.648 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -57.73 -43.81 85.58 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 119.328 0.967 . . . . 0.0 110.139 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.29 -50.2 61.36 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.015 -0.88 . . . . 0.0 111.166 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -58.02 -51.43 69.68 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.243 1.022 . . . . 0.0 110.912 -176.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.6 t -50.83 -55.89 5.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 126.841 2.057 . . . . 0.0 109.934 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -59.34 -46.91 87.31 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 119.405 1.002 . . . . 0.0 110.185 -173.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.07 -42.06 79.95 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.318 1.047 . . . . 0.0 110.547 177.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.463 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 45.4 mtt85 -72.23 -40.97 67.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 117.684 -1.15 . . . . 0.0 110.888 -177.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.413 ' HA ' HD23 ' A' ' 126' ' ' LEU . 99.2 t -54.5 -46.15 71.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 120.653 1.569 . . . . 0.0 109.763 169.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -62.21 -40.9 97.63 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.222 0.919 . . . . 0.0 110.861 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -62.61 -44.24 96.81 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 122.911 0.485 . . . . 0.0 110.542 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 123' ' ' VAL . 0.2 OUTLIER -64.32 -47.59 78.82 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 118.293 -0.86 . . . . 0.0 109.768 -178.111 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 67.3 mt -54.31 -41.46 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.787 0.835 . . . . 0.0 109.452 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.66 -31.53 72.42 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.84 1.2 . . . . 0.0 111.543 -173.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -66.15 -45.91 79.32 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.413 1.085 . . . . 0.0 110.814 176.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.2 pt -89.19 -27.03 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.813 1.245 . . . . 0.0 114.299 -169.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 63.4 m . . . . . 0 C--O 1.248 1.0 0 C-N-CA 125.882 1.673 . . . . 0.0 111.17 -179.231 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.7 mttm . . . . . 0 C--O 1.23 0.061 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.507 ' HE2' ' CE1' ' A' ' 73' ' ' TYR . 32.5 mtpt -96.15 129.14 43.53 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 118.508 -0.758 . . . . 0.0 109.593 175.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.6 p -105.31 140.26 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 118.673 0.67 . . . . 0.0 109.456 171.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.7 tpp -115.58 141.78 47.61 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 169.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -117.62 135.67 53.83 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 169.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -138.28 118.42 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 120.38 1.446 . . . . 0.0 109.382 -170.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.0 t -115.12 163.68 15.28 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.367 0.985 . . . . 0.0 109.723 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -61.45 -21.37 64.08 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 118.129 -0.939 . . . . 0.0 112.821 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -131.77 -0.97 3.83 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 62.32 -48.48 0.17 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 127.595 2.358 . . . . 0.0 115.105 -169.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.7 m -31.11 -40.59 0.03 OUTLIER 'General case' 0 C--O 1.235 0.313 0 N-CA-C 119.542 3.164 . . . . 0.0 119.542 -168.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.7 m -127.45 -63.86 1.02 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.66 1.118 . . . . 0.0 111.405 -169.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -58.13 -50.73 72.49 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.254 0.933 . . . . 0.0 109.787 -171.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 m -69.07 -41.17 77.91 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 117.85 0.296 . . . . 0.0 110.854 -174.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -70.3 -41.27 73.57 Favored 'General case' 0 N--CA 1.463 0.175 0 O-C-N 121.599 -0.688 . . . . 0.0 110.881 -169.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 66.2 mtm -62.06 -41.85 98.58 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 118.082 0.401 . . . . 0.0 110.893 171.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.34 -33.65 69.77 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 118.931 -0.557 . . . . 0.0 110.951 175.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.414 ' HA ' HG21 ' A' ' 32' ' ' VAL . 6.8 tt0 -59.21 -65.06 0.73 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.77 -39.5 77.06 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.015 -0.881 . . . . 0.0 112.549 -175.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -67.18 -45.01 78.23 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 119.274 1.537 . . . . 0.0 109.579 177.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.55 -43.6 93.43 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 120.372 1.442 . . . . 0.0 112.555 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.4 ptmt -69.18 -9.73 54.33 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.941 1.246 . . . . 0.0 113.1 175.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.4 m -92.81 -49.3 6.13 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 119.97 1.259 . . . . 0.0 110.618 170.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.4 mt -79.07 -39.91 32.61 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.352 1.461 . . . . 0.0 112.318 -169.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.343 0 CA-C-O 117.935 -1.481 . . . . 0.0 114.428 -169.058 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.3 pt . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 121.246 0.545 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -128.18 138.5 52.51 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 168.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.414 HG21 ' HA ' ' A' ' 19' ' ' GLU . 2.5 p -113.13 152.17 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-O 122.26 1.029 . . . . 0.0 113.412 -169.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.4 m -139.72 147.63 41.17 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 127.315 2.246 . . . . 0.0 105.123 167.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.3 m -132.21 146.71 52.2 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.831 1.252 . . . . 0.0 108.568 169.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 23.9 p -156.36 -161.79 1.17 Allowed 'General case' 0 C--O 1.242 0.666 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -176.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -151.66 156.96 26.97 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 169.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.3 tp -46.52 -36.87 7.19 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.979 1.712 . . . . 0.0 109.391 169.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -147.03 148.26 31.5 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 102.205 -3.257 . . . . 0.0 102.205 167.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.6 m -125.04 144.16 50.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.199 0.523 . . . . 0.0 112.284 -173.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.0 m -137.64 164.59 28.42 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.403 2.281 . . . . 0.0 107.551 173.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.93 145.62 1.44 Allowed 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.149 1.38 . . . . 0.0 113.232 -169.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.9 p -61.05 132.07 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 169.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.401 ' CE1' ' H ' ' A' ' 106' ' ' GLY . 14.7 t-80 -76.72 145.96 75.66 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.692 -172.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.17 -40.72 0.78 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 121.393 1.396 . . . . 0.0 112.534 -169.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.534 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 24.0 m -66.12 -17.07 64.48 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 120.044 -1.66 . . . . 0.0 111.864 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.68 -40.74 76.11 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 123.984 0.914 . . . . 0.0 110.836 170.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.0 mt -55.14 -52.19 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.18 -38.93 81.01 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 123.741 0.65 . . . . 0.0 111.917 -173.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.6 mmt -59.42 -49.84 76.26 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 122.403 1.097 . . . . 0.0 111.697 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.4 mtp -67.33 -36.15 80.86 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.164 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -61.75 -30.17 70.61 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.315 1.046 . . . . 0.0 111.295 174.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -64.13 -40.78 96.91 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.83 0.741 . . . . 0.0 110.336 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.1 t -75.2 -20.23 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.498 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.63 25.47 9.91 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.697 1.141 . . . . 0.0 111.332 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.531 HG22 ' H ' ' A' ' 56' ' ' ASP . 12.4 mt -121.62 -178.33 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.531 ' H ' HG22 ' A' ' 55' ' ' ILE . 9.8 t70 -146.51 151.73 37.83 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 120.457 -1.402 . . . . 0.0 109.694 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.6 pt -132.68 -3.96 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.405 1.082 . . . . 0.0 112.824 169.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 95.3 p -55.87 -30.62 61.82 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 120.187 1.358 . . . . 0.0 112.146 169.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.05 -7.43 87.6 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 118.729 -1.039 . . . . 0.0 114.087 -176.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.56 172.4 7.87 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.448 1.499 . . . . 0.0 111.16 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 16.8 p -129.46 157.62 41.48 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.368 1.067 . . . . 0.0 111.071 -170.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.6 p -68.21 156.67 37.09 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.717 1.207 . . . . 0.0 110.04 169.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -156.07 143.54 13.91 Favored Pre-proline 0 N--CA 1.469 0.5 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.038 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -81.32 150.4 17.37 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.835 2.357 . . . . 0.0 111.226 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.6 tt -55.27 -33.21 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.272 0.629 . . . . 0.0 111.362 173.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -56.92 -22.11 35.09 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.548 1.939 . . . . 0.0 112.418 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -79.46 -4.64 52.15 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.209 1.004 . . . . 0.0 112.85 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -128.13 177.91 6.59 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.768 1.167 . . . . 0.0 111.753 -175.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.03 140.14 52.84 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 127.183 2.193 . . . . 0.0 106.859 170.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.412 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -72.54 -23.0 60.93 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.115 0.966 . . . . 0.0 112.002 -177.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.86 -24.25 66.79 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.176 0.99 . . . . 0.0 112.472 -173.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -89.82 -15.16 32.9 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.033 0.933 . . . . 0.0 110.505 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.507 ' CE1' ' HE2' ' A' ' 3' ' ' LYS . 83.5 m-85 -86.69 141.62 28.79 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.901 1.281 . . . . 0.0 110.061 178.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -89.98 -34.84 15.85 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.151 0.98 . . . . 0.0 110.64 173.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -140.36 137.67 36.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -172.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.2 m -127.48 108.79 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 123.167 1.461 . . . . 0.0 109.39 -173.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.2 mm -104.26 96.67 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.3 t -71.17 157.0 38.91 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 167.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.21 52.37 0.43 Allowed 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 103.52 -2.77 . . . . 0.0 103.52 174.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 95.4 m . . . . . 0 C--O 1.232 0.147 0 C-N-CA 124.432 1.093 . . . . 0.0 110.153 176.628 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 CA--C 1.532 0.271 0 N-CA-C 114.703 1.372 . . . . 0.0 114.703 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.412 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 95.6 m95 -60.64 10.28 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.792 2.837 . . . . 0.0 114.427 172.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.2 p -128.02 18.61 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 124.623 1.169 . . . . 0.0 112.015 173.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 48.8 p -124.63 18.27 8.77 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -170.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -94.5 -174.9 3.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.52 1.528 . . . . 0.0 109.452 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -66.77 -34.98 79.02 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.57 -0.706 . . . . 0.0 112.506 -174.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.0 mt -134.71 136.58 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -174.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -137.61 138.14 39.22 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 169.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -146.92 159.98 42.88 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.659 1.583 . . . . 0.0 107.388 168.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -123.17 104.52 9.22 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.954 1.302 . . . . 0.0 108.744 169.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.409 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 41.9 m0 -80.71 88.72 5.76 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.996 0.918 . . . . 0.0 108.873 -177.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -62.71 104.49 0.54 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.47 1.108 . . . . 0.0 109.644 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 101' ' ' LEU . 1.2 mm? -136.92 172.16 13.43 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 126.217 1.807 . . . . 0.0 108.511 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -70.78 158.89 35.55 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 166.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -112.48 109.28 53.74 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 169.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.441 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 81.8 Cg_exo -53.31 1.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 1 C-N-CA 126.652 4.901 . . . . 0.0 119.514 -169.639 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -51.53 98.93 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.844 1.202 . . . . 0.0 112.094 174.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.401 ' H ' ' CE1' ' A' ' 43' ' ' HIS . . . 84.23 18.23 63.11 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 126.197 1.856 . . . . 0.0 113.111 171.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.441 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 24.8 mm-40 -95.18 178.22 5.6 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.811 1.305 . . . . 0.0 111.876 -169.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.9 m -74.09 153.89 39.41 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.236 1.414 . . . . 0.0 109.96 176.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 82.2 mt -60.14 -28.75 68.14 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.762 -0.586 . . . . 0.0 111.843 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.42 -38.8 92.55 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.087 0.403 . . . . 0.0 110.789 174.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 86.7 t -68.49 -46.29 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.534 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 16.3 m-85 -52.98 -54.55 33.45 Favored 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 122.704 0.401 . . . . 0.0 110.561 175.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -59.66 -40.67 88.5 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.175 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.8 m -62.55 -52.29 64.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.432 1.014 . . . . 0.0 109.668 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.86 -45.83 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-O 118.181 -0.914 . . . . 0.0 109.475 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -55.85 -49.61 72.84 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.448 1.022 . . . . 0.0 109.303 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.64 -49.1 82.34 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-O 118.368 -1.24 . . . . 0.0 110.482 -176.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -60.71 -53.49 56.82 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-N 118.371 1.085 . . . . 0.0 110.812 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 68.5 t -52.88 -46.13 51.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 124.355 1.062 . . . . 0.0 110.2 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -63.54 -49.9 71.63 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 119.724 1.147 . . . . 0.0 110.523 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.09 -43.44 70.36 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.338 1.055 . . . . 0.0 110.526 175.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.409 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 81.5 mtt-85 -72.24 -41.25 67.04 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 117.74 -1.124 . . . . 0.0 110.074 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.7 t -54.3 -49.0 66.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 120.629 1.559 . . . . 0.0 108.811 169.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -60.17 -39.85 87.88 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.29 0.95 . . . . 0.0 110.883 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -63.65 -45.48 89.98 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.309 1.043 . . . . 0.0 110.257 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -46.09 89.31 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 123.829 0.852 . . . . 0.0 109.645 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 64.1 mt -60.07 -38.07 75.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.672 1.189 . . . . 0.0 110.921 175.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.69 -31.72 71.88 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 120.139 1.336 . . . . 0.0 111.295 -174.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -69.7 -20.46 63.54 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.596 1.558 . . . . 0.0 113.023 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.7 pt -125.01 -21.21 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -168.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 C--O 1.251 1.134 0 C-N-CA 126.391 1.876 . . . . 0.0 111.124 173.746 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.467 0.386 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -93.08 128.22 38.9 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 169.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.4 p -113.0 136.74 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 123.477 0.711 . . . . 0.0 109.565 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 35.9 tpp -112.93 141.34 46.88 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 170.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -117.47 136.0 53.52 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 169.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.423 HG11 HD12 ' A' ' 65' ' ' ILE . 12.1 t -138.87 131.03 37.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -174.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.23 165.9 18.09 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 120.116 1.325 . . . . 0.0 109.971 169.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -62.74 -10.81 14.05 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.6 ptm85 -153.93 114.27 3.95 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 103.168 -2.901 . . . . 0.0 103.168 169.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -51.83 -25.6 8.13 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.327 1.851 . . . . 0.0 113.25 -176.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.4 p -40.05 -36.87 0.53 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 118.42 2.748 . . . . 0.0 118.42 -168.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.0 p -137.55 -54.52 0.68 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 -169.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -64.59 -51.93 60.16 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 122.221 2.282 . . . . 0.0 108.863 -169.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 82.2 p -70.31 -39.04 75.06 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -170.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -55.89 -50.57 70.3 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.184 0.993 . . . . 0.0 111.096 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 60.0 mtm -64.18 -46.21 84.96 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 117.489 0.132 . . . . 0.0 110.709 178.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.78 -39.49 71.32 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 119.524 -0.274 . . . . 0.0 110.508 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.532 ' HA ' HG21 ' A' ' 32' ' ' VAL . 36.2 tt0 -65.55 -45.35 83.73 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 119.434 -0.317 . . . . 0.0 111.137 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.38 -41.79 99.74 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -65.39 -49.05 70.76 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 117.997 0.899 . . . . 0.0 109.107 174.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.32 -43.15 88.08 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.169 0.895 . . . . 0.0 112.391 -172.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -69.37 -36.56 76.96 Favored 'General case' 0 C--O 1.219 -0.546 0 C-N-CA 118.991 -1.083 . . . . 0.0 110.946 175.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 52.2 m -67.19 -42.48 84.11 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 120.762 1.619 . . . . 0.0 110.495 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.3 mt -77.16 -37.63 53.45 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.38 1.472 . . . . 0.0 111.423 -174.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.702 0 CA-C-O 116.578 -2.234 . . . . 0.0 117.441 -169.116 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.2 pt . . . . . 0 C--O 1.234 0.269 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.73 127.84 53.22 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 105.472 -2.048 . . . . 0.0 105.472 169.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.532 HG21 ' HA ' ' A' ' 19' ' ' GLU . 3.0 p -112.17 150.87 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -173.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.1 m -141.03 144.28 34.9 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 126.012 1.725 . . . . 0.0 107.452 168.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.8 p -117.11 152.73 34.1 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.816 1.646 . . . . 0.0 109.003 168.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 32.1 p -158.14 -165.01 1.61 Allowed 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 176.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.47 160.05 28.31 Favored Glycine 0 CA--C 1.503 -0.68 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 169.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.3 tp -47.51 -35.66 9.15 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.369 1.468 . . . . 0.0 109.758 169.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -142.07 144.14 33.43 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 168.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.2 p -73.75 155.74 38.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.75 0.786 . . . . 0.0 110.885 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 67.5 m -159.19 150.57 20.26 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.513 1.925 . . . . 0.0 106.018 169.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.7 ttt-85 -49.08 146.94 3.16 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.876 1.271 . . . . 0.0 110.831 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.6 t -57.32 129.34 19.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.519 -1.659 . . . . 0.0 106.519 169.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -71.66 137.32 83.06 Favored Pre-proline 0 N--CA 1.444 -0.747 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -72.95 -38.64 2.77 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.04 1.16 . . . . 0.0 111.66 -169.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.438 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 20.6 m -64.4 -24.69 67.72 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.737 -1.227 . . . . 0.0 111.571 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.04 -39.38 66.13 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 121.574 -0.704 . . . . 0.0 111.193 175.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.5 mt -55.86 -46.03 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.26 -40.22 93.67 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 123.99 0.916 . . . . 0.0 110.065 -170.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.9 mmm -67.14 -43.0 83.48 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 122.672 1.225 . . . . 0.0 110.685 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.417 ' SD ' HG12 ' A' ' 57' ' ' ILE . 9.4 mtp -65.42 -34.92 79.43 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.375 -0.828 . . . . 0.0 109.863 174.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.65 -30.53 68.8 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.717 0.69 . . . . 0.0 111.217 173.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -66.69 -38.1 86.08 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.192 0.451 . . . . 0.0 109.879 176.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 64.3 t -77.28 -24.66 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.612 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.13 26.03 5.89 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.161 1.362 . . . . 0.0 111.75 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.489 HG22 ' H ' ' A' ' 56' ' ' ASP . 9.7 mt -124.79 178.34 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 125.091 1.357 . . . . 0.0 107.476 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.489 ' H ' HG22 ' A' ' 55' ' ' ILE . 11.8 t70 -142.23 156.43 45.3 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.514 1.526 . . . . 0.0 109.301 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.417 HG12 ' SD ' ' A' ' 50' ' ' MET . 0.1 OUTLIER -129.06 -15.2 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.041 0.936 . . . . 0.0 112.634 170.505 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -44.62 -37.39 3.6 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.785 1.234 . . . . 0.0 112.715 172.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.95 -7.7 84.22 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.664 1.126 . . . . 0.0 114.384 -174.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -125.77 168.39 13.87 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.244 1.522 . . . . 0.0 110.667 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.0 p -129.36 169.37 14.97 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.207 1.003 . . . . 0.0 111.374 -169.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 54.7 m -89.61 159.66 17.04 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.17 0.988 . . . . 0.0 111.044 174.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -157.91 140.38 10.47 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.954 1.301 . . . . 0.0 108.875 -172.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.52 148.05 32.84 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.562 1.508 . . . . 0.0 110.417 -177.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.423 HD12 HG11 ' A' ' 7' ' ' VAL . 19.7 tt -52.15 -35.03 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 123.878 0.871 . . . . 0.0 111.559 174.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -58.05 -22.21 49.09 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.455 1.902 . . . . 0.0 112.316 -175.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -80.43 -7.01 58.97 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.343 1.057 . . . . 0.0 112.835 -177.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -125.02 179.86 4.85 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.575 1.08 . . . . 0.0 111.06 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.44 139.62 52.26 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 127.085 2.154 . . . . 0.0 107.254 171.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.62 -24.09 66.26 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.97 1.308 . . . . 0.0 111.891 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -60.18 -23.88 64.32 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.008 0.923 . . . . 0.0 112.45 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -83.54 -13.11 55.24 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.036 0.934 . . . . 0.0 110.785 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -107.23 128.0 54.03 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 125.743 1.617 . . . . 0.0 109.208 -174.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -77.17 -34.8 56.29 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.1 p -132.55 137.65 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 123.385 0.674 . . . . 0.0 109.524 -175.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.88 129.04 60.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 122.548 1.166 . . . . 0.0 109.94 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.5 mm -124.06 101.3 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -170.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.7 m -73.74 154.17 39.72 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 168.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -148.62 45.36 1.03 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 177.516 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 99.1 m . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 117.744 -1.122 . . . . 0.0 112.046 -169.535 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -61.63 1.11 0.26 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.122 1.769 . . . . 0.0 113.572 170.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.9 p -121.6 6.23 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.494 1.118 . . . . 0.0 112.019 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 82.8 p -127.48 22.38 6.47 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.355 0.98 . . . . 0.0 112.718 -172.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -89.28 -177.33 5.36 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.432 0.693 . . . . 0.0 109.922 173.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -64.0 -31.79 73.11 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.131 0.573 . . . . 0.0 112.525 -171.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.3 mt -135.84 134.36 51.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -141.04 138.12 33.4 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 169.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -145.26 157.19 44.12 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.03 1.332 . . . . 0.0 107.968 168.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -120.94 102.92 8.67 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.1 1.36 . . . . 0.0 109.177 169.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.424 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 39.8 m0 -78.88 93.79 5.08 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.877 1.671 . . . . 0.0 108.927 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -65.99 107.22 1.81 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -129.41 157.67 41.31 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 125.712 1.605 . . . . 0.0 109.906 -175.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -82.48 61.09 5.46 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.419 1.488 . . . . 0.0 112.126 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 53.1 t0 4.11 83.27 0.04 OUTLIER Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 129.603 3.161 . . . . 0.0 113.424 169.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.424 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 80.8 Cg_exo -60.06 -5.93 4.4 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 123.174 2.583 . . . . 0.0 117.491 -169.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -60.23 90.78 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.728 1.211 . . . . 0.0 111.86 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.89 15.08 27.43 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 126.283 1.896 . . . . 0.0 113.376 173.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.424 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 30.6 mm-40 -91.94 179.05 5.71 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.013 1.407 . . . . 0.0 112.866 -169.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 41.5 m -75.54 155.7 35.81 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.563 1.545 . . . . 0.0 109.988 175.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.77 -33.39 70.24 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.944 -0.473 . . . . 0.0 111.563 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.28 -39.18 93.4 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.577 0.351 . . . . 0.0 110.764 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 99.2 t -66.08 -47.55 84.53 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 175.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.438 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 7.2 m-85 -54.76 -51.38 65.86 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.006 0.522 . . . . 0.0 111.026 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 24.0 mtt180 -60.29 -42.77 96.15 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.473 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 88.9 m -62.18 -55.16 31.43 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.4 t -61.01 -43.08 95.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 118.855 -0.593 . . . . 0.0 110.312 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.76 -45.19 93.01 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 119.396 0.998 . . . . 0.0 110.374 -177.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.42 -46.5 90.31 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -63.85 -46.39 85.24 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.988 0.915 . . . . 0.0 111.186 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.0 t -56.77 -51.71 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 125.65 1.58 . . . . 0.0 110.228 171.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -58.4 -45.35 88.53 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.114 0.87 . . . . 0.0 110.366 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -55.67 -45.88 77.67 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.9 0.88 . . . . 0.0 109.254 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.424 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 60.4 mtt85 -70.38 -39.05 74.79 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-O 118.086 -0.959 . . . . 0.0 110.782 -174.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.5 t -54.81 -48.56 73.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 120.373 1.442 . . . . 0.0 109.594 169.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -60.85 -40.33 92.48 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 119.625 1.102 . . . . 0.0 110.858 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -61.21 -46.46 90.36 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.259 1.424 . . . . 0.0 109.945 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.32 -48.43 73.08 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 124.011 0.925 . . . . 0.0 110.08 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 45.8 mt -55.31 -38.99 50.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.751 1.22 . . . . 0.0 110.631 174.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.37 -30.73 70.72 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.772 1.169 . . . . 0.0 111.237 -173.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -72.78 -20.79 61.1 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.691 1.596 . . . . 0.0 112.638 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.0 pt -123.37 -22.36 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -168.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 C--O 1.251 1.159 0 C-N-CA 126.181 1.792 . . . . 0.0 111.194 175.854 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt . . . . . 0 N--CA 1.464 0.261 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.4 mttt -95.33 136.28 35.88 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 121.7 -0.625 . . . . 0.0 109.491 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.5 t -121.2 127.22 75.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -173.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 42.2 tpp -110.89 141.01 44.87 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 169.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -109.85 130.52 55.51 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 169.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.4 t -132.23 119.0 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 120.447 1.476 . . . . 0.0 109.141 -169.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.401 ' HB3' ' H ' ' A' ' 11' ' ' ASN . 41.1 t -124.7 159.27 31.24 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.969 1.258 . . . . 0.0 110.704 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.2 mttm -58.49 -12.81 4.34 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.189 0.995 . . . . 0.0 113.115 169.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -138.6 -12.13 1.34 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 173.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.401 ' H ' ' HB3' ' A' ' 8' ' ' CYS . 27.2 t-20 64.52 -43.82 0.3 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.744 2.418 . . . . 0.0 114.599 -169.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.0 m -40.25 -23.58 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 121.028 3.714 . . . . 0.0 121.028 -168.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 23.6 m -140.99 -62.84 0.47 Allowed 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 120.443 1.474 . . . . 0.0 111.174 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -59.79 -50.36 74.13 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.669 0.668 . . . . 0.0 109.583 -169.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.43 -43.81 69.17 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.389 0.276 . . . . 0.0 111.178 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -59.89 -46.4 89.44 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.69 0.796 . . . . 0.0 111.359 -174.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.525 ' HG2' HD11 ' A' ' 57' ' ' ILE . 56.6 mtm -67.71 -45.63 74.52 Favored 'General case' 0 C--O 1.231 0.114 0 O-C-N 122.276 -0.265 . . . . 0.0 110.551 177.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.48 -38.29 71.52 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 122.281 0.232 . . . . 0.0 111.053 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -64.91 -55.87 16.71 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 118.448 -0.787 . . . . 0.0 110.372 178.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -52.04 -40.25 50.75 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 119.481 -0.622 . . . . 0.0 112.149 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -64.9 -51.12 63.65 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 118.717 1.258 . . . . 0.0 110.266 173.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.6 -44.78 89.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 119.708 1.14 . . . . 0.0 112.88 -174.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -70.19 -9.69 56.53 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 119.732 1.151 . . . . 0.0 113.281 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.5 m -92.57 -48.2 6.73 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 119.892 1.224 . . . . 0.0 110.423 169.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.0 mt -77.49 -43.55 31.82 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.881 1.672 . . . . 0.0 112.073 -169.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.353 0 CA-C-O 118.038 -1.423 . . . . 0.0 114.923 -169.089 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.7 pt . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 121.564 0.697 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -123.63 133.24 53.96 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 104.381 -2.452 . . . . 0.0 104.381 169.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.4 p -118.45 155.28 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-O 121.88 0.848 . . . . 0.0 112.541 -169.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.8 m -148.26 152.72 37.63 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.915 1.686 . . . . 0.0 107.216 167.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.3 p -118.35 153.35 34.16 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.53 1.132 . . . . 0.0 108.535 168.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 23.4 p -152.43 -169.99 3.51 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 173.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.92 163.12 30.79 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 169.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.7 mt -58.5 -32.24 68.62 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.971 0.508 . . . . 0.0 110.601 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -142.45 132.76 24.86 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 103.623 -2.732 . . . . 0.0 103.623 168.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.3 p -76.24 149.97 37.09 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.951 0.5 . . . . 0.0 111.084 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.1 m -147.52 158.45 44.0 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.081 2.152 . . . . 0.0 106.513 169.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.04 144.8 11.32 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.922 0.889 . . . . 0.0 110.905 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.6 p -65.11 138.42 23.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 169.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.4 ' CG ' ' HD2' ' A' ' 44' ' ' PRO . 7.4 t-80 -83.38 149.48 58.14 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 123.479 0.711 . . . . 0.0 109.607 -174.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HD2' ' CG ' ' A' ' 43' ' ' HIS . 87.2 Cg_endo -81.86 -38.76 0.2 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 121.562 1.508 . . . . 0.0 112.907 -169.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.438 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 28.5 m -62.76 -27.23 69.14 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.297 1.408 . . . . 0.0 111.24 -177.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.28 -44.24 22.99 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.019 0.928 . . . . 0.0 111.175 171.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 52.3 mt -55.93 -45.52 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 C-N-CA 124.287 1.035 . . . . 0.0 108.291 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.47 -34.25 77.77 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.28 1.032 . . . . 0.0 110.104 -172.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 8.1 mmm -70.66 -41.49 72.02 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-O 122.547 1.165 . . . . 0.0 110.386 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.497 ' HG3' ' CG1' ' A' ' 57' ' ' ILE . 87.2 mmm -62.9 -41.13 99.33 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -61.63 -25.66 67.5 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.291 0.636 . . . . 0.0 111.096 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -65.61 -42.24 91.84 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 118.652 0.66 . . . . 0.0 110.094 171.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.3 t -76.22 -25.78 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.78 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.66 23.2 6.33 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.454 1.502 . . . . 0.0 111.958 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.4 mt -121.42 177.44 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 125.742 1.617 . . . . 0.0 107.693 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -143.9 157.51 44.31 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.484 1.513 . . . . 0.0 109.957 -176.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.525 HD11 ' HG2' ' A' ' 17' ' ' MET . 0.6 OUTLIER -130.45 -17.78 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.153 0.981 . . . . 0.0 111.983 169.607 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -42.58 -38.18 1.9 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.959 1.304 . . . . 0.0 113.292 173.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.0 -10.75 68.94 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 118.551 -1.138 . . . . 0.0 114.033 -175.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -123.99 168.75 12.41 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 119.181 1.491 . . . . 0.0 112.641 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.2 p -127.37 -176.05 3.62 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 126.526 1.931 . . . . 0.0 109.679 -174.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.7 p -113.56 158.95 20.12 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.284 1.433 . . . . 0.0 110.908 -175.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -151.22 149.9 25.84 Favored Pre-proline 0 N--CA 1.467 0.409 0 C-N-CA 124.218 1.007 . . . . 0.0 109.827 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.47 150.87 19.64 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.977 2.451 . . . . 0.0 110.617 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.2 tt -52.24 -36.22 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.766 1.226 . . . . 0.0 110.756 172.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -58.17 -25.55 61.64 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.838 1.655 . . . . 0.0 112.884 -171.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.81 -9.74 45.34 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -176.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -98.97 -174.45 2.77 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.371 0.987 . . . . 0.0 110.127 175.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.6 128.41 20.49 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 126.841 2.056 . . . . 0.0 106.941 175.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.92 -27.24 66.58 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.898 0.879 . . . . 0.0 111.969 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -60.28 -23.55 64.24 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.237 1.015 . . . . 0.0 112.644 -175.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -84.65 -16.55 41.55 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.101 0.56 . . . . 0.0 110.761 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -109.1 112.89 25.31 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 125.354 1.462 . . . . 0.0 108.323 -172.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -76.44 -21.6 55.71 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.328 0.585 . . . . 0.0 109.673 -176.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.1 t -133.98 134.83 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 125.803 1.641 . . . . 0.0 107.229 -172.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -137.36 119.39 19.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 123.023 1.392 . . . . 0.0 109.726 -176.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.2 mm -112.74 94.13 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 66.9 m -72.4 157.34 37.83 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 167.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.87 50.61 0.67 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 74.7 m . . . . . 0 N--CA 1.452 -0.334 0 C-N-CA 124.431 1.092 . . . . 0.0 108.89 171.964 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 . . . . . 0 N--CA 1.472 0.632 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -61.87 0.05 0.42 Allowed 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 126.024 1.73 . . . . 0.0 112.378 169.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.6 m -114.33 5.17 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 120.376 1.444 . . . . 0.0 112.46 170.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.8 p -120.98 21.99 11.18 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.979 0.911 . . . . 0.0 111.716 -177.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -90.52 -178.99 5.46 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.375 1.07 . . . . 0.0 109.382 171.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.56 -36.42 82.61 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.719 0.808 . . . . 0.0 112.922 -169.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.9 mt -133.16 134.77 57.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -141.63 136.92 31.45 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.355 1.062 . . . . 0.0 108.835 172.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -146.47 159.51 43.31 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.822 1.649 . . . . 0.0 107.68 168.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -124.55 92.47 3.66 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.182 1.393 . . . . 0.0 109.045 169.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -66.01 141.54 58.14 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.746 0.819 . . . . 0.0 110.891 -176.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -110.71 92.03 3.89 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.845 1.258 . . . . 0.0 107.689 -170.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -131.1 149.68 52.49 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.679 1.592 . . . . 0.0 109.107 -170.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -84.47 56.81 3.98 Favored 'General case' 0 C--O 1.228 -0.072 0 C-N-CA 126.37 1.868 . . . . 0.0 112.05 -172.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.3 t0 5.94 82.35 0.04 OUTLIER Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 129.903 3.281 . . . . 0.0 113.977 169.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.457 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 84.2 Cg_exo -54.5 -13.86 6.2 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 125.271 3.981 . . . . 0.0 118.633 -169.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.29 90.17 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 120.3 1.409 . . . . 0.0 111.925 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.85 6.69 26.25 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 126.282 1.896 . . . . 0.0 113.164 174.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.457 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 28.4 mm-40 -89.67 -178.5 5.55 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.81 1.305 . . . . 0.0 112.056 -169.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.0 m -78.98 156.96 28.24 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.971 1.308 . . . . 0.0 109.909 173.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 70.4 mt -59.79 -32.9 71.05 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 122.086 -0.384 . . . . 0.0 111.498 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -61.21 -39.9 91.96 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.376 0.534 . . . . 0.0 110.622 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.7 t -67.25 -46.57 83.72 Favored 'Isoleucine or valine' 0 C--N 1.338 0.086 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.438 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 11.7 m-85 -53.98 -52.57 60.29 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 122.608 0.363 . . . . 0.0 110.729 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.1 mtp180 -64.18 -40.91 97.1 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 118.511 -0.756 . . . . 0.0 111.09 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.5 m -63.37 -52.53 61.32 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.75 -42.74 95.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.216 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.79 -44.3 90.71 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-N 120.277 1.399 . . . . 0.0 110.365 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.84 -49.35 76.76 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -61.56 -44.9 96.19 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.266 1.033 . . . . 0.0 111.869 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.5 t -58.59 -50.05 80.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 125.606 1.562 . . . . 0.0 109.806 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -58.49 -45.78 88.02 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 119.478 1.035 . . . . 0.0 110.119 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.59 -43.6 80.24 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.307 1.043 . . . . 0.0 110.345 176.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 46.3 mtt85 -71.61 -40.9 69.52 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-O 117.965 -1.017 . . . . 0.0 111.088 -177.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.418 ' HA ' HD23 ' A' ' 126' ' ' LEU . 95.0 t -54.47 -48.22 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 120.505 1.502 . . . . 0.0 109.499 169.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -60.05 -40.13 88.34 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.4 1.0 . . . . 0.0 110.615 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -62.2 -45.74 92.02 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.244 1.018 . . . . 0.0 110.347 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 123' ' ' VAL . 0.2 OUTLIER -63.1 -47.45 82.79 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.012 0.925 . . . . 0.0 109.834 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 61.5 mt -58.88 -37.88 69.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 124.607 1.163 . . . . 0.0 110.491 176.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.79 -29.67 69.59 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.941 1.246 . . . . 0.0 111.486 -174.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 41.7 mttm -73.52 -19.57 60.88 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.974 1.71 . . . . 0.0 112.93 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.2 pt -125.95 -20.27 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.895 1.678 . . . . 0.0 114.941 -168.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.9 m . . . . . 0 C--O 1.251 1.16 0 C-N-CA 126.457 1.903 . . . . 0.0 110.886 169.883 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.467 0.392 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -102.46 117.99 35.91 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 72.9 t -97.37 137.94 23.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 125.517 1.527 . . . . 0.0 108.128 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 35.5 tpp -126.01 143.64 51.02 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 169.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.401 ' HE2' HG21 ' A' ' 32' ' ' VAL . 81.6 m-85 -114.02 133.23 55.64 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 169.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.3 t -136.26 122.15 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 120.065 1.302 . . . . 0.0 108.551 -169.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.442 ' HB3' ' H ' ' A' ' 11' ' ' ASN . 43.0 t -129.9 163.6 26.0 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.146 0.885 . . . . 0.0 111.288 -173.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -59.49 -21.96 60.89 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 118.202 -0.904 . . . . 0.0 112.303 169.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -138.01 -9.68 1.55 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 116.18 1.918 . . . . 0.0 116.18 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.442 ' H ' ' HB3' ' A' ' 8' ' ' CYS . 26.0 t-20 61.99 -43.1 0.16 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 128.346 2.659 . . . . 0.0 115.872 -174.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.7 p -35.16 -38.99 0.1 Allowed 'General case' 0 C--O 1.233 0.228 0 C-N-CA 129.596 3.159 . . . . 0.0 118.499 -168.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.4 p -133.13 -59.94 0.87 Allowed 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 118.757 -0.639 . . . . 0.0 111.129 -169.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.0 mtm180 -58.32 -56.73 18.27 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -171.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.6 -42.64 77.87 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.516 0.327 . . . . 0.0 111.063 -177.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -60.37 -45.86 92.02 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.65 0.78 . . . . 0.0 111.423 -174.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 49.4 mtm -62.3 -46.41 88.87 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 110.494 -0.187 . . . . 0.0 110.494 175.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.16 -39.15 78.1 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 119.742 -0.17 . . . . 0.0 111.062 -178.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -63.69 -45.88 88.02 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.47 0.708 . . . . 0.0 110.422 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.24 -44.55 97.54 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -65.55 -47.33 76.23 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 118.624 1.212 . . . . 0.0 108.75 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.81 -43.18 85.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 119.366 0.985 . . . . 0.0 112.372 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -76.25 -2.35 30.98 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 119.047 0.84 . . . . 0.0 113.159 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.0 m -96.9 -45.64 6.54 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 121.301 -0.874 . . . . 0.0 109.445 169.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 91.8 mt -74.05 -41.03 62.38 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.96 1.704 . . . . 0.0 111.151 -171.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.84 0 CA-C-O 117.971 -1.46 . . . . 0.0 115.631 -169.818 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.8 pt . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -118.3 134.71 54.8 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 169.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.401 HG21 ' HE2' ' A' ' 6' ' ' PHE . 13.5 p -123.64 152.55 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-O 121.439 0.637 . . . . 0.0 112.061 -176.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.3 m -144.35 161.88 37.87 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.944 1.298 . . . . 0.0 108.131 169.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 94.1 p -126.71 155.95 41.87 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 124.901 1.28 . . . . 0.0 109.107 168.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.3 p -154.51 -165.87 2.19 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 174.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.55 163.75 33.68 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 169.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.1 mt -52.08 -31.76 31.83 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.267 1.027 . . . . 0.0 110.237 174.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -148.01 145.67 28.61 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 168.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.5 p -79.03 161.68 26.43 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.579 0.704 . . . . 0.0 111.313 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.6 m -157.0 166.06 34.42 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.417 1.887 . . . . 0.0 107.284 169.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.1 ptt-85 -51.96 143.35 13.83 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.653 1.181 . . . . 0.0 110.728 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 56.0 t -63.4 130.34 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 168.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -70.63 138.78 86.0 Favored Pre-proline 0 N--CA 1.448 -0.555 0 CA-C-O 118.771 -0.633 . . . . 0.0 109.615 -174.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.18 -40.12 1.84 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 121.074 1.183 . . . . 0.0 111.471 -172.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.505 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 11.2 m -67.67 -18.08 64.82 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 120.488 -1.382 . . . . 0.0 111.916 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.441 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -58.21 -39.43 78.99 Favored 'General case' 0 C--N 1.339 0.116 0 O-C-N 121.275 -0.89 . . . . 0.0 110.63 171.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.4 mt -57.8 -46.15 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.54 -40.97 96.6 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.531 0.732 . . . . 0.0 112.036 -176.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.5 mmt -58.5 -49.15 78.42 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 122.558 1.17 . . . . 0.0 111.302 177.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.405 ' SD ' HG12 ' A' ' 57' ' ' ILE . 8.1 mtp -68.82 -36.26 77.99 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.651 -1.158 . . . . 0.0 108.899 -177.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -62.46 -28.96 70.18 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.18 0.592 . . . . 0.0 111.514 173.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -64.25 -39.67 94.42 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.02 0.827 . . . . 0.0 110.176 173.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.0 t -78.58 -23.98 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 119.743 -0.17 . . . . 0.0 110.766 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.46 24.95 6.52 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.913 1.245 . . . . 0.0 111.882 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.565 HG22 ' H ' ' A' ' 56' ' ' ASP . 11.1 mt -122.72 -178.23 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 C-N-CA 125.938 1.695 . . . . 0.0 106.821 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.565 ' H ' HG22 ' A' ' 55' ' ' ILE . 10.1 t70 -147.93 156.12 42.32 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 120.438 -1.414 . . . . 0.0 109.909 -176.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.446 HD13 HG21 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -129.79 -16.38 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.277 1.031 . . . . 0.0 112.227 169.534 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.7 p -51.86 -31.39 27.74 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.707 1.139 . . . . 0.0 112.451 177.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.84 -6.28 88.59 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.814 1.197 . . . . 0.0 114.366 -177.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -125.77 168.65 13.51 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.369 1.584 . . . . 0.0 110.824 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.7 p -128.0 170.92 12.34 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.063 0.945 . . . . 0.0 111.372 -171.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.6 p -85.62 162.99 18.59 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.188 1.395 . . . . 0.0 111.06 175.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -157.89 145.15 13.44 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 123.775 0.83 . . . . 0.0 109.345 -178.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -81.32 153.71 18.53 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.26 1.973 . . . . 0.0 110.936 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.4 tt -55.04 -34.03 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 123.706 0.802 . . . . 0.0 111.123 175.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -57.52 -23.22 49.0 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.369 1.867 . . . . 0.0 112.402 -174.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -85.17 -3.65 58.88 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.864 0.866 . . . . 0.0 112.819 -175.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -124.95 -174.25 2.99 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.426 1.09 . . . . 0.0 110.833 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.39 128.17 20.42 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.849 2.059 . . . . 0.0 107.63 175.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.84 -26.86 64.57 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.08 0.952 . . . . 0.0 112.554 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -59.42 -23.39 62.6 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.088 0.955 . . . . 0.0 112.488 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -83.67 -14.76 51.06 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.39 0.676 . . . . 0.0 110.799 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -108.32 120.36 42.15 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 125.704 1.602 . . . . 0.0 109.079 -172.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -75.25 -30.81 60.62 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.374 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.538 HG21 HD13 ' A' ' 126' ' ' LEU . 0.2 OUTLIER -131.52 130.13 62.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -173.635 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.0 m -127.73 115.29 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 123.618 1.675 . . . . 0.0 109.855 -174.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.0 mm -110.22 101.78 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -175.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.7 t -72.7 155.41 40.01 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 168.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.18 50.8 0.72 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 171.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 85.4 m . . . . . 0 CA--C 1.534 0.346 0 C-N-CA 123.45 0.7 . . . . 0.0 110.947 174.601 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -63.65 6.28 0.16 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 126.324 1.85 . . . . 0.0 112.593 169.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 p -117.85 2.18 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 125.23 1.412 . . . . 0.0 111.505 172.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.8 p -127.72 24.05 6.17 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.124 -0.985 . . . . 0.0 112.292 -172.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -90.55 -176.73 4.84 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.324 0.65 . . . . 0.0 109.26 169.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -66.13 -32.14 73.42 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -169.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.0 mt -134.11 132.38 55.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -177.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -140.1 138.21 35.11 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.143 0.977 . . . . 0.0 108.856 174.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -146.65 159.44 43.46 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.152 1.381 . . . . 0.0 107.762 168.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -122.05 113.43 19.53 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.879 1.272 . . . . 0.0 108.622 168.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.445 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 40.0 m0 -87.4 97.1 10.63 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -177.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -62.03 118.88 7.89 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 169.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 60.0 mt -150.21 150.57 31.77 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.236 1.415 . . . . 0.0 107.794 -169.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.8 mp0 -83.12 57.32 3.88 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.819 1.648 . . . . 0.0 111.999 -173.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.9 t70 2.76 85.53 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 129.377 3.071 . . . . 0.0 114.486 173.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.461 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 67.0 Cg_exo -60.13 -8.01 7.47 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.523 2.815 . . . . 0.0 117.411 -169.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -55.36 100.72 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 120.528 1.513 . . . . 0.0 111.811 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.24 18.32 43.13 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 126.482 1.991 . . . . 0.0 113.382 171.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.461 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 23.7 mm-40 -98.31 177.01 5.51 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.012 1.406 . . . . 0.0 113.234 -169.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 37.7 m -75.77 154.77 36.09 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.987 1.715 . . . . 0.0 110.081 175.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 71.1 mt -59.14 -31.34 68.87 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 121.812 -0.555 . . . . 0.0 111.899 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.7 mp0 -62.3 -41.07 98.21 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.417 0.687 . . . . 0.0 110.387 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.63 -43.4 86.87 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.505 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 14.3 m-85 -55.68 -52.44 63.84 Favored 'General case' 0 N--CA 1.458 -0.069 0 CA-C-O 118.683 -0.675 . . . . 0.0 110.752 175.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 72.9 mtp85 -59.54 -41.5 90.19 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.248 0.931 . . . . 0.0 111.758 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.9 m -61.04 -46.7 89.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 118.682 0.674 . . . . 0.0 110.039 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.4 t -70.46 -42.97 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 117.79 -1.1 . . . . 0.0 110.257 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.9 ttp180 -56.34 -44.85 80.43 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 119.923 1.238 . . . . 0.0 109.48 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.04 -48.8 84.32 Favored Glycine 0 CA--C 1.521 0.426 0 CA-C-O 118.702 -1.055 . . . . 0.0 110.69 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -59.8 -55.55 32.83 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 118.113 0.956 . . . . 0.0 110.182 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.7 t -48.17 -53.91 5.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.698 1.599 . . . . 0.0 110.234 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -63.55 -47.51 81.28 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 119.412 1.006 . . . . 0.0 110.221 -172.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -53.98 -45.27 71.35 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.654 0.781 . . . . 0.0 109.8 174.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.445 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 78.0 mtt-85 -71.46 -37.61 71.36 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.173 -173.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.403 ' HA ' HD23 ' A' ' 126' ' ' LEU . 96.2 t -56.44 -48.37 80.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 120.726 1.603 . . . . 0.0 109.242 168.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -60.54 -35.29 75.64 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.259 0.936 . . . . 0.0 110.598 177.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -65.2 -45.16 85.86 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.445 1.498 . . . . 0.0 110.414 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.538 HD13 HG21 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -65.24 -44.47 88.06 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 123.204 0.602 . . . . 0.0 110.372 179.357 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 86.4 mt -56.6 -36.9 49.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 124.286 1.034 . . . . 0.0 109.861 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.27 -35.46 77.92 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 120.363 1.438 . . . . 0.0 111.094 -177.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -59.03 -52.44 65.74 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.604 0.762 . . . . 0.0 110.37 174.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pt -80.1 -39.01 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.657 1.183 . . . . 0.0 112.517 -171.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . 0.259 6.0 p . . . . . 0 C--O 1.25 1.084 0 C-N-CA 130.744 3.617 . . . . 0.0 114.003 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -106.37 106.7 17.34 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 123.974 0.91 . . . . 0.0 109.725 178.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 57.2 t -85.41 139.7 17.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 125.934 1.694 . . . . 0.0 109.218 176.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 20.1 tpp -127.13 145.96 50.55 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.242 0.617 . . . . 0.0 109.59 169.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -120.47 120.77 36.86 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.825 1.65 . . . . 0.0 108.492 171.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.6 t -128.4 141.79 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.939 1.296 . . . . 0.0 109.263 -169.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 28.4 p -152.65 -170.61 3.68 Favored 'General case' 0 C--O 1.222 -0.354 0 O-C-N 120.976 -1.078 . . . . 0.0 112.869 -169.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -80.87 -24.96 37.99 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.321 1.048 . . . . 0.0 112.915 169.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -159.83 108.77 1.78 Allowed 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 -173.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -54.07 -17.51 2.76 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.525 1.53 . . . . 0.0 113.567 -173.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -38.93 -47.18 1.41 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 127.859 2.464 . . . . 0.0 117.177 -169.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.0 p -132.32 -77.32 0.5 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 116.009 -1.948 . . . . 0.0 114.561 -168.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.2 -49.14 33.92 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 121.601 2.0 . . . . 0.0 111.246 -168.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.77 -48.61 71.24 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.825 1.65 . . . . 0.0 110.709 -174.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -64.97 -42.02 94.94 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 124.541 1.136 . . . . 0.0 111.338 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 63.2 mtp -60.71 -48.78 80.24 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.27 1.028 . . . . 0.0 108.913 175.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.06 -41.04 87.0 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 122.968 0.507 . . . . 0.0 111.132 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -62.4 -45.23 94.07 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.505 0.722 . . . . 0.0 110.016 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.01 -45.2 97.1 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.448 -0.64 . . . . 0.0 111.645 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -65.26 -52.13 56.34 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 118.661 1.23 . . . . 0.0 108.58 175.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.01 -42.76 76.91 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.416 1.086 . . . . 0.0 112.508 -173.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -70.23 -35.54 73.91 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 118.791 0.723 . . . . 0.0 110.111 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.9 m -67.17 -43.27 82.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 119.521 -1.987 . . . . 0.0 110.504 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.6 mt -71.52 -39.94 70.43 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.071 1.748 . . . . 0.0 110.78 -174.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.844 0 CA-C-O 116.725 -2.153 . . . . 0.0 118.284 -169.479 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.5 pt . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.99 139.67 50.39 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 169.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 p -131.59 148.64 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.2 0.524 . . . . 0.0 111.871 -175.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 m -142.14 160.69 39.74 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.069 170.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 91.7 p -129.23 157.39 41.98 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.067 1.347 . . . . 0.0 108.265 168.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.4 p -153.04 -164.82 2.02 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.93 159.63 29.15 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 169.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 75.0 mt -52.5 -28.87 22.22 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.241 1.417 . . . . 0.0 110.556 172.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -144.57 146.58 32.41 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 168.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.1 p -72.1 159.25 34.46 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.94 0.896 . . . . 0.0 111.439 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.2 p -153.85 165.3 36.5 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.582 1.953 . . . . 0.0 106.904 170.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -66.09 154.16 40.35 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 120.896 -1.127 . . . . 0.0 109.556 172.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.4 t -62.46 132.75 28.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 169.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -74.14 140.4 76.7 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -75.3 -41.32 0.63 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.277 1.318 . . . . 0.0 112.124 -169.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.452 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 27.7 m -63.41 -25.34 68.23 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.536 -1.352 . . . . 0.0 111.576 -178.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.422 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -51.95 -39.44 59.24 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.467 0.707 . . . . 0.0 111.541 173.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.6 mt -56.2 -45.78 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.68 -38.25 88.75 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.265 1.026 . . . . 0.0 110.09 -170.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.3 mmm -69.84 -44.1 70.59 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 122.751 1.263 . . . . 0.0 110.569 -177.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.3 mtp -65.03 -36.15 83.45 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.482 -0.761 . . . . 0.0 109.683 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -63.25 -25.99 68.58 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.243 0.617 . . . . 0.0 111.417 174.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -66.26 -39.63 89.59 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.873 0.76 . . . . 0.0 109.817 173.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.3 t -76.96 -24.93 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.636 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.82 26.44 5.81 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.008 1.29 . . . . 0.0 111.67 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.458 HG22 ' H ' ' A' ' 56' ' ' ASP . 12.2 mt -122.67 177.32 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 125.194 1.398 . . . . 0.0 107.252 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.458 ' H ' HG22 ' A' ' 55' ' ' ILE . 13.8 t70 -142.16 156.43 45.35 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.107 1.363 . . . . 0.0 109.421 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.428 HD13 HG21 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -127.48 -16.96 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 123.781 0.832 . . . . 0.0 112.27 169.921 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -45.2 -39.08 5.89 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.679 1.192 . . . . 0.0 112.791 173.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.55 -4.56 89.27 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.625 1.107 . . . . 0.0 114.266 -172.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -126.78 165.47 19.23 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.125 1.462 . . . . 0.0 110.705 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 25.7 p -128.01 170.79 12.49 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.972 0.909 . . . . 0.0 111.361 -170.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.8 p -87.48 169.33 12.31 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.434 1.494 . . . . 0.0 112.034 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.24 135.07 6.64 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 123.966 0.907 . . . . 0.0 108.698 -174.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.36 154.29 31.8 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.767 2.311 . . . . 0.0 111.4 176.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.2 tt -55.9 -34.45 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 123.764 0.825 . . . . 0.0 111.33 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -60.1 -22.0 62.23 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.823 1.649 . . . . 0.0 112.205 -173.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -80.82 -2.5 47.5 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.179 0.992 . . . . 0.0 112.569 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -130.65 -179.87 5.55 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.586 1.085 . . . . 0.0 111.984 -174.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.08 139.43 45.96 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 127.812 2.445 . . . . 0.0 106.547 169.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.4 -24.89 66.55 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.549 1.14 . . . . 0.0 111.593 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -60.86 -24.56 66.01 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.022 0.929 . . . . 0.0 112.497 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -82.96 -17.92 41.81 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.909 0.884 . . . . 0.0 110.53 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -97.82 122.4 40.89 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 125.623 1.569 . . . . 0.0 108.546 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -73.11 -29.4 62.88 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 175.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.47 134.34 43.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 C-N-CA 122.507 0.323 . . . . 0.0 110.317 -170.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.5 m -127.03 128.98 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 122.135 0.969 . . . . 0.0 110.115 -175.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 49.9 mm -116.36 135.15 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.3 m -104.18 146.52 28.64 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 123.92 0.762 . . . . 0.0 109.233 169.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.97 53.92 0.35 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.047 1.739 . . . . 0.0 107.741 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 83.2 m . . . . . 0 CA--C 1.531 0.244 0 C-N-CA 123.802 0.841 . . . . 0.0 110.959 172.168 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -63.29 5.78 0.15 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.318 1.847 . . . . 0.0 113.756 170.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.4 p -126.44 5.17 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.338 1.055 . . . . 0.0 112.388 171.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.0 p -120.36 21.22 11.75 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.642 1.11 . . . . 0.0 112.61 -171.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -90.81 -176.78 4.79 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.624 0.769 . . . . 0.0 109.543 173.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -65.65 -31.56 72.65 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -170.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.7 mt -134.39 137.24 51.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -137.03 136.34 38.35 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 169.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -143.11 155.6 44.63 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.286 1.434 . . . . 0.0 107.853 169.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -120.63 132.53 55.17 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.147 1.379 . . . . 0.0 108.884 169.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.464 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 39.7 m0 -116.52 96.41 5.5 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.829 1.652 . . . . 0.0 107.472 -172.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -72.92 83.59 1.23 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.517 1.527 . . . . 0.0 109.721 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.32 154.0 23.12 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 125.208 1.403 . . . . 0.0 109.844 -175.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -78.25 65.85 3.7 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.204 1.402 . . . . 0.0 111.819 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -13.41 92.17 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 129.036 2.935 . . . . 0.0 114.308 178.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.428 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 52.6 Cg_exo -61.71 -6.91 8.13 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.927 3.085 . . . . 0.0 116.769 -169.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -60.42 88.62 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 120.214 1.37 . . . . 0.0 111.3 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.16 14.86 23.33 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 126.604 2.049 . . . . 0.0 113.874 175.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.428 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 29.9 mm-40 -93.82 179.75 5.25 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.51 1.655 . . . . 0.0 113.522 -169.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.9 m -77.74 156.48 30.56 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.769 1.628 . . . . 0.0 110.138 175.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 93.5 mt -58.14 -34.48 70.31 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.908 0.483 . . . . 0.0 111.462 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -66.81 -36.87 83.37 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.072 0.396 . . . . 0.0 110.695 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.0 t -65.87 -46.08 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.452 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 7.9 m-85 -56.4 -49.08 75.51 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.962 0.505 . . . . 0.0 111.078 176.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 16.4 mtp85 -59.08 -45.03 91.87 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.897 0.879 . . . . 0.0 111.05 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 92.9 m -60.94 -53.01 62.55 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 74.4 t -64.58 -40.47 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-O 118.506 -0.759 . . . . 0.0 110.5 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.84 -43.43 94.62 Favored 'General case' 0 CA--C 1.523 -0.071 0 CA-C-N 120.215 1.37 . . . . 0.0 110.446 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.43 -50.02 65.58 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-O 118.929 -0.928 . . . . 0.0 111.057 174.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -56.43 -50.3 72.06 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.27 1.035 . . . . 0.0 110.991 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 48.9 t -55.77 -54.92 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 126.32 1.848 . . . . 0.0 109.341 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -59.93 -45.53 92.31 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 119.336 0.971 . . . . 0.0 110.065 -173.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.18 -45.19 79.85 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.784 0.833 . . . . 0.0 110.248 176.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.464 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 45.2 mtt85 -70.32 -42.38 72.04 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 117.869 -1.062 . . . . 0.0 110.744 -176.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.5 t -52.82 -49.71 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 120.321 1.418 . . . . 0.0 110.293 169.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -60.77 -41.65 95.91 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.262 0.937 . . . . 0.0 110.599 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -61.38 -44.32 97.36 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.228 1.011 . . . . 0.0 110.176 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . 0.262 0.2 OUTLIER -67.97 -46.47 71.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.809 -179.375 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.8 mt -51.52 -42.81 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 119.373 0.988 . . . . 0.0 109.245 172.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.44 -30.1 70.37 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.68 1.127 . . . . 0.0 111.532 -172.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 47.1 mttt -71.98 -45.75 59.87 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.272 1.429 . . . . 0.0 110.863 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.2 pt -86.11 -27.56 6.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.684 1.193 . . . . 0.0 113.875 -171.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 C--O 1.248 1.012 0 C-N-CA 126.194 1.798 . . . . 0.0 111.009 176.588 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.8 mmtt . . . . . 0 N--CA 1.465 0.318 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.8 mttt -101.96 120.06 39.79 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 118.753 -0.642 . . . . 0.0 109.568 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.46 ' HA ' HG13 ' A' ' 75' ' ' VAL . 13.9 p -99.75 140.26 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 121.469 0.652 . . . . 0.0 110.438 175.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 33.9 tpp -121.37 140.61 51.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.596 -1.184 . . . . 0.0 108.202 169.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -112.5 127.11 55.96 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 169.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.5 t -128.92 126.5 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 120.088 1.313 . . . . 0.0 108.446 -169.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.7 t -134.68 156.49 48.68 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 119.106 0.867 . . . . 0.0 112.658 -174.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -56.94 -23.0 42.11 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.225 1.01 . . . . 0.0 111.405 169.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.6 ptt-85 -148.82 107.81 3.88 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 169.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -47.46 -36.49 10.15 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.225 1.01 . . . . 0.0 112.0 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.3 m -43.7 -24.5 0.12 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 130.931 3.693 . . . . 0.0 118.717 -169.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.0 p -130.92 -79.84 0.53 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 120.018 1.281 . . . . 0.0 112.44 -169.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -56.79 -52.18 66.06 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.358 1.063 . . . . 0.0 109.664 -169.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.13 -46.69 79.93 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 126.37 1.868 . . . . 0.0 111.558 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -62.22 -41.02 98.01 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.096 0.407 . . . . 0.0 111.14 -174.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 44.1 mtm -62.69 -47.89 81.67 Favored 'General case' 0 CA--C 1.529 0.15 0 O-C-N 122.3 -0.25 . . . . 0.0 111.127 172.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.32 -38.94 78.11 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 117.887 0.312 . . . . 0.0 111.227 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -62.49 -51.05 68.99 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.345 1.458 . . . . 0.0 109.445 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.46 -42.52 99.05 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 119.501 -0.61 . . . . 0.0 112.248 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -67.14 -49.47 64.7 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 119.006 1.403 . . . . 0.0 108.971 177.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.27 -36.84 76.27 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 119.303 0.956 . . . . 0.0 112.415 -176.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -72.17 -35.95 69.15 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 119.383 0.992 . . . . 0.0 110.633 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.0 m -66.99 -42.14 85.55 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 119.98 -1.7 . . . . 0.0 110.476 177.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.4 mt -75.83 -31.47 59.37 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.887 1.675 . . . . 0.0 111.512 -173.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.928 0 CA-C-O 117.212 -1.882 . . . . 0.0 117.539 -170.349 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.9 pt . . . . . 0 C--O 1.235 0.316 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.68 123.74 50.01 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 170.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.27 143.9 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 C-N-CA 126.441 1.896 . . . . 0.0 109.516 -169.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 86.7 m -152.04 160.41 43.46 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.841 1.656 . . . . 0.0 106.78 169.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.1 p -130.48 161.26 31.83 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.745 0.818 . . . . 0.0 109.688 168.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.2 p -153.77 -168.85 3.1 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 176.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.36 166.91 34.91 Favored Glycine 0 N--CA 1.448 -0.522 0 O-C-N 121.283 -0.885 . . . . 0.0 111.59 170.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.2 mp -52.15 -36.86 52.68 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.742 1.217 . . . . 0.0 110.014 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -142.89 144.65 32.54 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 169.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 p -84.0 155.72 22.62 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.674 0.749 . . . . 0.0 110.935 174.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.9 m -163.23 151.48 13.78 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 128.033 2.533 . . . . 0.0 105.203 169.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -55.45 156.41 4.55 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.028 0.831 . . . . 0.0 111.959 -170.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.2 t -60.92 135.17 25.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -72.66 143.02 84.33 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 123.614 0.766 . . . . 0.0 109.07 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.43 -42.07 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 121.426 1.417 . . . . 0.0 113.11 -169.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.524 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 21.5 m -66.66 -17.02 64.62 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.172 -1.58 . . . . 0.0 111.956 -176.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.433 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -56.37 -39.32 72.72 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.292 -0.88 . . . . 0.0 110.935 169.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 62.5 mt -56.66 -48.09 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.65 -40.71 93.03 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 123.967 0.907 . . . . 0.0 111.489 -173.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.2 mmt -59.54 -48.18 82.66 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 122.934 1.349 . . . . 0.0 111.517 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.0 mtp -68.17 -35.93 78.81 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.886 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -61.31 -30.15 70.31 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 118.783 -0.627 . . . . 0.0 111.64 172.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -65.13 -36.31 83.85 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.057 0.844 . . . . 0.0 110.435 175.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.1 t -80.99 -25.45 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 117.606 0.184 . . . . 0.0 111.058 176.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.91 27.81 5.26 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.692 1.139 . . . . 0.0 111.741 -177.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.541 HG22 ' H ' ' A' ' 56' ' ' ASP . 10.7 mt -123.32 -178.74 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 126.222 1.809 . . . . 0.0 106.874 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.541 ' H ' HG22 ' A' ' 55' ' ' ILE . 12.5 t70 -147.22 156.45 42.96 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.156 1.382 . . . . 0.0 109.483 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.442 HD13 HG21 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -128.49 -14.25 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.99 0.916 . . . . 0.0 112.341 169.833 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -46.83 -38.18 9.87 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.647 1.179 . . . . 0.0 112.678 173.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.65 -4.99 85.88 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 118.604 -1.109 . . . . 0.0 113.988 -172.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -128.64 167.06 17.73 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.135 1.467 . . . . 0.0 111.393 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.9 p -126.24 166.14 17.65 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.487 1.115 . . . . 0.0 111.566 -169.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.0 m -81.51 162.7 23.12 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.188 0.995 . . . . 0.0 111.252 175.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -153.56 144.12 15.81 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-O 118.47 -0.776 . . . . 0.0 109.973 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.77 152.74 17.2 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.423 2.082 . . . . 0.0 111.229 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.3 tt -55.88 -33.92 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 123.562 0.745 . . . . 0.0 111.202 174.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -57.94 -22.98 51.6 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.165 1.786 . . . . 0.0 112.39 -175.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -80.98 -5.65 57.81 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.988 0.915 . . . . 0.0 112.818 -176.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -126.13 -179.93 4.95 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.552 1.069 . . . . 0.0 111.805 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.01 139.31 51.05 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 127.558 2.343 . . . . 0.0 106.983 169.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.42 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -70.16 -22.39 62.97 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.207 1.003 . . . . 0.0 112.231 -177.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -61.77 -22.35 65.35 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.284 1.034 . . . . 0.0 112.507 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -83.8 -16.01 46.24 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.851 0.86 . . . . 0.0 110.491 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -103.77 130.09 51.26 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 125.176 1.39 . . . . 0.0 109.493 -172.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -78.81 -36.52 42.52 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 122.728 0.411 . . . . 0.0 111.166 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.46 HG13 ' HA ' ' A' ' 4' ' ' VAL . 1.4 p -133.39 132.95 57.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -171.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.5 m -125.67 108.06 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-O 123.124 1.44 . . . . 0.0 109.042 -173.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.7 mm -103.13 96.78 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.4 m -73.38 157.68 36.48 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 167.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.96 26.37 1.88 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 174.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 74.9 m . . . . . 0 CA--C 1.531 0.217 0 C-N-CA 125.648 1.579 . . . . 0.0 111.75 -171.486 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 N--CA 1.466 0.373 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.42 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 77.3 m95 -62.55 11.23 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 128.732 2.813 . . . . 0.0 113.857 176.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.7 p -119.38 15.21 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 124.824 1.25 . . . . 0.0 111.609 174.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.5 p -130.23 17.44 5.5 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -171.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -91.37 179.12 5.77 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.36 1.464 . . . . 0.0 109.464 178.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -61.57 -33.63 74.2 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.636 1.174 . . . . 0.0 113.551 -171.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.8 mt -137.7 134.0 45.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -137.35 138.63 40.15 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 171.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -146.53 158.84 43.96 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.016 1.727 . . . . 0.0 107.362 169.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -123.16 100.06 6.67 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.869 1.267 . . . . 0.0 108.612 168.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.475 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 43.8 m0 -73.02 102.16 3.43 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.268 1.027 . . . . 0.0 108.832 -177.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -68.89 93.16 0.54 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.659 1.184 . . . . 0.0 109.259 176.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.5 153.36 35.45 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 125.481 1.512 . . . . 0.0 109.974 -172.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -85.66 53.36 2.74 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.432 1.493 . . . . 0.0 111.829 -171.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.8 t70 5.62 87.07 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 129.287 3.035 . . . . 0.0 114.106 169.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.463 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 50.7 Cg_exo -61.64 -4.85 4.91 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.864 3.042 . . . . 0.0 116.805 -172.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -54.5 93.03 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.988 1.267 . . . . 0.0 112.686 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.08 17.75 39.36 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 126.329 1.918 . . . . 0.0 113.419 172.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.463 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 23.3 mm-40 -95.0 178.25 5.62 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.987 1.393 . . . . 0.0 113.055 -169.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.6 m -77.45 156.13 31.3 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.994 1.718 . . . . 0.0 110.139 175.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 99.8 mt -59.14 -32.48 69.91 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.785 -0.572 . . . . 0.0 111.817 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.67 -39.14 93.0 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.656 0.382 . . . . 0.0 110.622 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 90.6 t -67.82 -45.07 84.98 Favored 'Isoleucine or valine' 0 C--N 1.338 0.083 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.524 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 17.4 m-85 -56.9 -50.38 72.71 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 119.023 -0.513 . . . . 0.0 111.043 176.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 -58.82 -41.76 87.57 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.024 0.829 . . . . 0.0 111.663 176.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.7 m -60.89 -49.75 76.22 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 118.836 0.744 . . . . 0.0 109.489 177.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.7 t -65.26 -39.21 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-O 117.748 -1.12 . . . . 0.0 110.654 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.6 ttp-105 -55.35 -48.59 73.99 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 120.354 1.434 . . . . 0.0 108.898 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.05 -47.76 89.56 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-O 118.326 -1.263 . . . . 0.0 110.196 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -56.27 -56.08 25.42 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.518 1.159 . . . . 0.0 110.151 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.6 t -55.82 -54.2 29.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 126.746 2.018 . . . . 0.0 110.851 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -63.01 -47.63 82.25 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 119.645 1.111 . . . . 0.0 110.158 -169.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -41.69 72.38 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 123.781 0.833 . . . . 0.0 110.995 174.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.475 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 45.7 mtt85 -71.45 -42.71 67.84 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.676 -177.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.453 ' HA ' HD23 ' A' ' 126' ' ' LEU . 71.5 t -53.02 -47.81 53.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 120.732 1.605 . . . . 0.0 109.769 169.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -61.48 -41.04 96.65 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 118.894 0.77 . . . . 0.0 110.767 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -62.19 -46.36 89.27 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 123.099 0.56 . . . . 0.0 110.264 175.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 123' ' ' VAL . 0.2 OUTLIER -62.18 -46.32 89.47 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 118.249 -0.881 . . . . 0.0 109.793 -177.298 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 71.7 mt -57.0 -40.14 70.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.791 0.836 . . . . 0.0 109.596 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.62 -31.3 72.45 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 120.147 1.34 . . . . 0.0 111.593 -175.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -64.08 -36.24 83.37 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.28 1.032 . . . . 0.0 111.827 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 pt -104.14 -25.28 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -169.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.7 m . . . . . 0 C--O 1.248 0.996 0 C-N-CA 125.785 1.634 . . . . 0.0 111.143 179.489 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? . . . . . 0 N--CA 1.465 0.28 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -93.9 110.7 22.36 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 170.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 85.5 t -93.06 136.97 23.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 125.582 1.553 . . . . 0.0 107.966 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 39.6 tpp -119.06 143.06 47.33 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.458 1.103 . . . . 0.0 108.63 172.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -121.09 122.64 40.49 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.958 1.303 . . . . 0.0 108.114 170.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.8 t -127.45 123.91 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 120.771 1.623 . . . . 0.0 109.498 -174.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.4 t -118.39 165.11 14.27 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.872 0.76 . . . . 0.0 109.756 176.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -65.7 -11.54 46.13 Favored 'General case' 0 CA--C 1.548 0.893 0 O-C-N 121.82 -0.55 . . . . 0.0 111.548 169.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -154.47 107.53 2.85 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 128.238 2.615 . . . . 0.0 105.307 169.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -47.16 -38.42 11.77 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.927 1.291 . . . . 0.0 113.014 -178.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.9 p -38.77 -33.05 0.1 Allowed 'General case' 0 C--O 1.236 0.362 0 C-N-CA 129.507 3.123 . . . . 0.0 117.852 -169.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.8 m -122.62 -76.21 0.59 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.659 0.663 . . . . 0.0 111.791 -169.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -58.99 -51.11 71.5 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.264 0.484 . . . . 0.0 109.751 -169.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.76 -42.51 81.63 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.34 0.656 . . . . 0.0 111.271 -173.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -59.65 -45.05 93.2 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.547 0.739 . . . . 0.0 111.1 -175.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 53.5 mtm -65.66 -45.82 81.49 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 117.563 0.165 . . . . 0.0 111.07 176.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.43 -39.09 75.5 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 117.592 0.178 . . . . 0.0 110.859 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -65.41 -54.56 26.9 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.484 -0.77 . . . . 0.0 110.682 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.71 -41.38 50.39 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-O 119.271 -0.739 . . . . 0.0 112.456 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -68.02 -46.94 69.81 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 118.938 1.369 . . . . 0.0 109.457 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.04 -46.29 85.6 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 120.188 1.358 . . . . 0.0 112.894 -176.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -69.54 -5.77 26.47 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.523 1.056 . . . . 0.0 113.57 175.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.0 m -97.7 -47.99 5.39 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 119.927 1.239 . . . . 0.0 110.255 170.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 97.0 mt -77.45 -41.35 39.98 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.608 1.563 . . . . 0.0 111.86 -169.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.374 0 CA-C-O 117.86 -1.522 . . . . 0.0 114.877 -169.157 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.5 pt . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 121.313 0.578 . . . . 0.0 111.722 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -121.94 131.97 54.3 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 104.191 -2.522 . . . . 0.0 104.191 168.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 p -117.67 151.68 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -169.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.6 m -144.49 144.03 31.16 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 167.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.5 p -112.37 153.05 27.88 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 168.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.9 m -151.08 -170.13 3.58 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.39 160.56 29.94 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 169.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.1 mt -53.69 -30.65 44.63 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.369 0.668 . . . . 0.0 110.788 173.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -143.82 146.75 33.3 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 168.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.6 p -75.15 165.91 24.48 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.01 0.909 . . . . 0.0 111.756 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.7 p -151.59 -148.01 0.25 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.565 1.946 . . . . 0.0 106.322 173.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -133.13 155.65 48.89 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 173.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.4 t -63.21 128.71 25.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -173.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -70.96 137.85 85.05 Favored Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -70.58 -38.09 6.42 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 121.974 1.782 . . . . 0.0 112.428 -169.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.494 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 10.4 m -67.65 -18.86 65.1 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.407 -0.808 . . . . 0.0 111.878 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.44 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -58.48 -40.96 84.18 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 121.646 -0.659 . . . . 0.0 110.1 171.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.6 mp -61.99 -43.79 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.24 -37.67 81.09 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -176.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.4 mmt -62.31 -47.61 83.5 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 122.823 1.297 . . . . 0.0 111.441 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.2 mtp -69.0 -34.17 74.85 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.12 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -62.29 -29.83 70.7 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.584 0.754 . . . . 0.0 111.361 172.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -63.75 -39.31 93.97 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.872 0.76 . . . . 0.0 110.247 173.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.7 t -78.96 -25.33 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 121.219 -0.192 . . . . 0.0 110.97 178.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.61 24.89 5.94 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.104 1.335 . . . . 0.0 112.032 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.487 HG22 ' H ' ' A' ' 56' ' ' ASP . 11.8 mt -123.21 179.29 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 125.768 1.627 . . . . 0.0 107.249 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.487 ' H ' HG22 ' A' ' 55' ' ' ILE . 7.5 t70 -144.61 157.95 43.99 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.745 1.618 . . . . 0.0 108.942 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.44 HD12 ' HB1' ' A' ' 46' ' ' ALA . 0.7 OUTLIER -128.86 -16.95 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.888 0.875 . . . . 0.0 112.701 170.503 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 61.4 p -54.1 -28.58 40.3 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 120.076 1.307 . . . . 0.0 112.498 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.38 -11.22 71.44 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.706 1.146 . . . . 0.0 114.146 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -123.21 173.05 8.15 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.291 1.545 . . . . 0.0 111.163 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.4 p -128.53 164.79 22.04 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.458 1.103 . . . . 0.0 111.416 -169.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 73.6 m -80.6 158.62 25.65 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.904 0.882 . . . . 0.0 110.859 170.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -158.0 145.9 13.85 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.0 0.92 . . . . 0.0 109.663 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -82.85 150.83 14.33 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.606 2.204 . . . . 0.0 111.258 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.1 tt -55.55 -33.29 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.392 0.677 . . . . 0.0 111.807 175.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -58.75 -21.68 56.01 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.986 1.714 . . . . 0.0 112.35 -176.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -78.92 -6.94 57.46 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.953 0.901 . . . . 0.0 112.855 -176.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -127.97 -179.84 5.19 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.619 1.1 . . . . 0.0 111.433 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -127.24 127.39 44.34 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.789 2.036 . . . . 0.0 107.886 175.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.519 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -62.26 -24.07 67.05 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 -174.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -64.03 -21.03 66.34 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.775 0.43 . . . . 0.0 112.111 -177.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -81.41 -18.36 45.69 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.459 0.703 . . . . 0.0 110.19 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -97.11 130.26 44.41 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 125.45 1.5 . . . . 0.0 109.062 -177.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -89.65 -22.1 22.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.53 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.99 135.9 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -175.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.2 t -127.94 127.45 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 123.307 1.527 . . . . 0.0 109.566 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 35.4 mm -113.49 98.67 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.3 m -72.4 155.54 40.02 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 167.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.7 49.17 0.87 Allowed 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 102.878 -3.008 . . . . 0.0 102.878 172.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.5 m . . . . . 0 CA--C 1.532 0.26 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 170.727 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 . . . . . 0 CA--C 1.54 0.581 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.519 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 93.9 m95 -62.96 9.05 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.949 2.1 . . . . 0.0 113.01 169.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.3 p -132.15 7.3 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 124.204 1.002 . . . . 0.0 112.509 173.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 82.8 p -116.23 33.18 5.68 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 120.044 1.293 . . . . 0.0 112.852 -169.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -122.01 -172.03 2.36 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.527 1.531 . . . . 0.0 110.222 174.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -59.43 -36.37 75.76 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -168.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.7 mm -133.05 138.52 51.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -173.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -142.94 129.8 20.51 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.226 1.411 . . . . 0.0 107.402 169.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -141.79 158.76 43.41 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 168.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -122.5 101.66 7.62 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.021 1.328 . . . . 0.0 109.46 169.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.422 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 39.5 m0 -78.8 92.73 4.87 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.199 0.999 . . . . 0.0 109.656 -177.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -62.1 120.49 10.97 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 169.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 47.6 mt -151.72 152.96 33.43 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.147 1.779 . . . . 0.0 107.585 -169.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -82.13 71.7 9.18 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.461 1.105 . . . . 0.0 111.448 -176.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -22.38 97.88 0.06 OUTLIER Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 128.678 2.791 . . . . 0.0 112.7 -177.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.437 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 65.0 Cg_exo -59.79 -2.9 1.78 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.292 3.328 . . . . 0.0 117.221 -169.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -50.86 95.85 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.843 1.257 . . . . 0.0 112.656 173.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.36 21.9 46.59 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.29 1.9 . . . . 0.0 113.153 171.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.437 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 23.4 mm-40 -98.73 176.68 5.54 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.952 1.376 . . . . 0.0 112.755 -169.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 44.2 m -74.4 154.69 38.68 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.804 1.641 . . . . 0.0 110.166 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 91.9 mt -58.38 -31.12 67.35 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.796 -0.565 . . . . 0.0 111.658 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -72.31 -33.66 67.54 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.296 0.498 . . . . 0.0 111.155 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 80.8 t -65.43 -46.22 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 171.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.494 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 11.1 m-85 -55.46 -50.38 70.03 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 118.876 -0.583 . . . . 0.0 110.351 175.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -59.37 -43.16 92.91 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.877 0.871 . . . . 0.0 112.207 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 100.0 m -60.96 -51.06 70.85 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 119.01 0.823 . . . . 0.0 109.151 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.0 t -63.69 -45.35 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 117.875 -1.059 . . . . 0.0 110.039 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -55.78 -47.2 77.47 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 119.818 1.19 . . . . 0.0 109.392 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.88 -49.02 83.29 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-O 118.383 -1.231 . . . . 0.0 110.417 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -59.72 -56.83 16.92 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 118.359 1.079 . . . . 0.0 110.398 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.8 t -46.26 -51.32 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 125.888 1.675 . . . . 0.0 110.483 177.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -63.62 -48.71 76.2 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.449 1.022 . . . . 0.0 110.192 -175.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.56 -40.56 72.09 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.377 1.071 . . . . 0.0 111.155 175.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.422 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 82.8 mtt-85 -73.1 -43.26 62.01 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.921 -176.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 69.5 t -54.35 -46.74 69.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 120.417 1.462 . . . . 0.0 108.843 169.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -61.2 -39.54 90.61 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.051 0.841 . . . . 0.0 110.831 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -63.47 -47.43 81.81 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 123.196 0.598 . . . . 0.0 110.308 176.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . 0.251 0.2 OUTLIER -60.52 -44.31 96.16 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 118.858 -0.592 . . . . 0.0 109.724 -178.666 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.1 mt -60.79 -38.05 77.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.514 1.126 . . . . 0.0 110.764 173.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.37 -31.42 72.57 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 120.287 1.403 . . . . 0.0 111.223 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -66.78 -20.49 65.96 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.014 1.325 . . . . 0.0 113.169 177.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.5 pt -127.53 -20.95 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 116.382 1.993 . . . . 0.0 116.382 -167.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 C--O 1.249 1.033 0 C-N-CA 126.371 1.868 . . . . 0.0 111.118 174.501 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? . . . . . 0 N--CA 1.466 0.36 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -83.29 136.07 34.51 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 169.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.9 p -119.64 146.56 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-O 121.928 0.871 . . . . 0.0 109.526 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 33.3 tpp -127.17 142.51 51.48 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.308 -1.315 . . . . 0.0 108.423 -177.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -124.0 121.99 36.71 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 117.66 -1.162 . . . . 0.0 108.113 172.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.6 t -126.19 118.78 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 121.111 1.778 . . . . 0.0 110.055 -170.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.5 t -116.19 162.25 17.74 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.424 1.011 . . . . 0.0 112.081 -178.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.8 mttm -60.81 -17.88 52.25 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.767 0.827 . . . . 0.0 111.649 169.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.1 ptm85 -154.15 112.96 3.65 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 169.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -47.87 -30.57 4.22 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.025 0.93 . . . . 0.0 112.797 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.4 m -35.29 -35.86 0.05 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 130.085 3.354 . . . . 0.0 119.879 -171.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.8 p -137.68 -68.85 0.46 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 120.576 1.534 . . . . 0.0 113.51 -169.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -55.09 -51.1 67.45 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.045 0.838 . . . . 0.0 109.527 -169.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.412 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 0.0 OUTLIER -66.29 -49.14 68.09 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.955 2.102 . . . . 0.0 111.806 -179.478 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -60.26 -43.12 96.42 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.502 0.721 . . . . 0.0 110.847 -175.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 65.9 mtm -66.66 -47.14 73.47 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-O 119.569 -0.253 . . . . 0.0 110.991 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.99 -39.31 71.66 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 117.743 0.247 . . . . 0.0 110.773 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.409 ' HA ' HG21 ' A' ' 32' ' ' VAL . 17.8 tt0 -64.95 -55.22 20.49 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 118.485 -0.769 . . . . 0.0 110.938 177.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.5 -40.45 47.02 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-O 119.346 -0.697 . . . . 0.0 112.516 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -68.08 -47.01 69.44 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 119.008 1.404 . . . . 0.0 109.523 175.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.91 -45.49 90.21 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 120.187 1.358 . . . . 0.0 112.907 -176.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt -69.41 -9.45 53.63 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.685 1.129 . . . . 0.0 113.294 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.3 m -93.55 -48.59 6.29 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 119.852 1.206 . . . . 0.0 110.611 170.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 98.3 mt -77.23 -41.45 41.14 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.808 1.643 . . . . 0.0 111.92 -169.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.38 0 CA-C-O 117.759 -1.578 . . . . 0.0 114.962 -169.113 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.0 pt . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 121.29 0.567 . . . . 0.0 111.845 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -125.79 132.35 52.29 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 169.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.409 HG21 ' HA ' ' A' ' 19' ' ' GLU . 2.8 p -117.08 153.26 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -169.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.5 m -145.65 145.01 30.76 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 167.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.412 ' HB2' ' HB2' ' A' ' 15' ' ' SER . 27.2 p -113.53 157.5 21.95 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 120.896 -1.128 . . . . 0.0 109.008 168.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.5 m -151.37 -175.95 5.38 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.714 1.606 . . . . 0.0 107.035 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -152.4 163.13 30.18 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 169.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.4 mt -53.24 -34.74 58.43 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 124.245 0.614 . . . . 0.0 110.265 174.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -141.9 145.58 34.74 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 104.659 -2.349 . . . . 0.0 104.659 169.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.2 p -75.75 147.4 39.32 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.098 0.475 . . . . 0.0 110.44 174.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 59.5 m -150.51 149.22 29.67 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.145 2.178 . . . . 0.0 105.542 169.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.64 155.56 9.68 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.858 0.863 . . . . 0.0 111.966 -172.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.6 t -65.63 131.07 31.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -73.74 138.97 76.91 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.35 -35.95 4.49 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 121.974 1.782 . . . . 0.0 112.494 -169.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.518 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 4.8 m -67.84 -18.57 64.87 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.093 -1.004 . . . . 0.0 111.945 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.32 -41.44 76.03 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.698 -0.626 . . . . 0.0 110.184 170.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.8 mp -62.78 -41.31 91.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -178.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.7 -36.99 82.5 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 118.341 0.519 . . . . 0.0 112.043 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 24.5 mmt -62.51 -47.69 82.84 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 122.763 1.268 . . . . 0.0 111.463 175.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 10.6 mtp -68.27 -34.0 75.38 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.433 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -63.03 -28.77 70.32 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.128 0.971 . . . . 0.0 111.077 173.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -65.39 -38.72 90.85 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.788 0.722 . . . . 0.0 110.162 172.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.9 t -78.22 -25.09 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 121.256 -0.178 . . . . 0.0 110.809 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.77 25.65 6.14 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.161 1.363 . . . . 0.0 111.953 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 56' ' ' ASP . 10.5 mt -124.2 175.97 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 125.584 1.554 . . . . 0.0 107.348 -178.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.426 ' H ' HG22 ' A' ' 55' ' ' ILE . 12.2 t70 -140.81 158.06 44.5 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.507 1.523 . . . . 0.0 109.154 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.434 HD13 HG21 ' A' ' 57' ' ' ILE . 0.8 OUTLIER -129.34 -18.59 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 118.186 -0.911 . . . . 0.0 112.816 171.124 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.7 m -51.58 -30.16 19.99 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 120.393 1.451 . . . . 0.0 112.274 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.69 -11.56 69.17 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.81 1.195 . . . . 0.0 114.093 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -123.99 168.62 12.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.432 1.493 . . . . 0.0 110.876 176.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.8 p -126.92 172.08 10.74 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.443 1.097 . . . . 0.0 110.85 -173.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.2 m -76.89 165.05 25.21 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.45 0.7 . . . . 0.0 112.173 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.29 142.86 15.33 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 124.349 1.06 . . . . 0.0 108.73 177.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -85.18 153.15 10.9 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.903 2.402 . . . . 0.0 110.095 169.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.1 tt -54.29 -33.28 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 123.524 0.73 . . . . 0.0 111.135 173.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -56.04 -26.25 48.28 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.411 1.884 . . . . 0.0 112.676 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -81.06 -5.44 57.63 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -175.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -130.11 -176.67 4.01 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.151 0.98 . . . . 0.0 111.181 -176.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.67 131.04 33.06 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 126.595 1.958 . . . . 0.0 108.399 -177.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.33 -29.4 67.62 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.599 1.16 . . . . 0.0 113.191 -176.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -60.23 -22.15 62.68 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.976 0.91 . . . . 0.0 112.336 -176.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -85.23 -14.8 45.63 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.545 0.738 . . . . 0.0 110.777 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -109.31 137.31 47.37 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.945 1.298 . . . . 0.0 110.276 -172.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -93.48 -33.78 13.66 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.519 0.727 . . . . 0.0 110.238 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.06 136.45 53.53 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 CA-C-N 118.578 0.626 . . . . 0.0 109.415 -175.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.9 t -128.49 115.96 39.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 122.929 1.347 . . . . 0.0 108.531 -175.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.9 mm -107.79 93.91 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.3 m -71.24 157.29 38.38 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 117.759 -1.576 . . . . 0.0 106.857 168.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.82 46.88 0.94 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 177.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 86.2 m . . . . . 0 N--CA 1.454 -0.259 0 C-N-CA 123.553 0.741 . . . . 0.0 109.323 177.258 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -55.51 -25.74 38.94 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.826 -1.171 . . . . 0.0 111.871 171.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.7 p -84.8 -18.3 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 119.637 1.108 . . . . 0.0 110.347 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 56.8 p -100.42 18.51 18.82 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.591 0.756 . . . . 0.0 112.683 -169.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -83.98 -172.71 4.31 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.896 0.879 . . . . 0.0 109.72 173.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -63.44 -34.62 78.15 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.426 0.691 . . . . 0.0 112.344 -169.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.0 mt -140.73 140.13 33.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 -174.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -140.1 137.87 34.85 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.623 1.169 . . . . 0.0 108.228 170.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -146.5 160.17 42.46 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.695 1.598 . . . . 0.0 107.726 168.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -122.53 95.73 4.75 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.117 1.367 . . . . 0.0 108.533 169.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.443 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 46.1 m0 -68.45 101.4 1.24 Allowed 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.418 1.087 . . . . 0.0 109.432 -177.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -61.21 120.59 10.65 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 169.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.7 mt -157.78 146.77 19.55 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.161 1.385 . . . . 0.0 107.993 -169.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.9 mp0 -86.61 60.25 6.12 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.375 1.87 . . . . 0.0 111.925 -169.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -1.59 85.67 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 129.672 3.189 . . . . 0.0 113.852 174.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.44 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 71.6 Cg_exo -59.64 -11.13 13.32 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.963 3.109 . . . . 0.0 117.85 -169.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.3 96.18 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 120.46 1.482 . . . . 0.0 111.495 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.4 13.11 29.25 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 126.402 1.953 . . . . 0.0 113.232 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.44 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 24.9 mm-40 -98.72 178.12 5.08 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.182 1.491 . . . . 0.0 112.765 -169.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.9 m -76.35 154.98 34.53 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.975 1.71 . . . . 0.0 110.059 175.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.9 mt -59.3 -30.96 68.71 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.708 -0.62 . . . . 0.0 111.889 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -62.11 -40.11 94.8 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.134 0.574 . . . . 0.0 110.521 175.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.7 t -68.9 -43.8 82.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.518 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 13.3 m-85 -55.44 -52.07 64.82 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.538 175.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -60.1 -41.54 92.76 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.413 0.685 . . . . 0.0 111.772 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 56.3 m -61.0 -46.19 91.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.78 0.718 . . . . 0.0 110.0 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.7 t -69.07 -43.84 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-O 117.853 -1.07 . . . . 0.0 110.265 177.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -56.45 -44.79 80.82 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 119.828 1.195 . . . . 0.0 109.438 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.16 -50.25 69.27 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-O 118.33 -1.261 . . . . 0.0 110.576 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -57.52 -57.05 14.38 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 118.311 1.055 . . . . 0.0 110.098 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.6 t -48.91 -52.95 8.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.937 1.695 . . . . 0.0 110.619 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -64.68 -48.89 73.05 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 119.159 0.891 . . . . 0.0 109.795 -171.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.62 -44.33 69.41 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.924 0.89 . . . . 0.0 110.46 174.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.443 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 96.4 mtt180 -72.45 -39.37 67.84 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 117.484 -1.246 . . . . 0.0 110.764 -175.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 72.5 t -55.26 -48.68 76.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 121.046 1.748 . . . . 0.0 108.724 169.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -60.42 -38.81 85.25 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.226 0.921 . . . . 0.0 110.778 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -64.71 -45.19 87.6 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.508 1.123 . . . . 0.0 110.352 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.58 -46.97 85.9 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 124.102 0.961 . . . . 0.0 109.434 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.7 mt -59.16 -38.04 71.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.607 1.163 . . . . 0.0 110.861 175.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.77 -30.08 70.56 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 120.011 1.278 . . . . 0.0 111.413 -173.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -71.61 -19.56 62.1 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.833 1.653 . . . . 0.0 112.976 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.4 pt -126.26 -20.35 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 126.018 1.727 . . . . 0.0 115.269 -168.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.5 m . . . . . 0 C--O 1.248 0.99 0 C-N-CA 126.471 1.908 . . . . 0.0 111.019 171.018 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt . . . . . 0 N--CA 1.464 0.244 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -97.25 133.62 41.64 Favored 'General case' 0 CA--C 1.511 -0.547 0 O-C-N 121.48 -0.762 . . . . 0.0 109.234 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.9 p -114.77 140.9 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 123.293 0.637 . . . . 0.0 109.662 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 44.2 tpp -119.94 143.8 47.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.973 169.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -117.9 135.62 54.0 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.972 1.309 . . . . 0.0 107.717 169.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.1 t -141.4 123.88 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 120.017 1.281 . . . . 0.0 109.274 -173.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.4 p -127.59 174.69 8.85 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.805 1.184 . . . . 0.0 111.019 173.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -66.04 -16.44 63.92 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.227 0.611 . . . . 0.0 112.415 173.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -152.14 101.79 2.74 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 170.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -40.02 -36.67 0.5 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.255 1.822 . . . . 0.0 113.252 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.6 m -37.21 -32.12 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 129.421 3.088 . . . . 0.0 116.936 -178.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 71.5 m -119.87 -84.96 0.66 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.172 0.896 . . . . 0.0 112.4 -169.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.429 ' HD3' ' HD2' ' A' ' 104' ' ' PRO . 0.3 OUTLIER -60.02 -51.9 67.69 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.501 1.046 . . . . 0.0 110.069 -169.479 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.416 ' HB3' ' HB2' ' A' ' 34' ' ' SER . 1.4 m -56.34 -50.19 72.21 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.247 1.019 . . . . 0.0 110.519 -173.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -61.64 -45.07 95.63 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.434 0.694 . . . . 0.0 111.344 -173.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 65.7 mtm -64.22 -47.04 81.21 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 119.446 -0.311 . . . . 0.0 110.927 175.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.69 -40.04 71.82 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 122.451 0.3 . . . . 0.0 110.681 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -64.54 -55.03 23.2 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.414 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.42 -38.09 68.41 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 119.457 -0.635 . . . . 0.0 111.702 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -67.73 -47.76 68.37 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 118.753 1.276 . . . . 0.0 108.775 175.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.64 -44.82 93.38 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.931 1.241 . . . . 0.0 113.312 -175.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 ptmt -68.98 -9.0 50.05 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 119.736 1.153 . . . . 0.0 113.145 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.6 m -93.51 -47.52 6.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 119.783 1.174 . . . . 0.0 110.459 169.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.2 mt -76.39 -40.77 50.04 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 126.04 1.736 . . . . 0.0 112.076 -169.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.36 0 CA-C-O 117.879 -1.512 . . . . 0.0 115.296 -169.217 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.8 pt . . . . . 0 N--CA 1.452 -0.375 0 CA-C-O 121.523 0.678 . . . . 0.0 112.01 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -122.77 132.42 54.22 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 169.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -117.39 150.83 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 C-N-CA 124.02 0.928 . . . . 0.0 112.06 -170.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.4 m -144.23 152.55 40.99 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 167.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.416 ' HB2' ' HB3' ' A' ' 15' ' ' SER . 43.9 p -131.2 156.97 44.44 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 167.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.1 p -155.73 -159.99 0.97 Allowed 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.97 163.95 32.06 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 169.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 67.2 mt -52.93 -34.0 53.28 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.59 0.756 . . . . 0.0 109.622 172.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -142.6 146.22 34.33 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 103.199 -2.889 . . . . 0.0 103.199 168.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.3 m -124.51 148.6 47.64 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.287 0.565 . . . . 0.0 111.456 -178.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.3 m -143.86 168.59 19.6 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.997 2.519 . . . . 0.0 106.303 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.0 ptt85 -54.22 158.97 2.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.979 0.809 . . . . 0.0 112.478 -172.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.9 t -62.62 136.15 26.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -73.85 143.27 81.07 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.96 -40.98 0.57 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.307 1.338 . . . . 0.0 112.79 -169.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.527 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 11.5 m -67.3 -16.92 64.54 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.368 -1.458 . . . . 0.0 111.898 -177.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.443 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -55.52 -40.07 71.33 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.698 0.799 . . . . 0.0 110.503 169.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 59.4 mt -57.74 -48.39 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.97 -37.6 85.37 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 123.654 0.782 . . . . 0.0 111.828 -174.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 20.2 mmt -61.28 -47.58 85.34 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 122.858 1.313 . . . . 0.0 111.31 175.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 9.3 mtp -69.39 -33.11 72.54 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.516 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -61.89 -29.01 69.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.858 -0.592 . . . . 0.0 111.588 170.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -65.59 -36.32 83.4 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.18 0.9 . . . . 0.0 110.446 173.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.67 -25.71 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 117.474 0.124 . . . . 0.0 110.769 176.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.43 28.26 7.23 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.546 1.069 . . . . 0.0 111.461 -174.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.598 HG22 ' H ' ' A' ' 56' ' ' ASP . 7.6 mt -122.93 -177.53 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.598 ' H ' HG22 ' A' ' 55' ' ' ILE . 12.3 t70 -146.45 157.02 43.7 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.364 1.466 . . . . 0.0 109.158 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.443 HD12 ' HB1' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -127.47 -16.48 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.703 0.801 . . . . 0.0 112.339 169.889 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -45.29 -38.18 5.42 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.693 1.197 . . . . 0.0 112.768 173.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.88 -5.46 88.72 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 118.517 -1.157 . . . . 0.0 114.335 -173.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -125.86 168.19 14.19 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.319 1.56 . . . . 0.0 110.875 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.8 p -127.84 168.61 14.94 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.016 0.926 . . . . 0.0 111.542 -169.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.2 m -82.16 163.36 22.0 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.401 1.08 . . . . 0.0 111.426 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -156.8 141.34 12.0 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.495 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -81.88 151.72 16.64 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.826 2.351 . . . . 0.0 111.173 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.1 tt -57.33 -31.13 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 121.725 -0.609 . . . . 0.0 111.833 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -56.76 -22.3 34.72 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.704 2.001 . . . . 0.0 112.111 -177.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -82.04 -7.99 59.64 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.56 1.144 . . . . 0.0 113.096 -176.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -128.57 -178.5 4.61 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 120.025 1.284 . . . . 0.0 111.607 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -127.66 141.86 51.5 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 127.247 2.219 . . . . 0.0 107.57 169.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.09 -22.99 65.8 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.889 1.276 . . . . 0.0 111.985 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -60.21 -23.14 63.78 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.054 0.942 . . . . 0.0 112.352 -176.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -83.07 -12.25 57.3 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.875 0.87 . . . . 0.0 110.728 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -111.3 126.93 55.42 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 125.644 1.578 . . . . 0.0 109.368 -170.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -72.61 -42.13 64.82 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 175.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.4 p -128.02 134.06 65.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 C-N-CA 122.942 0.497 . . . . 0.0 110.123 -169.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.4 m -127.91 108.26 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-O 123.341 1.543 . . . . 0.0 109.141 -172.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.4 mm -104.12 100.34 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 114.22 -1.355 . . . . 0.0 107.388 -175.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.4 t -74.01 157.14 36.68 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 167.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.13 51.38 0.6 Allowed 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 175.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.7 p . . . . . 0 CA--C 1.534 0.334 0 O-C-N 120.712 -1.243 . . . . 0.0 110.907 -169.998 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 61.2 m95 -66.28 8.3 0.24 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 126.7 2.0 . . . . 0.0 113.152 171.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.1 p -118.06 2.68 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 124.891 1.277 . . . . 0.0 111.512 171.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.1 p -128.5 26.43 5.65 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.111 0.964 . . . . 0.0 112.131 -172.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -92.57 -173.1 3.26 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.548 0.739 . . . . 0.0 109.558 170.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -65.72 -33.44 75.88 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -169.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.2 mt -137.25 132.62 46.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -138.48 140.46 39.21 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -147.58 159.07 44.17 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.276 1.43 . . . . 0.0 107.34 168.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -122.22 110.7 16.05 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.718 1.207 . . . . 0.0 108.934 168.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.436 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 37.1 m0 -87.39 84.68 7.15 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.28 1.032 . . . . 0.0 108.461 -178.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -56.95 120.85 8.66 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 170.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 25.1 mt -151.03 153.05 34.38 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.986 1.314 . . . . 0.0 108.602 -169.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -78.16 74.83 4.7 Favored 'General case' 0 CA--C 1.523 -0.092 0 C-N-CA 125.105 1.362 . . . . 0.0 111.525 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -28.68 102.77 0.16 Allowed Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 127.432 2.293 . . . . 0.0 113.668 -175.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.482 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 87.3 Cg_exo -63.68 -0.37 2.47 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.966 3.111 . . . . 0.0 117.425 -169.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -56.04 102.93 0.08 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 119.964 1.256 . . . . 0.0 111.702 178.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.34 22.06 59.4 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 126.201 1.857 . . . . 0.0 113.134 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.482 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 21.5 mm-40 -97.68 177.37 5.51 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.703 1.251 . . . . 0.0 112.554 -169.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.8 m -74.37 154.97 38.6 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.431 1.493 . . . . 0.0 109.814 176.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 91.5 mt -59.3 -30.58 68.44 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 122.001 -0.437 . . . . 0.0 111.656 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -62.77 -39.25 93.59 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.405 0.548 . . . . 0.0 110.918 176.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 89.0 t -67.9 -46.07 82.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.527 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 14.7 m-85 -55.34 -50.46 69.59 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.896 175.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 -59.85 -42.6 94.0 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.959 0.904 . . . . 0.0 111.74 177.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.7 m -60.78 -50.54 73.05 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 118.935 0.789 . . . . 0.0 109.363 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.6 t -66.1 -44.47 91.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 117.626 -1.178 . . . . 0.0 110.316 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 48.0 ttp85 -53.08 -47.36 68.6 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 120.093 1.315 . . . . 0.0 108.988 176.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.98 -47.9 81.18 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-O 118.481 -1.177 . . . . 0.0 110.598 -175.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -61.21 -56.7 17.64 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 118.292 1.046 . . . . 0.0 110.37 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 82.4 t -50.09 -49.95 20.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 125.132 1.373 . . . . 0.0 110.386 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -62.03 -48.43 80.33 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 120.207 1.367 . . . . 0.0 110.445 -176.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -53.91 -45.81 71.26 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 123.681 0.793 . . . . 0.0 109.751 174.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.436 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 76.6 mtt-85 -70.82 -39.54 72.98 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 118.257 -0.878 . . . . 0.0 109.925 -173.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 75.4 t -55.6 -48.8 77.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 120.437 1.471 . . . . 0.0 109.189 169.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -60.94 -38.87 87.35 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.659 1.118 . . . . 0.0 110.754 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -62.04 -46.73 87.85 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.806 1.642 . . . . 0.0 109.832 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.28 -45.76 83.16 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 123.75 0.82 . . . . 0.0 110.106 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 60.1 mt -57.44 -38.32 62.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.574 1.149 . . . . 0.0 110.468 175.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.26 -29.19 69.7 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.873 1.215 . . . . 0.0 111.447 -173.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -73.75 -19.14 60.87 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.079 1.752 . . . . 0.0 112.802 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 pt -126.51 -20.08 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 126.21 1.804 . . . . 0.0 114.966 -168.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 C--O 1.25 1.124 0 C-N-CA 126.504 1.922 . . . . 0.0 110.9 170.11 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt . . . . . 0 C--O 1.231 0.12 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.7 mttt -106.48 124.74 50.05 Favored 'General case' 0 CA--C 1.508 -0.657 0 C-N-CA 122.885 0.474 . . . . 0.0 109.936 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.6 p -105.16 140.67 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 O-C-N 123.626 0.579 . . . . 0.0 110.656 175.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 39.7 tpp -119.07 142.39 47.91 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 169.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -116.08 134.53 54.84 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 169.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.3 t -136.9 123.05 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 119.641 1.11 . . . . 0.0 108.643 -171.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.4 t -123.23 157.12 33.79 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.066 0.848 . . . . 0.0 109.691 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.319 20.9 pttp -67.52 -2.48 6.59 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 175.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -139.17 -5.12 1.46 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 168.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 63.86 -44.13 0.26 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 127.332 2.253 . . . . 0.0 114.571 -172.389 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.3 m -34.03 -37.95 0.05 Allowed 'General case' 0 C--O 1.232 0.132 0 N-CA-C 119.684 3.216 . . . . 0.0 119.684 -168.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.9 p -136.12 -60.07 0.73 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-N 120.0 1.273 . . . . 0.0 112.202 -169.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -60.32 -50.12 74.89 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.001 0.819 . . . . 0.0 109.956 -171.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.04 -40.87 82.78 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 117.909 0.322 . . . . 0.0 110.579 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -61.75 -47.21 86.25 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.278 0.631 . . . . 0.0 111.131 -173.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.436 ' HG2' HD11 ' A' ' 57' ' ' ILE . 46.5 mtm -64.46 -43.05 95.45 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 119.837 -0.125 . . . . 0.0 110.745 176.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.85 -37.52 74.03 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.048 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.451 ' HA ' HG21 ' A' ' 32' ' ' VAL . 40.4 tt0 -65.73 -46.96 76.96 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 119.181 -0.438 . . . . 0.0 110.641 177.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.83 -42.76 98.24 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -67.48 -49.09 65.11 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 118.619 1.209 . . . . 0.0 109.624 176.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.1 -43.09 86.91 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 119.98 1.264 . . . . 0.0 112.092 -176.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.2 pttt -76.22 -2.46 31.44 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.4 m -98.62 -45.12 6.18 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 120.867 -1.145 . . . . 0.0 109.322 169.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.4 mt -72.15 -40.31 68.11 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.774 1.629 . . . . 0.0 110.79 -172.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.812 0 CA-C-O 117.403 -1.776 . . . . 0.0 116.612 -169.765 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.9 pt . . . . . 0 C--O 1.236 0.343 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.78 133.94 55.42 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 169.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.451 HG21 ' HA ' ' A' ' 19' ' ' GLU . 2.6 p -114.95 153.18 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 C-N-CA 124.074 0.95 . . . . 0.0 111.513 -175.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.9 m -144.01 148.19 34.91 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 167.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 63.2 p -121.92 148.67 44.46 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.33 1.452 . . . . 0.0 108.826 169.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 29.6 p -155.51 -165.11 1.9 Allowed 'General case' 0 C--O 1.241 0.63 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.22 168.48 33.07 Favored Glycine 0 N--CA 1.446 -0.698 0 O-C-N 121.541 -0.724 . . . . 0.0 111.976 169.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.2 mp -49.46 -39.85 34.91 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.044 0.937 . . . . 0.0 109.875 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -146.04 143.48 29.45 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 103.789 -2.671 . . . . 0.0 103.789 168.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.1 p -75.65 156.11 35.15 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 122.121 0.962 . . . . 0.0 111.503 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 63.5 m -158.39 153.92 26.1 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 127.72 2.408 . . . . 0.0 105.143 169.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -54.09 146.64 14.35 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 122.938 0.495 . . . . 0.0 110.894 -171.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 p -60.8 135.82 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 169.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -78.94 143.55 62.05 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 123.587 0.755 . . . . 0.0 109.858 -171.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.1 -41.63 0.28 Allowed 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 121.495 1.463 . . . . 0.0 112.409 -169.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.48 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 25.3 m -62.73 -24.57 67.75 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 120.422 -1.424 . . . . 0.0 111.292 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.417 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -51.36 -40.07 58.42 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.718 0.807 . . . . 0.0 111.663 173.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 62.9 mt -55.6 -46.0 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.12 -38.91 89.36 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 124.425 1.09 . . . . 0.0 110.161 -170.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.2 mmm -68.19 -44.19 76.44 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.744 1.259 . . . . 0.0 110.63 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.0 mtp -65.22 -35.87 82.39 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.221 -0.924 . . . . 0.0 109.963 175.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -63.89 -24.86 67.91 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.359 0.664 . . . . 0.0 111.489 173.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -65.82 -40.01 91.43 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 118.848 0.749 . . . . 0.0 109.746 172.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 92.7 t -76.78 -25.41 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.602 176.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.25 25.66 5.47 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.152 1.358 . . . . 0.0 111.727 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.525 HG22 ' H ' ' A' ' 56' ' ' ASP . 10.5 mt -123.37 178.85 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 125.128 1.371 . . . . 0.0 107.379 -178.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.525 ' H ' HG22 ' A' ' 55' ' ' ILE . 12.9 t70 -142.84 155.26 44.75 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.219 1.408 . . . . 0.0 109.557 -176.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.457 HD13 HG21 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -127.94 -13.88 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 123.955 0.902 . . . . 0.0 112.562 169.979 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -46.74 -37.17 8.07 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.53 1.132 . . . . 0.0 112.75 172.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.16 -6.23 85.96 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 118.697 -1.057 . . . . 0.0 114.248 -173.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -126.81 170.03 12.61 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.077 1.439 . . . . 0.0 111.204 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.6 p -129.2 166.57 19.12 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.645 1.178 . . . . 0.0 111.184 -170.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.2 m -92.08 155.78 17.83 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.798 1.239 . . . . 0.0 110.034 173.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -156.9 144.23 13.78 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 124.299 1.039 . . . . 0.0 110.07 -169.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.56 148.99 23.63 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 121.735 1.624 . . . . 0.0 111.158 -176.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.2 tt -52.01 -34.1 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.306 1.042 . . . . 0.0 111.761 173.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -58.44 -23.16 56.77 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.119 1.768 . . . . 0.0 112.404 -175.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -82.13 -6.83 59.48 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.916 0.886 . . . . 0.0 112.814 -175.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -125.39 -174.73 3.13 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.254 1.022 . . . . 0.0 110.356 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.47 130.71 30.82 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 126.399 1.88 . . . . 0.0 108.449 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.4 -28.39 66.87 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.633 1.173 . . . . 0.0 112.829 -176.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -60.49 -22.55 63.66 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.06 0.944 . . . . 0.0 112.452 -176.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -84.76 -13.2 51.96 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.428 0.691 . . . . 0.0 110.7 -178.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -108.77 127.37 53.95 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.972 1.309 . . . . 0.0 109.593 -172.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -74.17 -40.07 62.79 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.156 0.583 . . . . 0.0 109.967 175.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.97 136.38 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 122.823 0.449 . . . . 0.0 110.411 -169.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.7 m -129.15 110.53 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-O 122.839 1.304 . . . . 0.0 109.55 -170.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.7 mm -109.47 97.41 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -174.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.0 m -73.49 156.09 38.55 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 168.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.41 66.31 0.63 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 77.4 m . . . . . 0 N--CA 1.456 -0.146 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.391 -169.821 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -66.77 11.79 0.09 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.408 1.483 . . . . 0.0 112.624 169.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.7 p -124.01 3.24 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 125.563 1.545 . . . . 0.0 111.508 170.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 52.7 p -127.38 19.5 6.86 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.352 0.978 . . . . 0.0 112.649 -173.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -85.86 -173.64 4.71 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.223 0.609 . . . . 0.0 109.536 171.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -65.91 -32.5 74.04 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -169.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.2 mt -136.3 136.28 49.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -137.33 139.58 40.93 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 170.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -146.75 159.63 43.25 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.436 1.494 . . . . 0.0 107.441 168.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -123.35 96.39 4.97 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.488 1.515 . . . . 0.0 108.955 169.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -73.9 92.81 2.11 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.066 1.346 . . . . 0.0 109.54 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -65.81 97.37 0.34 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.889 1.276 . . . . 0.0 109.532 174.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -125.56 156.2 39.46 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.616 1.566 . . . . 0.0 109.906 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -78.7 66.35 4.18 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.518 1.927 . . . . 0.0 111.701 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -8.87 92.74 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 129.528 3.131 . . . . 0.0 113.553 169.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.415 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 77.5 Cg_exo -60.14 -4.38 2.99 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 124.707 3.605 . . . . 0.0 117.611 -169.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -54.64 98.85 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 120.244 1.384 . . . . 0.0 111.611 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.46 16.89 54.45 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.115 1.817 . . . . 0.0 113.522 170.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.415 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 25.7 mm-40 -94.95 179.59 5.17 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.792 1.296 . . . . 0.0 112.626 -169.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.2 m -76.35 155.43 34.15 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.254 1.422 . . . . 0.0 109.926 175.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.9 mt -58.89 -31.67 68.82 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.957 -0.464 . . . . 0.0 111.559 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -63.96 -40.53 96.63 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.088 0.404 . . . . 0.0 110.894 177.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.4 t -65.8 -47.44 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 176.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.48 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 8.1 m-85 -53.8 -54.24 41.06 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.225 0.61 . . . . 0.0 110.822 177.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 33.6 mtt180 -59.78 -42.06 92.48 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.707 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.5 m -61.67 -52.72 63.16 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 118.828 0.74 . . . . 0.0 109.222 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.3 t -64.04 -44.42 97.76 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.02 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -57.64 -45.5 85.39 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 119.728 1.149 . . . . 0.0 110.189 -177.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.46 -49.28 66.08 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-O 118.684 -1.064 . . . . 0.0 111.153 177.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -59.9 -50.06 75.25 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 118.661 1.231 . . . . 0.0 111.058 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.6 t -54.18 -48.13 66.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 124.634 1.174 . . . . 0.0 109.921 178.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -60.13 -46.94 87.96 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 120.071 1.305 . . . . 0.0 110.586 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -42.04 86.07 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.304 1.042 . . . . 0.0 110.68 178.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.6 mtt-85 -71.2 -41.88 69.71 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 117.821 -1.085 . . . . 0.0 109.863 -177.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.421 ' HA ' HD23 ' A' ' 126' ' ' LEU . 94.1 t -54.47 -46.06 70.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 120.461 1.482 . . . . 0.0 109.976 169.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -61.94 -40.21 94.74 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.465 1.03 . . . . 0.0 111.075 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -63.11 -44.62 95.14 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.048 0.539 . . . . 0.0 110.321 176.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 123' ' ' VAL . 0.2 OUTLIER -64.02 -46.79 82.92 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 118.447 -0.787 . . . . 0.0 109.951 -178.254 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.1 mt -52.86 -41.91 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 124.052 0.941 . . . . 0.0 109.423 173.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.31 -31.01 72.05 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.713 1.142 . . . . 0.0 111.571 -175.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -69.65 -39.25 77.18 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.497 1.119 . . . . 0.0 111.504 176.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.0 pt -95.81 -28.7 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -169.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.5 m . . . . . 0 C--O 1.25 1.132 0 C-N-CA 126.079 1.752 . . . . 0.0 111.22 -179.177 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? . . . . . 0 N--CA 1.466 0.366 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.7 mttt -102.72 104.13 14.43 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 123.515 0.726 . . . . 0.0 109.453 175.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 36.4 t -79.0 141.03 15.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 125.259 1.424 . . . . 0.0 108.837 175.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 30.6 tpp -127.18 142.41 51.5 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.707 1.203 . . . . 0.0 108.368 173.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -124.47 133.49 53.34 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.135 0.974 . . . . 0.0 108.893 173.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.3 t -144.19 122.81 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 120.259 1.39 . . . . 0.0 110.027 -169.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.2 p -132.4 179.9 5.84 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 120.058 1.299 . . . . 0.0 111.181 175.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.8 mttm -62.55 -10.57 12.46 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.789 1.236 . . . . 0.0 114.001 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -143.85 -10.45 0.69 Allowed 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 116.026 1.861 . . . . 0.0 116.026 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 63.2 -40.95 0.19 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 128.312 2.645 . . . . 0.0 114.291 -169.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.5 m -34.84 -39.14 0.09 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 129.252 3.021 . . . . 0.0 118.573 -169.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.7 p -132.64 -72.27 0.52 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 118.124 -0.941 . . . . 0.0 109.594 -169.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 -50.62 -52.58 38.12 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.928 0.785 . . . . 0.0 110.387 -169.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.65 -45.02 63.27 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.361 0.664 . . . . 0.0 111.349 -176.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -59.78 -44.01 94.11 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.204 1.002 . . . . 0.0 111.409 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 53.5 mtp -64.57 -48.29 75.52 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.877 1.271 . . . . 0.0 109.295 178.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.8 -40.14 79.22 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.363 0.265 . . . . 0.0 111.149 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -62.56 -46.95 85.97 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.761 0.425 . . . . 0.0 110.556 177.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.35 -43.43 95.68 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 119.443 -0.643 . . . . 0.0 111.875 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -67.24 -48.92 66.34 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 119.025 1.413 . . . . 0.0 109.159 176.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.71 -42.71 79.63 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 119.599 1.091 . . . . 0.0 112.395 -176.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.3 pttt -75.7 -2.41 29.41 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.9 m -99.16 -45.57 5.86 Favored 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 120.917 -1.114 . . . . 0.0 109.437 169.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 91.9 mt -71.25 -40.34 71.07 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.183 1.793 . . . . 0.0 110.945 -173.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.845 0 CA-C-O 117.444 -1.753 . . . . 0.0 116.8 -169.791 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.1 pt . . . . . 0 N--CA 1.451 -0.377 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -120.37 144.39 47.92 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 169.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.92 153.67 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 123.442 0.697 . . . . 0.0 112.631 -174.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.3 m -151.02 144.9 25.17 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.579 1.552 . . . . 0.0 106.873 168.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 97.6 p -112.01 157.74 20.38 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.35 -0.844 . . . . 0.0 109.665 168.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.7 p -152.02 -164.17 1.91 Allowed 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 171.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.32 161.8 35.18 Favored Glycine 0 CA--C 1.519 0.297 0 O-C-N 121.276 -0.89 . . . . 0.0 111.092 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 66.0 mt -54.75 -32.02 59.28 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.407 1.083 . . . . 0.0 111.123 -173.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -146.85 144.54 29.38 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 168.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.6 p -73.5 153.46 40.31 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.741 0.781 . . . . 0.0 111.296 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.3 m -160.21 154.07 22.86 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.502 2.321 . . . . 0.0 105.869 169.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -57.13 156.12 7.59 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.62 0.645 . . . . 0.0 111.408 -174.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.9 t -63.23 132.34 29.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 172.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -73.84 139.8 77.24 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -75.12 -41.59 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.358 1.372 . . . . 0.0 112.614 -169.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.494 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 25.5 m -64.65 -23.02 67.12 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 120.556 -1.34 . . . . 0.0 111.48 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.62 -40.55 60.11 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 123.622 0.769 . . . . 0.0 111.402 171.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 61.7 mt -56.2 -45.38 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.88 -40.17 91.36 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 124.249 1.02 . . . . 0.0 110.056 -171.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.8 mmm -64.47 -44.86 89.7 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 122.145 0.974 . . . . 0.0 110.16 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.1 mtp -66.94 -36.7 82.83 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.721 177.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -61.04 -29.92 70.01 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.306 0.643 . . . . 0.0 111.272 173.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -64.25 -39.81 94.72 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 118.884 0.766 . . . . 0.0 110.213 173.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 62.1 t -77.79 -17.06 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.027 177.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.92 25.44 10.54 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.787 1.184 . . . . 0.0 111.933 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.528 HG22 ' H ' ' A' ' 56' ' ' ASP . 11.9 mt -121.28 179.68 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 125.405 1.482 . . . . 0.0 107.279 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.528 ' H ' HG22 ' A' ' 55' ' ' ILE . 13.8 t70 -144.9 156.0 43.75 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.228 1.411 . . . . 0.0 109.351 -178.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -127.74 -16.85 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.831 0.852 . . . . 0.0 112.443 169.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -44.18 -38.71 3.89 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.692 1.197 . . . . 0.0 112.968 172.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.29 -6.45 86.37 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-O 118.582 -1.121 . . . . 0.0 114.268 -173.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -126.61 164.74 20.58 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.156 1.478 . . . . 0.0 110.732 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.5 p -129.88 167.26 18.44 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.017 0.927 . . . . 0.0 111.74 -169.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.1 m -77.45 164.64 25.26 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.573 1.149 . . . . 0.0 111.761 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -157.63 141.58 11.49 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-O 118.411 -0.804 . . . . 0.0 109.471 174.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -78.09 153.37 28.49 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.557 2.171 . . . . 0.0 111.232 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.1 tt -53.82 -33.86 24.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.798 1.239 . . . . 0.0 112.471 177.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -66.07 -20.98 66.34 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.251 1.42 . . . . 0.0 112.074 -169.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -83.33 -0.98 52.17 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.108 0.963 . . . . 0.0 112.561 -173.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -115.85 -173.12 2.29 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.847 0.859 . . . . 0.0 112.462 -170.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.431 ' HA ' ' CH2' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -142.91 131.39 22.32 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 127.284 2.234 . . . . 0.0 107.846 173.433 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.695 ' HB2' ' CE3' ' A' ' 90' ' ' TRP . . . -62.28 -29.16 70.22 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 119.142 -0.456 . . . . 0.0 112.208 178.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -61.73 -20.36 63.42 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.381 0.672 . . . . 0.0 112.372 -170.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -88.73 -22.84 23.13 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.601 0.76 . . . . 0.0 110.955 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -99.08 113.1 25.14 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.972 1.309 . . . . 0.0 108.832 -176.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -72.31 -28.91 63.38 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 122.315 -0.24 . . . . 0.0 110.875 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.18 135.13 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.081 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -172.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.7 t -131.74 129.63 61.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 122.786 1.279 . . . . 0.0 109.253 -173.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.3 mm -120.32 101.77 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -177.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.5 t -72.42 155.39 40.18 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 105.496 -2.039 . . . . 0.0 105.496 168.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.45 36.3 0.89 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 172.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 90.4 m . . . . . 0 CA--C 1.533 0.313 0 O-C-N 121.08 -1.013 . . . . 0.0 112.15 -173.913 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 122.075 0.94 . . . . 0.0 113.271 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.695 ' CE3' ' HB2' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -49.14 -27.52 3.56 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 128.209 2.604 . . . . 0.0 111.65 169.646 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.21 -2.14 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.811 0.844 . . . . 0.0 110.589 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 56.7 p -120.68 18.96 11.93 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.978 0.911 . . . . 0.0 113.151 -169.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -86.95 179.87 6.63 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.306 1.042 . . . . 0.0 110.339 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -57.3 -34.02 68.27 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.714 1.206 . . . . 0.0 113.082 -169.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.4 mt -132.8 139.15 50.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 174.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -140.61 132.92 28.28 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 169.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -142.27 159.13 42.85 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.292 1.437 . . . . 0.0 108.622 169.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -121.14 111.28 17.22 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.764 1.226 . . . . 0.0 109.428 168.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.427 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 41.0 m0 -85.33 93.83 8.8 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.566 1.146 . . . . 0.0 108.741 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -59.77 116.51 4.12 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 169.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.3 mt -149.68 149.32 30.43 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.565 1.546 . . . . 0.0 107.506 -169.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -84.61 63.23 7.8 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 125.023 1.329 . . . . 0.0 111.137 -175.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -0.99 88.0 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 129.021 2.929 . . . . 0.0 112.918 169.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.497 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 71.0 Cg_exo -58.68 -4.93 2.14 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 124.262 3.308 . . . . 0.0 117.33 -169.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -54.91 99.7 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.392 0.996 . . . . 0.0 111.738 176.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.17 18.06 54.35 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 126.16 1.838 . . . . 0.0 113.324 171.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.497 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 22.1 mm-40 -95.9 178.16 5.52 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.661 1.23 . . . . 0.0 112.562 -169.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.3 m -74.94 154.74 38.01 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.498 1.519 . . . . 0.0 110.048 174.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.9 mt -58.58 -32.67 69.16 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.786 -0.571 . . . . 0.0 111.574 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -63.31 -39.93 95.93 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 122.679 0.392 . . . . 0.0 110.664 177.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.7 t -66.39 -45.77 88.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 176.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.494 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 10.7 m-85 -55.4 -52.06 64.81 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.823 0.449 . . . . 0.0 110.803 177.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 34.8 mtt180 -61.76 -40.09 93.91 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.509 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.3 m -62.0 -51.49 67.82 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.393 0.997 . . . . 0.0 109.708 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 49.0 t -63.66 -45.1 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.958 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 -56.31 -45.83 80.11 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-N 119.705 1.139 . . . . 0.0 109.499 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.17 -50.34 68.75 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-O 118.176 -1.347 . . . . 0.0 110.408 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -59.36 -54.46 46.47 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 118.535 1.168 . . . . 0.0 110.512 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 65.1 t -47.32 -54.57 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 125.541 1.536 . . . . 0.0 110.297 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -62.99 -44.85 94.9 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 120.112 1.324 . . . . 0.0 110.626 -175.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -57.96 -42.19 84.47 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.727 1.211 . . . . 0.0 109.655 177.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.427 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 80.5 mtt-85 -74.61 -41.58 60.15 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 117.186 -1.388 . . . . 0.0 109.979 -175.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.449 ' HA ' HD23 ' A' ' 126' ' ' LEU . 95.6 t -53.15 -45.71 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 121.216 1.825 . . . . 0.0 109.564 169.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -62.29 -42.02 98.99 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.044 0.838 . . . . 0.0 111.218 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -60.91 -46.01 92.34 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 175.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 123' ' ' VAL . 0.2 OUTLIER -63.03 -48.97 76.44 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.252 -0.88 . . . . 0.0 109.561 -176.009 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 55.9 mt -52.35 -42.14 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 124.234 1.014 . . . . 0.0 109.443 173.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.26 -30.74 71.82 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.638 1.108 . . . . 0.0 111.58 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 44.7 mttt -70.38 -38.0 74.64 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.719 1.208 . . . . 0.0 111.537 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.7 pt -97.61 -27.12 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -169.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.8 m . . . . . 0 C--O 1.25 1.111 0 C-N-CA 126.125 1.77 . . . . 0.0 110.915 176.481 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.464 0.243 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -96.14 117.77 31.39 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 170.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 98.2 t -101.7 135.63 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 125.469 1.508 . . . . 0.0 107.673 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 51.9 ttm -118.86 138.28 52.84 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 168.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -108.68 130.22 55.34 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 169.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.9 t -129.17 113.23 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 120.326 1.421 . . . . 0.0 109.296 -170.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.6 t -111.59 162.63 14.95 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.97 0.805 . . . . 0.0 111.571 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.4 mttm -65.51 -13.01 57.95 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.824 -1.173 . . . . 0.0 112.383 171.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.6 ptt180 -153.81 114.33 3.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 104.149 -2.537 . . . . 0.0 104.149 169.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -69.56 52.92 0.11 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.795 1.238 . . . . 0.0 112.415 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.5 p -126.76 -23.3 3.72 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.842 1.257 . . . . 0.0 112.668 -170.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 78.6 m -133.99 -87.82 0.4 Allowed 'General case' 0 C--N 1.343 0.3 0 CA-C-O 118.379 -0.82 . . . . 0.0 111.185 -171.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -50.33 -50.6 50.46 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.016 0.825 . . . . 0.0 110.922 -169.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.1 p -70.25 -44.67 68.02 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 125.26 1.424 . . . . 0.0 110.974 -174.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -58.93 -46.39 88.09 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.649 1.18 . . . . 0.0 110.436 -177.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 52.2 mtp -63.76 -46.63 84.41 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.586 1.154 . . . . 0.0 109.598 177.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.74 -37.75 74.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 119.104 -0.474 . . . . 0.0 111.425 178.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -62.29 -53.31 56.98 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-O 118.464 -0.779 . . . . 0.0 109.855 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.91 -41.17 75.62 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -66.38 -49.79 65.68 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 118.271 1.036 . . . . 0.0 109.676 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.0 -46.43 88.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 120.09 1.314 . . . . 0.0 113.082 -174.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -71.14 -8.77 55.74 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 119.7 1.136 . . . . 0.0 113.201 176.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 38.0 m -92.77 -48.7 6.44 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 119.965 1.257 . . . . 0.0 110.552 169.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.2 mt -78.92 -41.55 29.25 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.998 1.719 . . . . 0.0 112.135 -169.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 CA-C-O 117.904 -1.498 . . . . 0.0 114.604 -169.066 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.8 pt . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 121.47 0.652 . . . . 0.0 112.124 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -123.74 134.11 53.74 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 168.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 p -119.45 151.35 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -170.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.2 m -141.71 131.71 24.58 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.132 1.373 . . . . 0.0 108.614 168.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.6 p -98.21 141.4 31.17 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.026 -1.046 . . . . 0.0 108.517 169.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.6 m -154.0 -177.28 6.3 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.413 1.885 . . . . 0.0 106.087 -169.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.53 170.77 43.3 Favored Glycine 0 N--CA 1.439 -1.11 0 O-C-N 121.377 -0.827 . . . . 0.0 111.522 175.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -53.62 -33.58 55.55 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 125.176 1.163 . . . . 0.0 110.048 174.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -143.57 146.23 33.15 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.986 1.714 . . . . 0.0 106.67 169.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 p -70.53 157.66 37.49 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.294 0.569 . . . . 0.0 109.612 169.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.6 m -162.16 148.56 13.39 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.199 1.8 . . . . 0.0 106.795 170.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -54.4 151.96 7.03 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.562 0.619 . . . . 0.0 110.907 -175.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.9 t -57.44 126.19 14.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 172.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -70.46 140.85 87.59 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -72.84 -41.68 1.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.265 1.31 . . . . 0.0 113.192 -169.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.505 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 29.8 m -65.01 -25.19 67.75 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.664 -1.272 . . . . 0.0 111.298 -177.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.475 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -51.46 -40.87 60.33 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.723 0.809 . . . . 0.0 111.335 173.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.8 mt -56.45 -45.88 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.12 -38.37 88.01 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.507 1.123 . . . . 0.0 110.578 -172.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.9 mmm -68.41 -44.02 75.93 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 122.915 1.34 . . . . 0.0 110.434 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.2 mtp -66.88 -34.29 77.46 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 121.124 -0.985 . . . . 0.0 110.005 175.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -62.48 -26.4 68.51 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.998 0.817 . . . . 0.0 111.423 172.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -65.55 -39.84 92.19 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 118.905 0.775 . . . . 0.0 109.768 173.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 63.9 t -78.46 -22.28 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 120.159 -0.617 . . . . 0.0 110.852 177.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.93 25.09 6.63 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.054 1.311 . . . . 0.0 111.948 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.525 HG22 ' H ' ' A' ' 56' ' ' ASP . 10.7 mt -122.68 179.03 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 125.227 1.411 . . . . 0.0 107.45 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.525 ' H ' HG22 ' A' ' 55' ' ' ILE . 9.8 t0 -144.28 155.96 44.06 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.863 1.665 . . . . 0.0 108.822 -176.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.475 HD12 ' HB1' ' A' ' 46' ' ' ALA . 0.5 OUTLIER -130.85 -13.04 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.981 0.913 . . . . 0.0 113.365 174.314 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.7 m -43.1 -34.24 1.03 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.993 1.717 . . . . 0.0 114.637 -176.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -102.82 1.93 48.52 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 117.853 -1.526 . . . . 0.0 114.576 -174.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -71.92 -26.78 62.44 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 120.528 2.164 . . . . 0.0 113.081 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.9 p 60.49 -161.06 0.29 Allowed 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.314 1.046 . . . . 0.0 110.264 -174.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.4 t -134.19 163.0 30.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.798 0.809 . . . . 0.0 111.406 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -161.21 133.9 4.48 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 126.304 1.842 . . . . 0.0 106.373 -171.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -85.0 158.51 11.57 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.875 2.384 . . . . 0.0 110.934 176.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.4 tt -54.28 -35.15 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 123.476 0.711 . . . . 0.0 111.02 172.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -57.22 -24.12 52.47 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.11 1.764 . . . . 0.0 112.66 -175.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -83.3 -2.34 55.44 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.569 0.748 . . . . 0.0 112.547 -176.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -128.88 -176.87 3.99 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.253 1.021 . . . . 0.0 111.005 -177.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.18 129.28 31.46 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 126.602 1.961 . . . . 0.0 108.274 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.31 -29.82 66.18 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.548 1.139 . . . . 0.0 112.939 -175.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -60.73 -22.7 64.27 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.036 0.934 . . . . 0.0 112.475 -176.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -84.31 -18.02 37.67 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.272 0.629 . . . . 0.0 110.605 -177.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -101.89 122.74 44.58 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 125.168 1.387 . . . . 0.0 108.959 -175.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -76.22 -32.34 58.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.841 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.9 138.01 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 123.518 0.727 . . . . 0.0 109.059 -171.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.0 128.01 45.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 122.97 1.367 . . . . 0.0 109.869 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.0 mm -120.33 96.16 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 -175.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.7 m -70.04 156.01 39.78 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 168.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.74 56.07 0.91 Allowed 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 102.753 -3.055 . . . . 0.0 102.753 173.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.4 m . . . . . 0 N--CA 1.452 -0.352 0 C-N-CA 123.834 0.854 . . . . 0.0 110.14 -178.042 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -64.65 8.7 0.11 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.115 1.766 . . . . 0.0 113.03 170.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.7 p -122.1 2.87 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 124.845 1.258 . . . . 0.0 111.652 172.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.9 p -128.05 23.48 6.09 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.212 1.005 . . . . 0.0 112.149 -173.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -88.58 179.87 6.19 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.621 0.768 . . . . 0.0 109.313 170.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -59.69 -33.6 71.79 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.23 1.012 . . . . 0.0 113.246 -171.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.9 mt -134.76 135.67 53.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 177.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -140.43 133.69 29.7 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 169.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -144.81 157.91 43.99 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.001 1.32 . . . . 0.0 107.573 168.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -119.48 117.54 28.71 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.7 1.2 . . . . 0.0 108.496 168.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -93.92 108.65 20.43 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.218 1.407 . . . . 0.0 109.543 -173.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -72.54 105.57 4.25 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.727 1.211 . . . . 0.0 108.511 178.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -135.76 151.94 50.62 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 125.038 1.335 . . . . 0.0 108.855 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -82.98 75.91 9.84 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.735 1.214 . . . . 0.0 110.657 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -21.92 98.86 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 128.096 2.558 . . . . 0.0 112.466 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.406 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 53.0 Cg_exo -60.81 -4.5 3.62 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 124.44 3.427 . . . . 0.0 116.785 -169.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -56.47 101.07 0.05 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.182 1.355 . . . . 0.0 111.485 177.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.37 18.24 55.66 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 126.096 1.808 . . . . 0.0 113.389 170.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.406 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 26.9 mm-40 -94.41 178.34 5.65 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.652 1.226 . . . . 0.0 112.763 -169.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.2 m -75.18 154.79 37.49 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.477 1.511 . . . . 0.0 109.955 175.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 93.5 mt -57.47 -32.6 67.13 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.017 -0.427 . . . . 0.0 111.479 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.98 -40.29 94.75 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.858 0.463 . . . . 0.0 110.874 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 88.6 t -65.26 -48.31 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 175.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.505 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 6.4 m-85 -53.94 -52.43 60.65 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.281 0.632 . . . . 0.0 110.954 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -60.97 -43.79 98.28 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.74 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.1 m -61.5 -50.78 71.36 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 118.867 0.758 . . . . 0.0 109.183 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 66.3 t -66.71 -43.67 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-O 118.349 -0.834 . . . . 0.0 110.153 -178.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.62 -43.38 89.64 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 119.966 1.257 . . . . 0.0 110.242 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.66 -49.03 71.97 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-O 118.595 -1.114 . . . . 0.0 111.244 176.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -59.96 -51.87 67.82 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 118.701 1.251 . . . . 0.0 110.884 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 64.4 t -52.78 -48.51 49.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 124.804 1.242 . . . . 0.0 109.959 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -60.02 -47.38 86.08 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.86 1.209 . . . . 0.0 110.399 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.04 -42.76 81.06 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.943 0.897 . . . . 0.0 110.341 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -70.6 -43.43 69.38 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 118.19 -0.909 . . . . 0.0 109.961 -176.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 74.6 t -53.83 -48.19 62.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 120.282 1.401 . . . . 0.0 109.661 169.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -59.48 -40.37 86.76 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.449 1.022 . . . . 0.0 110.559 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -62.54 -46.07 90.07 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.307 1.043 . . . . 0.0 110.316 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.38 -49.56 76.42 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 124.099 0.96 . . . . 0.0 109.488 178.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.88 -37.49 67.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.679 1.191 . . . . 0.0 110.795 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.52 -31.12 71.12 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.889 1.222 . . . . 0.0 111.328 -174.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -70.8 -20.15 62.62 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.689 1.595 . . . . 0.0 112.872 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.9 pt -125.28 -21.04 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -168.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 C--O 1.249 1.028 0 C-N-CA 126.186 1.795 . . . . 0.0 111.174 173.684 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 49.0 mmtt . . . . . 0 N--CA 1.463 0.224 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -92.06 137.71 32.14 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.3 p -122.47 143.83 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 121.866 0.841 . . . . 0.0 109.457 -178.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 31.2 tpp -124.38 141.88 51.73 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.368 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -121.67 125.01 45.64 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 170.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.7 t -128.69 129.53 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 120.402 1.456 . . . . 0.0 109.351 -169.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.8 t -137.84 161.05 37.61 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 119.528 1.058 . . . . 0.0 112.473 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.8 mttt -58.76 -21.42 55.58 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.854 1.262 . . . . 0.0 110.884 168.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.4 ptp85 -147.94 101.23 3.28 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 126.096 1.759 . . . . 0.0 107.05 169.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -44.65 -42.46 7.52 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.013 1.325 . . . . 0.0 112.2 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.7 p -45.21 -20.91 0.06 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 129.599 3.159 . . . . 0.0 118.266 -169.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.4 p -130.65 -74.73 0.53 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.953 1.251 . . . . 0.0 110.647 -171.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -61.22 -52.08 66.29 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -169.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.41 -42.94 78.26 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.425 0.29 . . . . 0.0 111.125 -178.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -59.3 -45.66 90.68 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.603 0.761 . . . . 0.0 111.579 -174.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 44.2 mtm -63.97 -46.6 83.91 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 117.78 0.264 . . . . 0.0 110.903 175.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.8 -39.04 76.61 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 117.606 0.185 . . . . 0.0 110.925 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.452 ' HA ' HG21 ' A' ' 32' ' ' VAL . 33.3 tt0 -63.43 -45.44 90.93 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 122.549 0.34 . . . . 0.0 111.163 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.24 -40.07 96.45 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -175.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -66.66 -46.44 75.68 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 118.146 0.973 . . . . 0.0 108.923 174.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.49 -44.04 84.62 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 119.338 0.972 . . . . 0.0 112.591 -173.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -67.93 -38.4 82.83 Favored 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 119.246 -0.982 . . . . 0.0 111.049 174.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.1 m -66.89 -43.4 83.54 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 120.478 1.49 . . . . 0.0 110.504 -177.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.1 -37.7 53.77 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.076 1.35 . . . . 0.0 111.184 -173.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.605 0 CA-C-O 116.55 -2.25 . . . . 0.0 117.582 -169.216 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.5 pt . . . . . 0 N--CA 1.449 -0.483 0 CA-C-O 121.361 0.6 . . . . 0.0 111.295 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -126.1 130.8 51.79 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 169.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.452 HG21 ' HA ' ' A' ' 19' ' ' GLU . 3.0 p -117.76 152.28 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 C-N-CA 123.331 0.652 . . . . 0.0 111.582 -171.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.4 m -151.69 135.4 16.31 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 167.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 89.0 p -97.43 161.82 13.61 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 121.207 -0.933 . . . . 0.0 109.795 169.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.8 p -151.85 -165.77 2.32 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 169.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.63 165.78 37.0 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 169.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 61.5 mt -54.99 -30.58 59.67 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.825 0.85 . . . . 0.0 110.5 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -148.82 145.96 27.77 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 168.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.2 p -89.55 152.56 21.35 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.593 0.757 . . . . 0.0 111.16 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.8 m -147.52 154.89 41.31 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.748 2.019 . . . . 0.0 106.276 170.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -57.89 148.49 25.36 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.933 0.788 . . . . 0.0 109.702 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 26.9 t -57.95 130.47 21.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -176.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -66.21 136.4 95.28 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -177.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.46 -40.24 6.05 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.273 1.982 . . . . 0.0 113.409 -168.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.502 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 6.1 m -68.0 -17.84 64.54 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.366 -0.834 . . . . 0.0 111.826 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.416 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -59.06 -41.27 87.52 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 121.679 -0.638 . . . . 0.0 110.026 171.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.08 -42.37 94.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.44 -38.92 85.65 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -177.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 21.9 mmt -61.85 -47.49 84.8 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 122.813 1.292 . . . . 0.0 111.326 176.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.0 mtp -69.41 -33.58 73.2 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.368 -178.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -61.95 -29.84 70.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.863 0.865 . . . . 0.0 111.128 172.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -64.98 -39.31 93.28 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.734 0.697 . . . . 0.0 110.328 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 62.1 t -78.67 -23.38 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.935 178.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.95 25.97 5.7 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.109 1.338 . . . . 0.0 112.034 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.429 HG22 ' H ' ' A' ' 56' ' ' ASP . 11.3 mt -124.64 176.84 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 125.688 1.595 . . . . 0.0 107.662 -176.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.429 ' H ' HG22 ' A' ' 55' ' ' ILE . 7.2 t70 -140.65 157.87 44.81 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.137 1.775 . . . . 0.0 108.605 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.416 HD12 ' HB1' ' A' ' 46' ' ' ALA . 0.9 OUTLIER -128.21 -20.18 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.649 0.78 . . . . 0.0 113.009 171.195 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 55.3 p -51.84 -33.36 35.72 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.198 0.908 . . . . 0.0 112.441 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.92 -24.75 59.33 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-O 118.024 -1.431 . . . . 0.0 114.324 -176.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -86.95 -27.41 23.33 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 120.122 1.961 . . . . 0.0 114.953 -169.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 29.2 p 65.87 176.6 0.22 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.719 1.608 . . . . 0.0 113.459 173.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.2 m -102.13 162.13 13.15 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.45 1.1 . . . . 0.0 112.202 -169.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -156.3 134.42 7.18 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-O 118.273 -0.87 . . . . 0.0 109.071 -174.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -80.07 156.24 23.12 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.973 2.448 . . . . 0.0 111.771 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.7 tt -56.7 -33.88 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 123.773 0.829 . . . . 0.0 111.419 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -58.28 -23.13 55.23 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.2 1.8 . . . . 0.0 112.222 -174.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -82.45 -3.17 55.25 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.094 0.958 . . . . 0.0 112.693 -176.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -129.51 177.27 7.32 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 119.916 1.235 . . . . 0.0 112.556 -173.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.43 141.63 50.53 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 128.05 2.54 . . . . 0.0 106.493 170.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.35 -23.9 62.0 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.084 0.954 . . . . 0.0 111.91 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -60.48 -23.09 64.21 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.012 0.925 . . . . 0.0 112.412 -175.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -81.59 -15.85 53.44 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.032 0.933 . . . . 0.0 110.894 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -107.84 128.0 54.22 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.698 1.599 . . . . 0.0 109.65 -172.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -72.44 -40.36 67.13 Favored 'General case' 0 C--O 1.232 0.152 0 O-C-N 121.954 -0.467 . . . . 0.0 110.331 174.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -130.28 135.4 60.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 122.908 0.483 . . . . 0.0 109.927 -170.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.7 t -122.62 119.05 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 122.413 1.101 . . . . 0.0 108.916 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 35.9 mm -108.45 96.7 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.3 t -70.18 156.39 39.29 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 168.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.19 40.32 0.78 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 172.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 85.6 m . . . . . 0 CA--C 1.534 0.34 0 C-N-CA 124.028 0.931 . . . . 0.0 111.55 179.762 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 CA--C 1.54 0.566 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -59.52 -3.96 0.54 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.074 2.15 . . . . 0.0 114.467 171.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.9 p -119.82 -5.62 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 119.545 1.066 . . . . 0.0 112.754 171.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.2 p -102.94 18.12 22.37 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.623 1.101 . . . . 0.0 111.919 -172.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -87.51 -176.96 5.78 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.487 1.115 . . . . 0.0 109.304 172.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -68.22 -32.66 73.02 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -169.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.2 mt -136.61 140.14 43.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -176.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -142.4 139.45 31.67 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.691 1.196 . . . . 0.0 108.661 171.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -147.07 159.68 43.31 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.935 1.694 . . . . 0.0 107.942 168.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -121.72 105.6 10.55 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.06 1.344 . . . . 0.0 108.728 168.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.43 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 43.1 m0 -78.38 93.16 4.66 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.067 0.947 . . . . 0.0 109.315 -178.078 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -60.67 119.93 9.06 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 169.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.8 mt -150.05 152.15 34.37 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.541 1.536 . . . . 0.0 107.529 -169.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -82.47 64.15 6.98 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 125.073 1.349 . . . . 0.0 111.142 -176.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -10.34 94.85 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 128.762 2.825 . . . . 0.0 113.804 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.506 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 76.2 Cg_exo -58.66 -9.95 8.31 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 124.081 3.187 . . . . 0.0 116.549 -173.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -54.81 101.99 0.06 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 120.262 1.392 . . . . 0.0 111.804 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.87 21.63 42.11 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.279 1.895 . . . . 0.0 113.433 172.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.506 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 18.5 mm-40 -102.07 178.12 4.7 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.839 1.319 . . . . 0.0 113.67 -169.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.2 m -78.73 156.07 29.08 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.204 1.802 . . . . 0.0 110.19 175.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 96.5 mt -60.3 -30.19 69.32 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.772 -0.58 . . . . 0.0 111.951 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.51 -39.07 93.1 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.326 0.512 . . . . 0.0 110.777 176.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 95.3 t -67.46 -45.9 84.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.502 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 12.1 m-85 -55.55 -51.8 65.86 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 118.902 -0.571 . . . . 0.0 110.547 176.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -59.19 -42.11 90.09 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.913 0.779 . . . . 0.0 111.919 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.8 m -61.52 -51.1 70.01 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.052 0.842 . . . . 0.0 109.627 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.7 t -65.46 -43.87 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 117.87 -1.062 . . . . 0.0 110.234 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -55.18 -45.01 75.78 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 119.821 1.191 . . . . 0.0 109.214 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.42 -49.9 72.34 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-O 118.214 -1.326 . . . . 0.0 110.409 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -60.07 -56.43 21.72 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 118.574 1.187 . . . . 0.0 110.423 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.9 t -46.62 -52.46 3.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 125.694 1.597 . . . . 0.0 110.444 176.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -63.61 -46.55 85.23 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 119.708 1.14 . . . . 0.0 110.114 -175.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -43.14 85.04 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.272 0.629 . . . . 0.0 110.197 178.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.43 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 79.6 mtt-85 -69.87 -42.74 73.1 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.894 -176.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 72.9 t -54.12 -49.18 63.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 120.393 1.451 . . . . 0.0 109.516 169.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -59.78 -39.85 86.27 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 119.448 1.022 . . . . 0.0 110.625 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -63.42 -45.9 88.83 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.328 1.051 . . . . 0.0 110.224 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -47.93 80.06 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 124.082 0.953 . . . . 0.0 109.815 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 61.8 mt -57.3 -38.49 62.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 124.703 1.201 . . . . 0.0 110.562 176.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.2 -28.94 69.51 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.776 1.171 . . . . 0.0 111.488 -173.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -73.66 -19.51 60.81 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.879 1.672 . . . . 0.0 112.731 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 pt -125.67 -20.1 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 126.151 1.78 . . . . 0.0 114.921 -168.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.3 m . . . . . 0 C--O 1.251 1.138 0 C-N-CA 126.432 1.893 . . . . 0.0 110.907 170.015 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 51.3 mmtt . . . . . 0 N--CA 1.465 0.297 0 N-CA-C 107.354 -1.351 . . . . 0.0 107.354 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.7 mttt -94.51 135.86 35.46 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.2 p -121.68 144.55 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-O 121.885 0.85 . . . . 0.0 109.548 -176.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 29.6 tpp -124.23 142.2 51.44 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.493 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -123.41 111.37 16.27 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.4 t -111.65 117.06 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 119.611 1.096 . . . . 0.0 108.546 -173.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.9 t -108.05 165.19 11.65 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.713 0.768 . . . . 0.0 110.824 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -59.03 -16.22 17.41 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.701 0.8 . . . . 0.0 111.875 169.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -158.62 115.69 2.81 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 128.241 2.616 . . . . 0.0 103.975 178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -65.02 40.27 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.751 1.62 . . . . 0.0 113.063 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.5 p -122.75 -20.37 5.93 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 119.839 -1.788 . . . . 0.0 113.559 -169.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 82.5 m -132.71 -89.06 0.42 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.595 0.634 . . . . 0.0 111.438 -169.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -56.3 -46.84 79.62 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 118.881 0.764 . . . . 0.0 110.555 -169.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 13.3 p -68.87 -37.53 79.11 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.584 1.153 . . . . 0.0 111.583 -174.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -66.08 -47.71 73.35 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.704 0.802 . . . . 0.0 109.927 -174.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 69.1 mtm -63.77 -46.16 86.51 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 119.434 -0.317 . . . . 0.0 110.645 176.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.85 -42.4 71.94 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 123.043 0.215 . . . . 0.0 110.822 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -65.29 -47.1 77.83 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 123.02 0.2 . . . . 0.0 110.807 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.63 -38.08 95.72 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -175.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -65.19 -49.75 68.55 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 174.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.09 -43.39 82.15 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 124.228 1.011 . . . . 0.0 113.079 -172.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -67.47 -37.79 83.46 Favored 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 118.926 -1.109 . . . . 0.0 111.048 174.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.4 m -68.1 -42.16 80.72 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 120.404 1.456 . . . . 0.0 110.481 -177.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.0 mt -75.44 -38.41 59.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.733 1.613 . . . . 0.0 111.555 -175.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.658 0 CA-C-O 116.732 -2.149 . . . . 0.0 117.98 -169.076 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.2 pt . . . . . 0 N--CA 1.451 -0.42 0 CA-C-O 121.406 0.622 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -125.34 131.23 53.04 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 169.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -117.29 152.78 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 123.32 0.648 . . . . 0.0 111.806 -170.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.9 m -148.5 134.42 19.07 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 167.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' ' 15' ' ' SER . 88.4 p -96.99 159.31 14.98 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 120.692 -1.255 . . . . 0.0 107.949 168.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.1 m -153.22 -170.3 3.57 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 176.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.78 164.96 33.91 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 169.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.4 mt -52.32 -30.1 26.71 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 124.627 0.84 . . . . 0.0 110.348 170.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -143.0 148.51 36.9 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 169.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 p -72.46 154.74 40.7 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.25 0.62 . . . . 0.0 109.552 169.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.9 m -159.78 147.1 16.67 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 169.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -58.64 147.66 31.8 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.471 0.578 . . . . 0.0 109.856 -177.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -60.19 129.58 22.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.405 ' CE1' ' H ' ' A' ' 106' ' ' GLY . 23.1 t-80 -70.27 139.85 87.46 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.63 -38.83 5.42 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.238 1.959 . . . . 0.0 113.315 -168.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.536 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 8.2 m -68.04 -17.16 64.32 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.315 -0.866 . . . . 0.0 111.647 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.433 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -59.04 -40.62 85.61 Favored 'General case' 0 C--N 1.341 0.229 0 O-C-N 121.456 -0.778 . . . . 0.0 110.26 171.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.9 mp -62.97 -42.15 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -178.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.34 -37.39 83.14 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 20.5 mmt -62.13 -47.02 86.44 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 122.921 1.343 . . . . 0.0 111.197 175.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 9.3 mtp -70.09 -31.81 69.56 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.61 -177.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -61.57 -29.13 69.82 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.495 0.718 . . . . 0.0 111.36 169.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -65.83 -35.98 82.2 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.083 0.856 . . . . 0.0 110.475 173.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.4 t -78.96 -26.02 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 117.512 0.142 . . . . 0.0 110.916 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.48 28.19 6.48 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.723 1.154 . . . . 0.0 111.818 -175.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.579 HG22 ' H ' ' A' ' 56' ' ' ASP . 6.5 mt -125.66 -177.57 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 126.018 1.727 . . . . 0.0 107.163 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.579 ' H ' HG22 ' A' ' 55' ' ' ILE . 3.6 t70 -147.03 158.38 43.91 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.589 1.955 . . . . 0.0 108.355 -178.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.433 HD12 ' HB1' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -130.57 -13.2 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 173.571 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.5 p -51.22 -29.31 13.84 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.534 1.061 . . . . 0.0 113.43 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.24 -13.94 65.05 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 118.121 -1.377 . . . . 0.0 114.249 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -74.51 -29.9 61.59 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 120.281 2.041 . . . . 0.0 113.137 -173.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.7 p 59.74 -163.49 0.23 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.482 0.713 . . . . 0.0 109.689 -169.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.5 m -138.07 156.15 48.07 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.937 -173.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -153.44 135.87 9.38 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.319 1.048 . . . . 0.0 109.106 -169.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.89 153.64 22.62 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.466 2.11 . . . . 0.0 111.272 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.6 tt -53.54 -34.09 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.831 0.852 . . . . 0.0 111.486 174.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -57.51 -23.55 50.85 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.079 1.752 . . . . 0.0 112.503 -176.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -86.15 -7.43 58.57 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.736 0.814 . . . . 0.0 112.872 -174.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -121.77 -176.38 3.31 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.459 1.027 . . . . 0.0 110.523 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -133.96 130.58 37.86 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 126.26 1.824 . . . . 0.0 108.439 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.27 -30.43 68.29 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.708 1.203 . . . . 0.0 112.742 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.63 -21.73 63.05 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.066 0.947 . . . . 0.0 112.571 -175.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -85.52 -13.83 47.8 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.452 0.701 . . . . 0.0 111.012 -177.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -109.22 125.17 51.96 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.735 1.214 . . . . 0.0 109.852 -172.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -72.14 -41.38 67.22 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 122.474 0.31 . . . . 0.0 110.229 175.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.65 134.61 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 122.959 0.504 . . . . 0.0 109.898 -169.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.8 t -125.56 111.18 26.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 123.091 1.424 . . . . 0.0 108.64 -177.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.9 mm -100.25 99.26 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 177.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.8 t -72.31 156.81 38.71 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 167.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.57 54.78 0.68 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 103.394 -2.817 . . . . 0.0 103.394 173.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 83.5 m . . . . . 0 N--CA 1.451 -0.389 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.111 173.38 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 . . . . . 0 N--CA 1.472 0.656 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -57.0 -25.76 59.04 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.31 1.044 . . . . 0.0 112.039 173.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.6 p -83.63 -16.18 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 119.625 1.102 . . . . 0.0 110.179 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.7 p -106.51 17.92 22.65 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.917 0.887 . . . . 0.0 112.266 -170.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -78.81 179.12 7.42 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.593 0.757 . . . . 0.0 109.764 171.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -63.61 -31.96 73.28 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -169.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.6 mt -135.64 137.49 49.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -142.21 139.15 31.93 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.228 1.011 . . . . 0.0 108.448 171.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -146.93 161.78 40.06 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.663 1.585 . . . . 0.0 108.003 168.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -122.53 100.77 7.1 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.742 1.617 . . . . 0.0 108.653 168.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.459 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 40.2 m0 -76.27 91.15 3.19 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.558 1.143 . . . . 0.0 108.594 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -64.99 100.65 0.44 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.768 1.227 . . . . 0.0 109.734 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -129.83 155.34 46.15 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.006 1.323 . . . . 0.0 110.856 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -78.06 80.77 4.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.061 1.744 . . . . 0.0 110.125 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -35.69 108.76 0.38 Allowed Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 126.318 1.847 . . . . 0.0 112.652 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.433 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 54.2 Cg_exo -60.26 -2.53 1.87 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 125.13 3.887 . . . . 0.0 117.579 -171.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -53.57 98.4 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 120.495 1.498 . . . . 0.0 112.435 175.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.405 ' H ' ' CE1' ' A' ' 43' ' ' HIS . . . 87.6 18.73 56.24 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 126.406 1.955 . . . . 0.0 112.963 171.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.433 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 24.1 mm-40 -95.33 177.21 5.92 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.69 1.245 . . . . 0.0 112.601 -169.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.9 m -74.93 154.91 37.95 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.48 1.512 . . . . 0.0 109.798 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.6 mt -59.5 -29.8 68.11 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.861 -0.524 . . . . 0.0 111.717 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.61 -39.0 92.39 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.226 0.466 . . . . 0.0 110.876 175.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 82.3 t -68.13 -46.55 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 176.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.536 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 17.8 m-85 -55.07 -50.65 68.62 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 119.283 -0.389 . . . . 0.0 110.89 176.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -60.54 -42.13 95.9 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.931 0.893 . . . . 0.0 111.972 177.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 93.6 m -60.82 -51.73 68.08 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 119.156 0.889 . . . . 0.0 109.147 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 74.6 t -61.61 -47.09 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-O 117.891 -1.052 . . . . 0.0 109.81 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 38.6 ttp85 -53.57 -51.41 63.04 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 119.661 1.118 . . . . 0.0 108.967 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.55 -48.48 72.82 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -173.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -60.91 -52.6 64.34 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.856 0.862 . . . . 0.0 110.402 -177.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.0 t -57.98 -49.59 80.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 125.369 1.467 . . . . 0.0 110.325 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -58.25 -48.05 81.65 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 121.034 1.743 . . . . 0.0 110.623 -178.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.98 -45.26 71.35 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.207 1.003 . . . . 0.0 110.505 174.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.459 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 49.9 mtt85 -70.59 -39.87 73.58 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 117.869 -1.062 . . . . 0.0 111.024 -177.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 80.9 t -54.47 -49.14 67.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 120.515 1.507 . . . . 0.0 109.349 169.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -60.47 -39.64 88.34 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.349 0.977 . . . . 0.0 110.58 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -62.81 -45.92 90.36 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.335 1.054 . . . . 0.0 110.464 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.69 -47.95 79.1 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 124.342 1.057 . . . . 0.0 109.714 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.4 mt -57.07 -38.48 60.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.544 1.137 . . . . 0.0 110.591 175.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.28 -28.93 69.54 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.875 1.216 . . . . 0.0 111.5 -173.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -73.64 -19.68 60.78 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.969 1.708 . . . . 0.0 112.79 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.4 pt -125.43 -20.21 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 126.175 1.79 . . . . 0.0 114.826 -168.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 C--O 1.248 1.013 0 C-N-CA 126.571 1.948 . . . . 0.0 110.857 170.005 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -97.17 118.77 34.35 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 172.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.468 ' HA ' HG13 ' A' ' 75' ' ' VAL . 8.9 p -101.37 138.38 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 O-C-N 123.688 0.617 . . . . 0.0 110.716 173.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 37.9 tpp -116.2 143.72 45.14 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 169.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -115.96 140.71 48.99 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.274 1.43 . . . . 0.0 108.149 169.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.7 t -146.4 129.87 9.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -170.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -133.83 172.16 13.17 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.098 0.863 . . . . 0.0 109.817 169.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -66.31 -12.11 54.64 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.42 -0.8 . . . . 0.0 112.946 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.1 ptm85 -155.23 106.17 2.57 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 171.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -46.99 -28.08 1.52 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.464 1.905 . . . . 0.0 114.135 -177.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -30.12 -42.39 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 129.81 3.244 . . . . 0.0 118.183 -169.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.7 p -136.25 -68.37 0.5 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 117.686 -1.149 . . . . 0.0 113.919 -169.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.5 ptt-85 -56.62 -48.7 76.91 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.507 1.503 . . . . 0.0 110.76 -172.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.83 -51.44 70.0 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.67 0.788 . . . . 0.0 110.121 176.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 -62.55 -44.88 95.26 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.68 0.792 . . . . 0.0 111.769 -173.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 51.4 mtm -62.87 -45.72 91.23 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.916 0.486 . . . . 0.0 110.384 175.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.99 -37.99 75.29 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 119.434 -0.317 . . . . 0.0 110.393 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -61.13 -50.03 74.88 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.4 0.68 . . . . 0.0 110.258 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.57 -44.69 94.71 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 119.348 -0.695 . . . . 0.0 111.866 -177.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -65.84 -46.98 76.54 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 118.773 1.286 . . . . 0.0 108.646 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.16 -43.3 87.32 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 119.779 1.172 . . . . 0.0 112.54 -175.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -68.26 -35.59 78.12 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.786 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.3 m -67.74 -42.43 81.86 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 120.047 -1.658 . . . . 0.0 110.758 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.9 mt -73.05 -40.1 65.39 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.031 1.732 . . . . 0.0 111.036 -174.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.799 0 CA-C-O 116.749 -2.14 . . . . 0.0 117.964 -169.506 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.3 pt . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.72 130.3 56.64 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 169.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.7 p -113.94 151.83 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-O 121.882 0.848 . . . . 0.0 111.911 -175.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.1 m -144.15 152.59 41.12 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 126.214 1.806 . . . . 0.0 106.206 167.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.0 p -129.26 157.07 42.9 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.135 0.974 . . . . 0.0 108.803 168.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.6 p -158.53 -161.39 0.98 Allowed 'General case' 0 C--O 1.241 0.642 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.66 163.96 33.35 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 169.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 65.3 mt -53.36 -31.79 46.23 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.37 1.068 . . . . 0.0 110.727 177.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -143.14 145.04 32.47 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 168.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.9 p -75.66 165.65 24.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.911 0.863 . . . . 0.0 111.567 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.5 p -150.03 -132.27 0.05 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.542 1.537 . . . . 0.0 106.957 177.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -144.55 157.73 44.09 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 171.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.5 t -65.24 131.6 31.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -177.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -71.99 138.54 82.22 Favored Pre-proline 0 N--CA 1.446 -0.65 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.96 -38.17 5.47 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 CA-C-N 120.423 1.187 . . . . 0.0 111.694 -169.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.493 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 8.6 m -67.59 -19.12 65.21 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.56 -1.338 . . . . 0.0 112.094 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.48 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -58.15 -39.2 78.17 Favored 'General case' 0 C--O 1.231 0.084 0 O-C-N 121.502 -0.749 . . . . 0.0 110.494 172.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.6 mt -58.37 -47.73 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.51 -40.33 91.04 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.808 0.843 . . . . 0.0 111.837 -175.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.2 mmt -60.26 -48.61 81.03 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.517 1.151 . . . . 0.0 111.21 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 9.3 mtp -69.04 -35.34 76.48 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.914 -178.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -61.18 -30.51 70.45 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.824 0.738 . . . . 0.0 111.55 172.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -63.22 -39.58 95.03 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.026 0.83 . . . . 0.0 110.384 173.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.1 t -79.76 -18.65 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-O 119.888 -0.101 . . . . 0.0 111.098 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.13 26.35 8.91 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.552 1.073 . . . . 0.0 111.816 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.607 HG22 ' H ' ' A' ' 56' ' ' ASP . 10.7 mt -122.09 -176.13 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 126.078 1.751 . . . . 0.0 106.505 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.607 ' H ' HG22 ' A' ' 55' ' ' ILE . 8.4 t70 -149.68 155.58 40.44 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 120.406 -1.434 . . . . 0.0 109.632 -177.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.48 HD12 ' HB1' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -130.49 -13.61 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.061 0.945 . . . . 0.0 112.538 169.465 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 99.7 p -52.99 -30.83 37.43 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.659 1.118 . . . . 0.0 112.432 176.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.14 -7.11 87.76 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 118.526 -1.152 . . . . 0.0 114.366 -176.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -125.3 169.9 11.84 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.37 1.585 . . . . 0.0 110.93 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 19.2 p -127.58 164.47 21.93 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.231 1.012 . . . . 0.0 112.365 -169.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.4 m -78.98 156.91 28.25 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.567 1.147 . . . . 0.0 110.953 171.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -155.42 145.14 15.46 Favored Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 123.935 0.894 . . . . 0.0 109.542 -177.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -80.32 151.94 20.56 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.246 1.964 . . . . 0.0 111.113 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.1 tt -54.25 -34.92 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.658 0.783 . . . . 0.0 111.442 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -60.59 -21.58 62.78 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.689 1.595 . . . . 0.0 112.471 -174.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -79.77 -5.54 55.52 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.564 0.746 . . . . 0.0 112.562 -177.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -124.76 -175.83 3.38 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.539 1.136 . . . . 0.0 110.651 -178.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.49 127.19 25.34 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 126.563 1.945 . . . . 0.0 107.583 176.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.79 -27.74 63.37 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.604 1.162 . . . . 0.0 112.447 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -59.82 -23.47 63.37 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.33 1.052 . . . . 0.0 112.739 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -85.0 -14.18 48.26 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.421 0.689 . . . . 0.0 110.72 -177.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -104.54 126.21 51.42 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 125.222 1.409 . . . . 0.0 109.012 -174.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.94 -42.63 76.45 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.468 HG13 ' HA ' ' A' ' 4' ' ' VAL . 1.8 p -130.99 136.08 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 C-N-CA 122.9 0.48 . . . . 0.0 109.918 -169.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.5 m -127.66 120.3 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-O 122.363 1.078 . . . . 0.0 108.651 -172.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.6 mm -116.72 102.84 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-N 115.006 -0.997 . . . . 0.0 108.389 -169.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.9 t -74.37 153.68 39.16 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 168.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.79 36.48 0.4 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 171.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 77.4 m . . . . . 0 C--N 1.339 0.128 0 O-C-N 120.92 -1.113 . . . . 0.0 112.151 -169.962 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 . . . . . 0 N--CA 1.471 0.609 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 56.1 m95 -67.44 11.29 0.13 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.628 1.971 . . . . 0.0 112.725 171.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.0 p -121.95 4.04 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 125.229 1.412 . . . . 0.0 111.651 169.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 36.3 p -131.71 25.9 4.7 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.17 -0.956 . . . . 0.0 112.602 -172.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -91.54 -170.72 2.69 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 170.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -64.55 -32.06 73.54 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.295 0.638 . . . . 0.0 112.235 -170.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.3 mt -137.9 138.3 44.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -134.61 134.88 41.73 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 169.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -141.25 152.06 44.23 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 169.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -119.95 124.74 46.72 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.448 1.099 . . . . 0.0 109.143 169.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.411 ' CZ3' ' HG2' ' A' ' 122' ' ' ARG . 66.1 m95 -107.76 86.64 2.33 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -54.82 125.11 18.79 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 169.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 25.0 mt -149.06 156.12 41.76 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.618 1.567 . . . . 0.0 107.4 -169.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -82.4 60.93 5.33 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.725 1.21 . . . . 0.0 111.151 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.3 t0 4.53 85.97 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.469 0 C-N-CA 129.348 3.059 . . . . 0.0 112.141 169.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.458 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 74.8 Cg_exo -61.56 -8.14 10.35 Favored 'Trans proline' 0 C--N 1.352 0.748 0 N-CA-C 116.71 1.773 . . . . 0.0 116.71 -169.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -61.04 95.98 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.848 1.204 . . . . 0.0 111.27 -177.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.5 16.1 25.55 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.243 1.878 . . . . 0.0 113.361 172.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.458 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 25.2 mm-40 -95.76 178.12 5.56 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.925 1.362 . . . . 0.0 113.167 -169.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.4 m -76.55 155.73 33.43 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.985 1.714 . . . . 0.0 110.143 174.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 97.0 mt -58.53 -32.5 68.92 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.853 -0.529 . . . . 0.0 111.621 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -71.15 -33.82 70.42 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.126 0.421 . . . . 0.0 110.852 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 72.1 t -65.82 -45.75 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 172.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.493 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 13.6 m-85 -57.38 -49.8 75.03 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 118.609 -0.71 . . . . 0.0 110.52 176.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 60.9 mtt180 -57.6 -43.35 84.61 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.425 1.011 . . . . 0.0 111.808 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 89.4 m -61.15 -53.58 55.24 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 50.4 t -63.58 -41.62 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.558 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -56.64 -48.36 77.7 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 120.205 1.366 . . . . 0.0 109.225 177.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.66 -45.31 96.54 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -59.31 -60.83 3.23 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 123.756 0.823 . . . . 0.0 109.017 177.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.4 t -45.29 -51.62 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 126.752 2.021 . . . . 0.0 110.974 177.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -63.54 -46.54 85.5 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 120.008 1.276 . . . . 0.0 110.38 -175.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.26 -42.12 85.75 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.708 0.803 . . . . 0.0 110.237 176.005 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.411 ' HG2' ' CZ3' ' A' ' 99' ' ' TRP . 82.9 mtt180 -69.33 -43.13 74.34 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.292 1.037 . . . . 0.0 109.914 -175.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 71.5 t -54.79 -48.97 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 119.427 1.012 . . . . 0.0 110.068 168.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -60.67 -38.96 86.66 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 120.017 1.281 . . . . 0.0 111.197 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -63.66 -44.38 93.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.439 1.096 . . . . 0.0 110.201 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.11 -40.8 67.91 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.101 -179.068 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.7 mt -51.88 -43.23 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 124.004 0.921 . . . . 0.0 108.697 169.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.15 -29.81 70.61 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.674 1.125 . . . . 0.0 111.494 -173.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -71.8 -44.8 63.33 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.121 1.368 . . . . 0.0 110.761 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 pt -85.02 -29.07 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.895 1.278 . . . . 0.0 113.89 -173.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.5 m . . . . . 0 C--O 1.249 1.053 0 C-N-CA 126.161 1.785 . . . . 0.0 111.102 179.693 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.4 mptt . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -88.93 116.96 27.6 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 170.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 98.3 t -99.04 138.3 23.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 125.286 1.435 . . . . 0.0 107.19 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.404 ' HA ' ' O ' ' A' ' 33' ' ' THR . 31.0 tpp -121.5 140.72 51.82 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.792 1.237 . . . . 0.0 108.889 175.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -122.19 134.85 54.71 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 170.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.7 t -140.35 133.89 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 119.42 1.009 . . . . 0.0 109.182 -170.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 p -139.71 167.76 21.38 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 119.897 1.226 . . . . 0.0 111.813 169.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -62.08 -18.16 59.85 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -146.83 102.93 3.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 169.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -44.56 -36.75 3.16 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 127.112 2.165 . . . . 0.0 113.355 -177.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.2 m -45.68 -13.5 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 129.519 3.128 . . . . 0.0 119.237 -168.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.5 p -128.97 -89.14 0.51 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 120.279 1.4 . . . . 0.0 111.17 -171.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -57.8 -48.28 80.16 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.555 0.616 . . . . 0.0 110.758 -169.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.435 ' HB3' ' HB3' ' A' ' 34' ' ' SER . 3.4 m -57.74 -44.43 86.04 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.462 0.705 . . . . 0.0 110.104 -175.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -76.25 -32.73 59.02 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 119.075 -0.488 . . . . 0.0 111.773 -173.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.476 ' HG2' HD11 ' A' ' 57' ' ' ILE . 65.4 mtm -65.55 -47.15 76.85 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.691 0.678 . . . . 0.0 109.986 169.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.22 -36.08 70.46 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.842 0.457 . . . . 0.0 110.831 177.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -59.08 -62.04 2.18 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.79 -39.66 68.61 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 119.144 -0.809 . . . . 0.0 111.883 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.405 ' CZ ' ' SD ' ' A' ' 50' ' ' MET . 40.5 m-85 -66.53 -50.25 63.8 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 119.038 1.419 . . . . 0.0 110.594 174.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.32 -43.47 98.76 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 120.233 1.378 . . . . 0.0 112.45 -172.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 ptmt -70.48 -9.04 55.52 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.626 1.103 . . . . 0.0 113.24 175.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.7 m -92.67 -49.4 6.11 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 119.982 1.265 . . . . 0.0 110.544 169.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.5 mt -78.32 -41.4 33.8 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 125.642 1.577 . . . . 0.0 112.205 -169.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.338 0 CA-C-O 118.034 -1.426 . . . . 0.0 114.75 -169.142 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.9 pt . . . . . 0 C--O 1.233 0.211 0 CA-C-O 121.342 0.591 . . . . 0.0 111.635 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.7 127.92 53.31 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 168.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.0 p -109.07 150.69 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-O 121.55 0.691 . . . . 0.0 111.654 -176.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 5' ' ' MET . 85.7 m -148.95 137.51 21.13 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 167.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.435 ' HB3' ' HB3' ' A' ' 15' ' ' SER . 11.3 m -124.02 152.46 42.57 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 121.752 -0.593 . . . . 0.0 110.291 178.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 19.3 p -157.56 -163.62 1.39 Allowed 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -171.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.65 168.77 41.82 Favored Glycine 0 N--CA 1.448 -0.504 0 O-C-N 121.318 -0.864 . . . . 0.0 111.098 174.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 65.6 mt -56.42 -32.3 64.73 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.085 0.554 . . . . 0.0 111.061 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -141.57 149.39 40.7 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 169.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.8 p -91.1 157.93 16.94 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.276 1.031 . . . . 0.0 110.599 170.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 28.5 m -164.88 158.23 17.05 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.826 2.85 . . . . 0.0 104.912 169.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 96.5 mtt-85 -50.93 136.73 22.28 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.643 1.111 . . . . 0.0 110.449 -172.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.7 p -58.17 131.72 22.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -70.33 142.83 90.0 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-O 118.851 -0.595 . . . . 0.0 109.872 -169.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.68 -39.7 0.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.53 1.486 . . . . 0.0 112.583 -169.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.466 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 29.3 m -62.44 -25.8 68.16 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.643 -1.286 . . . . 0.0 111.529 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.75 -43.98 38.11 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.61 0.764 . . . . 0.0 110.928 172.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.9 mt -54.99 -46.52 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 C-N-CA 124.257 1.023 . . . . 0.0 108.345 -178.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.4 -34.89 79.22 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 123.996 0.918 . . . . 0.0 110.051 -171.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.9 mmm -70.09 -41.94 73.39 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.062 0.934 . . . . 0.0 110.549 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.514 ' HG3' ' CG1' ' A' ' 57' ' ' ILE . 87.8 mmm -62.82 -41.23 99.24 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 174.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -61.79 -26.27 67.99 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.079 0.552 . . . . 0.0 111.129 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -66.25 -40.27 90.07 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 118.478 0.581 . . . . 0.0 110.025 172.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.5 t -77.96 -26.22 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.816 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.98 24.29 6.09 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 125.354 1.455 . . . . 0.0 112.009 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.8 mt -121.81 177.63 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 125.643 1.577 . . . . 0.0 107.576 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -143.37 159.0 43.16 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.495 1.518 . . . . 0.0 109.746 -177.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.514 ' CG1' ' HG3' ' A' ' 50' ' ' MET . 0.7 OUTLIER -131.3 -18.64 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.244 1.017 . . . . 0.0 111.776 169.62 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -42.64 -38.32 1.99 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.155 1.382 . . . . 0.0 113.345 174.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.13 -11.28 63.62 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.529 1.061 . . . . 0.0 113.899 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -128.13 172.8 10.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.413 1.485 . . . . 0.0 112.442 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.2 p -125.09 164.28 20.55 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.709 1.604 . . . . 0.0 110.348 -176.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.26 166.95 21.4 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.512 1.525 . . . . 0.0 111.539 174.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -154.91 142.67 14.09 Favored Pre-proline 0 N--CA 1.472 0.643 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.535 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -84.49 151.85 11.86 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.028 2.485 . . . . 0.0 111.868 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.2 tt -58.19 -32.75 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 123.951 0.9 . . . . 0.0 111.647 175.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -57.24 -21.6 35.2 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.255 1.822 . . . . 0.0 112.1 -176.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -74.72 -9.61 58.73 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.662 1.185 . . . . 0.0 112.855 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -134.1 179.7 6.09 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 120.24 1.382 . . . . 0.0 112.711 -175.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.42 143.08 51.15 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 127.901 2.48 . . . . 0.0 107.384 169.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.62 -25.31 62.98 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.194 0.998 . . . . 0.0 112.439 -176.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -60.88 -23.12 64.94 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.753 0.821 . . . . 0.0 112.325 -174.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -80.71 -16.44 53.94 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.122 0.969 . . . . 0.0 110.597 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -102.77 124.37 48.18 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 125.394 1.477 . . . . 0.0 109.083 -173.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -72.16 -36.43 69.3 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 176.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.73 132.32 56.9 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -170.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.1 t -124.04 132.52 71.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 122.188 0.994 . . . . 0.0 108.894 178.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.9 mm -121.87 102.74 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -178.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.3 m -73.95 155.08 39.03 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 168.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.27 26.71 0.96 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.633 1.573 . . . . 0.0 108.156 175.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 86.4 m . . . . . 0 C--N 1.339 0.138 0 C-N-CA 124.863 1.265 . . . . 0.0 113.276 -169.877 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -55.58 -28.47 55.22 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 124.821 1.248 . . . . 0.0 112.193 173.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.5 p -87.39 -2.63 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 118.935 0.789 . . . . 0.0 110.26 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.7 p -123.35 22.66 9.26 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.144 0.978 . . . . 0.0 112.716 -169.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -82.07 178.14 8.44 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.479 0.712 . . . . 0.0 110.7 174.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.72 -33.87 72.18 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.454 1.101 . . . . 0.0 112.224 -169.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.5 mt -129.2 138.58 54.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 172.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -141.94 134.49 28.23 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 170.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -141.15 153.9 45.6 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 168.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -120.08 104.9 10.51 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.715 1.206 . . . . 0.0 110.069 169.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.44 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 37.9 m0 -80.59 79.48 7.2 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.381 1.872 . . . . 0.0 108.564 178.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -55.02 118.67 4.51 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 171.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 30.6 mt -147.07 154.7 41.48 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.534 1.534 . . . . 0.0 107.785 -169.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -82.8 59.35 4.75 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.963 1.305 . . . . 0.0 111.982 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 47.8 t0 5.79 82.23 0.04 OUTLIER Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 129.925 3.29 . . . . 0.0 113.135 169.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.417 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 75.3 Cg_exo -59.49 -13.67 22.01 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.997 3.131 . . . . 0.0 118.691 -168.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -62.98 98.24 0.13 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.623 1.556 . . . . 0.0 110.217 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 106.24 10.94 28.71 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.22 1.867 . . . . 0.0 113.559 173.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.417 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 29.4 mm-40 -95.7 179.38 5.14 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.152 1.476 . . . . 0.0 113.29 -169.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.3 m -76.9 155.51 32.78 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.653 1.581 . . . . 0.0 110.123 175.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 57.3 mt -59.42 -32.2 69.97 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.879 -0.513 . . . . 0.0 111.686 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.36 -41.2 98.41 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.245 0.475 . . . . 0.0 110.765 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 97.3 t -66.28 -45.92 88.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.466 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 11.1 m-85 -55.69 -50.88 69.11 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.86 177.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 53.8 mtp85 -62.58 -40.49 97.05 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 118.31 -0.853 . . . . 0.0 111.486 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 93.9 m -62.08 -52.37 64.2 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 118.57 0.623 . . . . 0.0 109.334 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.9 t -66.37 -45.59 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 118.128 -0.939 . . . . 0.0 110.324 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -40.91 88.78 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 120.054 1.297 . . . . 0.0 110.298 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.48 -50.12 69.93 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-O 118.479 -1.178 . . . . 0.0 110.942 175.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -60.41 -53.72 54.26 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 118.652 1.226 . . . . 0.0 110.631 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.6 t -47.01 -51.92 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 125.212 1.405 . . . . 0.0 109.965 175.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -62.12 -48.35 80.52 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.604 1.093 . . . . 0.0 110.803 -177.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.36 -43.74 75.37 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.295 1.038 . . . . 0.0 110.257 177.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.44 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 81.7 mtt-85 -72.12 -40.85 67.84 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 117.833 -1.079 . . . . 0.0 110.094 -175.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 71.4 t -55.05 -48.74 75.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 120.71 1.595 . . . . 0.0 109.057 169.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.33 -39.8 88.34 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.34 0.973 . . . . 0.0 110.698 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -63.13 -46.01 89.3 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.201 1.0 . . . . 0.0 110.326 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.9 -44.14 90.56 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 123.148 0.579 . . . . 0.0 110.085 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.9 mt -58.56 -36.62 60.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.161 0.984 . . . . 0.0 110.775 174.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.96 -30.73 71.8 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.91 1.232 . . . . 0.0 111.34 -174.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -65.94 -24.87 66.91 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.285 1.434 . . . . 0.0 113.422 177.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.0 pt -123.23 -20.08 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 -167.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.3 m . . . . . 0 C--O 1.248 1.026 0 C-N-CA 126.074 1.75 . . . . 0.0 111.05 173.232 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.9 mptt . . . . . 0 N--CA 1.466 0.34 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -90.64 135.63 33.59 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 121.494 -0.754 . . . . 0.0 109.013 170.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.4 p -115.37 140.37 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 123.659 0.784 . . . . 0.0 109.483 173.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 45.2 tpp -118.59 143.26 46.91 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 171.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -118.38 127.28 53.53 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 169.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 53.4 t -126.69 114.12 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 119.999 1.272 . . . . 0.0 108.871 -171.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.2 t -110.94 160.35 16.88 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.766 0.712 . . . . 0.0 111.071 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -59.13 -18.13 33.05 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 121.321 -0.862 . . . . 0.0 112.637 174.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.11 -2.39 2.07 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -174.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.526 HD22 ' H ' ' A' ' 63' ' ' ASP . 37.0 t-20 37.71 35.73 0.08 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.314 1.846 . . . . 0.0 115.211 -169.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.7 p -107.88 -35.08 6.74 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 120.523 -1.361 . . . . 0.0 112.306 -171.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 20.4 m -134.75 -68.36 0.54 Allowed 'General case' 0 C--N 1.342 0.27 0 CA-C-O 117.948 -1.025 . . . . 0.0 111.727 -169.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -56.13 -53.51 56.25 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.46 1.027 . . . . 0.0 110.262 -170.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.9 p -68.45 -43.06 77.89 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.675 1.19 . . . . 0.0 110.467 -174.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -59.94 -47.51 85.51 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.773 1.229 . . . . 0.0 110.626 -177.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.44 ' HG2' HD11 ' A' ' 57' ' ' ILE . 44.7 mtm -65.75 -44.98 84.28 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 119.272 -0.394 . . . . 0.0 110.77 175.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.89 -40.16 66.36 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.818 0.281 . . . . 0.0 110.945 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.458 ' HA ' HG21 ' A' ' 32' ' ' VAL . 23.5 tt0 -63.6 -55.08 26.52 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 118.676 -0.678 . . . . 0.0 110.009 177.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -53.15 -40.17 59.07 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 119.077 -0.846 . . . . 0.0 111.974 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.446 ' CD1' ' HE3' ' A' ' 50' ' ' MET . 13.3 m-85 -66.29 -49.13 68.15 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 119.11 1.455 . . . . 0.0 108.525 176.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.58 -46.05 90.07 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 124.183 0.993 . . . . 0.0 112.942 -173.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.5 ptmt -68.54 -8.81 44.84 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 119.337 0.971 . . . . 0.0 113.173 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.1 m -94.48 -47.59 6.49 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 119.984 1.266 . . . . 0.0 110.72 169.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.1 mt -76.34 -42.66 44.15 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.885 1.674 . . . . 0.0 111.956 -169.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 CA-C-O 117.741 -1.588 . . . . 0.0 114.935 -169.084 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.1 pt . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -122.84 133.57 54.43 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 168.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.458 HG21 ' HA ' ' A' ' 19' ' ' GLU . 2.6 p -116.8 157.56 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -169.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 m -148.3 145.55 28.21 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 126.306 1.842 . . . . 0.0 107.678 168.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.7 p -115.85 141.21 48.4 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.492 1.517 . . . . 0.0 108.608 168.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.8 m -150.73 -177.68 6.13 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.059 1.744 . . . . 0.0 106.616 -171.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.13 168.87 39.46 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.114 -1.041 . . . . 0.0 112.953 173.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.0 mp -56.2 -36.45 68.43 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 125.305 1.238 . . . . 0.0 110.607 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -150.24 150.41 31.51 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 169.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 65.8 m -83.64 146.5 28.22 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.567 0.699 . . . . 0.0 112.223 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.4 m -144.12 158.1 43.92 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 128.444 2.697 . . . . 0.0 104.505 168.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.5 ptt-85 -57.52 146.2 30.78 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.403 1.001 . . . . 0.0 110.392 -175.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 p -62.91 133.91 28.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 169.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -78.48 145.15 67.12 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.295 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.44 -41.11 0.36 Allowed 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.44 1.426 . . . . 0.0 112.814 -169.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.475 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 38.6 m -63.09 -24.86 68.1 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.422 -1.424 . . . . 0.0 111.314 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.42 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -50.67 -40.59 53.97 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.882 0.873 . . . . 0.0 111.514 172.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 55.5 mt -56.42 -44.23 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 124.304 1.042 . . . . 0.0 108.248 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.01 -37.67 81.69 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 125.069 1.347 . . . . 0.0 110.29 -172.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.0 mmm -68.66 -41.92 78.66 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 123.088 1.423 . . . . 0.0 110.427 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.446 ' HE3' ' CD1' ' A' ' 21' ' ' PHE . 4.6 mtp -66.62 -34.3 77.57 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 120.689 -1.257 . . . . 0.0 109.948 175.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -61.3 -28.83 69.48 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.844 -0.598 . . . . 0.0 111.654 170.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -61.24 -40.85 95.57 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.23 0.923 . . . . 0.0 110.529 173.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.7 m -92.58 7.3 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 178.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.99 25.34 49.53 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.137 0.875 . . . . 0.0 112.6 170.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.682 HG22 ' H ' ' A' ' 56' ' ' ASP . 9.9 mt -123.84 -174.82 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 125.404 1.482 . . . . 0.0 107.159 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.682 ' H ' HG22 ' A' ' 55' ' ' ILE . 8.0 t70 -148.85 155.84 41.47 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.612 1.565 . . . . 0.0 109.349 -176.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.44 HD11 ' HG2' ' A' ' 17' ' ' MET . 0.1 OUTLIER -128.49 -15.44 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 124.148 0.979 . . . . 0.0 112.38 169.768 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.6 p -52.6 -30.82 33.28 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.544 1.065 . . . . 0.0 112.621 176.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.79 -7.48 86.13 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.729 1.157 . . . . 0.0 114.187 -177.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -123.65 173.7 7.93 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 119.3 1.55 . . . . 0.0 111.165 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.5 p -128.72 174.02 9.81 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.11 1.364 . . . . 0.0 110.749 -173.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.8 p -96.92 151.74 19.4 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.355 1.062 . . . . 0.0 110.1 172.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.526 ' H ' HD22 ' A' ' 11' ' ' ASN . 3.5 t70 -150.11 148.79 25.65 Favored Pre-proline 0 C--O 1.239 0.543 0 C-N-CA 125.415 1.486 . . . . 0.0 109.258 -171.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -84.04 151.72 12.55 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.957 1.772 . . . . 0.0 110.898 -177.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.8 tt -54.86 -31.45 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 123.309 0.644 . . . . 0.0 111.271 171.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -50.78 -28.93 10.28 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.243 2.617 . . . . 0.0 112.274 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -83.98 -4.82 59.0 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.269 1.028 . . . . 0.0 112.917 -172.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -129.58 -176.84 4.03 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.643 1.111 . . . . 0.0 110.998 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.83 139.49 50.17 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 127.113 2.165 . . . . 0.0 107.427 173.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.62 -26.58 65.43 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.427 1.091 . . . . 0.0 111.791 -178.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -59.91 -24.54 64.41 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.105 0.962 . . . . 0.0 112.317 -171.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -89.85 -13.04 37.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.766 0.827 . . . . 0.0 111.08 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -94.2 133.05 38.12 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 125.307 1.443 . . . . 0.0 109.798 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -75.48 -42.47 52.91 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.3 p -132.75 137.24 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 123.02 0.528 . . . . 0.0 110.454 -169.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.3 m -129.51 104.61 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-O 123.5 1.619 . . . . 0.0 109.336 -171.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.7 mm -101.65 99.11 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 -177.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.8 t -73.19 155.77 39.26 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 168.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.08 53.49 0.57 Allowed 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 173.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 90.2 m . . . . . 0 C--N 1.339 0.118 0 C-N-CA 123.835 0.854 . . . . 0.0 109.546 173.525 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -66.1 8.99 0.17 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 126.58 1.952 . . . . 0.0 113.396 171.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.9 p -119.95 1.43 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.836 1.255 . . . . 0.0 111.705 171.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.1 p -125.49 25.38 7.05 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.989 0.915 . . . . 0.0 112.156 -172.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -91.54 -172.75 3.34 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.464 0.705 . . . . 0.0 109.444 170.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -66.08 -33.98 77.02 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -169.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.6 mt -136.84 134.46 48.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -139.27 140.23 37.59 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.263 1.025 . . . . 0.0 108.61 173.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -148.91 160.54 43.17 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.372 1.469 . . . . 0.0 107.93 168.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -121.95 102.44 8.18 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.274 1.43 . . . . 0.0 108.743 168.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.422 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 44.2 m0 -77.91 98.62 5.7 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.131 0.972 . . . . 0.0 109.596 -176.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -69.25 104.39 2.2 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.799 1.239 . . . . 0.0 109.229 174.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -137.69 168.71 19.12 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 126.679 1.992 . . . . 0.0 108.033 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -67.53 162.4 23.42 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 166.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -117.1 105.32 49.3 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 171.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -54.7 -1.88 0.17 Allowed 'Trans proline' 0 CA--C 1.537 0.64 1 C-N-CA 125.882 4.388 . . . . 0.0 118.652 -169.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -50.67 91.64 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.365 1.866 . . . . 0.0 112.616 172.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.64 16.71 51.49 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 126.121 1.819 . . . . 0.0 113.244 171.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -94.38 -179.96 5.09 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.843 1.322 . . . . 0.0 112.075 -169.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.5 m -77.46 155.67 31.59 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.089 1.356 . . . . 0.0 109.937 175.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.3 mt -58.61 -32.08 68.68 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 122.032 -0.418 . . . . 0.0 111.546 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -61.96 -39.27 91.56 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.145 0.429 . . . . 0.0 110.731 176.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 89.1 t -67.65 -46.78 82.15 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.475 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 14.0 m-85 -54.04 -52.58 60.41 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.885 0.474 . . . . 0.0 110.898 176.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 28.9 mtt180 -59.29 -42.14 90.57 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.371 1.069 . . . . 0.0 111.621 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 95.4 m -60.86 -52.71 63.9 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 95.8 t -64.41 -42.88 96.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 118.803 -0.618 . . . . 0.0 110.094 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -55.26 -46.71 76.09 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.346 0.976 . . . . 0.0 109.738 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -69.38 -49.35 39.28 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-O 119.211 -0.772 . . . . 0.0 111.866 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -63.79 -45.09 91.28 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.657 1.228 . . . . 0.0 111.866 -174.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.4 t -64.07 -43.42 97.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 117.874 -1.06 . . . . 0.0 109.37 176.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -58.56 -46.37 87.02 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.472 1.487 . . . . 0.0 110.512 178.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.09 -44.13 78.73 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.587 1.155 . . . . 0.0 110.138 176.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.422 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 51.3 mtt85 -71.25 -39.64 71.5 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 117.953 -1.023 . . . . 0.0 111.042 -177.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 88.4 t -54.94 -48.02 75.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 120.514 1.506 . . . . 0.0 109.784 169.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -60.08 -39.6 86.64 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.459 1.027 . . . . 0.0 110.614 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -62.28 -45.51 92.96 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.211 1.004 . . . . 0.0 110.485 178.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.38 -47.62 78.57 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 124.033 0.933 . . . . 0.0 110.06 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 63.7 mt -56.62 -38.37 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.394 1.078 . . . . 0.0 110.329 175.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.98 -28.87 69.32 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.72 1.145 . . . . 0.0 111.44 -174.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -75.16 -19.59 59.79 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.806 1.643 . . . . 0.0 112.731 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.4 pt -125.11 -20.56 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 125.707 1.603 . . . . 0.0 115.29 -168.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 C--O 1.251 1.137 0 C-N-CA 126.573 1.949 . . . . 0.0 110.935 172.311 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? . . . . . 0 N--CA 1.467 0.382 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -92.36 126.21 37.35 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 169.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.7 p -115.88 135.5 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 O-C-N 123.721 0.638 . . . . 0.0 110.962 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 55.1 tpp -107.5 153.05 23.41 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.237 1.015 . . . . 0.0 109.204 170.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -130.03 104.48 7.37 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.985 1.714 . . . . 0.0 106.686 169.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.97 127.28 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 120.057 1.298 . . . . 0.0 109.158 -176.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.2 t -116.17 163.11 16.45 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.791 1.178 . . . . 0.0 112.34 176.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -58.99 -21.81 59.49 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.584 -0.697 . . . . 0.0 111.654 171.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.4 ptm85 -153.48 116.07 4.45 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 169.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -48.8 -29.29 4.41 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.214 1.006 . . . . 0.0 113.166 -175.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.2 m -40.38 -34.33 0.33 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 119.235 3.05 . . . . 0.0 119.235 -169.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.7 p -135.63 -71.68 0.47 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 121.006 1.73 . . . . 0.0 113.942 -169.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -55.14 -50.92 68.05 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.21 0.914 . . . . 0.0 109.886 -169.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 0.1 OUTLIER -63.65 -48.49 77.0 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.992 2.117 . . . . 0.0 111.787 -179.233 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -63.34 -42.95 98.99 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.317 0.647 . . . . 0.0 110.785 -175.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 67.5 mtm -64.82 -46.23 82.83 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 119.05 -0.5 . . . . 0.0 111.036 174.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.86 -41.55 70.93 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 118.233 0.47 . . . . 0.0 110.805 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.63 -46.25 79.98 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 122.843 0.457 . . . . 0.0 111.054 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.39 -40.4 97.52 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -66.63 -52.14 48.41 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 118.506 1.153 . . . . 0.0 108.009 176.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.27 -42.98 78.32 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.824 1.25 . . . . 0.0 113.052 -174.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.3 pttt -68.56 -35.74 77.81 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-N 119.169 0.895 . . . . 0.0 110.265 175.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.6 m -68.1 -41.77 81.32 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 119.555 -1.966 . . . . 0.0 110.569 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.8 mt -73.23 -37.3 66.44 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.086 1.754 . . . . 0.0 111.202 -175.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.909 0 CA-C-O 117.01 -1.995 . . . . 0.0 117.875 -169.768 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.9 pt . . . . . 0 C--O 1.234 0.261 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -110.89 114.65 28.15 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 170.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 p -102.33 151.66 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-O 121.797 0.808 . . . . 0.0 111.723 -176.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.0 m -145.91 151.32 37.66 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 126.182 1.793 . . . . 0.0 106.195 167.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' A' ' 15' ' ' SER . 58.5 p -122.92 158.11 31.12 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 121.043 -1.036 . . . . 0.0 108.673 168.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.8 m -152.18 -173.66 4.62 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.491 1.516 . . . . 0.0 107.525 -174.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.89 162.59 31.35 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 169.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.2 mp -50.2 -36.87 32.51 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.656 1.183 . . . . 0.0 110.075 174.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -141.11 150.06 42.36 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 169.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.0 p -78.02 157.96 29.41 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.988 0.899 . . . . 0.0 110.694 173.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.2 m -164.86 157.86 16.71 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 128.126 2.57 . . . . 0.0 105.231 169.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -56.47 154.18 8.89 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.027 0.83 . . . . 0.0 111.322 -175.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.8 t -62.96 129.71 26.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 172.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -69.37 141.37 91.0 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -176.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.63 -40.42 2.07 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.182 1.255 . . . . 0.0 111.759 -169.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.513 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 6.2 m -67.95 -17.06 64.33 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.453 -1.404 . . . . 0.0 111.868 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.43 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -58.71 -40.28 83.24 Favored 'General case' 0 C--N 1.34 0.168 0 O-C-N 121.338 -0.851 . . . . 0.0 110.459 171.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.2 mt -57.26 -45.48 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.01 99.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.321 0.649 . . . . 0.0 111.791 -175.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 21.4 mmt -57.81 -47.37 82.8 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 122.85 1.31 . . . . 0.0 111.227 176.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 6.7 mtp -69.81 -31.86 69.99 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.376 -177.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.12 -31.82 70.42 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.47 0.708 . . . . 0.0 111.278 170.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -64.98 -35.11 80.12 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 118.669 0.668 . . . . 0.0 110.368 175.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.0 t -79.44 -25.87 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 119.906 -0.093 . . . . 0.0 110.908 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.14 28.81 6.67 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.718 1.151 . . . . 0.0 111.682 -174.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.583 HG22 ' H ' ' A' ' 56' ' ' ASP . 6.7 mt -125.29 -178.81 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 125.942 1.697 . . . . 0.0 106.927 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.583 ' H ' HG22 ' A' ' 55' ' ' ILE . 5.7 t70 -145.92 155.97 43.22 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.979 1.711 . . . . 0.0 108.883 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.43 HD12 ' HB1' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -130.24 -15.61 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.108 0.963 . . . . 0.0 113.331 172.712 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.4 p -50.39 -32.03 16.45 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.647 1.179 . . . . 0.0 113.615 -174.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.46 -15.82 36.53 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 117.852 -1.526 . . . . 0.0 114.425 -172.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -85.8 -25.63 26.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.262 2.031 . . . . 0.0 114.507 -171.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 38.1 p 68.02 168.65 0.26 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.604 1.961 . . . . 0.0 114.116 170.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.8 m -85.14 166.7 16.39 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.718 -171.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.98 139.34 12.59 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 124.137 0.975 . . . . 0.0 109.041 174.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.45 153.58 13.84 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.067 2.512 . . . . 0.0 110.632 169.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.1 tt -53.62 -34.85 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 123.725 0.81 . . . . 0.0 111.355 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -58.82 -22.81 59.43 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.757 1.623 . . . . 0.0 112.528 -176.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -80.42 -5.13 56.04 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.198 0.599 . . . . 0.0 112.541 -177.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -133.41 -176.24 4.08 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.487 1.039 . . . . 0.0 111.336 -176.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -139.68 131.93 28.25 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 126.889 2.076 . . . . 0.0 108.209 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.84 -28.48 67.52 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.475 1.11 . . . . 0.0 112.856 -175.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -60.26 -24.17 64.69 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.849 0.86 . . . . 0.0 112.334 -176.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -83.62 -15.87 47.35 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.247 0.619 . . . . 0.0 110.618 -177.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -102.44 127.06 49.64 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 125.465 1.506 . . . . 0.0 108.701 -175.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -85.4 -25.84 26.78 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.342 0.592 . . . . 0.0 109.688 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.0 t -131.0 135.81 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 -173.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.3 p -135.34 102.71 3.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 123.198 1.475 . . . . 0.0 110.137 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.5 mm -84.7 144.59 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 104.799 -2.296 . . . . 0.0 104.799 168.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.4 m -132.72 158.23 42.89 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 168.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.83 63.57 0.99 Allowed 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 102.515 -3.142 . . . . 0.0 102.515 -171.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 76.2 m . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -177.564 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 . . . . . 0 CA--C 1.538 0.507 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -64.96 10.42 0.07 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.278 1.831 . . . . 0.0 112.496 169.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.1 p -126.12 5.13 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 125.039 1.336 . . . . 0.0 112.03 172.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.6 p -129.41 25.7 5.43 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.895 -1.128 . . . . 0.0 112.89 -170.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -94.31 -177.09 4.16 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.403 0.681 . . . . 0.0 109.682 173.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -57.36 -35.26 69.72 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.372 1.069 . . . . 0.0 112.994 -174.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.8 mt -135.84 138.39 47.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -139.25 137.0 35.54 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 169.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -146.36 151.86 38.17 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.132 1.373 . . . . 0.0 108.21 169.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -115.73 126.67 54.37 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.798 1.239 . . . . 0.0 109.624 169.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.441 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 40.0 m0 -107.09 91.61 3.73 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.412 1.485 . . . . 0.0 108.124 -173.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -69.9 103.69 2.29 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.951 1.3 . . . . 0.0 109.28 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -136.57 161.5 35.72 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.675 1.59 . . . . 0.0 110.517 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -81.65 66.74 7.34 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.02 1.728 . . . . 0.0 111.283 -178.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -9.99 91.93 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 129.731 3.212 . . . . 0.0 112.318 169.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.437 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 71.0 Cg_exo -57.43 -8.36 3.8 Favored 'Trans proline' 0 N--CA 1.459 -0.553 1 C-N-CA 125.409 4.073 . . . . 0.0 117.946 -169.102 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -57.43 95.14 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 120.32 1.418 . . . . 0.0 111.832 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 98.63 13.86 39.55 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 126.428 1.966 . . . . 0.0 113.241 172.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.437 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 28.8 mm-40 -93.31 177.99 5.86 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.039 1.42 . . . . 0.0 112.575 -169.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.8 m -74.6 154.72 38.43 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.407 1.483 . . . . 0.0 109.931 175.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.1 mt -60.07 -30.31 69.13 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.737 -0.602 . . . . 0.0 111.784 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -62.68 -39.87 95.32 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.106 0.412 . . . . 0.0 110.877 174.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.4 t -67.15 -45.2 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.057 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.513 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 16.2 m-85 -54.66 -52.98 60.63 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.322 0.51 . . . . 0.0 110.829 175.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 75.2 mtp85 -59.11 -42.07 89.67 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 118.434 -0.793 . . . . 0.0 111.956 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 91.1 m -62.16 -53.26 57.8 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 119.038 0.836 . . . . 0.0 109.059 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.2 t -62.36 -42.86 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-O 117.802 -1.094 . . . . 0.0 110.183 -178.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.3 ttp85 -53.41 -52.76 58.33 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 119.813 1.188 . . . . 0.0 108.88 176.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.31 -46.02 91.86 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -172.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -62.74 -49.65 74.19 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.918 0.887 . . . . 0.0 111.054 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.8 t -62.05 -48.15 89.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 125.731 1.612 . . . . 0.0 110.42 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -58.84 -47.35 85.17 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 120.625 1.557 . . . . 0.0 110.424 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -53.64 -46.59 70.6 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 123.792 0.837 . . . . 0.0 109.446 174.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.441 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 61.7 mtt85 -69.1 -38.22 78.84 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 117.604 -1.189 . . . . 0.0 110.946 -174.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.6 t -55.49 -49.64 71.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 120.803 1.638 . . . . 0.0 109.626 169.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -61.12 -39.94 91.9 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.519 1.054 . . . . 0.0 110.689 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -61.81 -46.38 89.75 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.486 1.514 . . . . 0.0 109.922 178.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.1 -52.71 62.79 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.477 1.111 . . . . 0.0 109.387 178.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 72.7 mt -52.14 -40.29 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 123.934 0.894 . . . . 0.0 109.67 177.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.19 -30.84 71.35 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.65 1.113 . . . . 0.0 111.622 -174.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 51.9 mttt -70.52 -37.23 74.09 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.985 1.314 . . . . 0.0 111.493 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.0 pt -99.99 -25.59 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -169.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 64.5 m . . . . . 0 C--O 1.248 1.005 0 C-N-CA 126.165 1.786 . . . . 0.0 111.249 179.612 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt . . . . . 0 N--CA 1.466 0.361 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -103.52 125.18 49.92 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -176.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.545 ' HA ' HG13 ' A' ' 75' ' ' VAL . 40.4 t -108.47 138.6 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 124.415 1.086 . . . . 0.0 108.16 -172.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 32.1 tpp -125.99 140.45 52.6 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.858 1.263 . . . . 0.0 108.803 178.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -122.22 132.98 54.71 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 118.098 -0.953 . . . . 0.0 108.538 170.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.8 t -134.04 116.52 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 121.041 1.746 . . . . 0.0 109.926 -171.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.9 t -115.71 163.08 16.34 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.653 1.115 . . . . 0.0 111.093 -177.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -55.54 -22.54 22.09 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.294 1.438 . . . . 0.0 112.67 172.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -135.21 -1.81 2.58 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 62.32 -52.85 0.15 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 127.589 2.356 . . . . 0.0 113.99 -168.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.9 m -41.43 -19.05 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 120.97 3.693 . . . . 0.0 120.97 -169.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.2 p -131.0 -80.6 0.53 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 120.152 1.342 . . . . 0.0 111.085 -169.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -55.12 -50.91 68.02 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.612 0.765 . . . . 0.0 109.002 -170.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.02 -40.99 74.87 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.221 0.608 . . . . 0.0 111.96 -173.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.8 mm100 -69.39 -40.28 77.47 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.579 -0.701 . . . . 0.0 110.678 -170.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 63.1 mtm -62.47 -44.83 95.45 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 119.58 -0.248 . . . . 0.0 110.393 171.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.37 -37.45 70.09 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 119.361 -0.352 . . . . 0.0 111.152 177.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -62.15 -52.15 65.0 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.172 0.589 . . . . 0.0 109.956 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.01 -41.04 99.65 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.341 -0.699 . . . . 0.0 111.503 -177.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.432 ' CD1' ' HE3' ' A' ' 50' ' ' MET . 25.0 m-85 -66.87 -51.3 57.09 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 118.733 1.266 . . . . 0.0 107.947 177.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.93 -42.77 80.63 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 124.2 1.0 . . . . 0.0 112.666 -174.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -68.41 -35.51 77.74 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 119.771 1.169 . . . . 0.0 110.962 175.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.5 m -67.06 -43.16 83.36 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 120.738 1.608 . . . . 0.0 110.404 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.5 mt -74.57 -36.83 63.06 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.051 1.34 . . . . 0.0 111.209 -173.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.835 0 CA-C-O 116.621 -2.211 . . . . 0.0 118.009 -169.162 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.5 pt . . . . . 0 N--CA 1.452 -0.367 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -121.05 133.62 55.25 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 169.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.14 149.84 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-O 121.331 0.586 . . . . 0.0 111.986 -173.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.8 m -142.35 150.82 41.24 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 167.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.4 m -124.75 153.17 42.82 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.951 0.9 . . . . 0.0 109.858 169.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 32.8 m -150.4 -171.46 3.92 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 126.482 1.913 . . . . 0.0 107.463 -170.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.05 169.1 39.52 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 169.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 67.7 mt -53.94 -35.87 62.2 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 124.63 0.841 . . . . 0.0 110.777 178.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -149.69 150.31 31.92 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 169.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.0 p -86.58 165.92 15.81 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 122.081 0.943 . . . . 0.0 111.85 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.1 m -161.68 172.38 16.35 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 128.796 2.838 . . . . 0.0 105.469 169.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.71 151.57 29.0 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.5 -1.375 . . . . 0.0 109.671 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.1 t -57.6 132.91 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 171.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 37.5 t60 -67.92 139.8 93.43 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-O 118.772 -0.632 . . . . 0.0 109.392 177.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.6 -42.29 0.36 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.207 1.938 . . . . 0.0 113.456 -171.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.441 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 5.6 m -62.61 -18.6 62.53 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 119.701 -1.874 . . . . 0.0 112.452 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.7 -38.95 73.01 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.01 0.924 . . . . 0.0 110.291 171.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 62.5 mt -56.49 -48.3 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.04 -40.4 93.47 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 123.972 0.909 . . . . 0.0 111.484 -174.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.5 mmt -59.72 -47.95 83.64 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 122.656 1.217 . . . . 0.0 111.358 176.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.432 ' HE3' ' CD1' ' A' ' 21' ' ' PHE . 8.2 mtp -68.31 -34.72 76.64 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.207 -178.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -61.81 -29.22 70.01 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.243 0.617 . . . . 0.0 111.657 171.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -65.31 -35.84 82.25 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.196 0.907 . . . . 0.0 110.489 173.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 t -78.61 -25.96 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 117.64 0.2 . . . . 0.0 111.0 175.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.25 28.05 7.0 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.522 1.058 . . . . 0.0 111.702 -174.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.584 HG22 ' H ' ' A' ' 56' ' ' ASP . 8.8 mt -121.88 -177.71 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 125.94 1.696 . . . . 0.0 106.731 177.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.584 ' H ' HG22 ' A' ' 55' ' ' ILE . 12.7 t70 -146.9 157.67 43.71 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.37 1.468 . . . . 0.0 109.383 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.407 HG12 ' SD ' ' A' ' 50' ' ' MET . 0.2 OUTLIER -128.45 -17.13 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.993 0.917 . . . . 0.0 112.314 169.803 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -45.0 -38.05 4.48 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.834 1.254 . . . . 0.0 112.783 173.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.86 -5.09 88.71 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.735 1.16 . . . . 0.0 113.972 -173.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -128.27 171.68 11.76 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.324 1.45 . . . . 0.0 110.82 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.3 p -123.86 164.59 18.93 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 122.016 0.913 . . . . 0.0 111.279 -171.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.3 p -74.47 168.25 20.09 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.983 1.713 . . . . 0.0 110.887 173.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -154.45 144.29 15.47 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.524 0.73 . . . . 0.0 109.744 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -86.27 153.11 9.39 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.063 2.508 . . . . 0.0 110.27 169.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.9 tt -54.09 -33.21 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.542 0.737 . . . . 0.0 111.469 173.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -58.28 -24.37 59.25 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.675 1.59 . . . . 0.0 112.552 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -80.11 -6.45 57.72 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -175.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -130.59 -176.51 4.0 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.377 0.99 . . . . 0.0 111.515 -175.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.67 134.17 38.91 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 126.8 2.04 . . . . 0.0 108.348 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.86 -30.87 70.38 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.842 1.257 . . . . 0.0 112.788 -176.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -60.89 -21.78 63.66 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.151 0.98 . . . . 0.0 112.286 -173.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -83.0 -19.47 36.94 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.521 0.729 . . . . 0.0 110.595 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -104.72 124.94 50.28 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.356 1.062 . . . . 0.0 110.282 -169.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -72.86 -38.45 67.04 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 175.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.545 HG13 ' HA ' ' A' ' 4' ' ' VAL . 2.0 p -132.26 131.67 60.81 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -170.008 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.2 t -124.41 109.29 22.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 123.219 1.485 . . . . 0.0 108.699 -176.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.2 mm -99.44 94.3 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 177.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.4 m -70.68 157.76 37.42 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 117.351 -1.74 . . . . 0.0 106.461 167.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.81 50.66 0.68 Allowed 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 103.742 -2.688 . . . . 0.0 103.742 176.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 64.9 m . . . . . 0 CA--C 1.533 0.29 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 169.358 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -55.8 -26.74 47.72 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 121.002 -1.061 . . . . 0.0 112.035 172.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.6 p -84.12 -16.33 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 119.579 1.081 . . . . 0.0 110.337 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.7 p -105.12 16.39 25.9 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.683 0.793 . . . . 0.0 112.477 -169.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -79.13 173.91 12.1 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.608 0.763 . . . . 0.0 109.241 170.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.6 mp0 -58.96 -33.77 71.01 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.343 1.057 . . . . 0.0 113.41 -169.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.2 mt -134.92 136.72 51.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -177.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -143.15 138.76 30.01 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.501 1.12 . . . . 0.0 108.833 175.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -147.23 162.27 39.26 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.367 1.467 . . . . 0.0 107.986 168.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -122.61 97.5 5.48 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.78 1.632 . . . . 0.0 108.805 169.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.45 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 43.7 m0 -74.05 97.81 2.95 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.778 0.831 . . . . 0.0 109.619 -178.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -63.05 119.16 8.96 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 169.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 47.6 mt -151.72 151.48 31.48 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.865 1.666 . . . . 0.0 107.581 -169.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -84.08 73.54 10.38 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.153 0.981 . . . . 0.0 111.002 -176.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -19.36 97.39 0.05 OUTLIER Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 128.765 2.826 . . . . 0.0 111.427 177.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -63.7 -7.43 12.84 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.965 2.443 . . . . 0.0 116.708 -169.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -61.62 90.86 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 120.849 1.658 . . . . 0.0 113.501 -172.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.61 12.48 28.35 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.955 1.741 . . . . 0.0 113.387 175.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -91.34 -179.64 5.45 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.035 1.417 . . . . 0.0 112.128 -171.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.6 m -76.14 155.44 34.63 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.43 1.492 . . . . 0.0 109.973 174.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.6 -31.62 68.22 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.793 -0.567 . . . . 0.0 111.748 -178.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.62 -34.61 76.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 118.418 0.554 . . . . 0.0 111.169 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 95.3 t -66.25 -45.78 89.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 172.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.441 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 18.8 m-85 -56.83 -49.46 75.33 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 119.066 -0.493 . . . . 0.0 110.489 175.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -57.84 -43.38 85.81 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.591 1.157 . . . . 0.0 111.799 176.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.7 m -61.03 -49.49 77.18 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 118.875 0.761 . . . . 0.0 109.406 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.57 -44.66 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 117.742 -1.123 . . . . 0.0 110.377 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 44.3 ttp85 -52.81 -47.11 67.88 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 119.984 1.266 . . . . 0.0 109.137 175.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.89 -49.79 65.45 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-O 118.341 -1.255 . . . . 0.0 110.398 -176.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -59.81 -56.5 21.02 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 118.36 1.08 . . . . 0.0 110.269 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 80.3 t -49.46 -53.28 9.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 125.285 1.434 . . . . 0.0 109.897 177.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -60.82 -46.9 88.73 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 121.049 1.75 . . . . 0.0 110.463 -175.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.15 -44.8 88.06 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.996 0.519 . . . . 0.0 110.269 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.45 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 79.2 mtt-85 -69.08 -40.97 78.14 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.152 -0.927 . . . . 0.0 110.175 -176.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 70.5 t -55.08 -49.05 74.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 120.446 1.476 . . . . 0.0 109.604 169.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -60.35 -39.0 85.57 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.389 0.995 . . . . 0.0 110.45 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -63.54 -45.85 88.68 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.318 1.047 . . . . 0.0 110.427 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.57 -47.12 79.91 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 123.963 0.905 . . . . 0.0 109.779 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.1 mt -53.88 -42.69 54.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 124.715 1.206 . . . . 0.0 109.968 174.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.15 -28.45 67.93 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.399 1.0 . . . . 0.0 111.67 -171.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -73.29 -20.44 60.82 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.91 1.684 . . . . 0.0 112.465 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.3 pt -124.64 -22.29 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 -168.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.9 m . . . . . 0 C--O 1.251 1.174 0 C-N-CA 125.591 1.557 . . . . 0.0 111.283 170.528 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.9 ttm . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 120.95 0.405 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -123.52 142.37 51.08 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 172.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.7 mttt -100.28 123.14 44.14 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.436 ' HA ' HG13 ' A' ' 75' ' ' VAL . 14.8 p -102.93 144.74 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 122.058 0.932 . . . . 0.0 110.51 177.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 29.6 tpp -124.24 142.69 51.04 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 125.042 1.337 . . . . 0.0 108.629 176.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -124.22 124.34 42.23 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 171.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.7 t -127.61 121.6 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 120.483 1.492 . . . . 0.0 109.073 -172.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.8 t -118.64 165.75 13.59 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.954 0.797 . . . . 0.0 109.687 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -56.32 -20.99 21.42 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.977 0.911 . . . . 0.0 112.455 170.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -139.51 -2.74 1.56 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 60.27 -47.15 0.1 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 128.53 2.732 . . . . 0.0 115.499 -169.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.7 p -43.96 -25.61 0.22 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 119.707 3.225 . . . . 0.0 119.707 -168.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 45.2 m -126.91 -72.47 0.64 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.909 0.777 . . . . 0.0 109.818 -169.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -63.98 -49.56 72.0 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -169.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.16 -42.08 72.97 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 117.76 0.254 . . . . 0.0 111.11 -177.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -60.09 -45.51 92.7 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.007 0.523 . . . . 0.0 111.166 -175.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.42 ' HG2' HD11 ' A' ' 57' ' ' ILE . 46.9 mtm -64.16 -44.35 92.38 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 121.235 -0.186 . . . . 0.0 110.853 175.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.16 -37.76 75.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 119.363 -0.351 . . . . 0.0 111.116 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -65.5 -45.06 85.08 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.946 0.339 . . . . 0.0 110.52 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.84 -44.14 97.33 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -67.03 -50.56 61.64 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 118.629 1.214 . . . . 0.0 109.412 176.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.36 -42.55 82.29 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 119.477 1.035 . . . . 0.0 112.432 -173.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -69.65 -36.88 76.46 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.46 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.9 m -66.79 -43.1 84.84 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 119.65 -1.906 . . . . 0.0 110.571 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.5 mt -73.02 -39.37 66.05 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.539 1.536 . . . . 0.0 110.79 -174.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -133.77 3.48 4.6 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 116.747 -2.14 . . . . 0.0 118.296 -169.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.85 112.54 1.06 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 121.433 2.616 . . . . 0.0 109.011 170.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.71 -24.22 5.53 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.671 1.129 . . . . 0.0 111.741 -175.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.48 -19.28 3.08 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.402 1.101 . . . . 0.0 111.844 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.6 pt -131.7 156.29 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 168.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -120.16 130.5 54.62 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 170.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 p -113.08 151.24 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 124.169 0.988 . . . . 0.0 111.381 -176.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.7 m -147.81 135.9 21.28 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 167.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.3 p -102.45 156.63 17.47 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 121.083 -1.011 . . . . 0.0 108.335 169.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.4 m -148.53 -175.3 4.87 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 125.848 1.659 . . . . 0.0 106.759 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.93 154.7 25.85 Favored Glycine 0 CA--C 1.497 -1.051 0 N-CA-C 108.301 -1.919 . . . . 0.0 108.301 169.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 68.7 tp -49.03 -34.41 13.27 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.877 1.271 . . . . 0.0 109.74 169.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -146.47 148.38 32.18 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 168.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 p -83.03 162.84 21.29 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.81 0.844 . . . . 0.0 111.548 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 69.3 m -160.03 160.28 33.06 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.392 2.277 . . . . 0.0 106.551 169.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.88 138.14 30.51 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 117.813 -1.089 . . . . 0.0 110.386 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.6 p -57.76 130.09 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 120.083 1.311 . . . . 0.0 107.846 170.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -74.29 142.76 78.94 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.083 -169.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.51 -42.29 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.341 1.361 . . . . 0.0 112.25 -169.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.455 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 26.3 m -62.77 -24.95 67.98 Favored 'General case' 0 CA--C 1.535 0.365 0 O-C-N 120.484 -1.385 . . . . 0.0 111.414 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.69 -40.2 59.68 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.462 0.705 . . . . 0.0 111.536 173.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.1 mt -55.68 -46.08 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.38 -38.83 91.18 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 124.439 1.096 . . . . 0.0 110.144 -171.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 8.7 mmm -68.64 -44.01 75.08 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 122.791 1.281 . . . . 0.0 110.557 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 9.7 mtp -65.64 -35.48 80.93 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.327 -0.858 . . . . 0.0 109.867 175.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -62.72 -26.53 68.73 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.657 0.662 . . . . 0.0 111.501 173.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -65.7 -39.87 91.68 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.823 0.738 . . . . 0.0 109.876 173.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 88.7 t -76.67 -25.37 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.617 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.45 25.86 5.61 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.034 1.302 . . . . 0.0 111.718 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.503 HG22 ' H ' ' A' ' 56' ' ' ASP . 12.9 mt -122.89 178.79 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 C-N-CA 125.255 1.422 . . . . 0.0 107.378 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.503 ' H ' HG22 ' A' ' 55' ' ' ILE . 13.3 t70 -143.1 156.1 44.74 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.315 1.446 . . . . 0.0 109.276 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.42 HD11 ' HG2' ' A' ' 17' ' ' MET . 0.4 OUTLIER -128.08 -15.6 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 123.881 0.872 . . . . 0.0 112.351 169.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -45.75 -38.09 6.65 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.687 1.195 . . . . 0.0 112.859 172.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.77 -6.59 85.37 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.557 1.075 . . . . 0.0 114.217 -173.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -125.15 169.59 12.05 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 119.01 1.405 . . . . 0.0 111.036 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.3 p -127.05 169.91 12.88 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.75 1.22 . . . . 0.0 110.819 -172.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.7 p -92.69 160.15 15.11 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.576 1.15 . . . . 0.0 111.284 178.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -154.81 138.7 11.14 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 118.364 -0.827 . . . . 0.0 109.474 -169.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -80.94 152.88 19.15 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.663 2.242 . . . . 0.0 111.703 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.0 tt -52.43 -34.86 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.763 1.225 . . . . 0.0 111.552 173.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -57.78 -23.64 53.26 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.128 1.771 . . . . 0.0 112.371 -175.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -83.37 -6.71 59.55 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.856 0.863 . . . . 0.0 112.79 -175.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -128.57 -176.89 3.97 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.465 1.029 . . . . 0.0 111.269 -176.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.56 132.53 37.31 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 126.672 1.989 . . . . 0.0 108.344 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.32 -30.01 69.24 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.732 1.213 . . . . 0.0 112.702 -176.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -61.29 -21.21 63.73 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.08 0.952 . . . . 0.0 112.496 -174.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -85.86 -15.26 42.4 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.3 0.64 . . . . 0.0 110.778 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -107.8 121.97 45.83 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 124.775 1.23 . . . . 0.0 109.309 -172.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -71.83 -38.33 70.17 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.312 0.245 . . . . 0.0 111.039 177.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.436 HG13 ' HA ' ' A' ' 4' ' ' VAL . 1.1 p -131.5 133.17 62.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -170.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.7 t -124.23 123.13 65.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 122.526 1.155 . . . . 0.0 108.404 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 35.5 mm -113.41 97.09 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.5 m -72.65 156.51 38.89 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 168.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.05 54.72 0.65 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 176.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.8 m -82.95 -34.19 26.56 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.193 0.997 . . . . 0.0 109.796 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.32 169.51 40.6 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 98.8 m 39.13 33.34 0.09 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.226 2.21 . . . . 0.0 114.639 -175.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.24 22.84 51.48 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.533 1.54 . . . . 0.0 114.59 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.6 t -62.33 144.59 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 169.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -141.03 178.81 7.11 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.004 0.922 . . . . 0.0 110.444 -169.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.8 mt -114.31 111.23 47.22 Favored Pre-proline 0 N--CA 1.453 -0.308 0 C-N-CA 126.305 1.842 . . . . 0.0 106.973 -170.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -50.61 -41.18 54.24 Favored 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 122.571 2.181 . . . . 0.0 115.355 169.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.35 -179.7 5.02 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.797 1.665 . . . . 0.0 114.1 -174.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -52.19 -16.58 0.84 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 129.307 3.043 . . . . 0.0 114.222 -174.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -57.51 -24.9 58.59 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 121.17 -0.956 . . . . 0.0 111.994 174.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.1 p -87.3 -9.97 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 119.65 1.114 . . . . 0.0 110.541 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 49.5 p -113.44 19.88 16.54 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.916 0.886 . . . . 0.0 112.549 -169.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -81.67 175.72 10.23 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.609 0.764 . . . . 0.0 109.663 171.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -57.77 -32.67 67.72 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.905 1.282 . . . . 0.0 113.588 -169.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.0 mt -135.17 139.08 47.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -141.93 137.83 31.57 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 124.276 1.03 . . . . 0.0 108.506 172.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -146.68 158.75 43.97 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.802 1.641 . . . . 0.0 107.421 168.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -121.92 101.4 7.54 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.015 1.326 . . . . 0.0 108.045 168.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.463 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 43.5 m0 -75.44 95.83 3.34 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.539 1.136 . . . . 0.0 108.955 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -59.91 118.55 6.36 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 169.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 38.3 mt -153.43 146.24 24.36 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.846 1.658 . . . . 0.0 107.204 -169.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -83.77 72.8 10.34 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.25 1.42 . . . . 0.0 110.946 -173.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -23.55 100.93 0.08 OUTLIER Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 128.007 2.523 . . . . 0.0 113.075 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.456 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 68.4 Cg_exo -60.97 -2.65 2.32 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 124.236 3.29 . . . . 0.0 116.925 -172.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -52.28 100.49 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.239 1.381 . . . . 0.0 112.157 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.75 20.47 59.69 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.341 1.924 . . . . 0.0 113.561 171.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.456 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 21.2 mm-40 -96.95 179.23 5.01 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.752 1.276 . . . . 0.0 113.052 -169.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.1 m -76.44 154.93 34.33 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.497 1.519 . . . . 0.0 109.877 175.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.8 mt -58.63 -31.77 68.42 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 122.053 -0.404 . . . . 0.0 111.461 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -63.39 -41.08 98.76 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.075 0.398 . . . . 0.0 110.889 177.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 88.9 t -65.63 -46.75 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.455 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 8.0 m-85 -54.59 -53.83 49.38 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.344 0.658 . . . . 0.0 110.732 176.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 31.2 mtt180 -59.75 -41.99 92.21 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 123.947 0.899 . . . . 0.0 111.463 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 93.9 m -61.46 -54.41 43.76 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.2 t -62.97 -43.21 98.91 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 CA-C-O 118.799 -0.62 . . . . 0.0 110.648 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -57.73 -43.81 85.58 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 119.328 0.967 . . . . 0.0 110.139 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.29 -50.2 61.36 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.015 -0.88 . . . . 0.0 111.166 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -58.02 -51.43 69.68 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.243 1.022 . . . . 0.0 110.912 -176.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.6 t -50.83 -55.89 5.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 126.841 2.057 . . . . 0.0 109.934 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -59.34 -46.91 87.31 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 119.405 1.002 . . . . 0.0 110.185 -173.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.07 -42.06 79.95 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.318 1.047 . . . . 0.0 110.547 177.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.463 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 45.4 mtt85 -72.23 -40.97 67.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 117.684 -1.15 . . . . 0.0 110.888 -177.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.413 ' HA ' HD23 ' A' ' 126' ' ' LEU . 99.2 t -54.5 -46.15 71.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 120.653 1.569 . . . . 0.0 109.763 169.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -62.21 -40.9 97.63 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.222 0.919 . . . . 0.0 110.861 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -62.61 -44.24 96.81 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 122.911 0.485 . . . . 0.0 110.542 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 123' ' ' VAL . 0.2 OUTLIER -64.32 -47.59 78.82 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 118.293 -0.86 . . . . 0.0 109.768 -178.111 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 67.3 mt -54.31 -41.46 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.787 0.835 . . . . 0.0 109.452 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.66 -31.53 72.42 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.84 1.2 . . . . 0.0 111.543 -173.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -66.15 -45.91 79.32 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.413 1.085 . . . . 0.0 110.814 176.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.2 pt -89.19 -27.03 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.813 1.245 . . . . 0.0 114.299 -169.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 63.4 m . . . . . 0 C--O 1.248 1.0 0 C-N-CA 125.882 1.673 . . . . 0.0 111.17 -179.231 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.9 ttm . . . . . 0 N--CA 1.484 1.254 0 CA-C-O 121.474 0.654 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -76.8 127.09 32.1 Favored 'General case' 0 C--O 1.23 0.061 0 C-N-CA 123.536 0.734 . . . . 0.0 109.238 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.507 ' HE2' ' CE1' ' A' ' 73' ' ' TYR . 32.5 mtpt -96.15 129.14 43.53 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 118.508 -0.758 . . . . 0.0 109.593 175.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.6 p -105.31 140.26 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 118.673 0.67 . . . . 0.0 109.456 171.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.7 tpp -115.58 141.78 47.61 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 169.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -117.62 135.67 53.83 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 169.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -138.28 118.42 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 120.38 1.446 . . . . 0.0 109.382 -170.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.0 t -115.12 163.68 15.28 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.367 0.985 . . . . 0.0 109.723 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -61.45 -21.37 64.08 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 118.129 -0.939 . . . . 0.0 112.821 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -131.77 -0.97 3.83 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 62.32 -48.48 0.17 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 127.595 2.358 . . . . 0.0 115.105 -169.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.7 m -31.11 -40.59 0.03 OUTLIER 'General case' 0 C--O 1.235 0.313 0 N-CA-C 119.542 3.164 . . . . 0.0 119.542 -168.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.7 m -127.45 -63.86 1.02 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.66 1.118 . . . . 0.0 111.405 -169.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -58.13 -50.73 72.49 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.254 0.933 . . . . 0.0 109.787 -171.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 m -69.07 -41.17 77.91 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 117.85 0.296 . . . . 0.0 110.854 -174.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -70.3 -41.27 73.57 Favored 'General case' 0 N--CA 1.463 0.175 0 O-C-N 121.599 -0.688 . . . . 0.0 110.881 -169.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 66.2 mtm -62.06 -41.85 98.58 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 118.082 0.401 . . . . 0.0 110.893 171.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.34 -33.65 69.77 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 118.931 -0.557 . . . . 0.0 110.951 175.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.414 ' HA ' HG21 ' A' ' 32' ' ' VAL . 6.8 tt0 -59.21 -65.06 0.73 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.77 -39.5 77.06 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.015 -0.881 . . . . 0.0 112.549 -175.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -67.18 -45.01 78.23 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 119.274 1.537 . . . . 0.0 109.579 177.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.55 -43.6 93.43 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 120.372 1.442 . . . . 0.0 112.555 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.4 ptmt -69.18 -9.73 54.33 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.941 1.246 . . . . 0.0 113.1 175.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.4 m -92.81 -49.3 6.13 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 119.97 1.259 . . . . 0.0 110.618 170.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.4 mt -79.07 -39.91 32.61 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.352 1.461 . . . . 0.0 112.318 -169.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.18 -10.41 15.68 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-O 117.935 -1.481 . . . . 0.0 114.428 -169.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.89 108.94 0.4 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.31 1.555 . . . . 0.0 109.18 169.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 137.36 -29.24 2.71 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.871 1.224 . . . . 0.0 111.541 -169.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.18 -23.95 2.13 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.402 1.081 . . . . 0.0 111.844 173.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.3 pt -128.37 162.13 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 123.344 0.658 . . . . 0.0 111.088 175.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -128.18 138.5 52.51 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 168.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.414 HG21 ' HA ' ' A' ' 19' ' ' GLU . 2.5 p -113.13 152.17 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-O 122.26 1.029 . . . . 0.0 113.412 -169.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.4 m -139.72 147.63 41.17 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 127.315 2.246 . . . . 0.0 105.123 167.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.3 m -132.21 146.71 52.2 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.831 1.252 . . . . 0.0 108.568 169.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 23.9 p -156.36 -161.79 1.17 Allowed 'General case' 0 C--O 1.242 0.666 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -176.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -151.66 156.96 26.97 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 169.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.3 tp -46.52 -36.87 7.19 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.979 1.712 . . . . 0.0 109.391 169.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -147.03 148.26 31.5 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 102.205 -3.257 . . . . 0.0 102.205 167.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.6 m -125.04 144.16 50.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.199 0.523 . . . . 0.0 112.284 -173.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.0 m -137.64 164.59 28.42 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.403 2.281 . . . . 0.0 107.551 173.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.93 145.62 1.44 Allowed 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.149 1.38 . . . . 0.0 113.232 -169.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.9 p -61.05 132.07 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 169.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.401 ' CE1' ' H ' ' A' ' 106' ' ' GLY . 14.7 t-80 -76.72 145.96 75.66 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.692 -172.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.17 -40.72 0.78 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 121.393 1.396 . . . . 0.0 112.534 -169.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.534 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 24.0 m -66.12 -17.07 64.48 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 120.044 -1.66 . . . . 0.0 111.864 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.68 -40.74 76.11 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 123.984 0.914 . . . . 0.0 110.836 170.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.0 mt -55.14 -52.19 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.18 -38.93 81.01 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 123.741 0.65 . . . . 0.0 111.917 -173.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.6 mmt -59.42 -49.84 76.26 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 122.403 1.097 . . . . 0.0 111.697 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.4 mtp -67.33 -36.15 80.86 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.164 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -61.75 -30.17 70.61 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.315 1.046 . . . . 0.0 111.295 174.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -64.13 -40.78 96.91 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.83 0.741 . . . . 0.0 110.336 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.1 t -75.2 -20.23 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.498 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.63 25.47 9.91 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.697 1.141 . . . . 0.0 111.332 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.531 HG22 ' H ' ' A' ' 56' ' ' ASP . 12.4 mt -121.62 -178.33 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.531 ' H ' HG22 ' A' ' 55' ' ' ILE . 9.8 t70 -146.51 151.73 37.83 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 120.457 -1.402 . . . . 0.0 109.694 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.6 pt -132.68 -3.96 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.405 1.082 . . . . 0.0 112.824 169.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 95.3 p -55.87 -30.62 61.82 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 120.187 1.358 . . . . 0.0 112.146 169.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.05 -7.43 87.6 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 118.729 -1.039 . . . . 0.0 114.087 -176.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.56 172.4 7.87 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.448 1.499 . . . . 0.0 111.16 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 16.8 p -129.46 157.62 41.48 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.368 1.067 . . . . 0.0 111.071 -170.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.6 p -68.21 156.67 37.09 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.717 1.207 . . . . 0.0 110.04 169.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -156.07 143.54 13.91 Favored Pre-proline 0 N--CA 1.469 0.5 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.038 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -81.32 150.4 17.37 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.835 2.357 . . . . 0.0 111.226 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.6 tt -55.27 -33.21 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.272 0.629 . . . . 0.0 111.362 173.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -56.92 -22.11 35.09 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.548 1.939 . . . . 0.0 112.418 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -79.46 -4.64 52.15 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.209 1.004 . . . . 0.0 112.85 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -128.13 177.91 6.59 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.768 1.167 . . . . 0.0 111.753 -175.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.03 140.14 52.84 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 127.183 2.193 . . . . 0.0 106.859 170.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.412 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -72.54 -23.0 60.93 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.115 0.966 . . . . 0.0 112.002 -177.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.86 -24.25 66.79 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.176 0.99 . . . . 0.0 112.472 -173.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -89.82 -15.16 32.9 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.033 0.933 . . . . 0.0 110.505 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.507 ' CE1' ' HE2' ' A' ' 3' ' ' LYS . 83.5 m-85 -86.69 141.62 28.79 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.901 1.281 . . . . 0.0 110.061 178.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -89.98 -34.84 15.85 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.151 0.98 . . . . 0.0 110.64 173.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -140.36 137.67 36.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -172.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.2 m -127.48 108.79 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 123.167 1.461 . . . . 0.0 109.39 -173.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.2 mm -104.26 96.67 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.3 t -71.17 157.0 38.91 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 167.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.21 52.37 0.43 Allowed 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 103.52 -2.77 . . . . 0.0 103.52 174.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 95.4 m -77.27 -34.67 55.64 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.432 1.093 . . . . 0.0 110.153 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.25 169.77 29.37 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -176.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 88.8 m 38.06 32.88 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.431 2.293 . . . . 0.0 115.318 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.08 25.54 59.91 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.057 1.313 . . . . 0.0 113.878 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.2 t -61.74 158.03 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.789 1.236 . . . . 0.0 107.959 169.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -139.24 -179.59 5.96 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.149 1.38 . . . . 0.0 108.937 -171.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 49.6 mt -119.85 92.23 46.31 Favored Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 126.763 2.025 . . . . 0.0 105.859 -171.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -47.12 -35.34 19.23 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 123.205 2.603 . . . . 0.0 116.667 175.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -68.37 -173.7 0.58 Allowed 'Trans proline' 0 C--N 1.356 0.928 0 CA-C-N 122.127 1.795 . . . . 0.0 113.983 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -45.16 -21.28 0.07 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 128.157 2.583 . . . . 0.0 114.703 171.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.412 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 95.6 m95 -60.64 10.28 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.792 2.837 . . . . 0.0 114.427 172.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.2 p -128.02 18.61 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 124.623 1.169 . . . . 0.0 112.015 173.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 48.8 p -124.63 18.27 8.77 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -170.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -94.5 -174.9 3.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.52 1.528 . . . . 0.0 109.452 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -66.77 -34.98 79.02 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.57 -0.706 . . . . 0.0 112.506 -174.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.0 mt -134.71 136.58 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -174.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -137.61 138.14 39.22 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 169.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -146.92 159.98 42.88 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.659 1.583 . . . . 0.0 107.388 168.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -123.17 104.52 9.22 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.954 1.302 . . . . 0.0 108.744 169.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.409 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 41.9 m0 -80.71 88.72 5.76 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.996 0.918 . . . . 0.0 108.873 -177.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -62.71 104.49 0.54 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.47 1.108 . . . . 0.0 109.644 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 101' ' ' LEU . 1.2 mm? -136.92 172.16 13.43 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 126.217 1.807 . . . . 0.0 108.511 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -70.78 158.89 35.55 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 166.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -112.48 109.28 53.74 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 169.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.441 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 81.8 Cg_exo -53.31 1.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 1 C-N-CA 126.652 4.901 . . . . 0.0 119.514 -169.639 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -51.53 98.93 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.844 1.202 . . . . 0.0 112.094 174.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.401 ' H ' ' CE1' ' A' ' 43' ' ' HIS . . . 84.23 18.23 63.11 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 126.197 1.856 . . . . 0.0 113.111 171.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.441 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 24.8 mm-40 -95.18 178.22 5.6 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.811 1.305 . . . . 0.0 111.876 -169.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.9 m -74.09 153.89 39.41 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.236 1.414 . . . . 0.0 109.96 176.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 82.2 mt -60.14 -28.75 68.14 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.762 -0.586 . . . . 0.0 111.843 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.42 -38.8 92.55 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.087 0.403 . . . . 0.0 110.789 174.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 86.7 t -68.49 -46.29 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.534 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 16.3 m-85 -52.98 -54.55 33.45 Favored 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 122.704 0.401 . . . . 0.0 110.561 175.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -59.66 -40.67 88.5 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.175 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.8 m -62.55 -52.29 64.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.432 1.014 . . . . 0.0 109.668 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.86 -45.83 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-O 118.181 -0.914 . . . . 0.0 109.475 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -55.85 -49.61 72.84 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.448 1.022 . . . . 0.0 109.303 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.64 -49.1 82.34 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-O 118.368 -1.24 . . . . 0.0 110.482 -176.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -60.71 -53.49 56.82 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-N 118.371 1.085 . . . . 0.0 110.812 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 68.5 t -52.88 -46.13 51.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 124.355 1.062 . . . . 0.0 110.2 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -63.54 -49.9 71.63 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 119.724 1.147 . . . . 0.0 110.523 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.09 -43.44 70.36 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.338 1.055 . . . . 0.0 110.526 175.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.409 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 81.5 mtt-85 -72.24 -41.25 67.04 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 117.74 -1.124 . . . . 0.0 110.074 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.7 t -54.3 -49.0 66.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 120.629 1.559 . . . . 0.0 108.811 169.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -60.17 -39.85 87.88 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.29 0.95 . . . . 0.0 110.883 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -63.65 -45.48 89.98 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.309 1.043 . . . . 0.0 110.257 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -46.09 89.31 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 123.829 0.852 . . . . 0.0 109.645 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 64.1 mt -60.07 -38.07 75.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.672 1.189 . . . . 0.0 110.921 175.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.69 -31.72 71.88 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 120.139 1.336 . . . . 0.0 111.295 -174.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -69.7 -20.46 63.54 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.596 1.558 . . . . 0.0 113.023 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.7 pt -125.01 -21.21 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -168.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 C--O 1.251 1.134 0 C-N-CA 126.391 1.876 . . . . 0.0 111.124 173.746 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.9 ttm . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.611 0.243 . . . . 0.0 110.457 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.69 141.91 43.31 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.582 0.753 . . . . 0.0 109.409 171.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -93.08 128.22 38.9 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 169.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.4 p -113.0 136.74 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 123.477 0.711 . . . . 0.0 109.565 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 35.9 tpp -112.93 141.34 46.88 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 170.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -117.47 136.0 53.52 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 169.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.423 HG11 HD12 ' A' ' 65' ' ' ILE . 12.1 t -138.87 131.03 37.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -174.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.23 165.9 18.09 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 120.116 1.325 . . . . 0.0 109.971 169.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -62.74 -10.81 14.05 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.6 ptm85 -153.93 114.27 3.95 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 103.168 -2.901 . . . . 0.0 103.168 169.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -51.83 -25.6 8.13 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.327 1.851 . . . . 0.0 113.25 -176.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.4 p -40.05 -36.87 0.53 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 118.42 2.748 . . . . 0.0 118.42 -168.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.0 p -137.55 -54.52 0.68 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 -169.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -64.59 -51.93 60.16 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 122.221 2.282 . . . . 0.0 108.863 -169.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 82.2 p -70.31 -39.04 75.06 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -170.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -55.89 -50.57 70.3 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.184 0.993 . . . . 0.0 111.096 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 60.0 mtm -64.18 -46.21 84.96 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 117.489 0.132 . . . . 0.0 110.709 178.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.78 -39.49 71.32 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 119.524 -0.274 . . . . 0.0 110.508 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.532 ' HA ' HG21 ' A' ' 32' ' ' VAL . 36.2 tt0 -65.55 -45.35 83.73 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 119.434 -0.317 . . . . 0.0 111.137 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.38 -41.79 99.74 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -65.39 -49.05 70.76 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 117.997 0.899 . . . . 0.0 109.107 174.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.32 -43.15 88.08 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.169 0.895 . . . . 0.0 112.391 -172.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -69.37 -36.56 76.96 Favored 'General case' 0 C--O 1.219 -0.546 0 C-N-CA 118.991 -1.083 . . . . 0.0 110.946 175.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 52.2 m -67.19 -42.48 84.11 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 120.762 1.619 . . . . 0.0 110.495 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.3 mt -77.16 -37.63 53.45 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.38 1.472 . . . . 0.0 111.423 -174.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.3 -1.13 5.32 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 116.578 -2.234 . . . . 0.0 117.441 -169.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.55 108.75 0.52 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 121.935 2.868 . . . . 0.0 108.86 169.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.53 -29.26 2.8 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.846 1.212 . . . . 0.0 111.65 -170.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -134.21 -11.85 2.5 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.259 1.024 . . . . 0.0 113.216 171.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.2 pt -130.09 155.22 41.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 119.063 0.847 . . . . 0.0 109.306 168.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.73 127.84 53.22 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 105.472 -2.048 . . . . 0.0 105.472 169.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.532 HG21 ' HA ' ' A' ' 19' ' ' GLU . 3.0 p -112.17 150.87 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -173.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.1 m -141.03 144.28 34.9 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 126.012 1.725 . . . . 0.0 107.452 168.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.8 p -117.11 152.73 34.1 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.816 1.646 . . . . 0.0 109.003 168.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 32.1 p -158.14 -165.01 1.61 Allowed 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 176.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.47 160.05 28.31 Favored Glycine 0 CA--C 1.503 -0.68 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 169.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.3 tp -47.51 -35.66 9.15 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.369 1.468 . . . . 0.0 109.758 169.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -142.07 144.14 33.43 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 168.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.2 p -73.75 155.74 38.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.75 0.786 . . . . 0.0 110.885 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 67.5 m -159.19 150.57 20.26 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.513 1.925 . . . . 0.0 106.018 169.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.7 ttt-85 -49.08 146.94 3.16 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.876 1.271 . . . . 0.0 110.831 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.6 t -57.32 129.34 19.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.519 -1.659 . . . . 0.0 106.519 169.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -71.66 137.32 83.06 Favored Pre-proline 0 N--CA 1.444 -0.747 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -72.95 -38.64 2.77 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.04 1.16 . . . . 0.0 111.66 -169.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.438 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 20.6 m -64.4 -24.69 67.72 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.737 -1.227 . . . . 0.0 111.571 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.04 -39.38 66.13 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 121.574 -0.704 . . . . 0.0 111.193 175.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.5 mt -55.86 -46.03 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.26 -40.22 93.67 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 123.99 0.916 . . . . 0.0 110.065 -170.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.9 mmm -67.14 -43.0 83.48 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 122.672 1.225 . . . . 0.0 110.685 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.417 ' SD ' HG12 ' A' ' 57' ' ' ILE . 9.4 mtp -65.42 -34.92 79.43 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.375 -0.828 . . . . 0.0 109.863 174.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.65 -30.53 68.8 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.717 0.69 . . . . 0.0 111.217 173.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -66.69 -38.1 86.08 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.192 0.451 . . . . 0.0 109.879 176.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 64.3 t -77.28 -24.66 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.612 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.13 26.03 5.89 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.161 1.362 . . . . 0.0 111.75 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.489 HG22 ' H ' ' A' ' 56' ' ' ASP . 9.7 mt -124.79 178.34 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 125.091 1.357 . . . . 0.0 107.476 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.489 ' H ' HG22 ' A' ' 55' ' ' ILE . 11.8 t70 -142.23 156.43 45.3 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.514 1.526 . . . . 0.0 109.301 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.417 HG12 ' SD ' ' A' ' 50' ' ' MET . 0.1 OUTLIER -129.06 -15.2 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.041 0.936 . . . . 0.0 112.634 170.505 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -44.62 -37.39 3.6 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.785 1.234 . . . . 0.0 112.715 172.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.95 -7.7 84.22 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.664 1.126 . . . . 0.0 114.384 -174.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -125.77 168.39 13.87 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.244 1.522 . . . . 0.0 110.667 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.0 p -129.36 169.37 14.97 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.207 1.003 . . . . 0.0 111.374 -169.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 54.7 m -89.61 159.66 17.04 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.17 0.988 . . . . 0.0 111.044 174.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -157.91 140.38 10.47 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.954 1.301 . . . . 0.0 108.875 -172.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.52 148.05 32.84 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.562 1.508 . . . . 0.0 110.417 -177.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.423 HD12 HG11 ' A' ' 7' ' ' VAL . 19.7 tt -52.15 -35.03 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 123.878 0.871 . . . . 0.0 111.559 174.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -58.05 -22.21 49.09 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.455 1.902 . . . . 0.0 112.316 -175.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -80.43 -7.01 58.97 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.343 1.057 . . . . 0.0 112.835 -177.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -125.02 179.86 4.85 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.575 1.08 . . . . 0.0 111.06 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.44 139.62 52.26 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 127.085 2.154 . . . . 0.0 107.254 171.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.62 -24.09 66.26 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.97 1.308 . . . . 0.0 111.891 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -60.18 -23.88 64.32 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.008 0.923 . . . . 0.0 112.45 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -83.54 -13.11 55.24 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.036 0.934 . . . . 0.0 110.785 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -107.23 128.0 54.03 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 125.743 1.617 . . . . 0.0 109.208 -174.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -77.17 -34.8 56.29 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.1 p -132.55 137.65 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 123.385 0.674 . . . . 0.0 109.524 -175.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.88 129.04 60.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 122.548 1.166 . . . . 0.0 109.94 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.5 mm -124.06 101.3 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -170.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.7 m -73.74 154.17 39.72 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 168.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -148.62 45.36 1.03 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 177.516 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 99.1 m -65.02 -59.39 4.2 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 117.744 -1.122 . . . . 0.0 112.046 -169.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 117.64 -22.94 9.81 Favored Glycine 0 N--CA 1.47 0.947 0 CA-C-N 119.873 1.215 . . . . 0.0 114.758 169.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 43.7 m -131.9 27.34 4.59 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.943 0.897 . . . . 0.0 111.867 -176.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.52 -1.68 65.41 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.813 1.196 . . . . 0.0 114.318 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.61 134.66 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 169.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -143.92 178.57 7.75 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.456 1.102 . . . . 0.0 110.103 -169.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 53.4 mt -117.69 99.33 52.26 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 124.36 1.064 . . . . 0.0 109.604 -169.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -52.26 -36.95 69.66 Favored 'Trans proline' 0 CA--C 1.549 1.249 0 C-N-CA 123.08 2.52 . . . . 0.0 116.915 169.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -67.65 -175.14 0.66 Allowed 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 122.267 1.978 . . . . 0.0 114.779 -173.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -45.39 -20.01 0.05 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.396 2.678 . . . . 0.0 115.492 171.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -61.63 1.11 0.26 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.122 1.769 . . . . 0.0 113.572 170.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.9 p -121.6 6.23 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.494 1.118 . . . . 0.0 112.019 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 82.8 p -127.48 22.38 6.47 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.355 0.98 . . . . 0.0 112.718 -172.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -89.28 -177.33 5.36 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.432 0.693 . . . . 0.0 109.922 173.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -64.0 -31.79 73.11 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.131 0.573 . . . . 0.0 112.525 -171.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.3 mt -135.84 134.36 51.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -141.04 138.12 33.4 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 169.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -145.26 157.19 44.12 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.03 1.332 . . . . 0.0 107.968 168.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -120.94 102.92 8.67 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.1 1.36 . . . . 0.0 109.177 169.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.424 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 39.8 m0 -78.88 93.79 5.08 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.877 1.671 . . . . 0.0 108.927 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -65.99 107.22 1.81 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -129.41 157.67 41.31 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 125.712 1.605 . . . . 0.0 109.906 -175.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -82.48 61.09 5.46 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.419 1.488 . . . . 0.0 112.126 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 53.1 t0 4.11 83.27 0.04 OUTLIER Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 129.603 3.161 . . . . 0.0 113.424 169.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.424 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 80.8 Cg_exo -60.06 -5.93 4.4 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 123.174 2.583 . . . . 0.0 117.491 -169.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -60.23 90.78 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.728 1.211 . . . . 0.0 111.86 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.89 15.08 27.43 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 126.283 1.896 . . . . 0.0 113.376 173.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.424 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 30.6 mm-40 -91.94 179.05 5.71 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.013 1.407 . . . . 0.0 112.866 -169.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 41.5 m -75.54 155.7 35.81 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.563 1.545 . . . . 0.0 109.988 175.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.77 -33.39 70.24 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.944 -0.473 . . . . 0.0 111.563 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.28 -39.18 93.4 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.577 0.351 . . . . 0.0 110.764 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 99.2 t -66.08 -47.55 84.53 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 175.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.438 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 7.2 m-85 -54.76 -51.38 65.86 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.006 0.522 . . . . 0.0 111.026 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 24.0 mtt180 -60.29 -42.77 96.15 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.473 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 88.9 m -62.18 -55.16 31.43 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.4 t -61.01 -43.08 95.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 118.855 -0.593 . . . . 0.0 110.312 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.76 -45.19 93.01 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 119.396 0.998 . . . . 0.0 110.374 -177.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.42 -46.5 90.31 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -63.85 -46.39 85.24 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.988 0.915 . . . . 0.0 111.186 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.0 t -56.77 -51.71 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 125.65 1.58 . . . . 0.0 110.228 171.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -58.4 -45.35 88.53 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.114 0.87 . . . . 0.0 110.366 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -55.67 -45.88 77.67 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.9 0.88 . . . . 0.0 109.254 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.424 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 60.4 mtt85 -70.38 -39.05 74.79 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-O 118.086 -0.959 . . . . 0.0 110.782 -174.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.5 t -54.81 -48.56 73.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 120.373 1.442 . . . . 0.0 109.594 169.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -60.85 -40.33 92.48 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 119.625 1.102 . . . . 0.0 110.858 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -61.21 -46.46 90.36 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.259 1.424 . . . . 0.0 109.945 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.32 -48.43 73.08 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 124.011 0.925 . . . . 0.0 110.08 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 45.8 mt -55.31 -38.99 50.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.751 1.22 . . . . 0.0 110.631 174.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.37 -30.73 70.72 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.772 1.169 . . . . 0.0 111.237 -173.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -72.78 -20.79 61.1 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.691 1.596 . . . . 0.0 112.638 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.0 pt -123.37 -22.36 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -168.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 C--O 1.251 1.159 0 C-N-CA 126.181 1.792 . . . . 0.0 111.194 175.854 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.6 ttm . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 120.755 0.312 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -120.32 136.32 54.73 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.4 mttt -95.33 136.28 35.88 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 121.7 -0.625 . . . . 0.0 109.491 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.5 t -121.2 127.22 75.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -173.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 42.2 tpp -110.89 141.01 44.87 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 169.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -109.85 130.52 55.51 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 169.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.4 t -132.23 119.0 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 120.447 1.476 . . . . 0.0 109.141 -169.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.401 ' HB3' ' H ' ' A' ' 11' ' ' ASN . 41.1 t -124.7 159.27 31.24 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.969 1.258 . . . . 0.0 110.704 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.2 mttm -58.49 -12.81 4.34 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.189 0.995 . . . . 0.0 113.115 169.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -138.6 -12.13 1.34 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 173.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.401 ' H ' ' HB3' ' A' ' 8' ' ' CYS . 27.2 t-20 64.52 -43.82 0.3 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.744 2.418 . . . . 0.0 114.599 -169.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.0 m -40.25 -23.58 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 121.028 3.714 . . . . 0.0 121.028 -168.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 23.6 m -140.99 -62.84 0.47 Allowed 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 120.443 1.474 . . . . 0.0 111.174 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -59.79 -50.36 74.13 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.669 0.668 . . . . 0.0 109.583 -169.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.43 -43.81 69.17 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.389 0.276 . . . . 0.0 111.178 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -59.89 -46.4 89.44 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.69 0.796 . . . . 0.0 111.359 -174.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.525 ' HG2' HD11 ' A' ' 57' ' ' ILE . 56.6 mtm -67.71 -45.63 74.52 Favored 'General case' 0 C--O 1.231 0.114 0 O-C-N 122.276 -0.265 . . . . 0.0 110.551 177.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.48 -38.29 71.52 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 122.281 0.232 . . . . 0.0 111.053 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -64.91 -55.87 16.71 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 118.448 -0.787 . . . . 0.0 110.372 178.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -52.04 -40.25 50.75 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 119.481 -0.622 . . . . 0.0 112.149 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -64.9 -51.12 63.65 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 118.717 1.258 . . . . 0.0 110.266 173.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.6 -44.78 89.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 119.708 1.14 . . . . 0.0 112.88 -174.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -70.19 -9.69 56.53 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 119.732 1.151 . . . . 0.0 113.281 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.5 m -92.57 -48.2 6.73 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 119.892 1.224 . . . . 0.0 110.423 169.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.0 mt -77.49 -43.55 31.82 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.881 1.672 . . . . 0.0 112.073 -169.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.35 -6.11 18.33 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-O 118.038 -1.423 . . . . 0.0 114.923 -169.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.41 110.0 0.57 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.61 1.705 . . . . 0.0 108.891 169.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.38 -29.94 2.75 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.981 1.276 . . . . 0.0 111.444 -169.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.63 -22.6 3.27 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.811 1.244 . . . . 0.0 111.896 172.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.7 pt -125.83 158.69 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-O 121.564 0.697 . . . . 0.0 111.903 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -123.63 133.24 53.96 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 104.381 -2.452 . . . . 0.0 104.381 169.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.4 p -118.45 155.28 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-O 121.88 0.848 . . . . 0.0 112.541 -169.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.8 m -148.26 152.72 37.63 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.915 1.686 . . . . 0.0 107.216 167.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.3 p -118.35 153.35 34.16 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.53 1.132 . . . . 0.0 108.535 168.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 23.4 p -152.43 -169.99 3.51 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 173.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.92 163.12 30.79 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 169.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.7 mt -58.5 -32.24 68.62 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.971 0.508 . . . . 0.0 110.601 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -142.45 132.76 24.86 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 103.623 -2.732 . . . . 0.0 103.623 168.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.3 p -76.24 149.97 37.09 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.951 0.5 . . . . 0.0 111.084 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.1 m -147.52 158.45 44.0 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.081 2.152 . . . . 0.0 106.513 169.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.04 144.8 11.32 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.922 0.889 . . . . 0.0 110.905 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.6 p -65.11 138.42 23.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 169.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.4 ' CG ' ' HD2' ' A' ' 44' ' ' PRO . 7.4 t-80 -83.38 149.48 58.14 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 123.479 0.711 . . . . 0.0 109.607 -174.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HD2' ' CG ' ' A' ' 43' ' ' HIS . 87.2 Cg_endo -81.86 -38.76 0.2 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 121.562 1.508 . . . . 0.0 112.907 -169.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.438 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 28.5 m -62.76 -27.23 69.14 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.297 1.408 . . . . 0.0 111.24 -177.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.28 -44.24 22.99 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.019 0.928 . . . . 0.0 111.175 171.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 52.3 mt -55.93 -45.52 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 C-N-CA 124.287 1.035 . . . . 0.0 108.291 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.47 -34.25 77.77 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.28 1.032 . . . . 0.0 110.104 -172.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 8.1 mmm -70.66 -41.49 72.02 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-O 122.547 1.165 . . . . 0.0 110.386 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.497 ' HG3' ' CG1' ' A' ' 57' ' ' ILE . 87.2 mmm -62.9 -41.13 99.33 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -61.63 -25.66 67.5 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.291 0.636 . . . . 0.0 111.096 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -65.61 -42.24 91.84 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 118.652 0.66 . . . . 0.0 110.094 171.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.3 t -76.22 -25.78 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.78 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.66 23.2 6.33 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.454 1.502 . . . . 0.0 111.958 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.4 mt -121.42 177.44 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 125.742 1.617 . . . . 0.0 107.693 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -143.9 157.51 44.31 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.484 1.513 . . . . 0.0 109.957 -176.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.525 HD11 ' HG2' ' A' ' 17' ' ' MET . 0.6 OUTLIER -130.45 -17.78 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.153 0.981 . . . . 0.0 111.983 169.607 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -42.58 -38.18 1.9 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.959 1.304 . . . . 0.0 113.292 173.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.0 -10.75 68.94 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 118.551 -1.138 . . . . 0.0 114.033 -175.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -123.99 168.75 12.41 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 119.181 1.491 . . . . 0.0 112.641 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.2 p -127.37 -176.05 3.62 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 126.526 1.931 . . . . 0.0 109.679 -174.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.7 p -113.56 158.95 20.12 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.284 1.433 . . . . 0.0 110.908 -175.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -151.22 149.9 25.84 Favored Pre-proline 0 N--CA 1.467 0.409 0 C-N-CA 124.218 1.007 . . . . 0.0 109.827 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.47 150.87 19.64 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.977 2.451 . . . . 0.0 110.617 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.2 tt -52.24 -36.22 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.766 1.226 . . . . 0.0 110.756 172.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -58.17 -25.55 61.64 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.838 1.655 . . . . 0.0 112.884 -171.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.81 -9.74 45.34 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -176.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -98.97 -174.45 2.77 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.371 0.987 . . . . 0.0 110.127 175.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.6 128.41 20.49 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 126.841 2.056 . . . . 0.0 106.941 175.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.92 -27.24 66.58 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.898 0.879 . . . . 0.0 111.969 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -60.28 -23.55 64.24 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.237 1.015 . . . . 0.0 112.644 -175.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -84.65 -16.55 41.55 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.101 0.56 . . . . 0.0 110.761 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -109.1 112.89 25.31 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 125.354 1.462 . . . . 0.0 108.323 -172.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -76.44 -21.6 55.71 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.328 0.585 . . . . 0.0 109.673 -176.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.1 t -133.98 134.83 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 125.803 1.641 . . . . 0.0 107.229 -172.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -137.36 119.39 19.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 123.023 1.392 . . . . 0.0 109.726 -176.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.2 mm -112.74 94.13 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 66.9 m -72.4 157.34 37.83 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 167.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.87 50.61 0.67 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 74.7 m -73.62 -42.02 62.02 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.431 1.092 . . . . 0.0 108.89 171.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.95 -56.58 0.74 Allowed Glycine 0 C--N 1.334 0.456 0 C-N-CA 124.459 1.028 . . . . 0.0 112.834 168.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 35.4 m -80.03 30.16 0.27 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -169.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.54 32.19 72.69 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.198 0.904 . . . . 0.0 110.868 -171.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.3 t -63.35 141.41 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 124.638 1.175 . . . . 0.0 108.783 -174.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -124.1 104.93 9.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.343 -172.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.1 mt -58.78 121.38 53.71 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 125.421 1.489 . . . . 0.0 108.659 -172.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -48.83 -40.1 39.42 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.444 2.096 . . . . 0.0 114.658 169.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.31 173.5 14.1 Favored 'Trans proline' 0 C--N 1.355 0.894 0 CA-C-N 121.623 1.615 . . . . 0.0 113.114 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -54.99 -6.93 0.14 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 129.235 3.014 . . . . 0.0 115.893 -176.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -61.87 0.05 0.42 Allowed 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 126.024 1.73 . . . . 0.0 112.378 169.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.6 m -114.33 5.17 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 120.376 1.444 . . . . 0.0 112.46 170.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.8 p -120.98 21.99 11.18 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.979 0.911 . . . . 0.0 111.716 -177.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -90.52 -178.99 5.46 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.375 1.07 . . . . 0.0 109.382 171.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.56 -36.42 82.61 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.719 0.808 . . . . 0.0 112.922 -169.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.9 mt -133.16 134.77 57.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -141.63 136.92 31.45 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.355 1.062 . . . . 0.0 108.835 172.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -146.47 159.51 43.31 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.822 1.649 . . . . 0.0 107.68 168.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -124.55 92.47 3.66 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.182 1.393 . . . . 0.0 109.045 169.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -66.01 141.54 58.14 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.746 0.819 . . . . 0.0 110.891 -176.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -110.71 92.03 3.89 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.845 1.258 . . . . 0.0 107.689 -170.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -131.1 149.68 52.49 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.679 1.592 . . . . 0.0 109.107 -170.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -84.47 56.81 3.98 Favored 'General case' 0 C--O 1.228 -0.072 0 C-N-CA 126.37 1.868 . . . . 0.0 112.05 -172.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.3 t0 5.94 82.35 0.04 OUTLIER Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 129.903 3.281 . . . . 0.0 113.977 169.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.457 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 84.2 Cg_exo -54.5 -13.86 6.2 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 125.271 3.981 . . . . 0.0 118.633 -169.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.29 90.17 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 120.3 1.409 . . . . 0.0 111.925 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.85 6.69 26.25 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 126.282 1.896 . . . . 0.0 113.164 174.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.457 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 28.4 mm-40 -89.67 -178.5 5.55 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.81 1.305 . . . . 0.0 112.056 -169.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.0 m -78.98 156.96 28.24 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.971 1.308 . . . . 0.0 109.909 173.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 70.4 mt -59.79 -32.9 71.05 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 122.086 -0.384 . . . . 0.0 111.498 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -61.21 -39.9 91.96 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.376 0.534 . . . . 0.0 110.622 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.7 t -67.25 -46.57 83.72 Favored 'Isoleucine or valine' 0 C--N 1.338 0.086 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.438 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 11.7 m-85 -53.98 -52.57 60.29 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 122.608 0.363 . . . . 0.0 110.729 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.1 mtp180 -64.18 -40.91 97.1 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 118.511 -0.756 . . . . 0.0 111.09 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.5 m -63.37 -52.53 61.32 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.75 -42.74 95.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.216 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.79 -44.3 90.71 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-N 120.277 1.399 . . . . 0.0 110.365 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.84 -49.35 76.76 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -61.56 -44.9 96.19 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.266 1.033 . . . . 0.0 111.869 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.5 t -58.59 -50.05 80.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 125.606 1.562 . . . . 0.0 109.806 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -58.49 -45.78 88.02 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 119.478 1.035 . . . . 0.0 110.119 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.59 -43.6 80.24 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.307 1.043 . . . . 0.0 110.345 176.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 46.3 mtt85 -71.61 -40.9 69.52 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-O 117.965 -1.017 . . . . 0.0 111.088 -177.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.418 ' HA ' HD23 ' A' ' 126' ' ' LEU . 95.0 t -54.47 -48.22 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 120.505 1.502 . . . . 0.0 109.499 169.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -60.05 -40.13 88.34 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.4 1.0 . . . . 0.0 110.615 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -62.2 -45.74 92.02 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.244 1.018 . . . . 0.0 110.347 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 123' ' ' VAL . 0.2 OUTLIER -63.1 -47.45 82.79 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.012 0.925 . . . . 0.0 109.834 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 61.5 mt -58.88 -37.88 69.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 124.607 1.163 . . . . 0.0 110.491 176.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.79 -29.67 69.59 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.941 1.246 . . . . 0.0 111.486 -174.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 41.7 mttm -73.52 -19.57 60.88 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.974 1.71 . . . . 0.0 112.93 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.2 pt -125.95 -20.27 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.895 1.678 . . . . 0.0 114.941 -168.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.9 m . . . . . 0 C--O 1.251 1.16 0 C-N-CA 126.457 1.903 . . . . 0.0 110.886 169.883 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.5 ttm . . . . . 0 N--CA 1.484 1.264 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.5 147.28 42.9 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.788 0.835 . . . . 0.0 109.392 170.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -102.46 117.99 35.91 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 72.9 t -97.37 137.94 23.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 125.517 1.527 . . . . 0.0 108.128 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 35.5 tpp -126.01 143.64 51.02 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 169.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.401 ' HE2' HG21 ' A' ' 32' ' ' VAL . 81.6 m-85 -114.02 133.23 55.64 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 169.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.3 t -136.26 122.15 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 120.065 1.302 . . . . 0.0 108.551 -169.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.442 ' HB3' ' H ' ' A' ' 11' ' ' ASN . 43.0 t -129.9 163.6 26.0 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.146 0.885 . . . . 0.0 111.288 -173.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -59.49 -21.96 60.89 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 118.202 -0.904 . . . . 0.0 112.303 169.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -138.01 -9.68 1.55 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 116.18 1.918 . . . . 0.0 116.18 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.442 ' H ' ' HB3' ' A' ' 8' ' ' CYS . 26.0 t-20 61.99 -43.1 0.16 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 128.346 2.659 . . . . 0.0 115.872 -174.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.7 p -35.16 -38.99 0.1 Allowed 'General case' 0 C--O 1.233 0.228 0 C-N-CA 129.596 3.159 . . . . 0.0 118.499 -168.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.4 p -133.13 -59.94 0.87 Allowed 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 118.757 -0.639 . . . . 0.0 111.129 -169.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.0 mtm180 -58.32 -56.73 18.27 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -171.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.6 -42.64 77.87 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.516 0.327 . . . . 0.0 111.063 -177.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -60.37 -45.86 92.02 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.65 0.78 . . . . 0.0 111.423 -174.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 49.4 mtm -62.3 -46.41 88.87 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 110.494 -0.187 . . . . 0.0 110.494 175.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.16 -39.15 78.1 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 119.742 -0.17 . . . . 0.0 111.062 -178.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -63.69 -45.88 88.02 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.47 0.708 . . . . 0.0 110.422 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.24 -44.55 97.54 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -65.55 -47.33 76.23 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 118.624 1.212 . . . . 0.0 108.75 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.81 -43.18 85.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 119.366 0.985 . . . . 0.0 112.372 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -76.25 -2.35 30.98 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 119.047 0.84 . . . . 0.0 113.159 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.0 m -96.9 -45.64 6.54 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 121.301 -0.874 . . . . 0.0 109.445 169.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 91.8 mt -74.05 -41.03 62.38 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.96 1.704 . . . . 0.0 111.151 -171.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.63 -6.14 4.73 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-O 117.971 -1.46 . . . . 0.0 115.631 -169.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.75 121.95 9.66 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 120.237 2.019 . . . . 0.0 109.406 174.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.15 -31.61 4.21 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.733 1.158 . . . . 0.0 110.607 -172.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.2 -13.58 5.58 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.503 1.121 . . . . 0.0 112.021 174.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.8 pt -130.5 156.56 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 168.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -118.3 134.71 54.8 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 169.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.401 HG21 ' HE2' ' A' ' 6' ' ' PHE . 13.5 p -123.64 152.55 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-O 121.439 0.637 . . . . 0.0 112.061 -176.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.3 m -144.35 161.88 37.87 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.944 1.298 . . . . 0.0 108.131 169.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 94.1 p -126.71 155.95 41.87 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 124.901 1.28 . . . . 0.0 109.107 168.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.3 p -154.51 -165.87 2.19 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 174.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.55 163.75 33.68 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 169.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.1 mt -52.08 -31.76 31.83 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.267 1.027 . . . . 0.0 110.237 174.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -148.01 145.67 28.61 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 168.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.5 p -79.03 161.68 26.43 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.579 0.704 . . . . 0.0 111.313 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.6 m -157.0 166.06 34.42 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.417 1.887 . . . . 0.0 107.284 169.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.1 ptt-85 -51.96 143.35 13.83 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.653 1.181 . . . . 0.0 110.728 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 56.0 t -63.4 130.34 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 168.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -70.63 138.78 86.0 Favored Pre-proline 0 N--CA 1.448 -0.555 0 CA-C-O 118.771 -0.633 . . . . 0.0 109.615 -174.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.18 -40.12 1.84 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 121.074 1.183 . . . . 0.0 111.471 -172.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.505 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 11.2 m -67.67 -18.08 64.82 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 120.488 -1.382 . . . . 0.0 111.916 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.441 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -58.21 -39.43 78.99 Favored 'General case' 0 C--N 1.339 0.116 0 O-C-N 121.275 -0.89 . . . . 0.0 110.63 171.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.4 mt -57.8 -46.15 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.54 -40.97 96.6 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.531 0.732 . . . . 0.0 112.036 -176.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.5 mmt -58.5 -49.15 78.42 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 122.558 1.17 . . . . 0.0 111.302 177.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.405 ' SD ' HG12 ' A' ' 57' ' ' ILE . 8.1 mtp -68.82 -36.26 77.99 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.651 -1.158 . . . . 0.0 108.899 -177.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -62.46 -28.96 70.18 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.18 0.592 . . . . 0.0 111.514 173.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -64.25 -39.67 94.42 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.02 0.827 . . . . 0.0 110.176 173.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.0 t -78.58 -23.98 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 119.743 -0.17 . . . . 0.0 110.766 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.46 24.95 6.52 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.913 1.245 . . . . 0.0 111.882 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.565 HG22 ' H ' ' A' ' 56' ' ' ASP . 11.1 mt -122.72 -178.23 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 C-N-CA 125.938 1.695 . . . . 0.0 106.821 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.565 ' H ' HG22 ' A' ' 55' ' ' ILE . 10.1 t70 -147.93 156.12 42.32 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 120.438 -1.414 . . . . 0.0 109.909 -176.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.446 HD13 HG21 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -129.79 -16.38 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.277 1.031 . . . . 0.0 112.227 169.534 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.7 p -51.86 -31.39 27.74 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.707 1.139 . . . . 0.0 112.451 177.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.84 -6.28 88.59 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.814 1.197 . . . . 0.0 114.366 -177.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -125.77 168.65 13.51 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.369 1.584 . . . . 0.0 110.824 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.7 p -128.0 170.92 12.34 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.063 0.945 . . . . 0.0 111.372 -171.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.6 p -85.62 162.99 18.59 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.188 1.395 . . . . 0.0 111.06 175.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -157.89 145.15 13.44 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 123.775 0.83 . . . . 0.0 109.345 -178.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -81.32 153.71 18.53 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.26 1.973 . . . . 0.0 110.936 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.4 tt -55.04 -34.03 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 123.706 0.802 . . . . 0.0 111.123 175.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -57.52 -23.22 49.0 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.369 1.867 . . . . 0.0 112.402 -174.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -85.17 -3.65 58.88 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.864 0.866 . . . . 0.0 112.819 -175.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -124.95 -174.25 2.99 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.426 1.09 . . . . 0.0 110.833 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.39 128.17 20.42 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.849 2.059 . . . . 0.0 107.63 175.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.84 -26.86 64.57 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.08 0.952 . . . . 0.0 112.554 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -59.42 -23.39 62.6 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.088 0.955 . . . . 0.0 112.488 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -83.67 -14.76 51.06 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.39 0.676 . . . . 0.0 110.799 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -108.32 120.36 42.15 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 125.704 1.602 . . . . 0.0 109.079 -172.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -75.25 -30.81 60.62 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.374 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.538 HG21 HD13 ' A' ' 126' ' ' LEU . 0.2 OUTLIER -131.52 130.13 62.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -173.635 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.0 m -127.73 115.29 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 123.618 1.675 . . . . 0.0 109.855 -174.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.0 mm -110.22 101.78 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -175.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.7 t -72.7 155.41 40.01 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 168.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.18 50.8 0.72 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 171.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 85.4 m -65.42 -18.96 65.72 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.45 0.7 . . . . 0.0 110.947 174.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.24 -64.18 3.31 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 125.159 1.362 . . . . 0.0 110.266 169.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 37.9 m -75.85 22.45 0.14 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.336 1.054 . . . . 0.0 113.681 -174.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 65.51 16.94 63.8 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.994 1.759 . . . . 0.0 113.54 -177.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 95.9 t -70.86 161.97 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 169.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -136.36 167.68 20.86 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.34 1.056 . . . . 0.0 109.235 -174.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.2 mt -90.37 112.54 53.41 Favored Pre-proline 0 N--CA 1.45 -0.437 0 C-N-CA 126.196 1.799 . . . . 0.0 107.031 -173.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -60.12 -36.25 89.59 Favored 'Trans proline' 0 CA--C 1.547 1.171 0 CA-C-O 116.581 -1.508 . . . . 0.0 114.756 171.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.12 179.4 6.16 Favored 'Trans proline' 0 C--N 1.355 0.912 0 CA-C-N 122.732 2.011 . . . . 0.0 113.163 -178.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -53.97 -10.67 0.35 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 128.589 2.756 . . . . 0.0 115.746 -176.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -63.65 6.28 0.16 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 126.324 1.85 . . . . 0.0 112.593 169.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 p -117.85 2.18 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 125.23 1.412 . . . . 0.0 111.505 172.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.8 p -127.72 24.05 6.17 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.124 -0.985 . . . . 0.0 112.292 -172.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -90.55 -176.73 4.84 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.324 0.65 . . . . 0.0 109.26 169.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -66.13 -32.14 73.42 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -169.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.0 mt -134.11 132.38 55.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -177.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -140.1 138.21 35.11 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.143 0.977 . . . . 0.0 108.856 174.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -146.65 159.44 43.46 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.152 1.381 . . . . 0.0 107.762 168.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -122.05 113.43 19.53 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.879 1.272 . . . . 0.0 108.622 168.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.445 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 40.0 m0 -87.4 97.1 10.63 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -177.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -62.03 118.88 7.89 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 169.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 60.0 mt -150.21 150.57 31.77 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.236 1.415 . . . . 0.0 107.794 -169.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.8 mp0 -83.12 57.32 3.88 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.819 1.648 . . . . 0.0 111.999 -173.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.9 t70 2.76 85.53 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 129.377 3.071 . . . . 0.0 114.486 173.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.461 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 67.0 Cg_exo -60.13 -8.01 7.47 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.523 2.815 . . . . 0.0 117.411 -169.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -55.36 100.72 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 120.528 1.513 . . . . 0.0 111.811 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.24 18.32 43.13 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 126.482 1.991 . . . . 0.0 113.382 171.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.461 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 23.7 mm-40 -98.31 177.01 5.51 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.012 1.406 . . . . 0.0 113.234 -169.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 37.7 m -75.77 154.77 36.09 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.987 1.715 . . . . 0.0 110.081 175.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 71.1 mt -59.14 -31.34 68.87 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 121.812 -0.555 . . . . 0.0 111.899 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.7 mp0 -62.3 -41.07 98.21 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.417 0.687 . . . . 0.0 110.387 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.63 -43.4 86.87 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.505 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 14.3 m-85 -55.68 -52.44 63.84 Favored 'General case' 0 N--CA 1.458 -0.069 0 CA-C-O 118.683 -0.675 . . . . 0.0 110.752 175.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 72.9 mtp85 -59.54 -41.5 90.19 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.248 0.931 . . . . 0.0 111.758 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.9 m -61.04 -46.7 89.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 118.682 0.674 . . . . 0.0 110.039 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.4 t -70.46 -42.97 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 117.79 -1.1 . . . . 0.0 110.257 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.9 ttp180 -56.34 -44.85 80.43 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 119.923 1.238 . . . . 0.0 109.48 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.04 -48.8 84.32 Favored Glycine 0 CA--C 1.521 0.426 0 CA-C-O 118.702 -1.055 . . . . 0.0 110.69 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -59.8 -55.55 32.83 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 118.113 0.956 . . . . 0.0 110.182 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.7 t -48.17 -53.91 5.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.698 1.599 . . . . 0.0 110.234 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -63.55 -47.51 81.28 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 119.412 1.006 . . . . 0.0 110.221 -172.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -53.98 -45.27 71.35 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.654 0.781 . . . . 0.0 109.8 174.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.445 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 78.0 mtt-85 -71.46 -37.61 71.36 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.173 -173.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.403 ' HA ' HD23 ' A' ' 126' ' ' LEU . 96.2 t -56.44 -48.37 80.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 120.726 1.603 . . . . 0.0 109.242 168.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -60.54 -35.29 75.64 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.259 0.936 . . . . 0.0 110.598 177.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -65.2 -45.16 85.86 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.445 1.498 . . . . 0.0 110.414 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.538 HD13 HG21 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -65.24 -44.47 88.06 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 123.204 0.602 . . . . 0.0 110.372 179.357 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 86.4 mt -56.6 -36.9 49.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 124.286 1.034 . . . . 0.0 109.861 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.27 -35.46 77.92 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 120.363 1.438 . . . . 0.0 111.094 -177.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -59.03 -52.44 65.74 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.604 0.762 . . . . 0.0 110.37 174.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pt -80.1 -39.01 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.657 1.183 . . . . 0.0 112.517 -171.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . 0.259 6.0 p . . . . . 0 C--O 1.25 1.084 0 C-N-CA 130.744 3.617 . . . . 0.0 114.003 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.1 ttm . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -121.04 150.49 41.08 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.052 0.941 . . . . 0.0 109.582 171.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -106.37 106.7 17.34 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 123.974 0.91 . . . . 0.0 109.725 178.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 57.2 t -85.41 139.7 17.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 125.934 1.694 . . . . 0.0 109.218 176.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 20.1 tpp -127.13 145.96 50.55 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.242 0.617 . . . . 0.0 109.59 169.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -120.47 120.77 36.86 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.825 1.65 . . . . 0.0 108.492 171.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.6 t -128.4 141.79 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.939 1.296 . . . . 0.0 109.263 -169.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 28.4 p -152.65 -170.61 3.68 Favored 'General case' 0 C--O 1.222 -0.354 0 O-C-N 120.976 -1.078 . . . . 0.0 112.869 -169.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -80.87 -24.96 37.99 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.321 1.048 . . . . 0.0 112.915 169.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -159.83 108.77 1.78 Allowed 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 -173.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -54.07 -17.51 2.76 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.525 1.53 . . . . 0.0 113.567 -173.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -38.93 -47.18 1.41 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 127.859 2.464 . . . . 0.0 117.177 -169.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.0 p -132.32 -77.32 0.5 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 116.009 -1.948 . . . . 0.0 114.561 -168.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.2 -49.14 33.92 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 121.601 2.0 . . . . 0.0 111.246 -168.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.77 -48.61 71.24 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.825 1.65 . . . . 0.0 110.709 -174.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -64.97 -42.02 94.94 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 124.541 1.136 . . . . 0.0 111.338 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 63.2 mtp -60.71 -48.78 80.24 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.27 1.028 . . . . 0.0 108.913 175.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.06 -41.04 87.0 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 122.968 0.507 . . . . 0.0 111.132 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -62.4 -45.23 94.07 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.505 0.722 . . . . 0.0 110.016 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.01 -45.2 97.1 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.448 -0.64 . . . . 0.0 111.645 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -65.26 -52.13 56.34 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 118.661 1.23 . . . . 0.0 108.58 175.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.01 -42.76 76.91 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.416 1.086 . . . . 0.0 112.508 -173.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -70.23 -35.54 73.91 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 118.791 0.723 . . . . 0.0 110.111 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.9 m -67.17 -43.27 82.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 119.521 -1.987 . . . . 0.0 110.504 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.6 mt -71.52 -39.94 70.43 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.071 1.748 . . . . 0.0 110.78 -174.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.19 4.19 4.13 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 116.725 -2.153 . . . . 0.0 118.284 -169.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.87 114.71 1.67 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 121.588 2.694 . . . . 0.0 109.041 169.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 124.01 -24.11 6.4 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.63 1.109 . . . . 0.0 111.548 -175.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.66 -20.19 3.26 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 118.327 1.063 . . . . 0.0 111.684 178.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.5 pt -132.07 156.87 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 168.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.99 139.67 50.39 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 169.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 p -131.59 148.64 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.2 0.524 . . . . 0.0 111.871 -175.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 m -142.14 160.69 39.74 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.069 170.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 91.7 p -129.23 157.39 41.98 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.067 1.347 . . . . 0.0 108.265 168.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.4 p -153.04 -164.82 2.02 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.93 159.63 29.15 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 169.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 75.0 mt -52.5 -28.87 22.22 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.241 1.417 . . . . 0.0 110.556 172.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -144.57 146.58 32.41 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 168.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.1 p -72.1 159.25 34.46 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.94 0.896 . . . . 0.0 111.439 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.2 p -153.85 165.3 36.5 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.582 1.953 . . . . 0.0 106.904 170.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -66.09 154.16 40.35 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 120.896 -1.127 . . . . 0.0 109.556 172.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.4 t -62.46 132.75 28.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 169.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -74.14 140.4 76.7 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -75.3 -41.32 0.63 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.277 1.318 . . . . 0.0 112.124 -169.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.452 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 27.7 m -63.41 -25.34 68.23 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.536 -1.352 . . . . 0.0 111.576 -178.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.422 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -51.95 -39.44 59.24 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.467 0.707 . . . . 0.0 111.541 173.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.6 mt -56.2 -45.78 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.68 -38.25 88.75 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.265 1.026 . . . . 0.0 110.09 -170.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.3 mmm -69.84 -44.1 70.59 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 122.751 1.263 . . . . 0.0 110.569 -177.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.3 mtp -65.03 -36.15 83.45 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.482 -0.761 . . . . 0.0 109.683 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -63.25 -25.99 68.58 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.243 0.617 . . . . 0.0 111.417 174.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -66.26 -39.63 89.59 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.873 0.76 . . . . 0.0 109.817 173.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.3 t -76.96 -24.93 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.636 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.82 26.44 5.81 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.008 1.29 . . . . 0.0 111.67 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.458 HG22 ' H ' ' A' ' 56' ' ' ASP . 12.2 mt -122.67 177.32 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 125.194 1.398 . . . . 0.0 107.252 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.458 ' H ' HG22 ' A' ' 55' ' ' ILE . 13.8 t70 -142.16 156.43 45.35 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.107 1.363 . . . . 0.0 109.421 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.428 HD13 HG21 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -127.48 -16.96 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 123.781 0.832 . . . . 0.0 112.27 169.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -45.2 -39.08 5.89 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.679 1.192 . . . . 0.0 112.791 173.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.55 -4.56 89.27 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.625 1.107 . . . . 0.0 114.266 -172.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -126.78 165.47 19.23 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.125 1.462 . . . . 0.0 110.705 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 25.7 p -128.01 170.79 12.49 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.972 0.909 . . . . 0.0 111.361 -170.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.8 p -87.48 169.33 12.31 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.434 1.494 . . . . 0.0 112.034 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.24 135.07 6.64 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 123.966 0.907 . . . . 0.0 108.698 -174.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.36 154.29 31.8 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.767 2.311 . . . . 0.0 111.4 176.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.2 tt -55.9 -34.45 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 123.764 0.825 . . . . 0.0 111.33 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -60.1 -22.0 62.23 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.823 1.649 . . . . 0.0 112.205 -173.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -80.82 -2.5 47.5 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.179 0.992 . . . . 0.0 112.569 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -130.65 -179.87 5.55 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.586 1.085 . . . . 0.0 111.984 -174.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.08 139.43 45.96 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 127.812 2.445 . . . . 0.0 106.547 169.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.4 -24.89 66.55 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.549 1.14 . . . . 0.0 111.593 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -60.86 -24.56 66.01 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.022 0.929 . . . . 0.0 112.497 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -82.96 -17.92 41.81 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.909 0.884 . . . . 0.0 110.53 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -97.82 122.4 40.89 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 125.623 1.569 . . . . 0.0 108.546 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -73.11 -29.4 62.88 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 175.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.47 134.34 43.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 C-N-CA 122.507 0.323 . . . . 0.0 110.317 -170.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.5 m -127.03 128.98 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 122.135 0.969 . . . . 0.0 110.115 -175.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 49.9 mm -116.36 135.15 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.3 m -104.18 146.52 28.64 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 123.92 0.762 . . . . 0.0 109.233 169.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.97 53.92 0.35 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.047 1.739 . . . . 0.0 107.741 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 83.2 m -61.66 -41.38 97.46 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.802 0.841 . . . . 0.0 110.959 172.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.91 -71.53 0.49 Allowed Glycine 0 CA--C 1.508 -0.36 0 N-CA-C 104.964 -3.254 . . . . 0.0 104.964 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 84.2 m -70.2 163.61 26.03 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 167.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.58 37.87 1.65 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 123.675 0.655 . . . . 0.0 113.378 -173.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 96.9 t -65.71 154.31 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 124.876 1.271 . . . . 0.0 107.976 171.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -132.82 -178.5 4.98 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.96 1.304 . . . . 0.0 109.862 -173.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.3 mt -122.49 95.23 47.06 Favored Pre-proline 0 CA--C 1.532 0.253 0 C-N-CA 125.693 1.597 . . . . 0.0 107.572 -169.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -48.45 -37.62 33.5 Favored 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 122.825 2.35 . . . . 0.0 116.239 172.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.39 -174.06 0.77 Allowed 'Trans proline' 0 C--N 1.356 0.936 0 CA-C-N 122.059 1.771 . . . . 0.0 114.523 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -46.56 -18.7 0.07 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 128.244 2.618 . . . . 0.0 115.468 172.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -63.29 5.78 0.15 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.318 1.847 . . . . 0.0 113.756 170.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.4 p -126.44 5.17 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.338 1.055 . . . . 0.0 112.388 171.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.0 p -120.36 21.22 11.75 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.642 1.11 . . . . 0.0 112.61 -171.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -90.81 -176.78 4.79 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.624 0.769 . . . . 0.0 109.543 173.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -65.65 -31.56 72.65 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -170.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.7 mt -134.39 137.24 51.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -137.03 136.34 38.35 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 169.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -143.11 155.6 44.63 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.286 1.434 . . . . 0.0 107.853 169.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -120.63 132.53 55.17 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.147 1.379 . . . . 0.0 108.884 169.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.464 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 39.7 m0 -116.52 96.41 5.5 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.829 1.652 . . . . 0.0 107.472 -172.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -72.92 83.59 1.23 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.517 1.527 . . . . 0.0 109.721 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.32 154.0 23.12 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 125.208 1.403 . . . . 0.0 109.844 -175.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -78.25 65.85 3.7 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.204 1.402 . . . . 0.0 111.819 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -13.41 92.17 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 129.036 2.935 . . . . 0.0 114.308 178.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.428 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 52.6 Cg_exo -61.71 -6.91 8.13 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.927 3.085 . . . . 0.0 116.769 -169.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -60.42 88.62 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 120.214 1.37 . . . . 0.0 111.3 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.16 14.86 23.33 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 126.604 2.049 . . . . 0.0 113.874 175.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.428 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 29.9 mm-40 -93.82 179.75 5.25 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.51 1.655 . . . . 0.0 113.522 -169.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.9 m -77.74 156.48 30.56 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.769 1.628 . . . . 0.0 110.138 175.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 93.5 mt -58.14 -34.48 70.31 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.908 0.483 . . . . 0.0 111.462 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -66.81 -36.87 83.37 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.072 0.396 . . . . 0.0 110.695 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.0 t -65.87 -46.08 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.452 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 7.9 m-85 -56.4 -49.08 75.51 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.962 0.505 . . . . 0.0 111.078 176.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 16.4 mtp85 -59.08 -45.03 91.87 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.897 0.879 . . . . 0.0 111.05 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 92.9 m -60.94 -53.01 62.55 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 74.4 t -64.58 -40.47 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-O 118.506 -0.759 . . . . 0.0 110.5 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.84 -43.43 94.62 Favored 'General case' 0 CA--C 1.523 -0.071 0 CA-C-N 120.215 1.37 . . . . 0.0 110.446 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.43 -50.02 65.58 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-O 118.929 -0.928 . . . . 0.0 111.057 174.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -56.43 -50.3 72.06 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.27 1.035 . . . . 0.0 110.991 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 48.9 t -55.77 -54.92 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 126.32 1.848 . . . . 0.0 109.341 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -59.93 -45.53 92.31 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 119.336 0.971 . . . . 0.0 110.065 -173.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.18 -45.19 79.85 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.784 0.833 . . . . 0.0 110.248 176.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.464 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 45.2 mtt85 -70.32 -42.38 72.04 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 117.869 -1.062 . . . . 0.0 110.744 -176.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.5 t -52.82 -49.71 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 120.321 1.418 . . . . 0.0 110.293 169.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -60.77 -41.65 95.91 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.262 0.937 . . . . 0.0 110.599 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -61.38 -44.32 97.36 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.228 1.011 . . . . 0.0 110.176 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . 0.262 0.2 OUTLIER -67.97 -46.47 71.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.809 -179.375 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.8 mt -51.52 -42.81 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 119.373 0.988 . . . . 0.0 109.245 172.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.44 -30.1 70.37 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.68 1.127 . . . . 0.0 111.532 -172.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 47.1 mttt -71.98 -45.75 59.87 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.272 1.429 . . . . 0.0 110.863 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.2 pt -86.11 -27.56 6.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.684 1.193 . . . . 0.0 113.875 -171.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 C--O 1.248 1.012 0 C-N-CA 126.194 1.798 . . . . 0.0 111.009 176.588 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.0 ttm . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.961 0.41 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.8 mmtt -125.77 144.33 50.68 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.299 1.44 . . . . 0.0 107.144 174.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.8 mttt -101.96 120.06 39.79 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 118.753 -0.642 . . . . 0.0 109.568 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.46 ' HA ' HG13 ' A' ' 75' ' ' VAL . 13.9 p -99.75 140.26 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 121.469 0.652 . . . . 0.0 110.438 175.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 33.9 tpp -121.37 140.61 51.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.596 -1.184 . . . . 0.0 108.202 169.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -112.5 127.11 55.96 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 169.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.5 t -128.92 126.5 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 120.088 1.313 . . . . 0.0 108.446 -169.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.7 t -134.68 156.49 48.68 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 119.106 0.867 . . . . 0.0 112.658 -174.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -56.94 -23.0 42.11 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.225 1.01 . . . . 0.0 111.405 169.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.6 ptt-85 -148.82 107.81 3.88 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 169.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -47.46 -36.49 10.15 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.225 1.01 . . . . 0.0 112.0 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.3 m -43.7 -24.5 0.12 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 130.931 3.693 . . . . 0.0 118.717 -169.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.0 p -130.92 -79.84 0.53 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 120.018 1.281 . . . . 0.0 112.44 -169.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -56.79 -52.18 66.06 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.358 1.063 . . . . 0.0 109.664 -169.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.13 -46.69 79.93 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 126.37 1.868 . . . . 0.0 111.558 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -62.22 -41.02 98.01 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.096 0.407 . . . . 0.0 111.14 -174.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 44.1 mtm -62.69 -47.89 81.67 Favored 'General case' 0 CA--C 1.529 0.15 0 O-C-N 122.3 -0.25 . . . . 0.0 111.127 172.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.32 -38.94 78.11 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 117.887 0.312 . . . . 0.0 111.227 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -62.49 -51.05 68.99 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.345 1.458 . . . . 0.0 109.445 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.46 -42.52 99.05 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 119.501 -0.61 . . . . 0.0 112.248 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -67.14 -49.47 64.7 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 119.006 1.403 . . . . 0.0 108.971 177.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.27 -36.84 76.27 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 119.303 0.956 . . . . 0.0 112.415 -176.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -72.17 -35.95 69.15 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 119.383 0.992 . . . . 0.0 110.633 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.0 m -66.99 -42.14 85.55 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 119.98 -1.7 . . . . 0.0 110.476 177.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.4 mt -75.83 -31.47 59.37 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.887 1.675 . . . . 0.0 111.512 -173.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -141.33 4.45 2.28 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 117.212 -1.882 . . . . 0.0 117.539 -170.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.12 113.56 1.59 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 120.989 2.394 . . . . 0.0 108.829 171.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.07 -24.34 5.7 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.64 1.114 . . . . 0.0 111.644 -175.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.94 -18.2 3.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.408 1.104 . . . . 0.0 112.24 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.9 pt -130.62 150.11 34.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 168.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.68 123.74 50.01 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 170.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.27 143.9 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 C-N-CA 126.441 1.896 . . . . 0.0 109.516 -169.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 86.7 m -152.04 160.41 43.46 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.841 1.656 . . . . 0.0 106.78 169.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.1 p -130.48 161.26 31.83 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.745 0.818 . . . . 0.0 109.688 168.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.2 p -153.77 -168.85 3.1 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 176.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.36 166.91 34.91 Favored Glycine 0 N--CA 1.448 -0.522 0 O-C-N 121.283 -0.885 . . . . 0.0 111.59 170.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.2 mp -52.15 -36.86 52.68 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.742 1.217 . . . . 0.0 110.014 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -142.89 144.65 32.54 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 169.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 p -84.0 155.72 22.62 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.674 0.749 . . . . 0.0 110.935 174.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.9 m -163.23 151.48 13.78 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 128.033 2.533 . . . . 0.0 105.203 169.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -55.45 156.41 4.55 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.028 0.831 . . . . 0.0 111.959 -170.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.2 t -60.92 135.17 25.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -72.66 143.02 84.33 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 123.614 0.766 . . . . 0.0 109.07 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.43 -42.07 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 121.426 1.417 . . . . 0.0 113.11 -169.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.524 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 21.5 m -66.66 -17.02 64.62 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.172 -1.58 . . . . 0.0 111.956 -176.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.433 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -56.37 -39.32 72.72 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.292 -0.88 . . . . 0.0 110.935 169.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 62.5 mt -56.66 -48.09 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.65 -40.71 93.03 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 123.967 0.907 . . . . 0.0 111.489 -173.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.2 mmt -59.54 -48.18 82.66 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 122.934 1.349 . . . . 0.0 111.517 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.0 mtp -68.17 -35.93 78.81 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.886 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -61.31 -30.15 70.31 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 118.783 -0.627 . . . . 0.0 111.64 172.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -65.13 -36.31 83.85 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.057 0.844 . . . . 0.0 110.435 175.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.1 t -80.99 -25.45 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 117.606 0.184 . . . . 0.0 111.058 176.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.91 27.81 5.26 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.692 1.139 . . . . 0.0 111.741 -177.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.541 HG22 ' H ' ' A' ' 56' ' ' ASP . 10.7 mt -123.32 -178.74 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 126.222 1.809 . . . . 0.0 106.874 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.541 ' H ' HG22 ' A' ' 55' ' ' ILE . 12.5 t70 -147.22 156.45 42.96 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.156 1.382 . . . . 0.0 109.483 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.442 HD13 HG21 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -128.49 -14.25 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.99 0.916 . . . . 0.0 112.341 169.833 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -46.83 -38.18 9.87 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.647 1.179 . . . . 0.0 112.678 173.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.65 -4.99 85.88 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 118.604 -1.109 . . . . 0.0 113.988 -172.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -128.64 167.06 17.73 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.135 1.467 . . . . 0.0 111.393 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.9 p -126.24 166.14 17.65 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.487 1.115 . . . . 0.0 111.566 -169.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.0 m -81.51 162.7 23.12 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.188 0.995 . . . . 0.0 111.252 175.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -153.56 144.12 15.81 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-O 118.47 -0.776 . . . . 0.0 109.973 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.77 152.74 17.2 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.423 2.082 . . . . 0.0 111.229 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.3 tt -55.88 -33.92 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 123.562 0.745 . . . . 0.0 111.202 174.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -57.94 -22.98 51.6 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.165 1.786 . . . . 0.0 112.39 -175.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -80.98 -5.65 57.81 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.988 0.915 . . . . 0.0 112.818 -176.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -126.13 -179.93 4.95 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.552 1.069 . . . . 0.0 111.805 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.01 139.31 51.05 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 127.558 2.343 . . . . 0.0 106.983 169.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.42 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -70.16 -22.39 62.97 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.207 1.003 . . . . 0.0 112.231 -177.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -61.77 -22.35 65.35 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.284 1.034 . . . . 0.0 112.507 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -83.8 -16.01 46.24 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.851 0.86 . . . . 0.0 110.491 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -103.77 130.09 51.26 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 125.176 1.39 . . . . 0.0 109.493 -172.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -78.81 -36.52 42.52 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 122.728 0.411 . . . . 0.0 111.166 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.46 HG13 ' HA ' ' A' ' 4' ' ' VAL . 1.4 p -133.39 132.95 57.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -171.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.5 m -125.67 108.06 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-O 123.124 1.44 . . . . 0.0 109.042 -173.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.7 mm -103.13 96.78 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.4 m -73.38 157.68 36.48 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 167.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.96 26.37 1.88 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 174.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 74.9 m -57.9 -33.57 68.9 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.648 1.579 . . . . 0.0 111.75 -171.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.47 -66.91 0.5 Allowed Glycine 0 C--N 1.334 0.442 0 C-N-CA 124.294 0.949 . . . . 0.0 112.022 168.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 85.6 m -83.76 33.4 0.48 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 117.668 0.734 . . . . 0.0 112.526 -169.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.24 24.45 72.02 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.397 0.998 . . . . 0.0 112.265 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.8 t -74.31 104.26 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 124.366 1.066 . . . . 0.0 108.616 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -75.97 156.99 33.63 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 122.211 1.005 . . . . 0.0 108.343 168.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.9 mt -77.56 123.3 86.7 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 114.092 -1.413 . . . . 0.0 107.356 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.94 -40.78 83.94 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.101 1.867 . . . . 0.0 113.632 169.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -77.36 -176.74 3.37 Favored 'Trans proline' 0 C--N 1.356 0.945 0 CA-C-N 121.533 1.583 . . . . 0.0 113.196 -174.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -45.64 -23.31 0.23 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 129.599 3.16 . . . . 0.0 114.921 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.42 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 77.3 m95 -62.55 11.23 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 128.732 2.813 . . . . 0.0 113.857 176.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.7 p -119.38 15.21 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 124.824 1.25 . . . . 0.0 111.609 174.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.5 p -130.23 17.44 5.5 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -171.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -91.37 179.12 5.77 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.36 1.464 . . . . 0.0 109.464 178.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -61.57 -33.63 74.2 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.636 1.174 . . . . 0.0 113.551 -171.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.8 mt -137.7 134.0 45.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -137.35 138.63 40.15 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 171.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -146.53 158.84 43.96 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.016 1.727 . . . . 0.0 107.362 169.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -123.16 100.06 6.67 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.869 1.267 . . . . 0.0 108.612 168.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.475 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 43.8 m0 -73.02 102.16 3.43 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.268 1.027 . . . . 0.0 108.832 -177.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -68.89 93.16 0.54 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.659 1.184 . . . . 0.0 109.259 176.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.5 153.36 35.45 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 125.481 1.512 . . . . 0.0 109.974 -172.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -85.66 53.36 2.74 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.432 1.493 . . . . 0.0 111.829 -171.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.8 t70 5.62 87.07 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 129.287 3.035 . . . . 0.0 114.106 169.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.463 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 50.7 Cg_exo -61.64 -4.85 4.91 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.864 3.042 . . . . 0.0 116.805 -172.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -54.5 93.03 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.988 1.267 . . . . 0.0 112.686 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.08 17.75 39.36 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 126.329 1.918 . . . . 0.0 113.419 172.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.463 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 23.3 mm-40 -95.0 178.25 5.62 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.987 1.393 . . . . 0.0 113.055 -169.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.6 m -77.45 156.13 31.3 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.994 1.718 . . . . 0.0 110.139 175.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 99.8 mt -59.14 -32.48 69.91 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.785 -0.572 . . . . 0.0 111.817 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.67 -39.14 93.0 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.656 0.382 . . . . 0.0 110.622 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 90.6 t -67.82 -45.07 84.98 Favored 'Isoleucine or valine' 0 C--N 1.338 0.083 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.524 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 17.4 m-85 -56.9 -50.38 72.71 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 119.023 -0.513 . . . . 0.0 111.043 176.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 -58.82 -41.76 87.57 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.024 0.829 . . . . 0.0 111.663 176.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.7 m -60.89 -49.75 76.22 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 118.836 0.744 . . . . 0.0 109.489 177.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.7 t -65.26 -39.21 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-O 117.748 -1.12 . . . . 0.0 110.654 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.6 ttp-105 -55.35 -48.59 73.99 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 120.354 1.434 . . . . 0.0 108.898 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.05 -47.76 89.56 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-O 118.326 -1.263 . . . . 0.0 110.196 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -56.27 -56.08 25.42 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.518 1.159 . . . . 0.0 110.151 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.6 t -55.82 -54.2 29.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 126.746 2.018 . . . . 0.0 110.851 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -63.01 -47.63 82.25 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 119.645 1.111 . . . . 0.0 110.158 -169.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -41.69 72.38 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 123.781 0.833 . . . . 0.0 110.995 174.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.475 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 45.7 mtt85 -71.45 -42.71 67.84 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.676 -177.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.453 ' HA ' HD23 ' A' ' 126' ' ' LEU . 71.5 t -53.02 -47.81 53.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 120.732 1.605 . . . . 0.0 109.769 169.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -61.48 -41.04 96.65 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 118.894 0.77 . . . . 0.0 110.767 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -62.19 -46.36 89.27 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 123.099 0.56 . . . . 0.0 110.264 175.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 123' ' ' VAL . 0.2 OUTLIER -62.18 -46.32 89.47 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 118.249 -0.881 . . . . 0.0 109.793 -177.298 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 71.7 mt -57.0 -40.14 70.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.791 0.836 . . . . 0.0 109.596 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.62 -31.3 72.45 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 120.147 1.34 . . . . 0.0 111.593 -175.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -64.08 -36.24 83.37 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.28 1.032 . . . . 0.0 111.827 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 pt -104.14 -25.28 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -169.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.7 m . . . . . 0 C--O 1.248 0.996 0 C-N-CA 125.785 1.634 . . . . 0.0 111.143 179.489 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.4 ttm . . . . . 0 N--CA 1.484 1.274 0 CA-C-O 121.094 0.473 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -96.64 138.72 33.79 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.547 0.739 . . . . 0.0 109.26 176.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -93.9 110.7 22.36 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 170.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 85.5 t -93.06 136.97 23.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 125.582 1.553 . . . . 0.0 107.966 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 39.6 tpp -119.06 143.06 47.33 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.458 1.103 . . . . 0.0 108.63 172.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -121.09 122.64 40.49 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.958 1.303 . . . . 0.0 108.114 170.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.8 t -127.45 123.91 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 120.771 1.623 . . . . 0.0 109.498 -174.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.4 t -118.39 165.11 14.27 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.872 0.76 . . . . 0.0 109.756 176.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -65.7 -11.54 46.13 Favored 'General case' 0 CA--C 1.548 0.893 0 O-C-N 121.82 -0.55 . . . . 0.0 111.548 169.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -154.47 107.53 2.85 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 128.238 2.615 . . . . 0.0 105.307 169.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -47.16 -38.42 11.77 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.927 1.291 . . . . 0.0 113.014 -178.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.9 p -38.77 -33.05 0.1 Allowed 'General case' 0 C--O 1.236 0.362 0 C-N-CA 129.507 3.123 . . . . 0.0 117.852 -169.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.8 m -122.62 -76.21 0.59 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.659 0.663 . . . . 0.0 111.791 -169.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -58.99 -51.11 71.5 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.264 0.484 . . . . 0.0 109.751 -169.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.76 -42.51 81.63 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.34 0.656 . . . . 0.0 111.271 -173.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -59.65 -45.05 93.2 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.547 0.739 . . . . 0.0 111.1 -175.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 53.5 mtm -65.66 -45.82 81.49 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 117.563 0.165 . . . . 0.0 111.07 176.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.43 -39.09 75.5 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 117.592 0.178 . . . . 0.0 110.859 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -65.41 -54.56 26.9 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.484 -0.77 . . . . 0.0 110.682 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.71 -41.38 50.39 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-O 119.271 -0.739 . . . . 0.0 112.456 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -68.02 -46.94 69.81 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 118.938 1.369 . . . . 0.0 109.457 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.04 -46.29 85.6 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 120.188 1.358 . . . . 0.0 112.894 -176.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -69.54 -5.77 26.47 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.523 1.056 . . . . 0.0 113.57 175.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.0 m -97.7 -47.99 5.39 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 119.927 1.239 . . . . 0.0 110.255 170.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 97.0 mt -77.45 -41.35 39.98 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.608 1.563 . . . . 0.0 111.86 -169.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -119.74 -5.22 11.16 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-O 117.86 -1.522 . . . . 0.0 114.877 -169.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.94 108.2 0.34 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.621 1.71 . . . . 0.0 108.825 169.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 137.69 -28.97 2.71 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.94 1.257 . . . . 0.0 111.643 -169.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.47 -22.32 3.36 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.569 1.148 . . . . 0.0 111.676 171.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.5 pt -123.82 156.04 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 121.313 0.578 . . . . 0.0 111.722 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -121.94 131.97 54.3 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 104.191 -2.522 . . . . 0.0 104.191 168.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 p -117.67 151.68 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -169.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.6 m -144.49 144.03 31.16 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 167.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.5 p -112.37 153.05 27.88 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 168.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.9 m -151.08 -170.13 3.58 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.39 160.56 29.94 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 169.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.1 mt -53.69 -30.65 44.63 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.369 0.668 . . . . 0.0 110.788 173.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -143.82 146.75 33.3 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 168.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.6 p -75.15 165.91 24.48 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.01 0.909 . . . . 0.0 111.756 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.7 p -151.59 -148.01 0.25 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.565 1.946 . . . . 0.0 106.322 173.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -133.13 155.65 48.89 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 173.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.4 t -63.21 128.71 25.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -173.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -70.96 137.85 85.05 Favored Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -70.58 -38.09 6.42 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 121.974 1.782 . . . . 0.0 112.428 -169.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.494 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 10.4 m -67.65 -18.86 65.1 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.407 -0.808 . . . . 0.0 111.878 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.44 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -58.48 -40.96 84.18 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 121.646 -0.659 . . . . 0.0 110.1 171.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.6 mp -61.99 -43.79 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.24 -37.67 81.09 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -176.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.4 mmt -62.31 -47.61 83.5 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 122.823 1.297 . . . . 0.0 111.441 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.2 mtp -69.0 -34.17 74.85 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.12 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -62.29 -29.83 70.7 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.584 0.754 . . . . 0.0 111.361 172.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -63.75 -39.31 93.97 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.872 0.76 . . . . 0.0 110.247 173.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.7 t -78.96 -25.33 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 121.219 -0.192 . . . . 0.0 110.97 178.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.61 24.89 5.94 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.104 1.335 . . . . 0.0 112.032 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.487 HG22 ' H ' ' A' ' 56' ' ' ASP . 11.8 mt -123.21 179.29 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 125.768 1.627 . . . . 0.0 107.249 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.487 ' H ' HG22 ' A' ' 55' ' ' ILE . 7.5 t70 -144.61 157.95 43.99 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.745 1.618 . . . . 0.0 108.942 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.44 HD12 ' HB1' ' A' ' 46' ' ' ALA . 0.7 OUTLIER -128.86 -16.95 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.888 0.875 . . . . 0.0 112.701 170.503 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 61.4 p -54.1 -28.58 40.3 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 120.076 1.307 . . . . 0.0 112.498 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.38 -11.22 71.44 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.706 1.146 . . . . 0.0 114.146 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -123.21 173.05 8.15 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.291 1.545 . . . . 0.0 111.163 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.4 p -128.53 164.79 22.04 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.458 1.103 . . . . 0.0 111.416 -169.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 73.6 m -80.6 158.62 25.65 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.904 0.882 . . . . 0.0 110.859 170.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -158.0 145.9 13.85 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.0 0.92 . . . . 0.0 109.663 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -82.85 150.83 14.33 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.606 2.204 . . . . 0.0 111.258 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.1 tt -55.55 -33.29 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.392 0.677 . . . . 0.0 111.807 175.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -58.75 -21.68 56.01 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.986 1.714 . . . . 0.0 112.35 -176.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -78.92 -6.94 57.46 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.953 0.901 . . . . 0.0 112.855 -176.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -127.97 -179.84 5.19 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.619 1.1 . . . . 0.0 111.433 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -127.24 127.39 44.34 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.789 2.036 . . . . 0.0 107.886 175.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.519 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -62.26 -24.07 67.05 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 -174.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -64.03 -21.03 66.34 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.775 0.43 . . . . 0.0 112.111 -177.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -81.41 -18.36 45.69 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.459 0.703 . . . . 0.0 110.19 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -97.11 130.26 44.41 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 125.45 1.5 . . . . 0.0 109.062 -177.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -89.65 -22.1 22.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.53 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.99 135.9 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -175.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.2 t -127.94 127.45 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 123.307 1.527 . . . . 0.0 109.566 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 35.4 mm -113.49 98.67 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.3 m -72.4 155.54 40.02 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 167.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.7 49.17 0.87 Allowed 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 102.878 -3.008 . . . . 0.0 102.878 172.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.5 m -75.49 -36.28 60.63 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 170.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.1 -42.15 1.6 Allowed Glycine 0 CA--C 1.52 0.402 0 C-N-CA 125.824 1.678 . . . . 0.0 115.622 167.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 40.0 m -74.15 25.68 0.08 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.126 1.463 . . . . 0.0 112.444 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.34 13.79 30.89 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 127.479 2.466 . . . . 0.0 114.014 -169.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.7 t -69.55 146.83 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 169.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -141.16 -177.85 5.31 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.291 1.036 . . . . 0.0 109.403 -171.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.7 mt -120.98 91.47 47.85 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 124.9 1.28 . . . . 0.0 108.064 -171.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.52 -37.08 41.6 Favored 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 123.289 2.659 . . . . 0.0 116.874 171.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -67.06 -176.78 0.84 Allowed 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.159 1.906 . . . . 0.0 113.911 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -51.15 -11.37 0.1 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.562 2.345 . . . . 0.0 115.155 173.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.519 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 93.9 m95 -62.96 9.05 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.949 2.1 . . . . 0.0 113.01 169.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.3 p -132.15 7.3 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 124.204 1.002 . . . . 0.0 112.509 173.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 82.8 p -116.23 33.18 5.68 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 120.044 1.293 . . . . 0.0 112.852 -169.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -122.01 -172.03 2.36 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.527 1.531 . . . . 0.0 110.222 174.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -59.43 -36.37 75.76 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -168.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.7 mm -133.05 138.52 51.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -173.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -142.94 129.8 20.51 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.226 1.411 . . . . 0.0 107.402 169.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -141.79 158.76 43.41 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 168.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -122.5 101.66 7.62 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.021 1.328 . . . . 0.0 109.46 169.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.422 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 39.5 m0 -78.8 92.73 4.87 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.199 0.999 . . . . 0.0 109.656 -177.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -62.1 120.49 10.97 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 169.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 47.6 mt -151.72 152.96 33.43 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.147 1.779 . . . . 0.0 107.585 -169.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -82.13 71.7 9.18 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.461 1.105 . . . . 0.0 111.448 -176.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -22.38 97.88 0.06 OUTLIER Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 128.678 2.791 . . . . 0.0 112.7 -177.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.437 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 65.0 Cg_exo -59.79 -2.9 1.78 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.292 3.328 . . . . 0.0 117.221 -169.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -50.86 95.85 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.843 1.257 . . . . 0.0 112.656 173.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.36 21.9 46.59 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.29 1.9 . . . . 0.0 113.153 171.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.437 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 23.4 mm-40 -98.73 176.68 5.54 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.952 1.376 . . . . 0.0 112.755 -169.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 44.2 m -74.4 154.69 38.68 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.804 1.641 . . . . 0.0 110.166 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 91.9 mt -58.38 -31.12 67.35 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.796 -0.565 . . . . 0.0 111.658 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -72.31 -33.66 67.54 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.296 0.498 . . . . 0.0 111.155 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 80.8 t -65.43 -46.22 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 171.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.494 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 11.1 m-85 -55.46 -50.38 70.03 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 118.876 -0.583 . . . . 0.0 110.351 175.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -59.37 -43.16 92.91 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.877 0.871 . . . . 0.0 112.207 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 100.0 m -60.96 -51.06 70.85 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 119.01 0.823 . . . . 0.0 109.151 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.0 t -63.69 -45.35 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 117.875 -1.059 . . . . 0.0 110.039 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -55.78 -47.2 77.47 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 119.818 1.19 . . . . 0.0 109.392 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.88 -49.02 83.29 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-O 118.383 -1.231 . . . . 0.0 110.417 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -59.72 -56.83 16.92 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 118.359 1.079 . . . . 0.0 110.398 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.8 t -46.26 -51.32 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 125.888 1.675 . . . . 0.0 110.483 177.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -63.62 -48.71 76.2 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.449 1.022 . . . . 0.0 110.192 -175.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.56 -40.56 72.09 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.377 1.071 . . . . 0.0 111.155 175.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.422 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 82.8 mtt-85 -73.1 -43.26 62.01 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.921 -176.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 69.5 t -54.35 -46.74 69.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 120.417 1.462 . . . . 0.0 108.843 169.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -61.2 -39.54 90.61 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.051 0.841 . . . . 0.0 110.831 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -63.47 -47.43 81.81 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 123.196 0.598 . . . . 0.0 110.308 176.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . 0.251 0.2 OUTLIER -60.52 -44.31 96.16 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 118.858 -0.592 . . . . 0.0 109.724 -178.666 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.1 mt -60.79 -38.05 77.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.514 1.126 . . . . 0.0 110.764 173.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.37 -31.42 72.57 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 120.287 1.403 . . . . 0.0 111.223 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -66.78 -20.49 65.96 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.014 1.325 . . . . 0.0 113.169 177.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.5 pt -127.53 -20.95 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 116.382 1.993 . . . . 0.0 116.382 -167.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 C--O 1.249 1.033 0 C-N-CA 126.371 1.868 . . . . 0.0 111.118 174.501 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.1 ttm . . . . . 0 N--CA 1.485 1.282 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -111.03 135.41 51.58 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 170.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -83.29 136.07 34.51 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 169.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.9 p -119.64 146.56 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-O 121.928 0.871 . . . . 0.0 109.526 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 33.3 tpp -127.17 142.51 51.48 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.308 -1.315 . . . . 0.0 108.423 -177.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -124.0 121.99 36.71 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 117.66 -1.162 . . . . 0.0 108.113 172.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.6 t -126.19 118.78 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 121.111 1.778 . . . . 0.0 110.055 -170.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.5 t -116.19 162.25 17.74 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.424 1.011 . . . . 0.0 112.081 -178.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.8 mttm -60.81 -17.88 52.25 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.767 0.827 . . . . 0.0 111.649 169.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.1 ptm85 -154.15 112.96 3.65 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 169.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -47.87 -30.57 4.22 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.025 0.93 . . . . 0.0 112.797 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.4 m -35.29 -35.86 0.05 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 130.085 3.354 . . . . 0.0 119.879 -171.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.8 p -137.68 -68.85 0.46 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 120.576 1.534 . . . . 0.0 113.51 -169.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -55.09 -51.1 67.45 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.045 0.838 . . . . 0.0 109.527 -169.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.412 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 0.0 OUTLIER -66.29 -49.14 68.09 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.955 2.102 . . . . 0.0 111.806 -179.478 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -60.26 -43.12 96.42 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.502 0.721 . . . . 0.0 110.847 -175.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 65.9 mtm -66.66 -47.14 73.47 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-O 119.569 -0.253 . . . . 0.0 110.991 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.99 -39.31 71.66 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 117.743 0.247 . . . . 0.0 110.773 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.409 ' HA ' HG21 ' A' ' 32' ' ' VAL . 17.8 tt0 -64.95 -55.22 20.49 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 118.485 -0.769 . . . . 0.0 110.938 177.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.5 -40.45 47.02 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-O 119.346 -0.697 . . . . 0.0 112.516 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -68.08 -47.01 69.44 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 119.008 1.404 . . . . 0.0 109.523 175.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.91 -45.49 90.21 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 120.187 1.358 . . . . 0.0 112.907 -176.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt -69.41 -9.45 53.63 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.685 1.129 . . . . 0.0 113.294 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.3 m -93.55 -48.59 6.29 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 119.852 1.206 . . . . 0.0 110.611 170.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 98.3 mt -77.23 -41.45 41.14 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.808 1.643 . . . . 0.0 111.92 -169.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -118.02 -5.75 13.15 Favored Glycine 0 C--N 1.333 0.38 0 CA-C-O 117.759 -1.578 . . . . 0.0 114.962 -169.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.4 109.11 0.4 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.702 1.751 . . . . 0.0 109.097 169.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.42 -28.88 2.85 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.974 1.273 . . . . 0.0 111.684 -169.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.82 -21.14 3.09 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.918 1.287 . . . . 0.0 111.677 172.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.0 pt -127.43 158.45 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.29 0.567 . . . . 0.0 111.845 174.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -125.79 132.35 52.29 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 169.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.409 HG21 ' HA ' ' A' ' 19' ' ' GLU . 2.8 p -117.08 153.26 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -169.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.5 m -145.65 145.01 30.76 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 167.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.412 ' HB2' ' HB2' ' A' ' 15' ' ' SER . 27.2 p -113.53 157.5 21.95 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 120.896 -1.128 . . . . 0.0 109.008 168.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.5 m -151.37 -175.95 5.38 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.714 1.606 . . . . 0.0 107.035 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -152.4 163.13 30.18 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 169.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.4 mt -53.24 -34.74 58.43 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 124.245 0.614 . . . . 0.0 110.265 174.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -141.9 145.58 34.74 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 104.659 -2.349 . . . . 0.0 104.659 169.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.2 p -75.75 147.4 39.32 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.098 0.475 . . . . 0.0 110.44 174.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 59.5 m -150.51 149.22 29.67 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.145 2.178 . . . . 0.0 105.542 169.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.64 155.56 9.68 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.858 0.863 . . . . 0.0 111.966 -172.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.6 t -65.63 131.07 31.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -73.74 138.97 76.91 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.35 -35.95 4.49 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 121.974 1.782 . . . . 0.0 112.494 -169.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.518 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 4.8 m -67.84 -18.57 64.87 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.093 -1.004 . . . . 0.0 111.945 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.32 -41.44 76.03 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.698 -0.626 . . . . 0.0 110.184 170.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.8 mp -62.78 -41.31 91.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -178.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.7 -36.99 82.5 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 118.341 0.519 . . . . 0.0 112.043 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 24.5 mmt -62.51 -47.69 82.84 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 122.763 1.268 . . . . 0.0 111.463 175.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 10.6 mtp -68.27 -34.0 75.38 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.433 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -63.03 -28.77 70.32 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.128 0.971 . . . . 0.0 111.077 173.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -65.39 -38.72 90.85 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.788 0.722 . . . . 0.0 110.162 172.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.9 t -78.22 -25.09 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 121.256 -0.178 . . . . 0.0 110.809 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.77 25.65 6.14 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.161 1.363 . . . . 0.0 111.953 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 56' ' ' ASP . 10.5 mt -124.2 175.97 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 125.584 1.554 . . . . 0.0 107.348 -178.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.426 ' H ' HG22 ' A' ' 55' ' ' ILE . 12.2 t70 -140.81 158.06 44.5 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.507 1.523 . . . . 0.0 109.154 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.434 HD13 HG21 ' A' ' 57' ' ' ILE . 0.8 OUTLIER -129.34 -18.59 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 118.186 -0.911 . . . . 0.0 112.816 171.124 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.7 m -51.58 -30.16 19.99 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 120.393 1.451 . . . . 0.0 112.274 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.69 -11.56 69.17 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.81 1.195 . . . . 0.0 114.093 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -123.99 168.62 12.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.432 1.493 . . . . 0.0 110.876 176.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.8 p -126.92 172.08 10.74 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.443 1.097 . . . . 0.0 110.85 -173.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.2 m -76.89 165.05 25.21 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.45 0.7 . . . . 0.0 112.173 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.29 142.86 15.33 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 124.349 1.06 . . . . 0.0 108.73 177.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -85.18 153.15 10.9 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.903 2.402 . . . . 0.0 110.095 169.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.1 tt -54.29 -33.28 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 123.524 0.73 . . . . 0.0 111.135 173.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -56.04 -26.25 48.28 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.411 1.884 . . . . 0.0 112.676 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -81.06 -5.44 57.63 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -175.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -130.11 -176.67 4.01 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.151 0.98 . . . . 0.0 111.181 -176.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.67 131.04 33.06 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 126.595 1.958 . . . . 0.0 108.399 -177.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.33 -29.4 67.62 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.599 1.16 . . . . 0.0 113.191 -176.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -60.23 -22.15 62.68 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.976 0.91 . . . . 0.0 112.336 -176.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -85.23 -14.8 45.63 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.545 0.738 . . . . 0.0 110.777 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -109.31 137.31 47.37 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.945 1.298 . . . . 0.0 110.276 -172.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -93.48 -33.78 13.66 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.519 0.727 . . . . 0.0 110.238 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.06 136.45 53.53 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 CA-C-N 118.578 0.626 . . . . 0.0 109.415 -175.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.9 t -128.49 115.96 39.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 122.929 1.347 . . . . 0.0 108.531 -175.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.9 mm -107.79 93.91 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.3 m -71.24 157.29 38.38 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 117.759 -1.576 . . . . 0.0 106.857 168.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.82 46.88 0.94 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 177.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 86.2 m -72.86 -41.86 64.3 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.553 0.741 . . . . 0.0 109.323 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.56 -62.47 0.64 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 123.81 0.719 . . . . 0.0 113.135 168.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 38.1 m -80.69 31.26 0.3 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -169.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 61.93 30.49 75.48 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -170.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 t -66.66 156.73 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.285 1.034 . . . . 0.0 108.295 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -135.58 156.01 49.55 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 124.211 1.004 . . . . 0.0 110.218 -169.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.5 mt -103.3 113.39 65.77 Favored Pre-proline 0 CA--C 1.53 0.206 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -172.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -50.89 -41.77 54.33 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 122.371 2.047 . . . . 0.0 114.798 169.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.73 176.49 9.74 Favored 'Trans proline' 0 C--N 1.356 0.95 0 CA-C-N 121.687 1.638 . . . . 0.0 113.753 -174.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -57.28 -12.19 2.23 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.248 2.219 . . . . 0.0 113.737 -173.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -55.51 -25.74 38.94 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.826 -1.171 . . . . 0.0 111.871 171.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.7 p -84.8 -18.3 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 119.637 1.108 . . . . 0.0 110.347 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 56.8 p -100.42 18.51 18.82 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.591 0.756 . . . . 0.0 112.683 -169.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -83.98 -172.71 4.31 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.896 0.879 . . . . 0.0 109.72 173.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -63.44 -34.62 78.15 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.426 0.691 . . . . 0.0 112.344 -169.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.0 mt -140.73 140.13 33.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 -174.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -140.1 137.87 34.85 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.623 1.169 . . . . 0.0 108.228 170.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -146.5 160.17 42.46 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.695 1.598 . . . . 0.0 107.726 168.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -122.53 95.73 4.75 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.117 1.367 . . . . 0.0 108.533 169.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.443 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 46.1 m0 -68.45 101.4 1.24 Allowed 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.418 1.087 . . . . 0.0 109.432 -177.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -61.21 120.59 10.65 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 169.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.7 mt -157.78 146.77 19.55 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.161 1.385 . . . . 0.0 107.993 -169.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.9 mp0 -86.61 60.25 6.12 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.375 1.87 . . . . 0.0 111.925 -169.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -1.59 85.67 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 129.672 3.189 . . . . 0.0 113.852 174.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.44 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 71.6 Cg_exo -59.64 -11.13 13.32 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.963 3.109 . . . . 0.0 117.85 -169.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.3 96.18 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 120.46 1.482 . . . . 0.0 111.495 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.4 13.11 29.25 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 126.402 1.953 . . . . 0.0 113.232 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.44 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 24.9 mm-40 -98.72 178.12 5.08 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.182 1.491 . . . . 0.0 112.765 -169.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.9 m -76.35 154.98 34.53 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.975 1.71 . . . . 0.0 110.059 175.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.9 mt -59.3 -30.96 68.71 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.708 -0.62 . . . . 0.0 111.889 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -62.11 -40.11 94.8 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.134 0.574 . . . . 0.0 110.521 175.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.7 t -68.9 -43.8 82.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.518 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 13.3 m-85 -55.44 -52.07 64.82 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.538 175.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -60.1 -41.54 92.76 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.413 0.685 . . . . 0.0 111.772 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 56.3 m -61.0 -46.19 91.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.78 0.718 . . . . 0.0 110.0 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.7 t -69.07 -43.84 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-O 117.853 -1.07 . . . . 0.0 110.265 177.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -56.45 -44.79 80.82 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 119.828 1.195 . . . . 0.0 109.438 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.16 -50.25 69.27 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-O 118.33 -1.261 . . . . 0.0 110.576 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -57.52 -57.05 14.38 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 118.311 1.055 . . . . 0.0 110.098 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.6 t -48.91 -52.95 8.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.937 1.695 . . . . 0.0 110.619 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -64.68 -48.89 73.05 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 119.159 0.891 . . . . 0.0 109.795 -171.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.62 -44.33 69.41 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.924 0.89 . . . . 0.0 110.46 174.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.443 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 96.4 mtt180 -72.45 -39.37 67.84 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 117.484 -1.246 . . . . 0.0 110.764 -175.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 72.5 t -55.26 -48.68 76.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 121.046 1.748 . . . . 0.0 108.724 169.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -60.42 -38.81 85.25 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.226 0.921 . . . . 0.0 110.778 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -64.71 -45.19 87.6 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.508 1.123 . . . . 0.0 110.352 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.58 -46.97 85.9 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 124.102 0.961 . . . . 0.0 109.434 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.7 mt -59.16 -38.04 71.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.607 1.163 . . . . 0.0 110.861 175.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.77 -30.08 70.56 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 120.011 1.278 . . . . 0.0 111.413 -173.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -71.61 -19.56 62.1 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.833 1.653 . . . . 0.0 112.976 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.4 pt -126.26 -20.35 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 126.018 1.727 . . . . 0.0 115.269 -168.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.5 m . . . . . 0 C--O 1.248 0.99 0 C-N-CA 126.471 1.908 . . . . 0.0 111.019 171.018 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.4 ttm . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 120.848 0.356 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -119.53 138.15 53.36 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.719 1.208 . . . . 0.0 107.758 176.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -97.25 133.62 41.64 Favored 'General case' 0 CA--C 1.511 -0.547 0 O-C-N 121.48 -0.762 . . . . 0.0 109.234 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.9 p -114.77 140.9 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 123.293 0.637 . . . . 0.0 109.662 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 44.2 tpp -119.94 143.8 47.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.973 169.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -117.9 135.62 54.0 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.972 1.309 . . . . 0.0 107.717 169.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.1 t -141.4 123.88 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 120.017 1.281 . . . . 0.0 109.274 -173.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.4 p -127.59 174.69 8.85 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.805 1.184 . . . . 0.0 111.019 173.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -66.04 -16.44 63.92 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.227 0.611 . . . . 0.0 112.415 173.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -152.14 101.79 2.74 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 170.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -40.02 -36.67 0.5 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.255 1.822 . . . . 0.0 113.252 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.6 m -37.21 -32.12 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 129.421 3.088 . . . . 0.0 116.936 -178.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 71.5 m -119.87 -84.96 0.66 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.172 0.896 . . . . 0.0 112.4 -169.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.429 ' HD3' ' HD2' ' A' ' 104' ' ' PRO . 0.3 OUTLIER -60.02 -51.9 67.69 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.501 1.046 . . . . 0.0 110.069 -169.479 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.416 ' HB3' ' HB2' ' A' ' 34' ' ' SER . 1.4 m -56.34 -50.19 72.21 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.247 1.019 . . . . 0.0 110.519 -173.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -61.64 -45.07 95.63 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.434 0.694 . . . . 0.0 111.344 -173.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 65.7 mtm -64.22 -47.04 81.21 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 119.446 -0.311 . . . . 0.0 110.927 175.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.69 -40.04 71.82 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 122.451 0.3 . . . . 0.0 110.681 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -64.54 -55.03 23.2 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.414 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.42 -38.09 68.41 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 119.457 -0.635 . . . . 0.0 111.702 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -67.73 -47.76 68.37 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 118.753 1.276 . . . . 0.0 108.775 175.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.64 -44.82 93.38 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.931 1.241 . . . . 0.0 113.312 -175.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 ptmt -68.98 -9.0 50.05 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 119.736 1.153 . . . . 0.0 113.145 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.6 m -93.51 -47.52 6.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 119.783 1.174 . . . . 0.0 110.459 169.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.2 mt -76.39 -40.77 50.04 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 126.04 1.736 . . . . 0.0 112.076 -169.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -121.93 -4.37 9.49 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-O 117.879 -1.512 . . . . 0.0 115.296 -169.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.27 110.08 0.57 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.763 1.781 . . . . 0.0 108.906 169.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.64 -30.43 2.68 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.931 1.253 . . . . 0.0 111.409 -169.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.07 -22.76 3.42 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.67 1.188 . . . . 0.0 111.892 172.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.8 pt -125.22 157.39 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-O 121.523 0.678 . . . . 0.0 112.01 176.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -122.77 132.42 54.22 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 169.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -117.39 150.83 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 C-N-CA 124.02 0.928 . . . . 0.0 112.06 -170.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.4 m -144.23 152.55 40.99 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 167.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.416 ' HB2' ' HB3' ' A' ' 15' ' ' SER . 43.9 p -131.2 156.97 44.44 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 167.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.1 p -155.73 -159.99 0.97 Allowed 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.97 163.95 32.06 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 169.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 67.2 mt -52.93 -34.0 53.28 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.59 0.756 . . . . 0.0 109.622 172.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -142.6 146.22 34.33 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 103.199 -2.889 . . . . 0.0 103.199 168.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.3 m -124.51 148.6 47.64 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.287 0.565 . . . . 0.0 111.456 -178.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.3 m -143.86 168.59 19.6 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.997 2.519 . . . . 0.0 106.303 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.0 ptt85 -54.22 158.97 2.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.979 0.809 . . . . 0.0 112.478 -172.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.9 t -62.62 136.15 26.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -73.85 143.27 81.07 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.96 -40.98 0.57 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.307 1.338 . . . . 0.0 112.79 -169.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.527 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 11.5 m -67.3 -16.92 64.54 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.368 -1.458 . . . . 0.0 111.898 -177.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.443 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -55.52 -40.07 71.33 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.698 0.799 . . . . 0.0 110.503 169.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 59.4 mt -57.74 -48.39 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.97 -37.6 85.37 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 123.654 0.782 . . . . 0.0 111.828 -174.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 20.2 mmt -61.28 -47.58 85.34 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 122.858 1.313 . . . . 0.0 111.31 175.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 9.3 mtp -69.39 -33.11 72.54 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.516 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -61.89 -29.01 69.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.858 -0.592 . . . . 0.0 111.588 170.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -65.59 -36.32 83.4 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.18 0.9 . . . . 0.0 110.446 173.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.67 -25.71 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 117.474 0.124 . . . . 0.0 110.769 176.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.43 28.26 7.23 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.546 1.069 . . . . 0.0 111.461 -174.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.598 HG22 ' H ' ' A' ' 56' ' ' ASP . 7.6 mt -122.93 -177.53 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.598 ' H ' HG22 ' A' ' 55' ' ' ILE . 12.3 t70 -146.45 157.02 43.7 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.364 1.466 . . . . 0.0 109.158 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.443 HD12 ' HB1' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -127.47 -16.48 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.703 0.801 . . . . 0.0 112.339 169.889 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -45.29 -38.18 5.42 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.693 1.197 . . . . 0.0 112.768 173.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.88 -5.46 88.72 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 118.517 -1.157 . . . . 0.0 114.335 -173.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -125.86 168.19 14.19 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.319 1.56 . . . . 0.0 110.875 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.8 p -127.84 168.61 14.94 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.016 0.926 . . . . 0.0 111.542 -169.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.2 m -82.16 163.36 22.0 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.401 1.08 . . . . 0.0 111.426 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -156.8 141.34 12.0 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.495 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -81.88 151.72 16.64 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.826 2.351 . . . . 0.0 111.173 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.1 tt -57.33 -31.13 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 121.725 -0.609 . . . . 0.0 111.833 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -56.76 -22.3 34.72 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.704 2.001 . . . . 0.0 112.111 -177.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -82.04 -7.99 59.64 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.56 1.144 . . . . 0.0 113.096 -176.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -128.57 -178.5 4.61 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 120.025 1.284 . . . . 0.0 111.607 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -127.66 141.86 51.5 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 127.247 2.219 . . . . 0.0 107.57 169.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.09 -22.99 65.8 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.889 1.276 . . . . 0.0 111.985 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -60.21 -23.14 63.78 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.054 0.942 . . . . 0.0 112.352 -176.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -83.07 -12.25 57.3 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.875 0.87 . . . . 0.0 110.728 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -111.3 126.93 55.42 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 125.644 1.578 . . . . 0.0 109.368 -170.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -72.61 -42.13 64.82 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 175.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.4 p -128.02 134.06 65.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 C-N-CA 122.942 0.497 . . . . 0.0 110.123 -169.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.4 m -127.91 108.26 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-O 123.341 1.543 . . . . 0.0 109.141 -172.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.4 mm -104.12 100.34 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 114.22 -1.355 . . . . 0.0 107.388 -175.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.4 t -74.01 157.14 36.68 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 167.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.13 51.38 0.6 Allowed 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 175.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.7 p -55.87 -52.47 63.94 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.712 -1.243 . . . . 0.0 110.907 -169.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.01 -27.71 2.88 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.282 1.42 . . . . 0.0 112.186 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 51.8 m -131.64 26.8 4.71 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.097 0.949 . . . . 0.0 113.482 -169.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.47 16.31 69.32 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.276 0.941 . . . . 0.0 114.489 176.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.406 HG23 ' H ' ' A' ' 84' ' ' VAL . 1.7 t -68.91 175.44 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 126.052 1.741 . . . . 0.0 108.24 169.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.77 158.33 44.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.16 0.984 . . . . 0.0 108.347 169.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 37.6 mt -62.42 121.41 66.75 Favored Pre-proline 0 C--N 1.327 -0.377 0 C-N-CA 125.867 1.667 . . . . 0.0 107.468 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -56.73 -41.35 76.58 Favored 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 122.063 1.842 . . . . 0.0 114.014 169.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.49 -177.05 3.56 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.709 1.606 . . . . 0.0 113.386 -172.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -47.71 -17.23 0.09 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 129.461 3.104 . . . . 0.0 115.632 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 61.2 m95 -66.28 8.3 0.24 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 126.7 2.0 . . . . 0.0 113.152 171.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.1 p -118.06 2.68 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 124.891 1.277 . . . . 0.0 111.512 171.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.1 p -128.5 26.43 5.65 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.111 0.964 . . . . 0.0 112.131 -172.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -92.57 -173.1 3.26 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.548 0.739 . . . . 0.0 109.558 170.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -65.72 -33.44 75.88 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -169.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.2 mt -137.25 132.62 46.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -138.48 140.46 39.21 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -147.58 159.07 44.17 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.276 1.43 . . . . 0.0 107.34 168.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -122.22 110.7 16.05 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.718 1.207 . . . . 0.0 108.934 168.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.436 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 37.1 m0 -87.39 84.68 7.15 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.28 1.032 . . . . 0.0 108.461 -178.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -56.95 120.85 8.66 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 170.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 25.1 mt -151.03 153.05 34.38 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.986 1.314 . . . . 0.0 108.602 -169.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -78.16 74.83 4.7 Favored 'General case' 0 CA--C 1.523 -0.092 0 C-N-CA 125.105 1.362 . . . . 0.0 111.525 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -28.68 102.77 0.16 Allowed Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 127.432 2.293 . . . . 0.0 113.668 -175.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.482 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 87.3 Cg_exo -63.68 -0.37 2.47 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.966 3.111 . . . . 0.0 117.425 -169.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -56.04 102.93 0.08 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 119.964 1.256 . . . . 0.0 111.702 178.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.34 22.06 59.4 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 126.201 1.857 . . . . 0.0 113.134 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.482 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 21.5 mm-40 -97.68 177.37 5.51 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.703 1.251 . . . . 0.0 112.554 -169.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.8 m -74.37 154.97 38.6 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.431 1.493 . . . . 0.0 109.814 176.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 91.5 mt -59.3 -30.58 68.44 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 122.001 -0.437 . . . . 0.0 111.656 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -62.77 -39.25 93.59 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.405 0.548 . . . . 0.0 110.918 176.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 89.0 t -67.9 -46.07 82.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.527 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 14.7 m-85 -55.34 -50.46 69.59 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.896 175.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 -59.85 -42.6 94.0 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.959 0.904 . . . . 0.0 111.74 177.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.7 m -60.78 -50.54 73.05 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 118.935 0.789 . . . . 0.0 109.363 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.6 t -66.1 -44.47 91.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 117.626 -1.178 . . . . 0.0 110.316 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 48.0 ttp85 -53.08 -47.36 68.6 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 120.093 1.315 . . . . 0.0 108.988 176.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.98 -47.9 81.18 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-O 118.481 -1.177 . . . . 0.0 110.598 -175.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -61.21 -56.7 17.64 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 118.292 1.046 . . . . 0.0 110.37 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 82.4 t -50.09 -49.95 20.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 125.132 1.373 . . . . 0.0 110.386 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -62.03 -48.43 80.33 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 120.207 1.367 . . . . 0.0 110.445 -176.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -53.91 -45.81 71.26 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 123.681 0.793 . . . . 0.0 109.751 174.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.436 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 76.6 mtt-85 -70.82 -39.54 72.98 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 118.257 -0.878 . . . . 0.0 109.925 -173.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 75.4 t -55.6 -48.8 77.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 120.437 1.471 . . . . 0.0 109.189 169.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -60.94 -38.87 87.35 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.659 1.118 . . . . 0.0 110.754 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -62.04 -46.73 87.85 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.806 1.642 . . . . 0.0 109.832 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.28 -45.76 83.16 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 123.75 0.82 . . . . 0.0 110.106 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 60.1 mt -57.44 -38.32 62.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.574 1.149 . . . . 0.0 110.468 175.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.26 -29.19 69.7 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.873 1.215 . . . . 0.0 111.447 -173.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -73.75 -19.14 60.87 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.079 1.752 . . . . 0.0 112.802 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 pt -126.51 -20.08 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 126.21 1.804 . . . . 0.0 114.966 -168.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 C--O 1.25 1.124 0 C-N-CA 126.504 1.922 . . . . 0.0 110.9 170.11 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.9 ttm . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 121.439 0.638 . . . . 0.0 110.392 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -78.45 124.23 27.9 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 175.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.7 mttt -106.48 124.74 50.05 Favored 'General case' 0 CA--C 1.508 -0.657 0 C-N-CA 122.885 0.474 . . . . 0.0 109.936 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.6 p -105.16 140.67 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 O-C-N 123.626 0.579 . . . . 0.0 110.656 175.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 39.7 tpp -119.07 142.39 47.91 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 169.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -116.08 134.53 54.84 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 169.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.3 t -136.9 123.05 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 119.641 1.11 . . . . 0.0 108.643 -171.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.4 t -123.23 157.12 33.79 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.066 0.848 . . . . 0.0 109.691 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.319 20.9 pttp -67.52 -2.48 6.59 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 175.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -139.17 -5.12 1.46 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 168.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 63.86 -44.13 0.26 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 127.332 2.253 . . . . 0.0 114.571 -172.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.3 m -34.03 -37.95 0.05 Allowed 'General case' 0 C--O 1.232 0.132 0 N-CA-C 119.684 3.216 . . . . 0.0 119.684 -168.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.9 p -136.12 -60.07 0.73 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-N 120.0 1.273 . . . . 0.0 112.202 -169.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -60.32 -50.12 74.89 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.001 0.819 . . . . 0.0 109.956 -171.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.04 -40.87 82.78 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 117.909 0.322 . . . . 0.0 110.579 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -61.75 -47.21 86.25 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.278 0.631 . . . . 0.0 111.131 -173.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.436 ' HG2' HD11 ' A' ' 57' ' ' ILE . 46.5 mtm -64.46 -43.05 95.45 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 119.837 -0.125 . . . . 0.0 110.745 176.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.85 -37.52 74.03 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.048 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.451 ' HA ' HG21 ' A' ' 32' ' ' VAL . 40.4 tt0 -65.73 -46.96 76.96 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 119.181 -0.438 . . . . 0.0 110.641 177.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.83 -42.76 98.24 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -67.48 -49.09 65.11 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 118.619 1.209 . . . . 0.0 109.624 176.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.1 -43.09 86.91 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 119.98 1.264 . . . . 0.0 112.092 -176.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.2 pttt -76.22 -2.46 31.44 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.4 m -98.62 -45.12 6.18 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 120.867 -1.145 . . . . 0.0 109.322 169.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.4 mt -72.15 -40.31 68.11 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.774 1.629 . . . . 0.0 110.79 -172.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.33 2.62 3.89 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 117.403 -1.776 . . . . 0.0 116.612 -169.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.44 116.07 2.45 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 120.607 2.204 . . . . 0.0 109.0 170.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.82 -24.19 6.45 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.599 1.095 . . . . 0.0 111.595 -175.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.35 -17.35 3.79 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.427 1.091 . . . . 0.0 111.912 176.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.9 pt -132.26 156.77 42.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 169.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.78 133.94 55.42 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 169.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.451 HG21 ' HA ' ' A' ' 19' ' ' GLU . 2.6 p -114.95 153.18 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 C-N-CA 124.074 0.95 . . . . 0.0 111.513 -175.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.9 m -144.01 148.19 34.91 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 167.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 63.2 p -121.92 148.67 44.46 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.33 1.452 . . . . 0.0 108.826 169.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 29.6 p -155.51 -165.11 1.9 Allowed 'General case' 0 C--O 1.241 0.63 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.22 168.48 33.07 Favored Glycine 0 N--CA 1.446 -0.698 0 O-C-N 121.541 -0.724 . . . . 0.0 111.976 169.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.2 mp -49.46 -39.85 34.91 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.044 0.937 . . . . 0.0 109.875 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -146.04 143.48 29.45 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 103.789 -2.671 . . . . 0.0 103.789 168.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.1 p -75.65 156.11 35.15 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 122.121 0.962 . . . . 0.0 111.503 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 63.5 m -158.39 153.92 26.1 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 127.72 2.408 . . . . 0.0 105.143 169.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -54.09 146.64 14.35 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 122.938 0.495 . . . . 0.0 110.894 -171.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 p -60.8 135.82 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 169.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -78.94 143.55 62.05 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 123.587 0.755 . . . . 0.0 109.858 -171.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.1 -41.63 0.28 Allowed 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 121.495 1.463 . . . . 0.0 112.409 -169.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.48 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 25.3 m -62.73 -24.57 67.75 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 120.422 -1.424 . . . . 0.0 111.292 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.417 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -51.36 -40.07 58.42 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.718 0.807 . . . . 0.0 111.663 173.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 62.9 mt -55.6 -46.0 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.12 -38.91 89.36 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 124.425 1.09 . . . . 0.0 110.161 -170.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.2 mmm -68.19 -44.19 76.44 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.744 1.259 . . . . 0.0 110.63 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.0 mtp -65.22 -35.87 82.39 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.221 -0.924 . . . . 0.0 109.963 175.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -63.89 -24.86 67.91 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.359 0.664 . . . . 0.0 111.489 173.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -65.82 -40.01 91.43 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 118.848 0.749 . . . . 0.0 109.746 172.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 92.7 t -76.78 -25.41 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.602 176.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.25 25.66 5.47 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.152 1.358 . . . . 0.0 111.727 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.525 HG22 ' H ' ' A' ' 56' ' ' ASP . 10.5 mt -123.37 178.85 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 125.128 1.371 . . . . 0.0 107.379 -178.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.525 ' H ' HG22 ' A' ' 55' ' ' ILE . 12.9 t70 -142.84 155.26 44.75 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.219 1.408 . . . . 0.0 109.557 -176.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.457 HD13 HG21 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -127.94 -13.88 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 123.955 0.902 . . . . 0.0 112.562 169.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -46.74 -37.17 8.07 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.53 1.132 . . . . 0.0 112.75 172.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.16 -6.23 85.96 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 118.697 -1.057 . . . . 0.0 114.248 -173.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -126.81 170.03 12.61 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.077 1.439 . . . . 0.0 111.204 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.6 p -129.2 166.57 19.12 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.645 1.178 . . . . 0.0 111.184 -170.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.2 m -92.08 155.78 17.83 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.798 1.239 . . . . 0.0 110.034 173.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -156.9 144.23 13.78 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 124.299 1.039 . . . . 0.0 110.07 -169.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.56 148.99 23.63 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 121.735 1.624 . . . . 0.0 111.158 -176.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.2 tt -52.01 -34.1 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.306 1.042 . . . . 0.0 111.761 173.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -58.44 -23.16 56.77 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.119 1.768 . . . . 0.0 112.404 -175.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -82.13 -6.83 59.48 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.916 0.886 . . . . 0.0 112.814 -175.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -125.39 -174.73 3.13 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.254 1.022 . . . . 0.0 110.356 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.47 130.71 30.82 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 126.399 1.88 . . . . 0.0 108.449 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.4 -28.39 66.87 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.633 1.173 . . . . 0.0 112.829 -176.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -60.49 -22.55 63.66 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.06 0.944 . . . . 0.0 112.452 -176.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -84.76 -13.2 51.96 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.428 0.691 . . . . 0.0 110.7 -178.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -108.77 127.37 53.95 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.972 1.309 . . . . 0.0 109.593 -172.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -74.17 -40.07 62.79 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.156 0.583 . . . . 0.0 109.967 175.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.97 136.38 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 122.823 0.449 . . . . 0.0 110.411 -169.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.7 m -129.15 110.53 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-O 122.839 1.304 . . . . 0.0 109.55 -170.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.7 mm -109.47 97.41 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -174.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.0 m -73.49 156.09 38.55 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 168.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.41 66.31 0.63 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 77.4 m -105.32 -43.84 4.89 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.391 -169.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.57 -96.78 0.24 Allowed Glycine 0 N--CA 1.465 0.574 0 CA-C-N 119.603 1.092 . . . . 0.0 112.905 168.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 56.2 m -76.94 39.19 0.22 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.614 1.566 . . . . 0.0 112.902 -169.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.12 14.66 78.85 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.455 1.026 . . . . 0.0 112.658 -172.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.5 t -58.74 126.06 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 169.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -137.94 -178.13 5.12 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.831 1.253 . . . . 0.0 109.531 -169.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.1 mt -113.16 108.21 53.15 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 123.981 0.912 . . . . 0.0 109.553 -169.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.19 -41.82 69.43 Favored 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 122.71 2.273 . . . . 0.0 115.078 169.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.63 -178.91 3.31 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.211 1.941 . . . . 0.0 113.432 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -59.1 -7.74 1.25 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.752 2.021 . . . . 0.0 114.151 -172.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -66.77 11.79 0.09 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.408 1.483 . . . . 0.0 112.624 169.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.7 p -124.01 3.24 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 125.563 1.545 . . . . 0.0 111.508 170.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 52.7 p -127.38 19.5 6.86 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.352 0.978 . . . . 0.0 112.649 -173.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -85.86 -173.64 4.71 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.223 0.609 . . . . 0.0 109.536 171.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -65.91 -32.5 74.04 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -169.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.2 mt -136.3 136.28 49.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -137.33 139.58 40.93 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 170.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -146.75 159.63 43.25 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.436 1.494 . . . . 0.0 107.441 168.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -123.35 96.39 4.97 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.488 1.515 . . . . 0.0 108.955 169.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -73.9 92.81 2.11 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.066 1.346 . . . . 0.0 109.54 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -65.81 97.37 0.34 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.889 1.276 . . . . 0.0 109.532 174.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -125.56 156.2 39.46 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.616 1.566 . . . . 0.0 109.906 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -78.7 66.35 4.18 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.518 1.927 . . . . 0.0 111.701 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -8.87 92.74 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 129.528 3.131 . . . . 0.0 113.553 169.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.415 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 77.5 Cg_exo -60.14 -4.38 2.99 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 124.707 3.605 . . . . 0.0 117.611 -169.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -54.64 98.85 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 120.244 1.384 . . . . 0.0 111.611 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.46 16.89 54.45 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.115 1.817 . . . . 0.0 113.522 170.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.415 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 25.7 mm-40 -94.95 179.59 5.17 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.792 1.296 . . . . 0.0 112.626 -169.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.2 m -76.35 155.43 34.15 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.254 1.422 . . . . 0.0 109.926 175.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.9 mt -58.89 -31.67 68.82 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.957 -0.464 . . . . 0.0 111.559 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -63.96 -40.53 96.63 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.088 0.404 . . . . 0.0 110.894 177.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.4 t -65.8 -47.44 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 176.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.48 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 8.1 m-85 -53.8 -54.24 41.06 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.225 0.61 . . . . 0.0 110.822 177.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 33.6 mtt180 -59.78 -42.06 92.48 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.707 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.5 m -61.67 -52.72 63.16 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 118.828 0.74 . . . . 0.0 109.222 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.3 t -64.04 -44.42 97.76 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.02 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -57.64 -45.5 85.39 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 119.728 1.149 . . . . 0.0 110.189 -177.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.46 -49.28 66.08 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-O 118.684 -1.064 . . . . 0.0 111.153 177.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -59.9 -50.06 75.25 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 118.661 1.231 . . . . 0.0 111.058 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.6 t -54.18 -48.13 66.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 124.634 1.174 . . . . 0.0 109.921 178.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -60.13 -46.94 87.96 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 120.071 1.305 . . . . 0.0 110.586 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -42.04 86.07 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.304 1.042 . . . . 0.0 110.68 178.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.6 mtt-85 -71.2 -41.88 69.71 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 117.821 -1.085 . . . . 0.0 109.863 -177.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.421 ' HA ' HD23 ' A' ' 126' ' ' LEU . 94.1 t -54.47 -46.06 70.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 120.461 1.482 . . . . 0.0 109.976 169.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -61.94 -40.21 94.74 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.465 1.03 . . . . 0.0 111.075 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -63.11 -44.62 95.14 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.048 0.539 . . . . 0.0 110.321 176.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 123' ' ' VAL . 0.2 OUTLIER -64.02 -46.79 82.92 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 118.447 -0.787 . . . . 0.0 109.951 -178.254 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.1 mt -52.86 -41.91 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 124.052 0.941 . . . . 0.0 109.423 173.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.31 -31.01 72.05 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.713 1.142 . . . . 0.0 111.571 -175.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -69.65 -39.25 77.18 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.497 1.119 . . . . 0.0 111.504 176.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.0 pt -95.81 -28.7 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -169.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.5 m . . . . . 0 C--O 1.25 1.132 0 C-N-CA 126.079 1.752 . . . . 0.0 111.22 -179.177 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.6 ttm . . . . . 0 N--CA 1.484 1.274 0 CA-C-O 120.752 0.31 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -119.94 147.73 44.38 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.629 1.172 . . . . 0.0 108.496 171.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.7 mttt -102.72 104.13 14.43 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 123.515 0.726 . . . . 0.0 109.453 175.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 36.4 t -79.0 141.03 15.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 125.259 1.424 . . . . 0.0 108.837 175.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 30.6 tpp -127.18 142.41 51.5 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.707 1.203 . . . . 0.0 108.368 173.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -124.47 133.49 53.34 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.135 0.974 . . . . 0.0 108.893 173.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.3 t -144.19 122.81 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 120.259 1.39 . . . . 0.0 110.027 -169.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.2 p -132.4 179.9 5.84 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 120.058 1.299 . . . . 0.0 111.181 175.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.8 mttm -62.55 -10.57 12.46 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.789 1.236 . . . . 0.0 114.001 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -143.85 -10.45 0.69 Allowed 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 116.026 1.861 . . . . 0.0 116.026 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 63.2 -40.95 0.19 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 128.312 2.645 . . . . 0.0 114.291 -169.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.5 m -34.84 -39.14 0.09 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 129.252 3.021 . . . . 0.0 118.573 -169.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.7 p -132.64 -72.27 0.52 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 118.124 -0.941 . . . . 0.0 109.594 -169.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 -50.62 -52.58 38.12 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.928 0.785 . . . . 0.0 110.387 -169.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.65 -45.02 63.27 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.361 0.664 . . . . 0.0 111.349 -176.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -59.78 -44.01 94.11 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.204 1.002 . . . . 0.0 111.409 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 53.5 mtp -64.57 -48.29 75.52 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.877 1.271 . . . . 0.0 109.295 178.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.8 -40.14 79.22 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.363 0.265 . . . . 0.0 111.149 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -62.56 -46.95 85.97 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.761 0.425 . . . . 0.0 110.556 177.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.35 -43.43 95.68 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 119.443 -0.643 . . . . 0.0 111.875 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -67.24 -48.92 66.34 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 119.025 1.413 . . . . 0.0 109.159 176.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.71 -42.71 79.63 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 119.599 1.091 . . . . 0.0 112.395 -176.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.3 pttt -75.7 -2.41 29.41 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.9 m -99.16 -45.57 5.86 Favored 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 120.917 -1.114 . . . . 0.0 109.437 169.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 91.9 mt -71.25 -40.34 71.07 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.183 1.793 . . . . 0.0 110.945 -173.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -133.87 0.15 4.04 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 117.444 -1.753 . . . . 0.0 116.8 -169.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.35 116.87 2.87 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 120.512 2.156 . . . . 0.0 109.35 172.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.29 -24.24 6.62 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.642 1.115 . . . . 0.0 111.514 -176.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.29 -18.75 4.0 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.455 1.102 . . . . 0.0 111.654 177.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.1 pt -131.0 158.45 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 168.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -120.37 144.39 47.92 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 169.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.92 153.67 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 123.442 0.697 . . . . 0.0 112.631 -174.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.3 m -151.02 144.9 25.17 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.579 1.552 . . . . 0.0 106.873 168.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 97.6 p -112.01 157.74 20.38 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.35 -0.844 . . . . 0.0 109.665 168.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.7 p -152.02 -164.17 1.91 Allowed 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 171.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.32 161.8 35.18 Favored Glycine 0 CA--C 1.519 0.297 0 O-C-N 121.276 -0.89 . . . . 0.0 111.092 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 66.0 mt -54.75 -32.02 59.28 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.407 1.083 . . . . 0.0 111.123 -173.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -146.85 144.54 29.38 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 168.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.6 p -73.5 153.46 40.31 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.741 0.781 . . . . 0.0 111.296 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.3 m -160.21 154.07 22.86 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.502 2.321 . . . . 0.0 105.869 169.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -57.13 156.12 7.59 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.62 0.645 . . . . 0.0 111.408 -174.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.9 t -63.23 132.34 29.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 172.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -73.84 139.8 77.24 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -75.12 -41.59 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.358 1.372 . . . . 0.0 112.614 -169.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.494 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 25.5 m -64.65 -23.02 67.12 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 120.556 -1.34 . . . . 0.0 111.48 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.62 -40.55 60.11 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 123.622 0.769 . . . . 0.0 111.402 171.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 61.7 mt -56.2 -45.38 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.88 -40.17 91.36 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 124.249 1.02 . . . . 0.0 110.056 -171.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.8 mmm -64.47 -44.86 89.7 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 122.145 0.974 . . . . 0.0 110.16 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.1 mtp -66.94 -36.7 82.83 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.721 177.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -61.04 -29.92 70.01 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.306 0.643 . . . . 0.0 111.272 173.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -64.25 -39.81 94.72 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 118.884 0.766 . . . . 0.0 110.213 173.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 62.1 t -77.79 -17.06 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.027 177.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.92 25.44 10.54 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.787 1.184 . . . . 0.0 111.933 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.528 HG22 ' H ' ' A' ' 56' ' ' ASP . 11.9 mt -121.28 179.68 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 125.405 1.482 . . . . 0.0 107.279 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.528 ' H ' HG22 ' A' ' 55' ' ' ILE . 13.8 t70 -144.9 156.0 43.75 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.228 1.411 . . . . 0.0 109.351 -178.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -127.74 -16.85 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.831 0.852 . . . . 0.0 112.443 169.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -44.18 -38.71 3.89 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.692 1.197 . . . . 0.0 112.968 172.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.29 -6.45 86.37 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-O 118.582 -1.121 . . . . 0.0 114.268 -173.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -126.61 164.74 20.58 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.156 1.478 . . . . 0.0 110.732 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.5 p -129.88 167.26 18.44 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.017 0.927 . . . . 0.0 111.74 -169.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.1 m -77.45 164.64 25.26 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.573 1.149 . . . . 0.0 111.761 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -157.63 141.58 11.49 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-O 118.411 -0.804 . . . . 0.0 109.471 174.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -78.09 153.37 28.49 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.557 2.171 . . . . 0.0 111.232 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.1 tt -53.82 -33.86 24.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.798 1.239 . . . . 0.0 112.471 177.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -66.07 -20.98 66.34 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.251 1.42 . . . . 0.0 112.074 -169.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -83.33 -0.98 52.17 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.108 0.963 . . . . 0.0 112.561 -173.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -115.85 -173.12 2.29 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.847 0.859 . . . . 0.0 112.462 -170.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.431 ' HA ' ' CH2' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -142.91 131.39 22.32 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 127.284 2.234 . . . . 0.0 107.846 173.433 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.695 ' HB2' ' CE3' ' A' ' 90' ' ' TRP . . . -62.28 -29.16 70.22 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 119.142 -0.456 . . . . 0.0 112.208 178.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -61.73 -20.36 63.42 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.381 0.672 . . . . 0.0 112.372 -170.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -88.73 -22.84 23.13 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.601 0.76 . . . . 0.0 110.955 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -99.08 113.1 25.14 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.972 1.309 . . . . 0.0 108.832 -176.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -72.31 -28.91 63.38 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 122.315 -0.24 . . . . 0.0 110.875 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.18 135.13 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.081 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -172.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.7 t -131.74 129.63 61.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 122.786 1.279 . . . . 0.0 109.253 -173.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.3 mm -120.32 101.77 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -177.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.5 t -72.42 155.39 40.18 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 105.496 -2.039 . . . . 0.0 105.496 168.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.45 36.3 0.89 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 172.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 90.4 m -60.35 -21.49 62.15 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.08 -1.013 . . . . 0.0 112.15 -173.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.52 -63.74 0.8 Allowed Glycine 0 CA--C 1.518 0.238 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 169.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 37.9 m -76.34 24.21 0.14 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -173.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.34 15.23 63.18 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.758 1.647 . . . . 0.0 113.57 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.22 156.07 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.442 1.497 . . . . 0.0 107.609 169.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -127.44 158.36 37.57 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.924 1.29 . . . . 0.0 108.126 174.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.0 mt -65.56 123.96 85.96 Favored Pre-proline 0 C--N 1.327 -0.398 0 C-N-CA 125.065 1.346 . . . . 0.0 108.472 -177.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -56.85 -41.26 77.29 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 122.037 1.825 . . . . 0.0 113.77 169.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.454 ' HB2' ' CE3' ' A' ' 90' ' ' TRP . 71.2 Cg_endo -75.91 172.37 16.42 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 121.724 1.652 . . . . 0.0 113.217 -170.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -54.24 -13.12 0.77 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 127.205 2.202 . . . . 0.0 113.271 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.695 ' CE3' ' HB2' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -49.14 -27.52 3.56 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 128.209 2.604 . . . . 0.0 111.65 169.646 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.21 -2.14 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.811 0.844 . . . . 0.0 110.589 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 56.7 p -120.68 18.96 11.93 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.978 0.911 . . . . 0.0 113.151 -169.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -86.95 179.87 6.63 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.306 1.042 . . . . 0.0 110.339 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -57.3 -34.02 68.27 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.714 1.206 . . . . 0.0 113.082 -169.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.4 mt -132.8 139.15 50.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 174.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -140.61 132.92 28.28 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 169.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -142.27 159.13 42.85 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.292 1.437 . . . . 0.0 108.622 169.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -121.14 111.28 17.22 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.764 1.226 . . . . 0.0 109.428 168.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.427 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 41.0 m0 -85.33 93.83 8.8 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.566 1.146 . . . . 0.0 108.741 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -59.77 116.51 4.12 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 169.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.3 mt -149.68 149.32 30.43 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.565 1.546 . . . . 0.0 107.506 -169.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -84.61 63.23 7.8 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 125.023 1.329 . . . . 0.0 111.137 -175.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -0.99 88.0 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 129.021 2.929 . . . . 0.0 112.918 169.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.497 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 71.0 Cg_exo -58.68 -4.93 2.14 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 124.262 3.308 . . . . 0.0 117.33 -169.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -54.91 99.7 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.392 0.996 . . . . 0.0 111.738 176.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.17 18.06 54.35 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 126.16 1.838 . . . . 0.0 113.324 171.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.497 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 22.1 mm-40 -95.9 178.16 5.52 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.661 1.23 . . . . 0.0 112.562 -169.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.3 m -74.94 154.74 38.01 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.498 1.519 . . . . 0.0 110.048 174.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.9 mt -58.58 -32.67 69.16 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.786 -0.571 . . . . 0.0 111.574 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -63.31 -39.93 95.93 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 122.679 0.392 . . . . 0.0 110.664 177.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.7 t -66.39 -45.77 88.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 176.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.494 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 10.7 m-85 -55.4 -52.06 64.81 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.823 0.449 . . . . 0.0 110.803 177.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 34.8 mtt180 -61.76 -40.09 93.91 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.509 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.3 m -62.0 -51.49 67.82 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.393 0.997 . . . . 0.0 109.708 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 49.0 t -63.66 -45.1 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.958 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 -56.31 -45.83 80.11 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-N 119.705 1.139 . . . . 0.0 109.499 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.17 -50.34 68.75 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-O 118.176 -1.347 . . . . 0.0 110.408 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -59.36 -54.46 46.47 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 118.535 1.168 . . . . 0.0 110.512 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 65.1 t -47.32 -54.57 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 125.541 1.536 . . . . 0.0 110.297 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -62.99 -44.85 94.9 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 120.112 1.324 . . . . 0.0 110.626 -175.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -57.96 -42.19 84.47 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.727 1.211 . . . . 0.0 109.655 177.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.427 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 80.5 mtt-85 -74.61 -41.58 60.15 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 117.186 -1.388 . . . . 0.0 109.979 -175.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.449 ' HA ' HD23 ' A' ' 126' ' ' LEU . 95.6 t -53.15 -45.71 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 121.216 1.825 . . . . 0.0 109.564 169.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -62.29 -42.02 98.99 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.044 0.838 . . . . 0.0 111.218 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -60.91 -46.01 92.34 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 175.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 123' ' ' VAL . 0.2 OUTLIER -63.03 -48.97 76.44 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.252 -0.88 . . . . 0.0 109.561 -176.009 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 55.9 mt -52.35 -42.14 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 124.234 1.014 . . . . 0.0 109.443 173.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.26 -30.74 71.82 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.638 1.108 . . . . 0.0 111.58 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 44.7 mttt -70.38 -38.0 74.64 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.719 1.208 . . . . 0.0 111.537 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.7 pt -97.61 -27.12 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -169.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.8 m . . . . . 0 C--O 1.25 1.111 0 C-N-CA 126.125 1.77 . . . . 0.0 110.915 176.481 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.8 ttm . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 120.819 0.342 . . . . 0.0 110.44 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.09 141.98 35.27 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.676 0.79 . . . . 0.0 109.711 173.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -96.14 117.77 31.39 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 170.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 98.2 t -101.7 135.63 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 125.469 1.508 . . . . 0.0 107.673 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 51.9 ttm -118.86 138.28 52.84 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 168.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -108.68 130.22 55.34 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 169.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.9 t -129.17 113.23 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 120.326 1.421 . . . . 0.0 109.296 -170.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.6 t -111.59 162.63 14.95 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.97 0.805 . . . . 0.0 111.571 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.4 mttm -65.51 -13.01 57.95 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.824 -1.173 . . . . 0.0 112.383 171.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.6 ptt180 -153.81 114.33 3.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 104.149 -2.537 . . . . 0.0 104.149 169.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -69.56 52.92 0.11 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.795 1.238 . . . . 0.0 112.415 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.5 p -126.76 -23.3 3.72 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.842 1.257 . . . . 0.0 112.668 -170.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 78.6 m -133.99 -87.82 0.4 Allowed 'General case' 0 C--N 1.343 0.3 0 CA-C-O 118.379 -0.82 . . . . 0.0 111.185 -171.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -50.33 -50.6 50.46 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.016 0.825 . . . . 0.0 110.922 -169.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.1 p -70.25 -44.67 68.02 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 125.26 1.424 . . . . 0.0 110.974 -174.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -58.93 -46.39 88.09 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.649 1.18 . . . . 0.0 110.436 -177.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 52.2 mtp -63.76 -46.63 84.41 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.586 1.154 . . . . 0.0 109.598 177.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.74 -37.75 74.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 119.104 -0.474 . . . . 0.0 111.425 178.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -62.29 -53.31 56.98 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-O 118.464 -0.779 . . . . 0.0 109.855 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.91 -41.17 75.62 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -66.38 -49.79 65.68 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 118.271 1.036 . . . . 0.0 109.676 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.0 -46.43 88.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 120.09 1.314 . . . . 0.0 113.082 -174.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -71.14 -8.77 55.74 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 119.7 1.136 . . . . 0.0 113.201 176.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 38.0 m -92.77 -48.7 6.44 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 119.965 1.257 . . . . 0.0 110.552 169.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.2 mt -78.92 -41.55 29.25 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.998 1.719 . . . . 0.0 112.135 -169.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.21 -7.32 16.95 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-O 117.904 -1.498 . . . . 0.0 114.604 -169.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.08 109.34 0.46 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.632 1.716 . . . . 0.0 108.897 169.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.09 -28.87 2.88 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.917 1.246 . . . . 0.0 111.622 -169.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.67 -21.38 2.78 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.619 1.168 . . . . 0.0 111.812 172.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.8 pt -126.77 158.87 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-O 121.47 0.652 . . . . 0.0 112.124 174.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -123.74 134.11 53.74 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 168.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 p -119.45 151.35 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -170.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.2 m -141.71 131.71 24.58 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.132 1.373 . . . . 0.0 108.614 168.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.6 p -98.21 141.4 31.17 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.026 -1.046 . . . . 0.0 108.517 169.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.6 m -154.0 -177.28 6.3 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.413 1.885 . . . . 0.0 106.087 -169.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.53 170.77 43.3 Favored Glycine 0 N--CA 1.439 -1.11 0 O-C-N 121.377 -0.827 . . . . 0.0 111.522 175.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -53.62 -33.58 55.55 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 125.176 1.163 . . . . 0.0 110.048 174.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -143.57 146.23 33.15 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.986 1.714 . . . . 0.0 106.67 169.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 p -70.53 157.66 37.49 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.294 0.569 . . . . 0.0 109.612 169.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.6 m -162.16 148.56 13.39 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.199 1.8 . . . . 0.0 106.795 170.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -54.4 151.96 7.03 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.562 0.619 . . . . 0.0 110.907 -175.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.9 t -57.44 126.19 14.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 172.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -70.46 140.85 87.59 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -72.84 -41.68 1.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.265 1.31 . . . . 0.0 113.192 -169.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.505 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 29.8 m -65.01 -25.19 67.75 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.664 -1.272 . . . . 0.0 111.298 -177.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.475 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -51.46 -40.87 60.33 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.723 0.809 . . . . 0.0 111.335 173.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.8 mt -56.45 -45.88 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.12 -38.37 88.01 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.507 1.123 . . . . 0.0 110.578 -172.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.9 mmm -68.41 -44.02 75.93 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 122.915 1.34 . . . . 0.0 110.434 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.2 mtp -66.88 -34.29 77.46 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 121.124 -0.985 . . . . 0.0 110.005 175.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -62.48 -26.4 68.51 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.998 0.817 . . . . 0.0 111.423 172.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -65.55 -39.84 92.19 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 118.905 0.775 . . . . 0.0 109.768 173.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 63.9 t -78.46 -22.28 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 120.159 -0.617 . . . . 0.0 110.852 177.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.93 25.09 6.63 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.054 1.311 . . . . 0.0 111.948 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.525 HG22 ' H ' ' A' ' 56' ' ' ASP . 10.7 mt -122.68 179.03 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 125.227 1.411 . . . . 0.0 107.45 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.525 ' H ' HG22 ' A' ' 55' ' ' ILE . 9.8 t0 -144.28 155.96 44.06 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.863 1.665 . . . . 0.0 108.822 -176.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.475 HD12 ' HB1' ' A' ' 46' ' ' ALA . 0.5 OUTLIER -130.85 -13.04 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.981 0.913 . . . . 0.0 113.365 174.314 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.7 m -43.1 -34.24 1.03 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.993 1.717 . . . . 0.0 114.637 -176.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -102.82 1.93 48.52 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 117.853 -1.526 . . . . 0.0 114.576 -174.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -71.92 -26.78 62.44 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 120.528 2.164 . . . . 0.0 113.081 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.9 p 60.49 -161.06 0.29 Allowed 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.314 1.046 . . . . 0.0 110.264 -174.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.4 t -134.19 163.0 30.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.798 0.809 . . . . 0.0 111.406 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -161.21 133.9 4.48 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 126.304 1.842 . . . . 0.0 106.373 -171.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -85.0 158.51 11.57 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.875 2.384 . . . . 0.0 110.934 176.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.4 tt -54.28 -35.15 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 123.476 0.711 . . . . 0.0 111.02 172.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -57.22 -24.12 52.47 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.11 1.764 . . . . 0.0 112.66 -175.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -83.3 -2.34 55.44 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.569 0.748 . . . . 0.0 112.547 -176.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -128.88 -176.87 3.99 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.253 1.021 . . . . 0.0 111.005 -177.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.18 129.28 31.46 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 126.602 1.961 . . . . 0.0 108.274 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.31 -29.82 66.18 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.548 1.139 . . . . 0.0 112.939 -175.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -60.73 -22.7 64.27 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.036 0.934 . . . . 0.0 112.475 -176.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -84.31 -18.02 37.67 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.272 0.629 . . . . 0.0 110.605 -177.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -101.89 122.74 44.58 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 125.168 1.387 . . . . 0.0 108.959 -175.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -76.22 -32.34 58.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.841 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.9 138.01 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 123.518 0.727 . . . . 0.0 109.059 -171.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.0 128.01 45.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 122.97 1.367 . . . . 0.0 109.869 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.0 mm -120.33 96.16 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 -175.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.7 m -70.04 156.01 39.78 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 168.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.74 56.07 0.91 Allowed 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 102.753 -3.055 . . . . 0.0 102.753 173.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.4 m -76.51 -34.15 58.6 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.834 0.854 . . . . 0.0 110.14 -178.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.53 176.13 47.19 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -170.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 91.4 m 37.48 32.15 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.594 2.357 . . . . 0.0 114.791 -172.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 53.36 26.43 29.75 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.493 1.52 . . . . 0.0 114.503 -175.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.1 t -64.13 156.26 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 125.19 1.396 . . . . 0.0 108.692 174.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -141.1 173.93 11.01 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 125.343 1.457 . . . . 0.0 109.485 174.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 68.2 mt -101.18 117.69 61.72 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 124.741 1.216 . . . . 0.0 108.953 -169.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.21 -40.52 69.29 Favored 'Trans proline' 0 CA--C 1.548 1.224 0 C-N-CA 122.367 2.045 . . . . 0.0 114.88 169.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.58 -178.98 4.07 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 121.879 1.72 . . . . 0.0 114.073 -175.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -52.94 -14.48 0.58 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 128.427 2.691 . . . . 0.0 114.055 -178.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -64.65 8.7 0.11 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.115 1.766 . . . . 0.0 113.03 170.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.7 p -122.1 2.87 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 124.845 1.258 . . . . 0.0 111.652 172.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.9 p -128.05 23.48 6.09 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.212 1.005 . . . . 0.0 112.149 -173.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -88.58 179.87 6.19 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.621 0.768 . . . . 0.0 109.313 170.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -59.69 -33.6 71.79 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.23 1.012 . . . . 0.0 113.246 -171.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.9 mt -134.76 135.67 53.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 177.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -140.43 133.69 29.7 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 169.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -144.81 157.91 43.99 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.001 1.32 . . . . 0.0 107.573 168.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -119.48 117.54 28.71 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.7 1.2 . . . . 0.0 108.496 168.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -93.92 108.65 20.43 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.218 1.407 . . . . 0.0 109.543 -173.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -72.54 105.57 4.25 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.727 1.211 . . . . 0.0 108.511 178.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -135.76 151.94 50.62 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 125.038 1.335 . . . . 0.0 108.855 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -82.98 75.91 9.84 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.735 1.214 . . . . 0.0 110.657 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -21.92 98.86 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 128.096 2.558 . . . . 0.0 112.466 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.406 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 53.0 Cg_exo -60.81 -4.5 3.62 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 124.44 3.427 . . . . 0.0 116.785 -169.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -56.47 101.07 0.05 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.182 1.355 . . . . 0.0 111.485 177.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.37 18.24 55.66 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 126.096 1.808 . . . . 0.0 113.389 170.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.406 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 26.9 mm-40 -94.41 178.34 5.65 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.652 1.226 . . . . 0.0 112.763 -169.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.2 m -75.18 154.79 37.49 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.477 1.511 . . . . 0.0 109.955 175.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 93.5 mt -57.47 -32.6 67.13 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.017 -0.427 . . . . 0.0 111.479 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.98 -40.29 94.75 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.858 0.463 . . . . 0.0 110.874 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 88.6 t -65.26 -48.31 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 175.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.505 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 6.4 m-85 -53.94 -52.43 60.65 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.281 0.632 . . . . 0.0 110.954 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -60.97 -43.79 98.28 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.74 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.1 m -61.5 -50.78 71.36 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 118.867 0.758 . . . . 0.0 109.183 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 66.3 t -66.71 -43.67 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-O 118.349 -0.834 . . . . 0.0 110.153 -178.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.62 -43.38 89.64 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 119.966 1.257 . . . . 0.0 110.242 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.66 -49.03 71.97 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-O 118.595 -1.114 . . . . 0.0 111.244 176.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -59.96 -51.87 67.82 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 118.701 1.251 . . . . 0.0 110.884 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 64.4 t -52.78 -48.51 49.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 124.804 1.242 . . . . 0.0 109.959 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -60.02 -47.38 86.08 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.86 1.209 . . . . 0.0 110.399 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.04 -42.76 81.06 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.943 0.897 . . . . 0.0 110.341 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -70.6 -43.43 69.38 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 118.19 -0.909 . . . . 0.0 109.961 -176.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 74.6 t -53.83 -48.19 62.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 120.282 1.401 . . . . 0.0 109.661 169.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -59.48 -40.37 86.76 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.449 1.022 . . . . 0.0 110.559 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -62.54 -46.07 90.07 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.307 1.043 . . . . 0.0 110.316 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.38 -49.56 76.42 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 124.099 0.96 . . . . 0.0 109.488 178.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.88 -37.49 67.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.679 1.191 . . . . 0.0 110.795 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.52 -31.12 71.12 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.889 1.222 . . . . 0.0 111.328 -174.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -70.8 -20.15 62.62 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.689 1.595 . . . . 0.0 112.872 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.9 pt -125.28 -21.04 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -168.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 C--O 1.249 1.028 0 C-N-CA 126.186 1.795 . . . . 0.0 111.174 173.684 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.4 ttm . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.855 0.359 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 49.0 mmtt -118.26 132.59 56.29 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 175.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -92.06 137.71 32.14 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.3 p -122.47 143.83 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 121.866 0.841 . . . . 0.0 109.457 -178.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 31.2 tpp -124.38 141.88 51.73 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.368 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -121.67 125.01 45.64 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 170.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.7 t -128.69 129.53 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 120.402 1.456 . . . . 0.0 109.351 -169.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.8 t -137.84 161.05 37.61 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 119.528 1.058 . . . . 0.0 112.473 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.8 mttt -58.76 -21.42 55.58 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.854 1.262 . . . . 0.0 110.884 168.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.4 ptp85 -147.94 101.23 3.28 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 126.096 1.759 . . . . 0.0 107.05 169.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -44.65 -42.46 7.52 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.013 1.325 . . . . 0.0 112.2 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.7 p -45.21 -20.91 0.06 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 129.599 3.159 . . . . 0.0 118.266 -169.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.4 p -130.65 -74.73 0.53 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.953 1.251 . . . . 0.0 110.647 -171.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -61.22 -52.08 66.29 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -169.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.41 -42.94 78.26 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.425 0.29 . . . . 0.0 111.125 -178.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -59.3 -45.66 90.68 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.603 0.761 . . . . 0.0 111.579 -174.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 44.2 mtm -63.97 -46.6 83.91 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 117.78 0.264 . . . . 0.0 110.903 175.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.8 -39.04 76.61 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 117.606 0.185 . . . . 0.0 110.925 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.452 ' HA ' HG21 ' A' ' 32' ' ' VAL . 33.3 tt0 -63.43 -45.44 90.93 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 122.549 0.34 . . . . 0.0 111.163 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.24 -40.07 96.45 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -175.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -66.66 -46.44 75.68 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 118.146 0.973 . . . . 0.0 108.923 174.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.49 -44.04 84.62 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 119.338 0.972 . . . . 0.0 112.591 -173.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -67.93 -38.4 82.83 Favored 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 119.246 -0.982 . . . . 0.0 111.049 174.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.1 m -66.89 -43.4 83.54 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 120.478 1.49 . . . . 0.0 110.504 -177.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.1 -37.7 53.77 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.076 1.35 . . . . 0.0 111.184 -173.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -129.57 -0.3 5.77 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-O 116.55 -2.25 . . . . 0.0 117.582 -169.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.75 105.93 0.25 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 121.582 2.691 . . . . 0.0 108.549 169.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 140.98 -30.29 2.27 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.025 1.298 . . . . 0.0 111.358 -169.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.26 -24.63 4.62 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.486 1.114 . . . . 0.0 111.409 169.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.5 pt -125.71 159.0 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 123.464 0.706 . . . . 0.0 111.295 176.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -126.1 130.8 51.79 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 169.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.452 HG21 ' HA ' ' A' ' 19' ' ' GLU . 3.0 p -117.76 152.28 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 C-N-CA 123.331 0.652 . . . . 0.0 111.582 -171.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.4 m -151.69 135.4 16.31 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 167.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 89.0 p -97.43 161.82 13.61 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 121.207 -0.933 . . . . 0.0 109.795 169.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.8 p -151.85 -165.77 2.32 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 169.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.63 165.78 37.0 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 169.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 61.5 mt -54.99 -30.58 59.67 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.825 0.85 . . . . 0.0 110.5 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -148.82 145.96 27.77 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 168.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.2 p -89.55 152.56 21.35 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.593 0.757 . . . . 0.0 111.16 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.8 m -147.52 154.89 41.31 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.748 2.019 . . . . 0.0 106.276 170.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -57.89 148.49 25.36 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.933 0.788 . . . . 0.0 109.702 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 26.9 t -57.95 130.47 21.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -176.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -66.21 136.4 95.28 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -177.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.46 -40.24 6.05 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.273 1.982 . . . . 0.0 113.409 -168.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.502 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 6.1 m -68.0 -17.84 64.54 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.366 -0.834 . . . . 0.0 111.826 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.416 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -59.06 -41.27 87.52 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 121.679 -0.638 . . . . 0.0 110.026 171.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.08 -42.37 94.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.44 -38.92 85.65 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -177.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 21.9 mmt -61.85 -47.49 84.8 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 122.813 1.292 . . . . 0.0 111.326 176.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.0 mtp -69.41 -33.58 73.2 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.368 -178.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -61.95 -29.84 70.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.863 0.865 . . . . 0.0 111.128 172.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -64.98 -39.31 93.28 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.734 0.697 . . . . 0.0 110.328 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 62.1 t -78.67 -23.38 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.935 178.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.95 25.97 5.7 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.109 1.338 . . . . 0.0 112.034 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.429 HG22 ' H ' ' A' ' 56' ' ' ASP . 11.3 mt -124.64 176.84 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 125.688 1.595 . . . . 0.0 107.662 -176.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.429 ' H ' HG22 ' A' ' 55' ' ' ILE . 7.2 t70 -140.65 157.87 44.81 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.137 1.775 . . . . 0.0 108.605 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.416 HD12 ' HB1' ' A' ' 46' ' ' ALA . 0.9 OUTLIER -128.21 -20.18 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.649 0.78 . . . . 0.0 113.009 171.195 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 55.3 p -51.84 -33.36 35.72 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.198 0.908 . . . . 0.0 112.441 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.92 -24.75 59.33 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-O 118.024 -1.431 . . . . 0.0 114.324 -176.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -86.95 -27.41 23.33 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 120.122 1.961 . . . . 0.0 114.953 -169.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 29.2 p 65.87 176.6 0.22 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.719 1.608 . . . . 0.0 113.459 173.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.2 m -102.13 162.13 13.15 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.45 1.1 . . . . 0.0 112.202 -169.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -156.3 134.42 7.18 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-O 118.273 -0.87 . . . . 0.0 109.071 -174.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -80.07 156.24 23.12 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.973 2.448 . . . . 0.0 111.771 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.7 tt -56.7 -33.88 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 123.773 0.829 . . . . 0.0 111.419 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -58.28 -23.13 55.23 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.2 1.8 . . . . 0.0 112.222 -174.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -82.45 -3.17 55.25 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.094 0.958 . . . . 0.0 112.693 -176.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -129.51 177.27 7.32 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 119.916 1.235 . . . . 0.0 112.556 -173.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.43 141.63 50.53 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 128.05 2.54 . . . . 0.0 106.493 170.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.35 -23.9 62.0 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.084 0.954 . . . . 0.0 111.91 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -60.48 -23.09 64.21 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.012 0.925 . . . . 0.0 112.412 -175.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -81.59 -15.85 53.44 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.032 0.933 . . . . 0.0 110.894 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -107.84 128.0 54.22 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.698 1.599 . . . . 0.0 109.65 -172.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -72.44 -40.36 67.13 Favored 'General case' 0 C--O 1.232 0.152 0 O-C-N 121.954 -0.467 . . . . 0.0 110.331 174.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -130.28 135.4 60.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 122.908 0.483 . . . . 0.0 109.927 -170.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.7 t -122.62 119.05 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 122.413 1.101 . . . . 0.0 108.916 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 35.9 mm -108.45 96.7 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.3 t -70.18 156.39 39.29 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 168.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.19 40.32 0.78 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 172.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 85.6 m -63.31 -20.31 65.37 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.028 0.931 . . . . 0.0 111.55 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.5 -59.86 0.45 Allowed Glycine 0 C--N 1.332 0.309 0 C-N-CA 125.289 1.423 . . . . 0.0 111.322 168.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 74.2 m -81.03 30.14 0.33 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 117.703 0.751 . . . . 0.0 113.006 -172.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.93 28.57 68.83 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.6 1.095 . . . . 0.0 111.964 -175.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 85' ' ' ASN . 2.4 t -68.72 169.07 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.769 1.228 . . . . 0.0 108.999 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.418 ' H ' HG12 ' A' ' 84' ' ' VAL . 7.7 t-20 -135.7 172.49 12.94 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.878 1.271 . . . . 0.0 110.092 -175.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.6 mt -124.34 83.87 56.77 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 -170.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -45.41 -33.13 8.67 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.422 2.748 . . . . 0.0 117.103 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -64.6 -173.2 0.22 Allowed 'Trans proline' 0 C--N 1.356 0.928 0 CA-C-N 122.177 1.813 . . . . 0.0 114.296 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -47.69 -19.45 0.21 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.613 1.965 . . . . 0.0 114.745 170.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -59.52 -3.96 0.54 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.074 2.15 . . . . 0.0 114.467 171.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.9 p -119.82 -5.62 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 119.545 1.066 . . . . 0.0 112.754 171.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.2 p -102.94 18.12 22.37 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.623 1.101 . . . . 0.0 111.919 -172.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -87.51 -176.96 5.78 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.487 1.115 . . . . 0.0 109.304 172.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -68.22 -32.66 73.02 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -169.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.2 mt -136.61 140.14 43.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -176.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -142.4 139.45 31.67 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.691 1.196 . . . . 0.0 108.661 171.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -147.07 159.68 43.31 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.935 1.694 . . . . 0.0 107.942 168.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -121.72 105.6 10.55 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.06 1.344 . . . . 0.0 108.728 168.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.43 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 43.1 m0 -78.38 93.16 4.66 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.067 0.947 . . . . 0.0 109.315 -178.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -60.67 119.93 9.06 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 169.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.8 mt -150.05 152.15 34.37 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.541 1.536 . . . . 0.0 107.529 -169.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -82.47 64.15 6.98 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 125.073 1.349 . . . . 0.0 111.142 -176.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -10.34 94.85 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 128.762 2.825 . . . . 0.0 113.804 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.506 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 76.2 Cg_exo -58.66 -9.95 8.31 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 124.081 3.187 . . . . 0.0 116.549 -173.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -54.81 101.99 0.06 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 120.262 1.392 . . . . 0.0 111.804 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.87 21.63 42.11 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.279 1.895 . . . . 0.0 113.433 172.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.506 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 18.5 mm-40 -102.07 178.12 4.7 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.839 1.319 . . . . 0.0 113.67 -169.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.2 m -78.73 156.07 29.08 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.204 1.802 . . . . 0.0 110.19 175.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 96.5 mt -60.3 -30.19 69.32 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.772 -0.58 . . . . 0.0 111.951 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.51 -39.07 93.1 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.326 0.512 . . . . 0.0 110.777 176.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 95.3 t -67.46 -45.9 84.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.502 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 12.1 m-85 -55.55 -51.8 65.86 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 118.902 -0.571 . . . . 0.0 110.547 176.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -59.19 -42.11 90.09 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.913 0.779 . . . . 0.0 111.919 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.8 m -61.52 -51.1 70.01 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.052 0.842 . . . . 0.0 109.627 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.7 t -65.46 -43.87 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 117.87 -1.062 . . . . 0.0 110.234 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -55.18 -45.01 75.78 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 119.821 1.191 . . . . 0.0 109.214 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.42 -49.9 72.34 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-O 118.214 -1.326 . . . . 0.0 110.409 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -60.07 -56.43 21.72 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 118.574 1.187 . . . . 0.0 110.423 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.9 t -46.62 -52.46 3.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 125.694 1.597 . . . . 0.0 110.444 176.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -63.61 -46.55 85.23 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 119.708 1.14 . . . . 0.0 110.114 -175.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -43.14 85.04 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.272 0.629 . . . . 0.0 110.197 178.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.43 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 79.6 mtt-85 -69.87 -42.74 73.1 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.894 -176.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 72.9 t -54.12 -49.18 63.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 120.393 1.451 . . . . 0.0 109.516 169.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -59.78 -39.85 86.27 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 119.448 1.022 . . . . 0.0 110.625 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -63.42 -45.9 88.83 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.328 1.051 . . . . 0.0 110.224 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -47.93 80.06 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 124.082 0.953 . . . . 0.0 109.815 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 61.8 mt -57.3 -38.49 62.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 124.703 1.201 . . . . 0.0 110.562 176.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.2 -28.94 69.51 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.776 1.171 . . . . 0.0 111.488 -173.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -73.66 -19.51 60.81 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.879 1.672 . . . . 0.0 112.731 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 pt -125.67 -20.1 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 126.151 1.78 . . . . 0.0 114.921 -168.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.3 m . . . . . 0 C--O 1.251 1.138 0 C-N-CA 126.432 1.893 . . . . 0.0 110.907 170.015 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.4 ttm . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 120.919 0.39 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 51.3 mmtt -119.99 134.64 55.19 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 107.354 -1.351 . . . . 0.0 107.354 175.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.7 mttt -94.51 135.86 35.46 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.2 p -121.68 144.55 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-O 121.885 0.85 . . . . 0.0 109.548 -176.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 29.6 tpp -124.23 142.2 51.44 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.493 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -123.41 111.37 16.27 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.4 t -111.65 117.06 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 119.611 1.096 . . . . 0.0 108.546 -173.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.9 t -108.05 165.19 11.65 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.713 0.768 . . . . 0.0 110.824 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -59.03 -16.22 17.41 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.701 0.8 . . . . 0.0 111.875 169.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -158.62 115.69 2.81 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 128.241 2.616 . . . . 0.0 103.975 178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -65.02 40.27 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.751 1.62 . . . . 0.0 113.063 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.5 p -122.75 -20.37 5.93 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 119.839 -1.788 . . . . 0.0 113.559 -169.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 82.5 m -132.71 -89.06 0.42 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.595 0.634 . . . . 0.0 111.438 -169.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -56.3 -46.84 79.62 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 118.881 0.764 . . . . 0.0 110.555 -169.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 13.3 p -68.87 -37.53 79.11 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.584 1.153 . . . . 0.0 111.583 -174.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -66.08 -47.71 73.35 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.704 0.802 . . . . 0.0 109.927 -174.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 69.1 mtm -63.77 -46.16 86.51 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 119.434 -0.317 . . . . 0.0 110.645 176.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.85 -42.4 71.94 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 123.043 0.215 . . . . 0.0 110.822 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -65.29 -47.1 77.83 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 123.02 0.2 . . . . 0.0 110.807 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.63 -38.08 95.72 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -175.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -65.19 -49.75 68.55 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 174.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.09 -43.39 82.15 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 124.228 1.011 . . . . 0.0 113.079 -172.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -67.47 -37.79 83.46 Favored 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 118.926 -1.109 . . . . 0.0 111.048 174.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.4 m -68.1 -42.16 80.72 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 120.404 1.456 . . . . 0.0 110.481 -177.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.0 mt -75.44 -38.41 59.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.733 1.613 . . . . 0.0 111.555 -175.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -131.17 0.32 5.22 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-O 116.732 -2.149 . . . . 0.0 117.98 -169.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.58 107.29 0.37 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 121.421 2.61 . . . . 0.0 108.629 169.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 140.06 -30.59 2.34 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.953 1.263 . . . . 0.0 111.349 -169.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.31 -24.47 4.64 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.454 1.101 . . . . 0.0 111.51 170.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.2 pt -125.55 158.01 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 123.298 0.639 . . . . 0.0 111.247 176.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -125.34 131.23 53.04 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 169.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -117.29 152.78 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 123.32 0.648 . . . . 0.0 111.806 -170.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.9 m -148.5 134.42 19.07 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 167.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' ' 15' ' ' SER . 88.4 p -96.99 159.31 14.98 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 120.692 -1.255 . . . . 0.0 107.949 168.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.1 m -153.22 -170.3 3.57 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 176.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.78 164.96 33.91 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 169.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.4 mt -52.32 -30.1 26.71 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 124.627 0.84 . . . . 0.0 110.348 170.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -143.0 148.51 36.9 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 169.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 p -72.46 154.74 40.7 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.25 0.62 . . . . 0.0 109.552 169.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.9 m -159.78 147.1 16.67 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 169.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -58.64 147.66 31.8 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.471 0.578 . . . . 0.0 109.856 -177.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -60.19 129.58 22.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.405 ' CE1' ' H ' ' A' ' 106' ' ' GLY . 23.1 t-80 -70.27 139.85 87.46 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.63 -38.83 5.42 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.238 1.959 . . . . 0.0 113.315 -168.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.536 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 8.2 m -68.04 -17.16 64.32 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.315 -0.866 . . . . 0.0 111.647 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.433 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -59.04 -40.62 85.61 Favored 'General case' 0 C--N 1.341 0.229 0 O-C-N 121.456 -0.778 . . . . 0.0 110.26 171.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.9 mp -62.97 -42.15 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -178.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.34 -37.39 83.14 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 20.5 mmt -62.13 -47.02 86.44 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 122.921 1.343 . . . . 0.0 111.197 175.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 9.3 mtp -70.09 -31.81 69.56 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.61 -177.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -61.57 -29.13 69.82 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.495 0.718 . . . . 0.0 111.36 169.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -65.83 -35.98 82.2 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.083 0.856 . . . . 0.0 110.475 173.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.4 t -78.96 -26.02 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 117.512 0.142 . . . . 0.0 110.916 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.48 28.19 6.48 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.723 1.154 . . . . 0.0 111.818 -175.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.579 HG22 ' H ' ' A' ' 56' ' ' ASP . 6.5 mt -125.66 -177.57 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 126.018 1.727 . . . . 0.0 107.163 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.579 ' H ' HG22 ' A' ' 55' ' ' ILE . 3.6 t70 -147.03 158.38 43.91 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.589 1.955 . . . . 0.0 108.355 -178.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.433 HD12 ' HB1' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -130.57 -13.2 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 173.571 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.5 p -51.22 -29.31 13.84 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.534 1.061 . . . . 0.0 113.43 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.24 -13.94 65.05 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 118.121 -1.377 . . . . 0.0 114.249 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -74.51 -29.9 61.59 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 120.281 2.041 . . . . 0.0 113.137 -173.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.7 p 59.74 -163.49 0.23 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.482 0.713 . . . . 0.0 109.689 -169.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.5 m -138.07 156.15 48.07 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.937 -173.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -153.44 135.87 9.38 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.319 1.048 . . . . 0.0 109.106 -169.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.89 153.64 22.62 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.466 2.11 . . . . 0.0 111.272 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.6 tt -53.54 -34.09 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.831 0.852 . . . . 0.0 111.486 174.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -57.51 -23.55 50.85 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.079 1.752 . . . . 0.0 112.503 -176.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -86.15 -7.43 58.57 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.736 0.814 . . . . 0.0 112.872 -174.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -121.77 -176.38 3.31 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.459 1.027 . . . . 0.0 110.523 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -133.96 130.58 37.86 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 126.26 1.824 . . . . 0.0 108.439 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.27 -30.43 68.29 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.708 1.203 . . . . 0.0 112.742 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.63 -21.73 63.05 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.066 0.947 . . . . 0.0 112.571 -175.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -85.52 -13.83 47.8 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.452 0.701 . . . . 0.0 111.012 -177.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -109.22 125.17 51.96 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.735 1.214 . . . . 0.0 109.852 -172.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -72.14 -41.38 67.22 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 122.474 0.31 . . . . 0.0 110.229 175.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.65 134.61 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 122.959 0.504 . . . . 0.0 109.898 -169.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.8 t -125.56 111.18 26.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 123.091 1.424 . . . . 0.0 108.64 -177.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.9 mm -100.25 99.26 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 177.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.8 t -72.31 156.81 38.71 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 167.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.57 54.78 0.68 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 103.394 -2.817 . . . . 0.0 103.394 173.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 83.5 m -85.55 -34.81 21.41 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.111 173.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.58 174.2 50.22 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 94.0 m 39.78 32.55 0.11 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.954 2.102 . . . . 0.0 114.009 -170.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.1 22.15 54.77 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.808 1.67 . . . . 0.0 114.599 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 79.2 t -62.67 141.42 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 169.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -135.62 -179.47 5.67 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.304 1.042 . . . . 0.0 109.699 -169.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 49.1 mt -113.46 108.38 52.23 Favored Pre-proline 0 N--CA 1.453 -0.286 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -170.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -50.22 -42.31 47.42 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 122.494 2.129 . . . . 0.0 115.097 169.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.22 179.65 5.93 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 121.834 1.69 . . . . 0.0 113.873 -174.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -56.46 -13.02 1.97 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 127.713 2.405 . . . . 0.0 113.826 -172.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -57.0 -25.76 59.04 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.31 1.044 . . . . 0.0 112.039 173.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.6 p -83.63 -16.18 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 119.625 1.102 . . . . 0.0 110.179 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.7 p -106.51 17.92 22.65 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.917 0.887 . . . . 0.0 112.266 -170.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -78.81 179.12 7.42 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.593 0.757 . . . . 0.0 109.764 171.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -63.61 -31.96 73.28 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -169.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.6 mt -135.64 137.49 49.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -142.21 139.15 31.93 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.228 1.011 . . . . 0.0 108.448 171.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -146.93 161.78 40.06 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.663 1.585 . . . . 0.0 108.003 168.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -122.53 100.77 7.1 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.742 1.617 . . . . 0.0 108.653 168.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.459 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 40.2 m0 -76.27 91.15 3.19 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.558 1.143 . . . . 0.0 108.594 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -64.99 100.65 0.44 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.768 1.227 . . . . 0.0 109.734 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -129.83 155.34 46.15 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.006 1.323 . . . . 0.0 110.856 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -78.06 80.77 4.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.061 1.744 . . . . 0.0 110.125 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -35.69 108.76 0.38 Allowed Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 126.318 1.847 . . . . 0.0 112.652 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.433 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 54.2 Cg_exo -60.26 -2.53 1.87 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 125.13 3.887 . . . . 0.0 117.579 -171.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -53.57 98.4 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 120.495 1.498 . . . . 0.0 112.435 175.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.405 ' H ' ' CE1' ' A' ' 43' ' ' HIS . . . 87.6 18.73 56.24 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 126.406 1.955 . . . . 0.0 112.963 171.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.433 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 24.1 mm-40 -95.33 177.21 5.92 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.69 1.245 . . . . 0.0 112.601 -169.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.9 m -74.93 154.91 37.95 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.48 1.512 . . . . 0.0 109.798 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.6 mt -59.5 -29.8 68.11 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.861 -0.524 . . . . 0.0 111.717 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.61 -39.0 92.39 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.226 0.466 . . . . 0.0 110.876 175.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 82.3 t -68.13 -46.55 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 176.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.536 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 17.8 m-85 -55.07 -50.65 68.62 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 119.283 -0.389 . . . . 0.0 110.89 176.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -60.54 -42.13 95.9 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.931 0.893 . . . . 0.0 111.972 177.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 93.6 m -60.82 -51.73 68.08 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 119.156 0.889 . . . . 0.0 109.147 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 74.6 t -61.61 -47.09 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-O 117.891 -1.052 . . . . 0.0 109.81 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 38.6 ttp85 -53.57 -51.41 63.04 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 119.661 1.118 . . . . 0.0 108.967 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.55 -48.48 72.82 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -173.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -60.91 -52.6 64.34 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.856 0.862 . . . . 0.0 110.402 -177.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.0 t -57.98 -49.59 80.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 125.369 1.467 . . . . 0.0 110.325 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -58.25 -48.05 81.65 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 121.034 1.743 . . . . 0.0 110.623 -178.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.98 -45.26 71.35 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.207 1.003 . . . . 0.0 110.505 174.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.459 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 49.9 mtt85 -70.59 -39.87 73.58 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 117.869 -1.062 . . . . 0.0 111.024 -177.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 80.9 t -54.47 -49.14 67.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 120.515 1.507 . . . . 0.0 109.349 169.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -60.47 -39.64 88.34 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.349 0.977 . . . . 0.0 110.58 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -62.81 -45.92 90.36 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.335 1.054 . . . . 0.0 110.464 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.69 -47.95 79.1 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 124.342 1.057 . . . . 0.0 109.714 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.4 mt -57.07 -38.48 60.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.544 1.137 . . . . 0.0 110.591 175.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.28 -28.93 69.54 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.875 1.216 . . . . 0.0 111.5 -173.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -73.64 -19.68 60.78 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.969 1.708 . . . . 0.0 112.79 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.4 pt -125.43 -20.21 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 126.175 1.79 . . . . 0.0 114.826 -168.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 C--O 1.248 1.013 0 C-N-CA 126.571 1.948 . . . . 0.0 110.857 170.005 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.1 ttm . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 120.564 0.221 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -115.68 145.61 42.59 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.972 0.909 . . . . 0.0 109.18 170.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -97.17 118.77 34.35 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 172.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.468 ' HA ' HG13 ' A' ' 75' ' ' VAL . 8.9 p -101.37 138.38 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 O-C-N 123.688 0.617 . . . . 0.0 110.716 173.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 37.9 tpp -116.2 143.72 45.14 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 169.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -115.96 140.71 48.99 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.274 1.43 . . . . 0.0 108.149 169.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.7 t -146.4 129.87 9.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -170.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -133.83 172.16 13.17 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.098 0.863 . . . . 0.0 109.817 169.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -66.31 -12.11 54.64 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.42 -0.8 . . . . 0.0 112.946 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.1 ptm85 -155.23 106.17 2.57 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 171.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -46.99 -28.08 1.52 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.464 1.905 . . . . 0.0 114.135 -177.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -30.12 -42.39 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 129.81 3.244 . . . . 0.0 118.183 -169.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.7 p -136.25 -68.37 0.5 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 117.686 -1.149 . . . . 0.0 113.919 -169.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.5 ptt-85 -56.62 -48.7 76.91 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.507 1.503 . . . . 0.0 110.76 -172.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.83 -51.44 70.0 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.67 0.788 . . . . 0.0 110.121 176.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 -62.55 -44.88 95.26 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.68 0.792 . . . . 0.0 111.769 -173.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 51.4 mtm -62.87 -45.72 91.23 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.916 0.486 . . . . 0.0 110.384 175.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.99 -37.99 75.29 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 119.434 -0.317 . . . . 0.0 110.393 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -61.13 -50.03 74.88 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.4 0.68 . . . . 0.0 110.258 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.57 -44.69 94.71 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 119.348 -0.695 . . . . 0.0 111.866 -177.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -65.84 -46.98 76.54 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 118.773 1.286 . . . . 0.0 108.646 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.16 -43.3 87.32 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 119.779 1.172 . . . . 0.0 112.54 -175.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -68.26 -35.59 78.12 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.786 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.3 m -67.74 -42.43 81.86 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 120.047 -1.658 . . . . 0.0 110.758 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.9 mt -73.05 -40.1 65.39 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.031 1.732 . . . . 0.0 111.036 -174.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -136.26 4.92 3.84 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 116.749 -2.14 . . . . 0.0 117.964 -169.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.46 115.68 2.65 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 121.643 2.721 . . . . 0.0 108.974 171.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 124.84 -24.9 5.96 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.59 1.09 . . . . 0.0 111.56 -173.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.21 -19.89 3.84 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.365 1.066 . . . . 0.0 111.456 176.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.3 pt -130.88 155.27 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 168.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.72 130.3 56.64 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 169.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.7 p -113.94 151.83 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-O 121.882 0.848 . . . . 0.0 111.911 -175.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.1 m -144.15 152.59 41.12 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 126.214 1.806 . . . . 0.0 106.206 167.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.0 p -129.26 157.07 42.9 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.135 0.974 . . . . 0.0 108.803 168.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.6 p -158.53 -161.39 0.98 Allowed 'General case' 0 C--O 1.241 0.642 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.66 163.96 33.35 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 169.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 65.3 mt -53.36 -31.79 46.23 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.37 1.068 . . . . 0.0 110.727 177.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -143.14 145.04 32.47 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 168.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.9 p -75.66 165.65 24.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.911 0.863 . . . . 0.0 111.567 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.5 p -150.03 -132.27 0.05 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.542 1.537 . . . . 0.0 106.957 177.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -144.55 157.73 44.09 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 171.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.5 t -65.24 131.6 31.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -177.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -71.99 138.54 82.22 Favored Pre-proline 0 N--CA 1.446 -0.65 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.96 -38.17 5.47 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 CA-C-N 120.423 1.187 . . . . 0.0 111.694 -169.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.493 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 8.6 m -67.59 -19.12 65.21 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.56 -1.338 . . . . 0.0 112.094 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.48 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -58.15 -39.2 78.17 Favored 'General case' 0 C--O 1.231 0.084 0 O-C-N 121.502 -0.749 . . . . 0.0 110.494 172.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.6 mt -58.37 -47.73 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.51 -40.33 91.04 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.808 0.843 . . . . 0.0 111.837 -175.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.2 mmt -60.26 -48.61 81.03 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.517 1.151 . . . . 0.0 111.21 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 9.3 mtp -69.04 -35.34 76.48 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.914 -178.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -61.18 -30.51 70.45 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.824 0.738 . . . . 0.0 111.55 172.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -63.22 -39.58 95.03 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.026 0.83 . . . . 0.0 110.384 173.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.1 t -79.76 -18.65 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-O 119.888 -0.101 . . . . 0.0 111.098 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.13 26.35 8.91 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.552 1.073 . . . . 0.0 111.816 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.607 HG22 ' H ' ' A' ' 56' ' ' ASP . 10.7 mt -122.09 -176.13 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 126.078 1.751 . . . . 0.0 106.505 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.607 ' H ' HG22 ' A' ' 55' ' ' ILE . 8.4 t70 -149.68 155.58 40.44 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 120.406 -1.434 . . . . 0.0 109.632 -177.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.48 HD12 ' HB1' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -130.49 -13.61 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.061 0.945 . . . . 0.0 112.538 169.465 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 99.7 p -52.99 -30.83 37.43 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.659 1.118 . . . . 0.0 112.432 176.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.14 -7.11 87.76 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 118.526 -1.152 . . . . 0.0 114.366 -176.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -125.3 169.9 11.84 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.37 1.585 . . . . 0.0 110.93 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 19.2 p -127.58 164.47 21.93 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.231 1.012 . . . . 0.0 112.365 -169.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.4 m -78.98 156.91 28.25 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.567 1.147 . . . . 0.0 110.953 171.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -155.42 145.14 15.46 Favored Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 123.935 0.894 . . . . 0.0 109.542 -177.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -80.32 151.94 20.56 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.246 1.964 . . . . 0.0 111.113 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.1 tt -54.25 -34.92 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.658 0.783 . . . . 0.0 111.442 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -60.59 -21.58 62.78 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.689 1.595 . . . . 0.0 112.471 -174.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -79.77 -5.54 55.52 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.564 0.746 . . . . 0.0 112.562 -177.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -124.76 -175.83 3.38 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.539 1.136 . . . . 0.0 110.651 -178.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.49 127.19 25.34 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 126.563 1.945 . . . . 0.0 107.583 176.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.79 -27.74 63.37 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.604 1.162 . . . . 0.0 112.447 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -59.82 -23.47 63.37 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.33 1.052 . . . . 0.0 112.739 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -85.0 -14.18 48.26 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.421 0.689 . . . . 0.0 110.72 -177.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -104.54 126.21 51.42 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 125.222 1.409 . . . . 0.0 109.012 -174.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.94 -42.63 76.45 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.468 HG13 ' HA ' ' A' ' 4' ' ' VAL . 1.8 p -130.99 136.08 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 C-N-CA 122.9 0.48 . . . . 0.0 109.918 -169.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.5 m -127.66 120.3 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-O 122.363 1.078 . . . . 0.0 108.651 -172.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.6 mm -116.72 102.84 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-N 115.006 -0.997 . . . . 0.0 108.389 -169.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.9 t -74.37 153.68 39.16 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 168.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.79 36.48 0.4 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 171.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 77.4 m -56.48 -43.98 80.18 Favored 'General case' 0 C--N 1.339 0.128 0 O-C-N 120.92 -1.113 . . . . 0.0 112.151 -169.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.43 165.96 36.4 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 -173.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 13.0 p 36.33 34.1 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.927 2.091 . . . . 0.0 115.42 -171.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.4 15.91 68.69 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.177 0.894 . . . . 0.0 114.867 176.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.0 t -67.13 156.17 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 169.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -143.55 -172.85 3.8 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.574 1.55 . . . . 0.0 109.076 -173.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 53.3 mt -117.51 100.04 52.6 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 125.255 1.422 . . . . 0.0 107.965 -169.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.82 -43.11 58.72 Favored 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 122.814 2.342 . . . . 0.0 115.828 172.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -75.51 -175.39 2.41 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.061 1.841 . . . . 0.0 113.131 -174.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -53.28 -12.89 0.45 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 128.706 2.802 . . . . 0.0 114.551 -175.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 56.1 m95 -67.44 11.29 0.13 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.628 1.971 . . . . 0.0 112.725 171.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.0 p -121.95 4.04 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 125.229 1.412 . . . . 0.0 111.651 169.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 36.3 p -131.71 25.9 4.7 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.17 -0.956 . . . . 0.0 112.602 -172.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -91.54 -170.72 2.69 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 170.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -64.55 -32.06 73.54 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.295 0.638 . . . . 0.0 112.235 -170.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.3 mt -137.9 138.3 44.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -134.61 134.88 41.73 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 169.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -141.25 152.06 44.23 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 169.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -119.95 124.74 46.72 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.448 1.099 . . . . 0.0 109.143 169.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.411 ' CZ3' ' HG2' ' A' ' 122' ' ' ARG . 66.1 m95 -107.76 86.64 2.33 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -54.82 125.11 18.79 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 169.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 25.0 mt -149.06 156.12 41.76 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.618 1.567 . . . . 0.0 107.4 -169.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -82.4 60.93 5.33 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.725 1.21 . . . . 0.0 111.151 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.3 t0 4.53 85.97 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.469 0 C-N-CA 129.348 3.059 . . . . 0.0 112.141 169.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.458 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 74.8 Cg_exo -61.56 -8.14 10.35 Favored 'Trans proline' 0 C--N 1.352 0.748 0 N-CA-C 116.71 1.773 . . . . 0.0 116.71 -169.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -61.04 95.98 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.848 1.204 . . . . 0.0 111.27 -177.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.5 16.1 25.55 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.243 1.878 . . . . 0.0 113.361 172.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.458 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 25.2 mm-40 -95.76 178.12 5.56 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.925 1.362 . . . . 0.0 113.167 -169.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.4 m -76.55 155.73 33.43 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.985 1.714 . . . . 0.0 110.143 174.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 97.0 mt -58.53 -32.5 68.92 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.853 -0.529 . . . . 0.0 111.621 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -71.15 -33.82 70.42 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.126 0.421 . . . . 0.0 110.852 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 72.1 t -65.82 -45.75 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 172.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.493 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 13.6 m-85 -57.38 -49.8 75.03 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 118.609 -0.71 . . . . 0.0 110.52 176.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 60.9 mtt180 -57.6 -43.35 84.61 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.425 1.011 . . . . 0.0 111.808 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 89.4 m -61.15 -53.58 55.24 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 50.4 t -63.58 -41.62 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.558 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -56.64 -48.36 77.7 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 120.205 1.366 . . . . 0.0 109.225 177.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.66 -45.31 96.54 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -59.31 -60.83 3.23 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 123.756 0.823 . . . . 0.0 109.017 177.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.4 t -45.29 -51.62 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 126.752 2.021 . . . . 0.0 110.974 177.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -63.54 -46.54 85.5 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 120.008 1.276 . . . . 0.0 110.38 -175.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.26 -42.12 85.75 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.708 0.803 . . . . 0.0 110.237 176.005 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.411 ' HG2' ' CZ3' ' A' ' 99' ' ' TRP . 82.9 mtt180 -69.33 -43.13 74.34 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.292 1.037 . . . . 0.0 109.914 -175.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 71.5 t -54.79 -48.97 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 119.427 1.012 . . . . 0.0 110.068 168.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -60.67 -38.96 86.66 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 120.017 1.281 . . . . 0.0 111.197 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -63.66 -44.38 93.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.439 1.096 . . . . 0.0 110.201 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.11 -40.8 67.91 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.101 -179.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.7 mt -51.88 -43.23 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 124.004 0.921 . . . . 0.0 108.697 169.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.15 -29.81 70.61 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.674 1.125 . . . . 0.0 111.494 -173.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -71.8 -44.8 63.33 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.121 1.368 . . . . 0.0 110.761 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 pt -85.02 -29.07 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.895 1.278 . . . . 0.0 113.89 -173.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.5 m . . . . . 0 C--O 1.249 1.053 0 C-N-CA 126.161 1.785 . . . . 0.0 111.102 179.693 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.8 ttm . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.54 0.209 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -108.4 140.92 41.01 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 173.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -88.93 116.96 27.6 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 170.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 98.3 t -99.04 138.3 23.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 125.286 1.435 . . . . 0.0 107.19 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.404 ' HA ' ' O ' ' A' ' 33' ' ' THR . 31.0 tpp -121.5 140.72 51.82 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.792 1.237 . . . . 0.0 108.889 175.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -122.19 134.85 54.71 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 170.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.7 t -140.35 133.89 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 119.42 1.009 . . . . 0.0 109.182 -170.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 p -139.71 167.76 21.38 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 119.897 1.226 . . . . 0.0 111.813 169.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -62.08 -18.16 59.85 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -146.83 102.93 3.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 169.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -44.56 -36.75 3.16 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 127.112 2.165 . . . . 0.0 113.355 -177.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.2 m -45.68 -13.5 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 129.519 3.128 . . . . 0.0 119.237 -168.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.5 p -128.97 -89.14 0.51 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 120.279 1.4 . . . . 0.0 111.17 -171.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -57.8 -48.28 80.16 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.555 0.616 . . . . 0.0 110.758 -169.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.435 ' HB3' ' HB3' ' A' ' 34' ' ' SER . 3.4 m -57.74 -44.43 86.04 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.462 0.705 . . . . 0.0 110.104 -175.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -76.25 -32.73 59.02 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 119.075 -0.488 . . . . 0.0 111.773 -173.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.476 ' HG2' HD11 ' A' ' 57' ' ' ILE . 65.4 mtm -65.55 -47.15 76.85 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.691 0.678 . . . . 0.0 109.986 169.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.22 -36.08 70.46 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.842 0.457 . . . . 0.0 110.831 177.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -59.08 -62.04 2.18 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.79 -39.66 68.61 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 119.144 -0.809 . . . . 0.0 111.883 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.405 ' CZ ' ' SD ' ' A' ' 50' ' ' MET . 40.5 m-85 -66.53 -50.25 63.8 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 119.038 1.419 . . . . 0.0 110.594 174.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.32 -43.47 98.76 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 120.233 1.378 . . . . 0.0 112.45 -172.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 ptmt -70.48 -9.04 55.52 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.626 1.103 . . . . 0.0 113.24 175.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.7 m -92.67 -49.4 6.11 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 119.982 1.265 . . . . 0.0 110.544 169.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.5 mt -78.32 -41.4 33.8 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 125.642 1.577 . . . . 0.0 112.205 -169.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.26 -7.65 16.23 Favored Glycine 0 C--N 1.332 0.338 0 CA-C-O 118.034 -1.426 . . . . 0.0 114.75 -169.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.98 109.79 0.51 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.477 1.639 . . . . 0.0 108.971 169.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.09 -29.4 2.83 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.838 1.209 . . . . 0.0 111.585 -169.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.27 -21.7 2.57 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.561 1.145 . . . . 0.0 111.848 173.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.9 pt -126.95 157.55 38.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 121.342 0.591 . . . . 0.0 111.635 174.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.7 127.92 53.31 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 168.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.0 p -109.07 150.69 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-O 121.55 0.691 . . . . 0.0 111.654 -176.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 5' ' ' MET . 85.7 m -148.95 137.51 21.13 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 167.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.435 ' HB3' ' HB3' ' A' ' 15' ' ' SER . 11.3 m -124.02 152.46 42.57 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 121.752 -0.593 . . . . 0.0 110.291 178.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 19.3 p -157.56 -163.62 1.39 Allowed 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -171.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.65 168.77 41.82 Favored Glycine 0 N--CA 1.448 -0.504 0 O-C-N 121.318 -0.864 . . . . 0.0 111.098 174.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 65.6 mt -56.42 -32.3 64.73 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.085 0.554 . . . . 0.0 111.061 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -141.57 149.39 40.7 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 169.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.8 p -91.1 157.93 16.94 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.276 1.031 . . . . 0.0 110.599 170.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 28.5 m -164.88 158.23 17.05 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.826 2.85 . . . . 0.0 104.912 169.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 96.5 mtt-85 -50.93 136.73 22.28 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.643 1.111 . . . . 0.0 110.449 -172.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.7 p -58.17 131.72 22.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -70.33 142.83 90.0 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-O 118.851 -0.595 . . . . 0.0 109.872 -169.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.68 -39.7 0.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.53 1.486 . . . . 0.0 112.583 -169.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.466 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 29.3 m -62.44 -25.8 68.16 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.643 -1.286 . . . . 0.0 111.529 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.75 -43.98 38.11 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.61 0.764 . . . . 0.0 110.928 172.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.9 mt -54.99 -46.52 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 C-N-CA 124.257 1.023 . . . . 0.0 108.345 -178.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.4 -34.89 79.22 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 123.996 0.918 . . . . 0.0 110.051 -171.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.9 mmm -70.09 -41.94 73.39 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.062 0.934 . . . . 0.0 110.549 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.514 ' HG3' ' CG1' ' A' ' 57' ' ' ILE . 87.8 mmm -62.82 -41.23 99.24 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 174.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -61.79 -26.27 67.99 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.079 0.552 . . . . 0.0 111.129 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -66.25 -40.27 90.07 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 118.478 0.581 . . . . 0.0 110.025 172.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.5 t -77.96 -26.22 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.816 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.98 24.29 6.09 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 125.354 1.455 . . . . 0.0 112.009 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.8 mt -121.81 177.63 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 125.643 1.577 . . . . 0.0 107.576 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -143.37 159.0 43.16 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.495 1.518 . . . . 0.0 109.746 -177.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.514 ' CG1' ' HG3' ' A' ' 50' ' ' MET . 0.7 OUTLIER -131.3 -18.64 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.244 1.017 . . . . 0.0 111.776 169.62 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -42.64 -38.32 1.99 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.155 1.382 . . . . 0.0 113.345 174.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.13 -11.28 63.62 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.529 1.061 . . . . 0.0 113.899 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -128.13 172.8 10.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.413 1.485 . . . . 0.0 112.442 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.2 p -125.09 164.28 20.55 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.709 1.604 . . . . 0.0 110.348 -176.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.26 166.95 21.4 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.512 1.525 . . . . 0.0 111.539 174.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -154.91 142.67 14.09 Favored Pre-proline 0 N--CA 1.472 0.643 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.535 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -84.49 151.85 11.86 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.028 2.485 . . . . 0.0 111.868 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.2 tt -58.19 -32.75 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 123.951 0.9 . . . . 0.0 111.647 175.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -57.24 -21.6 35.2 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.255 1.822 . . . . 0.0 112.1 -176.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -74.72 -9.61 58.73 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.662 1.185 . . . . 0.0 112.855 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -134.1 179.7 6.09 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 120.24 1.382 . . . . 0.0 112.711 -175.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.42 143.08 51.15 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 127.901 2.48 . . . . 0.0 107.384 169.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.62 -25.31 62.98 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.194 0.998 . . . . 0.0 112.439 -176.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -60.88 -23.12 64.94 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.753 0.821 . . . . 0.0 112.325 -174.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -80.71 -16.44 53.94 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.122 0.969 . . . . 0.0 110.597 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -102.77 124.37 48.18 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 125.394 1.477 . . . . 0.0 109.083 -173.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -72.16 -36.43 69.3 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 176.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.73 132.32 56.9 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -170.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.1 t -124.04 132.52 71.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 122.188 0.994 . . . . 0.0 108.894 178.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.9 mm -121.87 102.74 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -178.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.3 m -73.95 155.08 39.03 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 168.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.27 26.71 0.96 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.633 1.573 . . . . 0.0 108.156 175.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 86.4 m -54.92 -36.38 65.17 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 124.863 1.265 . . . . 0.0 113.276 -169.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.87 166.22 38.84 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 88.8 m 39.58 33.8 0.13 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.679 1.992 . . . . 0.0 114.413 -173.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 61.34 19.26 57.29 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.887 1.708 . . . . 0.0 115.211 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 97.2 t -68.3 155.15 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 169.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -154.45 -175.43 5.4 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.057 0.943 . . . . 0.0 110.379 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.0 mt -114.33 110.69 47.58 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 125.439 1.496 . . . . 0.0 108.71 -169.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -55.51 -42.76 64.66 Favored 'Trans proline' 0 CA--C 1.55 1.311 0 C-N-CA 122.36 2.04 . . . . 0.0 114.876 169.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.43 -179.94 5.58 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 121.934 1.756 . . . . 0.0 114.592 -170.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -47.02 -19.41 0.11 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 130.512 3.525 . . . . 0.0 115.863 -177.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -55.58 -28.47 55.22 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 124.821 1.248 . . . . 0.0 112.193 173.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.5 p -87.39 -2.63 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 118.935 0.789 . . . . 0.0 110.26 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.7 p -123.35 22.66 9.26 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.144 0.978 . . . . 0.0 112.716 -169.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -82.07 178.14 8.44 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.479 0.712 . . . . 0.0 110.7 174.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.72 -33.87 72.18 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.454 1.101 . . . . 0.0 112.224 -169.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.5 mt -129.2 138.58 54.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 172.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -141.94 134.49 28.23 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 170.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -141.15 153.9 45.6 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 168.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -120.08 104.9 10.51 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.715 1.206 . . . . 0.0 110.069 169.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.44 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 37.9 m0 -80.59 79.48 7.2 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.381 1.872 . . . . 0.0 108.564 178.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -55.02 118.67 4.51 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 171.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 30.6 mt -147.07 154.7 41.48 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.534 1.534 . . . . 0.0 107.785 -169.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -82.8 59.35 4.75 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.963 1.305 . . . . 0.0 111.982 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 47.8 t0 5.79 82.23 0.04 OUTLIER Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 129.925 3.29 . . . . 0.0 113.135 169.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.417 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 75.3 Cg_exo -59.49 -13.67 22.01 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.997 3.131 . . . . 0.0 118.691 -168.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -62.98 98.24 0.13 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.623 1.556 . . . . 0.0 110.217 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 106.24 10.94 28.71 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.22 1.867 . . . . 0.0 113.559 173.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.417 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 29.4 mm-40 -95.7 179.38 5.14 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.152 1.476 . . . . 0.0 113.29 -169.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.3 m -76.9 155.51 32.78 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.653 1.581 . . . . 0.0 110.123 175.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 57.3 mt -59.42 -32.2 69.97 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.879 -0.513 . . . . 0.0 111.686 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.36 -41.2 98.41 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.245 0.475 . . . . 0.0 110.765 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 97.3 t -66.28 -45.92 88.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.466 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 11.1 m-85 -55.69 -50.88 69.11 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.86 177.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 53.8 mtp85 -62.58 -40.49 97.05 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 118.31 -0.853 . . . . 0.0 111.486 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 93.9 m -62.08 -52.37 64.2 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 118.57 0.623 . . . . 0.0 109.334 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.9 t -66.37 -45.59 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 118.128 -0.939 . . . . 0.0 110.324 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -40.91 88.78 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 120.054 1.297 . . . . 0.0 110.298 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.48 -50.12 69.93 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-O 118.479 -1.178 . . . . 0.0 110.942 175.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -60.41 -53.72 54.26 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 118.652 1.226 . . . . 0.0 110.631 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.6 t -47.01 -51.92 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 125.212 1.405 . . . . 0.0 109.965 175.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -62.12 -48.35 80.52 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.604 1.093 . . . . 0.0 110.803 -177.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.36 -43.74 75.37 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.295 1.038 . . . . 0.0 110.257 177.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.44 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 81.7 mtt-85 -72.12 -40.85 67.84 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 117.833 -1.079 . . . . 0.0 110.094 -175.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 71.4 t -55.05 -48.74 75.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 120.71 1.595 . . . . 0.0 109.057 169.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.33 -39.8 88.34 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.34 0.973 . . . . 0.0 110.698 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -63.13 -46.01 89.3 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.201 1.0 . . . . 0.0 110.326 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.9 -44.14 90.56 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 123.148 0.579 . . . . 0.0 110.085 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.9 mt -58.56 -36.62 60.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.161 0.984 . . . . 0.0 110.775 174.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.96 -30.73 71.8 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.91 1.232 . . . . 0.0 111.34 -174.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -65.94 -24.87 66.91 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.285 1.434 . . . . 0.0 113.422 177.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.0 pt -123.23 -20.08 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 -167.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.3 m . . . . . 0 C--O 1.248 1.026 0 C-N-CA 126.074 1.75 . . . . 0.0 111.05 173.232 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.9 ttm . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.871 0.367 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -102.63 140.73 36.53 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -90.64 135.63 33.59 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 121.494 -0.754 . . . . 0.0 109.013 170.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.4 p -115.37 140.37 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 123.659 0.784 . . . . 0.0 109.483 173.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 45.2 tpp -118.59 143.26 46.91 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 171.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -118.38 127.28 53.53 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 169.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 53.4 t -126.69 114.12 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 119.999 1.272 . . . . 0.0 108.871 -171.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.2 t -110.94 160.35 16.88 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.766 0.712 . . . . 0.0 111.071 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -59.13 -18.13 33.05 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 121.321 -0.862 . . . . 0.0 112.637 174.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.11 -2.39 2.07 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -174.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.526 HD22 ' H ' ' A' ' 63' ' ' ASP . 37.0 t-20 37.71 35.73 0.08 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.314 1.846 . . . . 0.0 115.211 -169.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.7 p -107.88 -35.08 6.74 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 120.523 -1.361 . . . . 0.0 112.306 -171.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 20.4 m -134.75 -68.36 0.54 Allowed 'General case' 0 C--N 1.342 0.27 0 CA-C-O 117.948 -1.025 . . . . 0.0 111.727 -169.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -56.13 -53.51 56.25 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.46 1.027 . . . . 0.0 110.262 -170.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.9 p -68.45 -43.06 77.89 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.675 1.19 . . . . 0.0 110.467 -174.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -59.94 -47.51 85.51 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.773 1.229 . . . . 0.0 110.626 -177.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.44 ' HG2' HD11 ' A' ' 57' ' ' ILE . 44.7 mtm -65.75 -44.98 84.28 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 119.272 -0.394 . . . . 0.0 110.77 175.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.89 -40.16 66.36 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.818 0.281 . . . . 0.0 110.945 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.458 ' HA ' HG21 ' A' ' 32' ' ' VAL . 23.5 tt0 -63.6 -55.08 26.52 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 118.676 -0.678 . . . . 0.0 110.009 177.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -53.15 -40.17 59.07 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 119.077 -0.846 . . . . 0.0 111.974 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.446 ' CD1' ' HE3' ' A' ' 50' ' ' MET . 13.3 m-85 -66.29 -49.13 68.15 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 119.11 1.455 . . . . 0.0 108.525 176.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.58 -46.05 90.07 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 124.183 0.993 . . . . 0.0 112.942 -173.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.5 ptmt -68.54 -8.81 44.84 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 119.337 0.971 . . . . 0.0 113.173 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.1 m -94.48 -47.59 6.49 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 119.984 1.266 . . . . 0.0 110.72 169.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.1 mt -76.34 -42.66 44.15 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.885 1.674 . . . . 0.0 111.956 -169.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -119.27 -5.25 11.62 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-O 117.741 -1.588 . . . . 0.0 114.935 -169.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.33 109.58 0.45 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.833 1.816 . . . . 0.0 108.852 169.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.57 -29.93 2.73 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.988 1.28 . . . . 0.0 111.355 -169.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.05 -22.15 3.84 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.672 1.189 . . . . 0.0 111.741 170.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.1 pt -125.72 156.92 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -122.84 133.57 54.43 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 168.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.458 HG21 ' HA ' ' A' ' 19' ' ' GLU . 2.6 p -116.8 157.56 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -169.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 m -148.3 145.55 28.21 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 126.306 1.842 . . . . 0.0 107.678 168.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.7 p -115.85 141.21 48.4 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.492 1.517 . . . . 0.0 108.608 168.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.8 m -150.73 -177.68 6.13 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.059 1.744 . . . . 0.0 106.616 -171.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.13 168.87 39.46 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.114 -1.041 . . . . 0.0 112.953 173.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.0 mp -56.2 -36.45 68.43 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 125.305 1.238 . . . . 0.0 110.607 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -150.24 150.41 31.51 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 169.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 65.8 m -83.64 146.5 28.22 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.567 0.699 . . . . 0.0 112.223 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.4 m -144.12 158.1 43.92 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 128.444 2.697 . . . . 0.0 104.505 168.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.5 ptt-85 -57.52 146.2 30.78 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.403 1.001 . . . . 0.0 110.392 -175.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 p -62.91 133.91 28.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 169.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -78.48 145.15 67.12 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.295 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.44 -41.11 0.36 Allowed 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.44 1.426 . . . . 0.0 112.814 -169.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.475 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 38.6 m -63.09 -24.86 68.1 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.422 -1.424 . . . . 0.0 111.314 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.42 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -50.67 -40.59 53.97 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.882 0.873 . . . . 0.0 111.514 172.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 55.5 mt -56.42 -44.23 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 124.304 1.042 . . . . 0.0 108.248 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.01 -37.67 81.69 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 125.069 1.347 . . . . 0.0 110.29 -172.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.0 mmm -68.66 -41.92 78.66 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 123.088 1.423 . . . . 0.0 110.427 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.446 ' HE3' ' CD1' ' A' ' 21' ' ' PHE . 4.6 mtp -66.62 -34.3 77.57 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 120.689 -1.257 . . . . 0.0 109.948 175.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -61.3 -28.83 69.48 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.844 -0.598 . . . . 0.0 111.654 170.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -61.24 -40.85 95.57 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.23 0.923 . . . . 0.0 110.529 173.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.7 m -92.58 7.3 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 178.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.99 25.34 49.53 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.137 0.875 . . . . 0.0 112.6 170.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.682 HG22 ' H ' ' A' ' 56' ' ' ASP . 9.9 mt -123.84 -174.82 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 125.404 1.482 . . . . 0.0 107.159 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.682 ' H ' HG22 ' A' ' 55' ' ' ILE . 8.0 t70 -148.85 155.84 41.47 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.612 1.565 . . . . 0.0 109.349 -176.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.44 HD11 ' HG2' ' A' ' 17' ' ' MET . 0.1 OUTLIER -128.49 -15.44 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 124.148 0.979 . . . . 0.0 112.38 169.768 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.6 p -52.6 -30.82 33.28 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.544 1.065 . . . . 0.0 112.621 176.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.79 -7.48 86.13 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.729 1.157 . . . . 0.0 114.187 -177.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -123.65 173.7 7.93 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 119.3 1.55 . . . . 0.0 111.165 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.5 p -128.72 174.02 9.81 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.11 1.364 . . . . 0.0 110.749 -173.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.8 p -96.92 151.74 19.4 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.355 1.062 . . . . 0.0 110.1 172.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.526 ' H ' HD22 ' A' ' 11' ' ' ASN . 3.5 t70 -150.11 148.79 25.65 Favored Pre-proline 0 C--O 1.239 0.543 0 C-N-CA 125.415 1.486 . . . . 0.0 109.258 -171.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -84.04 151.72 12.55 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.957 1.772 . . . . 0.0 110.898 -177.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.8 tt -54.86 -31.45 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 123.309 0.644 . . . . 0.0 111.271 171.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -50.78 -28.93 10.28 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.243 2.617 . . . . 0.0 112.274 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -83.98 -4.82 59.0 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.269 1.028 . . . . 0.0 112.917 -172.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -129.58 -176.84 4.03 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.643 1.111 . . . . 0.0 110.998 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.83 139.49 50.17 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 127.113 2.165 . . . . 0.0 107.427 173.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.62 -26.58 65.43 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.427 1.091 . . . . 0.0 111.791 -178.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -59.91 -24.54 64.41 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.105 0.962 . . . . 0.0 112.317 -171.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -89.85 -13.04 37.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.766 0.827 . . . . 0.0 111.08 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -94.2 133.05 38.12 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 125.307 1.443 . . . . 0.0 109.798 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -75.48 -42.47 52.91 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.3 p -132.75 137.24 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 123.02 0.528 . . . . 0.0 110.454 -169.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.3 m -129.51 104.61 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-O 123.5 1.619 . . . . 0.0 109.336 -171.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.7 mm -101.65 99.11 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 -177.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.8 t -73.19 155.77 39.26 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 168.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.08 53.49 0.57 Allowed 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 173.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 90.2 m -71.58 -36.75 70.98 Favored 'General case' 0 C--N 1.339 0.118 0 C-N-CA 123.835 0.854 . . . . 0.0 109.546 173.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.92 -61.67 0.49 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 124.999 1.285 . . . . 0.0 111.295 169.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 56.2 m -80.3 27.54 0.33 Allowed 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -169.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.61 14.78 65.4 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 125.026 1.298 . . . . 0.0 113.21 -175.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 78.8 t -70.08 110.77 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 175.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -79.0 156.82 28.26 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 169.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.4 mt -70.18 121.84 84.39 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -54.98 -40.84 83.84 Favored 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 122.044 1.829 . . . . 0.0 114.067 169.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -77.23 -176.97 3.49 Favored 'Trans proline' 0 C--N 1.356 0.933 0 CA-C-N 121.49 1.568 . . . . 0.0 113.504 -173.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -47.47 -17.5 0.09 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 129.28 3.032 . . . . 0.0 115.574 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -66.1 8.99 0.17 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 126.58 1.952 . . . . 0.0 113.396 171.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.9 p -119.95 1.43 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.836 1.255 . . . . 0.0 111.705 171.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.1 p -125.49 25.38 7.05 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.989 0.915 . . . . 0.0 112.156 -172.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -91.54 -172.75 3.34 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.464 0.705 . . . . 0.0 109.444 170.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -66.08 -33.98 77.02 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -169.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.6 mt -136.84 134.46 48.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -139.27 140.23 37.59 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.263 1.025 . . . . 0.0 108.61 173.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -148.91 160.54 43.17 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.372 1.469 . . . . 0.0 107.93 168.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -121.95 102.44 8.18 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.274 1.43 . . . . 0.0 108.743 168.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.422 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 44.2 m0 -77.91 98.62 5.7 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.131 0.972 . . . . 0.0 109.596 -176.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -69.25 104.39 2.2 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.799 1.239 . . . . 0.0 109.229 174.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -137.69 168.71 19.12 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 126.679 1.992 . . . . 0.0 108.033 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -67.53 162.4 23.42 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 166.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -117.1 105.32 49.3 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 171.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -54.7 -1.88 0.17 Allowed 'Trans proline' 0 CA--C 1.537 0.64 1 C-N-CA 125.882 4.388 . . . . 0.0 118.652 -169.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -50.67 91.64 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.365 1.866 . . . . 0.0 112.616 172.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.64 16.71 51.49 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 126.121 1.819 . . . . 0.0 113.244 171.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -94.38 -179.96 5.09 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.843 1.322 . . . . 0.0 112.075 -169.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.5 m -77.46 155.67 31.59 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.089 1.356 . . . . 0.0 109.937 175.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.3 mt -58.61 -32.08 68.68 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 122.032 -0.418 . . . . 0.0 111.546 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -61.96 -39.27 91.56 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.145 0.429 . . . . 0.0 110.731 176.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 89.1 t -67.65 -46.78 82.15 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.475 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 14.0 m-85 -54.04 -52.58 60.41 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.885 0.474 . . . . 0.0 110.898 176.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 28.9 mtt180 -59.29 -42.14 90.57 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.371 1.069 . . . . 0.0 111.621 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 95.4 m -60.86 -52.71 63.9 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 95.8 t -64.41 -42.88 96.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 118.803 -0.618 . . . . 0.0 110.094 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -55.26 -46.71 76.09 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.346 0.976 . . . . 0.0 109.738 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -69.38 -49.35 39.28 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-O 119.211 -0.772 . . . . 0.0 111.866 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -63.79 -45.09 91.28 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.657 1.228 . . . . 0.0 111.866 -174.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.4 t -64.07 -43.42 97.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 117.874 -1.06 . . . . 0.0 109.37 176.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -58.56 -46.37 87.02 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.472 1.487 . . . . 0.0 110.512 178.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.09 -44.13 78.73 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.587 1.155 . . . . 0.0 110.138 176.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.422 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 51.3 mtt85 -71.25 -39.64 71.5 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 117.953 -1.023 . . . . 0.0 111.042 -177.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 88.4 t -54.94 -48.02 75.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 120.514 1.506 . . . . 0.0 109.784 169.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -60.08 -39.6 86.64 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.459 1.027 . . . . 0.0 110.614 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -62.28 -45.51 92.96 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.211 1.004 . . . . 0.0 110.485 178.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.38 -47.62 78.57 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 124.033 0.933 . . . . 0.0 110.06 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 63.7 mt -56.62 -38.37 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.394 1.078 . . . . 0.0 110.329 175.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.98 -28.87 69.32 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.72 1.145 . . . . 0.0 111.44 -174.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -75.16 -19.59 59.79 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.806 1.643 . . . . 0.0 112.731 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.4 pt -125.11 -20.56 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 125.707 1.603 . . . . 0.0 115.29 -168.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 C--O 1.251 1.137 0 C-N-CA 126.573 1.949 . . . . 0.0 110.935 172.311 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.7 ttm . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 120.791 0.329 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -112.96 141.13 47.15 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.15 0.98 . . . . 0.0 108.412 170.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -92.36 126.21 37.35 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 169.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.7 p -115.88 135.5 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 O-C-N 123.721 0.638 . . . . 0.0 110.962 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 55.1 tpp -107.5 153.05 23.41 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.237 1.015 . . . . 0.0 109.204 170.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -130.03 104.48 7.37 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.985 1.714 . . . . 0.0 106.686 169.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.97 127.28 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 120.057 1.298 . . . . 0.0 109.158 -176.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.2 t -116.17 163.11 16.45 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.791 1.178 . . . . 0.0 112.34 176.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -58.99 -21.81 59.49 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.584 -0.697 . . . . 0.0 111.654 171.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.4 ptm85 -153.48 116.07 4.45 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 169.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -48.8 -29.29 4.41 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.214 1.006 . . . . 0.0 113.166 -175.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.2 m -40.38 -34.33 0.33 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 119.235 3.05 . . . . 0.0 119.235 -169.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.7 p -135.63 -71.68 0.47 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 121.006 1.73 . . . . 0.0 113.942 -169.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -55.14 -50.92 68.05 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.21 0.914 . . . . 0.0 109.886 -169.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 0.1 OUTLIER -63.65 -48.49 77.0 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.992 2.117 . . . . 0.0 111.787 -179.233 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -63.34 -42.95 98.99 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.317 0.647 . . . . 0.0 110.785 -175.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 67.5 mtm -64.82 -46.23 82.83 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 119.05 -0.5 . . . . 0.0 111.036 174.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.86 -41.55 70.93 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 118.233 0.47 . . . . 0.0 110.805 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.63 -46.25 79.98 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 122.843 0.457 . . . . 0.0 111.054 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.39 -40.4 97.52 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -66.63 -52.14 48.41 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 118.506 1.153 . . . . 0.0 108.009 176.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.27 -42.98 78.32 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.824 1.25 . . . . 0.0 113.052 -174.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.3 pttt -68.56 -35.74 77.81 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-N 119.169 0.895 . . . . 0.0 110.265 175.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.6 m -68.1 -41.77 81.32 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 119.555 -1.966 . . . . 0.0 110.569 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.8 mt -73.23 -37.3 66.44 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.086 1.754 . . . . 0.0 111.202 -175.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -139.48 7.68 3.1 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 117.01 -1.995 . . . . 0.0 117.875 -169.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.01 114.34 1.71 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 121.317 2.558 . . . . 0.0 108.59 169.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 124.55 -23.02 6.43 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.525 1.059 . . . . 0.0 111.888 -174.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.444 ' HE2' HG23 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -131.96 -17.56 2.76 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.505 1.152 . . . . 0.0 112.135 177.049 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.9 pt -129.97 147.64 33.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 168.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -110.89 114.65 28.15 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 170.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 p -102.33 151.66 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-O 121.797 0.808 . . . . 0.0 111.723 -176.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.0 m -145.91 151.32 37.66 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 126.182 1.793 . . . . 0.0 106.195 167.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' A' ' 15' ' ' SER . 58.5 p -122.92 158.11 31.12 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 121.043 -1.036 . . . . 0.0 108.673 168.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.8 m -152.18 -173.66 4.62 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.491 1.516 . . . . 0.0 107.525 -174.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.89 162.59 31.35 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 169.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.2 mp -50.2 -36.87 32.51 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.656 1.183 . . . . 0.0 110.075 174.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -141.11 150.06 42.36 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 169.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.0 p -78.02 157.96 29.41 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.988 0.899 . . . . 0.0 110.694 173.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.2 m -164.86 157.86 16.71 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 128.126 2.57 . . . . 0.0 105.231 169.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -56.47 154.18 8.89 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.027 0.83 . . . . 0.0 111.322 -175.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.8 t -62.96 129.71 26.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 172.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -69.37 141.37 91.0 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -176.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.63 -40.42 2.07 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.182 1.255 . . . . 0.0 111.759 -169.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.513 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 6.2 m -67.95 -17.06 64.33 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.453 -1.404 . . . . 0.0 111.868 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.43 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -58.71 -40.28 83.24 Favored 'General case' 0 C--N 1.34 0.168 0 O-C-N 121.338 -0.851 . . . . 0.0 110.459 171.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.2 mt -57.26 -45.48 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.01 99.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.321 0.649 . . . . 0.0 111.791 -175.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 21.4 mmt -57.81 -47.37 82.8 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 122.85 1.31 . . . . 0.0 111.227 176.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 6.7 mtp -69.81 -31.86 69.99 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.376 -177.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.12 -31.82 70.42 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.47 0.708 . . . . 0.0 111.278 170.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -64.98 -35.11 80.12 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 118.669 0.668 . . . . 0.0 110.368 175.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.0 t -79.44 -25.87 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 119.906 -0.093 . . . . 0.0 110.908 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.14 28.81 6.67 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.718 1.151 . . . . 0.0 111.682 -174.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.583 HG22 ' H ' ' A' ' 56' ' ' ASP . 6.7 mt -125.29 -178.81 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 125.942 1.697 . . . . 0.0 106.927 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.583 ' H ' HG22 ' A' ' 55' ' ' ILE . 5.7 t70 -145.92 155.97 43.22 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.979 1.711 . . . . 0.0 108.883 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.43 HD12 ' HB1' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -130.24 -15.61 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.108 0.963 . . . . 0.0 113.331 172.712 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.4 p -50.39 -32.03 16.45 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.647 1.179 . . . . 0.0 113.615 -174.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.46 -15.82 36.53 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 117.852 -1.526 . . . . 0.0 114.425 -172.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -85.8 -25.63 26.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.262 2.031 . . . . 0.0 114.507 -171.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 38.1 p 68.02 168.65 0.26 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.604 1.961 . . . . 0.0 114.116 170.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.8 m -85.14 166.7 16.39 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.718 -171.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.98 139.34 12.59 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 124.137 0.975 . . . . 0.0 109.041 174.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.45 153.58 13.84 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.067 2.512 . . . . 0.0 110.632 169.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.1 tt -53.62 -34.85 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 123.725 0.81 . . . . 0.0 111.355 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -58.82 -22.81 59.43 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.757 1.623 . . . . 0.0 112.528 -176.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -80.42 -5.13 56.04 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.198 0.599 . . . . 0.0 112.541 -177.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -133.41 -176.24 4.08 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.487 1.039 . . . . 0.0 111.336 -176.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -139.68 131.93 28.25 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 126.889 2.076 . . . . 0.0 108.209 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.84 -28.48 67.52 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.475 1.11 . . . . 0.0 112.856 -175.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -60.26 -24.17 64.69 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.849 0.86 . . . . 0.0 112.334 -176.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -83.62 -15.87 47.35 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.247 0.619 . . . . 0.0 110.618 -177.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -102.44 127.06 49.64 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 125.465 1.506 . . . . 0.0 108.701 -175.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -85.4 -25.84 26.78 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.342 0.592 . . . . 0.0 109.688 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.0 t -131.0 135.81 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 -173.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.3 p -135.34 102.71 3.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 123.198 1.475 . . . . 0.0 110.137 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.5 mm -84.7 144.59 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 104.799 -2.296 . . . . 0.0 104.799 168.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.4 m -132.72 158.23 42.89 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 168.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.83 63.57 0.99 Allowed 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 102.515 -3.142 . . . . 0.0 102.515 -171.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 76.2 m -83.48 -39.0 21.08 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -177.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.01 169.81 45.52 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -175.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 95.4 m 38.85 32.86 0.06 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.401 2.28 . . . . 0.0 114.834 -175.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 56.28 24.1 43.53 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.68 1.609 . . . . 0.0 114.637 -176.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.1 t -64.8 151.33 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 169.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -138.49 -171.21 3.0 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.75 1.22 . . . . 0.0 110.071 -171.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 mp -131.15 105.54 14.93 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -169.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -49.92 -41.73 46.86 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 122.868 2.379 . . . . 0.0 115.483 170.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.34 -178.31 3.87 Favored 'Trans proline' 0 C--N 1.356 0.935 0 CA-C-N 121.794 1.677 . . . . 0.0 113.893 -175.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -59.77 -7.34 1.56 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.318 2.247 . . . . 0.0 114.116 -171.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -64.96 10.42 0.07 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.278 1.831 . . . . 0.0 112.496 169.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.1 p -126.12 5.13 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 125.039 1.336 . . . . 0.0 112.03 172.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.6 p -129.41 25.7 5.43 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.895 -1.128 . . . . 0.0 112.89 -170.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -94.31 -177.09 4.16 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.403 0.681 . . . . 0.0 109.682 173.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -57.36 -35.26 69.72 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.372 1.069 . . . . 0.0 112.994 -174.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.8 mt -135.84 138.39 47.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -139.25 137.0 35.54 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 169.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -146.36 151.86 38.17 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.132 1.373 . . . . 0.0 108.21 169.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -115.73 126.67 54.37 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.798 1.239 . . . . 0.0 109.624 169.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.441 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 40.0 m0 -107.09 91.61 3.73 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.412 1.485 . . . . 0.0 108.124 -173.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -69.9 103.69 2.29 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.951 1.3 . . . . 0.0 109.28 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -136.57 161.5 35.72 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.675 1.59 . . . . 0.0 110.517 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -81.65 66.74 7.34 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.02 1.728 . . . . 0.0 111.283 -178.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -9.99 91.93 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 129.731 3.212 . . . . 0.0 112.318 169.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.437 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 71.0 Cg_exo -57.43 -8.36 3.8 Favored 'Trans proline' 0 N--CA 1.459 -0.553 1 C-N-CA 125.409 4.073 . . . . 0.0 117.946 -169.102 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -57.43 95.14 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 120.32 1.418 . . . . 0.0 111.832 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 98.63 13.86 39.55 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 126.428 1.966 . . . . 0.0 113.241 172.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.437 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 28.8 mm-40 -93.31 177.99 5.86 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.039 1.42 . . . . 0.0 112.575 -169.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.8 m -74.6 154.72 38.43 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.407 1.483 . . . . 0.0 109.931 175.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.1 mt -60.07 -30.31 69.13 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.737 -0.602 . . . . 0.0 111.784 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -62.68 -39.87 95.32 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.106 0.412 . . . . 0.0 110.877 174.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.4 t -67.15 -45.2 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.057 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.513 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 16.2 m-85 -54.66 -52.98 60.63 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.322 0.51 . . . . 0.0 110.829 175.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 75.2 mtp85 -59.11 -42.07 89.67 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 118.434 -0.793 . . . . 0.0 111.956 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 91.1 m -62.16 -53.26 57.8 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 119.038 0.836 . . . . 0.0 109.059 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.2 t -62.36 -42.86 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-O 117.802 -1.094 . . . . 0.0 110.183 -178.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.3 ttp85 -53.41 -52.76 58.33 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 119.813 1.188 . . . . 0.0 108.88 176.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.31 -46.02 91.86 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -172.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -62.74 -49.65 74.19 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.918 0.887 . . . . 0.0 111.054 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.8 t -62.05 -48.15 89.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 125.731 1.612 . . . . 0.0 110.42 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -58.84 -47.35 85.17 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 120.625 1.557 . . . . 0.0 110.424 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -53.64 -46.59 70.6 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 123.792 0.837 . . . . 0.0 109.446 174.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.441 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 61.7 mtt85 -69.1 -38.22 78.84 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 117.604 -1.189 . . . . 0.0 110.946 -174.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.6 t -55.49 -49.64 71.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 120.803 1.638 . . . . 0.0 109.626 169.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -61.12 -39.94 91.9 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.519 1.054 . . . . 0.0 110.689 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -61.81 -46.38 89.75 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.486 1.514 . . . . 0.0 109.922 178.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.1 -52.71 62.79 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.477 1.111 . . . . 0.0 109.387 178.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.444 HG23 ' HE2' ' A' ' 29' ' ' LYS . 72.7 mt -52.14 -40.29 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 123.934 0.894 . . . . 0.0 109.67 177.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.19 -30.84 71.35 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.65 1.113 . . . . 0.0 111.622 -174.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 51.9 mttt -70.52 -37.23 74.09 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.985 1.314 . . . . 0.0 111.493 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.0 pt -99.99 -25.59 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -169.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 64.5 m . . . . . 0 C--O 1.248 1.005 0 C-N-CA 126.165 1.786 . . . . 0.0 111.249 179.612 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.0 ttm . . . . . 0 N--CA 1.484 1.255 0 CA-C-O 120.655 0.264 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt -121.51 143.5 49.24 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.579 1.151 . . . . 0.0 108.213 175.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -103.52 125.18 49.92 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -176.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.545 ' HA ' HG13 ' A' ' 75' ' ' VAL . 40.4 t -108.47 138.6 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 124.415 1.086 . . . . 0.0 108.16 -172.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 32.1 tpp -125.99 140.45 52.6 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.858 1.263 . . . . 0.0 108.803 178.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -122.22 132.98 54.71 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 118.098 -0.953 . . . . 0.0 108.538 170.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.8 t -134.04 116.52 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 121.041 1.746 . . . . 0.0 109.926 -171.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.9 t -115.71 163.08 16.34 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.653 1.115 . . . . 0.0 111.093 -177.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -55.54 -22.54 22.09 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.294 1.438 . . . . 0.0 112.67 172.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -135.21 -1.81 2.58 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 62.32 -52.85 0.15 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 127.589 2.356 . . . . 0.0 113.99 -168.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.9 m -41.43 -19.05 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 120.97 3.693 . . . . 0.0 120.97 -169.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.2 p -131.0 -80.6 0.53 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 120.152 1.342 . . . . 0.0 111.085 -169.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -55.12 -50.91 68.02 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.612 0.765 . . . . 0.0 109.002 -170.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.02 -40.99 74.87 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.221 0.608 . . . . 0.0 111.96 -173.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.8 mm100 -69.39 -40.28 77.47 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.579 -0.701 . . . . 0.0 110.678 -170.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 63.1 mtm -62.47 -44.83 95.45 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 119.58 -0.248 . . . . 0.0 110.393 171.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.37 -37.45 70.09 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 119.361 -0.352 . . . . 0.0 111.152 177.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -62.15 -52.15 65.0 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.172 0.589 . . . . 0.0 109.956 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.01 -41.04 99.65 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.341 -0.699 . . . . 0.0 111.503 -177.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.432 ' CD1' ' HE3' ' A' ' 50' ' ' MET . 25.0 m-85 -66.87 -51.3 57.09 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 118.733 1.266 . . . . 0.0 107.947 177.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.93 -42.77 80.63 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 124.2 1.0 . . . . 0.0 112.666 -174.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -68.41 -35.51 77.74 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 119.771 1.169 . . . . 0.0 110.962 175.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.5 m -67.06 -43.16 83.36 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 120.738 1.608 . . . . 0.0 110.404 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.5 mt -74.57 -36.83 63.06 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.051 1.34 . . . . 0.0 111.209 -173.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -131.69 -3.04 4.24 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 116.621 -2.211 . . . . 0.0 118.009 -169.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.79 109.25 0.6 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 121.901 2.85 . . . . 0.0 109.047 171.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.6 -29.32 2.78 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.813 1.197 . . . . 0.0 111.758 -170.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -133.45 -13.32 2.66 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.391 1.077 . . . . 0.0 112.824 171.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.5 pt -129.5 157.24 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 168.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -121.05 133.62 55.25 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 169.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.14 149.84 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-O 121.331 0.586 . . . . 0.0 111.986 -173.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.8 m -142.35 150.82 41.24 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 167.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.4 m -124.75 153.17 42.82 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.951 0.9 . . . . 0.0 109.858 169.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 32.8 m -150.4 -171.46 3.92 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 126.482 1.913 . . . . 0.0 107.463 -170.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.05 169.1 39.52 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 169.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 67.7 mt -53.94 -35.87 62.2 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 124.63 0.841 . . . . 0.0 110.777 178.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -149.69 150.31 31.92 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 169.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.0 p -86.58 165.92 15.81 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 122.081 0.943 . . . . 0.0 111.85 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.1 m -161.68 172.38 16.35 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 128.796 2.838 . . . . 0.0 105.469 169.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.71 151.57 29.0 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.5 -1.375 . . . . 0.0 109.671 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.1 t -57.6 132.91 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 171.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 37.5 t60 -67.92 139.8 93.43 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-O 118.772 -0.632 . . . . 0.0 109.392 177.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.6 -42.29 0.36 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.207 1.938 . . . . 0.0 113.456 -171.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.441 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 5.6 m -62.61 -18.6 62.53 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 119.701 -1.874 . . . . 0.0 112.452 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.7 -38.95 73.01 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.01 0.924 . . . . 0.0 110.291 171.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 62.5 mt -56.49 -48.3 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.04 -40.4 93.47 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 123.972 0.909 . . . . 0.0 111.484 -174.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.5 mmt -59.72 -47.95 83.64 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 122.656 1.217 . . . . 0.0 111.358 176.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.432 ' HE3' ' CD1' ' A' ' 21' ' ' PHE . 8.2 mtp -68.31 -34.72 76.64 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.207 -178.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -61.81 -29.22 70.01 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.243 0.617 . . . . 0.0 111.657 171.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -65.31 -35.84 82.25 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.196 0.907 . . . . 0.0 110.489 173.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 t -78.61 -25.96 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 117.64 0.2 . . . . 0.0 111.0 175.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.25 28.05 7.0 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.522 1.058 . . . . 0.0 111.702 -174.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.584 HG22 ' H ' ' A' ' 56' ' ' ASP . 8.8 mt -121.88 -177.71 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 125.94 1.696 . . . . 0.0 106.731 177.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.584 ' H ' HG22 ' A' ' 55' ' ' ILE . 12.7 t70 -146.9 157.67 43.71 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.37 1.468 . . . . 0.0 109.383 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.407 HG12 ' SD ' ' A' ' 50' ' ' MET . 0.2 OUTLIER -128.45 -17.13 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.993 0.917 . . . . 0.0 112.314 169.803 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -45.0 -38.05 4.48 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.834 1.254 . . . . 0.0 112.783 173.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.86 -5.09 88.71 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.735 1.16 . . . . 0.0 113.972 -173.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -128.27 171.68 11.76 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.324 1.45 . . . . 0.0 110.82 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.3 p -123.86 164.59 18.93 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 122.016 0.913 . . . . 0.0 111.279 -171.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.3 p -74.47 168.25 20.09 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.983 1.713 . . . . 0.0 110.887 173.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -154.45 144.29 15.47 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.524 0.73 . . . . 0.0 109.744 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -86.27 153.11 9.39 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.063 2.508 . . . . 0.0 110.27 169.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.9 tt -54.09 -33.21 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.542 0.737 . . . . 0.0 111.469 173.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -58.28 -24.37 59.25 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.675 1.59 . . . . 0.0 112.552 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -80.11 -6.45 57.72 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -175.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -130.59 -176.51 4.0 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.377 0.99 . . . . 0.0 111.515 -175.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.67 134.17 38.91 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 126.8 2.04 . . . . 0.0 108.348 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.86 -30.87 70.38 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.842 1.257 . . . . 0.0 112.788 -176.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -60.89 -21.78 63.66 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.151 0.98 . . . . 0.0 112.286 -173.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -83.0 -19.47 36.94 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.521 0.729 . . . . 0.0 110.595 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -104.72 124.94 50.28 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.356 1.062 . . . . 0.0 110.282 -169.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -72.86 -38.45 67.04 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 175.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.545 HG13 ' HA ' ' A' ' 4' ' ' VAL . 2.0 p -132.26 131.67 60.81 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -170.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.2 t -124.41 109.29 22.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 123.219 1.485 . . . . 0.0 108.699 -176.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.2 mm -99.44 94.3 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 177.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.4 m -70.68 157.76 37.42 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 117.351 -1.74 . . . . 0.0 106.461 167.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.81 50.66 0.68 Allowed 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 103.742 -2.688 . . . . 0.0 103.742 176.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 64.9 m -72.21 -32.72 67.02 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 169.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.58 -42.94 2.98 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 125.664 1.602 . . . . 0.0 114.24 168.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 34.8 m -74.57 23.74 0.09 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.523 1.162 . . . . 0.0 112.905 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.94 17.36 43.4 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.686 2.089 . . . . 0.0 113.515 -170.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.3 t -69.68 152.72 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 169.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -141.51 178.87 7.15 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.931 1.292 . . . . 0.0 108.662 -173.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.7 mt -110.11 109.63 58.84 Favored Pre-proline 0 N--CA 1.453 -0.309 0 C-N-CA 124.981 1.313 . . . . 0.0 107.811 -170.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.69 -42.09 58.39 Favored 'Trans proline' 0 CA--C 1.546 1.094 0 C-N-CA 122.353 2.035 . . . . 0.0 114.844 169.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.58 179.25 6.12 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 121.796 1.664 . . . . 0.0 113.824 -175.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -56.41 -13.0 1.92 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 127.714 2.406 . . . . 0.0 113.799 -172.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -55.8 -26.74 47.72 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 121.002 -1.061 . . . . 0.0 112.035 172.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.6 p -84.12 -16.33 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 119.579 1.081 . . . . 0.0 110.337 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.7 p -105.12 16.39 25.9 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.683 0.793 . . . . 0.0 112.477 -169.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -79.13 173.91 12.1 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.608 0.763 . . . . 0.0 109.241 170.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.6 mp0 -58.96 -33.77 71.01 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.343 1.057 . . . . 0.0 113.41 -169.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.2 mt -134.92 136.72 51.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -177.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -143.15 138.76 30.01 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.501 1.12 . . . . 0.0 108.833 175.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -147.23 162.27 39.26 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.367 1.467 . . . . 0.0 107.986 168.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -122.61 97.5 5.48 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.78 1.632 . . . . 0.0 108.805 169.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.45 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 43.7 m0 -74.05 97.81 2.95 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.778 0.831 . . . . 0.0 109.619 -178.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -63.05 119.16 8.96 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 169.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 47.6 mt -151.72 151.48 31.48 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.865 1.666 . . . . 0.0 107.581 -169.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -84.08 73.54 10.38 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.153 0.981 . . . . 0.0 111.002 -176.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -19.36 97.39 0.05 OUTLIER Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 128.765 2.826 . . . . 0.0 111.427 177.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -63.7 -7.43 12.84 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.965 2.443 . . . . 0.0 116.708 -169.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -61.62 90.86 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 120.849 1.658 . . . . 0.0 113.501 -172.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.61 12.48 28.35 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.955 1.741 . . . . 0.0 113.387 175.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -91.34 -179.64 5.45 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.035 1.417 . . . . 0.0 112.128 -171.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.6 m -76.14 155.44 34.63 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.43 1.492 . . . . 0.0 109.973 174.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.6 -31.62 68.22 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.793 -0.567 . . . . 0.0 111.748 -178.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.62 -34.61 76.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 118.418 0.554 . . . . 0.0 111.169 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 95.3 t -66.25 -45.78 89.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 172.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.441 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 18.8 m-85 -56.83 -49.46 75.33 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 119.066 -0.493 . . . . 0.0 110.489 175.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -57.84 -43.38 85.81 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.591 1.157 . . . . 0.0 111.799 176.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.7 m -61.03 -49.49 77.18 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 118.875 0.761 . . . . 0.0 109.406 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.57 -44.66 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 117.742 -1.123 . . . . 0.0 110.377 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 44.3 ttp85 -52.81 -47.11 67.88 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 119.984 1.266 . . . . 0.0 109.137 175.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.89 -49.79 65.45 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-O 118.341 -1.255 . . . . 0.0 110.398 -176.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -59.81 -56.5 21.02 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 118.36 1.08 . . . . 0.0 110.269 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 80.3 t -49.46 -53.28 9.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 125.285 1.434 . . . . 0.0 109.897 177.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -60.82 -46.9 88.73 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 121.049 1.75 . . . . 0.0 110.463 -175.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.15 -44.8 88.06 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.996 0.519 . . . . 0.0 110.269 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.45 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 79.2 mtt-85 -69.08 -40.97 78.14 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.152 -0.927 . . . . 0.0 110.175 -176.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 70.5 t -55.08 -49.05 74.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 120.446 1.476 . . . . 0.0 109.604 169.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -60.35 -39.0 85.57 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.389 0.995 . . . . 0.0 110.45 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -63.54 -45.85 88.68 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.318 1.047 . . . . 0.0 110.427 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.57 -47.12 79.91 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 123.963 0.905 . . . . 0.0 109.779 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.1 mt -53.88 -42.69 54.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 124.715 1.206 . . . . 0.0 109.968 174.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.15 -28.45 67.93 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.399 1.0 . . . . 0.0 111.67 -171.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -73.29 -20.44 60.82 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.91 1.684 . . . . 0.0 112.465 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.3 pt -124.64 -22.29 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 -168.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.9 m . . . . . 0 C--O 1.251 1.174 0 C-N-CA 125.591 1.557 . . . . 0.0 111.283 170.528 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt . . . . . 0 N--CA 1.465 0.312 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.7 mttt -100.28 123.14 44.14 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.436 ' HA ' HG13 ' A' ' 75' ' ' VAL . 14.8 p -102.93 144.74 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 122.058 0.932 . . . . 0.0 110.51 177.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 29.6 tpp -124.24 142.69 51.04 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 125.042 1.337 . . . . 0.0 108.629 176.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -124.22 124.34 42.23 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 171.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.7 t -127.61 121.6 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 120.483 1.492 . . . . 0.0 109.073 -172.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.8 t -118.64 165.75 13.59 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.954 0.797 . . . . 0.0 109.687 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -56.32 -20.99 21.42 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.977 0.911 . . . . 0.0 112.455 170.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -139.51 -2.74 1.56 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 60.27 -47.15 0.1 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 128.53 2.732 . . . . 0.0 115.499 -169.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.7 p -43.96 -25.61 0.22 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 119.707 3.225 . . . . 0.0 119.707 -168.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 45.2 m -126.91 -72.47 0.64 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.909 0.777 . . . . 0.0 109.818 -169.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -63.98 -49.56 72.0 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -169.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.16 -42.08 72.97 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 117.76 0.254 . . . . 0.0 111.11 -177.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -60.09 -45.51 92.7 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.007 0.523 . . . . 0.0 111.166 -175.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.42 ' HG2' HD11 ' A' ' 57' ' ' ILE . 46.9 mtm -64.16 -44.35 92.38 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 121.235 -0.186 . . . . 0.0 110.853 175.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.16 -37.76 75.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 119.363 -0.351 . . . . 0.0 111.116 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -65.5 -45.06 85.08 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.946 0.339 . . . . 0.0 110.52 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.84 -44.14 97.33 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -67.03 -50.56 61.64 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 118.629 1.214 . . . . 0.0 109.412 176.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.36 -42.55 82.29 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 119.477 1.035 . . . . 0.0 112.432 -173.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -69.65 -36.88 76.46 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.46 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.9 m -66.79 -43.1 84.84 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 119.65 -1.906 . . . . 0.0 110.571 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.5 mt -73.02 -39.37 66.05 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.539 1.536 . . . . 0.0 110.79 -174.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.874 0 CA-C-O 116.747 -2.14 . . . . 0.0 118.296 -169.509 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.6 pt . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -120.16 130.5 54.62 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 170.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 p -113.08 151.24 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 124.169 0.988 . . . . 0.0 111.381 -176.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.7 m -147.81 135.9 21.28 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 167.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.3 p -102.45 156.63 17.47 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 121.083 -1.011 . . . . 0.0 108.335 169.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.4 m -148.53 -175.3 4.87 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 125.848 1.659 . . . . 0.0 106.759 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.93 154.7 25.85 Favored Glycine 0 CA--C 1.497 -1.051 0 N-CA-C 108.301 -1.919 . . . . 0.0 108.301 169.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 68.7 tp -49.03 -34.41 13.27 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.877 1.271 . . . . 0.0 109.74 169.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -146.47 148.38 32.18 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 168.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 p -83.03 162.84 21.29 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.81 0.844 . . . . 0.0 111.548 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 69.3 m -160.03 160.28 33.06 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.392 2.277 . . . . 0.0 106.551 169.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.88 138.14 30.51 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 117.813 -1.089 . . . . 0.0 110.386 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.6 p -57.76 130.09 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 120.083 1.311 . . . . 0.0 107.846 170.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -74.29 142.76 78.94 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.083 -169.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.51 -42.29 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.341 1.361 . . . . 0.0 112.25 -169.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.455 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 26.3 m -62.77 -24.95 67.98 Favored 'General case' 0 CA--C 1.535 0.365 0 O-C-N 120.484 -1.385 . . . . 0.0 111.414 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.69 -40.2 59.68 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.462 0.705 . . . . 0.0 111.536 173.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.1 mt -55.68 -46.08 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.38 -38.83 91.18 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 124.439 1.096 . . . . 0.0 110.144 -171.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 8.7 mmm -68.64 -44.01 75.08 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 122.791 1.281 . . . . 0.0 110.557 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 9.7 mtp -65.64 -35.48 80.93 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.327 -0.858 . . . . 0.0 109.867 175.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -62.72 -26.53 68.73 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.657 0.662 . . . . 0.0 111.501 173.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -65.7 -39.87 91.68 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.823 0.738 . . . . 0.0 109.876 173.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 88.7 t -76.67 -25.37 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.617 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.45 25.86 5.61 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.034 1.302 . . . . 0.0 111.718 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.503 HG22 ' H ' ' A' ' 56' ' ' ASP . 12.9 mt -122.89 178.79 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 C-N-CA 125.255 1.422 . . . . 0.0 107.378 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.503 ' H ' HG22 ' A' ' 55' ' ' ILE . 13.3 t70 -143.1 156.1 44.74 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.315 1.446 . . . . 0.0 109.276 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.42 HD11 ' HG2' ' A' ' 17' ' ' MET . 0.4 OUTLIER -128.08 -15.6 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 123.881 0.872 . . . . 0.0 112.351 169.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -45.75 -38.09 6.65 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.687 1.195 . . . . 0.0 112.859 172.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.77 -6.59 85.37 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.557 1.075 . . . . 0.0 114.217 -173.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -125.15 169.59 12.05 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 119.01 1.405 . . . . 0.0 111.036 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.3 p -127.05 169.91 12.88 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.75 1.22 . . . . 0.0 110.819 -172.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.7 p -92.69 160.15 15.11 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.576 1.15 . . . . 0.0 111.284 178.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -154.81 138.7 11.14 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 118.364 -0.827 . . . . 0.0 109.474 -169.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -80.94 152.88 19.15 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.663 2.242 . . . . 0.0 111.703 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.0 tt -52.43 -34.86 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.763 1.225 . . . . 0.0 111.552 173.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -57.78 -23.64 53.26 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.128 1.771 . . . . 0.0 112.371 -175.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -83.37 -6.71 59.55 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.856 0.863 . . . . 0.0 112.79 -175.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -128.57 -176.89 3.97 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.465 1.029 . . . . 0.0 111.269 -176.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.56 132.53 37.31 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 126.672 1.989 . . . . 0.0 108.344 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.32 -30.01 69.24 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.732 1.213 . . . . 0.0 112.702 -176.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -61.29 -21.21 63.73 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.08 0.952 . . . . 0.0 112.496 -174.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -85.86 -15.26 42.4 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.3 0.64 . . . . 0.0 110.778 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -107.8 121.97 45.83 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 124.775 1.23 . . . . 0.0 109.309 -172.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -71.83 -38.33 70.17 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.312 0.245 . . . . 0.0 111.039 177.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.436 HG13 ' HA ' ' A' ' 4' ' ' VAL . 1.1 p -131.5 133.17 62.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -170.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.7 t -124.23 123.13 65.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 122.526 1.155 . . . . 0.0 108.404 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 35.5 mm -113.41 97.09 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.5 m -72.65 156.51 38.89 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 168.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.05 54.72 0.65 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 176.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.8 m . . . . . 0 CA--C 1.53 0.194 0 C-N-CA 124.193 0.997 . . . . 0.0 109.796 176.546 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 . . . . . 0 N--CA 1.466 0.332 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -57.51 -24.9 58.59 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 121.17 -0.956 . . . . 0.0 111.994 174.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.1 p -87.3 -9.97 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 119.65 1.114 . . . . 0.0 110.541 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 49.5 p -113.44 19.88 16.54 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.916 0.886 . . . . 0.0 112.549 -169.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -81.67 175.72 10.23 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.609 0.764 . . . . 0.0 109.663 171.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -57.77 -32.67 67.72 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.905 1.282 . . . . 0.0 113.588 -169.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.0 mt -135.17 139.08 47.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -141.93 137.83 31.57 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 124.276 1.03 . . . . 0.0 108.506 172.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -146.68 158.75 43.97 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.802 1.641 . . . . 0.0 107.421 168.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -121.92 101.4 7.54 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.015 1.326 . . . . 0.0 108.045 168.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.463 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 43.5 m0 -75.44 95.83 3.34 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.539 1.136 . . . . 0.0 108.955 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -59.91 118.55 6.36 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 169.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 38.3 mt -153.43 146.24 24.36 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.846 1.658 . . . . 0.0 107.204 -169.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -83.77 72.8 10.34 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.25 1.42 . . . . 0.0 110.946 -173.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -23.55 100.93 0.08 OUTLIER Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 128.007 2.523 . . . . 0.0 113.075 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.456 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 68.4 Cg_exo -60.97 -2.65 2.32 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 124.236 3.29 . . . . 0.0 116.925 -172.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -52.28 100.49 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.239 1.381 . . . . 0.0 112.157 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.75 20.47 59.69 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.341 1.924 . . . . 0.0 113.561 171.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.456 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 21.2 mm-40 -96.95 179.23 5.01 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.752 1.276 . . . . 0.0 113.052 -169.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.1 m -76.44 154.93 34.33 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.497 1.519 . . . . 0.0 109.877 175.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.8 mt -58.63 -31.77 68.42 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 122.053 -0.404 . . . . 0.0 111.461 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -63.39 -41.08 98.76 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.075 0.398 . . . . 0.0 110.889 177.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 88.9 t -65.63 -46.75 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.455 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 8.0 m-85 -54.59 -53.83 49.38 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.344 0.658 . . . . 0.0 110.732 176.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 31.2 mtt180 -59.75 -41.99 92.21 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 123.947 0.899 . . . . 0.0 111.463 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 93.9 m -61.46 -54.41 43.76 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.2 t -62.97 -43.21 98.91 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 CA-C-O 118.799 -0.62 . . . . 0.0 110.648 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -57.73 -43.81 85.58 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 119.328 0.967 . . . . 0.0 110.139 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.29 -50.2 61.36 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.015 -0.88 . . . . 0.0 111.166 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -58.02 -51.43 69.68 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.243 1.022 . . . . 0.0 110.912 -176.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.6 t -50.83 -55.89 5.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 126.841 2.057 . . . . 0.0 109.934 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -59.34 -46.91 87.31 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 119.405 1.002 . . . . 0.0 110.185 -173.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.07 -42.06 79.95 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.318 1.047 . . . . 0.0 110.547 177.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.463 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 45.4 mtt85 -72.23 -40.97 67.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 117.684 -1.15 . . . . 0.0 110.888 -177.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.413 ' HA ' HD23 ' A' ' 126' ' ' LEU . 99.2 t -54.5 -46.15 71.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 120.653 1.569 . . . . 0.0 109.763 169.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -62.21 -40.9 97.63 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.222 0.919 . . . . 0.0 110.861 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -62.61 -44.24 96.81 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 122.911 0.485 . . . . 0.0 110.542 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 123' ' ' VAL . 0.2 OUTLIER -64.32 -47.59 78.82 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 118.293 -0.86 . . . . 0.0 109.768 -178.111 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 67.3 mt -54.31 -41.46 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.787 0.835 . . . . 0.0 109.452 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.66 -31.53 72.42 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.84 1.2 . . . . 0.0 111.543 -173.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -66.15 -45.91 79.32 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.413 1.085 . . . . 0.0 110.814 176.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.2 pt -89.19 -27.03 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.813 1.245 . . . . 0.0 114.299 -169.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 63.4 m . . . . . 0 C--O 1.248 1.0 0 C-N-CA 125.882 1.673 . . . . 0.0 111.17 -179.231 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.7 mttm . . . . . 0 C--O 1.23 0.061 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.507 ' HE2' ' CE1' ' A' ' 73' ' ' TYR . 32.5 mtpt -96.15 129.14 43.53 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 118.508 -0.758 . . . . 0.0 109.593 175.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.6 p -105.31 140.26 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 118.673 0.67 . . . . 0.0 109.456 171.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.7 tpp -115.58 141.78 47.61 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 169.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -117.62 135.67 53.83 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 169.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -138.28 118.42 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 120.38 1.446 . . . . 0.0 109.382 -170.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.0 t -115.12 163.68 15.28 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.367 0.985 . . . . 0.0 109.723 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -61.45 -21.37 64.08 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 118.129 -0.939 . . . . 0.0 112.821 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -131.77 -0.97 3.83 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 62.32 -48.48 0.17 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 127.595 2.358 . . . . 0.0 115.105 -169.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.7 m -31.11 -40.59 0.03 OUTLIER 'General case' 0 C--O 1.235 0.313 0 N-CA-C 119.542 3.164 . . . . 0.0 119.542 -168.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.7 m -127.45 -63.86 1.02 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.66 1.118 . . . . 0.0 111.405 -169.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -58.13 -50.73 72.49 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.254 0.933 . . . . 0.0 109.787 -171.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 m -69.07 -41.17 77.91 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 117.85 0.296 . . . . 0.0 110.854 -174.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -70.3 -41.27 73.57 Favored 'General case' 0 N--CA 1.463 0.175 0 O-C-N 121.599 -0.688 . . . . 0.0 110.881 -169.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 66.2 mtm -62.06 -41.85 98.58 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 118.082 0.401 . . . . 0.0 110.893 171.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.34 -33.65 69.77 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 118.931 -0.557 . . . . 0.0 110.951 175.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.414 ' HA ' HG21 ' A' ' 32' ' ' VAL . 6.8 tt0 -59.21 -65.06 0.73 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.77 -39.5 77.06 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.015 -0.881 . . . . 0.0 112.549 -175.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -67.18 -45.01 78.23 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 119.274 1.537 . . . . 0.0 109.579 177.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.55 -43.6 93.43 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 120.372 1.442 . . . . 0.0 112.555 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.4 ptmt -69.18 -9.73 54.33 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.941 1.246 . . . . 0.0 113.1 175.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.4 m -92.81 -49.3 6.13 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 119.97 1.259 . . . . 0.0 110.618 170.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.4 mt -79.07 -39.91 32.61 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.352 1.461 . . . . 0.0 112.318 -169.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.343 0 CA-C-O 117.935 -1.481 . . . . 0.0 114.428 -169.058 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.3 pt . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 121.246 0.545 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -128.18 138.5 52.51 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 168.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.414 HG21 ' HA ' ' A' ' 19' ' ' GLU . 2.5 p -113.13 152.17 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-O 122.26 1.029 . . . . 0.0 113.412 -169.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.4 m -139.72 147.63 41.17 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 127.315 2.246 . . . . 0.0 105.123 167.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.3 m -132.21 146.71 52.2 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.831 1.252 . . . . 0.0 108.568 169.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 23.9 p -156.36 -161.79 1.17 Allowed 'General case' 0 C--O 1.242 0.666 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -176.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -151.66 156.96 26.97 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 169.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.3 tp -46.52 -36.87 7.19 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.979 1.712 . . . . 0.0 109.391 169.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -147.03 148.26 31.5 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 102.205 -3.257 . . . . 0.0 102.205 167.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.6 m -125.04 144.16 50.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.199 0.523 . . . . 0.0 112.284 -173.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.0 m -137.64 164.59 28.42 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.403 2.281 . . . . 0.0 107.551 173.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.93 145.62 1.44 Allowed 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.149 1.38 . . . . 0.0 113.232 -169.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.9 p -61.05 132.07 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 169.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.401 ' CE1' ' H ' ' A' ' 106' ' ' GLY . 14.7 t-80 -76.72 145.96 75.66 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.692 -172.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.17 -40.72 0.78 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 121.393 1.396 . . . . 0.0 112.534 -169.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.534 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 24.0 m -66.12 -17.07 64.48 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 120.044 -1.66 . . . . 0.0 111.864 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.68 -40.74 76.11 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 123.984 0.914 . . . . 0.0 110.836 170.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.0 mt -55.14 -52.19 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.18 -38.93 81.01 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 123.741 0.65 . . . . 0.0 111.917 -173.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.6 mmt -59.42 -49.84 76.26 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 122.403 1.097 . . . . 0.0 111.697 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.4 mtp -67.33 -36.15 80.86 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.164 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -61.75 -30.17 70.61 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.315 1.046 . . . . 0.0 111.295 174.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -64.13 -40.78 96.91 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.83 0.741 . . . . 0.0 110.336 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.1 t -75.2 -20.23 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.498 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.63 25.47 9.91 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.697 1.141 . . . . 0.0 111.332 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.531 HG22 ' H ' ' A' ' 56' ' ' ASP . 12.4 mt -121.62 -178.33 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.531 ' H ' HG22 ' A' ' 55' ' ' ILE . 9.8 t70 -146.51 151.73 37.83 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 120.457 -1.402 . . . . 0.0 109.694 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.6 pt -132.68 -3.96 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.405 1.082 . . . . 0.0 112.824 169.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 95.3 p -55.87 -30.62 61.82 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 120.187 1.358 . . . . 0.0 112.146 169.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.05 -7.43 87.6 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 118.729 -1.039 . . . . 0.0 114.087 -176.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.56 172.4 7.87 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.448 1.499 . . . . 0.0 111.16 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 16.8 p -129.46 157.62 41.48 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.368 1.067 . . . . 0.0 111.071 -170.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.6 p -68.21 156.67 37.09 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.717 1.207 . . . . 0.0 110.04 169.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -156.07 143.54 13.91 Favored Pre-proline 0 N--CA 1.469 0.5 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.038 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -81.32 150.4 17.37 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.835 2.357 . . . . 0.0 111.226 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.6 tt -55.27 -33.21 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.272 0.629 . . . . 0.0 111.362 173.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -56.92 -22.11 35.09 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.548 1.939 . . . . 0.0 112.418 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -79.46 -4.64 52.15 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.209 1.004 . . . . 0.0 112.85 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -128.13 177.91 6.59 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.768 1.167 . . . . 0.0 111.753 -175.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.03 140.14 52.84 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 127.183 2.193 . . . . 0.0 106.859 170.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.412 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -72.54 -23.0 60.93 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.115 0.966 . . . . 0.0 112.002 -177.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.86 -24.25 66.79 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.176 0.99 . . . . 0.0 112.472 -173.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -89.82 -15.16 32.9 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.033 0.933 . . . . 0.0 110.505 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.507 ' CE1' ' HE2' ' A' ' 3' ' ' LYS . 83.5 m-85 -86.69 141.62 28.79 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.901 1.281 . . . . 0.0 110.061 178.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -89.98 -34.84 15.85 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.151 0.98 . . . . 0.0 110.64 173.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -140.36 137.67 36.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -172.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.2 m -127.48 108.79 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 123.167 1.461 . . . . 0.0 109.39 -173.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.2 mm -104.26 96.67 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.3 t -71.17 157.0 38.91 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 167.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.21 52.37 0.43 Allowed 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 103.52 -2.77 . . . . 0.0 103.52 174.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 95.4 m . . . . . 0 C--O 1.232 0.147 0 C-N-CA 124.432 1.093 . . . . 0.0 110.153 176.628 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 CA--C 1.532 0.271 0 N-CA-C 114.703 1.372 . . . . 0.0 114.703 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.412 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 95.6 m95 -60.64 10.28 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.792 2.837 . . . . 0.0 114.427 172.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.2 p -128.02 18.61 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 124.623 1.169 . . . . 0.0 112.015 173.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 48.8 p -124.63 18.27 8.77 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -170.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -94.5 -174.9 3.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.52 1.528 . . . . 0.0 109.452 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -66.77 -34.98 79.02 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.57 -0.706 . . . . 0.0 112.506 -174.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.0 mt -134.71 136.58 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -174.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -137.61 138.14 39.22 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 169.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -146.92 159.98 42.88 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.659 1.583 . . . . 0.0 107.388 168.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -123.17 104.52 9.22 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.954 1.302 . . . . 0.0 108.744 169.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.409 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 41.9 m0 -80.71 88.72 5.76 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.996 0.918 . . . . 0.0 108.873 -177.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -62.71 104.49 0.54 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.47 1.108 . . . . 0.0 109.644 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 101' ' ' LEU . 1.2 mm? -136.92 172.16 13.43 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 126.217 1.807 . . . . 0.0 108.511 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -70.78 158.89 35.55 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 166.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -112.48 109.28 53.74 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 169.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.441 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 81.8 Cg_exo -53.31 1.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 1 C-N-CA 126.652 4.901 . . . . 0.0 119.514 -169.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -51.53 98.93 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.844 1.202 . . . . 0.0 112.094 174.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.401 ' H ' ' CE1' ' A' ' 43' ' ' HIS . . . 84.23 18.23 63.11 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 126.197 1.856 . . . . 0.0 113.111 171.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.441 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 24.8 mm-40 -95.18 178.22 5.6 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.811 1.305 . . . . 0.0 111.876 -169.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.9 m -74.09 153.89 39.41 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.236 1.414 . . . . 0.0 109.96 176.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 82.2 mt -60.14 -28.75 68.14 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.762 -0.586 . . . . 0.0 111.843 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.42 -38.8 92.55 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.087 0.403 . . . . 0.0 110.789 174.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 86.7 t -68.49 -46.29 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.534 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 16.3 m-85 -52.98 -54.55 33.45 Favored 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 122.704 0.401 . . . . 0.0 110.561 175.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -59.66 -40.67 88.5 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.175 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.8 m -62.55 -52.29 64.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.432 1.014 . . . . 0.0 109.668 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.86 -45.83 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-O 118.181 -0.914 . . . . 0.0 109.475 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -55.85 -49.61 72.84 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.448 1.022 . . . . 0.0 109.303 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.64 -49.1 82.34 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-O 118.368 -1.24 . . . . 0.0 110.482 -176.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -60.71 -53.49 56.82 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-N 118.371 1.085 . . . . 0.0 110.812 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 68.5 t -52.88 -46.13 51.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 124.355 1.062 . . . . 0.0 110.2 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -63.54 -49.9 71.63 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 119.724 1.147 . . . . 0.0 110.523 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.09 -43.44 70.36 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.338 1.055 . . . . 0.0 110.526 175.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.409 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 81.5 mtt-85 -72.24 -41.25 67.04 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 117.74 -1.124 . . . . 0.0 110.074 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.7 t -54.3 -49.0 66.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 120.629 1.559 . . . . 0.0 108.811 169.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -60.17 -39.85 87.88 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.29 0.95 . . . . 0.0 110.883 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -63.65 -45.48 89.98 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.309 1.043 . . . . 0.0 110.257 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -46.09 89.31 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 123.829 0.852 . . . . 0.0 109.645 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 64.1 mt -60.07 -38.07 75.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.672 1.189 . . . . 0.0 110.921 175.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.69 -31.72 71.88 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 120.139 1.336 . . . . 0.0 111.295 -174.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -69.7 -20.46 63.54 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.596 1.558 . . . . 0.0 113.023 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.7 pt -125.01 -21.21 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -168.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 C--O 1.251 1.134 0 C-N-CA 126.391 1.876 . . . . 0.0 111.124 173.746 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.467 0.386 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -93.08 128.22 38.9 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 169.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.4 p -113.0 136.74 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 123.477 0.711 . . . . 0.0 109.565 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 35.9 tpp -112.93 141.34 46.88 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 170.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -117.47 136.0 53.52 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 169.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.423 HG11 HD12 ' A' ' 65' ' ' ILE . 12.1 t -138.87 131.03 37.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -174.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.23 165.9 18.09 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 120.116 1.325 . . . . 0.0 109.971 169.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -62.74 -10.81 14.05 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.6 ptm85 -153.93 114.27 3.95 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 103.168 -2.901 . . . . 0.0 103.168 169.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -51.83 -25.6 8.13 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.327 1.851 . . . . 0.0 113.25 -176.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.4 p -40.05 -36.87 0.53 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 118.42 2.748 . . . . 0.0 118.42 -168.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.0 p -137.55 -54.52 0.68 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 -169.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -64.59 -51.93 60.16 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 122.221 2.282 . . . . 0.0 108.863 -169.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 82.2 p -70.31 -39.04 75.06 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -170.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -55.89 -50.57 70.3 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.184 0.993 . . . . 0.0 111.096 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 60.0 mtm -64.18 -46.21 84.96 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 117.489 0.132 . . . . 0.0 110.709 178.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.78 -39.49 71.32 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 119.524 -0.274 . . . . 0.0 110.508 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.532 ' HA ' HG21 ' A' ' 32' ' ' VAL . 36.2 tt0 -65.55 -45.35 83.73 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 119.434 -0.317 . . . . 0.0 111.137 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.38 -41.79 99.74 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -65.39 -49.05 70.76 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 117.997 0.899 . . . . 0.0 109.107 174.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.32 -43.15 88.08 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.169 0.895 . . . . 0.0 112.391 -172.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -69.37 -36.56 76.96 Favored 'General case' 0 C--O 1.219 -0.546 0 C-N-CA 118.991 -1.083 . . . . 0.0 110.946 175.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 52.2 m -67.19 -42.48 84.11 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 120.762 1.619 . . . . 0.0 110.495 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.3 mt -77.16 -37.63 53.45 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.38 1.472 . . . . 0.0 111.423 -174.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.702 0 CA-C-O 116.578 -2.234 . . . . 0.0 117.441 -169.116 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.2 pt . . . . . 0 C--O 1.234 0.269 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.73 127.84 53.22 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 105.472 -2.048 . . . . 0.0 105.472 169.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.532 HG21 ' HA ' ' A' ' 19' ' ' GLU . 3.0 p -112.17 150.87 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -173.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.1 m -141.03 144.28 34.9 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 126.012 1.725 . . . . 0.0 107.452 168.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.8 p -117.11 152.73 34.1 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.816 1.646 . . . . 0.0 109.003 168.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 32.1 p -158.14 -165.01 1.61 Allowed 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 176.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.47 160.05 28.31 Favored Glycine 0 CA--C 1.503 -0.68 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 169.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.3 tp -47.51 -35.66 9.15 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.369 1.468 . . . . 0.0 109.758 169.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -142.07 144.14 33.43 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 168.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.2 p -73.75 155.74 38.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.75 0.786 . . . . 0.0 110.885 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 67.5 m -159.19 150.57 20.26 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.513 1.925 . . . . 0.0 106.018 169.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.7 ttt-85 -49.08 146.94 3.16 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.876 1.271 . . . . 0.0 110.831 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.6 t -57.32 129.34 19.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.519 -1.659 . . . . 0.0 106.519 169.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -71.66 137.32 83.06 Favored Pre-proline 0 N--CA 1.444 -0.747 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -72.95 -38.64 2.77 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.04 1.16 . . . . 0.0 111.66 -169.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.438 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 20.6 m -64.4 -24.69 67.72 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.737 -1.227 . . . . 0.0 111.571 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.04 -39.38 66.13 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 121.574 -0.704 . . . . 0.0 111.193 175.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.5 mt -55.86 -46.03 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.26 -40.22 93.67 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 123.99 0.916 . . . . 0.0 110.065 -170.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.9 mmm -67.14 -43.0 83.48 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 122.672 1.225 . . . . 0.0 110.685 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.417 ' SD ' HG12 ' A' ' 57' ' ' ILE . 9.4 mtp -65.42 -34.92 79.43 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.375 -0.828 . . . . 0.0 109.863 174.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.65 -30.53 68.8 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.717 0.69 . . . . 0.0 111.217 173.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -66.69 -38.1 86.08 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.192 0.451 . . . . 0.0 109.879 176.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 64.3 t -77.28 -24.66 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.612 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.13 26.03 5.89 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.161 1.362 . . . . 0.0 111.75 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.489 HG22 ' H ' ' A' ' 56' ' ' ASP . 9.7 mt -124.79 178.34 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 125.091 1.357 . . . . 0.0 107.476 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.489 ' H ' HG22 ' A' ' 55' ' ' ILE . 11.8 t70 -142.23 156.43 45.3 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.514 1.526 . . . . 0.0 109.301 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.417 HG12 ' SD ' ' A' ' 50' ' ' MET . 0.1 OUTLIER -129.06 -15.2 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.041 0.936 . . . . 0.0 112.634 170.505 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -44.62 -37.39 3.6 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.785 1.234 . . . . 0.0 112.715 172.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.95 -7.7 84.22 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.664 1.126 . . . . 0.0 114.384 -174.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -125.77 168.39 13.87 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.244 1.522 . . . . 0.0 110.667 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.0 p -129.36 169.37 14.97 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.207 1.003 . . . . 0.0 111.374 -169.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 54.7 m -89.61 159.66 17.04 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.17 0.988 . . . . 0.0 111.044 174.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -157.91 140.38 10.47 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.954 1.301 . . . . 0.0 108.875 -172.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.52 148.05 32.84 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.562 1.508 . . . . 0.0 110.417 -177.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.423 HD12 HG11 ' A' ' 7' ' ' VAL . 19.7 tt -52.15 -35.03 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 123.878 0.871 . . . . 0.0 111.559 174.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -58.05 -22.21 49.09 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.455 1.902 . . . . 0.0 112.316 -175.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -80.43 -7.01 58.97 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.343 1.057 . . . . 0.0 112.835 -177.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -125.02 179.86 4.85 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.575 1.08 . . . . 0.0 111.06 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.44 139.62 52.26 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 127.085 2.154 . . . . 0.0 107.254 171.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.62 -24.09 66.26 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.97 1.308 . . . . 0.0 111.891 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -60.18 -23.88 64.32 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.008 0.923 . . . . 0.0 112.45 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -83.54 -13.11 55.24 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.036 0.934 . . . . 0.0 110.785 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -107.23 128.0 54.03 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 125.743 1.617 . . . . 0.0 109.208 -174.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -77.17 -34.8 56.29 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.1 p -132.55 137.65 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 123.385 0.674 . . . . 0.0 109.524 -175.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.88 129.04 60.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 122.548 1.166 . . . . 0.0 109.94 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.5 mm -124.06 101.3 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -170.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.7 m -73.74 154.17 39.72 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 168.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -148.62 45.36 1.03 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 177.516 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 99.1 m . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 117.744 -1.122 . . . . 0.0 112.046 -169.535 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -61.63 1.11 0.26 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.122 1.769 . . . . 0.0 113.572 170.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.9 p -121.6 6.23 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.494 1.118 . . . . 0.0 112.019 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 82.8 p -127.48 22.38 6.47 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.355 0.98 . . . . 0.0 112.718 -172.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -89.28 -177.33 5.36 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.432 0.693 . . . . 0.0 109.922 173.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -64.0 -31.79 73.11 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.131 0.573 . . . . 0.0 112.525 -171.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.3 mt -135.84 134.36 51.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -141.04 138.12 33.4 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 169.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -145.26 157.19 44.12 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.03 1.332 . . . . 0.0 107.968 168.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -120.94 102.92 8.67 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.1 1.36 . . . . 0.0 109.177 169.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.424 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 39.8 m0 -78.88 93.79 5.08 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.877 1.671 . . . . 0.0 108.927 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -65.99 107.22 1.81 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -129.41 157.67 41.31 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 125.712 1.605 . . . . 0.0 109.906 -175.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -82.48 61.09 5.46 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.419 1.488 . . . . 0.0 112.126 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 53.1 t0 4.11 83.27 0.04 OUTLIER Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 129.603 3.161 . . . . 0.0 113.424 169.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.424 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 80.8 Cg_exo -60.06 -5.93 4.4 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 123.174 2.583 . . . . 0.0 117.491 -169.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -60.23 90.78 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.728 1.211 . . . . 0.0 111.86 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.89 15.08 27.43 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 126.283 1.896 . . . . 0.0 113.376 173.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.424 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 30.6 mm-40 -91.94 179.05 5.71 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.013 1.407 . . . . 0.0 112.866 -169.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 41.5 m -75.54 155.7 35.81 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.563 1.545 . . . . 0.0 109.988 175.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.77 -33.39 70.24 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.944 -0.473 . . . . 0.0 111.563 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.28 -39.18 93.4 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.577 0.351 . . . . 0.0 110.764 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 99.2 t -66.08 -47.55 84.53 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 175.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.438 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 7.2 m-85 -54.76 -51.38 65.86 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.006 0.522 . . . . 0.0 111.026 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 24.0 mtt180 -60.29 -42.77 96.15 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.473 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 88.9 m -62.18 -55.16 31.43 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.4 t -61.01 -43.08 95.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 118.855 -0.593 . . . . 0.0 110.312 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.76 -45.19 93.01 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 119.396 0.998 . . . . 0.0 110.374 -177.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.42 -46.5 90.31 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -63.85 -46.39 85.24 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.988 0.915 . . . . 0.0 111.186 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.0 t -56.77 -51.71 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 125.65 1.58 . . . . 0.0 110.228 171.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -58.4 -45.35 88.53 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.114 0.87 . . . . 0.0 110.366 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -55.67 -45.88 77.67 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.9 0.88 . . . . 0.0 109.254 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.424 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 60.4 mtt85 -70.38 -39.05 74.79 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-O 118.086 -0.959 . . . . 0.0 110.782 -174.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.5 t -54.81 -48.56 73.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 120.373 1.442 . . . . 0.0 109.594 169.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -60.85 -40.33 92.48 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 119.625 1.102 . . . . 0.0 110.858 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -61.21 -46.46 90.36 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.259 1.424 . . . . 0.0 109.945 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.32 -48.43 73.08 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 124.011 0.925 . . . . 0.0 110.08 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 45.8 mt -55.31 -38.99 50.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.751 1.22 . . . . 0.0 110.631 174.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.37 -30.73 70.72 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.772 1.169 . . . . 0.0 111.237 -173.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -72.78 -20.79 61.1 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.691 1.596 . . . . 0.0 112.638 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.0 pt -123.37 -22.36 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -168.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 C--O 1.251 1.159 0 C-N-CA 126.181 1.792 . . . . 0.0 111.194 175.854 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt . . . . . 0 N--CA 1.464 0.261 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.4 mttt -95.33 136.28 35.88 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 121.7 -0.625 . . . . 0.0 109.491 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.5 t -121.2 127.22 75.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -173.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 42.2 tpp -110.89 141.01 44.87 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 169.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -109.85 130.52 55.51 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 169.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.4 t -132.23 119.0 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 120.447 1.476 . . . . 0.0 109.141 -169.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.401 ' HB3' ' H ' ' A' ' 11' ' ' ASN . 41.1 t -124.7 159.27 31.24 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.969 1.258 . . . . 0.0 110.704 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.2 mttm -58.49 -12.81 4.34 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.189 0.995 . . . . 0.0 113.115 169.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -138.6 -12.13 1.34 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 173.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.401 ' H ' ' HB3' ' A' ' 8' ' ' CYS . 27.2 t-20 64.52 -43.82 0.3 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.744 2.418 . . . . 0.0 114.599 -169.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.0 m -40.25 -23.58 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 121.028 3.714 . . . . 0.0 121.028 -168.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 23.6 m -140.99 -62.84 0.47 Allowed 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 120.443 1.474 . . . . 0.0 111.174 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -59.79 -50.36 74.13 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.669 0.668 . . . . 0.0 109.583 -169.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.43 -43.81 69.17 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.389 0.276 . . . . 0.0 111.178 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -59.89 -46.4 89.44 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.69 0.796 . . . . 0.0 111.359 -174.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.525 ' HG2' HD11 ' A' ' 57' ' ' ILE . 56.6 mtm -67.71 -45.63 74.52 Favored 'General case' 0 C--O 1.231 0.114 0 O-C-N 122.276 -0.265 . . . . 0.0 110.551 177.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.48 -38.29 71.52 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 122.281 0.232 . . . . 0.0 111.053 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -64.91 -55.87 16.71 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 118.448 -0.787 . . . . 0.0 110.372 178.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -52.04 -40.25 50.75 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 119.481 -0.622 . . . . 0.0 112.149 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -64.9 -51.12 63.65 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 118.717 1.258 . . . . 0.0 110.266 173.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.6 -44.78 89.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 119.708 1.14 . . . . 0.0 112.88 -174.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -70.19 -9.69 56.53 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 119.732 1.151 . . . . 0.0 113.281 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.5 m -92.57 -48.2 6.73 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 119.892 1.224 . . . . 0.0 110.423 169.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.0 mt -77.49 -43.55 31.82 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.881 1.672 . . . . 0.0 112.073 -169.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.353 0 CA-C-O 118.038 -1.423 . . . . 0.0 114.923 -169.089 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.7 pt . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 121.564 0.697 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -123.63 133.24 53.96 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 104.381 -2.452 . . . . 0.0 104.381 169.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.4 p -118.45 155.28 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-O 121.88 0.848 . . . . 0.0 112.541 -169.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.8 m -148.26 152.72 37.63 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.915 1.686 . . . . 0.0 107.216 167.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.3 p -118.35 153.35 34.16 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.53 1.132 . . . . 0.0 108.535 168.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 23.4 p -152.43 -169.99 3.51 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 173.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.92 163.12 30.79 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 169.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.7 mt -58.5 -32.24 68.62 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.971 0.508 . . . . 0.0 110.601 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -142.45 132.76 24.86 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 103.623 -2.732 . . . . 0.0 103.623 168.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.3 p -76.24 149.97 37.09 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.951 0.5 . . . . 0.0 111.084 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.1 m -147.52 158.45 44.0 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.081 2.152 . . . . 0.0 106.513 169.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.04 144.8 11.32 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.922 0.889 . . . . 0.0 110.905 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.6 p -65.11 138.42 23.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 169.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.4 ' CG ' ' HD2' ' A' ' 44' ' ' PRO . 7.4 t-80 -83.38 149.48 58.14 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 123.479 0.711 . . . . 0.0 109.607 -174.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HD2' ' CG ' ' A' ' 43' ' ' HIS . 87.2 Cg_endo -81.86 -38.76 0.2 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 121.562 1.508 . . . . 0.0 112.907 -169.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.438 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 28.5 m -62.76 -27.23 69.14 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.297 1.408 . . . . 0.0 111.24 -177.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.28 -44.24 22.99 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.019 0.928 . . . . 0.0 111.175 171.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 52.3 mt -55.93 -45.52 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 C-N-CA 124.287 1.035 . . . . 0.0 108.291 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.47 -34.25 77.77 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.28 1.032 . . . . 0.0 110.104 -172.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 8.1 mmm -70.66 -41.49 72.02 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-O 122.547 1.165 . . . . 0.0 110.386 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.497 ' HG3' ' CG1' ' A' ' 57' ' ' ILE . 87.2 mmm -62.9 -41.13 99.33 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -61.63 -25.66 67.5 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.291 0.636 . . . . 0.0 111.096 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -65.61 -42.24 91.84 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 118.652 0.66 . . . . 0.0 110.094 171.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.3 t -76.22 -25.78 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.78 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.66 23.2 6.33 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.454 1.502 . . . . 0.0 111.958 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.4 mt -121.42 177.44 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 125.742 1.617 . . . . 0.0 107.693 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -143.9 157.51 44.31 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.484 1.513 . . . . 0.0 109.957 -176.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.525 HD11 ' HG2' ' A' ' 17' ' ' MET . 0.6 OUTLIER -130.45 -17.78 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.153 0.981 . . . . 0.0 111.983 169.607 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -42.58 -38.18 1.9 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.959 1.304 . . . . 0.0 113.292 173.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.0 -10.75 68.94 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 118.551 -1.138 . . . . 0.0 114.033 -175.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -123.99 168.75 12.41 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 119.181 1.491 . . . . 0.0 112.641 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.2 p -127.37 -176.05 3.62 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 126.526 1.931 . . . . 0.0 109.679 -174.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.7 p -113.56 158.95 20.12 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.284 1.433 . . . . 0.0 110.908 -175.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -151.22 149.9 25.84 Favored Pre-proline 0 N--CA 1.467 0.409 0 C-N-CA 124.218 1.007 . . . . 0.0 109.827 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.47 150.87 19.64 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.977 2.451 . . . . 0.0 110.617 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.2 tt -52.24 -36.22 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.766 1.226 . . . . 0.0 110.756 172.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -58.17 -25.55 61.64 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.838 1.655 . . . . 0.0 112.884 -171.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.81 -9.74 45.34 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -176.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -98.97 -174.45 2.77 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.371 0.987 . . . . 0.0 110.127 175.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.6 128.41 20.49 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 126.841 2.056 . . . . 0.0 106.941 175.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.92 -27.24 66.58 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.898 0.879 . . . . 0.0 111.969 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -60.28 -23.55 64.24 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.237 1.015 . . . . 0.0 112.644 -175.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -84.65 -16.55 41.55 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.101 0.56 . . . . 0.0 110.761 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -109.1 112.89 25.31 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 125.354 1.462 . . . . 0.0 108.323 -172.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -76.44 -21.6 55.71 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.328 0.585 . . . . 0.0 109.673 -176.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.1 t -133.98 134.83 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 125.803 1.641 . . . . 0.0 107.229 -172.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -137.36 119.39 19.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 123.023 1.392 . . . . 0.0 109.726 -176.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.2 mm -112.74 94.13 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 66.9 m -72.4 157.34 37.83 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 167.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.87 50.61 0.67 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 74.7 m . . . . . 0 N--CA 1.452 -0.334 0 C-N-CA 124.431 1.092 . . . . 0.0 108.89 171.964 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 . . . . . 0 N--CA 1.472 0.632 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -61.87 0.05 0.42 Allowed 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 126.024 1.73 . . . . 0.0 112.378 169.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.6 m -114.33 5.17 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 120.376 1.444 . . . . 0.0 112.46 170.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.8 p -120.98 21.99 11.18 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.979 0.911 . . . . 0.0 111.716 -177.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -90.52 -178.99 5.46 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.375 1.07 . . . . 0.0 109.382 171.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.56 -36.42 82.61 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.719 0.808 . . . . 0.0 112.922 -169.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.9 mt -133.16 134.77 57.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -141.63 136.92 31.45 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.355 1.062 . . . . 0.0 108.835 172.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -146.47 159.51 43.31 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.822 1.649 . . . . 0.0 107.68 168.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -124.55 92.47 3.66 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.182 1.393 . . . . 0.0 109.045 169.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -66.01 141.54 58.14 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.746 0.819 . . . . 0.0 110.891 -176.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -110.71 92.03 3.89 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.845 1.258 . . . . 0.0 107.689 -170.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -131.1 149.68 52.49 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.679 1.592 . . . . 0.0 109.107 -170.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -84.47 56.81 3.98 Favored 'General case' 0 C--O 1.228 -0.072 0 C-N-CA 126.37 1.868 . . . . 0.0 112.05 -172.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.3 t0 5.94 82.35 0.04 OUTLIER Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 129.903 3.281 . . . . 0.0 113.977 169.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.457 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 84.2 Cg_exo -54.5 -13.86 6.2 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 125.271 3.981 . . . . 0.0 118.633 -169.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.29 90.17 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 120.3 1.409 . . . . 0.0 111.925 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.85 6.69 26.25 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 126.282 1.896 . . . . 0.0 113.164 174.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.457 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 28.4 mm-40 -89.67 -178.5 5.55 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.81 1.305 . . . . 0.0 112.056 -169.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.0 m -78.98 156.96 28.24 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.971 1.308 . . . . 0.0 109.909 173.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 70.4 mt -59.79 -32.9 71.05 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 122.086 -0.384 . . . . 0.0 111.498 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -61.21 -39.9 91.96 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.376 0.534 . . . . 0.0 110.622 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.7 t -67.25 -46.57 83.72 Favored 'Isoleucine or valine' 0 C--N 1.338 0.086 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.438 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 11.7 m-85 -53.98 -52.57 60.29 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 122.608 0.363 . . . . 0.0 110.729 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.1 mtp180 -64.18 -40.91 97.1 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 118.511 -0.756 . . . . 0.0 111.09 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.5 m -63.37 -52.53 61.32 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.75 -42.74 95.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.216 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.79 -44.3 90.71 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-N 120.277 1.399 . . . . 0.0 110.365 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.84 -49.35 76.76 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -61.56 -44.9 96.19 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.266 1.033 . . . . 0.0 111.869 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.5 t -58.59 -50.05 80.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 125.606 1.562 . . . . 0.0 109.806 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -58.49 -45.78 88.02 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 119.478 1.035 . . . . 0.0 110.119 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.59 -43.6 80.24 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.307 1.043 . . . . 0.0 110.345 176.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 46.3 mtt85 -71.61 -40.9 69.52 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-O 117.965 -1.017 . . . . 0.0 111.088 -177.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.418 ' HA ' HD23 ' A' ' 126' ' ' LEU . 95.0 t -54.47 -48.22 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 120.505 1.502 . . . . 0.0 109.499 169.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -60.05 -40.13 88.34 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.4 1.0 . . . . 0.0 110.615 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -62.2 -45.74 92.02 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.244 1.018 . . . . 0.0 110.347 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 123' ' ' VAL . 0.2 OUTLIER -63.1 -47.45 82.79 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.012 0.925 . . . . 0.0 109.834 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 61.5 mt -58.88 -37.88 69.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 124.607 1.163 . . . . 0.0 110.491 176.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.79 -29.67 69.59 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.941 1.246 . . . . 0.0 111.486 -174.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 41.7 mttm -73.52 -19.57 60.88 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.974 1.71 . . . . 0.0 112.93 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.2 pt -125.95 -20.27 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.895 1.678 . . . . 0.0 114.941 -168.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.9 m . . . . . 0 C--O 1.251 1.16 0 C-N-CA 126.457 1.903 . . . . 0.0 110.886 169.883 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.467 0.392 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -102.46 117.99 35.91 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 72.9 t -97.37 137.94 23.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 125.517 1.527 . . . . 0.0 108.128 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 35.5 tpp -126.01 143.64 51.02 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 169.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.401 ' HE2' HG21 ' A' ' 32' ' ' VAL . 81.6 m-85 -114.02 133.23 55.64 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 169.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.3 t -136.26 122.15 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 120.065 1.302 . . . . 0.0 108.551 -169.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.442 ' HB3' ' H ' ' A' ' 11' ' ' ASN . 43.0 t -129.9 163.6 26.0 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.146 0.885 . . . . 0.0 111.288 -173.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -59.49 -21.96 60.89 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 118.202 -0.904 . . . . 0.0 112.303 169.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -138.01 -9.68 1.55 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 116.18 1.918 . . . . 0.0 116.18 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.442 ' H ' ' HB3' ' A' ' 8' ' ' CYS . 26.0 t-20 61.99 -43.1 0.16 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 128.346 2.659 . . . . 0.0 115.872 -174.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.7 p -35.16 -38.99 0.1 Allowed 'General case' 0 C--O 1.233 0.228 0 C-N-CA 129.596 3.159 . . . . 0.0 118.499 -168.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.4 p -133.13 -59.94 0.87 Allowed 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 118.757 -0.639 . . . . 0.0 111.129 -169.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.0 mtm180 -58.32 -56.73 18.27 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -171.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.6 -42.64 77.87 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.516 0.327 . . . . 0.0 111.063 -177.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -60.37 -45.86 92.02 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.65 0.78 . . . . 0.0 111.423 -174.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 49.4 mtm -62.3 -46.41 88.87 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 110.494 -0.187 . . . . 0.0 110.494 175.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.16 -39.15 78.1 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 119.742 -0.17 . . . . 0.0 111.062 -178.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -63.69 -45.88 88.02 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.47 0.708 . . . . 0.0 110.422 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.24 -44.55 97.54 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -65.55 -47.33 76.23 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 118.624 1.212 . . . . 0.0 108.75 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.81 -43.18 85.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 119.366 0.985 . . . . 0.0 112.372 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -76.25 -2.35 30.98 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 119.047 0.84 . . . . 0.0 113.159 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.0 m -96.9 -45.64 6.54 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 121.301 -0.874 . . . . 0.0 109.445 169.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 91.8 mt -74.05 -41.03 62.38 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.96 1.704 . . . . 0.0 111.151 -171.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.84 0 CA-C-O 117.971 -1.46 . . . . 0.0 115.631 -169.818 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.8 pt . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -118.3 134.71 54.8 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 169.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.401 HG21 ' HE2' ' A' ' 6' ' ' PHE . 13.5 p -123.64 152.55 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-O 121.439 0.637 . . . . 0.0 112.061 -176.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.3 m -144.35 161.88 37.87 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.944 1.298 . . . . 0.0 108.131 169.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 94.1 p -126.71 155.95 41.87 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 124.901 1.28 . . . . 0.0 109.107 168.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.3 p -154.51 -165.87 2.19 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 174.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.55 163.75 33.68 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 169.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.1 mt -52.08 -31.76 31.83 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.267 1.027 . . . . 0.0 110.237 174.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -148.01 145.67 28.61 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 168.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.5 p -79.03 161.68 26.43 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.579 0.704 . . . . 0.0 111.313 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.6 m -157.0 166.06 34.42 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.417 1.887 . . . . 0.0 107.284 169.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.1 ptt-85 -51.96 143.35 13.83 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.653 1.181 . . . . 0.0 110.728 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 56.0 t -63.4 130.34 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 168.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -70.63 138.78 86.0 Favored Pre-proline 0 N--CA 1.448 -0.555 0 CA-C-O 118.771 -0.633 . . . . 0.0 109.615 -174.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.18 -40.12 1.84 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 121.074 1.183 . . . . 0.0 111.471 -172.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.505 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 11.2 m -67.67 -18.08 64.82 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 120.488 -1.382 . . . . 0.0 111.916 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.441 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -58.21 -39.43 78.99 Favored 'General case' 0 C--N 1.339 0.116 0 O-C-N 121.275 -0.89 . . . . 0.0 110.63 171.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.4 mt -57.8 -46.15 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.54 -40.97 96.6 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.531 0.732 . . . . 0.0 112.036 -176.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.5 mmt -58.5 -49.15 78.42 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 122.558 1.17 . . . . 0.0 111.302 177.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.405 ' SD ' HG12 ' A' ' 57' ' ' ILE . 8.1 mtp -68.82 -36.26 77.99 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.651 -1.158 . . . . 0.0 108.899 -177.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -62.46 -28.96 70.18 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.18 0.592 . . . . 0.0 111.514 173.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -64.25 -39.67 94.42 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.02 0.827 . . . . 0.0 110.176 173.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.0 t -78.58 -23.98 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 119.743 -0.17 . . . . 0.0 110.766 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.46 24.95 6.52 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.913 1.245 . . . . 0.0 111.882 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.565 HG22 ' H ' ' A' ' 56' ' ' ASP . 11.1 mt -122.72 -178.23 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 C-N-CA 125.938 1.695 . . . . 0.0 106.821 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.565 ' H ' HG22 ' A' ' 55' ' ' ILE . 10.1 t70 -147.93 156.12 42.32 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 120.438 -1.414 . . . . 0.0 109.909 -176.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.446 HD13 HG21 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -129.79 -16.38 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.277 1.031 . . . . 0.0 112.227 169.534 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.7 p -51.86 -31.39 27.74 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.707 1.139 . . . . 0.0 112.451 177.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.84 -6.28 88.59 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.814 1.197 . . . . 0.0 114.366 -177.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -125.77 168.65 13.51 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.369 1.584 . . . . 0.0 110.824 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.7 p -128.0 170.92 12.34 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.063 0.945 . . . . 0.0 111.372 -171.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.6 p -85.62 162.99 18.59 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.188 1.395 . . . . 0.0 111.06 175.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -157.89 145.15 13.44 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 123.775 0.83 . . . . 0.0 109.345 -178.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -81.32 153.71 18.53 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.26 1.973 . . . . 0.0 110.936 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.4 tt -55.04 -34.03 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 123.706 0.802 . . . . 0.0 111.123 175.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -57.52 -23.22 49.0 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.369 1.867 . . . . 0.0 112.402 -174.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -85.17 -3.65 58.88 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.864 0.866 . . . . 0.0 112.819 -175.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -124.95 -174.25 2.99 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.426 1.09 . . . . 0.0 110.833 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.39 128.17 20.42 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.849 2.059 . . . . 0.0 107.63 175.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.84 -26.86 64.57 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.08 0.952 . . . . 0.0 112.554 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -59.42 -23.39 62.6 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.088 0.955 . . . . 0.0 112.488 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -83.67 -14.76 51.06 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.39 0.676 . . . . 0.0 110.799 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -108.32 120.36 42.15 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 125.704 1.602 . . . . 0.0 109.079 -172.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -75.25 -30.81 60.62 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.374 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.538 HG21 HD13 ' A' ' 126' ' ' LEU . 0.2 OUTLIER -131.52 130.13 62.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -173.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.0 m -127.73 115.29 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 123.618 1.675 . . . . 0.0 109.855 -174.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.0 mm -110.22 101.78 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -175.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.7 t -72.7 155.41 40.01 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 168.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.18 50.8 0.72 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 171.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 85.4 m . . . . . 0 CA--C 1.534 0.346 0 C-N-CA 123.45 0.7 . . . . 0.0 110.947 174.601 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -63.65 6.28 0.16 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 126.324 1.85 . . . . 0.0 112.593 169.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 p -117.85 2.18 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 125.23 1.412 . . . . 0.0 111.505 172.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.8 p -127.72 24.05 6.17 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.124 -0.985 . . . . 0.0 112.292 -172.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -90.55 -176.73 4.84 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.324 0.65 . . . . 0.0 109.26 169.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -66.13 -32.14 73.42 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -169.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.0 mt -134.11 132.38 55.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -177.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -140.1 138.21 35.11 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.143 0.977 . . . . 0.0 108.856 174.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -146.65 159.44 43.46 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.152 1.381 . . . . 0.0 107.762 168.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -122.05 113.43 19.53 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.879 1.272 . . . . 0.0 108.622 168.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.445 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 40.0 m0 -87.4 97.1 10.63 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -177.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -62.03 118.88 7.89 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 169.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 60.0 mt -150.21 150.57 31.77 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.236 1.415 . . . . 0.0 107.794 -169.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.8 mp0 -83.12 57.32 3.88 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.819 1.648 . . . . 0.0 111.999 -173.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.9 t70 2.76 85.53 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 129.377 3.071 . . . . 0.0 114.486 173.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.461 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 67.0 Cg_exo -60.13 -8.01 7.47 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.523 2.815 . . . . 0.0 117.411 -169.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -55.36 100.72 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 120.528 1.513 . . . . 0.0 111.811 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.24 18.32 43.13 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 126.482 1.991 . . . . 0.0 113.382 171.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.461 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 23.7 mm-40 -98.31 177.01 5.51 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.012 1.406 . . . . 0.0 113.234 -169.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 37.7 m -75.77 154.77 36.09 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.987 1.715 . . . . 0.0 110.081 175.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 71.1 mt -59.14 -31.34 68.87 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 121.812 -0.555 . . . . 0.0 111.899 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.7 mp0 -62.3 -41.07 98.21 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.417 0.687 . . . . 0.0 110.387 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.63 -43.4 86.87 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.505 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 14.3 m-85 -55.68 -52.44 63.84 Favored 'General case' 0 N--CA 1.458 -0.069 0 CA-C-O 118.683 -0.675 . . . . 0.0 110.752 175.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 72.9 mtp85 -59.54 -41.5 90.19 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.248 0.931 . . . . 0.0 111.758 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.9 m -61.04 -46.7 89.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 118.682 0.674 . . . . 0.0 110.039 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.4 t -70.46 -42.97 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 117.79 -1.1 . . . . 0.0 110.257 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.9 ttp180 -56.34 -44.85 80.43 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 119.923 1.238 . . . . 0.0 109.48 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.04 -48.8 84.32 Favored Glycine 0 CA--C 1.521 0.426 0 CA-C-O 118.702 -1.055 . . . . 0.0 110.69 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -59.8 -55.55 32.83 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 118.113 0.956 . . . . 0.0 110.182 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.7 t -48.17 -53.91 5.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.698 1.599 . . . . 0.0 110.234 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -63.55 -47.51 81.28 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 119.412 1.006 . . . . 0.0 110.221 -172.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -53.98 -45.27 71.35 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.654 0.781 . . . . 0.0 109.8 174.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.445 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 78.0 mtt-85 -71.46 -37.61 71.36 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.173 -173.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.403 ' HA ' HD23 ' A' ' 126' ' ' LEU . 96.2 t -56.44 -48.37 80.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 120.726 1.603 . . . . 0.0 109.242 168.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -60.54 -35.29 75.64 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.259 0.936 . . . . 0.0 110.598 177.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -65.2 -45.16 85.86 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.445 1.498 . . . . 0.0 110.414 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.538 HD13 HG21 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -65.24 -44.47 88.06 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 123.204 0.602 . . . . 0.0 110.372 179.357 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 86.4 mt -56.6 -36.9 49.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 124.286 1.034 . . . . 0.0 109.861 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.27 -35.46 77.92 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 120.363 1.438 . . . . 0.0 111.094 -177.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -59.03 -52.44 65.74 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.604 0.762 . . . . 0.0 110.37 174.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pt -80.1 -39.01 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.657 1.183 . . . . 0.0 112.517 -171.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . 0.259 6.0 p . . . . . 0 C--O 1.25 1.084 0 C-N-CA 130.744 3.617 . . . . 0.0 114.003 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -106.37 106.7 17.34 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 123.974 0.91 . . . . 0.0 109.725 178.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 57.2 t -85.41 139.7 17.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 125.934 1.694 . . . . 0.0 109.218 176.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 20.1 tpp -127.13 145.96 50.55 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.242 0.617 . . . . 0.0 109.59 169.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -120.47 120.77 36.86 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.825 1.65 . . . . 0.0 108.492 171.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.6 t -128.4 141.79 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.939 1.296 . . . . 0.0 109.263 -169.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 28.4 p -152.65 -170.61 3.68 Favored 'General case' 0 C--O 1.222 -0.354 0 O-C-N 120.976 -1.078 . . . . 0.0 112.869 -169.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -80.87 -24.96 37.99 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.321 1.048 . . . . 0.0 112.915 169.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -159.83 108.77 1.78 Allowed 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 -173.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -54.07 -17.51 2.76 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.525 1.53 . . . . 0.0 113.567 -173.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -38.93 -47.18 1.41 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 127.859 2.464 . . . . 0.0 117.177 -169.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.0 p -132.32 -77.32 0.5 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 116.009 -1.948 . . . . 0.0 114.561 -168.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.2 -49.14 33.92 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 121.601 2.0 . . . . 0.0 111.246 -168.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.77 -48.61 71.24 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.825 1.65 . . . . 0.0 110.709 -174.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -64.97 -42.02 94.94 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 124.541 1.136 . . . . 0.0 111.338 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 63.2 mtp -60.71 -48.78 80.24 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.27 1.028 . . . . 0.0 108.913 175.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.06 -41.04 87.0 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 122.968 0.507 . . . . 0.0 111.132 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -62.4 -45.23 94.07 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.505 0.722 . . . . 0.0 110.016 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.01 -45.2 97.1 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.448 -0.64 . . . . 0.0 111.645 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -65.26 -52.13 56.34 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 118.661 1.23 . . . . 0.0 108.58 175.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.01 -42.76 76.91 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.416 1.086 . . . . 0.0 112.508 -173.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -70.23 -35.54 73.91 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 118.791 0.723 . . . . 0.0 110.111 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.9 m -67.17 -43.27 82.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 119.521 -1.987 . . . . 0.0 110.504 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.6 mt -71.52 -39.94 70.43 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.071 1.748 . . . . 0.0 110.78 -174.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.844 0 CA-C-O 116.725 -2.153 . . . . 0.0 118.284 -169.479 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.5 pt . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.99 139.67 50.39 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 169.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 p -131.59 148.64 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.2 0.524 . . . . 0.0 111.871 -175.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 m -142.14 160.69 39.74 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.069 170.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 91.7 p -129.23 157.39 41.98 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.067 1.347 . . . . 0.0 108.265 168.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.4 p -153.04 -164.82 2.02 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.93 159.63 29.15 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 169.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 75.0 mt -52.5 -28.87 22.22 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.241 1.417 . . . . 0.0 110.556 172.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -144.57 146.58 32.41 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 168.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.1 p -72.1 159.25 34.46 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.94 0.896 . . . . 0.0 111.439 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.2 p -153.85 165.3 36.5 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.582 1.953 . . . . 0.0 106.904 170.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -66.09 154.16 40.35 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 120.896 -1.127 . . . . 0.0 109.556 172.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.4 t -62.46 132.75 28.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 169.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -74.14 140.4 76.7 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -75.3 -41.32 0.63 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.277 1.318 . . . . 0.0 112.124 -169.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.452 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 27.7 m -63.41 -25.34 68.23 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.536 -1.352 . . . . 0.0 111.576 -178.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.422 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -51.95 -39.44 59.24 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.467 0.707 . . . . 0.0 111.541 173.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.6 mt -56.2 -45.78 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.68 -38.25 88.75 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.265 1.026 . . . . 0.0 110.09 -170.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.3 mmm -69.84 -44.1 70.59 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 122.751 1.263 . . . . 0.0 110.569 -177.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.3 mtp -65.03 -36.15 83.45 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.482 -0.761 . . . . 0.0 109.683 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -63.25 -25.99 68.58 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.243 0.617 . . . . 0.0 111.417 174.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -66.26 -39.63 89.59 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.873 0.76 . . . . 0.0 109.817 173.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.3 t -76.96 -24.93 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.636 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.82 26.44 5.81 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.008 1.29 . . . . 0.0 111.67 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.458 HG22 ' H ' ' A' ' 56' ' ' ASP . 12.2 mt -122.67 177.32 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 125.194 1.398 . . . . 0.0 107.252 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.458 ' H ' HG22 ' A' ' 55' ' ' ILE . 13.8 t70 -142.16 156.43 45.35 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.107 1.363 . . . . 0.0 109.421 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.428 HD13 HG21 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -127.48 -16.96 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 123.781 0.832 . . . . 0.0 112.27 169.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -45.2 -39.08 5.89 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.679 1.192 . . . . 0.0 112.791 173.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.55 -4.56 89.27 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.625 1.107 . . . . 0.0 114.266 -172.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -126.78 165.47 19.23 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.125 1.462 . . . . 0.0 110.705 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 25.7 p -128.01 170.79 12.49 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.972 0.909 . . . . 0.0 111.361 -170.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.8 p -87.48 169.33 12.31 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.434 1.494 . . . . 0.0 112.034 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.24 135.07 6.64 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 123.966 0.907 . . . . 0.0 108.698 -174.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.36 154.29 31.8 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.767 2.311 . . . . 0.0 111.4 176.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.2 tt -55.9 -34.45 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 123.764 0.825 . . . . 0.0 111.33 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -60.1 -22.0 62.23 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.823 1.649 . . . . 0.0 112.205 -173.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -80.82 -2.5 47.5 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.179 0.992 . . . . 0.0 112.569 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -130.65 -179.87 5.55 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.586 1.085 . . . . 0.0 111.984 -174.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.08 139.43 45.96 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 127.812 2.445 . . . . 0.0 106.547 169.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.4 -24.89 66.55 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.549 1.14 . . . . 0.0 111.593 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -60.86 -24.56 66.01 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.022 0.929 . . . . 0.0 112.497 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -82.96 -17.92 41.81 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.909 0.884 . . . . 0.0 110.53 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -97.82 122.4 40.89 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 125.623 1.569 . . . . 0.0 108.546 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -73.11 -29.4 62.88 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 175.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.47 134.34 43.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 C-N-CA 122.507 0.323 . . . . 0.0 110.317 -170.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.5 m -127.03 128.98 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 122.135 0.969 . . . . 0.0 110.115 -175.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 49.9 mm -116.36 135.15 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.3 m -104.18 146.52 28.64 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 123.92 0.762 . . . . 0.0 109.233 169.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.97 53.92 0.35 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.047 1.739 . . . . 0.0 107.741 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 83.2 m . . . . . 0 CA--C 1.531 0.244 0 C-N-CA 123.802 0.841 . . . . 0.0 110.959 172.168 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -63.29 5.78 0.15 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.318 1.847 . . . . 0.0 113.756 170.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.4 p -126.44 5.17 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.338 1.055 . . . . 0.0 112.388 171.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.0 p -120.36 21.22 11.75 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.642 1.11 . . . . 0.0 112.61 -171.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -90.81 -176.78 4.79 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.624 0.769 . . . . 0.0 109.543 173.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -65.65 -31.56 72.65 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -170.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.7 mt -134.39 137.24 51.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -137.03 136.34 38.35 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 169.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -143.11 155.6 44.63 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.286 1.434 . . . . 0.0 107.853 169.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -120.63 132.53 55.17 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.147 1.379 . . . . 0.0 108.884 169.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.464 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 39.7 m0 -116.52 96.41 5.5 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.829 1.652 . . . . 0.0 107.472 -172.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -72.92 83.59 1.23 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.517 1.527 . . . . 0.0 109.721 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.32 154.0 23.12 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 125.208 1.403 . . . . 0.0 109.844 -175.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -78.25 65.85 3.7 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.204 1.402 . . . . 0.0 111.819 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -13.41 92.17 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 129.036 2.935 . . . . 0.0 114.308 178.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.428 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 52.6 Cg_exo -61.71 -6.91 8.13 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.927 3.085 . . . . 0.0 116.769 -169.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -60.42 88.62 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 120.214 1.37 . . . . 0.0 111.3 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.16 14.86 23.33 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 126.604 2.049 . . . . 0.0 113.874 175.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.428 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 29.9 mm-40 -93.82 179.75 5.25 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.51 1.655 . . . . 0.0 113.522 -169.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.9 m -77.74 156.48 30.56 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.769 1.628 . . . . 0.0 110.138 175.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 93.5 mt -58.14 -34.48 70.31 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.908 0.483 . . . . 0.0 111.462 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -66.81 -36.87 83.37 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.072 0.396 . . . . 0.0 110.695 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.0 t -65.87 -46.08 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.452 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 7.9 m-85 -56.4 -49.08 75.51 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.962 0.505 . . . . 0.0 111.078 176.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 16.4 mtp85 -59.08 -45.03 91.87 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.897 0.879 . . . . 0.0 111.05 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 92.9 m -60.94 -53.01 62.55 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 74.4 t -64.58 -40.47 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-O 118.506 -0.759 . . . . 0.0 110.5 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.84 -43.43 94.62 Favored 'General case' 0 CA--C 1.523 -0.071 0 CA-C-N 120.215 1.37 . . . . 0.0 110.446 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.43 -50.02 65.58 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-O 118.929 -0.928 . . . . 0.0 111.057 174.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -56.43 -50.3 72.06 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.27 1.035 . . . . 0.0 110.991 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 48.9 t -55.77 -54.92 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 126.32 1.848 . . . . 0.0 109.341 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -59.93 -45.53 92.31 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 119.336 0.971 . . . . 0.0 110.065 -173.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.18 -45.19 79.85 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.784 0.833 . . . . 0.0 110.248 176.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.464 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 45.2 mtt85 -70.32 -42.38 72.04 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 117.869 -1.062 . . . . 0.0 110.744 -176.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.5 t -52.82 -49.71 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 120.321 1.418 . . . . 0.0 110.293 169.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -60.77 -41.65 95.91 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.262 0.937 . . . . 0.0 110.599 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -61.38 -44.32 97.36 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.228 1.011 . . . . 0.0 110.176 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . 0.262 0.2 OUTLIER -67.97 -46.47 71.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.809 -179.375 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.8 mt -51.52 -42.81 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 119.373 0.988 . . . . 0.0 109.245 172.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.44 -30.1 70.37 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.68 1.127 . . . . 0.0 111.532 -172.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 47.1 mttt -71.98 -45.75 59.87 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.272 1.429 . . . . 0.0 110.863 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.2 pt -86.11 -27.56 6.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.684 1.193 . . . . 0.0 113.875 -171.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 C--O 1.248 1.012 0 C-N-CA 126.194 1.798 . . . . 0.0 111.009 176.588 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.8 mmtt . . . . . 0 N--CA 1.465 0.318 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.8 mttt -101.96 120.06 39.79 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 118.753 -0.642 . . . . 0.0 109.568 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.46 ' HA ' HG13 ' A' ' 75' ' ' VAL . 13.9 p -99.75 140.26 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 121.469 0.652 . . . . 0.0 110.438 175.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 33.9 tpp -121.37 140.61 51.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.596 -1.184 . . . . 0.0 108.202 169.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -112.5 127.11 55.96 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 169.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.5 t -128.92 126.5 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 120.088 1.313 . . . . 0.0 108.446 -169.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.7 t -134.68 156.49 48.68 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 119.106 0.867 . . . . 0.0 112.658 -174.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -56.94 -23.0 42.11 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.225 1.01 . . . . 0.0 111.405 169.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.6 ptt-85 -148.82 107.81 3.88 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 169.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -47.46 -36.49 10.15 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.225 1.01 . . . . 0.0 112.0 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.3 m -43.7 -24.5 0.12 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 130.931 3.693 . . . . 0.0 118.717 -169.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.0 p -130.92 -79.84 0.53 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 120.018 1.281 . . . . 0.0 112.44 -169.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -56.79 -52.18 66.06 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.358 1.063 . . . . 0.0 109.664 -169.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.13 -46.69 79.93 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 126.37 1.868 . . . . 0.0 111.558 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -62.22 -41.02 98.01 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.096 0.407 . . . . 0.0 111.14 -174.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 44.1 mtm -62.69 -47.89 81.67 Favored 'General case' 0 CA--C 1.529 0.15 0 O-C-N 122.3 -0.25 . . . . 0.0 111.127 172.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.32 -38.94 78.11 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 117.887 0.312 . . . . 0.0 111.227 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -62.49 -51.05 68.99 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.345 1.458 . . . . 0.0 109.445 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.46 -42.52 99.05 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 119.501 -0.61 . . . . 0.0 112.248 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -67.14 -49.47 64.7 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 119.006 1.403 . . . . 0.0 108.971 177.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.27 -36.84 76.27 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 119.303 0.956 . . . . 0.0 112.415 -176.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -72.17 -35.95 69.15 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 119.383 0.992 . . . . 0.0 110.633 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.0 m -66.99 -42.14 85.55 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 119.98 -1.7 . . . . 0.0 110.476 177.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.4 mt -75.83 -31.47 59.37 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.887 1.675 . . . . 0.0 111.512 -173.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.928 0 CA-C-O 117.212 -1.882 . . . . 0.0 117.539 -170.349 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.9 pt . . . . . 0 C--O 1.235 0.316 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.68 123.74 50.01 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 170.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.27 143.9 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 C-N-CA 126.441 1.896 . . . . 0.0 109.516 -169.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 86.7 m -152.04 160.41 43.46 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.841 1.656 . . . . 0.0 106.78 169.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.1 p -130.48 161.26 31.83 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.745 0.818 . . . . 0.0 109.688 168.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.2 p -153.77 -168.85 3.1 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 176.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.36 166.91 34.91 Favored Glycine 0 N--CA 1.448 -0.522 0 O-C-N 121.283 -0.885 . . . . 0.0 111.59 170.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.2 mp -52.15 -36.86 52.68 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.742 1.217 . . . . 0.0 110.014 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -142.89 144.65 32.54 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 169.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 p -84.0 155.72 22.62 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.674 0.749 . . . . 0.0 110.935 174.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.9 m -163.23 151.48 13.78 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 128.033 2.533 . . . . 0.0 105.203 169.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -55.45 156.41 4.55 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.028 0.831 . . . . 0.0 111.959 -170.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.2 t -60.92 135.17 25.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -72.66 143.02 84.33 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 123.614 0.766 . . . . 0.0 109.07 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.43 -42.07 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 121.426 1.417 . . . . 0.0 113.11 -169.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.524 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 21.5 m -66.66 -17.02 64.62 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.172 -1.58 . . . . 0.0 111.956 -176.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.433 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -56.37 -39.32 72.72 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.292 -0.88 . . . . 0.0 110.935 169.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 62.5 mt -56.66 -48.09 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.65 -40.71 93.03 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 123.967 0.907 . . . . 0.0 111.489 -173.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.2 mmt -59.54 -48.18 82.66 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 122.934 1.349 . . . . 0.0 111.517 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.0 mtp -68.17 -35.93 78.81 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.886 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -61.31 -30.15 70.31 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 118.783 -0.627 . . . . 0.0 111.64 172.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -65.13 -36.31 83.85 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.057 0.844 . . . . 0.0 110.435 175.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.1 t -80.99 -25.45 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 117.606 0.184 . . . . 0.0 111.058 176.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.91 27.81 5.26 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.692 1.139 . . . . 0.0 111.741 -177.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.541 HG22 ' H ' ' A' ' 56' ' ' ASP . 10.7 mt -123.32 -178.74 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 126.222 1.809 . . . . 0.0 106.874 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.541 ' H ' HG22 ' A' ' 55' ' ' ILE . 12.5 t70 -147.22 156.45 42.96 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.156 1.382 . . . . 0.0 109.483 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.442 HD13 HG21 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -128.49 -14.25 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.99 0.916 . . . . 0.0 112.341 169.833 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -46.83 -38.18 9.87 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.647 1.179 . . . . 0.0 112.678 173.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.65 -4.99 85.88 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 118.604 -1.109 . . . . 0.0 113.988 -172.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -128.64 167.06 17.73 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.135 1.467 . . . . 0.0 111.393 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.9 p -126.24 166.14 17.65 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.487 1.115 . . . . 0.0 111.566 -169.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.0 m -81.51 162.7 23.12 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.188 0.995 . . . . 0.0 111.252 175.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -153.56 144.12 15.81 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-O 118.47 -0.776 . . . . 0.0 109.973 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.77 152.74 17.2 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.423 2.082 . . . . 0.0 111.229 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.3 tt -55.88 -33.92 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 123.562 0.745 . . . . 0.0 111.202 174.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -57.94 -22.98 51.6 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.165 1.786 . . . . 0.0 112.39 -175.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -80.98 -5.65 57.81 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.988 0.915 . . . . 0.0 112.818 -176.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -126.13 -179.93 4.95 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.552 1.069 . . . . 0.0 111.805 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.01 139.31 51.05 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 127.558 2.343 . . . . 0.0 106.983 169.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.42 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -70.16 -22.39 62.97 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.207 1.003 . . . . 0.0 112.231 -177.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -61.77 -22.35 65.35 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.284 1.034 . . . . 0.0 112.507 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -83.8 -16.01 46.24 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.851 0.86 . . . . 0.0 110.491 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -103.77 130.09 51.26 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 125.176 1.39 . . . . 0.0 109.493 -172.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -78.81 -36.52 42.52 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 122.728 0.411 . . . . 0.0 111.166 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.46 HG13 ' HA ' ' A' ' 4' ' ' VAL . 1.4 p -133.39 132.95 57.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -171.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.5 m -125.67 108.06 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-O 123.124 1.44 . . . . 0.0 109.042 -173.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.7 mm -103.13 96.78 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.4 m -73.38 157.68 36.48 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 167.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.96 26.37 1.88 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 174.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 74.9 m . . . . . 0 CA--C 1.531 0.217 0 C-N-CA 125.648 1.579 . . . . 0.0 111.75 -171.486 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 N--CA 1.466 0.373 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.42 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 77.3 m95 -62.55 11.23 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 128.732 2.813 . . . . 0.0 113.857 176.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.7 p -119.38 15.21 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 124.824 1.25 . . . . 0.0 111.609 174.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.5 p -130.23 17.44 5.5 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -171.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -91.37 179.12 5.77 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.36 1.464 . . . . 0.0 109.464 178.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -61.57 -33.63 74.2 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.636 1.174 . . . . 0.0 113.551 -171.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.8 mt -137.7 134.0 45.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -137.35 138.63 40.15 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 171.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -146.53 158.84 43.96 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.016 1.727 . . . . 0.0 107.362 169.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -123.16 100.06 6.67 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.869 1.267 . . . . 0.0 108.612 168.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.475 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 43.8 m0 -73.02 102.16 3.43 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.268 1.027 . . . . 0.0 108.832 -177.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -68.89 93.16 0.54 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.659 1.184 . . . . 0.0 109.259 176.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.5 153.36 35.45 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 125.481 1.512 . . . . 0.0 109.974 -172.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -85.66 53.36 2.74 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.432 1.493 . . . . 0.0 111.829 -171.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.8 t70 5.62 87.07 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 129.287 3.035 . . . . 0.0 114.106 169.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.463 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 50.7 Cg_exo -61.64 -4.85 4.91 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.864 3.042 . . . . 0.0 116.805 -172.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -54.5 93.03 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.988 1.267 . . . . 0.0 112.686 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.08 17.75 39.36 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 126.329 1.918 . . . . 0.0 113.419 172.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.463 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 23.3 mm-40 -95.0 178.25 5.62 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.987 1.393 . . . . 0.0 113.055 -169.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.6 m -77.45 156.13 31.3 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.994 1.718 . . . . 0.0 110.139 175.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 99.8 mt -59.14 -32.48 69.91 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.785 -0.572 . . . . 0.0 111.817 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.67 -39.14 93.0 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.656 0.382 . . . . 0.0 110.622 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 90.6 t -67.82 -45.07 84.98 Favored 'Isoleucine or valine' 0 C--N 1.338 0.083 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.524 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 17.4 m-85 -56.9 -50.38 72.71 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 119.023 -0.513 . . . . 0.0 111.043 176.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 -58.82 -41.76 87.57 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.024 0.829 . . . . 0.0 111.663 176.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.7 m -60.89 -49.75 76.22 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 118.836 0.744 . . . . 0.0 109.489 177.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.7 t -65.26 -39.21 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-O 117.748 -1.12 . . . . 0.0 110.654 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.6 ttp-105 -55.35 -48.59 73.99 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 120.354 1.434 . . . . 0.0 108.898 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.05 -47.76 89.56 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-O 118.326 -1.263 . . . . 0.0 110.196 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -56.27 -56.08 25.42 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.518 1.159 . . . . 0.0 110.151 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.6 t -55.82 -54.2 29.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 126.746 2.018 . . . . 0.0 110.851 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -63.01 -47.63 82.25 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 119.645 1.111 . . . . 0.0 110.158 -169.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -41.69 72.38 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 123.781 0.833 . . . . 0.0 110.995 174.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.475 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 45.7 mtt85 -71.45 -42.71 67.84 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.676 -177.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.453 ' HA ' HD23 ' A' ' 126' ' ' LEU . 71.5 t -53.02 -47.81 53.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 120.732 1.605 . . . . 0.0 109.769 169.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -61.48 -41.04 96.65 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 118.894 0.77 . . . . 0.0 110.767 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -62.19 -46.36 89.27 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 123.099 0.56 . . . . 0.0 110.264 175.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 123' ' ' VAL . 0.2 OUTLIER -62.18 -46.32 89.47 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 118.249 -0.881 . . . . 0.0 109.793 -177.298 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 71.7 mt -57.0 -40.14 70.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.791 0.836 . . . . 0.0 109.596 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.62 -31.3 72.45 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 120.147 1.34 . . . . 0.0 111.593 -175.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -64.08 -36.24 83.37 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.28 1.032 . . . . 0.0 111.827 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 pt -104.14 -25.28 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -169.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.7 m . . . . . 0 C--O 1.248 0.996 0 C-N-CA 125.785 1.634 . . . . 0.0 111.143 179.489 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? . . . . . 0 N--CA 1.465 0.28 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -93.9 110.7 22.36 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 170.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 85.5 t -93.06 136.97 23.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 125.582 1.553 . . . . 0.0 107.966 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 39.6 tpp -119.06 143.06 47.33 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.458 1.103 . . . . 0.0 108.63 172.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -121.09 122.64 40.49 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.958 1.303 . . . . 0.0 108.114 170.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.8 t -127.45 123.91 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 120.771 1.623 . . . . 0.0 109.498 -174.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.4 t -118.39 165.11 14.27 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.872 0.76 . . . . 0.0 109.756 176.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -65.7 -11.54 46.13 Favored 'General case' 0 CA--C 1.548 0.893 0 O-C-N 121.82 -0.55 . . . . 0.0 111.548 169.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -154.47 107.53 2.85 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 128.238 2.615 . . . . 0.0 105.307 169.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -47.16 -38.42 11.77 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.927 1.291 . . . . 0.0 113.014 -178.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.9 p -38.77 -33.05 0.1 Allowed 'General case' 0 C--O 1.236 0.362 0 C-N-CA 129.507 3.123 . . . . 0.0 117.852 -169.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.8 m -122.62 -76.21 0.59 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.659 0.663 . . . . 0.0 111.791 -169.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -58.99 -51.11 71.5 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.264 0.484 . . . . 0.0 109.751 -169.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.76 -42.51 81.63 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.34 0.656 . . . . 0.0 111.271 -173.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -59.65 -45.05 93.2 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.547 0.739 . . . . 0.0 111.1 -175.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 53.5 mtm -65.66 -45.82 81.49 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 117.563 0.165 . . . . 0.0 111.07 176.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.43 -39.09 75.5 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 117.592 0.178 . . . . 0.0 110.859 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -65.41 -54.56 26.9 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.484 -0.77 . . . . 0.0 110.682 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.71 -41.38 50.39 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-O 119.271 -0.739 . . . . 0.0 112.456 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -68.02 -46.94 69.81 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 118.938 1.369 . . . . 0.0 109.457 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.04 -46.29 85.6 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 120.188 1.358 . . . . 0.0 112.894 -176.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -69.54 -5.77 26.47 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.523 1.056 . . . . 0.0 113.57 175.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.0 m -97.7 -47.99 5.39 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 119.927 1.239 . . . . 0.0 110.255 170.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 97.0 mt -77.45 -41.35 39.98 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.608 1.563 . . . . 0.0 111.86 -169.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.374 0 CA-C-O 117.86 -1.522 . . . . 0.0 114.877 -169.157 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.5 pt . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 121.313 0.578 . . . . 0.0 111.722 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -121.94 131.97 54.3 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 104.191 -2.522 . . . . 0.0 104.191 168.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 p -117.67 151.68 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -169.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.6 m -144.49 144.03 31.16 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 167.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.5 p -112.37 153.05 27.88 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 168.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.9 m -151.08 -170.13 3.58 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.39 160.56 29.94 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 169.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.1 mt -53.69 -30.65 44.63 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.369 0.668 . . . . 0.0 110.788 173.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -143.82 146.75 33.3 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 168.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.6 p -75.15 165.91 24.48 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.01 0.909 . . . . 0.0 111.756 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.7 p -151.59 -148.01 0.25 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.565 1.946 . . . . 0.0 106.322 173.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -133.13 155.65 48.89 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 173.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.4 t -63.21 128.71 25.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -173.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -70.96 137.85 85.05 Favored Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -70.58 -38.09 6.42 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 121.974 1.782 . . . . 0.0 112.428 -169.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.494 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 10.4 m -67.65 -18.86 65.1 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.407 -0.808 . . . . 0.0 111.878 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.44 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -58.48 -40.96 84.18 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 121.646 -0.659 . . . . 0.0 110.1 171.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.6 mp -61.99 -43.79 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.24 -37.67 81.09 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -176.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.4 mmt -62.31 -47.61 83.5 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 122.823 1.297 . . . . 0.0 111.441 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.2 mtp -69.0 -34.17 74.85 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.12 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -62.29 -29.83 70.7 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.584 0.754 . . . . 0.0 111.361 172.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -63.75 -39.31 93.97 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.872 0.76 . . . . 0.0 110.247 173.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.7 t -78.96 -25.33 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 121.219 -0.192 . . . . 0.0 110.97 178.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.61 24.89 5.94 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.104 1.335 . . . . 0.0 112.032 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.487 HG22 ' H ' ' A' ' 56' ' ' ASP . 11.8 mt -123.21 179.29 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 125.768 1.627 . . . . 0.0 107.249 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.487 ' H ' HG22 ' A' ' 55' ' ' ILE . 7.5 t70 -144.61 157.95 43.99 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.745 1.618 . . . . 0.0 108.942 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.44 HD12 ' HB1' ' A' ' 46' ' ' ALA . 0.7 OUTLIER -128.86 -16.95 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.888 0.875 . . . . 0.0 112.701 170.503 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 61.4 p -54.1 -28.58 40.3 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 120.076 1.307 . . . . 0.0 112.498 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.38 -11.22 71.44 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.706 1.146 . . . . 0.0 114.146 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -123.21 173.05 8.15 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.291 1.545 . . . . 0.0 111.163 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.4 p -128.53 164.79 22.04 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.458 1.103 . . . . 0.0 111.416 -169.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 73.6 m -80.6 158.62 25.65 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.904 0.882 . . . . 0.0 110.859 170.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -158.0 145.9 13.85 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.0 0.92 . . . . 0.0 109.663 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -82.85 150.83 14.33 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.606 2.204 . . . . 0.0 111.258 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.1 tt -55.55 -33.29 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.392 0.677 . . . . 0.0 111.807 175.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -58.75 -21.68 56.01 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.986 1.714 . . . . 0.0 112.35 -176.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -78.92 -6.94 57.46 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.953 0.901 . . . . 0.0 112.855 -176.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -127.97 -179.84 5.19 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.619 1.1 . . . . 0.0 111.433 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -127.24 127.39 44.34 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.789 2.036 . . . . 0.0 107.886 175.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.519 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -62.26 -24.07 67.05 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 -174.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -64.03 -21.03 66.34 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.775 0.43 . . . . 0.0 112.111 -177.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -81.41 -18.36 45.69 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.459 0.703 . . . . 0.0 110.19 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -97.11 130.26 44.41 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 125.45 1.5 . . . . 0.0 109.062 -177.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -89.65 -22.1 22.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.53 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.99 135.9 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -175.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.2 t -127.94 127.45 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 123.307 1.527 . . . . 0.0 109.566 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 35.4 mm -113.49 98.67 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.3 m -72.4 155.54 40.02 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 167.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.7 49.17 0.87 Allowed 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 102.878 -3.008 . . . . 0.0 102.878 172.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.5 m . . . . . 0 CA--C 1.532 0.26 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 170.727 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 . . . . . 0 CA--C 1.54 0.581 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.519 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 93.9 m95 -62.96 9.05 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.949 2.1 . . . . 0.0 113.01 169.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.3 p -132.15 7.3 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 124.204 1.002 . . . . 0.0 112.509 173.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 82.8 p -116.23 33.18 5.68 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 120.044 1.293 . . . . 0.0 112.852 -169.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -122.01 -172.03 2.36 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.527 1.531 . . . . 0.0 110.222 174.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -59.43 -36.37 75.76 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -168.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.7 mm -133.05 138.52 51.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -173.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -142.94 129.8 20.51 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.226 1.411 . . . . 0.0 107.402 169.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -141.79 158.76 43.41 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 168.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -122.5 101.66 7.62 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.021 1.328 . . . . 0.0 109.46 169.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.422 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 39.5 m0 -78.8 92.73 4.87 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.199 0.999 . . . . 0.0 109.656 -177.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -62.1 120.49 10.97 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 169.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 47.6 mt -151.72 152.96 33.43 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.147 1.779 . . . . 0.0 107.585 -169.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -82.13 71.7 9.18 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.461 1.105 . . . . 0.0 111.448 -176.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -22.38 97.88 0.06 OUTLIER Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 128.678 2.791 . . . . 0.0 112.7 -177.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.437 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 65.0 Cg_exo -59.79 -2.9 1.78 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.292 3.328 . . . . 0.0 117.221 -169.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -50.86 95.85 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.843 1.257 . . . . 0.0 112.656 173.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.36 21.9 46.59 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.29 1.9 . . . . 0.0 113.153 171.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.437 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 23.4 mm-40 -98.73 176.68 5.54 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.952 1.376 . . . . 0.0 112.755 -169.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 44.2 m -74.4 154.69 38.68 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.804 1.641 . . . . 0.0 110.166 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 91.9 mt -58.38 -31.12 67.35 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.796 -0.565 . . . . 0.0 111.658 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -72.31 -33.66 67.54 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.296 0.498 . . . . 0.0 111.155 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 80.8 t -65.43 -46.22 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 171.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.494 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 11.1 m-85 -55.46 -50.38 70.03 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 118.876 -0.583 . . . . 0.0 110.351 175.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -59.37 -43.16 92.91 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.877 0.871 . . . . 0.0 112.207 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 100.0 m -60.96 -51.06 70.85 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 119.01 0.823 . . . . 0.0 109.151 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.0 t -63.69 -45.35 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 117.875 -1.059 . . . . 0.0 110.039 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -55.78 -47.2 77.47 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 119.818 1.19 . . . . 0.0 109.392 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.88 -49.02 83.29 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-O 118.383 -1.231 . . . . 0.0 110.417 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -59.72 -56.83 16.92 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 118.359 1.079 . . . . 0.0 110.398 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.8 t -46.26 -51.32 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 125.888 1.675 . . . . 0.0 110.483 177.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -63.62 -48.71 76.2 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.449 1.022 . . . . 0.0 110.192 -175.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.56 -40.56 72.09 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.377 1.071 . . . . 0.0 111.155 175.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.422 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 82.8 mtt-85 -73.1 -43.26 62.01 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.921 -176.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 69.5 t -54.35 -46.74 69.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 120.417 1.462 . . . . 0.0 108.843 169.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -61.2 -39.54 90.61 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.051 0.841 . . . . 0.0 110.831 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -63.47 -47.43 81.81 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 123.196 0.598 . . . . 0.0 110.308 176.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . 0.251 0.2 OUTLIER -60.52 -44.31 96.16 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 118.858 -0.592 . . . . 0.0 109.724 -178.666 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.1 mt -60.79 -38.05 77.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.514 1.126 . . . . 0.0 110.764 173.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.37 -31.42 72.57 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 120.287 1.403 . . . . 0.0 111.223 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -66.78 -20.49 65.96 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.014 1.325 . . . . 0.0 113.169 177.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.5 pt -127.53 -20.95 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 116.382 1.993 . . . . 0.0 116.382 -167.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 C--O 1.249 1.033 0 C-N-CA 126.371 1.868 . . . . 0.0 111.118 174.501 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? . . . . . 0 N--CA 1.466 0.36 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -83.29 136.07 34.51 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 169.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.9 p -119.64 146.56 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-O 121.928 0.871 . . . . 0.0 109.526 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 33.3 tpp -127.17 142.51 51.48 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.308 -1.315 . . . . 0.0 108.423 -177.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -124.0 121.99 36.71 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 117.66 -1.162 . . . . 0.0 108.113 172.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.6 t -126.19 118.78 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 121.111 1.778 . . . . 0.0 110.055 -170.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.5 t -116.19 162.25 17.74 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.424 1.011 . . . . 0.0 112.081 -178.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.8 mttm -60.81 -17.88 52.25 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.767 0.827 . . . . 0.0 111.649 169.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.1 ptm85 -154.15 112.96 3.65 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 169.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -47.87 -30.57 4.22 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.025 0.93 . . . . 0.0 112.797 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.4 m -35.29 -35.86 0.05 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 130.085 3.354 . . . . 0.0 119.879 -171.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.8 p -137.68 -68.85 0.46 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 120.576 1.534 . . . . 0.0 113.51 -169.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -55.09 -51.1 67.45 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.045 0.838 . . . . 0.0 109.527 -169.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.412 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 0.0 OUTLIER -66.29 -49.14 68.09 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.955 2.102 . . . . 0.0 111.806 -179.478 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -60.26 -43.12 96.42 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.502 0.721 . . . . 0.0 110.847 -175.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 65.9 mtm -66.66 -47.14 73.47 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-O 119.569 -0.253 . . . . 0.0 110.991 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.99 -39.31 71.66 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 117.743 0.247 . . . . 0.0 110.773 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.409 ' HA ' HG21 ' A' ' 32' ' ' VAL . 17.8 tt0 -64.95 -55.22 20.49 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 118.485 -0.769 . . . . 0.0 110.938 177.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.5 -40.45 47.02 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-O 119.346 -0.697 . . . . 0.0 112.516 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -68.08 -47.01 69.44 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 119.008 1.404 . . . . 0.0 109.523 175.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.91 -45.49 90.21 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 120.187 1.358 . . . . 0.0 112.907 -176.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt -69.41 -9.45 53.63 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.685 1.129 . . . . 0.0 113.294 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.3 m -93.55 -48.59 6.29 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 119.852 1.206 . . . . 0.0 110.611 170.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 98.3 mt -77.23 -41.45 41.14 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.808 1.643 . . . . 0.0 111.92 -169.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.38 0 CA-C-O 117.759 -1.578 . . . . 0.0 114.962 -169.113 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.0 pt . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 121.29 0.567 . . . . 0.0 111.845 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -125.79 132.35 52.29 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 169.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.409 HG21 ' HA ' ' A' ' 19' ' ' GLU . 2.8 p -117.08 153.26 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -169.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.5 m -145.65 145.01 30.76 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 167.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.412 ' HB2' ' HB2' ' A' ' 15' ' ' SER . 27.2 p -113.53 157.5 21.95 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 120.896 -1.128 . . . . 0.0 109.008 168.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.5 m -151.37 -175.95 5.38 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.714 1.606 . . . . 0.0 107.035 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -152.4 163.13 30.18 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 169.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.4 mt -53.24 -34.74 58.43 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 124.245 0.614 . . . . 0.0 110.265 174.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -141.9 145.58 34.74 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 104.659 -2.349 . . . . 0.0 104.659 169.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.2 p -75.75 147.4 39.32 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.098 0.475 . . . . 0.0 110.44 174.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 59.5 m -150.51 149.22 29.67 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.145 2.178 . . . . 0.0 105.542 169.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.64 155.56 9.68 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.858 0.863 . . . . 0.0 111.966 -172.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.6 t -65.63 131.07 31.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -73.74 138.97 76.91 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.35 -35.95 4.49 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 121.974 1.782 . . . . 0.0 112.494 -169.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.518 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 4.8 m -67.84 -18.57 64.87 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.093 -1.004 . . . . 0.0 111.945 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.32 -41.44 76.03 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.698 -0.626 . . . . 0.0 110.184 170.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.8 mp -62.78 -41.31 91.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -178.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.7 -36.99 82.5 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 118.341 0.519 . . . . 0.0 112.043 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 24.5 mmt -62.51 -47.69 82.84 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 122.763 1.268 . . . . 0.0 111.463 175.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 10.6 mtp -68.27 -34.0 75.38 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.433 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -63.03 -28.77 70.32 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.128 0.971 . . . . 0.0 111.077 173.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -65.39 -38.72 90.85 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.788 0.722 . . . . 0.0 110.162 172.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.9 t -78.22 -25.09 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 121.256 -0.178 . . . . 0.0 110.809 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.77 25.65 6.14 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.161 1.363 . . . . 0.0 111.953 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 56' ' ' ASP . 10.5 mt -124.2 175.97 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 125.584 1.554 . . . . 0.0 107.348 -178.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.426 ' H ' HG22 ' A' ' 55' ' ' ILE . 12.2 t70 -140.81 158.06 44.5 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.507 1.523 . . . . 0.0 109.154 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.434 HD13 HG21 ' A' ' 57' ' ' ILE . 0.8 OUTLIER -129.34 -18.59 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 118.186 -0.911 . . . . 0.0 112.816 171.124 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.7 m -51.58 -30.16 19.99 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 120.393 1.451 . . . . 0.0 112.274 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.69 -11.56 69.17 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.81 1.195 . . . . 0.0 114.093 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -123.99 168.62 12.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.432 1.493 . . . . 0.0 110.876 176.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.8 p -126.92 172.08 10.74 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.443 1.097 . . . . 0.0 110.85 -173.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.2 m -76.89 165.05 25.21 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.45 0.7 . . . . 0.0 112.173 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.29 142.86 15.33 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 124.349 1.06 . . . . 0.0 108.73 177.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -85.18 153.15 10.9 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.903 2.402 . . . . 0.0 110.095 169.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.1 tt -54.29 -33.28 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 123.524 0.73 . . . . 0.0 111.135 173.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -56.04 -26.25 48.28 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.411 1.884 . . . . 0.0 112.676 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -81.06 -5.44 57.63 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -175.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -130.11 -176.67 4.01 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.151 0.98 . . . . 0.0 111.181 -176.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.67 131.04 33.06 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 126.595 1.958 . . . . 0.0 108.399 -177.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.33 -29.4 67.62 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.599 1.16 . . . . 0.0 113.191 -176.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -60.23 -22.15 62.68 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.976 0.91 . . . . 0.0 112.336 -176.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -85.23 -14.8 45.63 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.545 0.738 . . . . 0.0 110.777 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -109.31 137.31 47.37 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.945 1.298 . . . . 0.0 110.276 -172.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -93.48 -33.78 13.66 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.519 0.727 . . . . 0.0 110.238 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.06 136.45 53.53 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 CA-C-N 118.578 0.626 . . . . 0.0 109.415 -175.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.9 t -128.49 115.96 39.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 122.929 1.347 . . . . 0.0 108.531 -175.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.9 mm -107.79 93.91 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.3 m -71.24 157.29 38.38 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 117.759 -1.576 . . . . 0.0 106.857 168.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.82 46.88 0.94 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 177.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 86.2 m . . . . . 0 N--CA 1.454 -0.259 0 C-N-CA 123.553 0.741 . . . . 0.0 109.323 177.258 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -55.51 -25.74 38.94 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.826 -1.171 . . . . 0.0 111.871 171.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.7 p -84.8 -18.3 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 119.637 1.108 . . . . 0.0 110.347 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 56.8 p -100.42 18.51 18.82 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.591 0.756 . . . . 0.0 112.683 -169.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -83.98 -172.71 4.31 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.896 0.879 . . . . 0.0 109.72 173.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -63.44 -34.62 78.15 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.426 0.691 . . . . 0.0 112.344 -169.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.0 mt -140.73 140.13 33.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 -174.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -140.1 137.87 34.85 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.623 1.169 . . . . 0.0 108.228 170.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -146.5 160.17 42.46 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.695 1.598 . . . . 0.0 107.726 168.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -122.53 95.73 4.75 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.117 1.367 . . . . 0.0 108.533 169.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.443 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 46.1 m0 -68.45 101.4 1.24 Allowed 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.418 1.087 . . . . 0.0 109.432 -177.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -61.21 120.59 10.65 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 169.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.7 mt -157.78 146.77 19.55 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.161 1.385 . . . . 0.0 107.993 -169.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.9 mp0 -86.61 60.25 6.12 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.375 1.87 . . . . 0.0 111.925 -169.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -1.59 85.67 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 129.672 3.189 . . . . 0.0 113.852 174.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.44 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 71.6 Cg_exo -59.64 -11.13 13.32 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.963 3.109 . . . . 0.0 117.85 -169.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.3 96.18 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 120.46 1.482 . . . . 0.0 111.495 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.4 13.11 29.25 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 126.402 1.953 . . . . 0.0 113.232 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.44 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 24.9 mm-40 -98.72 178.12 5.08 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.182 1.491 . . . . 0.0 112.765 -169.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.9 m -76.35 154.98 34.53 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.975 1.71 . . . . 0.0 110.059 175.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.9 mt -59.3 -30.96 68.71 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.708 -0.62 . . . . 0.0 111.889 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -62.11 -40.11 94.8 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.134 0.574 . . . . 0.0 110.521 175.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.7 t -68.9 -43.8 82.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.518 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 13.3 m-85 -55.44 -52.07 64.82 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.538 175.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -60.1 -41.54 92.76 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.413 0.685 . . . . 0.0 111.772 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 56.3 m -61.0 -46.19 91.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.78 0.718 . . . . 0.0 110.0 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.7 t -69.07 -43.84 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-O 117.853 -1.07 . . . . 0.0 110.265 177.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -56.45 -44.79 80.82 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 119.828 1.195 . . . . 0.0 109.438 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.16 -50.25 69.27 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-O 118.33 -1.261 . . . . 0.0 110.576 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -57.52 -57.05 14.38 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 118.311 1.055 . . . . 0.0 110.098 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.6 t -48.91 -52.95 8.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.937 1.695 . . . . 0.0 110.619 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -64.68 -48.89 73.05 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 119.159 0.891 . . . . 0.0 109.795 -171.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.62 -44.33 69.41 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.924 0.89 . . . . 0.0 110.46 174.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.443 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 96.4 mtt180 -72.45 -39.37 67.84 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 117.484 -1.246 . . . . 0.0 110.764 -175.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 72.5 t -55.26 -48.68 76.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 121.046 1.748 . . . . 0.0 108.724 169.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -60.42 -38.81 85.25 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.226 0.921 . . . . 0.0 110.778 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -64.71 -45.19 87.6 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.508 1.123 . . . . 0.0 110.352 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.58 -46.97 85.9 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 124.102 0.961 . . . . 0.0 109.434 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.7 mt -59.16 -38.04 71.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.607 1.163 . . . . 0.0 110.861 175.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.77 -30.08 70.56 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 120.011 1.278 . . . . 0.0 111.413 -173.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -71.61 -19.56 62.1 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.833 1.653 . . . . 0.0 112.976 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.4 pt -126.26 -20.35 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 126.018 1.727 . . . . 0.0 115.269 -168.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.5 m . . . . . 0 C--O 1.248 0.99 0 C-N-CA 126.471 1.908 . . . . 0.0 111.019 171.018 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt . . . . . 0 N--CA 1.464 0.244 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -97.25 133.62 41.64 Favored 'General case' 0 CA--C 1.511 -0.547 0 O-C-N 121.48 -0.762 . . . . 0.0 109.234 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.9 p -114.77 140.9 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 123.293 0.637 . . . . 0.0 109.662 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 44.2 tpp -119.94 143.8 47.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.973 169.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -117.9 135.62 54.0 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.972 1.309 . . . . 0.0 107.717 169.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.1 t -141.4 123.88 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 120.017 1.281 . . . . 0.0 109.274 -173.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.4 p -127.59 174.69 8.85 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.805 1.184 . . . . 0.0 111.019 173.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -66.04 -16.44 63.92 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.227 0.611 . . . . 0.0 112.415 173.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -152.14 101.79 2.74 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 170.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -40.02 -36.67 0.5 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.255 1.822 . . . . 0.0 113.252 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.6 m -37.21 -32.12 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 129.421 3.088 . . . . 0.0 116.936 -178.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 71.5 m -119.87 -84.96 0.66 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.172 0.896 . . . . 0.0 112.4 -169.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.429 ' HD3' ' HD2' ' A' ' 104' ' ' PRO . 0.3 OUTLIER -60.02 -51.9 67.69 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.501 1.046 . . . . 0.0 110.069 -169.479 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.416 ' HB3' ' HB2' ' A' ' 34' ' ' SER . 1.4 m -56.34 -50.19 72.21 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.247 1.019 . . . . 0.0 110.519 -173.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -61.64 -45.07 95.63 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.434 0.694 . . . . 0.0 111.344 -173.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 65.7 mtm -64.22 -47.04 81.21 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 119.446 -0.311 . . . . 0.0 110.927 175.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.69 -40.04 71.82 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 122.451 0.3 . . . . 0.0 110.681 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -64.54 -55.03 23.2 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.414 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.42 -38.09 68.41 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 119.457 -0.635 . . . . 0.0 111.702 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -67.73 -47.76 68.37 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 118.753 1.276 . . . . 0.0 108.775 175.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.64 -44.82 93.38 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.931 1.241 . . . . 0.0 113.312 -175.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 ptmt -68.98 -9.0 50.05 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 119.736 1.153 . . . . 0.0 113.145 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.6 m -93.51 -47.52 6.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 119.783 1.174 . . . . 0.0 110.459 169.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.2 mt -76.39 -40.77 50.04 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 126.04 1.736 . . . . 0.0 112.076 -169.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.36 0 CA-C-O 117.879 -1.512 . . . . 0.0 115.296 -169.217 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.8 pt . . . . . 0 N--CA 1.452 -0.375 0 CA-C-O 121.523 0.678 . . . . 0.0 112.01 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -122.77 132.42 54.22 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 169.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -117.39 150.83 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 C-N-CA 124.02 0.928 . . . . 0.0 112.06 -170.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.4 m -144.23 152.55 40.99 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 167.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.416 ' HB2' ' HB3' ' A' ' 15' ' ' SER . 43.9 p -131.2 156.97 44.44 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 167.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.1 p -155.73 -159.99 0.97 Allowed 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.97 163.95 32.06 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 169.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 67.2 mt -52.93 -34.0 53.28 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.59 0.756 . . . . 0.0 109.622 172.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -142.6 146.22 34.33 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 103.199 -2.889 . . . . 0.0 103.199 168.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.3 m -124.51 148.6 47.64 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.287 0.565 . . . . 0.0 111.456 -178.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.3 m -143.86 168.59 19.6 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.997 2.519 . . . . 0.0 106.303 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.0 ptt85 -54.22 158.97 2.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.979 0.809 . . . . 0.0 112.478 -172.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.9 t -62.62 136.15 26.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -73.85 143.27 81.07 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.96 -40.98 0.57 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.307 1.338 . . . . 0.0 112.79 -169.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.527 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 11.5 m -67.3 -16.92 64.54 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.368 -1.458 . . . . 0.0 111.898 -177.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.443 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -55.52 -40.07 71.33 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.698 0.799 . . . . 0.0 110.503 169.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 59.4 mt -57.74 -48.39 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.97 -37.6 85.37 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 123.654 0.782 . . . . 0.0 111.828 -174.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 20.2 mmt -61.28 -47.58 85.34 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 122.858 1.313 . . . . 0.0 111.31 175.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 9.3 mtp -69.39 -33.11 72.54 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.516 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -61.89 -29.01 69.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.858 -0.592 . . . . 0.0 111.588 170.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -65.59 -36.32 83.4 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.18 0.9 . . . . 0.0 110.446 173.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.67 -25.71 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 117.474 0.124 . . . . 0.0 110.769 176.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.43 28.26 7.23 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.546 1.069 . . . . 0.0 111.461 -174.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.598 HG22 ' H ' ' A' ' 56' ' ' ASP . 7.6 mt -122.93 -177.53 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.598 ' H ' HG22 ' A' ' 55' ' ' ILE . 12.3 t70 -146.45 157.02 43.7 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.364 1.466 . . . . 0.0 109.158 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.443 HD12 ' HB1' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -127.47 -16.48 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.703 0.801 . . . . 0.0 112.339 169.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -45.29 -38.18 5.42 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.693 1.197 . . . . 0.0 112.768 173.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.88 -5.46 88.72 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 118.517 -1.157 . . . . 0.0 114.335 -173.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -125.86 168.19 14.19 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.319 1.56 . . . . 0.0 110.875 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.8 p -127.84 168.61 14.94 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.016 0.926 . . . . 0.0 111.542 -169.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.2 m -82.16 163.36 22.0 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.401 1.08 . . . . 0.0 111.426 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -156.8 141.34 12.0 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.495 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -81.88 151.72 16.64 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.826 2.351 . . . . 0.0 111.173 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.1 tt -57.33 -31.13 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 121.725 -0.609 . . . . 0.0 111.833 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -56.76 -22.3 34.72 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.704 2.001 . . . . 0.0 112.111 -177.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -82.04 -7.99 59.64 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.56 1.144 . . . . 0.0 113.096 -176.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -128.57 -178.5 4.61 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 120.025 1.284 . . . . 0.0 111.607 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -127.66 141.86 51.5 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 127.247 2.219 . . . . 0.0 107.57 169.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.09 -22.99 65.8 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.889 1.276 . . . . 0.0 111.985 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -60.21 -23.14 63.78 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.054 0.942 . . . . 0.0 112.352 -176.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -83.07 -12.25 57.3 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.875 0.87 . . . . 0.0 110.728 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -111.3 126.93 55.42 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 125.644 1.578 . . . . 0.0 109.368 -170.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -72.61 -42.13 64.82 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 175.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.4 p -128.02 134.06 65.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 C-N-CA 122.942 0.497 . . . . 0.0 110.123 -169.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.4 m -127.91 108.26 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-O 123.341 1.543 . . . . 0.0 109.141 -172.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.4 mm -104.12 100.34 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 114.22 -1.355 . . . . 0.0 107.388 -175.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.4 t -74.01 157.14 36.68 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 167.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.13 51.38 0.6 Allowed 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 175.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.7 p . . . . . 0 CA--C 1.534 0.334 0 O-C-N 120.712 -1.243 . . . . 0.0 110.907 -169.998 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 61.2 m95 -66.28 8.3 0.24 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 126.7 2.0 . . . . 0.0 113.152 171.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.1 p -118.06 2.68 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 124.891 1.277 . . . . 0.0 111.512 171.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.1 p -128.5 26.43 5.65 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.111 0.964 . . . . 0.0 112.131 -172.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -92.57 -173.1 3.26 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.548 0.739 . . . . 0.0 109.558 170.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -65.72 -33.44 75.88 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -169.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.2 mt -137.25 132.62 46.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -138.48 140.46 39.21 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -147.58 159.07 44.17 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.276 1.43 . . . . 0.0 107.34 168.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -122.22 110.7 16.05 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.718 1.207 . . . . 0.0 108.934 168.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.436 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 37.1 m0 -87.39 84.68 7.15 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.28 1.032 . . . . 0.0 108.461 -178.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -56.95 120.85 8.66 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 170.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 25.1 mt -151.03 153.05 34.38 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.986 1.314 . . . . 0.0 108.602 -169.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -78.16 74.83 4.7 Favored 'General case' 0 CA--C 1.523 -0.092 0 C-N-CA 125.105 1.362 . . . . 0.0 111.525 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -28.68 102.77 0.16 Allowed Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 127.432 2.293 . . . . 0.0 113.668 -175.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.482 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 87.3 Cg_exo -63.68 -0.37 2.47 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.966 3.111 . . . . 0.0 117.425 -169.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -56.04 102.93 0.08 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 119.964 1.256 . . . . 0.0 111.702 178.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.34 22.06 59.4 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 126.201 1.857 . . . . 0.0 113.134 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.482 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 21.5 mm-40 -97.68 177.37 5.51 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.703 1.251 . . . . 0.0 112.554 -169.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.8 m -74.37 154.97 38.6 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.431 1.493 . . . . 0.0 109.814 176.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 91.5 mt -59.3 -30.58 68.44 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 122.001 -0.437 . . . . 0.0 111.656 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -62.77 -39.25 93.59 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.405 0.548 . . . . 0.0 110.918 176.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 89.0 t -67.9 -46.07 82.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.527 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 14.7 m-85 -55.34 -50.46 69.59 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.896 175.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 -59.85 -42.6 94.0 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.959 0.904 . . . . 0.0 111.74 177.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.7 m -60.78 -50.54 73.05 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 118.935 0.789 . . . . 0.0 109.363 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.6 t -66.1 -44.47 91.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 117.626 -1.178 . . . . 0.0 110.316 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 48.0 ttp85 -53.08 -47.36 68.6 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 120.093 1.315 . . . . 0.0 108.988 176.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.98 -47.9 81.18 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-O 118.481 -1.177 . . . . 0.0 110.598 -175.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -61.21 -56.7 17.64 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 118.292 1.046 . . . . 0.0 110.37 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 82.4 t -50.09 -49.95 20.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 125.132 1.373 . . . . 0.0 110.386 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -62.03 -48.43 80.33 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 120.207 1.367 . . . . 0.0 110.445 -176.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -53.91 -45.81 71.26 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 123.681 0.793 . . . . 0.0 109.751 174.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.436 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 76.6 mtt-85 -70.82 -39.54 72.98 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 118.257 -0.878 . . . . 0.0 109.925 -173.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 75.4 t -55.6 -48.8 77.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 120.437 1.471 . . . . 0.0 109.189 169.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -60.94 -38.87 87.35 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.659 1.118 . . . . 0.0 110.754 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -62.04 -46.73 87.85 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.806 1.642 . . . . 0.0 109.832 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.28 -45.76 83.16 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 123.75 0.82 . . . . 0.0 110.106 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 60.1 mt -57.44 -38.32 62.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.574 1.149 . . . . 0.0 110.468 175.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.26 -29.19 69.7 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.873 1.215 . . . . 0.0 111.447 -173.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -73.75 -19.14 60.87 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.079 1.752 . . . . 0.0 112.802 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 pt -126.51 -20.08 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 126.21 1.804 . . . . 0.0 114.966 -168.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 C--O 1.25 1.124 0 C-N-CA 126.504 1.922 . . . . 0.0 110.9 170.11 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt . . . . . 0 C--O 1.231 0.12 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.7 mttt -106.48 124.74 50.05 Favored 'General case' 0 CA--C 1.508 -0.657 0 C-N-CA 122.885 0.474 . . . . 0.0 109.936 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.6 p -105.16 140.67 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 O-C-N 123.626 0.579 . . . . 0.0 110.656 175.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 39.7 tpp -119.07 142.39 47.91 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 169.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -116.08 134.53 54.84 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 169.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.3 t -136.9 123.05 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 119.641 1.11 . . . . 0.0 108.643 -171.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.4 t -123.23 157.12 33.79 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.066 0.848 . . . . 0.0 109.691 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.319 20.9 pttp -67.52 -2.48 6.59 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 175.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -139.17 -5.12 1.46 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 168.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 63.86 -44.13 0.26 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 127.332 2.253 . . . . 0.0 114.571 -172.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.3 m -34.03 -37.95 0.05 Allowed 'General case' 0 C--O 1.232 0.132 0 N-CA-C 119.684 3.216 . . . . 0.0 119.684 -168.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.9 p -136.12 -60.07 0.73 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-N 120.0 1.273 . . . . 0.0 112.202 -169.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -60.32 -50.12 74.89 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.001 0.819 . . . . 0.0 109.956 -171.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.04 -40.87 82.78 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 117.909 0.322 . . . . 0.0 110.579 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -61.75 -47.21 86.25 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.278 0.631 . . . . 0.0 111.131 -173.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.436 ' HG2' HD11 ' A' ' 57' ' ' ILE . 46.5 mtm -64.46 -43.05 95.45 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 119.837 -0.125 . . . . 0.0 110.745 176.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.85 -37.52 74.03 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.048 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.451 ' HA ' HG21 ' A' ' 32' ' ' VAL . 40.4 tt0 -65.73 -46.96 76.96 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 119.181 -0.438 . . . . 0.0 110.641 177.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.83 -42.76 98.24 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -67.48 -49.09 65.11 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 118.619 1.209 . . . . 0.0 109.624 176.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.1 -43.09 86.91 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 119.98 1.264 . . . . 0.0 112.092 -176.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.2 pttt -76.22 -2.46 31.44 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.4 m -98.62 -45.12 6.18 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 120.867 -1.145 . . . . 0.0 109.322 169.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.4 mt -72.15 -40.31 68.11 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.774 1.629 . . . . 0.0 110.79 -172.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.812 0 CA-C-O 117.403 -1.776 . . . . 0.0 116.612 -169.765 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.9 pt . . . . . 0 C--O 1.236 0.343 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.78 133.94 55.42 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 169.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.451 HG21 ' HA ' ' A' ' 19' ' ' GLU . 2.6 p -114.95 153.18 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 C-N-CA 124.074 0.95 . . . . 0.0 111.513 -175.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.9 m -144.01 148.19 34.91 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 167.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 63.2 p -121.92 148.67 44.46 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.33 1.452 . . . . 0.0 108.826 169.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 29.6 p -155.51 -165.11 1.9 Allowed 'General case' 0 C--O 1.241 0.63 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.22 168.48 33.07 Favored Glycine 0 N--CA 1.446 -0.698 0 O-C-N 121.541 -0.724 . . . . 0.0 111.976 169.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.2 mp -49.46 -39.85 34.91 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.044 0.937 . . . . 0.0 109.875 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -146.04 143.48 29.45 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 103.789 -2.671 . . . . 0.0 103.789 168.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.1 p -75.65 156.11 35.15 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 122.121 0.962 . . . . 0.0 111.503 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 63.5 m -158.39 153.92 26.1 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 127.72 2.408 . . . . 0.0 105.143 169.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -54.09 146.64 14.35 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 122.938 0.495 . . . . 0.0 110.894 -171.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 p -60.8 135.82 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 169.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -78.94 143.55 62.05 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 123.587 0.755 . . . . 0.0 109.858 -171.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.1 -41.63 0.28 Allowed 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 121.495 1.463 . . . . 0.0 112.409 -169.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.48 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 25.3 m -62.73 -24.57 67.75 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 120.422 -1.424 . . . . 0.0 111.292 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.417 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -51.36 -40.07 58.42 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.718 0.807 . . . . 0.0 111.663 173.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 62.9 mt -55.6 -46.0 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.12 -38.91 89.36 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 124.425 1.09 . . . . 0.0 110.161 -170.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.2 mmm -68.19 -44.19 76.44 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.744 1.259 . . . . 0.0 110.63 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.0 mtp -65.22 -35.87 82.39 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.221 -0.924 . . . . 0.0 109.963 175.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -63.89 -24.86 67.91 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.359 0.664 . . . . 0.0 111.489 173.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -65.82 -40.01 91.43 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 118.848 0.749 . . . . 0.0 109.746 172.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 92.7 t -76.78 -25.41 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.602 176.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.25 25.66 5.47 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.152 1.358 . . . . 0.0 111.727 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.525 HG22 ' H ' ' A' ' 56' ' ' ASP . 10.5 mt -123.37 178.85 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 125.128 1.371 . . . . 0.0 107.379 -178.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.525 ' H ' HG22 ' A' ' 55' ' ' ILE . 12.9 t70 -142.84 155.26 44.75 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.219 1.408 . . . . 0.0 109.557 -176.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.457 HD13 HG21 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -127.94 -13.88 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 123.955 0.902 . . . . 0.0 112.562 169.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -46.74 -37.17 8.07 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.53 1.132 . . . . 0.0 112.75 172.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.16 -6.23 85.96 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 118.697 -1.057 . . . . 0.0 114.248 -173.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -126.81 170.03 12.61 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.077 1.439 . . . . 0.0 111.204 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.6 p -129.2 166.57 19.12 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.645 1.178 . . . . 0.0 111.184 -170.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.2 m -92.08 155.78 17.83 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.798 1.239 . . . . 0.0 110.034 173.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -156.9 144.23 13.78 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 124.299 1.039 . . . . 0.0 110.07 -169.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.56 148.99 23.63 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 121.735 1.624 . . . . 0.0 111.158 -176.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.2 tt -52.01 -34.1 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.306 1.042 . . . . 0.0 111.761 173.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -58.44 -23.16 56.77 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.119 1.768 . . . . 0.0 112.404 -175.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -82.13 -6.83 59.48 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.916 0.886 . . . . 0.0 112.814 -175.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -125.39 -174.73 3.13 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.254 1.022 . . . . 0.0 110.356 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.47 130.71 30.82 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 126.399 1.88 . . . . 0.0 108.449 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.4 -28.39 66.87 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.633 1.173 . . . . 0.0 112.829 -176.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -60.49 -22.55 63.66 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.06 0.944 . . . . 0.0 112.452 -176.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -84.76 -13.2 51.96 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.428 0.691 . . . . 0.0 110.7 -178.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -108.77 127.37 53.95 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.972 1.309 . . . . 0.0 109.593 -172.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -74.17 -40.07 62.79 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.156 0.583 . . . . 0.0 109.967 175.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.97 136.38 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 122.823 0.449 . . . . 0.0 110.411 -169.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.7 m -129.15 110.53 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-O 122.839 1.304 . . . . 0.0 109.55 -170.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.7 mm -109.47 97.41 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -174.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.0 m -73.49 156.09 38.55 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 168.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.41 66.31 0.63 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 77.4 m . . . . . 0 N--CA 1.456 -0.146 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.391 -169.821 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -66.77 11.79 0.09 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.408 1.483 . . . . 0.0 112.624 169.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.7 p -124.01 3.24 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 125.563 1.545 . . . . 0.0 111.508 170.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 52.7 p -127.38 19.5 6.86 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.352 0.978 . . . . 0.0 112.649 -173.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -85.86 -173.64 4.71 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.223 0.609 . . . . 0.0 109.536 171.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -65.91 -32.5 74.04 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -169.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.2 mt -136.3 136.28 49.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -137.33 139.58 40.93 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 170.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -146.75 159.63 43.25 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.436 1.494 . . . . 0.0 107.441 168.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -123.35 96.39 4.97 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.488 1.515 . . . . 0.0 108.955 169.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -73.9 92.81 2.11 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.066 1.346 . . . . 0.0 109.54 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -65.81 97.37 0.34 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.889 1.276 . . . . 0.0 109.532 174.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -125.56 156.2 39.46 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.616 1.566 . . . . 0.0 109.906 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -78.7 66.35 4.18 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.518 1.927 . . . . 0.0 111.701 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -8.87 92.74 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 129.528 3.131 . . . . 0.0 113.553 169.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.415 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 77.5 Cg_exo -60.14 -4.38 2.99 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 124.707 3.605 . . . . 0.0 117.611 -169.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -54.64 98.85 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 120.244 1.384 . . . . 0.0 111.611 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.46 16.89 54.45 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.115 1.817 . . . . 0.0 113.522 170.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.415 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 25.7 mm-40 -94.95 179.59 5.17 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.792 1.296 . . . . 0.0 112.626 -169.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.2 m -76.35 155.43 34.15 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.254 1.422 . . . . 0.0 109.926 175.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.9 mt -58.89 -31.67 68.82 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.957 -0.464 . . . . 0.0 111.559 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -63.96 -40.53 96.63 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.088 0.404 . . . . 0.0 110.894 177.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.4 t -65.8 -47.44 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 176.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.48 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 8.1 m-85 -53.8 -54.24 41.06 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.225 0.61 . . . . 0.0 110.822 177.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 33.6 mtt180 -59.78 -42.06 92.48 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.707 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.5 m -61.67 -52.72 63.16 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 118.828 0.74 . . . . 0.0 109.222 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.3 t -64.04 -44.42 97.76 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.02 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -57.64 -45.5 85.39 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 119.728 1.149 . . . . 0.0 110.189 -177.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.46 -49.28 66.08 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-O 118.684 -1.064 . . . . 0.0 111.153 177.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -59.9 -50.06 75.25 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 118.661 1.231 . . . . 0.0 111.058 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.6 t -54.18 -48.13 66.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 124.634 1.174 . . . . 0.0 109.921 178.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -60.13 -46.94 87.96 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 120.071 1.305 . . . . 0.0 110.586 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -42.04 86.07 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.304 1.042 . . . . 0.0 110.68 178.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.6 mtt-85 -71.2 -41.88 69.71 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 117.821 -1.085 . . . . 0.0 109.863 -177.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.421 ' HA ' HD23 ' A' ' 126' ' ' LEU . 94.1 t -54.47 -46.06 70.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 120.461 1.482 . . . . 0.0 109.976 169.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -61.94 -40.21 94.74 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.465 1.03 . . . . 0.0 111.075 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -63.11 -44.62 95.14 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.048 0.539 . . . . 0.0 110.321 176.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 123' ' ' VAL . 0.2 OUTLIER -64.02 -46.79 82.92 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 118.447 -0.787 . . . . 0.0 109.951 -178.254 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.1 mt -52.86 -41.91 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 124.052 0.941 . . . . 0.0 109.423 173.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.31 -31.01 72.05 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.713 1.142 . . . . 0.0 111.571 -175.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -69.65 -39.25 77.18 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.497 1.119 . . . . 0.0 111.504 176.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.0 pt -95.81 -28.7 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -169.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.5 m . . . . . 0 C--O 1.25 1.132 0 C-N-CA 126.079 1.752 . . . . 0.0 111.22 -179.177 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? . . . . . 0 N--CA 1.466 0.366 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.7 mttt -102.72 104.13 14.43 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 123.515 0.726 . . . . 0.0 109.453 175.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 36.4 t -79.0 141.03 15.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 125.259 1.424 . . . . 0.0 108.837 175.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 30.6 tpp -127.18 142.41 51.5 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.707 1.203 . . . . 0.0 108.368 173.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -124.47 133.49 53.34 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.135 0.974 . . . . 0.0 108.893 173.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.3 t -144.19 122.81 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 120.259 1.39 . . . . 0.0 110.027 -169.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.2 p -132.4 179.9 5.84 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 120.058 1.299 . . . . 0.0 111.181 175.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.8 mttm -62.55 -10.57 12.46 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.789 1.236 . . . . 0.0 114.001 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -143.85 -10.45 0.69 Allowed 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 116.026 1.861 . . . . 0.0 116.026 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 63.2 -40.95 0.19 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 128.312 2.645 . . . . 0.0 114.291 -169.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.5 m -34.84 -39.14 0.09 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 129.252 3.021 . . . . 0.0 118.573 -169.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.7 p -132.64 -72.27 0.52 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 118.124 -0.941 . . . . 0.0 109.594 -169.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 -50.62 -52.58 38.12 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.928 0.785 . . . . 0.0 110.387 -169.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.65 -45.02 63.27 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.361 0.664 . . . . 0.0 111.349 -176.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -59.78 -44.01 94.11 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.204 1.002 . . . . 0.0 111.409 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 53.5 mtp -64.57 -48.29 75.52 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.877 1.271 . . . . 0.0 109.295 178.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.8 -40.14 79.22 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.363 0.265 . . . . 0.0 111.149 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -62.56 -46.95 85.97 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.761 0.425 . . . . 0.0 110.556 177.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.35 -43.43 95.68 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 119.443 -0.643 . . . . 0.0 111.875 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -67.24 -48.92 66.34 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 119.025 1.413 . . . . 0.0 109.159 176.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.71 -42.71 79.63 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 119.599 1.091 . . . . 0.0 112.395 -176.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.3 pttt -75.7 -2.41 29.41 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.9 m -99.16 -45.57 5.86 Favored 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 120.917 -1.114 . . . . 0.0 109.437 169.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 91.9 mt -71.25 -40.34 71.07 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.183 1.793 . . . . 0.0 110.945 -173.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.845 0 CA-C-O 117.444 -1.753 . . . . 0.0 116.8 -169.791 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.1 pt . . . . . 0 N--CA 1.451 -0.377 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -120.37 144.39 47.92 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 169.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.92 153.67 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 123.442 0.697 . . . . 0.0 112.631 -174.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.3 m -151.02 144.9 25.17 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.579 1.552 . . . . 0.0 106.873 168.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 97.6 p -112.01 157.74 20.38 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.35 -0.844 . . . . 0.0 109.665 168.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.7 p -152.02 -164.17 1.91 Allowed 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 171.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.32 161.8 35.18 Favored Glycine 0 CA--C 1.519 0.297 0 O-C-N 121.276 -0.89 . . . . 0.0 111.092 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 66.0 mt -54.75 -32.02 59.28 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.407 1.083 . . . . 0.0 111.123 -173.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -146.85 144.54 29.38 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 168.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.6 p -73.5 153.46 40.31 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.741 0.781 . . . . 0.0 111.296 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.3 m -160.21 154.07 22.86 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.502 2.321 . . . . 0.0 105.869 169.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -57.13 156.12 7.59 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.62 0.645 . . . . 0.0 111.408 -174.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.9 t -63.23 132.34 29.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 172.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -73.84 139.8 77.24 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -75.12 -41.59 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.358 1.372 . . . . 0.0 112.614 -169.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.494 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 25.5 m -64.65 -23.02 67.12 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 120.556 -1.34 . . . . 0.0 111.48 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.62 -40.55 60.11 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 123.622 0.769 . . . . 0.0 111.402 171.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 61.7 mt -56.2 -45.38 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.88 -40.17 91.36 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 124.249 1.02 . . . . 0.0 110.056 -171.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.8 mmm -64.47 -44.86 89.7 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 122.145 0.974 . . . . 0.0 110.16 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.1 mtp -66.94 -36.7 82.83 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.721 177.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -61.04 -29.92 70.01 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.306 0.643 . . . . 0.0 111.272 173.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -64.25 -39.81 94.72 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 118.884 0.766 . . . . 0.0 110.213 173.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 62.1 t -77.79 -17.06 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.027 177.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.92 25.44 10.54 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.787 1.184 . . . . 0.0 111.933 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.528 HG22 ' H ' ' A' ' 56' ' ' ASP . 11.9 mt -121.28 179.68 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 125.405 1.482 . . . . 0.0 107.279 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.528 ' H ' HG22 ' A' ' 55' ' ' ILE . 13.8 t70 -144.9 156.0 43.75 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.228 1.411 . . . . 0.0 109.351 -178.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -127.74 -16.85 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.831 0.852 . . . . 0.0 112.443 169.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -44.18 -38.71 3.89 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.692 1.197 . . . . 0.0 112.968 172.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.29 -6.45 86.37 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-O 118.582 -1.121 . . . . 0.0 114.268 -173.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -126.61 164.74 20.58 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.156 1.478 . . . . 0.0 110.732 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.5 p -129.88 167.26 18.44 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.017 0.927 . . . . 0.0 111.74 -169.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.1 m -77.45 164.64 25.26 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.573 1.149 . . . . 0.0 111.761 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -157.63 141.58 11.49 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-O 118.411 -0.804 . . . . 0.0 109.471 174.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -78.09 153.37 28.49 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.557 2.171 . . . . 0.0 111.232 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.1 tt -53.82 -33.86 24.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.798 1.239 . . . . 0.0 112.471 177.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -66.07 -20.98 66.34 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.251 1.42 . . . . 0.0 112.074 -169.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -83.33 -0.98 52.17 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.108 0.963 . . . . 0.0 112.561 -173.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -115.85 -173.12 2.29 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.847 0.859 . . . . 0.0 112.462 -170.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.431 ' HA ' ' CH2' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -142.91 131.39 22.32 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 127.284 2.234 . . . . 0.0 107.846 173.433 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.695 ' HB2' ' CE3' ' A' ' 90' ' ' TRP . . . -62.28 -29.16 70.22 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 119.142 -0.456 . . . . 0.0 112.208 178.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -61.73 -20.36 63.42 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.381 0.672 . . . . 0.0 112.372 -170.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -88.73 -22.84 23.13 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.601 0.76 . . . . 0.0 110.955 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -99.08 113.1 25.14 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.972 1.309 . . . . 0.0 108.832 -176.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -72.31 -28.91 63.38 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 122.315 -0.24 . . . . 0.0 110.875 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.18 135.13 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.081 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -172.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.7 t -131.74 129.63 61.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 122.786 1.279 . . . . 0.0 109.253 -173.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.3 mm -120.32 101.77 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -177.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.5 t -72.42 155.39 40.18 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 105.496 -2.039 . . . . 0.0 105.496 168.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.45 36.3 0.89 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 172.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 90.4 m . . . . . 0 CA--C 1.533 0.313 0 O-C-N 121.08 -1.013 . . . . 0.0 112.15 -173.913 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 122.075 0.94 . . . . 0.0 113.271 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.695 ' CE3' ' HB2' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -49.14 -27.52 3.56 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 128.209 2.604 . . . . 0.0 111.65 169.646 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.21 -2.14 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.811 0.844 . . . . 0.0 110.589 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 56.7 p -120.68 18.96 11.93 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.978 0.911 . . . . 0.0 113.151 -169.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -86.95 179.87 6.63 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.306 1.042 . . . . 0.0 110.339 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -57.3 -34.02 68.27 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.714 1.206 . . . . 0.0 113.082 -169.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.4 mt -132.8 139.15 50.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 174.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -140.61 132.92 28.28 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 169.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -142.27 159.13 42.85 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.292 1.437 . . . . 0.0 108.622 169.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -121.14 111.28 17.22 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.764 1.226 . . . . 0.0 109.428 168.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.427 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 41.0 m0 -85.33 93.83 8.8 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.566 1.146 . . . . 0.0 108.741 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -59.77 116.51 4.12 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 169.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.3 mt -149.68 149.32 30.43 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.565 1.546 . . . . 0.0 107.506 -169.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -84.61 63.23 7.8 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 125.023 1.329 . . . . 0.0 111.137 -175.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -0.99 88.0 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 129.021 2.929 . . . . 0.0 112.918 169.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.497 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 71.0 Cg_exo -58.68 -4.93 2.14 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 124.262 3.308 . . . . 0.0 117.33 -169.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -54.91 99.7 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.392 0.996 . . . . 0.0 111.738 176.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.17 18.06 54.35 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 126.16 1.838 . . . . 0.0 113.324 171.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.497 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 22.1 mm-40 -95.9 178.16 5.52 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.661 1.23 . . . . 0.0 112.562 -169.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.3 m -74.94 154.74 38.01 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.498 1.519 . . . . 0.0 110.048 174.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.9 mt -58.58 -32.67 69.16 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.786 -0.571 . . . . 0.0 111.574 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -63.31 -39.93 95.93 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 122.679 0.392 . . . . 0.0 110.664 177.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.7 t -66.39 -45.77 88.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 176.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.494 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 10.7 m-85 -55.4 -52.06 64.81 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.823 0.449 . . . . 0.0 110.803 177.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 34.8 mtt180 -61.76 -40.09 93.91 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.509 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.3 m -62.0 -51.49 67.82 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.393 0.997 . . . . 0.0 109.708 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 49.0 t -63.66 -45.1 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.958 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 -56.31 -45.83 80.11 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-N 119.705 1.139 . . . . 0.0 109.499 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.17 -50.34 68.75 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-O 118.176 -1.347 . . . . 0.0 110.408 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -59.36 -54.46 46.47 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 118.535 1.168 . . . . 0.0 110.512 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 65.1 t -47.32 -54.57 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 125.541 1.536 . . . . 0.0 110.297 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -62.99 -44.85 94.9 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 120.112 1.324 . . . . 0.0 110.626 -175.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -57.96 -42.19 84.47 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.727 1.211 . . . . 0.0 109.655 177.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.427 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 80.5 mtt-85 -74.61 -41.58 60.15 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 117.186 -1.388 . . . . 0.0 109.979 -175.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.449 ' HA ' HD23 ' A' ' 126' ' ' LEU . 95.6 t -53.15 -45.71 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 121.216 1.825 . . . . 0.0 109.564 169.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -62.29 -42.02 98.99 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.044 0.838 . . . . 0.0 111.218 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -60.91 -46.01 92.34 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 175.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 123' ' ' VAL . 0.2 OUTLIER -63.03 -48.97 76.44 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.252 -0.88 . . . . 0.0 109.561 -176.009 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 55.9 mt -52.35 -42.14 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 124.234 1.014 . . . . 0.0 109.443 173.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.26 -30.74 71.82 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.638 1.108 . . . . 0.0 111.58 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 44.7 mttt -70.38 -38.0 74.64 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.719 1.208 . . . . 0.0 111.537 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.7 pt -97.61 -27.12 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -169.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.8 m . . . . . 0 C--O 1.25 1.111 0 C-N-CA 126.125 1.77 . . . . 0.0 110.915 176.481 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.464 0.243 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -96.14 117.77 31.39 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 170.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 98.2 t -101.7 135.63 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 125.469 1.508 . . . . 0.0 107.673 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 51.9 ttm -118.86 138.28 52.84 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 168.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -108.68 130.22 55.34 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 169.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.9 t -129.17 113.23 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 120.326 1.421 . . . . 0.0 109.296 -170.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.6 t -111.59 162.63 14.95 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.97 0.805 . . . . 0.0 111.571 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.4 mttm -65.51 -13.01 57.95 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.824 -1.173 . . . . 0.0 112.383 171.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.6 ptt180 -153.81 114.33 3.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 104.149 -2.537 . . . . 0.0 104.149 169.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -69.56 52.92 0.11 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.795 1.238 . . . . 0.0 112.415 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.5 p -126.76 -23.3 3.72 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.842 1.257 . . . . 0.0 112.668 -170.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 78.6 m -133.99 -87.82 0.4 Allowed 'General case' 0 C--N 1.343 0.3 0 CA-C-O 118.379 -0.82 . . . . 0.0 111.185 -171.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -50.33 -50.6 50.46 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.016 0.825 . . . . 0.0 110.922 -169.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.1 p -70.25 -44.67 68.02 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 125.26 1.424 . . . . 0.0 110.974 -174.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -58.93 -46.39 88.09 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.649 1.18 . . . . 0.0 110.436 -177.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 52.2 mtp -63.76 -46.63 84.41 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.586 1.154 . . . . 0.0 109.598 177.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.74 -37.75 74.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 119.104 -0.474 . . . . 0.0 111.425 178.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -62.29 -53.31 56.98 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-O 118.464 -0.779 . . . . 0.0 109.855 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.91 -41.17 75.62 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -66.38 -49.79 65.68 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 118.271 1.036 . . . . 0.0 109.676 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.0 -46.43 88.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 120.09 1.314 . . . . 0.0 113.082 -174.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -71.14 -8.77 55.74 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 119.7 1.136 . . . . 0.0 113.201 176.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 38.0 m -92.77 -48.7 6.44 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 119.965 1.257 . . . . 0.0 110.552 169.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.2 mt -78.92 -41.55 29.25 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.998 1.719 . . . . 0.0 112.135 -169.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 CA-C-O 117.904 -1.498 . . . . 0.0 114.604 -169.066 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.8 pt . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 121.47 0.652 . . . . 0.0 112.124 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -123.74 134.11 53.74 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 168.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 p -119.45 151.35 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -170.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.2 m -141.71 131.71 24.58 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.132 1.373 . . . . 0.0 108.614 168.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.6 p -98.21 141.4 31.17 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.026 -1.046 . . . . 0.0 108.517 169.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.6 m -154.0 -177.28 6.3 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.413 1.885 . . . . 0.0 106.087 -169.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.53 170.77 43.3 Favored Glycine 0 N--CA 1.439 -1.11 0 O-C-N 121.377 -0.827 . . . . 0.0 111.522 175.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -53.62 -33.58 55.55 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 125.176 1.163 . . . . 0.0 110.048 174.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -143.57 146.23 33.15 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.986 1.714 . . . . 0.0 106.67 169.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 p -70.53 157.66 37.49 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.294 0.569 . . . . 0.0 109.612 169.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.6 m -162.16 148.56 13.39 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.199 1.8 . . . . 0.0 106.795 170.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -54.4 151.96 7.03 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.562 0.619 . . . . 0.0 110.907 -175.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.9 t -57.44 126.19 14.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 172.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -70.46 140.85 87.59 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -72.84 -41.68 1.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.265 1.31 . . . . 0.0 113.192 -169.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.505 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 29.8 m -65.01 -25.19 67.75 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.664 -1.272 . . . . 0.0 111.298 -177.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.475 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -51.46 -40.87 60.33 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.723 0.809 . . . . 0.0 111.335 173.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.8 mt -56.45 -45.88 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.12 -38.37 88.01 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.507 1.123 . . . . 0.0 110.578 -172.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.9 mmm -68.41 -44.02 75.93 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 122.915 1.34 . . . . 0.0 110.434 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.2 mtp -66.88 -34.29 77.46 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 121.124 -0.985 . . . . 0.0 110.005 175.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -62.48 -26.4 68.51 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.998 0.817 . . . . 0.0 111.423 172.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -65.55 -39.84 92.19 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 118.905 0.775 . . . . 0.0 109.768 173.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 63.9 t -78.46 -22.28 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 120.159 -0.617 . . . . 0.0 110.852 177.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.93 25.09 6.63 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.054 1.311 . . . . 0.0 111.948 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.525 HG22 ' H ' ' A' ' 56' ' ' ASP . 10.7 mt -122.68 179.03 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 125.227 1.411 . . . . 0.0 107.45 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.525 ' H ' HG22 ' A' ' 55' ' ' ILE . 9.8 t0 -144.28 155.96 44.06 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.863 1.665 . . . . 0.0 108.822 -176.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.475 HD12 ' HB1' ' A' ' 46' ' ' ALA . 0.5 OUTLIER -130.85 -13.04 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.981 0.913 . . . . 0.0 113.365 174.314 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.7 m -43.1 -34.24 1.03 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.993 1.717 . . . . 0.0 114.637 -176.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -102.82 1.93 48.52 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 117.853 -1.526 . . . . 0.0 114.576 -174.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -71.92 -26.78 62.44 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 120.528 2.164 . . . . 0.0 113.081 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.9 p 60.49 -161.06 0.29 Allowed 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.314 1.046 . . . . 0.0 110.264 -174.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.4 t -134.19 163.0 30.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.798 0.809 . . . . 0.0 111.406 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -161.21 133.9 4.48 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 126.304 1.842 . . . . 0.0 106.373 -171.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -85.0 158.51 11.57 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.875 2.384 . . . . 0.0 110.934 176.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.4 tt -54.28 -35.15 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 123.476 0.711 . . . . 0.0 111.02 172.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -57.22 -24.12 52.47 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.11 1.764 . . . . 0.0 112.66 -175.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -83.3 -2.34 55.44 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.569 0.748 . . . . 0.0 112.547 -176.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -128.88 -176.87 3.99 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.253 1.021 . . . . 0.0 111.005 -177.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.18 129.28 31.46 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 126.602 1.961 . . . . 0.0 108.274 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.31 -29.82 66.18 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.548 1.139 . . . . 0.0 112.939 -175.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -60.73 -22.7 64.27 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.036 0.934 . . . . 0.0 112.475 -176.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -84.31 -18.02 37.67 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.272 0.629 . . . . 0.0 110.605 -177.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -101.89 122.74 44.58 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 125.168 1.387 . . . . 0.0 108.959 -175.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -76.22 -32.34 58.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.841 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.9 138.01 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 123.518 0.727 . . . . 0.0 109.059 -171.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.0 128.01 45.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 122.97 1.367 . . . . 0.0 109.869 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.0 mm -120.33 96.16 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 -175.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.7 m -70.04 156.01 39.78 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 168.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.74 56.07 0.91 Allowed 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 102.753 -3.055 . . . . 0.0 102.753 173.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.4 m . . . . . 0 N--CA 1.452 -0.352 0 C-N-CA 123.834 0.854 . . . . 0.0 110.14 -178.042 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -64.65 8.7 0.11 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.115 1.766 . . . . 0.0 113.03 170.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.7 p -122.1 2.87 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 124.845 1.258 . . . . 0.0 111.652 172.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.9 p -128.05 23.48 6.09 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.212 1.005 . . . . 0.0 112.149 -173.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -88.58 179.87 6.19 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.621 0.768 . . . . 0.0 109.313 170.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -59.69 -33.6 71.79 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.23 1.012 . . . . 0.0 113.246 -171.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.9 mt -134.76 135.67 53.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 177.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -140.43 133.69 29.7 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 169.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -144.81 157.91 43.99 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.001 1.32 . . . . 0.0 107.573 168.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -119.48 117.54 28.71 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.7 1.2 . . . . 0.0 108.496 168.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -93.92 108.65 20.43 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.218 1.407 . . . . 0.0 109.543 -173.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -72.54 105.57 4.25 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.727 1.211 . . . . 0.0 108.511 178.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -135.76 151.94 50.62 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 125.038 1.335 . . . . 0.0 108.855 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -82.98 75.91 9.84 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.735 1.214 . . . . 0.0 110.657 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -21.92 98.86 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 128.096 2.558 . . . . 0.0 112.466 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.406 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 53.0 Cg_exo -60.81 -4.5 3.62 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 124.44 3.427 . . . . 0.0 116.785 -169.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -56.47 101.07 0.05 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.182 1.355 . . . . 0.0 111.485 177.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.37 18.24 55.66 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 126.096 1.808 . . . . 0.0 113.389 170.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.406 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 26.9 mm-40 -94.41 178.34 5.65 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.652 1.226 . . . . 0.0 112.763 -169.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.2 m -75.18 154.79 37.49 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.477 1.511 . . . . 0.0 109.955 175.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 93.5 mt -57.47 -32.6 67.13 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.017 -0.427 . . . . 0.0 111.479 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.98 -40.29 94.75 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.858 0.463 . . . . 0.0 110.874 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 88.6 t -65.26 -48.31 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 175.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.505 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 6.4 m-85 -53.94 -52.43 60.65 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.281 0.632 . . . . 0.0 110.954 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -60.97 -43.79 98.28 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.74 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.1 m -61.5 -50.78 71.36 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 118.867 0.758 . . . . 0.0 109.183 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 66.3 t -66.71 -43.67 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-O 118.349 -0.834 . . . . 0.0 110.153 -178.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.62 -43.38 89.64 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 119.966 1.257 . . . . 0.0 110.242 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.66 -49.03 71.97 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-O 118.595 -1.114 . . . . 0.0 111.244 176.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -59.96 -51.87 67.82 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 118.701 1.251 . . . . 0.0 110.884 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 64.4 t -52.78 -48.51 49.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 124.804 1.242 . . . . 0.0 109.959 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -60.02 -47.38 86.08 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.86 1.209 . . . . 0.0 110.399 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.04 -42.76 81.06 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.943 0.897 . . . . 0.0 110.341 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -70.6 -43.43 69.38 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 118.19 -0.909 . . . . 0.0 109.961 -176.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 74.6 t -53.83 -48.19 62.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 120.282 1.401 . . . . 0.0 109.661 169.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -59.48 -40.37 86.76 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.449 1.022 . . . . 0.0 110.559 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -62.54 -46.07 90.07 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.307 1.043 . . . . 0.0 110.316 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.38 -49.56 76.42 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 124.099 0.96 . . . . 0.0 109.488 178.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.88 -37.49 67.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.679 1.191 . . . . 0.0 110.795 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.52 -31.12 71.12 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.889 1.222 . . . . 0.0 111.328 -174.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -70.8 -20.15 62.62 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.689 1.595 . . . . 0.0 112.872 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.9 pt -125.28 -21.04 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -168.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 C--O 1.249 1.028 0 C-N-CA 126.186 1.795 . . . . 0.0 111.174 173.684 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 49.0 mmtt . . . . . 0 N--CA 1.463 0.224 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -92.06 137.71 32.14 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.3 p -122.47 143.83 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 121.866 0.841 . . . . 0.0 109.457 -178.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 31.2 tpp -124.38 141.88 51.73 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.368 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -121.67 125.01 45.64 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 170.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.7 t -128.69 129.53 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 120.402 1.456 . . . . 0.0 109.351 -169.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.8 t -137.84 161.05 37.61 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 119.528 1.058 . . . . 0.0 112.473 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.8 mttt -58.76 -21.42 55.58 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.854 1.262 . . . . 0.0 110.884 168.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.4 ptp85 -147.94 101.23 3.28 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 126.096 1.759 . . . . 0.0 107.05 169.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -44.65 -42.46 7.52 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.013 1.325 . . . . 0.0 112.2 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.7 p -45.21 -20.91 0.06 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 129.599 3.159 . . . . 0.0 118.266 -169.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.4 p -130.65 -74.73 0.53 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.953 1.251 . . . . 0.0 110.647 -171.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -61.22 -52.08 66.29 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -169.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.41 -42.94 78.26 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.425 0.29 . . . . 0.0 111.125 -178.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -59.3 -45.66 90.68 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.603 0.761 . . . . 0.0 111.579 -174.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 44.2 mtm -63.97 -46.6 83.91 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 117.78 0.264 . . . . 0.0 110.903 175.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.8 -39.04 76.61 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 117.606 0.185 . . . . 0.0 110.925 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.452 ' HA ' HG21 ' A' ' 32' ' ' VAL . 33.3 tt0 -63.43 -45.44 90.93 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 122.549 0.34 . . . . 0.0 111.163 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.24 -40.07 96.45 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -175.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -66.66 -46.44 75.68 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 118.146 0.973 . . . . 0.0 108.923 174.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.49 -44.04 84.62 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 119.338 0.972 . . . . 0.0 112.591 -173.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -67.93 -38.4 82.83 Favored 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 119.246 -0.982 . . . . 0.0 111.049 174.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.1 m -66.89 -43.4 83.54 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 120.478 1.49 . . . . 0.0 110.504 -177.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.1 -37.7 53.77 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.076 1.35 . . . . 0.0 111.184 -173.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.605 0 CA-C-O 116.55 -2.25 . . . . 0.0 117.582 -169.216 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.5 pt . . . . . 0 N--CA 1.449 -0.483 0 CA-C-O 121.361 0.6 . . . . 0.0 111.295 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -126.1 130.8 51.79 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 169.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.452 HG21 ' HA ' ' A' ' 19' ' ' GLU . 3.0 p -117.76 152.28 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 C-N-CA 123.331 0.652 . . . . 0.0 111.582 -171.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.4 m -151.69 135.4 16.31 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 167.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 89.0 p -97.43 161.82 13.61 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 121.207 -0.933 . . . . 0.0 109.795 169.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.8 p -151.85 -165.77 2.32 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 169.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.63 165.78 37.0 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 169.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 61.5 mt -54.99 -30.58 59.67 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.825 0.85 . . . . 0.0 110.5 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -148.82 145.96 27.77 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 168.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.2 p -89.55 152.56 21.35 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.593 0.757 . . . . 0.0 111.16 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.8 m -147.52 154.89 41.31 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.748 2.019 . . . . 0.0 106.276 170.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -57.89 148.49 25.36 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.933 0.788 . . . . 0.0 109.702 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 26.9 t -57.95 130.47 21.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -176.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -66.21 136.4 95.28 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -177.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.46 -40.24 6.05 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.273 1.982 . . . . 0.0 113.409 -168.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.502 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 6.1 m -68.0 -17.84 64.54 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.366 -0.834 . . . . 0.0 111.826 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.416 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -59.06 -41.27 87.52 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 121.679 -0.638 . . . . 0.0 110.026 171.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.08 -42.37 94.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.44 -38.92 85.65 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -177.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 21.9 mmt -61.85 -47.49 84.8 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 122.813 1.292 . . . . 0.0 111.326 176.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.0 mtp -69.41 -33.58 73.2 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.368 -178.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -61.95 -29.84 70.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.863 0.865 . . . . 0.0 111.128 172.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -64.98 -39.31 93.28 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.734 0.697 . . . . 0.0 110.328 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 62.1 t -78.67 -23.38 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.935 178.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.95 25.97 5.7 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.109 1.338 . . . . 0.0 112.034 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.429 HG22 ' H ' ' A' ' 56' ' ' ASP . 11.3 mt -124.64 176.84 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 125.688 1.595 . . . . 0.0 107.662 -176.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.429 ' H ' HG22 ' A' ' 55' ' ' ILE . 7.2 t70 -140.65 157.87 44.81 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.137 1.775 . . . . 0.0 108.605 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.416 HD12 ' HB1' ' A' ' 46' ' ' ALA . 0.9 OUTLIER -128.21 -20.18 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.649 0.78 . . . . 0.0 113.009 171.195 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 55.3 p -51.84 -33.36 35.72 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.198 0.908 . . . . 0.0 112.441 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.92 -24.75 59.33 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-O 118.024 -1.431 . . . . 0.0 114.324 -176.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -86.95 -27.41 23.33 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 120.122 1.961 . . . . 0.0 114.953 -169.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 29.2 p 65.87 176.6 0.22 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.719 1.608 . . . . 0.0 113.459 173.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.2 m -102.13 162.13 13.15 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.45 1.1 . . . . 0.0 112.202 -169.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -156.3 134.42 7.18 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-O 118.273 -0.87 . . . . 0.0 109.071 -174.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -80.07 156.24 23.12 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.973 2.448 . . . . 0.0 111.771 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.7 tt -56.7 -33.88 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 123.773 0.829 . . . . 0.0 111.419 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -58.28 -23.13 55.23 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.2 1.8 . . . . 0.0 112.222 -174.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -82.45 -3.17 55.25 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.094 0.958 . . . . 0.0 112.693 -176.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -129.51 177.27 7.32 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 119.916 1.235 . . . . 0.0 112.556 -173.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.43 141.63 50.53 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 128.05 2.54 . . . . 0.0 106.493 170.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.35 -23.9 62.0 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.084 0.954 . . . . 0.0 111.91 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -60.48 -23.09 64.21 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.012 0.925 . . . . 0.0 112.412 -175.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -81.59 -15.85 53.44 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.032 0.933 . . . . 0.0 110.894 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -107.84 128.0 54.22 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.698 1.599 . . . . 0.0 109.65 -172.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -72.44 -40.36 67.13 Favored 'General case' 0 C--O 1.232 0.152 0 O-C-N 121.954 -0.467 . . . . 0.0 110.331 174.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -130.28 135.4 60.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 122.908 0.483 . . . . 0.0 109.927 -170.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.7 t -122.62 119.05 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 122.413 1.101 . . . . 0.0 108.916 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 35.9 mm -108.45 96.7 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.3 t -70.18 156.39 39.29 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 168.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.19 40.32 0.78 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 172.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 85.6 m . . . . . 0 CA--C 1.534 0.34 0 C-N-CA 124.028 0.931 . . . . 0.0 111.55 179.762 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 CA--C 1.54 0.566 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -59.52 -3.96 0.54 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.074 2.15 . . . . 0.0 114.467 171.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.9 p -119.82 -5.62 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 119.545 1.066 . . . . 0.0 112.754 171.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.2 p -102.94 18.12 22.37 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.623 1.101 . . . . 0.0 111.919 -172.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -87.51 -176.96 5.78 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.487 1.115 . . . . 0.0 109.304 172.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -68.22 -32.66 73.02 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -169.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.2 mt -136.61 140.14 43.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -176.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -142.4 139.45 31.67 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.691 1.196 . . . . 0.0 108.661 171.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -147.07 159.68 43.31 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.935 1.694 . . . . 0.0 107.942 168.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -121.72 105.6 10.55 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.06 1.344 . . . . 0.0 108.728 168.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.43 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 43.1 m0 -78.38 93.16 4.66 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.067 0.947 . . . . 0.0 109.315 -178.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -60.67 119.93 9.06 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 169.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.8 mt -150.05 152.15 34.37 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.541 1.536 . . . . 0.0 107.529 -169.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -82.47 64.15 6.98 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 125.073 1.349 . . . . 0.0 111.142 -176.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -10.34 94.85 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 128.762 2.825 . . . . 0.0 113.804 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.506 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 76.2 Cg_exo -58.66 -9.95 8.31 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 124.081 3.187 . . . . 0.0 116.549 -173.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -54.81 101.99 0.06 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 120.262 1.392 . . . . 0.0 111.804 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.87 21.63 42.11 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.279 1.895 . . . . 0.0 113.433 172.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.506 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 18.5 mm-40 -102.07 178.12 4.7 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.839 1.319 . . . . 0.0 113.67 -169.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.2 m -78.73 156.07 29.08 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.204 1.802 . . . . 0.0 110.19 175.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 96.5 mt -60.3 -30.19 69.32 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.772 -0.58 . . . . 0.0 111.951 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.51 -39.07 93.1 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.326 0.512 . . . . 0.0 110.777 176.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 95.3 t -67.46 -45.9 84.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.502 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 12.1 m-85 -55.55 -51.8 65.86 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 118.902 -0.571 . . . . 0.0 110.547 176.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -59.19 -42.11 90.09 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.913 0.779 . . . . 0.0 111.919 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.8 m -61.52 -51.1 70.01 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.052 0.842 . . . . 0.0 109.627 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.7 t -65.46 -43.87 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 117.87 -1.062 . . . . 0.0 110.234 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -55.18 -45.01 75.78 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 119.821 1.191 . . . . 0.0 109.214 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.42 -49.9 72.34 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-O 118.214 -1.326 . . . . 0.0 110.409 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -60.07 -56.43 21.72 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 118.574 1.187 . . . . 0.0 110.423 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.9 t -46.62 -52.46 3.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 125.694 1.597 . . . . 0.0 110.444 176.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -63.61 -46.55 85.23 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 119.708 1.14 . . . . 0.0 110.114 -175.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -43.14 85.04 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.272 0.629 . . . . 0.0 110.197 178.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.43 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 79.6 mtt-85 -69.87 -42.74 73.1 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.894 -176.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 72.9 t -54.12 -49.18 63.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 120.393 1.451 . . . . 0.0 109.516 169.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -59.78 -39.85 86.27 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 119.448 1.022 . . . . 0.0 110.625 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -63.42 -45.9 88.83 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.328 1.051 . . . . 0.0 110.224 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -47.93 80.06 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 124.082 0.953 . . . . 0.0 109.815 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 61.8 mt -57.3 -38.49 62.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 124.703 1.201 . . . . 0.0 110.562 176.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.2 -28.94 69.51 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.776 1.171 . . . . 0.0 111.488 -173.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -73.66 -19.51 60.81 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.879 1.672 . . . . 0.0 112.731 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 pt -125.67 -20.1 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 126.151 1.78 . . . . 0.0 114.921 -168.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.3 m . . . . . 0 C--O 1.251 1.138 0 C-N-CA 126.432 1.893 . . . . 0.0 110.907 170.015 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 51.3 mmtt . . . . . 0 N--CA 1.465 0.297 0 N-CA-C 107.354 -1.351 . . . . 0.0 107.354 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.7 mttt -94.51 135.86 35.46 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.2 p -121.68 144.55 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-O 121.885 0.85 . . . . 0.0 109.548 -176.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 29.6 tpp -124.23 142.2 51.44 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.493 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -123.41 111.37 16.27 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.4 t -111.65 117.06 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 119.611 1.096 . . . . 0.0 108.546 -173.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.9 t -108.05 165.19 11.65 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.713 0.768 . . . . 0.0 110.824 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -59.03 -16.22 17.41 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.701 0.8 . . . . 0.0 111.875 169.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -158.62 115.69 2.81 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 128.241 2.616 . . . . 0.0 103.975 178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -65.02 40.27 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.751 1.62 . . . . 0.0 113.063 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.5 p -122.75 -20.37 5.93 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 119.839 -1.788 . . . . 0.0 113.559 -169.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 82.5 m -132.71 -89.06 0.42 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.595 0.634 . . . . 0.0 111.438 -169.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -56.3 -46.84 79.62 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 118.881 0.764 . . . . 0.0 110.555 -169.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 13.3 p -68.87 -37.53 79.11 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.584 1.153 . . . . 0.0 111.583 -174.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -66.08 -47.71 73.35 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.704 0.802 . . . . 0.0 109.927 -174.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 69.1 mtm -63.77 -46.16 86.51 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 119.434 -0.317 . . . . 0.0 110.645 176.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.85 -42.4 71.94 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 123.043 0.215 . . . . 0.0 110.822 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -65.29 -47.1 77.83 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 123.02 0.2 . . . . 0.0 110.807 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.63 -38.08 95.72 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -175.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -65.19 -49.75 68.55 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 174.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.09 -43.39 82.15 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 124.228 1.011 . . . . 0.0 113.079 -172.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -67.47 -37.79 83.46 Favored 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 118.926 -1.109 . . . . 0.0 111.048 174.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.4 m -68.1 -42.16 80.72 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 120.404 1.456 . . . . 0.0 110.481 -177.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.0 mt -75.44 -38.41 59.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.733 1.613 . . . . 0.0 111.555 -175.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.658 0 CA-C-O 116.732 -2.149 . . . . 0.0 117.98 -169.076 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.2 pt . . . . . 0 N--CA 1.451 -0.42 0 CA-C-O 121.406 0.622 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -125.34 131.23 53.04 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 169.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -117.29 152.78 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 123.32 0.648 . . . . 0.0 111.806 -170.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.9 m -148.5 134.42 19.07 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 167.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' ' 15' ' ' SER . 88.4 p -96.99 159.31 14.98 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 120.692 -1.255 . . . . 0.0 107.949 168.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.1 m -153.22 -170.3 3.57 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 176.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.78 164.96 33.91 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 169.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.4 mt -52.32 -30.1 26.71 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 124.627 0.84 . . . . 0.0 110.348 170.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -143.0 148.51 36.9 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 169.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 p -72.46 154.74 40.7 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.25 0.62 . . . . 0.0 109.552 169.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.9 m -159.78 147.1 16.67 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 169.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -58.64 147.66 31.8 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.471 0.578 . . . . 0.0 109.856 -177.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -60.19 129.58 22.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.405 ' CE1' ' H ' ' A' ' 106' ' ' GLY . 23.1 t-80 -70.27 139.85 87.46 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.63 -38.83 5.42 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.238 1.959 . . . . 0.0 113.315 -168.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.536 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 8.2 m -68.04 -17.16 64.32 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.315 -0.866 . . . . 0.0 111.647 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.433 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -59.04 -40.62 85.61 Favored 'General case' 0 C--N 1.341 0.229 0 O-C-N 121.456 -0.778 . . . . 0.0 110.26 171.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.9 mp -62.97 -42.15 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -178.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.34 -37.39 83.14 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 20.5 mmt -62.13 -47.02 86.44 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 122.921 1.343 . . . . 0.0 111.197 175.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 9.3 mtp -70.09 -31.81 69.56 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.61 -177.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -61.57 -29.13 69.82 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.495 0.718 . . . . 0.0 111.36 169.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -65.83 -35.98 82.2 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.083 0.856 . . . . 0.0 110.475 173.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.4 t -78.96 -26.02 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 117.512 0.142 . . . . 0.0 110.916 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.48 28.19 6.48 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.723 1.154 . . . . 0.0 111.818 -175.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.579 HG22 ' H ' ' A' ' 56' ' ' ASP . 6.5 mt -125.66 -177.57 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 126.018 1.727 . . . . 0.0 107.163 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.579 ' H ' HG22 ' A' ' 55' ' ' ILE . 3.6 t70 -147.03 158.38 43.91 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.589 1.955 . . . . 0.0 108.355 -178.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.433 HD12 ' HB1' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -130.57 -13.2 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 173.571 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.5 p -51.22 -29.31 13.84 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.534 1.061 . . . . 0.0 113.43 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.24 -13.94 65.05 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 118.121 -1.377 . . . . 0.0 114.249 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -74.51 -29.9 61.59 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 120.281 2.041 . . . . 0.0 113.137 -173.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.7 p 59.74 -163.49 0.23 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.482 0.713 . . . . 0.0 109.689 -169.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.5 m -138.07 156.15 48.07 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.937 -173.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -153.44 135.87 9.38 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.319 1.048 . . . . 0.0 109.106 -169.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.89 153.64 22.62 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.466 2.11 . . . . 0.0 111.272 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.6 tt -53.54 -34.09 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.831 0.852 . . . . 0.0 111.486 174.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -57.51 -23.55 50.85 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.079 1.752 . . . . 0.0 112.503 -176.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -86.15 -7.43 58.57 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.736 0.814 . . . . 0.0 112.872 -174.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -121.77 -176.38 3.31 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.459 1.027 . . . . 0.0 110.523 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -133.96 130.58 37.86 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 126.26 1.824 . . . . 0.0 108.439 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.27 -30.43 68.29 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.708 1.203 . . . . 0.0 112.742 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.63 -21.73 63.05 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.066 0.947 . . . . 0.0 112.571 -175.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -85.52 -13.83 47.8 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.452 0.701 . . . . 0.0 111.012 -177.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -109.22 125.17 51.96 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.735 1.214 . . . . 0.0 109.852 -172.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -72.14 -41.38 67.22 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 122.474 0.31 . . . . 0.0 110.229 175.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.65 134.61 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 122.959 0.504 . . . . 0.0 109.898 -169.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.8 t -125.56 111.18 26.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 123.091 1.424 . . . . 0.0 108.64 -177.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.9 mm -100.25 99.26 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 177.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.8 t -72.31 156.81 38.71 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 167.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.57 54.78 0.68 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 103.394 -2.817 . . . . 0.0 103.394 173.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 83.5 m . . . . . 0 N--CA 1.451 -0.389 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.111 173.38 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 . . . . . 0 N--CA 1.472 0.656 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -57.0 -25.76 59.04 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.31 1.044 . . . . 0.0 112.039 173.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.6 p -83.63 -16.18 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 119.625 1.102 . . . . 0.0 110.179 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.7 p -106.51 17.92 22.65 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.917 0.887 . . . . 0.0 112.266 -170.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -78.81 179.12 7.42 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.593 0.757 . . . . 0.0 109.764 171.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -63.61 -31.96 73.28 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -169.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.6 mt -135.64 137.49 49.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -142.21 139.15 31.93 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.228 1.011 . . . . 0.0 108.448 171.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -146.93 161.78 40.06 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.663 1.585 . . . . 0.0 108.003 168.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -122.53 100.77 7.1 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.742 1.617 . . . . 0.0 108.653 168.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.459 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 40.2 m0 -76.27 91.15 3.19 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.558 1.143 . . . . 0.0 108.594 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -64.99 100.65 0.44 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.768 1.227 . . . . 0.0 109.734 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -129.83 155.34 46.15 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.006 1.323 . . . . 0.0 110.856 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -78.06 80.77 4.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.061 1.744 . . . . 0.0 110.125 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -35.69 108.76 0.38 Allowed Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 126.318 1.847 . . . . 0.0 112.652 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.433 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 54.2 Cg_exo -60.26 -2.53 1.87 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 125.13 3.887 . . . . 0.0 117.579 -171.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -53.57 98.4 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 120.495 1.498 . . . . 0.0 112.435 175.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.405 ' H ' ' CE1' ' A' ' 43' ' ' HIS . . . 87.6 18.73 56.24 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 126.406 1.955 . . . . 0.0 112.963 171.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.433 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 24.1 mm-40 -95.33 177.21 5.92 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.69 1.245 . . . . 0.0 112.601 -169.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.9 m -74.93 154.91 37.95 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.48 1.512 . . . . 0.0 109.798 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.6 mt -59.5 -29.8 68.11 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.861 -0.524 . . . . 0.0 111.717 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.61 -39.0 92.39 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.226 0.466 . . . . 0.0 110.876 175.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 82.3 t -68.13 -46.55 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 176.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.536 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 17.8 m-85 -55.07 -50.65 68.62 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 119.283 -0.389 . . . . 0.0 110.89 176.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -60.54 -42.13 95.9 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.931 0.893 . . . . 0.0 111.972 177.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 93.6 m -60.82 -51.73 68.08 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 119.156 0.889 . . . . 0.0 109.147 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 74.6 t -61.61 -47.09 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-O 117.891 -1.052 . . . . 0.0 109.81 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 38.6 ttp85 -53.57 -51.41 63.04 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 119.661 1.118 . . . . 0.0 108.967 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.55 -48.48 72.82 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -173.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -60.91 -52.6 64.34 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.856 0.862 . . . . 0.0 110.402 -177.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.0 t -57.98 -49.59 80.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 125.369 1.467 . . . . 0.0 110.325 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -58.25 -48.05 81.65 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 121.034 1.743 . . . . 0.0 110.623 -178.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.98 -45.26 71.35 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.207 1.003 . . . . 0.0 110.505 174.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.459 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 49.9 mtt85 -70.59 -39.87 73.58 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 117.869 -1.062 . . . . 0.0 111.024 -177.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 80.9 t -54.47 -49.14 67.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 120.515 1.507 . . . . 0.0 109.349 169.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -60.47 -39.64 88.34 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.349 0.977 . . . . 0.0 110.58 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -62.81 -45.92 90.36 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.335 1.054 . . . . 0.0 110.464 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.69 -47.95 79.1 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 124.342 1.057 . . . . 0.0 109.714 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.4 mt -57.07 -38.48 60.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.544 1.137 . . . . 0.0 110.591 175.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.28 -28.93 69.54 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.875 1.216 . . . . 0.0 111.5 -173.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -73.64 -19.68 60.78 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.969 1.708 . . . . 0.0 112.79 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.4 pt -125.43 -20.21 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 126.175 1.79 . . . . 0.0 114.826 -168.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 C--O 1.248 1.013 0 C-N-CA 126.571 1.948 . . . . 0.0 110.857 170.005 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -97.17 118.77 34.35 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 172.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.468 ' HA ' HG13 ' A' ' 75' ' ' VAL . 8.9 p -101.37 138.38 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 O-C-N 123.688 0.617 . . . . 0.0 110.716 173.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 37.9 tpp -116.2 143.72 45.14 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 169.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -115.96 140.71 48.99 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.274 1.43 . . . . 0.0 108.149 169.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.7 t -146.4 129.87 9.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -170.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -133.83 172.16 13.17 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.098 0.863 . . . . 0.0 109.817 169.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -66.31 -12.11 54.64 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.42 -0.8 . . . . 0.0 112.946 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.1 ptm85 -155.23 106.17 2.57 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 171.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -46.99 -28.08 1.52 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.464 1.905 . . . . 0.0 114.135 -177.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -30.12 -42.39 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 129.81 3.244 . . . . 0.0 118.183 -169.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.7 p -136.25 -68.37 0.5 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 117.686 -1.149 . . . . 0.0 113.919 -169.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.5 ptt-85 -56.62 -48.7 76.91 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.507 1.503 . . . . 0.0 110.76 -172.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.83 -51.44 70.0 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.67 0.788 . . . . 0.0 110.121 176.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 -62.55 -44.88 95.26 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.68 0.792 . . . . 0.0 111.769 -173.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 51.4 mtm -62.87 -45.72 91.23 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.916 0.486 . . . . 0.0 110.384 175.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.99 -37.99 75.29 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 119.434 -0.317 . . . . 0.0 110.393 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -61.13 -50.03 74.88 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.4 0.68 . . . . 0.0 110.258 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.57 -44.69 94.71 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 119.348 -0.695 . . . . 0.0 111.866 -177.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -65.84 -46.98 76.54 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 118.773 1.286 . . . . 0.0 108.646 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.16 -43.3 87.32 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 119.779 1.172 . . . . 0.0 112.54 -175.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -68.26 -35.59 78.12 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.786 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.3 m -67.74 -42.43 81.86 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 120.047 -1.658 . . . . 0.0 110.758 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.9 mt -73.05 -40.1 65.39 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.031 1.732 . . . . 0.0 111.036 -174.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.799 0 CA-C-O 116.749 -2.14 . . . . 0.0 117.964 -169.506 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.3 pt . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.72 130.3 56.64 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 169.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.7 p -113.94 151.83 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-O 121.882 0.848 . . . . 0.0 111.911 -175.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.1 m -144.15 152.59 41.12 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 126.214 1.806 . . . . 0.0 106.206 167.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.0 p -129.26 157.07 42.9 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.135 0.974 . . . . 0.0 108.803 168.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.6 p -158.53 -161.39 0.98 Allowed 'General case' 0 C--O 1.241 0.642 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.66 163.96 33.35 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 169.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 65.3 mt -53.36 -31.79 46.23 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.37 1.068 . . . . 0.0 110.727 177.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -143.14 145.04 32.47 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 168.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.9 p -75.66 165.65 24.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.911 0.863 . . . . 0.0 111.567 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.5 p -150.03 -132.27 0.05 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.542 1.537 . . . . 0.0 106.957 177.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -144.55 157.73 44.09 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 171.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.5 t -65.24 131.6 31.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -177.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -71.99 138.54 82.22 Favored Pre-proline 0 N--CA 1.446 -0.65 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.96 -38.17 5.47 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 CA-C-N 120.423 1.187 . . . . 0.0 111.694 -169.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.493 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 8.6 m -67.59 -19.12 65.21 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.56 -1.338 . . . . 0.0 112.094 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.48 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -58.15 -39.2 78.17 Favored 'General case' 0 C--O 1.231 0.084 0 O-C-N 121.502 -0.749 . . . . 0.0 110.494 172.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.6 mt -58.37 -47.73 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.51 -40.33 91.04 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.808 0.843 . . . . 0.0 111.837 -175.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.2 mmt -60.26 -48.61 81.03 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.517 1.151 . . . . 0.0 111.21 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 9.3 mtp -69.04 -35.34 76.48 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.914 -178.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -61.18 -30.51 70.45 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.824 0.738 . . . . 0.0 111.55 172.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -63.22 -39.58 95.03 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.026 0.83 . . . . 0.0 110.384 173.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.1 t -79.76 -18.65 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-O 119.888 -0.101 . . . . 0.0 111.098 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.13 26.35 8.91 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.552 1.073 . . . . 0.0 111.816 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.607 HG22 ' H ' ' A' ' 56' ' ' ASP . 10.7 mt -122.09 -176.13 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 126.078 1.751 . . . . 0.0 106.505 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.607 ' H ' HG22 ' A' ' 55' ' ' ILE . 8.4 t70 -149.68 155.58 40.44 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 120.406 -1.434 . . . . 0.0 109.632 -177.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.48 HD12 ' HB1' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -130.49 -13.61 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.061 0.945 . . . . 0.0 112.538 169.465 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 99.7 p -52.99 -30.83 37.43 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.659 1.118 . . . . 0.0 112.432 176.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.14 -7.11 87.76 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 118.526 -1.152 . . . . 0.0 114.366 -176.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -125.3 169.9 11.84 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.37 1.585 . . . . 0.0 110.93 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 19.2 p -127.58 164.47 21.93 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.231 1.012 . . . . 0.0 112.365 -169.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.4 m -78.98 156.91 28.25 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.567 1.147 . . . . 0.0 110.953 171.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -155.42 145.14 15.46 Favored Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 123.935 0.894 . . . . 0.0 109.542 -177.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -80.32 151.94 20.56 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.246 1.964 . . . . 0.0 111.113 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.1 tt -54.25 -34.92 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.658 0.783 . . . . 0.0 111.442 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -60.59 -21.58 62.78 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.689 1.595 . . . . 0.0 112.471 -174.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -79.77 -5.54 55.52 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.564 0.746 . . . . 0.0 112.562 -177.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -124.76 -175.83 3.38 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.539 1.136 . . . . 0.0 110.651 -178.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.49 127.19 25.34 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 126.563 1.945 . . . . 0.0 107.583 176.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.79 -27.74 63.37 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.604 1.162 . . . . 0.0 112.447 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -59.82 -23.47 63.37 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.33 1.052 . . . . 0.0 112.739 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -85.0 -14.18 48.26 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.421 0.689 . . . . 0.0 110.72 -177.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -104.54 126.21 51.42 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 125.222 1.409 . . . . 0.0 109.012 -174.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.94 -42.63 76.45 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.468 HG13 ' HA ' ' A' ' 4' ' ' VAL . 1.8 p -130.99 136.08 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 C-N-CA 122.9 0.48 . . . . 0.0 109.918 -169.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.5 m -127.66 120.3 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-O 122.363 1.078 . . . . 0.0 108.651 -172.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.6 mm -116.72 102.84 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-N 115.006 -0.997 . . . . 0.0 108.389 -169.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.9 t -74.37 153.68 39.16 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 168.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.79 36.48 0.4 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 171.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 77.4 m . . . . . 0 C--N 1.339 0.128 0 O-C-N 120.92 -1.113 . . . . 0.0 112.151 -169.962 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 . . . . . 0 N--CA 1.471 0.609 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 56.1 m95 -67.44 11.29 0.13 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.628 1.971 . . . . 0.0 112.725 171.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.0 p -121.95 4.04 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 125.229 1.412 . . . . 0.0 111.651 169.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 36.3 p -131.71 25.9 4.7 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.17 -0.956 . . . . 0.0 112.602 -172.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -91.54 -170.72 2.69 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 170.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -64.55 -32.06 73.54 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.295 0.638 . . . . 0.0 112.235 -170.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.3 mt -137.9 138.3 44.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -134.61 134.88 41.73 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 169.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -141.25 152.06 44.23 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 169.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -119.95 124.74 46.72 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.448 1.099 . . . . 0.0 109.143 169.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.411 ' CZ3' ' HG2' ' A' ' 122' ' ' ARG . 66.1 m95 -107.76 86.64 2.33 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -54.82 125.11 18.79 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 169.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 25.0 mt -149.06 156.12 41.76 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.618 1.567 . . . . 0.0 107.4 -169.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -82.4 60.93 5.33 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.725 1.21 . . . . 0.0 111.151 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.3 t0 4.53 85.97 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.469 0 C-N-CA 129.348 3.059 . . . . 0.0 112.141 169.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.458 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 74.8 Cg_exo -61.56 -8.14 10.35 Favored 'Trans proline' 0 C--N 1.352 0.748 0 N-CA-C 116.71 1.773 . . . . 0.0 116.71 -169.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -61.04 95.98 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.848 1.204 . . . . 0.0 111.27 -177.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.5 16.1 25.55 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.243 1.878 . . . . 0.0 113.361 172.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.458 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 25.2 mm-40 -95.76 178.12 5.56 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.925 1.362 . . . . 0.0 113.167 -169.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.4 m -76.55 155.73 33.43 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.985 1.714 . . . . 0.0 110.143 174.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 97.0 mt -58.53 -32.5 68.92 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.853 -0.529 . . . . 0.0 111.621 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -71.15 -33.82 70.42 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.126 0.421 . . . . 0.0 110.852 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 72.1 t -65.82 -45.75 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 172.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.493 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 13.6 m-85 -57.38 -49.8 75.03 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 118.609 -0.71 . . . . 0.0 110.52 176.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 60.9 mtt180 -57.6 -43.35 84.61 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.425 1.011 . . . . 0.0 111.808 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 89.4 m -61.15 -53.58 55.24 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 50.4 t -63.58 -41.62 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.558 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -56.64 -48.36 77.7 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 120.205 1.366 . . . . 0.0 109.225 177.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.66 -45.31 96.54 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -59.31 -60.83 3.23 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 123.756 0.823 . . . . 0.0 109.017 177.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.4 t -45.29 -51.62 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 126.752 2.021 . . . . 0.0 110.974 177.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -63.54 -46.54 85.5 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 120.008 1.276 . . . . 0.0 110.38 -175.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.26 -42.12 85.75 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.708 0.803 . . . . 0.0 110.237 176.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.411 ' HG2' ' CZ3' ' A' ' 99' ' ' TRP . 82.9 mtt180 -69.33 -43.13 74.34 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.292 1.037 . . . . 0.0 109.914 -175.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 71.5 t -54.79 -48.97 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 119.427 1.012 . . . . 0.0 110.068 168.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -60.67 -38.96 86.66 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 120.017 1.281 . . . . 0.0 111.197 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -63.66 -44.38 93.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.439 1.096 . . . . 0.0 110.201 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.11 -40.8 67.91 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.101 -179.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.7 mt -51.88 -43.23 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 124.004 0.921 . . . . 0.0 108.697 169.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.15 -29.81 70.61 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.674 1.125 . . . . 0.0 111.494 -173.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -71.8 -44.8 63.33 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.121 1.368 . . . . 0.0 110.761 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 pt -85.02 -29.07 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.895 1.278 . . . . 0.0 113.89 -173.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.5 m . . . . . 0 C--O 1.249 1.053 0 C-N-CA 126.161 1.785 . . . . 0.0 111.102 179.693 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.4 mptt . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -88.93 116.96 27.6 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 170.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 98.3 t -99.04 138.3 23.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 125.286 1.435 . . . . 0.0 107.19 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.404 ' HA ' ' O ' ' A' ' 33' ' ' THR . 31.0 tpp -121.5 140.72 51.82 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.792 1.237 . . . . 0.0 108.889 175.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -122.19 134.85 54.71 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 170.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.7 t -140.35 133.89 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 119.42 1.009 . . . . 0.0 109.182 -170.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 p -139.71 167.76 21.38 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 119.897 1.226 . . . . 0.0 111.813 169.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -62.08 -18.16 59.85 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -146.83 102.93 3.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 169.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -44.56 -36.75 3.16 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 127.112 2.165 . . . . 0.0 113.355 -177.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.2 m -45.68 -13.5 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 129.519 3.128 . . . . 0.0 119.237 -168.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.5 p -128.97 -89.14 0.51 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 120.279 1.4 . . . . 0.0 111.17 -171.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -57.8 -48.28 80.16 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.555 0.616 . . . . 0.0 110.758 -169.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.435 ' HB3' ' HB3' ' A' ' 34' ' ' SER . 3.4 m -57.74 -44.43 86.04 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.462 0.705 . . . . 0.0 110.104 -175.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -76.25 -32.73 59.02 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 119.075 -0.488 . . . . 0.0 111.773 -173.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.476 ' HG2' HD11 ' A' ' 57' ' ' ILE . 65.4 mtm -65.55 -47.15 76.85 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.691 0.678 . . . . 0.0 109.986 169.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.22 -36.08 70.46 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.842 0.457 . . . . 0.0 110.831 177.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -59.08 -62.04 2.18 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.79 -39.66 68.61 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 119.144 -0.809 . . . . 0.0 111.883 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.405 ' CZ ' ' SD ' ' A' ' 50' ' ' MET . 40.5 m-85 -66.53 -50.25 63.8 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 119.038 1.419 . . . . 0.0 110.594 174.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.32 -43.47 98.76 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 120.233 1.378 . . . . 0.0 112.45 -172.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 ptmt -70.48 -9.04 55.52 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.626 1.103 . . . . 0.0 113.24 175.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.7 m -92.67 -49.4 6.11 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 119.982 1.265 . . . . 0.0 110.544 169.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.5 mt -78.32 -41.4 33.8 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 125.642 1.577 . . . . 0.0 112.205 -169.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.338 0 CA-C-O 118.034 -1.426 . . . . 0.0 114.75 -169.142 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.9 pt . . . . . 0 C--O 1.233 0.211 0 CA-C-O 121.342 0.591 . . . . 0.0 111.635 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.7 127.92 53.31 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 168.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.0 p -109.07 150.69 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-O 121.55 0.691 . . . . 0.0 111.654 -176.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 5' ' ' MET . 85.7 m -148.95 137.51 21.13 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 167.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.435 ' HB3' ' HB3' ' A' ' 15' ' ' SER . 11.3 m -124.02 152.46 42.57 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 121.752 -0.593 . . . . 0.0 110.291 178.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 19.3 p -157.56 -163.62 1.39 Allowed 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -171.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.65 168.77 41.82 Favored Glycine 0 N--CA 1.448 -0.504 0 O-C-N 121.318 -0.864 . . . . 0.0 111.098 174.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 65.6 mt -56.42 -32.3 64.73 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.085 0.554 . . . . 0.0 111.061 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -141.57 149.39 40.7 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 169.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.8 p -91.1 157.93 16.94 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.276 1.031 . . . . 0.0 110.599 170.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 28.5 m -164.88 158.23 17.05 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.826 2.85 . . . . 0.0 104.912 169.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 96.5 mtt-85 -50.93 136.73 22.28 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.643 1.111 . . . . 0.0 110.449 -172.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.7 p -58.17 131.72 22.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -70.33 142.83 90.0 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-O 118.851 -0.595 . . . . 0.0 109.872 -169.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.68 -39.7 0.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.53 1.486 . . . . 0.0 112.583 -169.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.466 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 29.3 m -62.44 -25.8 68.16 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.643 -1.286 . . . . 0.0 111.529 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.75 -43.98 38.11 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.61 0.764 . . . . 0.0 110.928 172.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.9 mt -54.99 -46.52 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 C-N-CA 124.257 1.023 . . . . 0.0 108.345 -178.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.4 -34.89 79.22 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 123.996 0.918 . . . . 0.0 110.051 -171.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.9 mmm -70.09 -41.94 73.39 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.062 0.934 . . . . 0.0 110.549 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.514 ' HG3' ' CG1' ' A' ' 57' ' ' ILE . 87.8 mmm -62.82 -41.23 99.24 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 174.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -61.79 -26.27 67.99 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.079 0.552 . . . . 0.0 111.129 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -66.25 -40.27 90.07 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 118.478 0.581 . . . . 0.0 110.025 172.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.5 t -77.96 -26.22 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.816 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.98 24.29 6.09 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 125.354 1.455 . . . . 0.0 112.009 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.8 mt -121.81 177.63 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 125.643 1.577 . . . . 0.0 107.576 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -143.37 159.0 43.16 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.495 1.518 . . . . 0.0 109.746 -177.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.514 ' CG1' ' HG3' ' A' ' 50' ' ' MET . 0.7 OUTLIER -131.3 -18.64 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.244 1.017 . . . . 0.0 111.776 169.62 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -42.64 -38.32 1.99 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.155 1.382 . . . . 0.0 113.345 174.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.13 -11.28 63.62 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.529 1.061 . . . . 0.0 113.899 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -128.13 172.8 10.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.413 1.485 . . . . 0.0 112.442 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.2 p -125.09 164.28 20.55 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.709 1.604 . . . . 0.0 110.348 -176.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.26 166.95 21.4 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.512 1.525 . . . . 0.0 111.539 174.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -154.91 142.67 14.09 Favored Pre-proline 0 N--CA 1.472 0.643 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.535 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -84.49 151.85 11.86 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.028 2.485 . . . . 0.0 111.868 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.2 tt -58.19 -32.75 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 123.951 0.9 . . . . 0.0 111.647 175.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -57.24 -21.6 35.2 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.255 1.822 . . . . 0.0 112.1 -176.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -74.72 -9.61 58.73 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.662 1.185 . . . . 0.0 112.855 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -134.1 179.7 6.09 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 120.24 1.382 . . . . 0.0 112.711 -175.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.42 143.08 51.15 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 127.901 2.48 . . . . 0.0 107.384 169.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.62 -25.31 62.98 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.194 0.998 . . . . 0.0 112.439 -176.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -60.88 -23.12 64.94 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.753 0.821 . . . . 0.0 112.325 -174.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -80.71 -16.44 53.94 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.122 0.969 . . . . 0.0 110.597 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -102.77 124.37 48.18 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 125.394 1.477 . . . . 0.0 109.083 -173.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -72.16 -36.43 69.3 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 176.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.73 132.32 56.9 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -170.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.1 t -124.04 132.52 71.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 122.188 0.994 . . . . 0.0 108.894 178.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.9 mm -121.87 102.74 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -178.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.3 m -73.95 155.08 39.03 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 168.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.27 26.71 0.96 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.633 1.573 . . . . 0.0 108.156 175.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 86.4 m . . . . . 0 C--N 1.339 0.138 0 C-N-CA 124.863 1.265 . . . . 0.0 113.276 -169.877 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -55.58 -28.47 55.22 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 124.821 1.248 . . . . 0.0 112.193 173.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.5 p -87.39 -2.63 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 118.935 0.789 . . . . 0.0 110.26 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.7 p -123.35 22.66 9.26 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.144 0.978 . . . . 0.0 112.716 -169.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -82.07 178.14 8.44 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.479 0.712 . . . . 0.0 110.7 174.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.72 -33.87 72.18 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.454 1.101 . . . . 0.0 112.224 -169.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.5 mt -129.2 138.58 54.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 172.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -141.94 134.49 28.23 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 170.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -141.15 153.9 45.6 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 168.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -120.08 104.9 10.51 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.715 1.206 . . . . 0.0 110.069 169.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.44 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 37.9 m0 -80.59 79.48 7.2 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.381 1.872 . . . . 0.0 108.564 178.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -55.02 118.67 4.51 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 171.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 30.6 mt -147.07 154.7 41.48 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.534 1.534 . . . . 0.0 107.785 -169.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -82.8 59.35 4.75 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.963 1.305 . . . . 0.0 111.982 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 47.8 t0 5.79 82.23 0.04 OUTLIER Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 129.925 3.29 . . . . 0.0 113.135 169.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.417 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 75.3 Cg_exo -59.49 -13.67 22.01 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.997 3.131 . . . . 0.0 118.691 -168.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -62.98 98.24 0.13 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.623 1.556 . . . . 0.0 110.217 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 106.24 10.94 28.71 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.22 1.867 . . . . 0.0 113.559 173.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.417 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 29.4 mm-40 -95.7 179.38 5.14 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.152 1.476 . . . . 0.0 113.29 -169.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.3 m -76.9 155.51 32.78 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.653 1.581 . . . . 0.0 110.123 175.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 57.3 mt -59.42 -32.2 69.97 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.879 -0.513 . . . . 0.0 111.686 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.36 -41.2 98.41 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.245 0.475 . . . . 0.0 110.765 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 97.3 t -66.28 -45.92 88.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.466 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 11.1 m-85 -55.69 -50.88 69.11 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.86 177.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 53.8 mtp85 -62.58 -40.49 97.05 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 118.31 -0.853 . . . . 0.0 111.486 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 93.9 m -62.08 -52.37 64.2 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 118.57 0.623 . . . . 0.0 109.334 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.9 t -66.37 -45.59 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 118.128 -0.939 . . . . 0.0 110.324 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -40.91 88.78 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 120.054 1.297 . . . . 0.0 110.298 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.48 -50.12 69.93 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-O 118.479 -1.178 . . . . 0.0 110.942 175.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -60.41 -53.72 54.26 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 118.652 1.226 . . . . 0.0 110.631 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.6 t -47.01 -51.92 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 125.212 1.405 . . . . 0.0 109.965 175.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -62.12 -48.35 80.52 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.604 1.093 . . . . 0.0 110.803 -177.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.36 -43.74 75.37 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.295 1.038 . . . . 0.0 110.257 177.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.44 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 81.7 mtt-85 -72.12 -40.85 67.84 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 117.833 -1.079 . . . . 0.0 110.094 -175.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 71.4 t -55.05 -48.74 75.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 120.71 1.595 . . . . 0.0 109.057 169.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.33 -39.8 88.34 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.34 0.973 . . . . 0.0 110.698 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -63.13 -46.01 89.3 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.201 1.0 . . . . 0.0 110.326 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.9 -44.14 90.56 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 123.148 0.579 . . . . 0.0 110.085 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.9 mt -58.56 -36.62 60.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.161 0.984 . . . . 0.0 110.775 174.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.96 -30.73 71.8 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.91 1.232 . . . . 0.0 111.34 -174.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -65.94 -24.87 66.91 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.285 1.434 . . . . 0.0 113.422 177.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.0 pt -123.23 -20.08 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 -167.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.3 m . . . . . 0 C--O 1.248 1.026 0 C-N-CA 126.074 1.75 . . . . 0.0 111.05 173.232 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.9 mptt . . . . . 0 N--CA 1.466 0.34 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -90.64 135.63 33.59 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 121.494 -0.754 . . . . 0.0 109.013 170.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.4 p -115.37 140.37 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 123.659 0.784 . . . . 0.0 109.483 173.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 45.2 tpp -118.59 143.26 46.91 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 171.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -118.38 127.28 53.53 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 169.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 53.4 t -126.69 114.12 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 119.999 1.272 . . . . 0.0 108.871 -171.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.2 t -110.94 160.35 16.88 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.766 0.712 . . . . 0.0 111.071 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -59.13 -18.13 33.05 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 121.321 -0.862 . . . . 0.0 112.637 174.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.11 -2.39 2.07 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -174.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.526 HD22 ' H ' ' A' ' 63' ' ' ASP . 37.0 t-20 37.71 35.73 0.08 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.314 1.846 . . . . 0.0 115.211 -169.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.7 p -107.88 -35.08 6.74 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 120.523 -1.361 . . . . 0.0 112.306 -171.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 20.4 m -134.75 -68.36 0.54 Allowed 'General case' 0 C--N 1.342 0.27 0 CA-C-O 117.948 -1.025 . . . . 0.0 111.727 -169.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -56.13 -53.51 56.25 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.46 1.027 . . . . 0.0 110.262 -170.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.9 p -68.45 -43.06 77.89 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.675 1.19 . . . . 0.0 110.467 -174.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -59.94 -47.51 85.51 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.773 1.229 . . . . 0.0 110.626 -177.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.44 ' HG2' HD11 ' A' ' 57' ' ' ILE . 44.7 mtm -65.75 -44.98 84.28 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 119.272 -0.394 . . . . 0.0 110.77 175.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.89 -40.16 66.36 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.818 0.281 . . . . 0.0 110.945 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.458 ' HA ' HG21 ' A' ' 32' ' ' VAL . 23.5 tt0 -63.6 -55.08 26.52 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 118.676 -0.678 . . . . 0.0 110.009 177.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -53.15 -40.17 59.07 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 119.077 -0.846 . . . . 0.0 111.974 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.446 ' CD1' ' HE3' ' A' ' 50' ' ' MET . 13.3 m-85 -66.29 -49.13 68.15 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 119.11 1.455 . . . . 0.0 108.525 176.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.58 -46.05 90.07 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 124.183 0.993 . . . . 0.0 112.942 -173.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.5 ptmt -68.54 -8.81 44.84 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 119.337 0.971 . . . . 0.0 113.173 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.1 m -94.48 -47.59 6.49 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 119.984 1.266 . . . . 0.0 110.72 169.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.1 mt -76.34 -42.66 44.15 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.885 1.674 . . . . 0.0 111.956 -169.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 CA-C-O 117.741 -1.588 . . . . 0.0 114.935 -169.084 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.1 pt . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -122.84 133.57 54.43 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 168.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.458 HG21 ' HA ' ' A' ' 19' ' ' GLU . 2.6 p -116.8 157.56 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -169.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 m -148.3 145.55 28.21 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 126.306 1.842 . . . . 0.0 107.678 168.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.7 p -115.85 141.21 48.4 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.492 1.517 . . . . 0.0 108.608 168.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.8 m -150.73 -177.68 6.13 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.059 1.744 . . . . 0.0 106.616 -171.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.13 168.87 39.46 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.114 -1.041 . . . . 0.0 112.953 173.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.0 mp -56.2 -36.45 68.43 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 125.305 1.238 . . . . 0.0 110.607 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -150.24 150.41 31.51 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 169.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 65.8 m -83.64 146.5 28.22 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.567 0.699 . . . . 0.0 112.223 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.4 m -144.12 158.1 43.92 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 128.444 2.697 . . . . 0.0 104.505 168.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.5 ptt-85 -57.52 146.2 30.78 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.403 1.001 . . . . 0.0 110.392 -175.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 p -62.91 133.91 28.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 169.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -78.48 145.15 67.12 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.295 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.44 -41.11 0.36 Allowed 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.44 1.426 . . . . 0.0 112.814 -169.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.475 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 38.6 m -63.09 -24.86 68.1 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.422 -1.424 . . . . 0.0 111.314 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.42 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -50.67 -40.59 53.97 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.882 0.873 . . . . 0.0 111.514 172.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 55.5 mt -56.42 -44.23 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 124.304 1.042 . . . . 0.0 108.248 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.01 -37.67 81.69 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 125.069 1.347 . . . . 0.0 110.29 -172.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.0 mmm -68.66 -41.92 78.66 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 123.088 1.423 . . . . 0.0 110.427 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.446 ' HE3' ' CD1' ' A' ' 21' ' ' PHE . 4.6 mtp -66.62 -34.3 77.57 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 120.689 -1.257 . . . . 0.0 109.948 175.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -61.3 -28.83 69.48 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.844 -0.598 . . . . 0.0 111.654 170.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -61.24 -40.85 95.57 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.23 0.923 . . . . 0.0 110.529 173.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.7 m -92.58 7.3 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 178.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.99 25.34 49.53 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.137 0.875 . . . . 0.0 112.6 170.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.682 HG22 ' H ' ' A' ' 56' ' ' ASP . 9.9 mt -123.84 -174.82 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 125.404 1.482 . . . . 0.0 107.159 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.682 ' H ' HG22 ' A' ' 55' ' ' ILE . 8.0 t70 -148.85 155.84 41.47 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.612 1.565 . . . . 0.0 109.349 -176.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.44 HD11 ' HG2' ' A' ' 17' ' ' MET . 0.1 OUTLIER -128.49 -15.44 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 124.148 0.979 . . . . 0.0 112.38 169.768 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.6 p -52.6 -30.82 33.28 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.544 1.065 . . . . 0.0 112.621 176.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.79 -7.48 86.13 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.729 1.157 . . . . 0.0 114.187 -177.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -123.65 173.7 7.93 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 119.3 1.55 . . . . 0.0 111.165 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.5 p -128.72 174.02 9.81 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.11 1.364 . . . . 0.0 110.749 -173.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.8 p -96.92 151.74 19.4 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.355 1.062 . . . . 0.0 110.1 172.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.526 ' H ' HD22 ' A' ' 11' ' ' ASN . 3.5 t70 -150.11 148.79 25.65 Favored Pre-proline 0 C--O 1.239 0.543 0 C-N-CA 125.415 1.486 . . . . 0.0 109.258 -171.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -84.04 151.72 12.55 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.957 1.772 . . . . 0.0 110.898 -177.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.8 tt -54.86 -31.45 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 123.309 0.644 . . . . 0.0 111.271 171.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -50.78 -28.93 10.28 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.243 2.617 . . . . 0.0 112.274 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -83.98 -4.82 59.0 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.269 1.028 . . . . 0.0 112.917 -172.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -129.58 -176.84 4.03 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.643 1.111 . . . . 0.0 110.998 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.83 139.49 50.17 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 127.113 2.165 . . . . 0.0 107.427 173.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.62 -26.58 65.43 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.427 1.091 . . . . 0.0 111.791 -178.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -59.91 -24.54 64.41 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.105 0.962 . . . . 0.0 112.317 -171.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -89.85 -13.04 37.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.766 0.827 . . . . 0.0 111.08 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -94.2 133.05 38.12 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 125.307 1.443 . . . . 0.0 109.798 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -75.48 -42.47 52.91 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.3 p -132.75 137.24 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 123.02 0.528 . . . . 0.0 110.454 -169.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.3 m -129.51 104.61 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-O 123.5 1.619 . . . . 0.0 109.336 -171.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.7 mm -101.65 99.11 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 -177.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.8 t -73.19 155.77 39.26 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 168.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.08 53.49 0.57 Allowed 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 173.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 90.2 m . . . . . 0 C--N 1.339 0.118 0 C-N-CA 123.835 0.854 . . . . 0.0 109.546 173.525 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -66.1 8.99 0.17 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 126.58 1.952 . . . . 0.0 113.396 171.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.9 p -119.95 1.43 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.836 1.255 . . . . 0.0 111.705 171.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.1 p -125.49 25.38 7.05 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.989 0.915 . . . . 0.0 112.156 -172.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -91.54 -172.75 3.34 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.464 0.705 . . . . 0.0 109.444 170.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -66.08 -33.98 77.02 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -169.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.6 mt -136.84 134.46 48.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -139.27 140.23 37.59 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.263 1.025 . . . . 0.0 108.61 173.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -148.91 160.54 43.17 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.372 1.469 . . . . 0.0 107.93 168.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -121.95 102.44 8.18 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.274 1.43 . . . . 0.0 108.743 168.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.422 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 44.2 m0 -77.91 98.62 5.7 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.131 0.972 . . . . 0.0 109.596 -176.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -69.25 104.39 2.2 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.799 1.239 . . . . 0.0 109.229 174.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -137.69 168.71 19.12 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 126.679 1.992 . . . . 0.0 108.033 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -67.53 162.4 23.42 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 166.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -117.1 105.32 49.3 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 171.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -54.7 -1.88 0.17 Allowed 'Trans proline' 0 CA--C 1.537 0.64 1 C-N-CA 125.882 4.388 . . . . 0.0 118.652 -169.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -50.67 91.64 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.365 1.866 . . . . 0.0 112.616 172.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.64 16.71 51.49 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 126.121 1.819 . . . . 0.0 113.244 171.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -94.38 -179.96 5.09 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.843 1.322 . . . . 0.0 112.075 -169.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.5 m -77.46 155.67 31.59 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.089 1.356 . . . . 0.0 109.937 175.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.3 mt -58.61 -32.08 68.68 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 122.032 -0.418 . . . . 0.0 111.546 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -61.96 -39.27 91.56 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.145 0.429 . . . . 0.0 110.731 176.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 89.1 t -67.65 -46.78 82.15 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.475 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 14.0 m-85 -54.04 -52.58 60.41 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.885 0.474 . . . . 0.0 110.898 176.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 28.9 mtt180 -59.29 -42.14 90.57 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.371 1.069 . . . . 0.0 111.621 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 95.4 m -60.86 -52.71 63.9 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 95.8 t -64.41 -42.88 96.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 118.803 -0.618 . . . . 0.0 110.094 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -55.26 -46.71 76.09 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.346 0.976 . . . . 0.0 109.738 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -69.38 -49.35 39.28 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-O 119.211 -0.772 . . . . 0.0 111.866 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -63.79 -45.09 91.28 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.657 1.228 . . . . 0.0 111.866 -174.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.4 t -64.07 -43.42 97.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 117.874 -1.06 . . . . 0.0 109.37 176.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -58.56 -46.37 87.02 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.472 1.487 . . . . 0.0 110.512 178.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.09 -44.13 78.73 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.587 1.155 . . . . 0.0 110.138 176.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.422 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 51.3 mtt85 -71.25 -39.64 71.5 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 117.953 -1.023 . . . . 0.0 111.042 -177.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 88.4 t -54.94 -48.02 75.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 120.514 1.506 . . . . 0.0 109.784 169.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -60.08 -39.6 86.64 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.459 1.027 . . . . 0.0 110.614 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -62.28 -45.51 92.96 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.211 1.004 . . . . 0.0 110.485 178.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.38 -47.62 78.57 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 124.033 0.933 . . . . 0.0 110.06 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 63.7 mt -56.62 -38.37 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.394 1.078 . . . . 0.0 110.329 175.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.98 -28.87 69.32 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.72 1.145 . . . . 0.0 111.44 -174.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -75.16 -19.59 59.79 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.806 1.643 . . . . 0.0 112.731 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.4 pt -125.11 -20.56 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 125.707 1.603 . . . . 0.0 115.29 -168.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 C--O 1.251 1.137 0 C-N-CA 126.573 1.949 . . . . 0.0 110.935 172.311 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? . . . . . 0 N--CA 1.467 0.382 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -92.36 126.21 37.35 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 169.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.7 p -115.88 135.5 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 O-C-N 123.721 0.638 . . . . 0.0 110.962 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 55.1 tpp -107.5 153.05 23.41 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.237 1.015 . . . . 0.0 109.204 170.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -130.03 104.48 7.37 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.985 1.714 . . . . 0.0 106.686 169.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.97 127.28 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 120.057 1.298 . . . . 0.0 109.158 -176.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.2 t -116.17 163.11 16.45 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.791 1.178 . . . . 0.0 112.34 176.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -58.99 -21.81 59.49 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.584 -0.697 . . . . 0.0 111.654 171.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.4 ptm85 -153.48 116.07 4.45 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 169.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -48.8 -29.29 4.41 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.214 1.006 . . . . 0.0 113.166 -175.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.2 m -40.38 -34.33 0.33 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 119.235 3.05 . . . . 0.0 119.235 -169.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.7 p -135.63 -71.68 0.47 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 121.006 1.73 . . . . 0.0 113.942 -169.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -55.14 -50.92 68.05 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.21 0.914 . . . . 0.0 109.886 -169.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 0.1 OUTLIER -63.65 -48.49 77.0 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.992 2.117 . . . . 0.0 111.787 -179.233 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -63.34 -42.95 98.99 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.317 0.647 . . . . 0.0 110.785 -175.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 67.5 mtm -64.82 -46.23 82.83 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 119.05 -0.5 . . . . 0.0 111.036 174.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.86 -41.55 70.93 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 118.233 0.47 . . . . 0.0 110.805 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.63 -46.25 79.98 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 122.843 0.457 . . . . 0.0 111.054 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.39 -40.4 97.52 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -66.63 -52.14 48.41 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 118.506 1.153 . . . . 0.0 108.009 176.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.27 -42.98 78.32 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.824 1.25 . . . . 0.0 113.052 -174.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.3 pttt -68.56 -35.74 77.81 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-N 119.169 0.895 . . . . 0.0 110.265 175.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.6 m -68.1 -41.77 81.32 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 119.555 -1.966 . . . . 0.0 110.569 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.8 mt -73.23 -37.3 66.44 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.086 1.754 . . . . 0.0 111.202 -175.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.909 0 CA-C-O 117.01 -1.995 . . . . 0.0 117.875 -169.768 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.9 pt . . . . . 0 C--O 1.234 0.261 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -110.89 114.65 28.15 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 170.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 p -102.33 151.66 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-O 121.797 0.808 . . . . 0.0 111.723 -176.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.0 m -145.91 151.32 37.66 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 126.182 1.793 . . . . 0.0 106.195 167.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' A' ' 15' ' ' SER . 58.5 p -122.92 158.11 31.12 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 121.043 -1.036 . . . . 0.0 108.673 168.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.8 m -152.18 -173.66 4.62 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.491 1.516 . . . . 0.0 107.525 -174.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.89 162.59 31.35 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 169.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.2 mp -50.2 -36.87 32.51 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.656 1.183 . . . . 0.0 110.075 174.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -141.11 150.06 42.36 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 169.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.0 p -78.02 157.96 29.41 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.988 0.899 . . . . 0.0 110.694 173.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.2 m -164.86 157.86 16.71 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 128.126 2.57 . . . . 0.0 105.231 169.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -56.47 154.18 8.89 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.027 0.83 . . . . 0.0 111.322 -175.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.8 t -62.96 129.71 26.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 172.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -69.37 141.37 91.0 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -176.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.63 -40.42 2.07 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.182 1.255 . . . . 0.0 111.759 -169.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.513 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 6.2 m -67.95 -17.06 64.33 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.453 -1.404 . . . . 0.0 111.868 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.43 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -58.71 -40.28 83.24 Favored 'General case' 0 C--N 1.34 0.168 0 O-C-N 121.338 -0.851 . . . . 0.0 110.459 171.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.2 mt -57.26 -45.48 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.01 99.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.321 0.649 . . . . 0.0 111.791 -175.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 21.4 mmt -57.81 -47.37 82.8 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 122.85 1.31 . . . . 0.0 111.227 176.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 6.7 mtp -69.81 -31.86 69.99 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.376 -177.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.12 -31.82 70.42 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.47 0.708 . . . . 0.0 111.278 170.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -64.98 -35.11 80.12 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 118.669 0.668 . . . . 0.0 110.368 175.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.0 t -79.44 -25.87 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 119.906 -0.093 . . . . 0.0 110.908 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.14 28.81 6.67 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.718 1.151 . . . . 0.0 111.682 -174.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.583 HG22 ' H ' ' A' ' 56' ' ' ASP . 6.7 mt -125.29 -178.81 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 125.942 1.697 . . . . 0.0 106.927 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.583 ' H ' HG22 ' A' ' 55' ' ' ILE . 5.7 t70 -145.92 155.97 43.22 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.979 1.711 . . . . 0.0 108.883 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.43 HD12 ' HB1' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -130.24 -15.61 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.108 0.963 . . . . 0.0 113.331 172.712 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.4 p -50.39 -32.03 16.45 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.647 1.179 . . . . 0.0 113.615 -174.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.46 -15.82 36.53 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 117.852 -1.526 . . . . 0.0 114.425 -172.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -85.8 -25.63 26.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.262 2.031 . . . . 0.0 114.507 -171.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 38.1 p 68.02 168.65 0.26 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.604 1.961 . . . . 0.0 114.116 170.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.8 m -85.14 166.7 16.39 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.718 -171.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.98 139.34 12.59 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 124.137 0.975 . . . . 0.0 109.041 174.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.45 153.58 13.84 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.067 2.512 . . . . 0.0 110.632 169.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.1 tt -53.62 -34.85 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 123.725 0.81 . . . . 0.0 111.355 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -58.82 -22.81 59.43 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.757 1.623 . . . . 0.0 112.528 -176.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -80.42 -5.13 56.04 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.198 0.599 . . . . 0.0 112.541 -177.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -133.41 -176.24 4.08 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.487 1.039 . . . . 0.0 111.336 -176.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -139.68 131.93 28.25 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 126.889 2.076 . . . . 0.0 108.209 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.84 -28.48 67.52 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.475 1.11 . . . . 0.0 112.856 -175.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -60.26 -24.17 64.69 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.849 0.86 . . . . 0.0 112.334 -176.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -83.62 -15.87 47.35 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.247 0.619 . . . . 0.0 110.618 -177.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -102.44 127.06 49.64 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 125.465 1.506 . . . . 0.0 108.701 -175.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -85.4 -25.84 26.78 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.342 0.592 . . . . 0.0 109.688 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.0 t -131.0 135.81 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 -173.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.3 p -135.34 102.71 3.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 123.198 1.475 . . . . 0.0 110.137 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.5 mm -84.7 144.59 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 104.799 -2.296 . . . . 0.0 104.799 168.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.4 m -132.72 158.23 42.89 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 168.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.83 63.57 0.99 Allowed 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 102.515 -3.142 . . . . 0.0 102.515 -171.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 76.2 m . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -177.564 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 . . . . . 0 CA--C 1.538 0.507 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -64.96 10.42 0.07 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.278 1.831 . . . . 0.0 112.496 169.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.1 p -126.12 5.13 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 125.039 1.336 . . . . 0.0 112.03 172.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.6 p -129.41 25.7 5.43 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.895 -1.128 . . . . 0.0 112.89 -170.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -94.31 -177.09 4.16 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.403 0.681 . . . . 0.0 109.682 173.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -57.36 -35.26 69.72 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.372 1.069 . . . . 0.0 112.994 -174.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.8 mt -135.84 138.39 47.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -139.25 137.0 35.54 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 169.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -146.36 151.86 38.17 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.132 1.373 . . . . 0.0 108.21 169.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -115.73 126.67 54.37 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.798 1.239 . . . . 0.0 109.624 169.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.441 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 40.0 m0 -107.09 91.61 3.73 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.412 1.485 . . . . 0.0 108.124 -173.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -69.9 103.69 2.29 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.951 1.3 . . . . 0.0 109.28 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -136.57 161.5 35.72 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.675 1.59 . . . . 0.0 110.517 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -81.65 66.74 7.34 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.02 1.728 . . . . 0.0 111.283 -178.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -9.99 91.93 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 129.731 3.212 . . . . 0.0 112.318 169.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.437 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 71.0 Cg_exo -57.43 -8.36 3.8 Favored 'Trans proline' 0 N--CA 1.459 -0.553 1 C-N-CA 125.409 4.073 . . . . 0.0 117.946 -169.102 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -57.43 95.14 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 120.32 1.418 . . . . 0.0 111.832 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 98.63 13.86 39.55 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 126.428 1.966 . . . . 0.0 113.241 172.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.437 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 28.8 mm-40 -93.31 177.99 5.86 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.039 1.42 . . . . 0.0 112.575 -169.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.8 m -74.6 154.72 38.43 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.407 1.483 . . . . 0.0 109.931 175.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.1 mt -60.07 -30.31 69.13 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.737 -0.602 . . . . 0.0 111.784 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -62.68 -39.87 95.32 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.106 0.412 . . . . 0.0 110.877 174.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.4 t -67.15 -45.2 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.057 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.513 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 16.2 m-85 -54.66 -52.98 60.63 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.322 0.51 . . . . 0.0 110.829 175.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 75.2 mtp85 -59.11 -42.07 89.67 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 118.434 -0.793 . . . . 0.0 111.956 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 91.1 m -62.16 -53.26 57.8 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 119.038 0.836 . . . . 0.0 109.059 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.2 t -62.36 -42.86 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-O 117.802 -1.094 . . . . 0.0 110.183 -178.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.3 ttp85 -53.41 -52.76 58.33 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 119.813 1.188 . . . . 0.0 108.88 176.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.31 -46.02 91.86 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -172.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -62.74 -49.65 74.19 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.918 0.887 . . . . 0.0 111.054 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.8 t -62.05 -48.15 89.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 125.731 1.612 . . . . 0.0 110.42 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -58.84 -47.35 85.17 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 120.625 1.557 . . . . 0.0 110.424 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -53.64 -46.59 70.6 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 123.792 0.837 . . . . 0.0 109.446 174.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.441 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 61.7 mtt85 -69.1 -38.22 78.84 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 117.604 -1.189 . . . . 0.0 110.946 -174.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.6 t -55.49 -49.64 71.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 120.803 1.638 . . . . 0.0 109.626 169.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -61.12 -39.94 91.9 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.519 1.054 . . . . 0.0 110.689 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -61.81 -46.38 89.75 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.486 1.514 . . . . 0.0 109.922 178.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.1 -52.71 62.79 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.477 1.111 . . . . 0.0 109.387 178.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 72.7 mt -52.14 -40.29 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 123.934 0.894 . . . . 0.0 109.67 177.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.19 -30.84 71.35 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.65 1.113 . . . . 0.0 111.622 -174.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 51.9 mttt -70.52 -37.23 74.09 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.985 1.314 . . . . 0.0 111.493 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.0 pt -99.99 -25.59 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -169.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 64.5 m . . . . . 0 C--O 1.248 1.005 0 C-N-CA 126.165 1.786 . . . . 0.0 111.249 179.612 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt . . . . . 0 N--CA 1.466 0.361 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -103.52 125.18 49.92 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -176.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.545 ' HA ' HG13 ' A' ' 75' ' ' VAL . 40.4 t -108.47 138.6 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 124.415 1.086 . . . . 0.0 108.16 -172.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 32.1 tpp -125.99 140.45 52.6 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.858 1.263 . . . . 0.0 108.803 178.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -122.22 132.98 54.71 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 118.098 -0.953 . . . . 0.0 108.538 170.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.8 t -134.04 116.52 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 121.041 1.746 . . . . 0.0 109.926 -171.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.9 t -115.71 163.08 16.34 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.653 1.115 . . . . 0.0 111.093 -177.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -55.54 -22.54 22.09 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.294 1.438 . . . . 0.0 112.67 172.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -135.21 -1.81 2.58 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 62.32 -52.85 0.15 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 127.589 2.356 . . . . 0.0 113.99 -168.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.9 m -41.43 -19.05 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 120.97 3.693 . . . . 0.0 120.97 -169.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.2 p -131.0 -80.6 0.53 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 120.152 1.342 . . . . 0.0 111.085 -169.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -55.12 -50.91 68.02 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.612 0.765 . . . . 0.0 109.002 -170.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.02 -40.99 74.87 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.221 0.608 . . . . 0.0 111.96 -173.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.8 mm100 -69.39 -40.28 77.47 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.579 -0.701 . . . . 0.0 110.678 -170.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 63.1 mtm -62.47 -44.83 95.45 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 119.58 -0.248 . . . . 0.0 110.393 171.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.37 -37.45 70.09 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 119.361 -0.352 . . . . 0.0 111.152 177.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -62.15 -52.15 65.0 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.172 0.589 . . . . 0.0 109.956 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.01 -41.04 99.65 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.341 -0.699 . . . . 0.0 111.503 -177.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.432 ' CD1' ' HE3' ' A' ' 50' ' ' MET . 25.0 m-85 -66.87 -51.3 57.09 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 118.733 1.266 . . . . 0.0 107.947 177.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.93 -42.77 80.63 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 124.2 1.0 . . . . 0.0 112.666 -174.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -68.41 -35.51 77.74 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 119.771 1.169 . . . . 0.0 110.962 175.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.5 m -67.06 -43.16 83.36 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 120.738 1.608 . . . . 0.0 110.404 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.5 mt -74.57 -36.83 63.06 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.051 1.34 . . . . 0.0 111.209 -173.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.835 0 CA-C-O 116.621 -2.211 . . . . 0.0 118.009 -169.162 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.5 pt . . . . . 0 N--CA 1.452 -0.367 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -121.05 133.62 55.25 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 169.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.14 149.84 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-O 121.331 0.586 . . . . 0.0 111.986 -173.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.8 m -142.35 150.82 41.24 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 167.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.4 m -124.75 153.17 42.82 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.951 0.9 . . . . 0.0 109.858 169.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 32.8 m -150.4 -171.46 3.92 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 126.482 1.913 . . . . 0.0 107.463 -170.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.05 169.1 39.52 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 169.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 67.7 mt -53.94 -35.87 62.2 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 124.63 0.841 . . . . 0.0 110.777 178.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -149.69 150.31 31.92 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 169.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.0 p -86.58 165.92 15.81 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 122.081 0.943 . . . . 0.0 111.85 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.1 m -161.68 172.38 16.35 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 128.796 2.838 . . . . 0.0 105.469 169.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.71 151.57 29.0 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.5 -1.375 . . . . 0.0 109.671 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.1 t -57.6 132.91 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 171.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 37.5 t60 -67.92 139.8 93.43 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-O 118.772 -0.632 . . . . 0.0 109.392 177.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.6 -42.29 0.36 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.207 1.938 . . . . 0.0 113.456 -171.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.441 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 5.6 m -62.61 -18.6 62.53 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 119.701 -1.874 . . . . 0.0 112.452 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.7 -38.95 73.01 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.01 0.924 . . . . 0.0 110.291 171.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 62.5 mt -56.49 -48.3 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.04 -40.4 93.47 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 123.972 0.909 . . . . 0.0 111.484 -174.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.5 mmt -59.72 -47.95 83.64 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 122.656 1.217 . . . . 0.0 111.358 176.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.432 ' HE3' ' CD1' ' A' ' 21' ' ' PHE . 8.2 mtp -68.31 -34.72 76.64 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.207 -178.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -61.81 -29.22 70.01 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.243 0.617 . . . . 0.0 111.657 171.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -65.31 -35.84 82.25 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.196 0.907 . . . . 0.0 110.489 173.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 t -78.61 -25.96 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 117.64 0.2 . . . . 0.0 111.0 175.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.25 28.05 7.0 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.522 1.058 . . . . 0.0 111.702 -174.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.584 HG22 ' H ' ' A' ' 56' ' ' ASP . 8.8 mt -121.88 -177.71 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 125.94 1.696 . . . . 0.0 106.731 177.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.584 ' H ' HG22 ' A' ' 55' ' ' ILE . 12.7 t70 -146.9 157.67 43.71 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.37 1.468 . . . . 0.0 109.383 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.407 HG12 ' SD ' ' A' ' 50' ' ' MET . 0.2 OUTLIER -128.45 -17.13 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.993 0.917 . . . . 0.0 112.314 169.803 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -45.0 -38.05 4.48 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.834 1.254 . . . . 0.0 112.783 173.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.86 -5.09 88.71 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.735 1.16 . . . . 0.0 113.972 -173.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -128.27 171.68 11.76 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.324 1.45 . . . . 0.0 110.82 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.3 p -123.86 164.59 18.93 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 122.016 0.913 . . . . 0.0 111.279 -171.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.3 p -74.47 168.25 20.09 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.983 1.713 . . . . 0.0 110.887 173.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -154.45 144.29 15.47 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.524 0.73 . . . . 0.0 109.744 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -86.27 153.11 9.39 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.063 2.508 . . . . 0.0 110.27 169.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.9 tt -54.09 -33.21 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.542 0.737 . . . . 0.0 111.469 173.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -58.28 -24.37 59.25 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.675 1.59 . . . . 0.0 112.552 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -80.11 -6.45 57.72 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -175.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -130.59 -176.51 4.0 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.377 0.99 . . . . 0.0 111.515 -175.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.67 134.17 38.91 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 126.8 2.04 . . . . 0.0 108.348 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.86 -30.87 70.38 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.842 1.257 . . . . 0.0 112.788 -176.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -60.89 -21.78 63.66 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.151 0.98 . . . . 0.0 112.286 -173.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -83.0 -19.47 36.94 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.521 0.729 . . . . 0.0 110.595 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -104.72 124.94 50.28 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.356 1.062 . . . . 0.0 110.282 -169.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -72.86 -38.45 67.04 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 175.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.545 HG13 ' HA ' ' A' ' 4' ' ' VAL . 2.0 p -132.26 131.67 60.81 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -170.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.2 t -124.41 109.29 22.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 123.219 1.485 . . . . 0.0 108.699 -176.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.2 mm -99.44 94.3 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 177.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.4 m -70.68 157.76 37.42 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 117.351 -1.74 . . . . 0.0 106.461 167.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.81 50.66 0.68 Allowed 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 103.742 -2.688 . . . . 0.0 103.742 176.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 64.9 m . . . . . 0 CA--C 1.533 0.29 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 169.358 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -55.8 -26.74 47.72 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 121.002 -1.061 . . . . 0.0 112.035 172.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.6 p -84.12 -16.33 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 119.579 1.081 . . . . 0.0 110.337 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.7 p -105.12 16.39 25.9 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.683 0.793 . . . . 0.0 112.477 -169.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -79.13 173.91 12.1 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.608 0.763 . . . . 0.0 109.241 170.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.6 mp0 -58.96 -33.77 71.01 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.343 1.057 . . . . 0.0 113.41 -169.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.2 mt -134.92 136.72 51.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -177.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -143.15 138.76 30.01 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.501 1.12 . . . . 0.0 108.833 175.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -147.23 162.27 39.26 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.367 1.467 . . . . 0.0 107.986 168.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -122.61 97.5 5.48 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.78 1.632 . . . . 0.0 108.805 169.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.45 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 43.7 m0 -74.05 97.81 2.95 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.778 0.831 . . . . 0.0 109.619 -178.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -63.05 119.16 8.96 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 169.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 47.6 mt -151.72 151.48 31.48 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.865 1.666 . . . . 0.0 107.581 -169.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -84.08 73.54 10.38 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.153 0.981 . . . . 0.0 111.002 -176.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -19.36 97.39 0.05 OUTLIER Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 128.765 2.826 . . . . 0.0 111.427 177.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -63.7 -7.43 12.84 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.965 2.443 . . . . 0.0 116.708 -169.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -61.62 90.86 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 120.849 1.658 . . . . 0.0 113.501 -172.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.61 12.48 28.35 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.955 1.741 . . . . 0.0 113.387 175.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -91.34 -179.64 5.45 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.035 1.417 . . . . 0.0 112.128 -171.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.6 m -76.14 155.44 34.63 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.43 1.492 . . . . 0.0 109.973 174.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.6 -31.62 68.22 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.793 -0.567 . . . . 0.0 111.748 -178.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.62 -34.61 76.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 118.418 0.554 . . . . 0.0 111.169 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 95.3 t -66.25 -45.78 89.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 172.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.441 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 18.8 m-85 -56.83 -49.46 75.33 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 119.066 -0.493 . . . . 0.0 110.489 175.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -57.84 -43.38 85.81 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.591 1.157 . . . . 0.0 111.799 176.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.7 m -61.03 -49.49 77.18 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 118.875 0.761 . . . . 0.0 109.406 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.57 -44.66 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 117.742 -1.123 . . . . 0.0 110.377 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 44.3 ttp85 -52.81 -47.11 67.88 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 119.984 1.266 . . . . 0.0 109.137 175.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.89 -49.79 65.45 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-O 118.341 -1.255 . . . . 0.0 110.398 -176.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -59.81 -56.5 21.02 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 118.36 1.08 . . . . 0.0 110.269 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 80.3 t -49.46 -53.28 9.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 125.285 1.434 . . . . 0.0 109.897 177.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -60.82 -46.9 88.73 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 121.049 1.75 . . . . 0.0 110.463 -175.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.15 -44.8 88.06 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.996 0.519 . . . . 0.0 110.269 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.45 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 79.2 mtt-85 -69.08 -40.97 78.14 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.152 -0.927 . . . . 0.0 110.175 -176.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 70.5 t -55.08 -49.05 74.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 120.446 1.476 . . . . 0.0 109.604 169.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -60.35 -39.0 85.57 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.389 0.995 . . . . 0.0 110.45 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -63.54 -45.85 88.68 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.318 1.047 . . . . 0.0 110.427 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.57 -47.12 79.91 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 123.963 0.905 . . . . 0.0 109.779 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.1 mt -53.88 -42.69 54.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 124.715 1.206 . . . . 0.0 109.968 174.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.15 -28.45 67.93 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.399 1.0 . . . . 0.0 111.67 -171.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -73.29 -20.44 60.82 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.91 1.684 . . . . 0.0 112.465 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.3 pt -124.64 -22.29 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 -168.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.9 m . . . . . 0 C--O 1.251 1.174 0 C-N-CA 125.591 1.557 . . . . 0.0 111.283 170.528 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.9 ttm . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 120.95 0.405 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -123.52 142.37 51.08 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 172.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.7 mttt -100.28 123.14 44.14 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.436 ' HA ' HG13 ' A' ' 75' ' ' VAL . 14.8 p -102.93 144.74 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 122.058 0.932 . . . . 0.0 110.51 177.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 29.6 tpp -124.24 142.69 51.04 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 125.042 1.337 . . . . 0.0 108.629 176.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -124.22 124.34 42.23 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 171.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.7 t -127.61 121.6 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 120.483 1.492 . . . . 0.0 109.073 -172.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.8 t -118.64 165.75 13.59 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.954 0.797 . . . . 0.0 109.687 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -56.32 -20.99 21.42 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.977 0.911 . . . . 0.0 112.455 170.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -139.51 -2.74 1.56 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 60.27 -47.15 0.1 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 128.53 2.732 . . . . 0.0 115.499 -169.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.7 p -43.96 -25.61 0.22 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 119.707 3.225 . . . . 0.0 119.707 -168.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 45.2 m -126.91 -72.47 0.64 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.909 0.777 . . . . 0.0 109.818 -169.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -63.98 -49.56 72.0 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -169.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.16 -42.08 72.97 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 117.76 0.254 . . . . 0.0 111.11 -177.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -60.09 -45.51 92.7 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.007 0.523 . . . . 0.0 111.166 -175.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.42 ' HG2' HD11 ' A' ' 57' ' ' ILE . 46.9 mtm -64.16 -44.35 92.38 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 121.235 -0.186 . . . . 0.0 110.853 175.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.16 -37.76 75.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 119.363 -0.351 . . . . 0.0 111.116 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -65.5 -45.06 85.08 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.946 0.339 . . . . 0.0 110.52 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.84 -44.14 97.33 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -67.03 -50.56 61.64 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 118.629 1.214 . . . . 0.0 109.412 176.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.36 -42.55 82.29 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 119.477 1.035 . . . . 0.0 112.432 -173.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -69.65 -36.88 76.46 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.46 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.9 m -66.79 -43.1 84.84 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 119.65 -1.906 . . . . 0.0 110.571 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.5 mt -73.02 -39.37 66.05 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.539 1.536 . . . . 0.0 110.79 -174.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -133.77 3.48 4.6 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 116.747 -2.14 . . . . 0.0 118.296 -169.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.85 112.54 1.06 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 121.433 2.616 . . . . 0.0 109.011 170.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.71 -24.22 5.53 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.671 1.129 . . . . 0.0 111.741 -175.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.48 -19.28 3.08 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.402 1.101 . . . . 0.0 111.844 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.6 pt -131.7 156.29 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 168.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -120.16 130.5 54.62 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 170.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 p -113.08 151.24 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 124.169 0.988 . . . . 0.0 111.381 -176.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.7 m -147.81 135.9 21.28 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 167.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.3 p -102.45 156.63 17.47 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 121.083 -1.011 . . . . 0.0 108.335 169.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.4 m -148.53 -175.3 4.87 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 125.848 1.659 . . . . 0.0 106.759 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.93 154.7 25.85 Favored Glycine 0 CA--C 1.497 -1.051 0 N-CA-C 108.301 -1.919 . . . . 0.0 108.301 169.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 68.7 tp -49.03 -34.41 13.27 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.877 1.271 . . . . 0.0 109.74 169.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -146.47 148.38 32.18 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 168.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 p -83.03 162.84 21.29 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.81 0.844 . . . . 0.0 111.548 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 69.3 m -160.03 160.28 33.06 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.392 2.277 . . . . 0.0 106.551 169.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.88 138.14 30.51 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 117.813 -1.089 . . . . 0.0 110.386 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.6 p -57.76 130.09 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 120.083 1.311 . . . . 0.0 107.846 170.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -74.29 142.76 78.94 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.083 -169.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.51 -42.29 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.341 1.361 . . . . 0.0 112.25 -169.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.455 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 26.3 m -62.77 -24.95 67.98 Favored 'General case' 0 CA--C 1.535 0.365 0 O-C-N 120.484 -1.385 . . . . 0.0 111.414 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.69 -40.2 59.68 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.462 0.705 . . . . 0.0 111.536 173.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.1 mt -55.68 -46.08 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.38 -38.83 91.18 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 124.439 1.096 . . . . 0.0 110.144 -171.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 8.7 mmm -68.64 -44.01 75.08 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 122.791 1.281 . . . . 0.0 110.557 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 9.7 mtp -65.64 -35.48 80.93 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.327 -0.858 . . . . 0.0 109.867 175.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -62.72 -26.53 68.73 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.657 0.662 . . . . 0.0 111.501 173.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -65.7 -39.87 91.68 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.823 0.738 . . . . 0.0 109.876 173.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 88.7 t -76.67 -25.37 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.617 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.45 25.86 5.61 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.034 1.302 . . . . 0.0 111.718 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.503 HG22 ' H ' ' A' ' 56' ' ' ASP . 12.9 mt -122.89 178.79 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 C-N-CA 125.255 1.422 . . . . 0.0 107.378 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.503 ' H ' HG22 ' A' ' 55' ' ' ILE . 13.3 t70 -143.1 156.1 44.74 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.315 1.446 . . . . 0.0 109.276 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.42 HD11 ' HG2' ' A' ' 17' ' ' MET . 0.4 OUTLIER -128.08 -15.6 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 123.881 0.872 . . . . 0.0 112.351 169.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -45.75 -38.09 6.65 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.687 1.195 . . . . 0.0 112.859 172.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.77 -6.59 85.37 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.557 1.075 . . . . 0.0 114.217 -173.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -125.15 169.59 12.05 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 119.01 1.405 . . . . 0.0 111.036 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.3 p -127.05 169.91 12.88 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.75 1.22 . . . . 0.0 110.819 -172.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.7 p -92.69 160.15 15.11 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.576 1.15 . . . . 0.0 111.284 178.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -154.81 138.7 11.14 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 118.364 -0.827 . . . . 0.0 109.474 -169.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -80.94 152.88 19.15 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.663 2.242 . . . . 0.0 111.703 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.0 tt -52.43 -34.86 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.763 1.225 . . . . 0.0 111.552 173.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -57.78 -23.64 53.26 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.128 1.771 . . . . 0.0 112.371 -175.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -83.37 -6.71 59.55 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.856 0.863 . . . . 0.0 112.79 -175.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -128.57 -176.89 3.97 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.465 1.029 . . . . 0.0 111.269 -176.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.56 132.53 37.31 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 126.672 1.989 . . . . 0.0 108.344 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.32 -30.01 69.24 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.732 1.213 . . . . 0.0 112.702 -176.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -61.29 -21.21 63.73 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.08 0.952 . . . . 0.0 112.496 -174.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -85.86 -15.26 42.4 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.3 0.64 . . . . 0.0 110.778 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -107.8 121.97 45.83 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 124.775 1.23 . . . . 0.0 109.309 -172.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -71.83 -38.33 70.17 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.312 0.245 . . . . 0.0 111.039 177.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.436 HG13 ' HA ' ' A' ' 4' ' ' VAL . 1.1 p -131.5 133.17 62.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -170.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.7 t -124.23 123.13 65.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 122.526 1.155 . . . . 0.0 108.404 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 35.5 mm -113.41 97.09 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.5 m -72.65 156.51 38.89 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 168.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.05 54.72 0.65 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 176.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.8 m -82.95 -34.19 26.56 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.193 0.997 . . . . 0.0 109.796 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.32 169.51 40.6 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 98.8 m 39.13 33.34 0.09 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.226 2.21 . . . . 0.0 114.639 -175.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.24 22.84 51.48 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.533 1.54 . . . . 0.0 114.59 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.6 t -62.33 144.59 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 169.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -141.03 178.81 7.11 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.004 0.922 . . . . 0.0 110.444 -169.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.8 mt -114.31 111.23 47.22 Favored Pre-proline 0 N--CA 1.453 -0.308 0 C-N-CA 126.305 1.842 . . . . 0.0 106.973 -170.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -50.61 -41.18 54.24 Favored 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 122.571 2.181 . . . . 0.0 115.355 169.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.35 -179.7 5.02 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.797 1.665 . . . . 0.0 114.1 -174.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -52.19 -16.58 0.84 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 129.307 3.043 . . . . 0.0 114.222 -174.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -57.51 -24.9 58.59 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 121.17 -0.956 . . . . 0.0 111.994 174.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.1 p -87.3 -9.97 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 119.65 1.114 . . . . 0.0 110.541 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 49.5 p -113.44 19.88 16.54 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.916 0.886 . . . . 0.0 112.549 -169.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -81.67 175.72 10.23 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.609 0.764 . . . . 0.0 109.663 171.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -57.77 -32.67 67.72 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.905 1.282 . . . . 0.0 113.588 -169.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.0 mt -135.17 139.08 47.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -141.93 137.83 31.57 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 124.276 1.03 . . . . 0.0 108.506 172.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -146.68 158.75 43.97 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.802 1.641 . . . . 0.0 107.421 168.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -121.92 101.4 7.54 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.015 1.326 . . . . 0.0 108.045 168.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.463 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 43.5 m0 -75.44 95.83 3.34 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.539 1.136 . . . . 0.0 108.955 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -59.91 118.55 6.36 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 169.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 38.3 mt -153.43 146.24 24.36 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.846 1.658 . . . . 0.0 107.204 -169.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -83.77 72.8 10.34 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.25 1.42 . . . . 0.0 110.946 -173.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -23.55 100.93 0.08 OUTLIER Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 128.007 2.523 . . . . 0.0 113.075 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.456 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 68.4 Cg_exo -60.97 -2.65 2.32 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 124.236 3.29 . . . . 0.0 116.925 -172.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -52.28 100.49 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.239 1.381 . . . . 0.0 112.157 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.75 20.47 59.69 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.341 1.924 . . . . 0.0 113.561 171.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.456 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 21.2 mm-40 -96.95 179.23 5.01 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.752 1.276 . . . . 0.0 113.052 -169.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.1 m -76.44 154.93 34.33 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.497 1.519 . . . . 0.0 109.877 175.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.8 mt -58.63 -31.77 68.42 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 122.053 -0.404 . . . . 0.0 111.461 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -63.39 -41.08 98.76 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.075 0.398 . . . . 0.0 110.889 177.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 88.9 t -65.63 -46.75 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.455 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 8.0 m-85 -54.59 -53.83 49.38 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.344 0.658 . . . . 0.0 110.732 176.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 31.2 mtt180 -59.75 -41.99 92.21 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 123.947 0.899 . . . . 0.0 111.463 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 93.9 m -61.46 -54.41 43.76 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.2 t -62.97 -43.21 98.91 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 CA-C-O 118.799 -0.62 . . . . 0.0 110.648 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -57.73 -43.81 85.58 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 119.328 0.967 . . . . 0.0 110.139 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.29 -50.2 61.36 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.015 -0.88 . . . . 0.0 111.166 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -58.02 -51.43 69.68 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.243 1.022 . . . . 0.0 110.912 -176.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.6 t -50.83 -55.89 5.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 126.841 2.057 . . . . 0.0 109.934 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -59.34 -46.91 87.31 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 119.405 1.002 . . . . 0.0 110.185 -173.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.07 -42.06 79.95 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.318 1.047 . . . . 0.0 110.547 177.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.463 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 45.4 mtt85 -72.23 -40.97 67.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 117.684 -1.15 . . . . 0.0 110.888 -177.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.413 ' HA ' HD23 ' A' ' 126' ' ' LEU . 99.2 t -54.5 -46.15 71.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 120.653 1.569 . . . . 0.0 109.763 169.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -62.21 -40.9 97.63 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.222 0.919 . . . . 0.0 110.861 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -62.61 -44.24 96.81 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 122.911 0.485 . . . . 0.0 110.542 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 123' ' ' VAL . 0.2 OUTLIER -64.32 -47.59 78.82 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 118.293 -0.86 . . . . 0.0 109.768 -178.111 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 67.3 mt -54.31 -41.46 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.787 0.835 . . . . 0.0 109.452 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.66 -31.53 72.42 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.84 1.2 . . . . 0.0 111.543 -173.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -66.15 -45.91 79.32 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.413 1.085 . . . . 0.0 110.814 176.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.2 pt -89.19 -27.03 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.813 1.245 . . . . 0.0 114.299 -169.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 63.4 m . . . . . 0 C--O 1.248 1.0 0 C-N-CA 125.882 1.673 . . . . 0.0 111.17 -179.231 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.9 ttm . . . . . 0 N--CA 1.484 1.254 0 CA-C-O 121.474 0.654 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -76.8 127.09 32.1 Favored 'General case' 0 C--O 1.23 0.061 0 C-N-CA 123.536 0.734 . . . . 0.0 109.238 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.507 ' HE2' ' CE1' ' A' ' 73' ' ' TYR . 32.5 mtpt -96.15 129.14 43.53 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 118.508 -0.758 . . . . 0.0 109.593 175.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.6 p -105.31 140.26 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 118.673 0.67 . . . . 0.0 109.456 171.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.7 tpp -115.58 141.78 47.61 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 169.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -117.62 135.67 53.83 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 169.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -138.28 118.42 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 120.38 1.446 . . . . 0.0 109.382 -170.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.0 t -115.12 163.68 15.28 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.367 0.985 . . . . 0.0 109.723 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -61.45 -21.37 64.08 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 118.129 -0.939 . . . . 0.0 112.821 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -131.77 -0.97 3.83 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 62.32 -48.48 0.17 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 127.595 2.358 . . . . 0.0 115.105 -169.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.7 m -31.11 -40.59 0.03 OUTLIER 'General case' 0 C--O 1.235 0.313 0 N-CA-C 119.542 3.164 . . . . 0.0 119.542 -168.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.7 m -127.45 -63.86 1.02 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.66 1.118 . . . . 0.0 111.405 -169.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -58.13 -50.73 72.49 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.254 0.933 . . . . 0.0 109.787 -171.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 m -69.07 -41.17 77.91 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 117.85 0.296 . . . . 0.0 110.854 -174.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -70.3 -41.27 73.57 Favored 'General case' 0 N--CA 1.463 0.175 0 O-C-N 121.599 -0.688 . . . . 0.0 110.881 -169.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 66.2 mtm -62.06 -41.85 98.58 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 118.082 0.401 . . . . 0.0 110.893 171.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.34 -33.65 69.77 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 118.931 -0.557 . . . . 0.0 110.951 175.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.414 ' HA ' HG21 ' A' ' 32' ' ' VAL . 6.8 tt0 -59.21 -65.06 0.73 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.77 -39.5 77.06 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.015 -0.881 . . . . 0.0 112.549 -175.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -67.18 -45.01 78.23 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 119.274 1.537 . . . . 0.0 109.579 177.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.55 -43.6 93.43 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 120.372 1.442 . . . . 0.0 112.555 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.4 ptmt -69.18 -9.73 54.33 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.941 1.246 . . . . 0.0 113.1 175.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.4 m -92.81 -49.3 6.13 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 119.97 1.259 . . . . 0.0 110.618 170.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.4 mt -79.07 -39.91 32.61 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.352 1.461 . . . . 0.0 112.318 -169.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.18 -10.41 15.68 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-O 117.935 -1.481 . . . . 0.0 114.428 -169.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.89 108.94 0.4 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.31 1.555 . . . . 0.0 109.18 169.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 137.36 -29.24 2.71 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.871 1.224 . . . . 0.0 111.541 -169.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.18 -23.95 2.13 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.402 1.081 . . . . 0.0 111.844 173.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.3 pt -128.37 162.13 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 123.344 0.658 . . . . 0.0 111.088 175.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -128.18 138.5 52.51 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 168.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.414 HG21 ' HA ' ' A' ' 19' ' ' GLU . 2.5 p -113.13 152.17 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-O 122.26 1.029 . . . . 0.0 113.412 -169.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.4 m -139.72 147.63 41.17 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 127.315 2.246 . . . . 0.0 105.123 167.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.3 m -132.21 146.71 52.2 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.831 1.252 . . . . 0.0 108.568 169.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 23.9 p -156.36 -161.79 1.17 Allowed 'General case' 0 C--O 1.242 0.666 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -176.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -151.66 156.96 26.97 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 169.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.3 tp -46.52 -36.87 7.19 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.979 1.712 . . . . 0.0 109.391 169.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -147.03 148.26 31.5 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 102.205 -3.257 . . . . 0.0 102.205 167.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.6 m -125.04 144.16 50.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.199 0.523 . . . . 0.0 112.284 -173.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.0 m -137.64 164.59 28.42 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.403 2.281 . . . . 0.0 107.551 173.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.93 145.62 1.44 Allowed 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.149 1.38 . . . . 0.0 113.232 -169.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.9 p -61.05 132.07 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 169.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.401 ' CE1' ' H ' ' A' ' 106' ' ' GLY . 14.7 t-80 -76.72 145.96 75.66 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.692 -172.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.17 -40.72 0.78 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 121.393 1.396 . . . . 0.0 112.534 -169.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.534 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 24.0 m -66.12 -17.07 64.48 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 120.044 -1.66 . . . . 0.0 111.864 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.68 -40.74 76.11 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 123.984 0.914 . . . . 0.0 110.836 170.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.0 mt -55.14 -52.19 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.18 -38.93 81.01 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 123.741 0.65 . . . . 0.0 111.917 -173.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.6 mmt -59.42 -49.84 76.26 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 122.403 1.097 . . . . 0.0 111.697 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.4 mtp -67.33 -36.15 80.86 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.164 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -61.75 -30.17 70.61 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.315 1.046 . . . . 0.0 111.295 174.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -64.13 -40.78 96.91 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.83 0.741 . . . . 0.0 110.336 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.1 t -75.2 -20.23 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.498 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.63 25.47 9.91 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.697 1.141 . . . . 0.0 111.332 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.531 HG22 ' H ' ' A' ' 56' ' ' ASP . 12.4 mt -121.62 -178.33 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.531 ' H ' HG22 ' A' ' 55' ' ' ILE . 9.8 t70 -146.51 151.73 37.83 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 120.457 -1.402 . . . . 0.0 109.694 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.6 pt -132.68 -3.96 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.405 1.082 . . . . 0.0 112.824 169.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 95.3 p -55.87 -30.62 61.82 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 120.187 1.358 . . . . 0.0 112.146 169.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.05 -7.43 87.6 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 118.729 -1.039 . . . . 0.0 114.087 -176.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.56 172.4 7.87 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.448 1.499 . . . . 0.0 111.16 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 16.8 p -129.46 157.62 41.48 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.368 1.067 . . . . 0.0 111.071 -170.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.6 p -68.21 156.67 37.09 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.717 1.207 . . . . 0.0 110.04 169.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -156.07 143.54 13.91 Favored Pre-proline 0 N--CA 1.469 0.5 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.038 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -81.32 150.4 17.37 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.835 2.357 . . . . 0.0 111.226 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.6 tt -55.27 -33.21 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.272 0.629 . . . . 0.0 111.362 173.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -56.92 -22.11 35.09 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.548 1.939 . . . . 0.0 112.418 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -79.46 -4.64 52.15 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.209 1.004 . . . . 0.0 112.85 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -128.13 177.91 6.59 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.768 1.167 . . . . 0.0 111.753 -175.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.03 140.14 52.84 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 127.183 2.193 . . . . 0.0 106.859 170.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.412 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -72.54 -23.0 60.93 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.115 0.966 . . . . 0.0 112.002 -177.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.86 -24.25 66.79 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.176 0.99 . . . . 0.0 112.472 -173.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -89.82 -15.16 32.9 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.033 0.933 . . . . 0.0 110.505 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.507 ' CE1' ' HE2' ' A' ' 3' ' ' LYS . 83.5 m-85 -86.69 141.62 28.79 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.901 1.281 . . . . 0.0 110.061 178.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -89.98 -34.84 15.85 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.151 0.98 . . . . 0.0 110.64 173.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -140.36 137.67 36.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -172.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.2 m -127.48 108.79 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 123.167 1.461 . . . . 0.0 109.39 -173.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.2 mm -104.26 96.67 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.3 t -71.17 157.0 38.91 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 167.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.21 52.37 0.43 Allowed 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 103.52 -2.77 . . . . 0.0 103.52 174.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 95.4 m -77.27 -34.67 55.64 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.432 1.093 . . . . 0.0 110.153 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.25 169.77 29.37 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -176.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 88.8 m 38.06 32.88 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.431 2.293 . . . . 0.0 115.318 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.08 25.54 59.91 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.057 1.313 . . . . 0.0 113.878 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.2 t -61.74 158.03 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.789 1.236 . . . . 0.0 107.959 169.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -139.24 -179.59 5.96 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.149 1.38 . . . . 0.0 108.937 -171.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 49.6 mt -119.85 92.23 46.31 Favored Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 126.763 2.025 . . . . 0.0 105.859 -171.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -47.12 -35.34 19.23 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 123.205 2.603 . . . . 0.0 116.667 175.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -68.37 -173.7 0.58 Allowed 'Trans proline' 0 C--N 1.356 0.928 0 CA-C-N 122.127 1.795 . . . . 0.0 113.983 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -45.16 -21.28 0.07 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 128.157 2.583 . . . . 0.0 114.703 171.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.412 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 95.6 m95 -60.64 10.28 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.792 2.837 . . . . 0.0 114.427 172.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.2 p -128.02 18.61 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 124.623 1.169 . . . . 0.0 112.015 173.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 48.8 p -124.63 18.27 8.77 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -170.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -94.5 -174.9 3.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.52 1.528 . . . . 0.0 109.452 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -66.77 -34.98 79.02 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.57 -0.706 . . . . 0.0 112.506 -174.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.0 mt -134.71 136.58 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -174.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -137.61 138.14 39.22 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 169.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -146.92 159.98 42.88 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.659 1.583 . . . . 0.0 107.388 168.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -123.17 104.52 9.22 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.954 1.302 . . . . 0.0 108.744 169.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.409 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 41.9 m0 -80.71 88.72 5.76 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.996 0.918 . . . . 0.0 108.873 -177.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -62.71 104.49 0.54 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.47 1.108 . . . . 0.0 109.644 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 101' ' ' LEU . 1.2 mm? -136.92 172.16 13.43 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 126.217 1.807 . . . . 0.0 108.511 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -70.78 158.89 35.55 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 166.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -112.48 109.28 53.74 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 169.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.441 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 81.8 Cg_exo -53.31 1.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 1 C-N-CA 126.652 4.901 . . . . 0.0 119.514 -169.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -51.53 98.93 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.844 1.202 . . . . 0.0 112.094 174.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.401 ' H ' ' CE1' ' A' ' 43' ' ' HIS . . . 84.23 18.23 63.11 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 126.197 1.856 . . . . 0.0 113.111 171.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.441 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 24.8 mm-40 -95.18 178.22 5.6 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.811 1.305 . . . . 0.0 111.876 -169.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.9 m -74.09 153.89 39.41 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.236 1.414 . . . . 0.0 109.96 176.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 82.2 mt -60.14 -28.75 68.14 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.762 -0.586 . . . . 0.0 111.843 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.42 -38.8 92.55 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.087 0.403 . . . . 0.0 110.789 174.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 86.7 t -68.49 -46.29 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.534 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 16.3 m-85 -52.98 -54.55 33.45 Favored 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 122.704 0.401 . . . . 0.0 110.561 175.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -59.66 -40.67 88.5 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.175 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.8 m -62.55 -52.29 64.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.432 1.014 . . . . 0.0 109.668 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.86 -45.83 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-O 118.181 -0.914 . . . . 0.0 109.475 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -55.85 -49.61 72.84 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.448 1.022 . . . . 0.0 109.303 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.64 -49.1 82.34 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-O 118.368 -1.24 . . . . 0.0 110.482 -176.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -60.71 -53.49 56.82 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-N 118.371 1.085 . . . . 0.0 110.812 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 68.5 t -52.88 -46.13 51.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 124.355 1.062 . . . . 0.0 110.2 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -63.54 -49.9 71.63 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 119.724 1.147 . . . . 0.0 110.523 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.09 -43.44 70.36 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.338 1.055 . . . . 0.0 110.526 175.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.409 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 81.5 mtt-85 -72.24 -41.25 67.04 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 117.74 -1.124 . . . . 0.0 110.074 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.7 t -54.3 -49.0 66.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 120.629 1.559 . . . . 0.0 108.811 169.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -60.17 -39.85 87.88 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.29 0.95 . . . . 0.0 110.883 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -63.65 -45.48 89.98 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.309 1.043 . . . . 0.0 110.257 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -46.09 89.31 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 123.829 0.852 . . . . 0.0 109.645 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 64.1 mt -60.07 -38.07 75.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.672 1.189 . . . . 0.0 110.921 175.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.69 -31.72 71.88 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 120.139 1.336 . . . . 0.0 111.295 -174.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -69.7 -20.46 63.54 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.596 1.558 . . . . 0.0 113.023 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.7 pt -125.01 -21.21 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -168.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 C--O 1.251 1.134 0 C-N-CA 126.391 1.876 . . . . 0.0 111.124 173.746 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.9 ttm . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.611 0.243 . . . . 0.0 110.457 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.69 141.91 43.31 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.582 0.753 . . . . 0.0 109.409 171.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -93.08 128.22 38.9 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 169.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.4 p -113.0 136.74 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 123.477 0.711 . . . . 0.0 109.565 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 35.9 tpp -112.93 141.34 46.88 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 170.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -117.47 136.0 53.52 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 169.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.423 HG11 HD12 ' A' ' 65' ' ' ILE . 12.1 t -138.87 131.03 37.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -174.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.23 165.9 18.09 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 120.116 1.325 . . . . 0.0 109.971 169.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -62.74 -10.81 14.05 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.6 ptm85 -153.93 114.27 3.95 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 103.168 -2.901 . . . . 0.0 103.168 169.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -51.83 -25.6 8.13 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.327 1.851 . . . . 0.0 113.25 -176.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.4 p -40.05 -36.87 0.53 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 118.42 2.748 . . . . 0.0 118.42 -168.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.0 p -137.55 -54.52 0.68 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 -169.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -64.59 -51.93 60.16 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 122.221 2.282 . . . . 0.0 108.863 -169.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 82.2 p -70.31 -39.04 75.06 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -170.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -55.89 -50.57 70.3 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.184 0.993 . . . . 0.0 111.096 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 60.0 mtm -64.18 -46.21 84.96 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 117.489 0.132 . . . . 0.0 110.709 178.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.78 -39.49 71.32 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 119.524 -0.274 . . . . 0.0 110.508 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.532 ' HA ' HG21 ' A' ' 32' ' ' VAL . 36.2 tt0 -65.55 -45.35 83.73 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 119.434 -0.317 . . . . 0.0 111.137 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.38 -41.79 99.74 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -65.39 -49.05 70.76 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 117.997 0.899 . . . . 0.0 109.107 174.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.32 -43.15 88.08 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.169 0.895 . . . . 0.0 112.391 -172.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -69.37 -36.56 76.96 Favored 'General case' 0 C--O 1.219 -0.546 0 C-N-CA 118.991 -1.083 . . . . 0.0 110.946 175.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 52.2 m -67.19 -42.48 84.11 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 120.762 1.619 . . . . 0.0 110.495 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.3 mt -77.16 -37.63 53.45 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.38 1.472 . . . . 0.0 111.423 -174.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.3 -1.13 5.32 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 116.578 -2.234 . . . . 0.0 117.441 -169.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.55 108.75 0.52 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 121.935 2.868 . . . . 0.0 108.86 169.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.53 -29.26 2.8 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.846 1.212 . . . . 0.0 111.65 -170.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -134.21 -11.85 2.5 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.259 1.024 . . . . 0.0 113.216 171.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.2 pt -130.09 155.22 41.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 119.063 0.847 . . . . 0.0 109.306 168.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.73 127.84 53.22 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 105.472 -2.048 . . . . 0.0 105.472 169.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.532 HG21 ' HA ' ' A' ' 19' ' ' GLU . 3.0 p -112.17 150.87 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -173.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.1 m -141.03 144.28 34.9 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 126.012 1.725 . . . . 0.0 107.452 168.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.8 p -117.11 152.73 34.1 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.816 1.646 . . . . 0.0 109.003 168.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 32.1 p -158.14 -165.01 1.61 Allowed 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 176.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.47 160.05 28.31 Favored Glycine 0 CA--C 1.503 -0.68 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 169.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.3 tp -47.51 -35.66 9.15 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.369 1.468 . . . . 0.0 109.758 169.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -142.07 144.14 33.43 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 168.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.2 p -73.75 155.74 38.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.75 0.786 . . . . 0.0 110.885 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 67.5 m -159.19 150.57 20.26 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.513 1.925 . . . . 0.0 106.018 169.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.7 ttt-85 -49.08 146.94 3.16 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.876 1.271 . . . . 0.0 110.831 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.6 t -57.32 129.34 19.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.519 -1.659 . . . . 0.0 106.519 169.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -71.66 137.32 83.06 Favored Pre-proline 0 N--CA 1.444 -0.747 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -72.95 -38.64 2.77 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.04 1.16 . . . . 0.0 111.66 -169.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.438 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 20.6 m -64.4 -24.69 67.72 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.737 -1.227 . . . . 0.0 111.571 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.04 -39.38 66.13 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 121.574 -0.704 . . . . 0.0 111.193 175.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.5 mt -55.86 -46.03 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.26 -40.22 93.67 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 123.99 0.916 . . . . 0.0 110.065 -170.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.9 mmm -67.14 -43.0 83.48 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 122.672 1.225 . . . . 0.0 110.685 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.417 ' SD ' HG12 ' A' ' 57' ' ' ILE . 9.4 mtp -65.42 -34.92 79.43 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.375 -0.828 . . . . 0.0 109.863 174.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.65 -30.53 68.8 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.717 0.69 . . . . 0.0 111.217 173.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -66.69 -38.1 86.08 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.192 0.451 . . . . 0.0 109.879 176.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 64.3 t -77.28 -24.66 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.612 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.13 26.03 5.89 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.161 1.362 . . . . 0.0 111.75 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.489 HG22 ' H ' ' A' ' 56' ' ' ASP . 9.7 mt -124.79 178.34 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 125.091 1.357 . . . . 0.0 107.476 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.489 ' H ' HG22 ' A' ' 55' ' ' ILE . 11.8 t70 -142.23 156.43 45.3 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.514 1.526 . . . . 0.0 109.301 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.417 HG12 ' SD ' ' A' ' 50' ' ' MET . 0.1 OUTLIER -129.06 -15.2 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.041 0.936 . . . . 0.0 112.634 170.505 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -44.62 -37.39 3.6 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.785 1.234 . . . . 0.0 112.715 172.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.95 -7.7 84.22 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.664 1.126 . . . . 0.0 114.384 -174.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -125.77 168.39 13.87 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.244 1.522 . . . . 0.0 110.667 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.0 p -129.36 169.37 14.97 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.207 1.003 . . . . 0.0 111.374 -169.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 54.7 m -89.61 159.66 17.04 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.17 0.988 . . . . 0.0 111.044 174.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -157.91 140.38 10.47 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.954 1.301 . . . . 0.0 108.875 -172.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.52 148.05 32.84 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.562 1.508 . . . . 0.0 110.417 -177.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.423 HD12 HG11 ' A' ' 7' ' ' VAL . 19.7 tt -52.15 -35.03 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 123.878 0.871 . . . . 0.0 111.559 174.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -58.05 -22.21 49.09 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.455 1.902 . . . . 0.0 112.316 -175.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -80.43 -7.01 58.97 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.343 1.057 . . . . 0.0 112.835 -177.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -125.02 179.86 4.85 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.575 1.08 . . . . 0.0 111.06 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.44 139.62 52.26 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 127.085 2.154 . . . . 0.0 107.254 171.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.62 -24.09 66.26 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.97 1.308 . . . . 0.0 111.891 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -60.18 -23.88 64.32 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.008 0.923 . . . . 0.0 112.45 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -83.54 -13.11 55.24 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.036 0.934 . . . . 0.0 110.785 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -107.23 128.0 54.03 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 125.743 1.617 . . . . 0.0 109.208 -174.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -77.17 -34.8 56.29 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.1 p -132.55 137.65 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 123.385 0.674 . . . . 0.0 109.524 -175.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.88 129.04 60.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 122.548 1.166 . . . . 0.0 109.94 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.5 mm -124.06 101.3 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -170.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.7 m -73.74 154.17 39.72 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 168.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -148.62 45.36 1.03 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 177.516 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 99.1 m -65.02 -59.39 4.2 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 117.744 -1.122 . . . . 0.0 112.046 -169.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 117.64 -22.94 9.81 Favored Glycine 0 N--CA 1.47 0.947 0 CA-C-N 119.873 1.215 . . . . 0.0 114.758 169.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 43.7 m -131.9 27.34 4.59 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.943 0.897 . . . . 0.0 111.867 -176.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.52 -1.68 65.41 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.813 1.196 . . . . 0.0 114.318 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.61 134.66 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 169.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -143.92 178.57 7.75 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.456 1.102 . . . . 0.0 110.103 -169.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 53.4 mt -117.69 99.33 52.26 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 124.36 1.064 . . . . 0.0 109.604 -169.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -52.26 -36.95 69.66 Favored 'Trans proline' 0 CA--C 1.549 1.249 0 C-N-CA 123.08 2.52 . . . . 0.0 116.915 169.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -67.65 -175.14 0.66 Allowed 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 122.267 1.978 . . . . 0.0 114.779 -173.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -45.39 -20.01 0.05 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.396 2.678 . . . . 0.0 115.492 171.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -61.63 1.11 0.26 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.122 1.769 . . . . 0.0 113.572 170.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.9 p -121.6 6.23 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.494 1.118 . . . . 0.0 112.019 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 82.8 p -127.48 22.38 6.47 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.355 0.98 . . . . 0.0 112.718 -172.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -89.28 -177.33 5.36 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.432 0.693 . . . . 0.0 109.922 173.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -64.0 -31.79 73.11 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.131 0.573 . . . . 0.0 112.525 -171.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.3 mt -135.84 134.36 51.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -141.04 138.12 33.4 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 169.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -145.26 157.19 44.12 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.03 1.332 . . . . 0.0 107.968 168.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -120.94 102.92 8.67 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.1 1.36 . . . . 0.0 109.177 169.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.424 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 39.8 m0 -78.88 93.79 5.08 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.877 1.671 . . . . 0.0 108.927 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -65.99 107.22 1.81 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -129.41 157.67 41.31 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 125.712 1.605 . . . . 0.0 109.906 -175.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -82.48 61.09 5.46 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.419 1.488 . . . . 0.0 112.126 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 53.1 t0 4.11 83.27 0.04 OUTLIER Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 129.603 3.161 . . . . 0.0 113.424 169.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.424 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 80.8 Cg_exo -60.06 -5.93 4.4 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 123.174 2.583 . . . . 0.0 117.491 -169.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -60.23 90.78 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.728 1.211 . . . . 0.0 111.86 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.89 15.08 27.43 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 126.283 1.896 . . . . 0.0 113.376 173.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.424 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 30.6 mm-40 -91.94 179.05 5.71 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.013 1.407 . . . . 0.0 112.866 -169.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 41.5 m -75.54 155.7 35.81 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.563 1.545 . . . . 0.0 109.988 175.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.77 -33.39 70.24 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.944 -0.473 . . . . 0.0 111.563 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.28 -39.18 93.4 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.577 0.351 . . . . 0.0 110.764 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 99.2 t -66.08 -47.55 84.53 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 175.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.438 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 7.2 m-85 -54.76 -51.38 65.86 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.006 0.522 . . . . 0.0 111.026 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 24.0 mtt180 -60.29 -42.77 96.15 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.473 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 88.9 m -62.18 -55.16 31.43 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.4 t -61.01 -43.08 95.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 118.855 -0.593 . . . . 0.0 110.312 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.76 -45.19 93.01 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 119.396 0.998 . . . . 0.0 110.374 -177.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.42 -46.5 90.31 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -63.85 -46.39 85.24 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.988 0.915 . . . . 0.0 111.186 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.0 t -56.77 -51.71 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 125.65 1.58 . . . . 0.0 110.228 171.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -58.4 -45.35 88.53 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.114 0.87 . . . . 0.0 110.366 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -55.67 -45.88 77.67 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.9 0.88 . . . . 0.0 109.254 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.424 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 60.4 mtt85 -70.38 -39.05 74.79 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-O 118.086 -0.959 . . . . 0.0 110.782 -174.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.5 t -54.81 -48.56 73.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 120.373 1.442 . . . . 0.0 109.594 169.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -60.85 -40.33 92.48 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 119.625 1.102 . . . . 0.0 110.858 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -61.21 -46.46 90.36 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.259 1.424 . . . . 0.0 109.945 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.32 -48.43 73.08 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 124.011 0.925 . . . . 0.0 110.08 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 45.8 mt -55.31 -38.99 50.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.751 1.22 . . . . 0.0 110.631 174.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.37 -30.73 70.72 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.772 1.169 . . . . 0.0 111.237 -173.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -72.78 -20.79 61.1 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.691 1.596 . . . . 0.0 112.638 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.0 pt -123.37 -22.36 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -168.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 C--O 1.251 1.159 0 C-N-CA 126.181 1.792 . . . . 0.0 111.194 175.854 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.6 ttm . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 120.755 0.312 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -120.32 136.32 54.73 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.4 mttt -95.33 136.28 35.88 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 121.7 -0.625 . . . . 0.0 109.491 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.5 t -121.2 127.22 75.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -173.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 42.2 tpp -110.89 141.01 44.87 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 169.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -109.85 130.52 55.51 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 169.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.4 t -132.23 119.0 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 120.447 1.476 . . . . 0.0 109.141 -169.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.401 ' HB3' ' H ' ' A' ' 11' ' ' ASN . 41.1 t -124.7 159.27 31.24 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.969 1.258 . . . . 0.0 110.704 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.2 mttm -58.49 -12.81 4.34 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.189 0.995 . . . . 0.0 113.115 169.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -138.6 -12.13 1.34 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 173.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.401 ' H ' ' HB3' ' A' ' 8' ' ' CYS . 27.2 t-20 64.52 -43.82 0.3 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.744 2.418 . . . . 0.0 114.599 -169.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.0 m -40.25 -23.58 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 121.028 3.714 . . . . 0.0 121.028 -168.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 23.6 m -140.99 -62.84 0.47 Allowed 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 120.443 1.474 . . . . 0.0 111.174 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -59.79 -50.36 74.13 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.669 0.668 . . . . 0.0 109.583 -169.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.43 -43.81 69.17 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.389 0.276 . . . . 0.0 111.178 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -59.89 -46.4 89.44 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.69 0.796 . . . . 0.0 111.359 -174.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.525 ' HG2' HD11 ' A' ' 57' ' ' ILE . 56.6 mtm -67.71 -45.63 74.52 Favored 'General case' 0 C--O 1.231 0.114 0 O-C-N 122.276 -0.265 . . . . 0.0 110.551 177.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.48 -38.29 71.52 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 122.281 0.232 . . . . 0.0 111.053 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -64.91 -55.87 16.71 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 118.448 -0.787 . . . . 0.0 110.372 178.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -52.04 -40.25 50.75 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 119.481 -0.622 . . . . 0.0 112.149 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -64.9 -51.12 63.65 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 118.717 1.258 . . . . 0.0 110.266 173.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.6 -44.78 89.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 119.708 1.14 . . . . 0.0 112.88 -174.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -70.19 -9.69 56.53 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 119.732 1.151 . . . . 0.0 113.281 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.5 m -92.57 -48.2 6.73 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 119.892 1.224 . . . . 0.0 110.423 169.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.0 mt -77.49 -43.55 31.82 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.881 1.672 . . . . 0.0 112.073 -169.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.35 -6.11 18.33 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-O 118.038 -1.423 . . . . 0.0 114.923 -169.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.41 110.0 0.57 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.61 1.705 . . . . 0.0 108.891 169.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.38 -29.94 2.75 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.981 1.276 . . . . 0.0 111.444 -169.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.63 -22.6 3.27 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.811 1.244 . . . . 0.0 111.896 172.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.7 pt -125.83 158.69 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-O 121.564 0.697 . . . . 0.0 111.903 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -123.63 133.24 53.96 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 104.381 -2.452 . . . . 0.0 104.381 169.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.4 p -118.45 155.28 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-O 121.88 0.848 . . . . 0.0 112.541 -169.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.8 m -148.26 152.72 37.63 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.915 1.686 . . . . 0.0 107.216 167.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.3 p -118.35 153.35 34.16 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.53 1.132 . . . . 0.0 108.535 168.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 23.4 p -152.43 -169.99 3.51 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 173.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.92 163.12 30.79 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 169.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.7 mt -58.5 -32.24 68.62 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.971 0.508 . . . . 0.0 110.601 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -142.45 132.76 24.86 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 103.623 -2.732 . . . . 0.0 103.623 168.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.3 p -76.24 149.97 37.09 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.951 0.5 . . . . 0.0 111.084 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.1 m -147.52 158.45 44.0 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.081 2.152 . . . . 0.0 106.513 169.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.04 144.8 11.32 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.922 0.889 . . . . 0.0 110.905 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.6 p -65.11 138.42 23.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 169.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.4 ' CG ' ' HD2' ' A' ' 44' ' ' PRO . 7.4 t-80 -83.38 149.48 58.14 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 123.479 0.711 . . . . 0.0 109.607 -174.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HD2' ' CG ' ' A' ' 43' ' ' HIS . 87.2 Cg_endo -81.86 -38.76 0.2 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 121.562 1.508 . . . . 0.0 112.907 -169.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.438 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 28.5 m -62.76 -27.23 69.14 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.297 1.408 . . . . 0.0 111.24 -177.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.28 -44.24 22.99 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.019 0.928 . . . . 0.0 111.175 171.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 52.3 mt -55.93 -45.52 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 C-N-CA 124.287 1.035 . . . . 0.0 108.291 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.47 -34.25 77.77 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.28 1.032 . . . . 0.0 110.104 -172.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 8.1 mmm -70.66 -41.49 72.02 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-O 122.547 1.165 . . . . 0.0 110.386 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.497 ' HG3' ' CG1' ' A' ' 57' ' ' ILE . 87.2 mmm -62.9 -41.13 99.33 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -61.63 -25.66 67.5 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.291 0.636 . . . . 0.0 111.096 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -65.61 -42.24 91.84 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 118.652 0.66 . . . . 0.0 110.094 171.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.3 t -76.22 -25.78 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.78 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.66 23.2 6.33 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.454 1.502 . . . . 0.0 111.958 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.4 mt -121.42 177.44 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 125.742 1.617 . . . . 0.0 107.693 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -143.9 157.51 44.31 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.484 1.513 . . . . 0.0 109.957 -176.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.525 HD11 ' HG2' ' A' ' 17' ' ' MET . 0.6 OUTLIER -130.45 -17.78 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.153 0.981 . . . . 0.0 111.983 169.607 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -42.58 -38.18 1.9 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.959 1.304 . . . . 0.0 113.292 173.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.0 -10.75 68.94 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 118.551 -1.138 . . . . 0.0 114.033 -175.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -123.99 168.75 12.41 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 119.181 1.491 . . . . 0.0 112.641 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.2 p -127.37 -176.05 3.62 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 126.526 1.931 . . . . 0.0 109.679 -174.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.7 p -113.56 158.95 20.12 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.284 1.433 . . . . 0.0 110.908 -175.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -151.22 149.9 25.84 Favored Pre-proline 0 N--CA 1.467 0.409 0 C-N-CA 124.218 1.007 . . . . 0.0 109.827 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.47 150.87 19.64 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.977 2.451 . . . . 0.0 110.617 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.2 tt -52.24 -36.22 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.766 1.226 . . . . 0.0 110.756 172.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -58.17 -25.55 61.64 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.838 1.655 . . . . 0.0 112.884 -171.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.81 -9.74 45.34 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -176.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -98.97 -174.45 2.77 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.371 0.987 . . . . 0.0 110.127 175.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.6 128.41 20.49 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 126.841 2.056 . . . . 0.0 106.941 175.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.92 -27.24 66.58 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.898 0.879 . . . . 0.0 111.969 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -60.28 -23.55 64.24 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.237 1.015 . . . . 0.0 112.644 -175.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -84.65 -16.55 41.55 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.101 0.56 . . . . 0.0 110.761 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -109.1 112.89 25.31 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 125.354 1.462 . . . . 0.0 108.323 -172.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -76.44 -21.6 55.71 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.328 0.585 . . . . 0.0 109.673 -176.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.1 t -133.98 134.83 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 125.803 1.641 . . . . 0.0 107.229 -172.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -137.36 119.39 19.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 123.023 1.392 . . . . 0.0 109.726 -176.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.2 mm -112.74 94.13 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 66.9 m -72.4 157.34 37.83 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 167.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.87 50.61 0.67 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 74.7 m -73.62 -42.02 62.02 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.431 1.092 . . . . 0.0 108.89 171.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.95 -56.58 0.74 Allowed Glycine 0 C--N 1.334 0.456 0 C-N-CA 124.459 1.028 . . . . 0.0 112.834 168.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 35.4 m -80.03 30.16 0.27 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -169.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.54 32.19 72.69 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.198 0.904 . . . . 0.0 110.868 -171.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.3 t -63.35 141.41 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 124.638 1.175 . . . . 0.0 108.783 -174.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -124.1 104.93 9.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.343 -172.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.1 mt -58.78 121.38 53.71 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 125.421 1.489 . . . . 0.0 108.659 -172.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -48.83 -40.1 39.42 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.444 2.096 . . . . 0.0 114.658 169.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.31 173.5 14.1 Favored 'Trans proline' 0 C--N 1.355 0.894 0 CA-C-N 121.623 1.615 . . . . 0.0 113.114 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -54.99 -6.93 0.14 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 129.235 3.014 . . . . 0.0 115.893 -176.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -61.87 0.05 0.42 Allowed 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 126.024 1.73 . . . . 0.0 112.378 169.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.6 m -114.33 5.17 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 120.376 1.444 . . . . 0.0 112.46 170.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.8 p -120.98 21.99 11.18 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.979 0.911 . . . . 0.0 111.716 -177.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -90.52 -178.99 5.46 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.375 1.07 . . . . 0.0 109.382 171.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.56 -36.42 82.61 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.719 0.808 . . . . 0.0 112.922 -169.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.9 mt -133.16 134.77 57.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -141.63 136.92 31.45 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.355 1.062 . . . . 0.0 108.835 172.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -146.47 159.51 43.31 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.822 1.649 . . . . 0.0 107.68 168.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -124.55 92.47 3.66 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.182 1.393 . . . . 0.0 109.045 169.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -66.01 141.54 58.14 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.746 0.819 . . . . 0.0 110.891 -176.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -110.71 92.03 3.89 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.845 1.258 . . . . 0.0 107.689 -170.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -131.1 149.68 52.49 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.679 1.592 . . . . 0.0 109.107 -170.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -84.47 56.81 3.98 Favored 'General case' 0 C--O 1.228 -0.072 0 C-N-CA 126.37 1.868 . . . . 0.0 112.05 -172.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.3 t0 5.94 82.35 0.04 OUTLIER Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 129.903 3.281 . . . . 0.0 113.977 169.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.457 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 84.2 Cg_exo -54.5 -13.86 6.2 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 125.271 3.981 . . . . 0.0 118.633 -169.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.29 90.17 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 120.3 1.409 . . . . 0.0 111.925 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.85 6.69 26.25 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 126.282 1.896 . . . . 0.0 113.164 174.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.457 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 28.4 mm-40 -89.67 -178.5 5.55 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.81 1.305 . . . . 0.0 112.056 -169.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.0 m -78.98 156.96 28.24 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.971 1.308 . . . . 0.0 109.909 173.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 70.4 mt -59.79 -32.9 71.05 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 122.086 -0.384 . . . . 0.0 111.498 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -61.21 -39.9 91.96 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.376 0.534 . . . . 0.0 110.622 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.7 t -67.25 -46.57 83.72 Favored 'Isoleucine or valine' 0 C--N 1.338 0.086 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.438 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 11.7 m-85 -53.98 -52.57 60.29 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 122.608 0.363 . . . . 0.0 110.729 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.1 mtp180 -64.18 -40.91 97.1 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 118.511 -0.756 . . . . 0.0 111.09 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.5 m -63.37 -52.53 61.32 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.75 -42.74 95.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.216 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.79 -44.3 90.71 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-N 120.277 1.399 . . . . 0.0 110.365 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.84 -49.35 76.76 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -61.56 -44.9 96.19 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.266 1.033 . . . . 0.0 111.869 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.5 t -58.59 -50.05 80.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 125.606 1.562 . . . . 0.0 109.806 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -58.49 -45.78 88.02 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 119.478 1.035 . . . . 0.0 110.119 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.59 -43.6 80.24 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.307 1.043 . . . . 0.0 110.345 176.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 46.3 mtt85 -71.61 -40.9 69.52 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-O 117.965 -1.017 . . . . 0.0 111.088 -177.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.418 ' HA ' HD23 ' A' ' 126' ' ' LEU . 95.0 t -54.47 -48.22 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 120.505 1.502 . . . . 0.0 109.499 169.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -60.05 -40.13 88.34 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.4 1.0 . . . . 0.0 110.615 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -62.2 -45.74 92.02 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.244 1.018 . . . . 0.0 110.347 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 123' ' ' VAL . 0.2 OUTLIER -63.1 -47.45 82.79 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.012 0.925 . . . . 0.0 109.834 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 61.5 mt -58.88 -37.88 69.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 124.607 1.163 . . . . 0.0 110.491 176.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.79 -29.67 69.59 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.941 1.246 . . . . 0.0 111.486 -174.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 41.7 mttm -73.52 -19.57 60.88 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.974 1.71 . . . . 0.0 112.93 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.2 pt -125.95 -20.27 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.895 1.678 . . . . 0.0 114.941 -168.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.9 m . . . . . 0 C--O 1.251 1.16 0 C-N-CA 126.457 1.903 . . . . 0.0 110.886 169.883 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.5 ttm . . . . . 0 N--CA 1.484 1.264 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.5 147.28 42.9 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.788 0.835 . . . . 0.0 109.392 170.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -102.46 117.99 35.91 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 72.9 t -97.37 137.94 23.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 125.517 1.527 . . . . 0.0 108.128 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 35.5 tpp -126.01 143.64 51.02 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 169.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.401 ' HE2' HG21 ' A' ' 32' ' ' VAL . 81.6 m-85 -114.02 133.23 55.64 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 169.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.3 t -136.26 122.15 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 120.065 1.302 . . . . 0.0 108.551 -169.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.442 ' HB3' ' H ' ' A' ' 11' ' ' ASN . 43.0 t -129.9 163.6 26.0 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.146 0.885 . . . . 0.0 111.288 -173.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -59.49 -21.96 60.89 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 118.202 -0.904 . . . . 0.0 112.303 169.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -138.01 -9.68 1.55 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 116.18 1.918 . . . . 0.0 116.18 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.442 ' H ' ' HB3' ' A' ' 8' ' ' CYS . 26.0 t-20 61.99 -43.1 0.16 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 128.346 2.659 . . . . 0.0 115.872 -174.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.7 p -35.16 -38.99 0.1 Allowed 'General case' 0 C--O 1.233 0.228 0 C-N-CA 129.596 3.159 . . . . 0.0 118.499 -168.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.4 p -133.13 -59.94 0.87 Allowed 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 118.757 -0.639 . . . . 0.0 111.129 -169.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.0 mtm180 -58.32 -56.73 18.27 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -171.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.6 -42.64 77.87 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.516 0.327 . . . . 0.0 111.063 -177.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -60.37 -45.86 92.02 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.65 0.78 . . . . 0.0 111.423 -174.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 49.4 mtm -62.3 -46.41 88.87 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 110.494 -0.187 . . . . 0.0 110.494 175.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.16 -39.15 78.1 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 119.742 -0.17 . . . . 0.0 111.062 -178.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -63.69 -45.88 88.02 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.47 0.708 . . . . 0.0 110.422 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.24 -44.55 97.54 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -65.55 -47.33 76.23 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 118.624 1.212 . . . . 0.0 108.75 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.81 -43.18 85.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 119.366 0.985 . . . . 0.0 112.372 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -76.25 -2.35 30.98 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 119.047 0.84 . . . . 0.0 113.159 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.0 m -96.9 -45.64 6.54 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 121.301 -0.874 . . . . 0.0 109.445 169.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 91.8 mt -74.05 -41.03 62.38 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.96 1.704 . . . . 0.0 111.151 -171.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.63 -6.14 4.73 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-O 117.971 -1.46 . . . . 0.0 115.631 -169.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.75 121.95 9.66 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 120.237 2.019 . . . . 0.0 109.406 174.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.15 -31.61 4.21 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.733 1.158 . . . . 0.0 110.607 -172.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.2 -13.58 5.58 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.503 1.121 . . . . 0.0 112.021 174.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.8 pt -130.5 156.56 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 168.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -118.3 134.71 54.8 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 169.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.401 HG21 ' HE2' ' A' ' 6' ' ' PHE . 13.5 p -123.64 152.55 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-O 121.439 0.637 . . . . 0.0 112.061 -176.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.3 m -144.35 161.88 37.87 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.944 1.298 . . . . 0.0 108.131 169.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 94.1 p -126.71 155.95 41.87 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 124.901 1.28 . . . . 0.0 109.107 168.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.3 p -154.51 -165.87 2.19 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 174.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.55 163.75 33.68 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 169.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.1 mt -52.08 -31.76 31.83 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.267 1.027 . . . . 0.0 110.237 174.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -148.01 145.67 28.61 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 168.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.5 p -79.03 161.68 26.43 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.579 0.704 . . . . 0.0 111.313 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.6 m -157.0 166.06 34.42 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.417 1.887 . . . . 0.0 107.284 169.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.1 ptt-85 -51.96 143.35 13.83 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.653 1.181 . . . . 0.0 110.728 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 56.0 t -63.4 130.34 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 168.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -70.63 138.78 86.0 Favored Pre-proline 0 N--CA 1.448 -0.555 0 CA-C-O 118.771 -0.633 . . . . 0.0 109.615 -174.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.18 -40.12 1.84 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 121.074 1.183 . . . . 0.0 111.471 -172.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.505 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 11.2 m -67.67 -18.08 64.82 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 120.488 -1.382 . . . . 0.0 111.916 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.441 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -58.21 -39.43 78.99 Favored 'General case' 0 C--N 1.339 0.116 0 O-C-N 121.275 -0.89 . . . . 0.0 110.63 171.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.4 mt -57.8 -46.15 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.54 -40.97 96.6 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.531 0.732 . . . . 0.0 112.036 -176.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.5 mmt -58.5 -49.15 78.42 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 122.558 1.17 . . . . 0.0 111.302 177.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.405 ' SD ' HG12 ' A' ' 57' ' ' ILE . 8.1 mtp -68.82 -36.26 77.99 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.651 -1.158 . . . . 0.0 108.899 -177.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -62.46 -28.96 70.18 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.18 0.592 . . . . 0.0 111.514 173.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -64.25 -39.67 94.42 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.02 0.827 . . . . 0.0 110.176 173.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.0 t -78.58 -23.98 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 119.743 -0.17 . . . . 0.0 110.766 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.46 24.95 6.52 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.913 1.245 . . . . 0.0 111.882 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.565 HG22 ' H ' ' A' ' 56' ' ' ASP . 11.1 mt -122.72 -178.23 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 C-N-CA 125.938 1.695 . . . . 0.0 106.821 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.565 ' H ' HG22 ' A' ' 55' ' ' ILE . 10.1 t70 -147.93 156.12 42.32 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 120.438 -1.414 . . . . 0.0 109.909 -176.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.446 HD13 HG21 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -129.79 -16.38 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.277 1.031 . . . . 0.0 112.227 169.534 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.7 p -51.86 -31.39 27.74 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.707 1.139 . . . . 0.0 112.451 177.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.84 -6.28 88.59 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.814 1.197 . . . . 0.0 114.366 -177.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -125.77 168.65 13.51 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.369 1.584 . . . . 0.0 110.824 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.7 p -128.0 170.92 12.34 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.063 0.945 . . . . 0.0 111.372 -171.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.6 p -85.62 162.99 18.59 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.188 1.395 . . . . 0.0 111.06 175.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -157.89 145.15 13.44 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 123.775 0.83 . . . . 0.0 109.345 -178.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -81.32 153.71 18.53 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.26 1.973 . . . . 0.0 110.936 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.4 tt -55.04 -34.03 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 123.706 0.802 . . . . 0.0 111.123 175.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -57.52 -23.22 49.0 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.369 1.867 . . . . 0.0 112.402 -174.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -85.17 -3.65 58.88 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.864 0.866 . . . . 0.0 112.819 -175.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -124.95 -174.25 2.99 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.426 1.09 . . . . 0.0 110.833 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.39 128.17 20.42 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.849 2.059 . . . . 0.0 107.63 175.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.84 -26.86 64.57 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.08 0.952 . . . . 0.0 112.554 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -59.42 -23.39 62.6 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.088 0.955 . . . . 0.0 112.488 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -83.67 -14.76 51.06 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.39 0.676 . . . . 0.0 110.799 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -108.32 120.36 42.15 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 125.704 1.602 . . . . 0.0 109.079 -172.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -75.25 -30.81 60.62 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.374 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.538 HG21 HD13 ' A' ' 126' ' ' LEU . 0.2 OUTLIER -131.52 130.13 62.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -173.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.0 m -127.73 115.29 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 123.618 1.675 . . . . 0.0 109.855 -174.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.0 mm -110.22 101.78 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -175.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.7 t -72.7 155.41 40.01 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 168.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.18 50.8 0.72 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 171.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 85.4 m -65.42 -18.96 65.72 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.45 0.7 . . . . 0.0 110.947 174.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.24 -64.18 3.31 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 125.159 1.362 . . . . 0.0 110.266 169.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 37.9 m -75.85 22.45 0.14 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.336 1.054 . . . . 0.0 113.681 -174.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 65.51 16.94 63.8 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.994 1.759 . . . . 0.0 113.54 -177.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 95.9 t -70.86 161.97 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 169.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -136.36 167.68 20.86 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.34 1.056 . . . . 0.0 109.235 -174.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.2 mt -90.37 112.54 53.41 Favored Pre-proline 0 N--CA 1.45 -0.437 0 C-N-CA 126.196 1.799 . . . . 0.0 107.031 -173.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -60.12 -36.25 89.59 Favored 'Trans proline' 0 CA--C 1.547 1.171 0 CA-C-O 116.581 -1.508 . . . . 0.0 114.756 171.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.12 179.4 6.16 Favored 'Trans proline' 0 C--N 1.355 0.912 0 CA-C-N 122.732 2.011 . . . . 0.0 113.163 -178.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -53.97 -10.67 0.35 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 128.589 2.756 . . . . 0.0 115.746 -176.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -63.65 6.28 0.16 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 126.324 1.85 . . . . 0.0 112.593 169.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 p -117.85 2.18 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 125.23 1.412 . . . . 0.0 111.505 172.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.8 p -127.72 24.05 6.17 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.124 -0.985 . . . . 0.0 112.292 -172.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -90.55 -176.73 4.84 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.324 0.65 . . . . 0.0 109.26 169.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -66.13 -32.14 73.42 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -169.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.0 mt -134.11 132.38 55.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -177.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -140.1 138.21 35.11 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.143 0.977 . . . . 0.0 108.856 174.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -146.65 159.44 43.46 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.152 1.381 . . . . 0.0 107.762 168.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -122.05 113.43 19.53 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.879 1.272 . . . . 0.0 108.622 168.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.445 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 40.0 m0 -87.4 97.1 10.63 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -177.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -62.03 118.88 7.89 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 169.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 60.0 mt -150.21 150.57 31.77 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.236 1.415 . . . . 0.0 107.794 -169.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.8 mp0 -83.12 57.32 3.88 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.819 1.648 . . . . 0.0 111.999 -173.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.9 t70 2.76 85.53 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 129.377 3.071 . . . . 0.0 114.486 173.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.461 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 67.0 Cg_exo -60.13 -8.01 7.47 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.523 2.815 . . . . 0.0 117.411 -169.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -55.36 100.72 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 120.528 1.513 . . . . 0.0 111.811 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.24 18.32 43.13 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 126.482 1.991 . . . . 0.0 113.382 171.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.461 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 23.7 mm-40 -98.31 177.01 5.51 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.012 1.406 . . . . 0.0 113.234 -169.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 37.7 m -75.77 154.77 36.09 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.987 1.715 . . . . 0.0 110.081 175.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 71.1 mt -59.14 -31.34 68.87 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 121.812 -0.555 . . . . 0.0 111.899 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.7 mp0 -62.3 -41.07 98.21 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.417 0.687 . . . . 0.0 110.387 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.63 -43.4 86.87 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.505 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 14.3 m-85 -55.68 -52.44 63.84 Favored 'General case' 0 N--CA 1.458 -0.069 0 CA-C-O 118.683 -0.675 . . . . 0.0 110.752 175.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 72.9 mtp85 -59.54 -41.5 90.19 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.248 0.931 . . . . 0.0 111.758 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.9 m -61.04 -46.7 89.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 118.682 0.674 . . . . 0.0 110.039 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.4 t -70.46 -42.97 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 117.79 -1.1 . . . . 0.0 110.257 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.9 ttp180 -56.34 -44.85 80.43 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 119.923 1.238 . . . . 0.0 109.48 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.04 -48.8 84.32 Favored Glycine 0 CA--C 1.521 0.426 0 CA-C-O 118.702 -1.055 . . . . 0.0 110.69 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -59.8 -55.55 32.83 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 118.113 0.956 . . . . 0.0 110.182 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.7 t -48.17 -53.91 5.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.698 1.599 . . . . 0.0 110.234 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -63.55 -47.51 81.28 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 119.412 1.006 . . . . 0.0 110.221 -172.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -53.98 -45.27 71.35 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.654 0.781 . . . . 0.0 109.8 174.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.445 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 78.0 mtt-85 -71.46 -37.61 71.36 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.173 -173.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.403 ' HA ' HD23 ' A' ' 126' ' ' LEU . 96.2 t -56.44 -48.37 80.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 120.726 1.603 . . . . 0.0 109.242 168.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -60.54 -35.29 75.64 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.259 0.936 . . . . 0.0 110.598 177.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -65.2 -45.16 85.86 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.445 1.498 . . . . 0.0 110.414 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.538 HD13 HG21 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -65.24 -44.47 88.06 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 123.204 0.602 . . . . 0.0 110.372 179.357 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 86.4 mt -56.6 -36.9 49.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 124.286 1.034 . . . . 0.0 109.861 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.27 -35.46 77.92 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 120.363 1.438 . . . . 0.0 111.094 -177.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -59.03 -52.44 65.74 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.604 0.762 . . . . 0.0 110.37 174.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pt -80.1 -39.01 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.657 1.183 . . . . 0.0 112.517 -171.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . 0.259 6.0 p . . . . . 0 C--O 1.25 1.084 0 C-N-CA 130.744 3.617 . . . . 0.0 114.003 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.1 ttm . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -121.04 150.49 41.08 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.052 0.941 . . . . 0.0 109.582 171.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -106.37 106.7 17.34 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 123.974 0.91 . . . . 0.0 109.725 178.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 57.2 t -85.41 139.7 17.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 125.934 1.694 . . . . 0.0 109.218 176.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 20.1 tpp -127.13 145.96 50.55 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.242 0.617 . . . . 0.0 109.59 169.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -120.47 120.77 36.86 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.825 1.65 . . . . 0.0 108.492 171.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.6 t -128.4 141.79 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.939 1.296 . . . . 0.0 109.263 -169.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 28.4 p -152.65 -170.61 3.68 Favored 'General case' 0 C--O 1.222 -0.354 0 O-C-N 120.976 -1.078 . . . . 0.0 112.869 -169.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -80.87 -24.96 37.99 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.321 1.048 . . . . 0.0 112.915 169.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -159.83 108.77 1.78 Allowed 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 -173.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -54.07 -17.51 2.76 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.525 1.53 . . . . 0.0 113.567 -173.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -38.93 -47.18 1.41 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 127.859 2.464 . . . . 0.0 117.177 -169.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.0 p -132.32 -77.32 0.5 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 116.009 -1.948 . . . . 0.0 114.561 -168.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.2 -49.14 33.92 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 121.601 2.0 . . . . 0.0 111.246 -168.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.77 -48.61 71.24 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.825 1.65 . . . . 0.0 110.709 -174.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -64.97 -42.02 94.94 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 124.541 1.136 . . . . 0.0 111.338 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 63.2 mtp -60.71 -48.78 80.24 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.27 1.028 . . . . 0.0 108.913 175.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.06 -41.04 87.0 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 122.968 0.507 . . . . 0.0 111.132 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -62.4 -45.23 94.07 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.505 0.722 . . . . 0.0 110.016 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.01 -45.2 97.1 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.448 -0.64 . . . . 0.0 111.645 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -65.26 -52.13 56.34 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 118.661 1.23 . . . . 0.0 108.58 175.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.01 -42.76 76.91 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.416 1.086 . . . . 0.0 112.508 -173.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -70.23 -35.54 73.91 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 118.791 0.723 . . . . 0.0 110.111 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.9 m -67.17 -43.27 82.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 119.521 -1.987 . . . . 0.0 110.504 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.6 mt -71.52 -39.94 70.43 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.071 1.748 . . . . 0.0 110.78 -174.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.19 4.19 4.13 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 116.725 -2.153 . . . . 0.0 118.284 -169.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.87 114.71 1.67 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 121.588 2.694 . . . . 0.0 109.041 169.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 124.01 -24.11 6.4 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.63 1.109 . . . . 0.0 111.548 -175.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.66 -20.19 3.26 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 118.327 1.063 . . . . 0.0 111.684 178.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.5 pt -132.07 156.87 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 168.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.99 139.67 50.39 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 169.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 p -131.59 148.64 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.2 0.524 . . . . 0.0 111.871 -175.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 m -142.14 160.69 39.74 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.069 170.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 91.7 p -129.23 157.39 41.98 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.067 1.347 . . . . 0.0 108.265 168.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.4 p -153.04 -164.82 2.02 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.93 159.63 29.15 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 169.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 75.0 mt -52.5 -28.87 22.22 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.241 1.417 . . . . 0.0 110.556 172.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -144.57 146.58 32.41 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 168.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.1 p -72.1 159.25 34.46 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.94 0.896 . . . . 0.0 111.439 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.2 p -153.85 165.3 36.5 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.582 1.953 . . . . 0.0 106.904 170.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -66.09 154.16 40.35 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 120.896 -1.127 . . . . 0.0 109.556 172.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.4 t -62.46 132.75 28.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 169.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -74.14 140.4 76.7 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -75.3 -41.32 0.63 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.277 1.318 . . . . 0.0 112.124 -169.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.452 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 27.7 m -63.41 -25.34 68.23 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.536 -1.352 . . . . 0.0 111.576 -178.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.422 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -51.95 -39.44 59.24 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.467 0.707 . . . . 0.0 111.541 173.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.6 mt -56.2 -45.78 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.68 -38.25 88.75 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.265 1.026 . . . . 0.0 110.09 -170.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.3 mmm -69.84 -44.1 70.59 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 122.751 1.263 . . . . 0.0 110.569 -177.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.3 mtp -65.03 -36.15 83.45 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.482 -0.761 . . . . 0.0 109.683 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -63.25 -25.99 68.58 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.243 0.617 . . . . 0.0 111.417 174.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -66.26 -39.63 89.59 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.873 0.76 . . . . 0.0 109.817 173.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.3 t -76.96 -24.93 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.636 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.82 26.44 5.81 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.008 1.29 . . . . 0.0 111.67 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.458 HG22 ' H ' ' A' ' 56' ' ' ASP . 12.2 mt -122.67 177.32 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 125.194 1.398 . . . . 0.0 107.252 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.458 ' H ' HG22 ' A' ' 55' ' ' ILE . 13.8 t70 -142.16 156.43 45.35 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.107 1.363 . . . . 0.0 109.421 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.428 HD13 HG21 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -127.48 -16.96 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 123.781 0.832 . . . . 0.0 112.27 169.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -45.2 -39.08 5.89 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.679 1.192 . . . . 0.0 112.791 173.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.55 -4.56 89.27 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.625 1.107 . . . . 0.0 114.266 -172.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -126.78 165.47 19.23 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.125 1.462 . . . . 0.0 110.705 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 25.7 p -128.01 170.79 12.49 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.972 0.909 . . . . 0.0 111.361 -170.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.8 p -87.48 169.33 12.31 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.434 1.494 . . . . 0.0 112.034 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.24 135.07 6.64 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 123.966 0.907 . . . . 0.0 108.698 -174.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.36 154.29 31.8 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.767 2.311 . . . . 0.0 111.4 176.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.2 tt -55.9 -34.45 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 123.764 0.825 . . . . 0.0 111.33 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -60.1 -22.0 62.23 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.823 1.649 . . . . 0.0 112.205 -173.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -80.82 -2.5 47.5 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.179 0.992 . . . . 0.0 112.569 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -130.65 -179.87 5.55 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.586 1.085 . . . . 0.0 111.984 -174.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.08 139.43 45.96 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 127.812 2.445 . . . . 0.0 106.547 169.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.4 -24.89 66.55 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.549 1.14 . . . . 0.0 111.593 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -60.86 -24.56 66.01 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.022 0.929 . . . . 0.0 112.497 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -82.96 -17.92 41.81 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.909 0.884 . . . . 0.0 110.53 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -97.82 122.4 40.89 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 125.623 1.569 . . . . 0.0 108.546 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -73.11 -29.4 62.88 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 175.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.47 134.34 43.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 C-N-CA 122.507 0.323 . . . . 0.0 110.317 -170.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.5 m -127.03 128.98 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 122.135 0.969 . . . . 0.0 110.115 -175.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 49.9 mm -116.36 135.15 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.3 m -104.18 146.52 28.64 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 123.92 0.762 . . . . 0.0 109.233 169.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.97 53.92 0.35 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.047 1.739 . . . . 0.0 107.741 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 83.2 m -61.66 -41.38 97.46 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.802 0.841 . . . . 0.0 110.959 172.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.91 -71.53 0.49 Allowed Glycine 0 CA--C 1.508 -0.36 0 N-CA-C 104.964 -3.254 . . . . 0.0 104.964 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 84.2 m -70.2 163.61 26.03 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 167.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.58 37.87 1.65 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 123.675 0.655 . . . . 0.0 113.378 -173.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 96.9 t -65.71 154.31 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 124.876 1.271 . . . . 0.0 107.976 171.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -132.82 -178.5 4.98 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.96 1.304 . . . . 0.0 109.862 -173.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.3 mt -122.49 95.23 47.06 Favored Pre-proline 0 CA--C 1.532 0.253 0 C-N-CA 125.693 1.597 . . . . 0.0 107.572 -169.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -48.45 -37.62 33.5 Favored 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 122.825 2.35 . . . . 0.0 116.239 172.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.39 -174.06 0.77 Allowed 'Trans proline' 0 C--N 1.356 0.936 0 CA-C-N 122.059 1.771 . . . . 0.0 114.523 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -46.56 -18.7 0.07 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 128.244 2.618 . . . . 0.0 115.468 172.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -63.29 5.78 0.15 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.318 1.847 . . . . 0.0 113.756 170.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.4 p -126.44 5.17 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.338 1.055 . . . . 0.0 112.388 171.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.0 p -120.36 21.22 11.75 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.642 1.11 . . . . 0.0 112.61 -171.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -90.81 -176.78 4.79 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.624 0.769 . . . . 0.0 109.543 173.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -65.65 -31.56 72.65 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -170.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.7 mt -134.39 137.24 51.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -137.03 136.34 38.35 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 169.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -143.11 155.6 44.63 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.286 1.434 . . . . 0.0 107.853 169.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -120.63 132.53 55.17 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.147 1.379 . . . . 0.0 108.884 169.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.464 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 39.7 m0 -116.52 96.41 5.5 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.829 1.652 . . . . 0.0 107.472 -172.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -72.92 83.59 1.23 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.517 1.527 . . . . 0.0 109.721 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.32 154.0 23.12 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 125.208 1.403 . . . . 0.0 109.844 -175.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -78.25 65.85 3.7 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.204 1.402 . . . . 0.0 111.819 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -13.41 92.17 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 129.036 2.935 . . . . 0.0 114.308 178.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.428 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 52.6 Cg_exo -61.71 -6.91 8.13 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.927 3.085 . . . . 0.0 116.769 -169.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -60.42 88.62 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 120.214 1.37 . . . . 0.0 111.3 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.16 14.86 23.33 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 126.604 2.049 . . . . 0.0 113.874 175.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.428 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 29.9 mm-40 -93.82 179.75 5.25 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.51 1.655 . . . . 0.0 113.522 -169.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.9 m -77.74 156.48 30.56 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.769 1.628 . . . . 0.0 110.138 175.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 93.5 mt -58.14 -34.48 70.31 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.908 0.483 . . . . 0.0 111.462 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -66.81 -36.87 83.37 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.072 0.396 . . . . 0.0 110.695 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.0 t -65.87 -46.08 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.452 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 7.9 m-85 -56.4 -49.08 75.51 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.962 0.505 . . . . 0.0 111.078 176.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 16.4 mtp85 -59.08 -45.03 91.87 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.897 0.879 . . . . 0.0 111.05 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 92.9 m -60.94 -53.01 62.55 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 74.4 t -64.58 -40.47 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-O 118.506 -0.759 . . . . 0.0 110.5 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.84 -43.43 94.62 Favored 'General case' 0 CA--C 1.523 -0.071 0 CA-C-N 120.215 1.37 . . . . 0.0 110.446 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.43 -50.02 65.58 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-O 118.929 -0.928 . . . . 0.0 111.057 174.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -56.43 -50.3 72.06 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.27 1.035 . . . . 0.0 110.991 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 48.9 t -55.77 -54.92 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 126.32 1.848 . . . . 0.0 109.341 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -59.93 -45.53 92.31 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 119.336 0.971 . . . . 0.0 110.065 -173.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.18 -45.19 79.85 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.784 0.833 . . . . 0.0 110.248 176.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.464 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 45.2 mtt85 -70.32 -42.38 72.04 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 117.869 -1.062 . . . . 0.0 110.744 -176.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.5 t -52.82 -49.71 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 120.321 1.418 . . . . 0.0 110.293 169.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -60.77 -41.65 95.91 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.262 0.937 . . . . 0.0 110.599 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -61.38 -44.32 97.36 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.228 1.011 . . . . 0.0 110.176 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . 0.262 0.2 OUTLIER -67.97 -46.47 71.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.809 -179.375 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.8 mt -51.52 -42.81 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 119.373 0.988 . . . . 0.0 109.245 172.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.44 -30.1 70.37 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.68 1.127 . . . . 0.0 111.532 -172.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 47.1 mttt -71.98 -45.75 59.87 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.272 1.429 . . . . 0.0 110.863 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.2 pt -86.11 -27.56 6.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.684 1.193 . . . . 0.0 113.875 -171.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 C--O 1.248 1.012 0 C-N-CA 126.194 1.798 . . . . 0.0 111.009 176.588 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.0 ttm . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.961 0.41 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.8 mmtt -125.77 144.33 50.68 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.299 1.44 . . . . 0.0 107.144 174.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.8 mttt -101.96 120.06 39.79 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 118.753 -0.642 . . . . 0.0 109.568 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.46 ' HA ' HG13 ' A' ' 75' ' ' VAL . 13.9 p -99.75 140.26 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 121.469 0.652 . . . . 0.0 110.438 175.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 33.9 tpp -121.37 140.61 51.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.596 -1.184 . . . . 0.0 108.202 169.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -112.5 127.11 55.96 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 169.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.5 t -128.92 126.5 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 120.088 1.313 . . . . 0.0 108.446 -169.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.7 t -134.68 156.49 48.68 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 119.106 0.867 . . . . 0.0 112.658 -174.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -56.94 -23.0 42.11 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.225 1.01 . . . . 0.0 111.405 169.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.6 ptt-85 -148.82 107.81 3.88 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 169.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -47.46 -36.49 10.15 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.225 1.01 . . . . 0.0 112.0 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.3 m -43.7 -24.5 0.12 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 130.931 3.693 . . . . 0.0 118.717 -169.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.0 p -130.92 -79.84 0.53 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 120.018 1.281 . . . . 0.0 112.44 -169.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -56.79 -52.18 66.06 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.358 1.063 . . . . 0.0 109.664 -169.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.13 -46.69 79.93 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 126.37 1.868 . . . . 0.0 111.558 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -62.22 -41.02 98.01 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.096 0.407 . . . . 0.0 111.14 -174.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 44.1 mtm -62.69 -47.89 81.67 Favored 'General case' 0 CA--C 1.529 0.15 0 O-C-N 122.3 -0.25 . . . . 0.0 111.127 172.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.32 -38.94 78.11 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 117.887 0.312 . . . . 0.0 111.227 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -62.49 -51.05 68.99 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.345 1.458 . . . . 0.0 109.445 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.46 -42.52 99.05 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 119.501 -0.61 . . . . 0.0 112.248 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -67.14 -49.47 64.7 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 119.006 1.403 . . . . 0.0 108.971 177.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.27 -36.84 76.27 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 119.303 0.956 . . . . 0.0 112.415 -176.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -72.17 -35.95 69.15 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 119.383 0.992 . . . . 0.0 110.633 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.0 m -66.99 -42.14 85.55 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 119.98 -1.7 . . . . 0.0 110.476 177.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.4 mt -75.83 -31.47 59.37 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.887 1.675 . . . . 0.0 111.512 -173.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -141.33 4.45 2.28 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 117.212 -1.882 . . . . 0.0 117.539 -170.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.12 113.56 1.59 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 120.989 2.394 . . . . 0.0 108.829 171.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.07 -24.34 5.7 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.64 1.114 . . . . 0.0 111.644 -175.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.94 -18.2 3.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.408 1.104 . . . . 0.0 112.24 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.9 pt -130.62 150.11 34.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 168.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.68 123.74 50.01 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 170.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.27 143.9 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 C-N-CA 126.441 1.896 . . . . 0.0 109.516 -169.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 86.7 m -152.04 160.41 43.46 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.841 1.656 . . . . 0.0 106.78 169.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.1 p -130.48 161.26 31.83 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.745 0.818 . . . . 0.0 109.688 168.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.2 p -153.77 -168.85 3.1 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 176.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.36 166.91 34.91 Favored Glycine 0 N--CA 1.448 -0.522 0 O-C-N 121.283 -0.885 . . . . 0.0 111.59 170.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.2 mp -52.15 -36.86 52.68 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.742 1.217 . . . . 0.0 110.014 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -142.89 144.65 32.54 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 169.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 p -84.0 155.72 22.62 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.674 0.749 . . . . 0.0 110.935 174.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.9 m -163.23 151.48 13.78 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 128.033 2.533 . . . . 0.0 105.203 169.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -55.45 156.41 4.55 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.028 0.831 . . . . 0.0 111.959 -170.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.2 t -60.92 135.17 25.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -72.66 143.02 84.33 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 123.614 0.766 . . . . 0.0 109.07 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.43 -42.07 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 121.426 1.417 . . . . 0.0 113.11 -169.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.524 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 21.5 m -66.66 -17.02 64.62 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.172 -1.58 . . . . 0.0 111.956 -176.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.433 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -56.37 -39.32 72.72 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.292 -0.88 . . . . 0.0 110.935 169.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 62.5 mt -56.66 -48.09 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.65 -40.71 93.03 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 123.967 0.907 . . . . 0.0 111.489 -173.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.2 mmt -59.54 -48.18 82.66 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 122.934 1.349 . . . . 0.0 111.517 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.0 mtp -68.17 -35.93 78.81 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.886 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -61.31 -30.15 70.31 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 118.783 -0.627 . . . . 0.0 111.64 172.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -65.13 -36.31 83.85 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.057 0.844 . . . . 0.0 110.435 175.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.1 t -80.99 -25.45 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 117.606 0.184 . . . . 0.0 111.058 176.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.91 27.81 5.26 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.692 1.139 . . . . 0.0 111.741 -177.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.541 HG22 ' H ' ' A' ' 56' ' ' ASP . 10.7 mt -123.32 -178.74 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 126.222 1.809 . . . . 0.0 106.874 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.541 ' H ' HG22 ' A' ' 55' ' ' ILE . 12.5 t70 -147.22 156.45 42.96 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.156 1.382 . . . . 0.0 109.483 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.442 HD13 HG21 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -128.49 -14.25 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.99 0.916 . . . . 0.0 112.341 169.833 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -46.83 -38.18 9.87 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.647 1.179 . . . . 0.0 112.678 173.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.65 -4.99 85.88 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 118.604 -1.109 . . . . 0.0 113.988 -172.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -128.64 167.06 17.73 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.135 1.467 . . . . 0.0 111.393 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.9 p -126.24 166.14 17.65 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.487 1.115 . . . . 0.0 111.566 -169.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.0 m -81.51 162.7 23.12 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.188 0.995 . . . . 0.0 111.252 175.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -153.56 144.12 15.81 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-O 118.47 -0.776 . . . . 0.0 109.973 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.77 152.74 17.2 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.423 2.082 . . . . 0.0 111.229 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.3 tt -55.88 -33.92 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 123.562 0.745 . . . . 0.0 111.202 174.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -57.94 -22.98 51.6 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.165 1.786 . . . . 0.0 112.39 -175.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -80.98 -5.65 57.81 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.988 0.915 . . . . 0.0 112.818 -176.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -126.13 -179.93 4.95 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.552 1.069 . . . . 0.0 111.805 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.01 139.31 51.05 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 127.558 2.343 . . . . 0.0 106.983 169.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.42 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -70.16 -22.39 62.97 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.207 1.003 . . . . 0.0 112.231 -177.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -61.77 -22.35 65.35 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.284 1.034 . . . . 0.0 112.507 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -83.8 -16.01 46.24 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.851 0.86 . . . . 0.0 110.491 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -103.77 130.09 51.26 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 125.176 1.39 . . . . 0.0 109.493 -172.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -78.81 -36.52 42.52 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 122.728 0.411 . . . . 0.0 111.166 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.46 HG13 ' HA ' ' A' ' 4' ' ' VAL . 1.4 p -133.39 132.95 57.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -171.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.5 m -125.67 108.06 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-O 123.124 1.44 . . . . 0.0 109.042 -173.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.7 mm -103.13 96.78 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.4 m -73.38 157.68 36.48 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 167.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.96 26.37 1.88 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 174.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 74.9 m -57.9 -33.57 68.9 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.648 1.579 . . . . 0.0 111.75 -171.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.47 -66.91 0.5 Allowed Glycine 0 C--N 1.334 0.442 0 C-N-CA 124.294 0.949 . . . . 0.0 112.022 168.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 85.6 m -83.76 33.4 0.48 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 117.668 0.734 . . . . 0.0 112.526 -169.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.24 24.45 72.02 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.397 0.998 . . . . 0.0 112.265 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.8 t -74.31 104.26 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 124.366 1.066 . . . . 0.0 108.616 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -75.97 156.99 33.63 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 122.211 1.005 . . . . 0.0 108.343 168.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.9 mt -77.56 123.3 86.7 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 114.092 -1.413 . . . . 0.0 107.356 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.94 -40.78 83.94 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.101 1.867 . . . . 0.0 113.632 169.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -77.36 -176.74 3.37 Favored 'Trans proline' 0 C--N 1.356 0.945 0 CA-C-N 121.533 1.583 . . . . 0.0 113.196 -174.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -45.64 -23.31 0.23 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 129.599 3.16 . . . . 0.0 114.921 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.42 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 77.3 m95 -62.55 11.23 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 128.732 2.813 . . . . 0.0 113.857 176.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.7 p -119.38 15.21 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 124.824 1.25 . . . . 0.0 111.609 174.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.5 p -130.23 17.44 5.5 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -171.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -91.37 179.12 5.77 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.36 1.464 . . . . 0.0 109.464 178.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -61.57 -33.63 74.2 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.636 1.174 . . . . 0.0 113.551 -171.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.8 mt -137.7 134.0 45.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -137.35 138.63 40.15 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 171.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -146.53 158.84 43.96 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.016 1.727 . . . . 0.0 107.362 169.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -123.16 100.06 6.67 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.869 1.267 . . . . 0.0 108.612 168.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.475 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 43.8 m0 -73.02 102.16 3.43 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.268 1.027 . . . . 0.0 108.832 -177.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -68.89 93.16 0.54 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.659 1.184 . . . . 0.0 109.259 176.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.5 153.36 35.45 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 125.481 1.512 . . . . 0.0 109.974 -172.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -85.66 53.36 2.74 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.432 1.493 . . . . 0.0 111.829 -171.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.8 t70 5.62 87.07 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 129.287 3.035 . . . . 0.0 114.106 169.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.463 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 50.7 Cg_exo -61.64 -4.85 4.91 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.864 3.042 . . . . 0.0 116.805 -172.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -54.5 93.03 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.988 1.267 . . . . 0.0 112.686 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.08 17.75 39.36 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 126.329 1.918 . . . . 0.0 113.419 172.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.463 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 23.3 mm-40 -95.0 178.25 5.62 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.987 1.393 . . . . 0.0 113.055 -169.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.6 m -77.45 156.13 31.3 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.994 1.718 . . . . 0.0 110.139 175.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 99.8 mt -59.14 -32.48 69.91 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.785 -0.572 . . . . 0.0 111.817 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.67 -39.14 93.0 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.656 0.382 . . . . 0.0 110.622 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 90.6 t -67.82 -45.07 84.98 Favored 'Isoleucine or valine' 0 C--N 1.338 0.083 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.524 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 17.4 m-85 -56.9 -50.38 72.71 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 119.023 -0.513 . . . . 0.0 111.043 176.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 -58.82 -41.76 87.57 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.024 0.829 . . . . 0.0 111.663 176.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.7 m -60.89 -49.75 76.22 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 118.836 0.744 . . . . 0.0 109.489 177.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.7 t -65.26 -39.21 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-O 117.748 -1.12 . . . . 0.0 110.654 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.6 ttp-105 -55.35 -48.59 73.99 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 120.354 1.434 . . . . 0.0 108.898 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.05 -47.76 89.56 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-O 118.326 -1.263 . . . . 0.0 110.196 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -56.27 -56.08 25.42 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.518 1.159 . . . . 0.0 110.151 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.6 t -55.82 -54.2 29.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 126.746 2.018 . . . . 0.0 110.851 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -63.01 -47.63 82.25 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 119.645 1.111 . . . . 0.0 110.158 -169.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -41.69 72.38 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 123.781 0.833 . . . . 0.0 110.995 174.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.475 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 45.7 mtt85 -71.45 -42.71 67.84 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.676 -177.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.453 ' HA ' HD23 ' A' ' 126' ' ' LEU . 71.5 t -53.02 -47.81 53.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 120.732 1.605 . . . . 0.0 109.769 169.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -61.48 -41.04 96.65 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 118.894 0.77 . . . . 0.0 110.767 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -62.19 -46.36 89.27 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 123.099 0.56 . . . . 0.0 110.264 175.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 123' ' ' VAL . 0.2 OUTLIER -62.18 -46.32 89.47 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 118.249 -0.881 . . . . 0.0 109.793 -177.298 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 71.7 mt -57.0 -40.14 70.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.791 0.836 . . . . 0.0 109.596 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.62 -31.3 72.45 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 120.147 1.34 . . . . 0.0 111.593 -175.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -64.08 -36.24 83.37 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.28 1.032 . . . . 0.0 111.827 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 pt -104.14 -25.28 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -169.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.7 m . . . . . 0 C--O 1.248 0.996 0 C-N-CA 125.785 1.634 . . . . 0.0 111.143 179.489 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.4 ttm . . . . . 0 N--CA 1.484 1.274 0 CA-C-O 121.094 0.473 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -96.64 138.72 33.79 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.547 0.739 . . . . 0.0 109.26 176.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -93.9 110.7 22.36 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 170.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 85.5 t -93.06 136.97 23.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 125.582 1.553 . . . . 0.0 107.966 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 39.6 tpp -119.06 143.06 47.33 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.458 1.103 . . . . 0.0 108.63 172.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -121.09 122.64 40.49 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.958 1.303 . . . . 0.0 108.114 170.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.8 t -127.45 123.91 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 120.771 1.623 . . . . 0.0 109.498 -174.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.4 t -118.39 165.11 14.27 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.872 0.76 . . . . 0.0 109.756 176.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -65.7 -11.54 46.13 Favored 'General case' 0 CA--C 1.548 0.893 0 O-C-N 121.82 -0.55 . . . . 0.0 111.548 169.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -154.47 107.53 2.85 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 128.238 2.615 . . . . 0.0 105.307 169.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -47.16 -38.42 11.77 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.927 1.291 . . . . 0.0 113.014 -178.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.9 p -38.77 -33.05 0.1 Allowed 'General case' 0 C--O 1.236 0.362 0 C-N-CA 129.507 3.123 . . . . 0.0 117.852 -169.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.8 m -122.62 -76.21 0.59 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.659 0.663 . . . . 0.0 111.791 -169.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -58.99 -51.11 71.5 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.264 0.484 . . . . 0.0 109.751 -169.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.76 -42.51 81.63 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.34 0.656 . . . . 0.0 111.271 -173.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -59.65 -45.05 93.2 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.547 0.739 . . . . 0.0 111.1 -175.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 53.5 mtm -65.66 -45.82 81.49 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 117.563 0.165 . . . . 0.0 111.07 176.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.43 -39.09 75.5 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 117.592 0.178 . . . . 0.0 110.859 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -65.41 -54.56 26.9 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.484 -0.77 . . . . 0.0 110.682 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.71 -41.38 50.39 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-O 119.271 -0.739 . . . . 0.0 112.456 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -68.02 -46.94 69.81 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 118.938 1.369 . . . . 0.0 109.457 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.04 -46.29 85.6 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 120.188 1.358 . . . . 0.0 112.894 -176.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -69.54 -5.77 26.47 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.523 1.056 . . . . 0.0 113.57 175.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.0 m -97.7 -47.99 5.39 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 119.927 1.239 . . . . 0.0 110.255 170.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 97.0 mt -77.45 -41.35 39.98 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.608 1.563 . . . . 0.0 111.86 -169.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -119.74 -5.22 11.16 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-O 117.86 -1.522 . . . . 0.0 114.877 -169.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.94 108.2 0.34 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.621 1.71 . . . . 0.0 108.825 169.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 137.69 -28.97 2.71 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.94 1.257 . . . . 0.0 111.643 -169.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.47 -22.32 3.36 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.569 1.148 . . . . 0.0 111.676 171.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.5 pt -123.82 156.04 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 121.313 0.578 . . . . 0.0 111.722 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -121.94 131.97 54.3 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 104.191 -2.522 . . . . 0.0 104.191 168.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 p -117.67 151.68 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -169.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.6 m -144.49 144.03 31.16 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 167.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.5 p -112.37 153.05 27.88 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 168.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.9 m -151.08 -170.13 3.58 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.39 160.56 29.94 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 169.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.1 mt -53.69 -30.65 44.63 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.369 0.668 . . . . 0.0 110.788 173.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -143.82 146.75 33.3 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 168.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.6 p -75.15 165.91 24.48 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.01 0.909 . . . . 0.0 111.756 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.7 p -151.59 -148.01 0.25 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.565 1.946 . . . . 0.0 106.322 173.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -133.13 155.65 48.89 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 173.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.4 t -63.21 128.71 25.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -173.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -70.96 137.85 85.05 Favored Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -70.58 -38.09 6.42 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 121.974 1.782 . . . . 0.0 112.428 -169.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.494 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 10.4 m -67.65 -18.86 65.1 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.407 -0.808 . . . . 0.0 111.878 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.44 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -58.48 -40.96 84.18 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 121.646 -0.659 . . . . 0.0 110.1 171.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.6 mp -61.99 -43.79 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.24 -37.67 81.09 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -176.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.4 mmt -62.31 -47.61 83.5 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 122.823 1.297 . . . . 0.0 111.441 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.2 mtp -69.0 -34.17 74.85 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.12 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -62.29 -29.83 70.7 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.584 0.754 . . . . 0.0 111.361 172.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -63.75 -39.31 93.97 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.872 0.76 . . . . 0.0 110.247 173.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.7 t -78.96 -25.33 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 121.219 -0.192 . . . . 0.0 110.97 178.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.61 24.89 5.94 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.104 1.335 . . . . 0.0 112.032 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.487 HG22 ' H ' ' A' ' 56' ' ' ASP . 11.8 mt -123.21 179.29 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 125.768 1.627 . . . . 0.0 107.249 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.487 ' H ' HG22 ' A' ' 55' ' ' ILE . 7.5 t70 -144.61 157.95 43.99 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.745 1.618 . . . . 0.0 108.942 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.44 HD12 ' HB1' ' A' ' 46' ' ' ALA . 0.7 OUTLIER -128.86 -16.95 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.888 0.875 . . . . 0.0 112.701 170.503 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 61.4 p -54.1 -28.58 40.3 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 120.076 1.307 . . . . 0.0 112.498 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.38 -11.22 71.44 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.706 1.146 . . . . 0.0 114.146 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -123.21 173.05 8.15 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.291 1.545 . . . . 0.0 111.163 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.4 p -128.53 164.79 22.04 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.458 1.103 . . . . 0.0 111.416 -169.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 73.6 m -80.6 158.62 25.65 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.904 0.882 . . . . 0.0 110.859 170.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -158.0 145.9 13.85 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.0 0.92 . . . . 0.0 109.663 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -82.85 150.83 14.33 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.606 2.204 . . . . 0.0 111.258 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.1 tt -55.55 -33.29 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.392 0.677 . . . . 0.0 111.807 175.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -58.75 -21.68 56.01 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.986 1.714 . . . . 0.0 112.35 -176.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -78.92 -6.94 57.46 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.953 0.901 . . . . 0.0 112.855 -176.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -127.97 -179.84 5.19 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.619 1.1 . . . . 0.0 111.433 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -127.24 127.39 44.34 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.789 2.036 . . . . 0.0 107.886 175.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.519 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -62.26 -24.07 67.05 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 -174.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -64.03 -21.03 66.34 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.775 0.43 . . . . 0.0 112.111 -177.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -81.41 -18.36 45.69 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.459 0.703 . . . . 0.0 110.19 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -97.11 130.26 44.41 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 125.45 1.5 . . . . 0.0 109.062 -177.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -89.65 -22.1 22.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.53 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.99 135.9 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -175.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.2 t -127.94 127.45 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 123.307 1.527 . . . . 0.0 109.566 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 35.4 mm -113.49 98.67 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.3 m -72.4 155.54 40.02 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 167.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.7 49.17 0.87 Allowed 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 102.878 -3.008 . . . . 0.0 102.878 172.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.5 m -75.49 -36.28 60.63 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 170.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.1 -42.15 1.6 Allowed Glycine 0 CA--C 1.52 0.402 0 C-N-CA 125.824 1.678 . . . . 0.0 115.622 167.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 40.0 m -74.15 25.68 0.08 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.126 1.463 . . . . 0.0 112.444 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.34 13.79 30.89 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 127.479 2.466 . . . . 0.0 114.014 -169.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.7 t -69.55 146.83 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 169.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -141.16 -177.85 5.31 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.291 1.036 . . . . 0.0 109.403 -171.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.7 mt -120.98 91.47 47.85 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 124.9 1.28 . . . . 0.0 108.064 -171.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.52 -37.08 41.6 Favored 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 123.289 2.659 . . . . 0.0 116.874 171.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -67.06 -176.78 0.84 Allowed 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.159 1.906 . . . . 0.0 113.911 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -51.15 -11.37 0.1 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.562 2.345 . . . . 0.0 115.155 173.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.519 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 93.9 m95 -62.96 9.05 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.949 2.1 . . . . 0.0 113.01 169.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.3 p -132.15 7.3 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 124.204 1.002 . . . . 0.0 112.509 173.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 82.8 p -116.23 33.18 5.68 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 120.044 1.293 . . . . 0.0 112.852 -169.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -122.01 -172.03 2.36 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.527 1.531 . . . . 0.0 110.222 174.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -59.43 -36.37 75.76 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -168.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.7 mm -133.05 138.52 51.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -173.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -142.94 129.8 20.51 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.226 1.411 . . . . 0.0 107.402 169.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -141.79 158.76 43.41 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 168.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -122.5 101.66 7.62 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.021 1.328 . . . . 0.0 109.46 169.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.422 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 39.5 m0 -78.8 92.73 4.87 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.199 0.999 . . . . 0.0 109.656 -177.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -62.1 120.49 10.97 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 169.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 47.6 mt -151.72 152.96 33.43 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.147 1.779 . . . . 0.0 107.585 -169.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -82.13 71.7 9.18 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.461 1.105 . . . . 0.0 111.448 -176.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -22.38 97.88 0.06 OUTLIER Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 128.678 2.791 . . . . 0.0 112.7 -177.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.437 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 65.0 Cg_exo -59.79 -2.9 1.78 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.292 3.328 . . . . 0.0 117.221 -169.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -50.86 95.85 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.843 1.257 . . . . 0.0 112.656 173.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.36 21.9 46.59 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.29 1.9 . . . . 0.0 113.153 171.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.437 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 23.4 mm-40 -98.73 176.68 5.54 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.952 1.376 . . . . 0.0 112.755 -169.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 44.2 m -74.4 154.69 38.68 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.804 1.641 . . . . 0.0 110.166 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 91.9 mt -58.38 -31.12 67.35 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.796 -0.565 . . . . 0.0 111.658 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -72.31 -33.66 67.54 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.296 0.498 . . . . 0.0 111.155 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 80.8 t -65.43 -46.22 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 171.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.494 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 11.1 m-85 -55.46 -50.38 70.03 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 118.876 -0.583 . . . . 0.0 110.351 175.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -59.37 -43.16 92.91 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.877 0.871 . . . . 0.0 112.207 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 100.0 m -60.96 -51.06 70.85 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 119.01 0.823 . . . . 0.0 109.151 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.0 t -63.69 -45.35 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 117.875 -1.059 . . . . 0.0 110.039 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -55.78 -47.2 77.47 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 119.818 1.19 . . . . 0.0 109.392 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.88 -49.02 83.29 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-O 118.383 -1.231 . . . . 0.0 110.417 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -59.72 -56.83 16.92 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 118.359 1.079 . . . . 0.0 110.398 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.8 t -46.26 -51.32 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 125.888 1.675 . . . . 0.0 110.483 177.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -63.62 -48.71 76.2 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.449 1.022 . . . . 0.0 110.192 -175.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.56 -40.56 72.09 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.377 1.071 . . . . 0.0 111.155 175.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.422 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 82.8 mtt-85 -73.1 -43.26 62.01 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.921 -176.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 69.5 t -54.35 -46.74 69.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 120.417 1.462 . . . . 0.0 108.843 169.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -61.2 -39.54 90.61 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.051 0.841 . . . . 0.0 110.831 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -63.47 -47.43 81.81 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 123.196 0.598 . . . . 0.0 110.308 176.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . 0.251 0.2 OUTLIER -60.52 -44.31 96.16 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 118.858 -0.592 . . . . 0.0 109.724 -178.666 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.1 mt -60.79 -38.05 77.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.514 1.126 . . . . 0.0 110.764 173.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.37 -31.42 72.57 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 120.287 1.403 . . . . 0.0 111.223 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -66.78 -20.49 65.96 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.014 1.325 . . . . 0.0 113.169 177.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.5 pt -127.53 -20.95 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 116.382 1.993 . . . . 0.0 116.382 -167.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 C--O 1.249 1.033 0 C-N-CA 126.371 1.868 . . . . 0.0 111.118 174.501 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.1 ttm . . . . . 0 N--CA 1.485 1.282 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -111.03 135.41 51.58 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 170.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -83.29 136.07 34.51 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 169.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.9 p -119.64 146.56 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-O 121.928 0.871 . . . . 0.0 109.526 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 33.3 tpp -127.17 142.51 51.48 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.308 -1.315 . . . . 0.0 108.423 -177.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -124.0 121.99 36.71 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 117.66 -1.162 . . . . 0.0 108.113 172.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.6 t -126.19 118.78 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 121.111 1.778 . . . . 0.0 110.055 -170.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.5 t -116.19 162.25 17.74 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.424 1.011 . . . . 0.0 112.081 -178.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.8 mttm -60.81 -17.88 52.25 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.767 0.827 . . . . 0.0 111.649 169.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.1 ptm85 -154.15 112.96 3.65 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 169.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -47.87 -30.57 4.22 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.025 0.93 . . . . 0.0 112.797 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.4 m -35.29 -35.86 0.05 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 130.085 3.354 . . . . 0.0 119.879 -171.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.8 p -137.68 -68.85 0.46 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 120.576 1.534 . . . . 0.0 113.51 -169.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -55.09 -51.1 67.45 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.045 0.838 . . . . 0.0 109.527 -169.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.412 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 0.0 OUTLIER -66.29 -49.14 68.09 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.955 2.102 . . . . 0.0 111.806 -179.478 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -60.26 -43.12 96.42 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.502 0.721 . . . . 0.0 110.847 -175.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 65.9 mtm -66.66 -47.14 73.47 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-O 119.569 -0.253 . . . . 0.0 110.991 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.99 -39.31 71.66 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 117.743 0.247 . . . . 0.0 110.773 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.409 ' HA ' HG21 ' A' ' 32' ' ' VAL . 17.8 tt0 -64.95 -55.22 20.49 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 118.485 -0.769 . . . . 0.0 110.938 177.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.5 -40.45 47.02 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-O 119.346 -0.697 . . . . 0.0 112.516 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -68.08 -47.01 69.44 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 119.008 1.404 . . . . 0.0 109.523 175.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.91 -45.49 90.21 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 120.187 1.358 . . . . 0.0 112.907 -176.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt -69.41 -9.45 53.63 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.685 1.129 . . . . 0.0 113.294 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.3 m -93.55 -48.59 6.29 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 119.852 1.206 . . . . 0.0 110.611 170.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 98.3 mt -77.23 -41.45 41.14 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.808 1.643 . . . . 0.0 111.92 -169.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -118.02 -5.75 13.15 Favored Glycine 0 C--N 1.333 0.38 0 CA-C-O 117.759 -1.578 . . . . 0.0 114.962 -169.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.4 109.11 0.4 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.702 1.751 . . . . 0.0 109.097 169.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.42 -28.88 2.85 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.974 1.273 . . . . 0.0 111.684 -169.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.82 -21.14 3.09 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.918 1.287 . . . . 0.0 111.677 172.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.0 pt -127.43 158.45 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.29 0.567 . . . . 0.0 111.845 174.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -125.79 132.35 52.29 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 169.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.409 HG21 ' HA ' ' A' ' 19' ' ' GLU . 2.8 p -117.08 153.26 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -169.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.5 m -145.65 145.01 30.76 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 167.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.412 ' HB2' ' HB2' ' A' ' 15' ' ' SER . 27.2 p -113.53 157.5 21.95 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 120.896 -1.128 . . . . 0.0 109.008 168.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.5 m -151.37 -175.95 5.38 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.714 1.606 . . . . 0.0 107.035 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -152.4 163.13 30.18 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 169.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.4 mt -53.24 -34.74 58.43 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 124.245 0.614 . . . . 0.0 110.265 174.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -141.9 145.58 34.74 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 104.659 -2.349 . . . . 0.0 104.659 169.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.2 p -75.75 147.4 39.32 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.098 0.475 . . . . 0.0 110.44 174.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 59.5 m -150.51 149.22 29.67 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.145 2.178 . . . . 0.0 105.542 169.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.64 155.56 9.68 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.858 0.863 . . . . 0.0 111.966 -172.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.6 t -65.63 131.07 31.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -73.74 138.97 76.91 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.35 -35.95 4.49 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 121.974 1.782 . . . . 0.0 112.494 -169.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.518 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 4.8 m -67.84 -18.57 64.87 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.093 -1.004 . . . . 0.0 111.945 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.32 -41.44 76.03 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.698 -0.626 . . . . 0.0 110.184 170.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.8 mp -62.78 -41.31 91.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -178.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.7 -36.99 82.5 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 118.341 0.519 . . . . 0.0 112.043 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 24.5 mmt -62.51 -47.69 82.84 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 122.763 1.268 . . . . 0.0 111.463 175.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 10.6 mtp -68.27 -34.0 75.38 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.433 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -63.03 -28.77 70.32 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.128 0.971 . . . . 0.0 111.077 173.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -65.39 -38.72 90.85 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.788 0.722 . . . . 0.0 110.162 172.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.9 t -78.22 -25.09 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 121.256 -0.178 . . . . 0.0 110.809 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.77 25.65 6.14 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.161 1.363 . . . . 0.0 111.953 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 56' ' ' ASP . 10.5 mt -124.2 175.97 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 125.584 1.554 . . . . 0.0 107.348 -178.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.426 ' H ' HG22 ' A' ' 55' ' ' ILE . 12.2 t70 -140.81 158.06 44.5 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.507 1.523 . . . . 0.0 109.154 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.434 HD13 HG21 ' A' ' 57' ' ' ILE . 0.8 OUTLIER -129.34 -18.59 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 118.186 -0.911 . . . . 0.0 112.816 171.124 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.7 m -51.58 -30.16 19.99 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 120.393 1.451 . . . . 0.0 112.274 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.69 -11.56 69.17 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.81 1.195 . . . . 0.0 114.093 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -123.99 168.62 12.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.432 1.493 . . . . 0.0 110.876 176.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.8 p -126.92 172.08 10.74 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.443 1.097 . . . . 0.0 110.85 -173.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.2 m -76.89 165.05 25.21 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.45 0.7 . . . . 0.0 112.173 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.29 142.86 15.33 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 124.349 1.06 . . . . 0.0 108.73 177.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -85.18 153.15 10.9 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.903 2.402 . . . . 0.0 110.095 169.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.1 tt -54.29 -33.28 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 123.524 0.73 . . . . 0.0 111.135 173.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -56.04 -26.25 48.28 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.411 1.884 . . . . 0.0 112.676 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -81.06 -5.44 57.63 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -175.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -130.11 -176.67 4.01 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.151 0.98 . . . . 0.0 111.181 -176.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.67 131.04 33.06 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 126.595 1.958 . . . . 0.0 108.399 -177.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.33 -29.4 67.62 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.599 1.16 . . . . 0.0 113.191 -176.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -60.23 -22.15 62.68 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.976 0.91 . . . . 0.0 112.336 -176.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -85.23 -14.8 45.63 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.545 0.738 . . . . 0.0 110.777 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -109.31 137.31 47.37 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.945 1.298 . . . . 0.0 110.276 -172.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -93.48 -33.78 13.66 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.519 0.727 . . . . 0.0 110.238 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.06 136.45 53.53 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 CA-C-N 118.578 0.626 . . . . 0.0 109.415 -175.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.9 t -128.49 115.96 39.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 122.929 1.347 . . . . 0.0 108.531 -175.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.9 mm -107.79 93.91 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.3 m -71.24 157.29 38.38 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 117.759 -1.576 . . . . 0.0 106.857 168.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.82 46.88 0.94 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 177.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 86.2 m -72.86 -41.86 64.3 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.553 0.741 . . . . 0.0 109.323 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.56 -62.47 0.64 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 123.81 0.719 . . . . 0.0 113.135 168.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 38.1 m -80.69 31.26 0.3 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -169.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 61.93 30.49 75.48 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -170.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 t -66.66 156.73 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.285 1.034 . . . . 0.0 108.295 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -135.58 156.01 49.55 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 124.211 1.004 . . . . 0.0 110.218 -169.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.5 mt -103.3 113.39 65.77 Favored Pre-proline 0 CA--C 1.53 0.206 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -172.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -50.89 -41.77 54.33 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 122.371 2.047 . . . . 0.0 114.798 169.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.73 176.49 9.74 Favored 'Trans proline' 0 C--N 1.356 0.95 0 CA-C-N 121.687 1.638 . . . . 0.0 113.753 -174.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -57.28 -12.19 2.23 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.248 2.219 . . . . 0.0 113.737 -173.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -55.51 -25.74 38.94 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 120.826 -1.171 . . . . 0.0 111.871 171.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.7 p -84.8 -18.3 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 119.637 1.108 . . . . 0.0 110.347 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 56.8 p -100.42 18.51 18.82 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.591 0.756 . . . . 0.0 112.683 -169.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -83.98 -172.71 4.31 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.896 0.879 . . . . 0.0 109.72 173.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -63.44 -34.62 78.15 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.426 0.691 . . . . 0.0 112.344 -169.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.0 mt -140.73 140.13 33.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 -174.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -140.1 137.87 34.85 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.623 1.169 . . . . 0.0 108.228 170.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -146.5 160.17 42.46 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.695 1.598 . . . . 0.0 107.726 168.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -122.53 95.73 4.75 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.117 1.367 . . . . 0.0 108.533 169.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.443 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 46.1 m0 -68.45 101.4 1.24 Allowed 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.418 1.087 . . . . 0.0 109.432 -177.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -61.21 120.59 10.65 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 169.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.7 mt -157.78 146.77 19.55 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.161 1.385 . . . . 0.0 107.993 -169.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.9 mp0 -86.61 60.25 6.12 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.375 1.87 . . . . 0.0 111.925 -169.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -1.59 85.67 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 129.672 3.189 . . . . 0.0 113.852 174.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.44 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 71.6 Cg_exo -59.64 -11.13 13.32 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.963 3.109 . . . . 0.0 117.85 -169.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.3 96.18 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 120.46 1.482 . . . . 0.0 111.495 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.4 13.11 29.25 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 126.402 1.953 . . . . 0.0 113.232 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.44 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 24.9 mm-40 -98.72 178.12 5.08 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.182 1.491 . . . . 0.0 112.765 -169.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.9 m -76.35 154.98 34.53 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.975 1.71 . . . . 0.0 110.059 175.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.9 mt -59.3 -30.96 68.71 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.708 -0.62 . . . . 0.0 111.889 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -62.11 -40.11 94.8 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.134 0.574 . . . . 0.0 110.521 175.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.7 t -68.9 -43.8 82.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.518 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 13.3 m-85 -55.44 -52.07 64.82 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.538 175.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -60.1 -41.54 92.76 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.413 0.685 . . . . 0.0 111.772 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 56.3 m -61.0 -46.19 91.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.78 0.718 . . . . 0.0 110.0 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.7 t -69.07 -43.84 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-O 117.853 -1.07 . . . . 0.0 110.265 177.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -56.45 -44.79 80.82 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 119.828 1.195 . . . . 0.0 109.438 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.16 -50.25 69.27 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-O 118.33 -1.261 . . . . 0.0 110.576 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -57.52 -57.05 14.38 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 118.311 1.055 . . . . 0.0 110.098 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.6 t -48.91 -52.95 8.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.937 1.695 . . . . 0.0 110.619 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -64.68 -48.89 73.05 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 119.159 0.891 . . . . 0.0 109.795 -171.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.62 -44.33 69.41 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.924 0.89 . . . . 0.0 110.46 174.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.443 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 96.4 mtt180 -72.45 -39.37 67.84 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 117.484 -1.246 . . . . 0.0 110.764 -175.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 72.5 t -55.26 -48.68 76.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 121.046 1.748 . . . . 0.0 108.724 169.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -60.42 -38.81 85.25 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.226 0.921 . . . . 0.0 110.778 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -64.71 -45.19 87.6 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.508 1.123 . . . . 0.0 110.352 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.58 -46.97 85.9 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 124.102 0.961 . . . . 0.0 109.434 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.7 mt -59.16 -38.04 71.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.607 1.163 . . . . 0.0 110.861 175.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.77 -30.08 70.56 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 120.011 1.278 . . . . 0.0 111.413 -173.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -71.61 -19.56 62.1 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.833 1.653 . . . . 0.0 112.976 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.4 pt -126.26 -20.35 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 126.018 1.727 . . . . 0.0 115.269 -168.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.5 m . . . . . 0 C--O 1.248 0.99 0 C-N-CA 126.471 1.908 . . . . 0.0 111.019 171.018 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.4 ttm . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 120.848 0.356 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -119.53 138.15 53.36 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.719 1.208 . . . . 0.0 107.758 176.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -97.25 133.62 41.64 Favored 'General case' 0 CA--C 1.511 -0.547 0 O-C-N 121.48 -0.762 . . . . 0.0 109.234 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.9 p -114.77 140.9 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 123.293 0.637 . . . . 0.0 109.662 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 44.2 tpp -119.94 143.8 47.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.973 169.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -117.9 135.62 54.0 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.972 1.309 . . . . 0.0 107.717 169.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.1 t -141.4 123.88 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 120.017 1.281 . . . . 0.0 109.274 -173.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.4 p -127.59 174.69 8.85 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.805 1.184 . . . . 0.0 111.019 173.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -66.04 -16.44 63.92 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.227 0.611 . . . . 0.0 112.415 173.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -152.14 101.79 2.74 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 170.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -40.02 -36.67 0.5 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.255 1.822 . . . . 0.0 113.252 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.6 m -37.21 -32.12 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 129.421 3.088 . . . . 0.0 116.936 -178.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 71.5 m -119.87 -84.96 0.66 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.172 0.896 . . . . 0.0 112.4 -169.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.429 ' HD3' ' HD2' ' A' ' 104' ' ' PRO . 0.3 OUTLIER -60.02 -51.9 67.69 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.501 1.046 . . . . 0.0 110.069 -169.479 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.416 ' HB3' ' HB2' ' A' ' 34' ' ' SER . 1.4 m -56.34 -50.19 72.21 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.247 1.019 . . . . 0.0 110.519 -173.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -61.64 -45.07 95.63 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.434 0.694 . . . . 0.0 111.344 -173.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 65.7 mtm -64.22 -47.04 81.21 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 119.446 -0.311 . . . . 0.0 110.927 175.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.69 -40.04 71.82 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 122.451 0.3 . . . . 0.0 110.681 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -64.54 -55.03 23.2 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.414 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.42 -38.09 68.41 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 119.457 -0.635 . . . . 0.0 111.702 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -67.73 -47.76 68.37 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 118.753 1.276 . . . . 0.0 108.775 175.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.64 -44.82 93.38 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.931 1.241 . . . . 0.0 113.312 -175.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 ptmt -68.98 -9.0 50.05 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 119.736 1.153 . . . . 0.0 113.145 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.6 m -93.51 -47.52 6.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 119.783 1.174 . . . . 0.0 110.459 169.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.2 mt -76.39 -40.77 50.04 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 126.04 1.736 . . . . 0.0 112.076 -169.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -121.93 -4.37 9.49 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-O 117.879 -1.512 . . . . 0.0 115.296 -169.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.27 110.08 0.57 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.763 1.781 . . . . 0.0 108.906 169.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.64 -30.43 2.68 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.931 1.253 . . . . 0.0 111.409 -169.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.07 -22.76 3.42 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.67 1.188 . . . . 0.0 111.892 172.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.8 pt -125.22 157.39 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-O 121.523 0.678 . . . . 0.0 112.01 176.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -122.77 132.42 54.22 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 169.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -117.39 150.83 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 C-N-CA 124.02 0.928 . . . . 0.0 112.06 -170.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.4 m -144.23 152.55 40.99 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 167.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.416 ' HB2' ' HB3' ' A' ' 15' ' ' SER . 43.9 p -131.2 156.97 44.44 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 167.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.1 p -155.73 -159.99 0.97 Allowed 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.97 163.95 32.06 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 169.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 67.2 mt -52.93 -34.0 53.28 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.59 0.756 . . . . 0.0 109.622 172.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -142.6 146.22 34.33 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 103.199 -2.889 . . . . 0.0 103.199 168.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.3 m -124.51 148.6 47.64 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.287 0.565 . . . . 0.0 111.456 -178.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.3 m -143.86 168.59 19.6 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.997 2.519 . . . . 0.0 106.303 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.0 ptt85 -54.22 158.97 2.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.979 0.809 . . . . 0.0 112.478 -172.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.9 t -62.62 136.15 26.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -73.85 143.27 81.07 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.96 -40.98 0.57 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.307 1.338 . . . . 0.0 112.79 -169.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.527 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 11.5 m -67.3 -16.92 64.54 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.368 -1.458 . . . . 0.0 111.898 -177.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.443 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -55.52 -40.07 71.33 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.698 0.799 . . . . 0.0 110.503 169.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 59.4 mt -57.74 -48.39 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.97 -37.6 85.37 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 123.654 0.782 . . . . 0.0 111.828 -174.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 20.2 mmt -61.28 -47.58 85.34 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 122.858 1.313 . . . . 0.0 111.31 175.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 9.3 mtp -69.39 -33.11 72.54 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.516 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -61.89 -29.01 69.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.858 -0.592 . . . . 0.0 111.588 170.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -65.59 -36.32 83.4 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.18 0.9 . . . . 0.0 110.446 173.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.67 -25.71 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 117.474 0.124 . . . . 0.0 110.769 176.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.43 28.26 7.23 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.546 1.069 . . . . 0.0 111.461 -174.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.598 HG22 ' H ' ' A' ' 56' ' ' ASP . 7.6 mt -122.93 -177.53 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.598 ' H ' HG22 ' A' ' 55' ' ' ILE . 12.3 t70 -146.45 157.02 43.7 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.364 1.466 . . . . 0.0 109.158 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.443 HD12 ' HB1' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -127.47 -16.48 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.703 0.801 . . . . 0.0 112.339 169.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -45.29 -38.18 5.42 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.693 1.197 . . . . 0.0 112.768 173.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.88 -5.46 88.72 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 118.517 -1.157 . . . . 0.0 114.335 -173.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -125.86 168.19 14.19 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.319 1.56 . . . . 0.0 110.875 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.8 p -127.84 168.61 14.94 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.016 0.926 . . . . 0.0 111.542 -169.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.2 m -82.16 163.36 22.0 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.401 1.08 . . . . 0.0 111.426 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -156.8 141.34 12.0 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.495 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -81.88 151.72 16.64 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.826 2.351 . . . . 0.0 111.173 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.1 tt -57.33 -31.13 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 121.725 -0.609 . . . . 0.0 111.833 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -56.76 -22.3 34.72 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.704 2.001 . . . . 0.0 112.111 -177.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -82.04 -7.99 59.64 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.56 1.144 . . . . 0.0 113.096 -176.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -128.57 -178.5 4.61 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 120.025 1.284 . . . . 0.0 111.607 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -127.66 141.86 51.5 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 127.247 2.219 . . . . 0.0 107.57 169.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.09 -22.99 65.8 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.889 1.276 . . . . 0.0 111.985 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -60.21 -23.14 63.78 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.054 0.942 . . . . 0.0 112.352 -176.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -83.07 -12.25 57.3 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.875 0.87 . . . . 0.0 110.728 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -111.3 126.93 55.42 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 125.644 1.578 . . . . 0.0 109.368 -170.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -72.61 -42.13 64.82 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 175.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.4 p -128.02 134.06 65.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 C-N-CA 122.942 0.497 . . . . 0.0 110.123 -169.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.4 m -127.91 108.26 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-O 123.341 1.543 . . . . 0.0 109.141 -172.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.4 mm -104.12 100.34 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 114.22 -1.355 . . . . 0.0 107.388 -175.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.4 t -74.01 157.14 36.68 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 167.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.13 51.38 0.6 Allowed 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 175.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.7 p -55.87 -52.47 63.94 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.712 -1.243 . . . . 0.0 110.907 -169.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.01 -27.71 2.88 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.282 1.42 . . . . 0.0 112.186 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 51.8 m -131.64 26.8 4.71 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.097 0.949 . . . . 0.0 113.482 -169.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.47 16.31 69.32 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.276 0.941 . . . . 0.0 114.489 176.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.406 HG23 ' H ' ' A' ' 84' ' ' VAL . 1.7 t -68.91 175.44 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 126.052 1.741 . . . . 0.0 108.24 169.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.77 158.33 44.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.16 0.984 . . . . 0.0 108.347 169.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 37.6 mt -62.42 121.41 66.75 Favored Pre-proline 0 C--N 1.327 -0.377 0 C-N-CA 125.867 1.667 . . . . 0.0 107.468 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -56.73 -41.35 76.58 Favored 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 122.063 1.842 . . . . 0.0 114.014 169.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.49 -177.05 3.56 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.709 1.606 . . . . 0.0 113.386 -172.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -47.71 -17.23 0.09 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 129.461 3.104 . . . . 0.0 115.632 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 61.2 m95 -66.28 8.3 0.24 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 126.7 2.0 . . . . 0.0 113.152 171.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.1 p -118.06 2.68 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 124.891 1.277 . . . . 0.0 111.512 171.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.1 p -128.5 26.43 5.65 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.111 0.964 . . . . 0.0 112.131 -172.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -92.57 -173.1 3.26 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.548 0.739 . . . . 0.0 109.558 170.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -65.72 -33.44 75.88 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -169.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.2 mt -137.25 132.62 46.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -138.48 140.46 39.21 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -147.58 159.07 44.17 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.276 1.43 . . . . 0.0 107.34 168.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -122.22 110.7 16.05 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.718 1.207 . . . . 0.0 108.934 168.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.436 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 37.1 m0 -87.39 84.68 7.15 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.28 1.032 . . . . 0.0 108.461 -178.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -56.95 120.85 8.66 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 170.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 25.1 mt -151.03 153.05 34.38 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.986 1.314 . . . . 0.0 108.602 -169.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -78.16 74.83 4.7 Favored 'General case' 0 CA--C 1.523 -0.092 0 C-N-CA 125.105 1.362 . . . . 0.0 111.525 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -28.68 102.77 0.16 Allowed Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 127.432 2.293 . . . . 0.0 113.668 -175.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.482 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 87.3 Cg_exo -63.68 -0.37 2.47 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.966 3.111 . . . . 0.0 117.425 -169.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -56.04 102.93 0.08 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 119.964 1.256 . . . . 0.0 111.702 178.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.34 22.06 59.4 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 126.201 1.857 . . . . 0.0 113.134 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.482 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 21.5 mm-40 -97.68 177.37 5.51 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.703 1.251 . . . . 0.0 112.554 -169.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.8 m -74.37 154.97 38.6 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.431 1.493 . . . . 0.0 109.814 176.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 91.5 mt -59.3 -30.58 68.44 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 122.001 -0.437 . . . . 0.0 111.656 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -62.77 -39.25 93.59 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.405 0.548 . . . . 0.0 110.918 176.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 89.0 t -67.9 -46.07 82.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.527 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 14.7 m-85 -55.34 -50.46 69.59 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.896 175.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 -59.85 -42.6 94.0 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.959 0.904 . . . . 0.0 111.74 177.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.7 m -60.78 -50.54 73.05 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 118.935 0.789 . . . . 0.0 109.363 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.6 t -66.1 -44.47 91.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 117.626 -1.178 . . . . 0.0 110.316 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 48.0 ttp85 -53.08 -47.36 68.6 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 120.093 1.315 . . . . 0.0 108.988 176.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.98 -47.9 81.18 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-O 118.481 -1.177 . . . . 0.0 110.598 -175.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -61.21 -56.7 17.64 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 118.292 1.046 . . . . 0.0 110.37 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 82.4 t -50.09 -49.95 20.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 125.132 1.373 . . . . 0.0 110.386 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -62.03 -48.43 80.33 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 120.207 1.367 . . . . 0.0 110.445 -176.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -53.91 -45.81 71.26 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 123.681 0.793 . . . . 0.0 109.751 174.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.436 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 76.6 mtt-85 -70.82 -39.54 72.98 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 118.257 -0.878 . . . . 0.0 109.925 -173.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 75.4 t -55.6 -48.8 77.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 120.437 1.471 . . . . 0.0 109.189 169.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -60.94 -38.87 87.35 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.659 1.118 . . . . 0.0 110.754 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -62.04 -46.73 87.85 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.806 1.642 . . . . 0.0 109.832 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.28 -45.76 83.16 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 123.75 0.82 . . . . 0.0 110.106 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 60.1 mt -57.44 -38.32 62.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.574 1.149 . . . . 0.0 110.468 175.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.26 -29.19 69.7 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.873 1.215 . . . . 0.0 111.447 -173.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -73.75 -19.14 60.87 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.079 1.752 . . . . 0.0 112.802 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 pt -126.51 -20.08 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 126.21 1.804 . . . . 0.0 114.966 -168.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 C--O 1.25 1.124 0 C-N-CA 126.504 1.922 . . . . 0.0 110.9 170.11 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.9 ttm . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 121.439 0.638 . . . . 0.0 110.392 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -78.45 124.23 27.9 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 175.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.7 mttt -106.48 124.74 50.05 Favored 'General case' 0 CA--C 1.508 -0.657 0 C-N-CA 122.885 0.474 . . . . 0.0 109.936 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.6 p -105.16 140.67 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 O-C-N 123.626 0.579 . . . . 0.0 110.656 175.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 39.7 tpp -119.07 142.39 47.91 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 169.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -116.08 134.53 54.84 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 169.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.3 t -136.9 123.05 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 119.641 1.11 . . . . 0.0 108.643 -171.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.4 t -123.23 157.12 33.79 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.066 0.848 . . . . 0.0 109.691 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.319 20.9 pttp -67.52 -2.48 6.59 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 175.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -139.17 -5.12 1.46 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 168.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 63.86 -44.13 0.26 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 127.332 2.253 . . . . 0.0 114.571 -172.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.3 m -34.03 -37.95 0.05 Allowed 'General case' 0 C--O 1.232 0.132 0 N-CA-C 119.684 3.216 . . . . 0.0 119.684 -168.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.9 p -136.12 -60.07 0.73 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-N 120.0 1.273 . . . . 0.0 112.202 -169.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -60.32 -50.12 74.89 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.001 0.819 . . . . 0.0 109.956 -171.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.04 -40.87 82.78 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 117.909 0.322 . . . . 0.0 110.579 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -61.75 -47.21 86.25 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.278 0.631 . . . . 0.0 111.131 -173.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.436 ' HG2' HD11 ' A' ' 57' ' ' ILE . 46.5 mtm -64.46 -43.05 95.45 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 119.837 -0.125 . . . . 0.0 110.745 176.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.85 -37.52 74.03 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.048 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.451 ' HA ' HG21 ' A' ' 32' ' ' VAL . 40.4 tt0 -65.73 -46.96 76.96 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 119.181 -0.438 . . . . 0.0 110.641 177.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.83 -42.76 98.24 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -67.48 -49.09 65.11 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 118.619 1.209 . . . . 0.0 109.624 176.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.1 -43.09 86.91 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 119.98 1.264 . . . . 0.0 112.092 -176.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.2 pttt -76.22 -2.46 31.44 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.4 m -98.62 -45.12 6.18 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 120.867 -1.145 . . . . 0.0 109.322 169.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.4 mt -72.15 -40.31 68.11 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.774 1.629 . . . . 0.0 110.79 -172.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.33 2.62 3.89 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 117.403 -1.776 . . . . 0.0 116.612 -169.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.44 116.07 2.45 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 120.607 2.204 . . . . 0.0 109.0 170.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.82 -24.19 6.45 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.599 1.095 . . . . 0.0 111.595 -175.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.35 -17.35 3.79 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.427 1.091 . . . . 0.0 111.912 176.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.9 pt -132.26 156.77 42.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 169.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.78 133.94 55.42 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 169.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.451 HG21 ' HA ' ' A' ' 19' ' ' GLU . 2.6 p -114.95 153.18 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 C-N-CA 124.074 0.95 . . . . 0.0 111.513 -175.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.9 m -144.01 148.19 34.91 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 167.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 63.2 p -121.92 148.67 44.46 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.33 1.452 . . . . 0.0 108.826 169.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 29.6 p -155.51 -165.11 1.9 Allowed 'General case' 0 C--O 1.241 0.63 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.22 168.48 33.07 Favored Glycine 0 N--CA 1.446 -0.698 0 O-C-N 121.541 -0.724 . . . . 0.0 111.976 169.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.2 mp -49.46 -39.85 34.91 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.044 0.937 . . . . 0.0 109.875 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -146.04 143.48 29.45 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 103.789 -2.671 . . . . 0.0 103.789 168.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.1 p -75.65 156.11 35.15 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 122.121 0.962 . . . . 0.0 111.503 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 63.5 m -158.39 153.92 26.1 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 127.72 2.408 . . . . 0.0 105.143 169.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -54.09 146.64 14.35 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 122.938 0.495 . . . . 0.0 110.894 -171.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 p -60.8 135.82 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 169.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -78.94 143.55 62.05 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 123.587 0.755 . . . . 0.0 109.858 -171.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.1 -41.63 0.28 Allowed 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 121.495 1.463 . . . . 0.0 112.409 -169.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.48 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 25.3 m -62.73 -24.57 67.75 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 120.422 -1.424 . . . . 0.0 111.292 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.417 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -51.36 -40.07 58.42 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.718 0.807 . . . . 0.0 111.663 173.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 62.9 mt -55.6 -46.0 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.12 -38.91 89.36 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 124.425 1.09 . . . . 0.0 110.161 -170.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.2 mmm -68.19 -44.19 76.44 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.744 1.259 . . . . 0.0 110.63 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.0 mtp -65.22 -35.87 82.39 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.221 -0.924 . . . . 0.0 109.963 175.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -63.89 -24.86 67.91 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.359 0.664 . . . . 0.0 111.489 173.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -65.82 -40.01 91.43 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 118.848 0.749 . . . . 0.0 109.746 172.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 92.7 t -76.78 -25.41 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.602 176.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.25 25.66 5.47 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.152 1.358 . . . . 0.0 111.727 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.525 HG22 ' H ' ' A' ' 56' ' ' ASP . 10.5 mt -123.37 178.85 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 125.128 1.371 . . . . 0.0 107.379 -178.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.525 ' H ' HG22 ' A' ' 55' ' ' ILE . 12.9 t70 -142.84 155.26 44.75 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.219 1.408 . . . . 0.0 109.557 -176.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.457 HD13 HG21 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -127.94 -13.88 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 123.955 0.902 . . . . 0.0 112.562 169.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -46.74 -37.17 8.07 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.53 1.132 . . . . 0.0 112.75 172.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.16 -6.23 85.96 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 118.697 -1.057 . . . . 0.0 114.248 -173.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -126.81 170.03 12.61 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.077 1.439 . . . . 0.0 111.204 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.6 p -129.2 166.57 19.12 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.645 1.178 . . . . 0.0 111.184 -170.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.2 m -92.08 155.78 17.83 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.798 1.239 . . . . 0.0 110.034 173.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -156.9 144.23 13.78 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 124.299 1.039 . . . . 0.0 110.07 -169.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.56 148.99 23.63 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 121.735 1.624 . . . . 0.0 111.158 -176.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.2 tt -52.01 -34.1 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.306 1.042 . . . . 0.0 111.761 173.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -58.44 -23.16 56.77 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.119 1.768 . . . . 0.0 112.404 -175.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -82.13 -6.83 59.48 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.916 0.886 . . . . 0.0 112.814 -175.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -125.39 -174.73 3.13 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.254 1.022 . . . . 0.0 110.356 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.47 130.71 30.82 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 126.399 1.88 . . . . 0.0 108.449 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.4 -28.39 66.87 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.633 1.173 . . . . 0.0 112.829 -176.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -60.49 -22.55 63.66 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.06 0.944 . . . . 0.0 112.452 -176.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -84.76 -13.2 51.96 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.428 0.691 . . . . 0.0 110.7 -178.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -108.77 127.37 53.95 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.972 1.309 . . . . 0.0 109.593 -172.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -74.17 -40.07 62.79 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.156 0.583 . . . . 0.0 109.967 175.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.97 136.38 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 122.823 0.449 . . . . 0.0 110.411 -169.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.7 m -129.15 110.53 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-O 122.839 1.304 . . . . 0.0 109.55 -170.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.7 mm -109.47 97.41 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -174.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.0 m -73.49 156.09 38.55 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 168.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.41 66.31 0.63 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 77.4 m -105.32 -43.84 4.89 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.391 -169.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.57 -96.78 0.24 Allowed Glycine 0 N--CA 1.465 0.574 0 CA-C-N 119.603 1.092 . . . . 0.0 112.905 168.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 56.2 m -76.94 39.19 0.22 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.614 1.566 . . . . 0.0 112.902 -169.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.12 14.66 78.85 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.455 1.026 . . . . 0.0 112.658 -172.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.5 t -58.74 126.06 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 169.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -137.94 -178.13 5.12 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.831 1.253 . . . . 0.0 109.531 -169.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.1 mt -113.16 108.21 53.15 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 123.981 0.912 . . . . 0.0 109.553 -169.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.19 -41.82 69.43 Favored 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 122.71 2.273 . . . . 0.0 115.078 169.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.63 -178.91 3.31 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.211 1.941 . . . . 0.0 113.432 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -59.1 -7.74 1.25 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.752 2.021 . . . . 0.0 114.151 -172.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -66.77 11.79 0.09 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.408 1.483 . . . . 0.0 112.624 169.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.7 p -124.01 3.24 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 125.563 1.545 . . . . 0.0 111.508 170.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 52.7 p -127.38 19.5 6.86 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.352 0.978 . . . . 0.0 112.649 -173.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -85.86 -173.64 4.71 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.223 0.609 . . . . 0.0 109.536 171.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -65.91 -32.5 74.04 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -169.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.2 mt -136.3 136.28 49.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -137.33 139.58 40.93 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 170.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -146.75 159.63 43.25 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.436 1.494 . . . . 0.0 107.441 168.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -123.35 96.39 4.97 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.488 1.515 . . . . 0.0 108.955 169.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -73.9 92.81 2.11 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.066 1.346 . . . . 0.0 109.54 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -65.81 97.37 0.34 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.889 1.276 . . . . 0.0 109.532 174.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -125.56 156.2 39.46 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.616 1.566 . . . . 0.0 109.906 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -78.7 66.35 4.18 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.518 1.927 . . . . 0.0 111.701 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -8.87 92.74 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 129.528 3.131 . . . . 0.0 113.553 169.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.415 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 77.5 Cg_exo -60.14 -4.38 2.99 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 124.707 3.605 . . . . 0.0 117.611 -169.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -54.64 98.85 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 120.244 1.384 . . . . 0.0 111.611 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.46 16.89 54.45 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.115 1.817 . . . . 0.0 113.522 170.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.415 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 25.7 mm-40 -94.95 179.59 5.17 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.792 1.296 . . . . 0.0 112.626 -169.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.2 m -76.35 155.43 34.15 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.254 1.422 . . . . 0.0 109.926 175.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.9 mt -58.89 -31.67 68.82 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.957 -0.464 . . . . 0.0 111.559 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -63.96 -40.53 96.63 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.088 0.404 . . . . 0.0 110.894 177.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.4 t -65.8 -47.44 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 176.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.48 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 8.1 m-85 -53.8 -54.24 41.06 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.225 0.61 . . . . 0.0 110.822 177.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 33.6 mtt180 -59.78 -42.06 92.48 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.707 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.5 m -61.67 -52.72 63.16 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 118.828 0.74 . . . . 0.0 109.222 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.3 t -64.04 -44.42 97.76 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.02 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -57.64 -45.5 85.39 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 119.728 1.149 . . . . 0.0 110.189 -177.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.46 -49.28 66.08 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-O 118.684 -1.064 . . . . 0.0 111.153 177.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -59.9 -50.06 75.25 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 118.661 1.231 . . . . 0.0 111.058 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.6 t -54.18 -48.13 66.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 124.634 1.174 . . . . 0.0 109.921 178.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -60.13 -46.94 87.96 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 120.071 1.305 . . . . 0.0 110.586 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -42.04 86.07 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.304 1.042 . . . . 0.0 110.68 178.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.6 mtt-85 -71.2 -41.88 69.71 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 117.821 -1.085 . . . . 0.0 109.863 -177.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.421 ' HA ' HD23 ' A' ' 126' ' ' LEU . 94.1 t -54.47 -46.06 70.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 120.461 1.482 . . . . 0.0 109.976 169.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -61.94 -40.21 94.74 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.465 1.03 . . . . 0.0 111.075 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -63.11 -44.62 95.14 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.048 0.539 . . . . 0.0 110.321 176.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 123' ' ' VAL . 0.2 OUTLIER -64.02 -46.79 82.92 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 118.447 -0.787 . . . . 0.0 109.951 -178.254 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.1 mt -52.86 -41.91 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 124.052 0.941 . . . . 0.0 109.423 173.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.31 -31.01 72.05 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.713 1.142 . . . . 0.0 111.571 -175.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -69.65 -39.25 77.18 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.497 1.119 . . . . 0.0 111.504 176.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.0 pt -95.81 -28.7 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -169.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.5 m . . . . . 0 C--O 1.25 1.132 0 C-N-CA 126.079 1.752 . . . . 0.0 111.22 -179.177 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.6 ttm . . . . . 0 N--CA 1.484 1.274 0 CA-C-O 120.752 0.31 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -119.94 147.73 44.38 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.629 1.172 . . . . 0.0 108.496 171.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.7 mttt -102.72 104.13 14.43 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 123.515 0.726 . . . . 0.0 109.453 175.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 36.4 t -79.0 141.03 15.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 125.259 1.424 . . . . 0.0 108.837 175.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 30.6 tpp -127.18 142.41 51.5 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.707 1.203 . . . . 0.0 108.368 173.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -124.47 133.49 53.34 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.135 0.974 . . . . 0.0 108.893 173.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.3 t -144.19 122.81 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 120.259 1.39 . . . . 0.0 110.027 -169.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.2 p -132.4 179.9 5.84 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 120.058 1.299 . . . . 0.0 111.181 175.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.8 mttm -62.55 -10.57 12.46 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.789 1.236 . . . . 0.0 114.001 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -143.85 -10.45 0.69 Allowed 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 116.026 1.861 . . . . 0.0 116.026 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 63.2 -40.95 0.19 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 128.312 2.645 . . . . 0.0 114.291 -169.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.5 m -34.84 -39.14 0.09 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 129.252 3.021 . . . . 0.0 118.573 -169.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.7 p -132.64 -72.27 0.52 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 118.124 -0.941 . . . . 0.0 109.594 -169.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 -50.62 -52.58 38.12 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.928 0.785 . . . . 0.0 110.387 -169.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.65 -45.02 63.27 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.361 0.664 . . . . 0.0 111.349 -176.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -59.78 -44.01 94.11 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.204 1.002 . . . . 0.0 111.409 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 53.5 mtp -64.57 -48.29 75.52 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.877 1.271 . . . . 0.0 109.295 178.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.8 -40.14 79.22 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.363 0.265 . . . . 0.0 111.149 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -62.56 -46.95 85.97 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.761 0.425 . . . . 0.0 110.556 177.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.35 -43.43 95.68 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 119.443 -0.643 . . . . 0.0 111.875 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -67.24 -48.92 66.34 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 119.025 1.413 . . . . 0.0 109.159 176.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.71 -42.71 79.63 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 119.599 1.091 . . . . 0.0 112.395 -176.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.3 pttt -75.7 -2.41 29.41 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.9 m -99.16 -45.57 5.86 Favored 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 120.917 -1.114 . . . . 0.0 109.437 169.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 91.9 mt -71.25 -40.34 71.07 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.183 1.793 . . . . 0.0 110.945 -173.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -133.87 0.15 4.04 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 117.444 -1.753 . . . . 0.0 116.8 -169.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.35 116.87 2.87 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 120.512 2.156 . . . . 0.0 109.35 172.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.29 -24.24 6.62 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.642 1.115 . . . . 0.0 111.514 -176.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.29 -18.75 4.0 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.455 1.102 . . . . 0.0 111.654 177.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.1 pt -131.0 158.45 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 168.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -120.37 144.39 47.92 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 169.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.92 153.67 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 123.442 0.697 . . . . 0.0 112.631 -174.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.3 m -151.02 144.9 25.17 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.579 1.552 . . . . 0.0 106.873 168.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 97.6 p -112.01 157.74 20.38 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.35 -0.844 . . . . 0.0 109.665 168.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.7 p -152.02 -164.17 1.91 Allowed 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 171.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.32 161.8 35.18 Favored Glycine 0 CA--C 1.519 0.297 0 O-C-N 121.276 -0.89 . . . . 0.0 111.092 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 66.0 mt -54.75 -32.02 59.28 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.407 1.083 . . . . 0.0 111.123 -173.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -146.85 144.54 29.38 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 168.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.6 p -73.5 153.46 40.31 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.741 0.781 . . . . 0.0 111.296 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.3 m -160.21 154.07 22.86 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.502 2.321 . . . . 0.0 105.869 169.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -57.13 156.12 7.59 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.62 0.645 . . . . 0.0 111.408 -174.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.9 t -63.23 132.34 29.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 172.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -73.84 139.8 77.24 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -75.12 -41.59 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.358 1.372 . . . . 0.0 112.614 -169.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.494 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 25.5 m -64.65 -23.02 67.12 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 120.556 -1.34 . . . . 0.0 111.48 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.62 -40.55 60.11 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 123.622 0.769 . . . . 0.0 111.402 171.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 61.7 mt -56.2 -45.38 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.88 -40.17 91.36 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 124.249 1.02 . . . . 0.0 110.056 -171.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.8 mmm -64.47 -44.86 89.7 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 122.145 0.974 . . . . 0.0 110.16 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.1 mtp -66.94 -36.7 82.83 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.721 177.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -61.04 -29.92 70.01 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.306 0.643 . . . . 0.0 111.272 173.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -64.25 -39.81 94.72 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 118.884 0.766 . . . . 0.0 110.213 173.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 62.1 t -77.79 -17.06 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.027 177.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.92 25.44 10.54 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.787 1.184 . . . . 0.0 111.933 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.528 HG22 ' H ' ' A' ' 56' ' ' ASP . 11.9 mt -121.28 179.68 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 125.405 1.482 . . . . 0.0 107.279 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.528 ' H ' HG22 ' A' ' 55' ' ' ILE . 13.8 t70 -144.9 156.0 43.75 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.228 1.411 . . . . 0.0 109.351 -178.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -127.74 -16.85 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.831 0.852 . . . . 0.0 112.443 169.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -44.18 -38.71 3.89 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.692 1.197 . . . . 0.0 112.968 172.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.29 -6.45 86.37 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-O 118.582 -1.121 . . . . 0.0 114.268 -173.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -126.61 164.74 20.58 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.156 1.478 . . . . 0.0 110.732 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.5 p -129.88 167.26 18.44 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.017 0.927 . . . . 0.0 111.74 -169.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.1 m -77.45 164.64 25.26 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.573 1.149 . . . . 0.0 111.761 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -157.63 141.58 11.49 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-O 118.411 -0.804 . . . . 0.0 109.471 174.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -78.09 153.37 28.49 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.557 2.171 . . . . 0.0 111.232 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.1 tt -53.82 -33.86 24.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.798 1.239 . . . . 0.0 112.471 177.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -66.07 -20.98 66.34 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.251 1.42 . . . . 0.0 112.074 -169.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -83.33 -0.98 52.17 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.108 0.963 . . . . 0.0 112.561 -173.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -115.85 -173.12 2.29 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.847 0.859 . . . . 0.0 112.462 -170.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.431 ' HA ' ' CH2' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -142.91 131.39 22.32 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 127.284 2.234 . . . . 0.0 107.846 173.433 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.695 ' HB2' ' CE3' ' A' ' 90' ' ' TRP . . . -62.28 -29.16 70.22 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 119.142 -0.456 . . . . 0.0 112.208 178.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -61.73 -20.36 63.42 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.381 0.672 . . . . 0.0 112.372 -170.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -88.73 -22.84 23.13 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.601 0.76 . . . . 0.0 110.955 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -99.08 113.1 25.14 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.972 1.309 . . . . 0.0 108.832 -176.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -72.31 -28.91 63.38 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 122.315 -0.24 . . . . 0.0 110.875 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.18 135.13 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.081 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -172.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.7 t -131.74 129.63 61.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 122.786 1.279 . . . . 0.0 109.253 -173.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.3 mm -120.32 101.77 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -177.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.5 t -72.42 155.39 40.18 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 105.496 -2.039 . . . . 0.0 105.496 168.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.45 36.3 0.89 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 172.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 90.4 m -60.35 -21.49 62.15 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.08 -1.013 . . . . 0.0 112.15 -173.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.52 -63.74 0.8 Allowed Glycine 0 CA--C 1.518 0.238 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 169.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 37.9 m -76.34 24.21 0.14 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -173.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.34 15.23 63.18 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.758 1.647 . . . . 0.0 113.57 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.22 156.07 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.442 1.497 . . . . 0.0 107.609 169.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -127.44 158.36 37.57 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.924 1.29 . . . . 0.0 108.126 174.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.0 mt -65.56 123.96 85.96 Favored Pre-proline 0 C--N 1.327 -0.398 0 C-N-CA 125.065 1.346 . . . . 0.0 108.472 -177.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -56.85 -41.26 77.29 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 122.037 1.825 . . . . 0.0 113.77 169.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.454 ' HB2' ' CE3' ' A' ' 90' ' ' TRP . 71.2 Cg_endo -75.91 172.37 16.42 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 121.724 1.652 . . . . 0.0 113.217 -170.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -54.24 -13.12 0.77 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 127.205 2.202 . . . . 0.0 113.271 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.695 ' CE3' ' HB2' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -49.14 -27.52 3.56 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 128.209 2.604 . . . . 0.0 111.65 169.646 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.21 -2.14 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.811 0.844 . . . . 0.0 110.589 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 56.7 p -120.68 18.96 11.93 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.978 0.911 . . . . 0.0 113.151 -169.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -86.95 179.87 6.63 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.306 1.042 . . . . 0.0 110.339 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -57.3 -34.02 68.27 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.714 1.206 . . . . 0.0 113.082 -169.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.4 mt -132.8 139.15 50.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 174.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -140.61 132.92 28.28 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 169.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -142.27 159.13 42.85 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.292 1.437 . . . . 0.0 108.622 169.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -121.14 111.28 17.22 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.764 1.226 . . . . 0.0 109.428 168.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.427 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 41.0 m0 -85.33 93.83 8.8 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.566 1.146 . . . . 0.0 108.741 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -59.77 116.51 4.12 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 169.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.3 mt -149.68 149.32 30.43 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.565 1.546 . . . . 0.0 107.506 -169.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -84.61 63.23 7.8 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 125.023 1.329 . . . . 0.0 111.137 -175.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -0.99 88.0 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 129.021 2.929 . . . . 0.0 112.918 169.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.497 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 71.0 Cg_exo -58.68 -4.93 2.14 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 124.262 3.308 . . . . 0.0 117.33 -169.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -54.91 99.7 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.392 0.996 . . . . 0.0 111.738 176.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.17 18.06 54.35 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 126.16 1.838 . . . . 0.0 113.324 171.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.497 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 22.1 mm-40 -95.9 178.16 5.52 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.661 1.23 . . . . 0.0 112.562 -169.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.3 m -74.94 154.74 38.01 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.498 1.519 . . . . 0.0 110.048 174.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.9 mt -58.58 -32.67 69.16 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.786 -0.571 . . . . 0.0 111.574 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -63.31 -39.93 95.93 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 122.679 0.392 . . . . 0.0 110.664 177.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.7 t -66.39 -45.77 88.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 176.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.494 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 10.7 m-85 -55.4 -52.06 64.81 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.823 0.449 . . . . 0.0 110.803 177.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 34.8 mtt180 -61.76 -40.09 93.91 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.509 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.3 m -62.0 -51.49 67.82 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.393 0.997 . . . . 0.0 109.708 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 49.0 t -63.66 -45.1 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.958 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 -56.31 -45.83 80.11 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-N 119.705 1.139 . . . . 0.0 109.499 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.17 -50.34 68.75 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-O 118.176 -1.347 . . . . 0.0 110.408 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -59.36 -54.46 46.47 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 118.535 1.168 . . . . 0.0 110.512 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 65.1 t -47.32 -54.57 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 125.541 1.536 . . . . 0.0 110.297 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -62.99 -44.85 94.9 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 120.112 1.324 . . . . 0.0 110.626 -175.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -57.96 -42.19 84.47 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.727 1.211 . . . . 0.0 109.655 177.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.427 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 80.5 mtt-85 -74.61 -41.58 60.15 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 117.186 -1.388 . . . . 0.0 109.979 -175.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.449 ' HA ' HD23 ' A' ' 126' ' ' LEU . 95.6 t -53.15 -45.71 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 121.216 1.825 . . . . 0.0 109.564 169.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -62.29 -42.02 98.99 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.044 0.838 . . . . 0.0 111.218 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -60.91 -46.01 92.34 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 175.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 123' ' ' VAL . 0.2 OUTLIER -63.03 -48.97 76.44 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.252 -0.88 . . . . 0.0 109.561 -176.009 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 55.9 mt -52.35 -42.14 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 124.234 1.014 . . . . 0.0 109.443 173.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.26 -30.74 71.82 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.638 1.108 . . . . 0.0 111.58 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 44.7 mttt -70.38 -38.0 74.64 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.719 1.208 . . . . 0.0 111.537 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.7 pt -97.61 -27.12 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -169.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.8 m . . . . . 0 C--O 1.25 1.111 0 C-N-CA 126.125 1.77 . . . . 0.0 110.915 176.481 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.8 ttm . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 120.819 0.342 . . . . 0.0 110.44 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.09 141.98 35.27 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.676 0.79 . . . . 0.0 109.711 173.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -96.14 117.77 31.39 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 170.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 98.2 t -101.7 135.63 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 125.469 1.508 . . . . 0.0 107.673 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 51.9 ttm -118.86 138.28 52.84 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 168.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -108.68 130.22 55.34 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 169.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.9 t -129.17 113.23 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 120.326 1.421 . . . . 0.0 109.296 -170.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.6 t -111.59 162.63 14.95 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.97 0.805 . . . . 0.0 111.571 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.4 mttm -65.51 -13.01 57.95 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.824 -1.173 . . . . 0.0 112.383 171.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.6 ptt180 -153.81 114.33 3.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 104.149 -2.537 . . . . 0.0 104.149 169.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -69.56 52.92 0.11 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.795 1.238 . . . . 0.0 112.415 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.5 p -126.76 -23.3 3.72 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.842 1.257 . . . . 0.0 112.668 -170.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 78.6 m -133.99 -87.82 0.4 Allowed 'General case' 0 C--N 1.343 0.3 0 CA-C-O 118.379 -0.82 . . . . 0.0 111.185 -171.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -50.33 -50.6 50.46 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.016 0.825 . . . . 0.0 110.922 -169.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.1 p -70.25 -44.67 68.02 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 125.26 1.424 . . . . 0.0 110.974 -174.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -58.93 -46.39 88.09 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.649 1.18 . . . . 0.0 110.436 -177.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 52.2 mtp -63.76 -46.63 84.41 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.586 1.154 . . . . 0.0 109.598 177.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.74 -37.75 74.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 119.104 -0.474 . . . . 0.0 111.425 178.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -62.29 -53.31 56.98 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-O 118.464 -0.779 . . . . 0.0 109.855 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.91 -41.17 75.62 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -66.38 -49.79 65.68 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 118.271 1.036 . . . . 0.0 109.676 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.0 -46.43 88.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 120.09 1.314 . . . . 0.0 113.082 -174.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -71.14 -8.77 55.74 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 119.7 1.136 . . . . 0.0 113.201 176.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 38.0 m -92.77 -48.7 6.44 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 119.965 1.257 . . . . 0.0 110.552 169.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.2 mt -78.92 -41.55 29.25 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.998 1.719 . . . . 0.0 112.135 -169.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.21 -7.32 16.95 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-O 117.904 -1.498 . . . . 0.0 114.604 -169.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.08 109.34 0.46 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.632 1.716 . . . . 0.0 108.897 169.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.09 -28.87 2.88 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.917 1.246 . . . . 0.0 111.622 -169.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.67 -21.38 2.78 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.619 1.168 . . . . 0.0 111.812 172.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.8 pt -126.77 158.87 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-O 121.47 0.652 . . . . 0.0 112.124 174.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -123.74 134.11 53.74 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 168.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 p -119.45 151.35 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -170.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.2 m -141.71 131.71 24.58 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.132 1.373 . . . . 0.0 108.614 168.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.6 p -98.21 141.4 31.17 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.026 -1.046 . . . . 0.0 108.517 169.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.6 m -154.0 -177.28 6.3 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.413 1.885 . . . . 0.0 106.087 -169.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.53 170.77 43.3 Favored Glycine 0 N--CA 1.439 -1.11 0 O-C-N 121.377 -0.827 . . . . 0.0 111.522 175.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -53.62 -33.58 55.55 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 125.176 1.163 . . . . 0.0 110.048 174.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -143.57 146.23 33.15 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.986 1.714 . . . . 0.0 106.67 169.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 p -70.53 157.66 37.49 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.294 0.569 . . . . 0.0 109.612 169.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.6 m -162.16 148.56 13.39 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.199 1.8 . . . . 0.0 106.795 170.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -54.4 151.96 7.03 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.562 0.619 . . . . 0.0 110.907 -175.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.9 t -57.44 126.19 14.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 172.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -70.46 140.85 87.59 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -72.84 -41.68 1.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.265 1.31 . . . . 0.0 113.192 -169.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.505 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 29.8 m -65.01 -25.19 67.75 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.664 -1.272 . . . . 0.0 111.298 -177.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.475 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -51.46 -40.87 60.33 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.723 0.809 . . . . 0.0 111.335 173.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.8 mt -56.45 -45.88 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.12 -38.37 88.01 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.507 1.123 . . . . 0.0 110.578 -172.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.9 mmm -68.41 -44.02 75.93 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 122.915 1.34 . . . . 0.0 110.434 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.2 mtp -66.88 -34.29 77.46 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 121.124 -0.985 . . . . 0.0 110.005 175.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -62.48 -26.4 68.51 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.998 0.817 . . . . 0.0 111.423 172.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -65.55 -39.84 92.19 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 118.905 0.775 . . . . 0.0 109.768 173.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 63.9 t -78.46 -22.28 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 120.159 -0.617 . . . . 0.0 110.852 177.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.93 25.09 6.63 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.054 1.311 . . . . 0.0 111.948 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.525 HG22 ' H ' ' A' ' 56' ' ' ASP . 10.7 mt -122.68 179.03 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 125.227 1.411 . . . . 0.0 107.45 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.525 ' H ' HG22 ' A' ' 55' ' ' ILE . 9.8 t0 -144.28 155.96 44.06 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.863 1.665 . . . . 0.0 108.822 -176.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.475 HD12 ' HB1' ' A' ' 46' ' ' ALA . 0.5 OUTLIER -130.85 -13.04 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.981 0.913 . . . . 0.0 113.365 174.314 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.7 m -43.1 -34.24 1.03 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.993 1.717 . . . . 0.0 114.637 -176.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -102.82 1.93 48.52 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 117.853 -1.526 . . . . 0.0 114.576 -174.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -71.92 -26.78 62.44 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 120.528 2.164 . . . . 0.0 113.081 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.9 p 60.49 -161.06 0.29 Allowed 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.314 1.046 . . . . 0.0 110.264 -174.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.4 t -134.19 163.0 30.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.798 0.809 . . . . 0.0 111.406 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -161.21 133.9 4.48 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 126.304 1.842 . . . . 0.0 106.373 -171.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -85.0 158.51 11.57 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.875 2.384 . . . . 0.0 110.934 176.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.4 tt -54.28 -35.15 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 123.476 0.711 . . . . 0.0 111.02 172.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -57.22 -24.12 52.47 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.11 1.764 . . . . 0.0 112.66 -175.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -83.3 -2.34 55.44 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.569 0.748 . . . . 0.0 112.547 -176.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -128.88 -176.87 3.99 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.253 1.021 . . . . 0.0 111.005 -177.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.18 129.28 31.46 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 126.602 1.961 . . . . 0.0 108.274 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.31 -29.82 66.18 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.548 1.139 . . . . 0.0 112.939 -175.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -60.73 -22.7 64.27 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.036 0.934 . . . . 0.0 112.475 -176.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -84.31 -18.02 37.67 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.272 0.629 . . . . 0.0 110.605 -177.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -101.89 122.74 44.58 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 125.168 1.387 . . . . 0.0 108.959 -175.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -76.22 -32.34 58.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.841 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.9 138.01 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 123.518 0.727 . . . . 0.0 109.059 -171.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.0 128.01 45.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 122.97 1.367 . . . . 0.0 109.869 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.0 mm -120.33 96.16 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 -175.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.7 m -70.04 156.01 39.78 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 168.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.74 56.07 0.91 Allowed 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 102.753 -3.055 . . . . 0.0 102.753 173.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.4 m -76.51 -34.15 58.6 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.834 0.854 . . . . 0.0 110.14 -178.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.53 176.13 47.19 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -170.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 91.4 m 37.48 32.15 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.594 2.357 . . . . 0.0 114.791 -172.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 53.36 26.43 29.75 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.493 1.52 . . . . 0.0 114.503 -175.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.1 t -64.13 156.26 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 125.19 1.396 . . . . 0.0 108.692 174.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -141.1 173.93 11.01 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 125.343 1.457 . . . . 0.0 109.485 174.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 68.2 mt -101.18 117.69 61.72 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 124.741 1.216 . . . . 0.0 108.953 -169.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.21 -40.52 69.29 Favored 'Trans proline' 0 CA--C 1.548 1.224 0 C-N-CA 122.367 2.045 . . . . 0.0 114.88 169.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.58 -178.98 4.07 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 121.879 1.72 . . . . 0.0 114.073 -175.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -52.94 -14.48 0.58 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 128.427 2.691 . . . . 0.0 114.055 -178.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -64.65 8.7 0.11 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.115 1.766 . . . . 0.0 113.03 170.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.7 p -122.1 2.87 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 124.845 1.258 . . . . 0.0 111.652 172.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.9 p -128.05 23.48 6.09 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.212 1.005 . . . . 0.0 112.149 -173.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -88.58 179.87 6.19 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.621 0.768 . . . . 0.0 109.313 170.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -59.69 -33.6 71.79 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.23 1.012 . . . . 0.0 113.246 -171.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.9 mt -134.76 135.67 53.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 177.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -140.43 133.69 29.7 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 169.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -144.81 157.91 43.99 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.001 1.32 . . . . 0.0 107.573 168.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -119.48 117.54 28.71 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.7 1.2 . . . . 0.0 108.496 168.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -93.92 108.65 20.43 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.218 1.407 . . . . 0.0 109.543 -173.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -72.54 105.57 4.25 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.727 1.211 . . . . 0.0 108.511 178.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -135.76 151.94 50.62 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 125.038 1.335 . . . . 0.0 108.855 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -82.98 75.91 9.84 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.735 1.214 . . . . 0.0 110.657 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -21.92 98.86 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 128.096 2.558 . . . . 0.0 112.466 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.406 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 53.0 Cg_exo -60.81 -4.5 3.62 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 124.44 3.427 . . . . 0.0 116.785 -169.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -56.47 101.07 0.05 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.182 1.355 . . . . 0.0 111.485 177.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.37 18.24 55.66 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 126.096 1.808 . . . . 0.0 113.389 170.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.406 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 26.9 mm-40 -94.41 178.34 5.65 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.652 1.226 . . . . 0.0 112.763 -169.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.2 m -75.18 154.79 37.49 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.477 1.511 . . . . 0.0 109.955 175.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 93.5 mt -57.47 -32.6 67.13 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.017 -0.427 . . . . 0.0 111.479 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.98 -40.29 94.75 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.858 0.463 . . . . 0.0 110.874 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 88.6 t -65.26 -48.31 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 175.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.505 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 6.4 m-85 -53.94 -52.43 60.65 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.281 0.632 . . . . 0.0 110.954 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -60.97 -43.79 98.28 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.74 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.1 m -61.5 -50.78 71.36 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 118.867 0.758 . . . . 0.0 109.183 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 66.3 t -66.71 -43.67 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-O 118.349 -0.834 . . . . 0.0 110.153 -178.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.62 -43.38 89.64 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 119.966 1.257 . . . . 0.0 110.242 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.66 -49.03 71.97 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-O 118.595 -1.114 . . . . 0.0 111.244 176.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -59.96 -51.87 67.82 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 118.701 1.251 . . . . 0.0 110.884 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 64.4 t -52.78 -48.51 49.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 124.804 1.242 . . . . 0.0 109.959 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -60.02 -47.38 86.08 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.86 1.209 . . . . 0.0 110.399 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.04 -42.76 81.06 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.943 0.897 . . . . 0.0 110.341 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -70.6 -43.43 69.38 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 118.19 -0.909 . . . . 0.0 109.961 -176.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 74.6 t -53.83 -48.19 62.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 120.282 1.401 . . . . 0.0 109.661 169.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -59.48 -40.37 86.76 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.449 1.022 . . . . 0.0 110.559 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -62.54 -46.07 90.07 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.307 1.043 . . . . 0.0 110.316 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.38 -49.56 76.42 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 124.099 0.96 . . . . 0.0 109.488 178.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.88 -37.49 67.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.679 1.191 . . . . 0.0 110.795 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.52 -31.12 71.12 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.889 1.222 . . . . 0.0 111.328 -174.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -70.8 -20.15 62.62 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.689 1.595 . . . . 0.0 112.872 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.9 pt -125.28 -21.04 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -168.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 C--O 1.249 1.028 0 C-N-CA 126.186 1.795 . . . . 0.0 111.174 173.684 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.4 ttm . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.855 0.359 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 49.0 mmtt -118.26 132.59 56.29 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 175.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -92.06 137.71 32.14 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.3 p -122.47 143.83 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 121.866 0.841 . . . . 0.0 109.457 -178.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 31.2 tpp -124.38 141.88 51.73 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.368 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -121.67 125.01 45.64 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 170.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.7 t -128.69 129.53 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 120.402 1.456 . . . . 0.0 109.351 -169.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.8 t -137.84 161.05 37.61 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 119.528 1.058 . . . . 0.0 112.473 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.8 mttt -58.76 -21.42 55.58 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.854 1.262 . . . . 0.0 110.884 168.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.4 ptp85 -147.94 101.23 3.28 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 126.096 1.759 . . . . 0.0 107.05 169.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -44.65 -42.46 7.52 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.013 1.325 . . . . 0.0 112.2 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.7 p -45.21 -20.91 0.06 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 129.599 3.159 . . . . 0.0 118.266 -169.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.4 p -130.65 -74.73 0.53 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.953 1.251 . . . . 0.0 110.647 -171.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -61.22 -52.08 66.29 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -169.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.41 -42.94 78.26 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.425 0.29 . . . . 0.0 111.125 -178.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -59.3 -45.66 90.68 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.603 0.761 . . . . 0.0 111.579 -174.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 44.2 mtm -63.97 -46.6 83.91 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 117.78 0.264 . . . . 0.0 110.903 175.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.8 -39.04 76.61 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 117.606 0.185 . . . . 0.0 110.925 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.452 ' HA ' HG21 ' A' ' 32' ' ' VAL . 33.3 tt0 -63.43 -45.44 90.93 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 122.549 0.34 . . . . 0.0 111.163 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.24 -40.07 96.45 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -175.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -66.66 -46.44 75.68 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 118.146 0.973 . . . . 0.0 108.923 174.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.49 -44.04 84.62 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 119.338 0.972 . . . . 0.0 112.591 -173.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -67.93 -38.4 82.83 Favored 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 119.246 -0.982 . . . . 0.0 111.049 174.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.1 m -66.89 -43.4 83.54 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 120.478 1.49 . . . . 0.0 110.504 -177.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.1 -37.7 53.77 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.076 1.35 . . . . 0.0 111.184 -173.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -129.57 -0.3 5.77 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-O 116.55 -2.25 . . . . 0.0 117.582 -169.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.75 105.93 0.25 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 121.582 2.691 . . . . 0.0 108.549 169.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 140.98 -30.29 2.27 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.025 1.298 . . . . 0.0 111.358 -169.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.26 -24.63 4.62 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.486 1.114 . . . . 0.0 111.409 169.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.5 pt -125.71 159.0 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 123.464 0.706 . . . . 0.0 111.295 176.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -126.1 130.8 51.79 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 169.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.452 HG21 ' HA ' ' A' ' 19' ' ' GLU . 3.0 p -117.76 152.28 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 C-N-CA 123.331 0.652 . . . . 0.0 111.582 -171.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.4 m -151.69 135.4 16.31 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 167.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 89.0 p -97.43 161.82 13.61 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 121.207 -0.933 . . . . 0.0 109.795 169.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.8 p -151.85 -165.77 2.32 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 169.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.63 165.78 37.0 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 169.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 61.5 mt -54.99 -30.58 59.67 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.825 0.85 . . . . 0.0 110.5 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -148.82 145.96 27.77 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 168.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.2 p -89.55 152.56 21.35 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.593 0.757 . . . . 0.0 111.16 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.8 m -147.52 154.89 41.31 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.748 2.019 . . . . 0.0 106.276 170.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -57.89 148.49 25.36 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.933 0.788 . . . . 0.0 109.702 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 26.9 t -57.95 130.47 21.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -176.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -66.21 136.4 95.28 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -177.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.46 -40.24 6.05 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.273 1.982 . . . . 0.0 113.409 -168.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.502 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 6.1 m -68.0 -17.84 64.54 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.366 -0.834 . . . . 0.0 111.826 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.416 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -59.06 -41.27 87.52 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 121.679 -0.638 . . . . 0.0 110.026 171.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.08 -42.37 94.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.44 -38.92 85.65 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -177.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 21.9 mmt -61.85 -47.49 84.8 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 122.813 1.292 . . . . 0.0 111.326 176.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.0 mtp -69.41 -33.58 73.2 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.368 -178.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -61.95 -29.84 70.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.863 0.865 . . . . 0.0 111.128 172.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -64.98 -39.31 93.28 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.734 0.697 . . . . 0.0 110.328 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 62.1 t -78.67 -23.38 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.935 178.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.95 25.97 5.7 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.109 1.338 . . . . 0.0 112.034 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.429 HG22 ' H ' ' A' ' 56' ' ' ASP . 11.3 mt -124.64 176.84 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 125.688 1.595 . . . . 0.0 107.662 -176.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.429 ' H ' HG22 ' A' ' 55' ' ' ILE . 7.2 t70 -140.65 157.87 44.81 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.137 1.775 . . . . 0.0 108.605 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.416 HD12 ' HB1' ' A' ' 46' ' ' ALA . 0.9 OUTLIER -128.21 -20.18 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.649 0.78 . . . . 0.0 113.009 171.195 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 55.3 p -51.84 -33.36 35.72 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.198 0.908 . . . . 0.0 112.441 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.92 -24.75 59.33 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-O 118.024 -1.431 . . . . 0.0 114.324 -176.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -86.95 -27.41 23.33 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 120.122 1.961 . . . . 0.0 114.953 -169.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 29.2 p 65.87 176.6 0.22 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.719 1.608 . . . . 0.0 113.459 173.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.2 m -102.13 162.13 13.15 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.45 1.1 . . . . 0.0 112.202 -169.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -156.3 134.42 7.18 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-O 118.273 -0.87 . . . . 0.0 109.071 -174.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -80.07 156.24 23.12 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.973 2.448 . . . . 0.0 111.771 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.7 tt -56.7 -33.88 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 123.773 0.829 . . . . 0.0 111.419 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -58.28 -23.13 55.23 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.2 1.8 . . . . 0.0 112.222 -174.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -82.45 -3.17 55.25 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.094 0.958 . . . . 0.0 112.693 -176.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -129.51 177.27 7.32 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 119.916 1.235 . . . . 0.0 112.556 -173.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.43 141.63 50.53 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 128.05 2.54 . . . . 0.0 106.493 170.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.35 -23.9 62.0 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.084 0.954 . . . . 0.0 111.91 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -60.48 -23.09 64.21 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.012 0.925 . . . . 0.0 112.412 -175.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -81.59 -15.85 53.44 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.032 0.933 . . . . 0.0 110.894 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -107.84 128.0 54.22 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.698 1.599 . . . . 0.0 109.65 -172.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -72.44 -40.36 67.13 Favored 'General case' 0 C--O 1.232 0.152 0 O-C-N 121.954 -0.467 . . . . 0.0 110.331 174.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -130.28 135.4 60.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 122.908 0.483 . . . . 0.0 109.927 -170.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.7 t -122.62 119.05 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 122.413 1.101 . . . . 0.0 108.916 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 35.9 mm -108.45 96.7 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.3 t -70.18 156.39 39.29 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 168.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.19 40.32 0.78 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 172.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 85.6 m -63.31 -20.31 65.37 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.028 0.931 . . . . 0.0 111.55 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.5 -59.86 0.45 Allowed Glycine 0 C--N 1.332 0.309 0 C-N-CA 125.289 1.423 . . . . 0.0 111.322 168.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 74.2 m -81.03 30.14 0.33 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 117.703 0.751 . . . . 0.0 113.006 -172.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.93 28.57 68.83 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.6 1.095 . . . . 0.0 111.964 -175.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 85' ' ' ASN . 2.4 t -68.72 169.07 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.769 1.228 . . . . 0.0 108.999 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.418 ' H ' HG12 ' A' ' 84' ' ' VAL . 7.7 t-20 -135.7 172.49 12.94 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.878 1.271 . . . . 0.0 110.092 -175.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.6 mt -124.34 83.87 56.77 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 -170.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -45.41 -33.13 8.67 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.422 2.748 . . . . 0.0 117.103 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -64.6 -173.2 0.22 Allowed 'Trans proline' 0 C--N 1.356 0.928 0 CA-C-N 122.177 1.813 . . . . 0.0 114.296 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -47.69 -19.45 0.21 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.613 1.965 . . . . 0.0 114.745 170.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -59.52 -3.96 0.54 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.074 2.15 . . . . 0.0 114.467 171.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.9 p -119.82 -5.62 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 119.545 1.066 . . . . 0.0 112.754 171.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.2 p -102.94 18.12 22.37 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.623 1.101 . . . . 0.0 111.919 -172.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -87.51 -176.96 5.78 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.487 1.115 . . . . 0.0 109.304 172.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -68.22 -32.66 73.02 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -169.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.2 mt -136.61 140.14 43.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -176.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -142.4 139.45 31.67 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.691 1.196 . . . . 0.0 108.661 171.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -147.07 159.68 43.31 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.935 1.694 . . . . 0.0 107.942 168.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -121.72 105.6 10.55 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.06 1.344 . . . . 0.0 108.728 168.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.43 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 43.1 m0 -78.38 93.16 4.66 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.067 0.947 . . . . 0.0 109.315 -178.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -60.67 119.93 9.06 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 169.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.8 mt -150.05 152.15 34.37 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.541 1.536 . . . . 0.0 107.529 -169.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -82.47 64.15 6.98 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 125.073 1.349 . . . . 0.0 111.142 -176.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -10.34 94.85 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 128.762 2.825 . . . . 0.0 113.804 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.506 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 76.2 Cg_exo -58.66 -9.95 8.31 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 124.081 3.187 . . . . 0.0 116.549 -173.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -54.81 101.99 0.06 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 120.262 1.392 . . . . 0.0 111.804 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.87 21.63 42.11 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.279 1.895 . . . . 0.0 113.433 172.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.506 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 18.5 mm-40 -102.07 178.12 4.7 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.839 1.319 . . . . 0.0 113.67 -169.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.2 m -78.73 156.07 29.08 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.204 1.802 . . . . 0.0 110.19 175.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 96.5 mt -60.3 -30.19 69.32 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.772 -0.58 . . . . 0.0 111.951 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.51 -39.07 93.1 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.326 0.512 . . . . 0.0 110.777 176.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 95.3 t -67.46 -45.9 84.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.502 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 12.1 m-85 -55.55 -51.8 65.86 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 118.902 -0.571 . . . . 0.0 110.547 176.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -59.19 -42.11 90.09 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.913 0.779 . . . . 0.0 111.919 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.8 m -61.52 -51.1 70.01 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.052 0.842 . . . . 0.0 109.627 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.7 t -65.46 -43.87 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 117.87 -1.062 . . . . 0.0 110.234 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -55.18 -45.01 75.78 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 119.821 1.191 . . . . 0.0 109.214 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.42 -49.9 72.34 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-O 118.214 -1.326 . . . . 0.0 110.409 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -60.07 -56.43 21.72 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 118.574 1.187 . . . . 0.0 110.423 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.9 t -46.62 -52.46 3.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 125.694 1.597 . . . . 0.0 110.444 176.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -63.61 -46.55 85.23 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 119.708 1.14 . . . . 0.0 110.114 -175.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -43.14 85.04 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.272 0.629 . . . . 0.0 110.197 178.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.43 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 79.6 mtt-85 -69.87 -42.74 73.1 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.894 -176.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 72.9 t -54.12 -49.18 63.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 120.393 1.451 . . . . 0.0 109.516 169.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -59.78 -39.85 86.27 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 119.448 1.022 . . . . 0.0 110.625 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -63.42 -45.9 88.83 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.328 1.051 . . . . 0.0 110.224 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -47.93 80.06 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 124.082 0.953 . . . . 0.0 109.815 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 61.8 mt -57.3 -38.49 62.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 124.703 1.201 . . . . 0.0 110.562 176.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.2 -28.94 69.51 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.776 1.171 . . . . 0.0 111.488 -173.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -73.66 -19.51 60.81 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.879 1.672 . . . . 0.0 112.731 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 pt -125.67 -20.1 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 126.151 1.78 . . . . 0.0 114.921 -168.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.3 m . . . . . 0 C--O 1.251 1.138 0 C-N-CA 126.432 1.893 . . . . 0.0 110.907 170.015 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.4 ttm . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 120.919 0.39 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 51.3 mmtt -119.99 134.64 55.19 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 107.354 -1.351 . . . . 0.0 107.354 175.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.7 mttt -94.51 135.86 35.46 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.2 p -121.68 144.55 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-O 121.885 0.85 . . . . 0.0 109.548 -176.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 29.6 tpp -124.23 142.2 51.44 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.493 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -123.41 111.37 16.27 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.4 t -111.65 117.06 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 119.611 1.096 . . . . 0.0 108.546 -173.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.9 t -108.05 165.19 11.65 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.713 0.768 . . . . 0.0 110.824 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -59.03 -16.22 17.41 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.701 0.8 . . . . 0.0 111.875 169.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -158.62 115.69 2.81 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 128.241 2.616 . . . . 0.0 103.975 178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -65.02 40.27 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.751 1.62 . . . . 0.0 113.063 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.5 p -122.75 -20.37 5.93 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 119.839 -1.788 . . . . 0.0 113.559 -169.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 82.5 m -132.71 -89.06 0.42 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.595 0.634 . . . . 0.0 111.438 -169.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -56.3 -46.84 79.62 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 118.881 0.764 . . . . 0.0 110.555 -169.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 13.3 p -68.87 -37.53 79.11 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.584 1.153 . . . . 0.0 111.583 -174.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -66.08 -47.71 73.35 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.704 0.802 . . . . 0.0 109.927 -174.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 69.1 mtm -63.77 -46.16 86.51 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 119.434 -0.317 . . . . 0.0 110.645 176.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.85 -42.4 71.94 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 123.043 0.215 . . . . 0.0 110.822 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -65.29 -47.1 77.83 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 123.02 0.2 . . . . 0.0 110.807 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.63 -38.08 95.72 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -175.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -65.19 -49.75 68.55 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 174.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.09 -43.39 82.15 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 124.228 1.011 . . . . 0.0 113.079 -172.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -67.47 -37.79 83.46 Favored 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 118.926 -1.109 . . . . 0.0 111.048 174.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.4 m -68.1 -42.16 80.72 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 120.404 1.456 . . . . 0.0 110.481 -177.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.0 mt -75.44 -38.41 59.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.733 1.613 . . . . 0.0 111.555 -175.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -131.17 0.32 5.22 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-O 116.732 -2.149 . . . . 0.0 117.98 -169.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.58 107.29 0.37 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 121.421 2.61 . . . . 0.0 108.629 169.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 140.06 -30.59 2.34 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.953 1.263 . . . . 0.0 111.349 -169.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.31 -24.47 4.64 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.454 1.101 . . . . 0.0 111.51 170.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.2 pt -125.55 158.01 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 123.298 0.639 . . . . 0.0 111.247 176.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -125.34 131.23 53.04 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 169.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -117.29 152.78 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 123.32 0.648 . . . . 0.0 111.806 -170.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.9 m -148.5 134.42 19.07 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 167.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' ' 15' ' ' SER . 88.4 p -96.99 159.31 14.98 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 120.692 -1.255 . . . . 0.0 107.949 168.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.1 m -153.22 -170.3 3.57 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 176.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.78 164.96 33.91 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 169.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.4 mt -52.32 -30.1 26.71 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 124.627 0.84 . . . . 0.0 110.348 170.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -143.0 148.51 36.9 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 169.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 p -72.46 154.74 40.7 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.25 0.62 . . . . 0.0 109.552 169.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.9 m -159.78 147.1 16.67 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 169.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -58.64 147.66 31.8 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.471 0.578 . . . . 0.0 109.856 -177.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -60.19 129.58 22.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.405 ' CE1' ' H ' ' A' ' 106' ' ' GLY . 23.1 t-80 -70.27 139.85 87.46 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.63 -38.83 5.42 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.238 1.959 . . . . 0.0 113.315 -168.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.536 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 8.2 m -68.04 -17.16 64.32 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.315 -0.866 . . . . 0.0 111.647 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.433 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -59.04 -40.62 85.61 Favored 'General case' 0 C--N 1.341 0.229 0 O-C-N 121.456 -0.778 . . . . 0.0 110.26 171.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.9 mp -62.97 -42.15 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -178.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.34 -37.39 83.14 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 20.5 mmt -62.13 -47.02 86.44 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 122.921 1.343 . . . . 0.0 111.197 175.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 9.3 mtp -70.09 -31.81 69.56 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.61 -177.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -61.57 -29.13 69.82 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.495 0.718 . . . . 0.0 111.36 169.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -65.83 -35.98 82.2 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.083 0.856 . . . . 0.0 110.475 173.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.4 t -78.96 -26.02 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 117.512 0.142 . . . . 0.0 110.916 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.48 28.19 6.48 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.723 1.154 . . . . 0.0 111.818 -175.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.579 HG22 ' H ' ' A' ' 56' ' ' ASP . 6.5 mt -125.66 -177.57 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 126.018 1.727 . . . . 0.0 107.163 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.579 ' H ' HG22 ' A' ' 55' ' ' ILE . 3.6 t70 -147.03 158.38 43.91 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.589 1.955 . . . . 0.0 108.355 -178.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.433 HD12 ' HB1' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -130.57 -13.2 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 173.571 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.5 p -51.22 -29.31 13.84 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.534 1.061 . . . . 0.0 113.43 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.24 -13.94 65.05 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 118.121 -1.377 . . . . 0.0 114.249 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -74.51 -29.9 61.59 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 120.281 2.041 . . . . 0.0 113.137 -173.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.7 p 59.74 -163.49 0.23 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.482 0.713 . . . . 0.0 109.689 -169.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.5 m -138.07 156.15 48.07 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.937 -173.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -153.44 135.87 9.38 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.319 1.048 . . . . 0.0 109.106 -169.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.89 153.64 22.62 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.466 2.11 . . . . 0.0 111.272 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.6 tt -53.54 -34.09 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.831 0.852 . . . . 0.0 111.486 174.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -57.51 -23.55 50.85 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.079 1.752 . . . . 0.0 112.503 -176.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -86.15 -7.43 58.57 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.736 0.814 . . . . 0.0 112.872 -174.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -121.77 -176.38 3.31 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.459 1.027 . . . . 0.0 110.523 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -133.96 130.58 37.86 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 126.26 1.824 . . . . 0.0 108.439 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.27 -30.43 68.29 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.708 1.203 . . . . 0.0 112.742 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.63 -21.73 63.05 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.066 0.947 . . . . 0.0 112.571 -175.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -85.52 -13.83 47.8 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.452 0.701 . . . . 0.0 111.012 -177.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -109.22 125.17 51.96 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.735 1.214 . . . . 0.0 109.852 -172.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -72.14 -41.38 67.22 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 122.474 0.31 . . . . 0.0 110.229 175.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.65 134.61 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 122.959 0.504 . . . . 0.0 109.898 -169.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.8 t -125.56 111.18 26.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 123.091 1.424 . . . . 0.0 108.64 -177.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.9 mm -100.25 99.26 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 177.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.8 t -72.31 156.81 38.71 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 167.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.57 54.78 0.68 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 103.394 -2.817 . . . . 0.0 103.394 173.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 83.5 m -85.55 -34.81 21.41 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.111 173.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.58 174.2 50.22 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 94.0 m 39.78 32.55 0.11 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.954 2.102 . . . . 0.0 114.009 -170.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.1 22.15 54.77 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.808 1.67 . . . . 0.0 114.599 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 79.2 t -62.67 141.42 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 169.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -135.62 -179.47 5.67 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.304 1.042 . . . . 0.0 109.699 -169.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 49.1 mt -113.46 108.38 52.23 Favored Pre-proline 0 N--CA 1.453 -0.286 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -170.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -50.22 -42.31 47.42 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 122.494 2.129 . . . . 0.0 115.097 169.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.22 179.65 5.93 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 121.834 1.69 . . . . 0.0 113.873 -174.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -56.46 -13.02 1.97 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 127.713 2.405 . . . . 0.0 113.826 -172.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -57.0 -25.76 59.04 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.31 1.044 . . . . 0.0 112.039 173.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.6 p -83.63 -16.18 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 119.625 1.102 . . . . 0.0 110.179 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.7 p -106.51 17.92 22.65 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.917 0.887 . . . . 0.0 112.266 -170.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -78.81 179.12 7.42 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.593 0.757 . . . . 0.0 109.764 171.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -63.61 -31.96 73.28 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -169.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.6 mt -135.64 137.49 49.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -142.21 139.15 31.93 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.228 1.011 . . . . 0.0 108.448 171.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -146.93 161.78 40.06 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.663 1.585 . . . . 0.0 108.003 168.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -122.53 100.77 7.1 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.742 1.617 . . . . 0.0 108.653 168.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.459 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 40.2 m0 -76.27 91.15 3.19 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.558 1.143 . . . . 0.0 108.594 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -64.99 100.65 0.44 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.768 1.227 . . . . 0.0 109.734 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -129.83 155.34 46.15 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.006 1.323 . . . . 0.0 110.856 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -78.06 80.77 4.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.061 1.744 . . . . 0.0 110.125 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -35.69 108.76 0.38 Allowed Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 126.318 1.847 . . . . 0.0 112.652 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.433 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 54.2 Cg_exo -60.26 -2.53 1.87 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 125.13 3.887 . . . . 0.0 117.579 -171.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -53.57 98.4 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 120.495 1.498 . . . . 0.0 112.435 175.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.405 ' H ' ' CE1' ' A' ' 43' ' ' HIS . . . 87.6 18.73 56.24 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 126.406 1.955 . . . . 0.0 112.963 171.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.433 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 24.1 mm-40 -95.33 177.21 5.92 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.69 1.245 . . . . 0.0 112.601 -169.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.9 m -74.93 154.91 37.95 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.48 1.512 . . . . 0.0 109.798 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.6 mt -59.5 -29.8 68.11 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.861 -0.524 . . . . 0.0 111.717 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.61 -39.0 92.39 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.226 0.466 . . . . 0.0 110.876 175.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 82.3 t -68.13 -46.55 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 176.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.536 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 17.8 m-85 -55.07 -50.65 68.62 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 119.283 -0.389 . . . . 0.0 110.89 176.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -60.54 -42.13 95.9 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.931 0.893 . . . . 0.0 111.972 177.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 93.6 m -60.82 -51.73 68.08 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 119.156 0.889 . . . . 0.0 109.147 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 74.6 t -61.61 -47.09 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-O 117.891 -1.052 . . . . 0.0 109.81 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 38.6 ttp85 -53.57 -51.41 63.04 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 119.661 1.118 . . . . 0.0 108.967 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.55 -48.48 72.82 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -173.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -60.91 -52.6 64.34 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.856 0.862 . . . . 0.0 110.402 -177.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.0 t -57.98 -49.59 80.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 125.369 1.467 . . . . 0.0 110.325 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -58.25 -48.05 81.65 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 121.034 1.743 . . . . 0.0 110.623 -178.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.98 -45.26 71.35 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.207 1.003 . . . . 0.0 110.505 174.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.459 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 49.9 mtt85 -70.59 -39.87 73.58 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 117.869 -1.062 . . . . 0.0 111.024 -177.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 80.9 t -54.47 -49.14 67.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 120.515 1.507 . . . . 0.0 109.349 169.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -60.47 -39.64 88.34 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.349 0.977 . . . . 0.0 110.58 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -62.81 -45.92 90.36 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.335 1.054 . . . . 0.0 110.464 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.69 -47.95 79.1 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 124.342 1.057 . . . . 0.0 109.714 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.4 mt -57.07 -38.48 60.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.544 1.137 . . . . 0.0 110.591 175.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.28 -28.93 69.54 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.875 1.216 . . . . 0.0 111.5 -173.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -73.64 -19.68 60.78 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.969 1.708 . . . . 0.0 112.79 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.4 pt -125.43 -20.21 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 126.175 1.79 . . . . 0.0 114.826 -168.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 C--O 1.248 1.013 0 C-N-CA 126.571 1.948 . . . . 0.0 110.857 170.005 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.1 ttm . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 120.564 0.221 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -115.68 145.61 42.59 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.972 0.909 . . . . 0.0 109.18 170.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -97.17 118.77 34.35 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 172.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.468 ' HA ' HG13 ' A' ' 75' ' ' VAL . 8.9 p -101.37 138.38 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 O-C-N 123.688 0.617 . . . . 0.0 110.716 173.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 37.9 tpp -116.2 143.72 45.14 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 169.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -115.96 140.71 48.99 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.274 1.43 . . . . 0.0 108.149 169.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.7 t -146.4 129.87 9.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -170.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -133.83 172.16 13.17 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.098 0.863 . . . . 0.0 109.817 169.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -66.31 -12.11 54.64 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.42 -0.8 . . . . 0.0 112.946 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.1 ptm85 -155.23 106.17 2.57 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 171.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -46.99 -28.08 1.52 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.464 1.905 . . . . 0.0 114.135 -177.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -30.12 -42.39 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 129.81 3.244 . . . . 0.0 118.183 -169.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.7 p -136.25 -68.37 0.5 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 117.686 -1.149 . . . . 0.0 113.919 -169.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.5 ptt-85 -56.62 -48.7 76.91 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.507 1.503 . . . . 0.0 110.76 -172.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.83 -51.44 70.0 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.67 0.788 . . . . 0.0 110.121 176.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 -62.55 -44.88 95.26 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.68 0.792 . . . . 0.0 111.769 -173.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 51.4 mtm -62.87 -45.72 91.23 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.916 0.486 . . . . 0.0 110.384 175.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.99 -37.99 75.29 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 119.434 -0.317 . . . . 0.0 110.393 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -61.13 -50.03 74.88 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.4 0.68 . . . . 0.0 110.258 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.57 -44.69 94.71 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 119.348 -0.695 . . . . 0.0 111.866 -177.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -65.84 -46.98 76.54 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 118.773 1.286 . . . . 0.0 108.646 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.16 -43.3 87.32 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 119.779 1.172 . . . . 0.0 112.54 -175.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -68.26 -35.59 78.12 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.786 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.3 m -67.74 -42.43 81.86 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 120.047 -1.658 . . . . 0.0 110.758 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.9 mt -73.05 -40.1 65.39 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.031 1.732 . . . . 0.0 111.036 -174.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -136.26 4.92 3.84 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 116.749 -2.14 . . . . 0.0 117.964 -169.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.46 115.68 2.65 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 121.643 2.721 . . . . 0.0 108.974 171.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 124.84 -24.9 5.96 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.59 1.09 . . . . 0.0 111.56 -173.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.21 -19.89 3.84 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.365 1.066 . . . . 0.0 111.456 176.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.3 pt -130.88 155.27 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 168.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.72 130.3 56.64 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 169.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.7 p -113.94 151.83 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-O 121.882 0.848 . . . . 0.0 111.911 -175.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.1 m -144.15 152.59 41.12 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 126.214 1.806 . . . . 0.0 106.206 167.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.0 p -129.26 157.07 42.9 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.135 0.974 . . . . 0.0 108.803 168.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.6 p -158.53 -161.39 0.98 Allowed 'General case' 0 C--O 1.241 0.642 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.66 163.96 33.35 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 169.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 65.3 mt -53.36 -31.79 46.23 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.37 1.068 . . . . 0.0 110.727 177.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -143.14 145.04 32.47 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 168.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.9 p -75.66 165.65 24.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.911 0.863 . . . . 0.0 111.567 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.5 p -150.03 -132.27 0.05 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.542 1.537 . . . . 0.0 106.957 177.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -144.55 157.73 44.09 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 171.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.5 t -65.24 131.6 31.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -177.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -71.99 138.54 82.22 Favored Pre-proline 0 N--CA 1.446 -0.65 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.96 -38.17 5.47 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 CA-C-N 120.423 1.187 . . . . 0.0 111.694 -169.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.493 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 8.6 m -67.59 -19.12 65.21 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.56 -1.338 . . . . 0.0 112.094 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.48 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -58.15 -39.2 78.17 Favored 'General case' 0 C--O 1.231 0.084 0 O-C-N 121.502 -0.749 . . . . 0.0 110.494 172.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.6 mt -58.37 -47.73 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.51 -40.33 91.04 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.808 0.843 . . . . 0.0 111.837 -175.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.2 mmt -60.26 -48.61 81.03 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.517 1.151 . . . . 0.0 111.21 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 9.3 mtp -69.04 -35.34 76.48 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.914 -178.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -61.18 -30.51 70.45 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.824 0.738 . . . . 0.0 111.55 172.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -63.22 -39.58 95.03 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.026 0.83 . . . . 0.0 110.384 173.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.1 t -79.76 -18.65 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-O 119.888 -0.101 . . . . 0.0 111.098 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.13 26.35 8.91 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.552 1.073 . . . . 0.0 111.816 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.607 HG22 ' H ' ' A' ' 56' ' ' ASP . 10.7 mt -122.09 -176.13 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 126.078 1.751 . . . . 0.0 106.505 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.607 ' H ' HG22 ' A' ' 55' ' ' ILE . 8.4 t70 -149.68 155.58 40.44 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 120.406 -1.434 . . . . 0.0 109.632 -177.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.48 HD12 ' HB1' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -130.49 -13.61 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.061 0.945 . . . . 0.0 112.538 169.465 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 99.7 p -52.99 -30.83 37.43 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.659 1.118 . . . . 0.0 112.432 176.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.14 -7.11 87.76 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 118.526 -1.152 . . . . 0.0 114.366 -176.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -125.3 169.9 11.84 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.37 1.585 . . . . 0.0 110.93 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 19.2 p -127.58 164.47 21.93 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.231 1.012 . . . . 0.0 112.365 -169.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.4 m -78.98 156.91 28.25 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.567 1.147 . . . . 0.0 110.953 171.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -155.42 145.14 15.46 Favored Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 123.935 0.894 . . . . 0.0 109.542 -177.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -80.32 151.94 20.56 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.246 1.964 . . . . 0.0 111.113 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.1 tt -54.25 -34.92 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.658 0.783 . . . . 0.0 111.442 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -60.59 -21.58 62.78 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.689 1.595 . . . . 0.0 112.471 -174.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -79.77 -5.54 55.52 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.564 0.746 . . . . 0.0 112.562 -177.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -124.76 -175.83 3.38 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.539 1.136 . . . . 0.0 110.651 -178.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.49 127.19 25.34 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 126.563 1.945 . . . . 0.0 107.583 176.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.79 -27.74 63.37 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.604 1.162 . . . . 0.0 112.447 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -59.82 -23.47 63.37 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.33 1.052 . . . . 0.0 112.739 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -85.0 -14.18 48.26 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.421 0.689 . . . . 0.0 110.72 -177.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -104.54 126.21 51.42 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 125.222 1.409 . . . . 0.0 109.012 -174.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.94 -42.63 76.45 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.468 HG13 ' HA ' ' A' ' 4' ' ' VAL . 1.8 p -130.99 136.08 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 C-N-CA 122.9 0.48 . . . . 0.0 109.918 -169.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.5 m -127.66 120.3 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-O 122.363 1.078 . . . . 0.0 108.651 -172.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.6 mm -116.72 102.84 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-N 115.006 -0.997 . . . . 0.0 108.389 -169.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.9 t -74.37 153.68 39.16 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 168.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.79 36.48 0.4 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 171.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 77.4 m -56.48 -43.98 80.18 Favored 'General case' 0 C--N 1.339 0.128 0 O-C-N 120.92 -1.113 . . . . 0.0 112.151 -169.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.43 165.96 36.4 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 -173.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 13.0 p 36.33 34.1 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.927 2.091 . . . . 0.0 115.42 -171.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.4 15.91 68.69 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.177 0.894 . . . . 0.0 114.867 176.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.0 t -67.13 156.17 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 169.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -143.55 -172.85 3.8 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.574 1.55 . . . . 0.0 109.076 -173.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 53.3 mt -117.51 100.04 52.6 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 125.255 1.422 . . . . 0.0 107.965 -169.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.82 -43.11 58.72 Favored 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 122.814 2.342 . . . . 0.0 115.828 172.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -75.51 -175.39 2.41 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.061 1.841 . . . . 0.0 113.131 -174.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -53.28 -12.89 0.45 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 128.706 2.802 . . . . 0.0 114.551 -175.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 56.1 m95 -67.44 11.29 0.13 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.628 1.971 . . . . 0.0 112.725 171.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.0 p -121.95 4.04 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 125.229 1.412 . . . . 0.0 111.651 169.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 36.3 p -131.71 25.9 4.7 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.17 -0.956 . . . . 0.0 112.602 -172.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -91.54 -170.72 2.69 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 170.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -64.55 -32.06 73.54 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.295 0.638 . . . . 0.0 112.235 -170.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.3 mt -137.9 138.3 44.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -134.61 134.88 41.73 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 169.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -141.25 152.06 44.23 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 169.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -119.95 124.74 46.72 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.448 1.099 . . . . 0.0 109.143 169.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.411 ' CZ3' ' HG2' ' A' ' 122' ' ' ARG . 66.1 m95 -107.76 86.64 2.33 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -54.82 125.11 18.79 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 169.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 25.0 mt -149.06 156.12 41.76 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.618 1.567 . . . . 0.0 107.4 -169.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -82.4 60.93 5.33 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.725 1.21 . . . . 0.0 111.151 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.3 t0 4.53 85.97 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.469 0 C-N-CA 129.348 3.059 . . . . 0.0 112.141 169.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.458 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 74.8 Cg_exo -61.56 -8.14 10.35 Favored 'Trans proline' 0 C--N 1.352 0.748 0 N-CA-C 116.71 1.773 . . . . 0.0 116.71 -169.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -61.04 95.98 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.848 1.204 . . . . 0.0 111.27 -177.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.5 16.1 25.55 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.243 1.878 . . . . 0.0 113.361 172.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.458 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 25.2 mm-40 -95.76 178.12 5.56 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.925 1.362 . . . . 0.0 113.167 -169.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.4 m -76.55 155.73 33.43 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.985 1.714 . . . . 0.0 110.143 174.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 97.0 mt -58.53 -32.5 68.92 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.853 -0.529 . . . . 0.0 111.621 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -71.15 -33.82 70.42 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.126 0.421 . . . . 0.0 110.852 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 72.1 t -65.82 -45.75 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 172.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.493 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 13.6 m-85 -57.38 -49.8 75.03 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 118.609 -0.71 . . . . 0.0 110.52 176.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 60.9 mtt180 -57.6 -43.35 84.61 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.425 1.011 . . . . 0.0 111.808 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 89.4 m -61.15 -53.58 55.24 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 50.4 t -63.58 -41.62 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.558 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -56.64 -48.36 77.7 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 120.205 1.366 . . . . 0.0 109.225 177.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.66 -45.31 96.54 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -59.31 -60.83 3.23 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 123.756 0.823 . . . . 0.0 109.017 177.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.4 t -45.29 -51.62 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 126.752 2.021 . . . . 0.0 110.974 177.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -63.54 -46.54 85.5 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 120.008 1.276 . . . . 0.0 110.38 -175.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.26 -42.12 85.75 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.708 0.803 . . . . 0.0 110.237 176.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.411 ' HG2' ' CZ3' ' A' ' 99' ' ' TRP . 82.9 mtt180 -69.33 -43.13 74.34 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.292 1.037 . . . . 0.0 109.914 -175.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 71.5 t -54.79 -48.97 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 119.427 1.012 . . . . 0.0 110.068 168.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -60.67 -38.96 86.66 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 120.017 1.281 . . . . 0.0 111.197 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -63.66 -44.38 93.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.439 1.096 . . . . 0.0 110.201 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.11 -40.8 67.91 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.101 -179.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.7 mt -51.88 -43.23 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 124.004 0.921 . . . . 0.0 108.697 169.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.15 -29.81 70.61 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.674 1.125 . . . . 0.0 111.494 -173.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -71.8 -44.8 63.33 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.121 1.368 . . . . 0.0 110.761 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 pt -85.02 -29.07 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.895 1.278 . . . . 0.0 113.89 -173.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.5 m . . . . . 0 C--O 1.249 1.053 0 C-N-CA 126.161 1.785 . . . . 0.0 111.102 179.693 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.8 ttm . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.54 0.209 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -108.4 140.92 41.01 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 173.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -88.93 116.96 27.6 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 170.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 98.3 t -99.04 138.3 23.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 125.286 1.435 . . . . 0.0 107.19 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.404 ' HA ' ' O ' ' A' ' 33' ' ' THR . 31.0 tpp -121.5 140.72 51.82 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.792 1.237 . . . . 0.0 108.889 175.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -122.19 134.85 54.71 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 170.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.7 t -140.35 133.89 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 119.42 1.009 . . . . 0.0 109.182 -170.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 p -139.71 167.76 21.38 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 119.897 1.226 . . . . 0.0 111.813 169.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -62.08 -18.16 59.85 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -146.83 102.93 3.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 169.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -44.56 -36.75 3.16 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 127.112 2.165 . . . . 0.0 113.355 -177.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.2 m -45.68 -13.5 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 129.519 3.128 . . . . 0.0 119.237 -168.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.5 p -128.97 -89.14 0.51 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 120.279 1.4 . . . . 0.0 111.17 -171.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -57.8 -48.28 80.16 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.555 0.616 . . . . 0.0 110.758 -169.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.435 ' HB3' ' HB3' ' A' ' 34' ' ' SER . 3.4 m -57.74 -44.43 86.04 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.462 0.705 . . . . 0.0 110.104 -175.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -76.25 -32.73 59.02 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 119.075 -0.488 . . . . 0.0 111.773 -173.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.476 ' HG2' HD11 ' A' ' 57' ' ' ILE . 65.4 mtm -65.55 -47.15 76.85 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.691 0.678 . . . . 0.0 109.986 169.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.22 -36.08 70.46 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.842 0.457 . . . . 0.0 110.831 177.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -59.08 -62.04 2.18 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.79 -39.66 68.61 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 119.144 -0.809 . . . . 0.0 111.883 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.405 ' CZ ' ' SD ' ' A' ' 50' ' ' MET . 40.5 m-85 -66.53 -50.25 63.8 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 119.038 1.419 . . . . 0.0 110.594 174.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.32 -43.47 98.76 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 120.233 1.378 . . . . 0.0 112.45 -172.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 ptmt -70.48 -9.04 55.52 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.626 1.103 . . . . 0.0 113.24 175.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.7 m -92.67 -49.4 6.11 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 119.982 1.265 . . . . 0.0 110.544 169.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.5 mt -78.32 -41.4 33.8 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 125.642 1.577 . . . . 0.0 112.205 -169.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.26 -7.65 16.23 Favored Glycine 0 C--N 1.332 0.338 0 CA-C-O 118.034 -1.426 . . . . 0.0 114.75 -169.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.98 109.79 0.51 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.477 1.639 . . . . 0.0 108.971 169.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.09 -29.4 2.83 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.838 1.209 . . . . 0.0 111.585 -169.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.27 -21.7 2.57 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.561 1.145 . . . . 0.0 111.848 173.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.9 pt -126.95 157.55 38.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 121.342 0.591 . . . . 0.0 111.635 174.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.7 127.92 53.31 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 168.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.0 p -109.07 150.69 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-O 121.55 0.691 . . . . 0.0 111.654 -176.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 5' ' ' MET . 85.7 m -148.95 137.51 21.13 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 167.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.435 ' HB3' ' HB3' ' A' ' 15' ' ' SER . 11.3 m -124.02 152.46 42.57 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 121.752 -0.593 . . . . 0.0 110.291 178.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 19.3 p -157.56 -163.62 1.39 Allowed 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -171.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.65 168.77 41.82 Favored Glycine 0 N--CA 1.448 -0.504 0 O-C-N 121.318 -0.864 . . . . 0.0 111.098 174.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 65.6 mt -56.42 -32.3 64.73 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.085 0.554 . . . . 0.0 111.061 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -141.57 149.39 40.7 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 169.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.8 p -91.1 157.93 16.94 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.276 1.031 . . . . 0.0 110.599 170.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 28.5 m -164.88 158.23 17.05 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.826 2.85 . . . . 0.0 104.912 169.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 96.5 mtt-85 -50.93 136.73 22.28 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.643 1.111 . . . . 0.0 110.449 -172.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.7 p -58.17 131.72 22.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -70.33 142.83 90.0 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-O 118.851 -0.595 . . . . 0.0 109.872 -169.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.68 -39.7 0.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.53 1.486 . . . . 0.0 112.583 -169.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.466 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 29.3 m -62.44 -25.8 68.16 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.643 -1.286 . . . . 0.0 111.529 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.75 -43.98 38.11 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.61 0.764 . . . . 0.0 110.928 172.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.9 mt -54.99 -46.52 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 C-N-CA 124.257 1.023 . . . . 0.0 108.345 -178.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.4 -34.89 79.22 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 123.996 0.918 . . . . 0.0 110.051 -171.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.9 mmm -70.09 -41.94 73.39 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.062 0.934 . . . . 0.0 110.549 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.514 ' HG3' ' CG1' ' A' ' 57' ' ' ILE . 87.8 mmm -62.82 -41.23 99.24 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 174.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -61.79 -26.27 67.99 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.079 0.552 . . . . 0.0 111.129 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -66.25 -40.27 90.07 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 118.478 0.581 . . . . 0.0 110.025 172.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.5 t -77.96 -26.22 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.816 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.98 24.29 6.09 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 125.354 1.455 . . . . 0.0 112.009 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.8 mt -121.81 177.63 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 125.643 1.577 . . . . 0.0 107.576 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -143.37 159.0 43.16 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.495 1.518 . . . . 0.0 109.746 -177.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.514 ' CG1' ' HG3' ' A' ' 50' ' ' MET . 0.7 OUTLIER -131.3 -18.64 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.244 1.017 . . . . 0.0 111.776 169.62 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -42.64 -38.32 1.99 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.155 1.382 . . . . 0.0 113.345 174.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.13 -11.28 63.62 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.529 1.061 . . . . 0.0 113.899 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -128.13 172.8 10.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.413 1.485 . . . . 0.0 112.442 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.2 p -125.09 164.28 20.55 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.709 1.604 . . . . 0.0 110.348 -176.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.26 166.95 21.4 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.512 1.525 . . . . 0.0 111.539 174.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -154.91 142.67 14.09 Favored Pre-proline 0 N--CA 1.472 0.643 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.535 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -84.49 151.85 11.86 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.028 2.485 . . . . 0.0 111.868 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.2 tt -58.19 -32.75 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 123.951 0.9 . . . . 0.0 111.647 175.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -57.24 -21.6 35.2 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.255 1.822 . . . . 0.0 112.1 -176.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -74.72 -9.61 58.73 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.662 1.185 . . . . 0.0 112.855 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -134.1 179.7 6.09 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 120.24 1.382 . . . . 0.0 112.711 -175.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.42 143.08 51.15 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 127.901 2.48 . . . . 0.0 107.384 169.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.62 -25.31 62.98 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.194 0.998 . . . . 0.0 112.439 -176.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -60.88 -23.12 64.94 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.753 0.821 . . . . 0.0 112.325 -174.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -80.71 -16.44 53.94 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.122 0.969 . . . . 0.0 110.597 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -102.77 124.37 48.18 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 125.394 1.477 . . . . 0.0 109.083 -173.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -72.16 -36.43 69.3 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 176.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.73 132.32 56.9 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -170.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.1 t -124.04 132.52 71.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 122.188 0.994 . . . . 0.0 108.894 178.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.9 mm -121.87 102.74 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -178.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.3 m -73.95 155.08 39.03 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 168.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.27 26.71 0.96 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.633 1.573 . . . . 0.0 108.156 175.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 86.4 m -54.92 -36.38 65.17 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 124.863 1.265 . . . . 0.0 113.276 -169.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.87 166.22 38.84 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 88.8 m 39.58 33.8 0.13 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.679 1.992 . . . . 0.0 114.413 -173.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 61.34 19.26 57.29 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.887 1.708 . . . . 0.0 115.211 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 97.2 t -68.3 155.15 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 169.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -154.45 -175.43 5.4 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.057 0.943 . . . . 0.0 110.379 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.0 mt -114.33 110.69 47.58 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 125.439 1.496 . . . . 0.0 108.71 -169.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -55.51 -42.76 64.66 Favored 'Trans proline' 0 CA--C 1.55 1.311 0 C-N-CA 122.36 2.04 . . . . 0.0 114.876 169.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.43 -179.94 5.58 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 121.934 1.756 . . . . 0.0 114.592 -170.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -47.02 -19.41 0.11 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 130.512 3.525 . . . . 0.0 115.863 -177.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -55.58 -28.47 55.22 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 124.821 1.248 . . . . 0.0 112.193 173.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.5 p -87.39 -2.63 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 118.935 0.789 . . . . 0.0 110.26 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.7 p -123.35 22.66 9.26 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.144 0.978 . . . . 0.0 112.716 -169.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -82.07 178.14 8.44 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.479 0.712 . . . . 0.0 110.7 174.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.72 -33.87 72.18 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.454 1.101 . . . . 0.0 112.224 -169.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.5 mt -129.2 138.58 54.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 172.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -141.94 134.49 28.23 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 170.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -141.15 153.9 45.6 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 168.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -120.08 104.9 10.51 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.715 1.206 . . . . 0.0 110.069 169.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.44 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 37.9 m0 -80.59 79.48 7.2 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.381 1.872 . . . . 0.0 108.564 178.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -55.02 118.67 4.51 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 171.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 30.6 mt -147.07 154.7 41.48 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.534 1.534 . . . . 0.0 107.785 -169.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -82.8 59.35 4.75 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.963 1.305 . . . . 0.0 111.982 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 47.8 t0 5.79 82.23 0.04 OUTLIER Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 129.925 3.29 . . . . 0.0 113.135 169.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.417 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 75.3 Cg_exo -59.49 -13.67 22.01 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.997 3.131 . . . . 0.0 118.691 -168.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -62.98 98.24 0.13 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.623 1.556 . . . . 0.0 110.217 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 106.24 10.94 28.71 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.22 1.867 . . . . 0.0 113.559 173.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.417 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 29.4 mm-40 -95.7 179.38 5.14 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.152 1.476 . . . . 0.0 113.29 -169.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.3 m -76.9 155.51 32.78 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.653 1.581 . . . . 0.0 110.123 175.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 57.3 mt -59.42 -32.2 69.97 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.879 -0.513 . . . . 0.0 111.686 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.36 -41.2 98.41 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.245 0.475 . . . . 0.0 110.765 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 97.3 t -66.28 -45.92 88.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.466 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 11.1 m-85 -55.69 -50.88 69.11 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.86 177.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 53.8 mtp85 -62.58 -40.49 97.05 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 118.31 -0.853 . . . . 0.0 111.486 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 93.9 m -62.08 -52.37 64.2 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 118.57 0.623 . . . . 0.0 109.334 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.9 t -66.37 -45.59 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 118.128 -0.939 . . . . 0.0 110.324 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -40.91 88.78 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 120.054 1.297 . . . . 0.0 110.298 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.48 -50.12 69.93 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-O 118.479 -1.178 . . . . 0.0 110.942 175.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -60.41 -53.72 54.26 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 118.652 1.226 . . . . 0.0 110.631 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.6 t -47.01 -51.92 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 125.212 1.405 . . . . 0.0 109.965 175.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -62.12 -48.35 80.52 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.604 1.093 . . . . 0.0 110.803 -177.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.36 -43.74 75.37 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.295 1.038 . . . . 0.0 110.257 177.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.44 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 81.7 mtt-85 -72.12 -40.85 67.84 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 117.833 -1.079 . . . . 0.0 110.094 -175.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 71.4 t -55.05 -48.74 75.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 120.71 1.595 . . . . 0.0 109.057 169.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.33 -39.8 88.34 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.34 0.973 . . . . 0.0 110.698 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -63.13 -46.01 89.3 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.201 1.0 . . . . 0.0 110.326 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.9 -44.14 90.56 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 123.148 0.579 . . . . 0.0 110.085 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.9 mt -58.56 -36.62 60.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.161 0.984 . . . . 0.0 110.775 174.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.96 -30.73 71.8 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.91 1.232 . . . . 0.0 111.34 -174.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -65.94 -24.87 66.91 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.285 1.434 . . . . 0.0 113.422 177.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.0 pt -123.23 -20.08 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 -167.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.3 m . . . . . 0 C--O 1.248 1.026 0 C-N-CA 126.074 1.75 . . . . 0.0 111.05 173.232 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.9 ttm . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.871 0.367 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -102.63 140.73 36.53 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -90.64 135.63 33.59 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 121.494 -0.754 . . . . 0.0 109.013 170.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.4 p -115.37 140.37 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 123.659 0.784 . . . . 0.0 109.483 173.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 45.2 tpp -118.59 143.26 46.91 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 171.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -118.38 127.28 53.53 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 169.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 53.4 t -126.69 114.12 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 119.999 1.272 . . . . 0.0 108.871 -171.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.2 t -110.94 160.35 16.88 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.766 0.712 . . . . 0.0 111.071 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -59.13 -18.13 33.05 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 121.321 -0.862 . . . . 0.0 112.637 174.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.11 -2.39 2.07 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -174.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.526 HD22 ' H ' ' A' ' 63' ' ' ASP . 37.0 t-20 37.71 35.73 0.08 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.314 1.846 . . . . 0.0 115.211 -169.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.7 p -107.88 -35.08 6.74 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 120.523 -1.361 . . . . 0.0 112.306 -171.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 20.4 m -134.75 -68.36 0.54 Allowed 'General case' 0 C--N 1.342 0.27 0 CA-C-O 117.948 -1.025 . . . . 0.0 111.727 -169.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -56.13 -53.51 56.25 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.46 1.027 . . . . 0.0 110.262 -170.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.9 p -68.45 -43.06 77.89 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.675 1.19 . . . . 0.0 110.467 -174.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -59.94 -47.51 85.51 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.773 1.229 . . . . 0.0 110.626 -177.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.44 ' HG2' HD11 ' A' ' 57' ' ' ILE . 44.7 mtm -65.75 -44.98 84.28 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 119.272 -0.394 . . . . 0.0 110.77 175.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.89 -40.16 66.36 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.818 0.281 . . . . 0.0 110.945 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.458 ' HA ' HG21 ' A' ' 32' ' ' VAL . 23.5 tt0 -63.6 -55.08 26.52 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 118.676 -0.678 . . . . 0.0 110.009 177.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -53.15 -40.17 59.07 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 119.077 -0.846 . . . . 0.0 111.974 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.446 ' CD1' ' HE3' ' A' ' 50' ' ' MET . 13.3 m-85 -66.29 -49.13 68.15 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 119.11 1.455 . . . . 0.0 108.525 176.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.58 -46.05 90.07 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 124.183 0.993 . . . . 0.0 112.942 -173.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.5 ptmt -68.54 -8.81 44.84 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 119.337 0.971 . . . . 0.0 113.173 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.1 m -94.48 -47.59 6.49 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 119.984 1.266 . . . . 0.0 110.72 169.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.1 mt -76.34 -42.66 44.15 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.885 1.674 . . . . 0.0 111.956 -169.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -119.27 -5.25 11.62 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-O 117.741 -1.588 . . . . 0.0 114.935 -169.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.33 109.58 0.45 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.833 1.816 . . . . 0.0 108.852 169.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.57 -29.93 2.73 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.988 1.28 . . . . 0.0 111.355 -169.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.05 -22.15 3.84 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.672 1.189 . . . . 0.0 111.741 170.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.1 pt -125.72 156.92 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -122.84 133.57 54.43 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 168.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.458 HG21 ' HA ' ' A' ' 19' ' ' GLU . 2.6 p -116.8 157.56 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -169.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 m -148.3 145.55 28.21 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 126.306 1.842 . . . . 0.0 107.678 168.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.7 p -115.85 141.21 48.4 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.492 1.517 . . . . 0.0 108.608 168.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.8 m -150.73 -177.68 6.13 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.059 1.744 . . . . 0.0 106.616 -171.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.13 168.87 39.46 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.114 -1.041 . . . . 0.0 112.953 173.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.0 mp -56.2 -36.45 68.43 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 125.305 1.238 . . . . 0.0 110.607 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -150.24 150.41 31.51 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 169.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 65.8 m -83.64 146.5 28.22 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.567 0.699 . . . . 0.0 112.223 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.4 m -144.12 158.1 43.92 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 128.444 2.697 . . . . 0.0 104.505 168.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.5 ptt-85 -57.52 146.2 30.78 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.403 1.001 . . . . 0.0 110.392 -175.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 p -62.91 133.91 28.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 169.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -78.48 145.15 67.12 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.295 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.44 -41.11 0.36 Allowed 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.44 1.426 . . . . 0.0 112.814 -169.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.475 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 38.6 m -63.09 -24.86 68.1 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.422 -1.424 . . . . 0.0 111.314 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.42 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -50.67 -40.59 53.97 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.882 0.873 . . . . 0.0 111.514 172.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 55.5 mt -56.42 -44.23 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 124.304 1.042 . . . . 0.0 108.248 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.01 -37.67 81.69 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 125.069 1.347 . . . . 0.0 110.29 -172.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.0 mmm -68.66 -41.92 78.66 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 123.088 1.423 . . . . 0.0 110.427 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.446 ' HE3' ' CD1' ' A' ' 21' ' ' PHE . 4.6 mtp -66.62 -34.3 77.57 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 120.689 -1.257 . . . . 0.0 109.948 175.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -61.3 -28.83 69.48 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.844 -0.598 . . . . 0.0 111.654 170.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -61.24 -40.85 95.57 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.23 0.923 . . . . 0.0 110.529 173.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.7 m -92.58 7.3 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 178.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.99 25.34 49.53 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.137 0.875 . . . . 0.0 112.6 170.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.682 HG22 ' H ' ' A' ' 56' ' ' ASP . 9.9 mt -123.84 -174.82 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 125.404 1.482 . . . . 0.0 107.159 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.682 ' H ' HG22 ' A' ' 55' ' ' ILE . 8.0 t70 -148.85 155.84 41.47 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.612 1.565 . . . . 0.0 109.349 -176.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.44 HD11 ' HG2' ' A' ' 17' ' ' MET . 0.1 OUTLIER -128.49 -15.44 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 124.148 0.979 . . . . 0.0 112.38 169.768 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.6 p -52.6 -30.82 33.28 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.544 1.065 . . . . 0.0 112.621 176.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.79 -7.48 86.13 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.729 1.157 . . . . 0.0 114.187 -177.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -123.65 173.7 7.93 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 119.3 1.55 . . . . 0.0 111.165 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.5 p -128.72 174.02 9.81 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.11 1.364 . . . . 0.0 110.749 -173.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.8 p -96.92 151.74 19.4 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.355 1.062 . . . . 0.0 110.1 172.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.526 ' H ' HD22 ' A' ' 11' ' ' ASN . 3.5 t70 -150.11 148.79 25.65 Favored Pre-proline 0 C--O 1.239 0.543 0 C-N-CA 125.415 1.486 . . . . 0.0 109.258 -171.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -84.04 151.72 12.55 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.957 1.772 . . . . 0.0 110.898 -177.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.8 tt -54.86 -31.45 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 123.309 0.644 . . . . 0.0 111.271 171.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -50.78 -28.93 10.28 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.243 2.617 . . . . 0.0 112.274 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -83.98 -4.82 59.0 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.269 1.028 . . . . 0.0 112.917 -172.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -129.58 -176.84 4.03 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.643 1.111 . . . . 0.0 110.998 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.83 139.49 50.17 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 127.113 2.165 . . . . 0.0 107.427 173.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.62 -26.58 65.43 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.427 1.091 . . . . 0.0 111.791 -178.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -59.91 -24.54 64.41 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.105 0.962 . . . . 0.0 112.317 -171.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -89.85 -13.04 37.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.766 0.827 . . . . 0.0 111.08 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -94.2 133.05 38.12 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 125.307 1.443 . . . . 0.0 109.798 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -75.48 -42.47 52.91 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.3 p -132.75 137.24 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 123.02 0.528 . . . . 0.0 110.454 -169.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.3 m -129.51 104.61 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-O 123.5 1.619 . . . . 0.0 109.336 -171.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.7 mm -101.65 99.11 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 -177.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.8 t -73.19 155.77 39.26 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 168.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.08 53.49 0.57 Allowed 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 173.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 90.2 m -71.58 -36.75 70.98 Favored 'General case' 0 C--N 1.339 0.118 0 C-N-CA 123.835 0.854 . . . . 0.0 109.546 173.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.92 -61.67 0.49 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 124.999 1.285 . . . . 0.0 111.295 169.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 56.2 m -80.3 27.54 0.33 Allowed 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -169.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.61 14.78 65.4 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 125.026 1.298 . . . . 0.0 113.21 -175.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 78.8 t -70.08 110.77 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 175.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -79.0 156.82 28.26 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 169.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.4 mt -70.18 121.84 84.39 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -54.98 -40.84 83.84 Favored 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 122.044 1.829 . . . . 0.0 114.067 169.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -77.23 -176.97 3.49 Favored 'Trans proline' 0 C--N 1.356 0.933 0 CA-C-N 121.49 1.568 . . . . 0.0 113.504 -173.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -47.47 -17.5 0.09 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 129.28 3.032 . . . . 0.0 115.574 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -66.1 8.99 0.17 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 126.58 1.952 . . . . 0.0 113.396 171.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.9 p -119.95 1.43 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.836 1.255 . . . . 0.0 111.705 171.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.1 p -125.49 25.38 7.05 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.989 0.915 . . . . 0.0 112.156 -172.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -91.54 -172.75 3.34 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.464 0.705 . . . . 0.0 109.444 170.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -66.08 -33.98 77.02 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -169.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.6 mt -136.84 134.46 48.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -139.27 140.23 37.59 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.263 1.025 . . . . 0.0 108.61 173.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -148.91 160.54 43.17 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.372 1.469 . . . . 0.0 107.93 168.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -121.95 102.44 8.18 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.274 1.43 . . . . 0.0 108.743 168.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.422 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 44.2 m0 -77.91 98.62 5.7 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.131 0.972 . . . . 0.0 109.596 -176.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -69.25 104.39 2.2 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.799 1.239 . . . . 0.0 109.229 174.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -137.69 168.71 19.12 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 126.679 1.992 . . . . 0.0 108.033 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -67.53 162.4 23.42 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 166.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -117.1 105.32 49.3 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 171.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -54.7 -1.88 0.17 Allowed 'Trans proline' 0 CA--C 1.537 0.64 1 C-N-CA 125.882 4.388 . . . . 0.0 118.652 -169.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -50.67 91.64 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.365 1.866 . . . . 0.0 112.616 172.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.64 16.71 51.49 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 126.121 1.819 . . . . 0.0 113.244 171.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -94.38 -179.96 5.09 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.843 1.322 . . . . 0.0 112.075 -169.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.5 m -77.46 155.67 31.59 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.089 1.356 . . . . 0.0 109.937 175.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.3 mt -58.61 -32.08 68.68 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 122.032 -0.418 . . . . 0.0 111.546 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -61.96 -39.27 91.56 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.145 0.429 . . . . 0.0 110.731 176.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 89.1 t -67.65 -46.78 82.15 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.475 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 14.0 m-85 -54.04 -52.58 60.41 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.885 0.474 . . . . 0.0 110.898 176.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 28.9 mtt180 -59.29 -42.14 90.57 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.371 1.069 . . . . 0.0 111.621 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 95.4 m -60.86 -52.71 63.9 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 95.8 t -64.41 -42.88 96.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 118.803 -0.618 . . . . 0.0 110.094 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -55.26 -46.71 76.09 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.346 0.976 . . . . 0.0 109.738 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -69.38 -49.35 39.28 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-O 119.211 -0.772 . . . . 0.0 111.866 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -63.79 -45.09 91.28 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.657 1.228 . . . . 0.0 111.866 -174.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.4 t -64.07 -43.42 97.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 117.874 -1.06 . . . . 0.0 109.37 176.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -58.56 -46.37 87.02 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.472 1.487 . . . . 0.0 110.512 178.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.09 -44.13 78.73 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.587 1.155 . . . . 0.0 110.138 176.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.422 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 51.3 mtt85 -71.25 -39.64 71.5 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 117.953 -1.023 . . . . 0.0 111.042 -177.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 88.4 t -54.94 -48.02 75.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 120.514 1.506 . . . . 0.0 109.784 169.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -60.08 -39.6 86.64 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.459 1.027 . . . . 0.0 110.614 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -62.28 -45.51 92.96 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.211 1.004 . . . . 0.0 110.485 178.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.38 -47.62 78.57 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 124.033 0.933 . . . . 0.0 110.06 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 63.7 mt -56.62 -38.37 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.394 1.078 . . . . 0.0 110.329 175.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.98 -28.87 69.32 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.72 1.145 . . . . 0.0 111.44 -174.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -75.16 -19.59 59.79 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.806 1.643 . . . . 0.0 112.731 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.4 pt -125.11 -20.56 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 125.707 1.603 . . . . 0.0 115.29 -168.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 C--O 1.251 1.137 0 C-N-CA 126.573 1.949 . . . . 0.0 110.935 172.311 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.7 ttm . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 120.791 0.329 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -112.96 141.13 47.15 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.15 0.98 . . . . 0.0 108.412 170.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -92.36 126.21 37.35 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 169.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.7 p -115.88 135.5 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 O-C-N 123.721 0.638 . . . . 0.0 110.962 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 55.1 tpp -107.5 153.05 23.41 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.237 1.015 . . . . 0.0 109.204 170.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -130.03 104.48 7.37 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.985 1.714 . . . . 0.0 106.686 169.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.97 127.28 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 120.057 1.298 . . . . 0.0 109.158 -176.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.2 t -116.17 163.11 16.45 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.791 1.178 . . . . 0.0 112.34 176.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -58.99 -21.81 59.49 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.584 -0.697 . . . . 0.0 111.654 171.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.4 ptm85 -153.48 116.07 4.45 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 169.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -48.8 -29.29 4.41 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.214 1.006 . . . . 0.0 113.166 -175.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.2 m -40.38 -34.33 0.33 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 119.235 3.05 . . . . 0.0 119.235 -169.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.7 p -135.63 -71.68 0.47 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 121.006 1.73 . . . . 0.0 113.942 -169.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -55.14 -50.92 68.05 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.21 0.914 . . . . 0.0 109.886 -169.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 0.1 OUTLIER -63.65 -48.49 77.0 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.992 2.117 . . . . 0.0 111.787 -179.233 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -63.34 -42.95 98.99 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.317 0.647 . . . . 0.0 110.785 -175.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 67.5 mtm -64.82 -46.23 82.83 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 119.05 -0.5 . . . . 0.0 111.036 174.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.86 -41.55 70.93 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 118.233 0.47 . . . . 0.0 110.805 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.63 -46.25 79.98 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 122.843 0.457 . . . . 0.0 111.054 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.39 -40.4 97.52 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -66.63 -52.14 48.41 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 118.506 1.153 . . . . 0.0 108.009 176.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.27 -42.98 78.32 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.824 1.25 . . . . 0.0 113.052 -174.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.3 pttt -68.56 -35.74 77.81 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-N 119.169 0.895 . . . . 0.0 110.265 175.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.6 m -68.1 -41.77 81.32 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 119.555 -1.966 . . . . 0.0 110.569 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.8 mt -73.23 -37.3 66.44 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.086 1.754 . . . . 0.0 111.202 -175.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -139.48 7.68 3.1 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 117.01 -1.995 . . . . 0.0 117.875 -169.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.01 114.34 1.71 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 121.317 2.558 . . . . 0.0 108.59 169.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 124.55 -23.02 6.43 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.525 1.059 . . . . 0.0 111.888 -174.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.444 ' HE2' HG23 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -131.96 -17.56 2.76 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.505 1.152 . . . . 0.0 112.135 177.049 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.9 pt -129.97 147.64 33.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 168.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -110.89 114.65 28.15 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 170.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 p -102.33 151.66 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-O 121.797 0.808 . . . . 0.0 111.723 -176.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.0 m -145.91 151.32 37.66 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 126.182 1.793 . . . . 0.0 106.195 167.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' A' ' 15' ' ' SER . 58.5 p -122.92 158.11 31.12 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 121.043 -1.036 . . . . 0.0 108.673 168.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.8 m -152.18 -173.66 4.62 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.491 1.516 . . . . 0.0 107.525 -174.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.89 162.59 31.35 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 169.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.2 mp -50.2 -36.87 32.51 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.656 1.183 . . . . 0.0 110.075 174.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -141.11 150.06 42.36 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 169.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.0 p -78.02 157.96 29.41 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.988 0.899 . . . . 0.0 110.694 173.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.2 m -164.86 157.86 16.71 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 128.126 2.57 . . . . 0.0 105.231 169.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -56.47 154.18 8.89 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.027 0.83 . . . . 0.0 111.322 -175.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.8 t -62.96 129.71 26.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 172.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -69.37 141.37 91.0 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -176.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.63 -40.42 2.07 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.182 1.255 . . . . 0.0 111.759 -169.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.513 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 6.2 m -67.95 -17.06 64.33 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.453 -1.404 . . . . 0.0 111.868 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.43 ' HB1' HD12 ' A' ' 57' ' ' ILE . . . -58.71 -40.28 83.24 Favored 'General case' 0 C--N 1.34 0.168 0 O-C-N 121.338 -0.851 . . . . 0.0 110.459 171.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.2 mt -57.26 -45.48 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.01 99.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.321 0.649 . . . . 0.0 111.791 -175.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 21.4 mmt -57.81 -47.37 82.8 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 122.85 1.31 . . . . 0.0 111.227 176.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 6.7 mtp -69.81 -31.86 69.99 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.376 -177.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.12 -31.82 70.42 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.47 0.708 . . . . 0.0 111.278 170.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -64.98 -35.11 80.12 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 118.669 0.668 . . . . 0.0 110.368 175.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.0 t -79.44 -25.87 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 119.906 -0.093 . . . . 0.0 110.908 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.14 28.81 6.67 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.718 1.151 . . . . 0.0 111.682 -174.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.583 HG22 ' H ' ' A' ' 56' ' ' ASP . 6.7 mt -125.29 -178.81 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 125.942 1.697 . . . . 0.0 106.927 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.583 ' H ' HG22 ' A' ' 55' ' ' ILE . 5.7 t70 -145.92 155.97 43.22 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.979 1.711 . . . . 0.0 108.883 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.43 HD12 ' HB1' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -130.24 -15.61 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.108 0.963 . . . . 0.0 113.331 172.712 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.4 p -50.39 -32.03 16.45 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.647 1.179 . . . . 0.0 113.615 -174.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.46 -15.82 36.53 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 117.852 -1.526 . . . . 0.0 114.425 -172.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -85.8 -25.63 26.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.262 2.031 . . . . 0.0 114.507 -171.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 38.1 p 68.02 168.65 0.26 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.604 1.961 . . . . 0.0 114.116 170.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.8 m -85.14 166.7 16.39 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.718 -171.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.98 139.34 12.59 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 124.137 0.975 . . . . 0.0 109.041 174.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.45 153.58 13.84 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.067 2.512 . . . . 0.0 110.632 169.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.1 tt -53.62 -34.85 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 123.725 0.81 . . . . 0.0 111.355 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -58.82 -22.81 59.43 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.757 1.623 . . . . 0.0 112.528 -176.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -80.42 -5.13 56.04 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.198 0.599 . . . . 0.0 112.541 -177.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -133.41 -176.24 4.08 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.487 1.039 . . . . 0.0 111.336 -176.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -139.68 131.93 28.25 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 126.889 2.076 . . . . 0.0 108.209 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.84 -28.48 67.52 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.475 1.11 . . . . 0.0 112.856 -175.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -60.26 -24.17 64.69 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.849 0.86 . . . . 0.0 112.334 -176.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -83.62 -15.87 47.35 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.247 0.619 . . . . 0.0 110.618 -177.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -102.44 127.06 49.64 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 125.465 1.506 . . . . 0.0 108.701 -175.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -85.4 -25.84 26.78 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.342 0.592 . . . . 0.0 109.688 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.0 t -131.0 135.81 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 -173.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.3 p -135.34 102.71 3.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 123.198 1.475 . . . . 0.0 110.137 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.5 mm -84.7 144.59 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 104.799 -2.296 . . . . 0.0 104.799 168.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.4 m -132.72 158.23 42.89 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 168.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.83 63.57 0.99 Allowed 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 102.515 -3.142 . . . . 0.0 102.515 -171.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 76.2 m -83.48 -39.0 21.08 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -177.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.01 169.81 45.52 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -175.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 95.4 m 38.85 32.86 0.06 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.401 2.28 . . . . 0.0 114.834 -175.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 56.28 24.1 43.53 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.68 1.609 . . . . 0.0 114.637 -176.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.1 t -64.8 151.33 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 169.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -138.49 -171.21 3.0 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.75 1.22 . . . . 0.0 110.071 -171.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 mp -131.15 105.54 14.93 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -169.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -49.92 -41.73 46.86 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 122.868 2.379 . . . . 0.0 115.483 170.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.34 -178.31 3.87 Favored 'Trans proline' 0 C--N 1.356 0.935 0 CA-C-N 121.794 1.677 . . . . 0.0 113.893 -175.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -59.77 -7.34 1.56 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.318 2.247 . . . . 0.0 114.116 -171.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -64.96 10.42 0.07 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.278 1.831 . . . . 0.0 112.496 169.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.1 p -126.12 5.13 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 125.039 1.336 . . . . 0.0 112.03 172.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.6 p -129.41 25.7 5.43 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.895 -1.128 . . . . 0.0 112.89 -170.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -94.31 -177.09 4.16 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.403 0.681 . . . . 0.0 109.682 173.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -57.36 -35.26 69.72 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.372 1.069 . . . . 0.0 112.994 -174.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.8 mt -135.84 138.39 47.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -139.25 137.0 35.54 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 169.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -146.36 151.86 38.17 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.132 1.373 . . . . 0.0 108.21 169.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -115.73 126.67 54.37 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.798 1.239 . . . . 0.0 109.624 169.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.441 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 40.0 m0 -107.09 91.61 3.73 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.412 1.485 . . . . 0.0 108.124 -173.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -69.9 103.69 2.29 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.951 1.3 . . . . 0.0 109.28 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -136.57 161.5 35.72 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.675 1.59 . . . . 0.0 110.517 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -81.65 66.74 7.34 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.02 1.728 . . . . 0.0 111.283 -178.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -9.99 91.93 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 129.731 3.212 . . . . 0.0 112.318 169.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.437 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 71.0 Cg_exo -57.43 -8.36 3.8 Favored 'Trans proline' 0 N--CA 1.459 -0.553 1 C-N-CA 125.409 4.073 . . . . 0.0 117.946 -169.102 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -57.43 95.14 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 120.32 1.418 . . . . 0.0 111.832 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 98.63 13.86 39.55 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 126.428 1.966 . . . . 0.0 113.241 172.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.437 ' HG3' ' HA ' ' A' ' 104' ' ' PRO . 28.8 mm-40 -93.31 177.99 5.86 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.039 1.42 . . . . 0.0 112.575 -169.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.8 m -74.6 154.72 38.43 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.407 1.483 . . . . 0.0 109.931 175.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.1 mt -60.07 -30.31 69.13 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.737 -0.602 . . . . 0.0 111.784 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -62.68 -39.87 95.32 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.106 0.412 . . . . 0.0 110.877 174.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.4 t -67.15 -45.2 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.057 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.513 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 16.2 m-85 -54.66 -52.98 60.63 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.322 0.51 . . . . 0.0 110.829 175.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 75.2 mtp85 -59.11 -42.07 89.67 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 118.434 -0.793 . . . . 0.0 111.956 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 91.1 m -62.16 -53.26 57.8 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 119.038 0.836 . . . . 0.0 109.059 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.2 t -62.36 -42.86 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-O 117.802 -1.094 . . . . 0.0 110.183 -178.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.3 ttp85 -53.41 -52.76 58.33 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 119.813 1.188 . . . . 0.0 108.88 176.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.31 -46.02 91.86 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -172.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -62.74 -49.65 74.19 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.918 0.887 . . . . 0.0 111.054 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.8 t -62.05 -48.15 89.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 125.731 1.612 . . . . 0.0 110.42 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -58.84 -47.35 85.17 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 120.625 1.557 . . . . 0.0 110.424 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -53.64 -46.59 70.6 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 123.792 0.837 . . . . 0.0 109.446 174.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.441 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 61.7 mtt85 -69.1 -38.22 78.84 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 117.604 -1.189 . . . . 0.0 110.946 -174.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.6 t -55.49 -49.64 71.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 120.803 1.638 . . . . 0.0 109.626 169.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -61.12 -39.94 91.9 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.519 1.054 . . . . 0.0 110.689 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -61.81 -46.38 89.75 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.486 1.514 . . . . 0.0 109.922 178.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.1 -52.71 62.79 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.477 1.111 . . . . 0.0 109.387 178.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.444 HG23 ' HE2' ' A' ' 29' ' ' LYS . 72.7 mt -52.14 -40.29 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 123.934 0.894 . . . . 0.0 109.67 177.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.19 -30.84 71.35 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.65 1.113 . . . . 0.0 111.622 -174.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 51.9 mttt -70.52 -37.23 74.09 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.985 1.314 . . . . 0.0 111.493 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.0 pt -99.99 -25.59 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -169.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 64.5 m . . . . . 0 C--O 1.248 1.005 0 C-N-CA 126.165 1.786 . . . . 0.0 111.249 179.612 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.0 ttm . . . . . 0 N--CA 1.484 1.255 0 CA-C-O 120.655 0.264 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt -121.51 143.5 49.24 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.579 1.151 . . . . 0.0 108.213 175.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -103.52 125.18 49.92 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -176.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.545 ' HA ' HG13 ' A' ' 75' ' ' VAL . 40.4 t -108.47 138.6 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 124.415 1.086 . . . . 0.0 108.16 -172.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 32.1 tpp -125.99 140.45 52.6 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.858 1.263 . . . . 0.0 108.803 178.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -122.22 132.98 54.71 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 118.098 -0.953 . . . . 0.0 108.538 170.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.8 t -134.04 116.52 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 121.041 1.746 . . . . 0.0 109.926 -171.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.9 t -115.71 163.08 16.34 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.653 1.115 . . . . 0.0 111.093 -177.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -55.54 -22.54 22.09 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.294 1.438 . . . . 0.0 112.67 172.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -135.21 -1.81 2.58 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 62.32 -52.85 0.15 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 127.589 2.356 . . . . 0.0 113.99 -168.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.9 m -41.43 -19.05 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 120.97 3.693 . . . . 0.0 120.97 -169.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.2 p -131.0 -80.6 0.53 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 120.152 1.342 . . . . 0.0 111.085 -169.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -55.12 -50.91 68.02 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.612 0.765 . . . . 0.0 109.002 -170.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.02 -40.99 74.87 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.221 0.608 . . . . 0.0 111.96 -173.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.8 mm100 -69.39 -40.28 77.47 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.579 -0.701 . . . . 0.0 110.678 -170.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 63.1 mtm -62.47 -44.83 95.45 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 119.58 -0.248 . . . . 0.0 110.393 171.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.37 -37.45 70.09 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 119.361 -0.352 . . . . 0.0 111.152 177.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -62.15 -52.15 65.0 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.172 0.589 . . . . 0.0 109.956 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.01 -41.04 99.65 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.341 -0.699 . . . . 0.0 111.503 -177.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.432 ' CD1' ' HE3' ' A' ' 50' ' ' MET . 25.0 m-85 -66.87 -51.3 57.09 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 118.733 1.266 . . . . 0.0 107.947 177.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.93 -42.77 80.63 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 124.2 1.0 . . . . 0.0 112.666 -174.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -68.41 -35.51 77.74 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 119.771 1.169 . . . . 0.0 110.962 175.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.5 m -67.06 -43.16 83.36 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 120.738 1.608 . . . . 0.0 110.404 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.5 mt -74.57 -36.83 63.06 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.051 1.34 . . . . 0.0 111.209 -173.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -131.69 -3.04 4.24 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 116.621 -2.211 . . . . 0.0 118.009 -169.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.79 109.25 0.6 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 121.901 2.85 . . . . 0.0 109.047 171.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.6 -29.32 2.78 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.813 1.197 . . . . 0.0 111.758 -170.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -133.45 -13.32 2.66 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.391 1.077 . . . . 0.0 112.824 171.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.5 pt -129.5 157.24 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 168.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -121.05 133.62 55.25 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 169.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.14 149.84 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-O 121.331 0.586 . . . . 0.0 111.986 -173.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.8 m -142.35 150.82 41.24 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 167.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.4 m -124.75 153.17 42.82 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 123.951 0.9 . . . . 0.0 109.858 169.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 32.8 m -150.4 -171.46 3.92 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 126.482 1.913 . . . . 0.0 107.463 -170.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.05 169.1 39.52 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 169.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 67.7 mt -53.94 -35.87 62.2 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 124.63 0.841 . . . . 0.0 110.777 178.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -149.69 150.31 31.92 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 169.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.0 p -86.58 165.92 15.81 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 122.081 0.943 . . . . 0.0 111.85 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.1 m -161.68 172.38 16.35 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 128.796 2.838 . . . . 0.0 105.469 169.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.71 151.57 29.0 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.5 -1.375 . . . . 0.0 109.671 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.1 t -57.6 132.91 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 171.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 37.5 t60 -67.92 139.8 93.43 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-O 118.772 -0.632 . . . . 0.0 109.392 177.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.6 -42.29 0.36 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.207 1.938 . . . . 0.0 113.456 -171.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.441 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 5.6 m -62.61 -18.6 62.53 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 119.701 -1.874 . . . . 0.0 112.452 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.7 -38.95 73.01 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.01 0.924 . . . . 0.0 110.291 171.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 62.5 mt -56.49 -48.3 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.04 -40.4 93.47 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 123.972 0.909 . . . . 0.0 111.484 -174.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.5 mmt -59.72 -47.95 83.64 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 122.656 1.217 . . . . 0.0 111.358 176.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.432 ' HE3' ' CD1' ' A' ' 21' ' ' PHE . 8.2 mtp -68.31 -34.72 76.64 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.207 -178.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -61.81 -29.22 70.01 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.243 0.617 . . . . 0.0 111.657 171.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -65.31 -35.84 82.25 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.196 0.907 . . . . 0.0 110.489 173.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 t -78.61 -25.96 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 117.64 0.2 . . . . 0.0 111.0 175.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.25 28.05 7.0 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.522 1.058 . . . . 0.0 111.702 -174.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.584 HG22 ' H ' ' A' ' 56' ' ' ASP . 8.8 mt -121.88 -177.71 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 125.94 1.696 . . . . 0.0 106.731 177.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.584 ' H ' HG22 ' A' ' 55' ' ' ILE . 12.7 t70 -146.9 157.67 43.71 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.37 1.468 . . . . 0.0 109.383 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.407 HG12 ' SD ' ' A' ' 50' ' ' MET . 0.2 OUTLIER -128.45 -17.13 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.993 0.917 . . . . 0.0 112.314 169.803 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -45.0 -38.05 4.48 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.834 1.254 . . . . 0.0 112.783 173.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.86 -5.09 88.71 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.735 1.16 . . . . 0.0 113.972 -173.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -128.27 171.68 11.76 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.324 1.45 . . . . 0.0 110.82 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.3 p -123.86 164.59 18.93 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 122.016 0.913 . . . . 0.0 111.279 -171.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.3 p -74.47 168.25 20.09 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.983 1.713 . . . . 0.0 110.887 173.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -154.45 144.29 15.47 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.524 0.73 . . . . 0.0 109.744 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -86.27 153.11 9.39 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.063 2.508 . . . . 0.0 110.27 169.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.9 tt -54.09 -33.21 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.542 0.737 . . . . 0.0 111.469 173.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -58.28 -24.37 59.25 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.675 1.59 . . . . 0.0 112.552 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -80.11 -6.45 57.72 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -175.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -130.59 -176.51 4.0 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.377 0.99 . . . . 0.0 111.515 -175.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.67 134.17 38.91 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 126.8 2.04 . . . . 0.0 108.348 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.86 -30.87 70.38 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.842 1.257 . . . . 0.0 112.788 -176.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -60.89 -21.78 63.66 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.151 0.98 . . . . 0.0 112.286 -173.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -83.0 -19.47 36.94 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.521 0.729 . . . . 0.0 110.595 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -104.72 124.94 50.28 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.356 1.062 . . . . 0.0 110.282 -169.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -72.86 -38.45 67.04 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 175.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.545 HG13 ' HA ' ' A' ' 4' ' ' VAL . 2.0 p -132.26 131.67 60.81 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -170.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.2 t -124.41 109.29 22.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 123.219 1.485 . . . . 0.0 108.699 -176.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.2 mm -99.44 94.3 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 177.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.4 m -70.68 157.76 37.42 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 117.351 -1.74 . . . . 0.0 106.461 167.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.81 50.66 0.68 Allowed 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 103.742 -2.688 . . . . 0.0 103.742 176.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 64.9 m -72.21 -32.72 67.02 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 169.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.58 -42.94 2.98 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 125.664 1.602 . . . . 0.0 114.24 168.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 34.8 m -74.57 23.74 0.09 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.523 1.162 . . . . 0.0 112.905 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.94 17.36 43.4 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.686 2.089 . . . . 0.0 113.515 -170.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.3 t -69.68 152.72 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 169.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -141.51 178.87 7.15 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.931 1.292 . . . . 0.0 108.662 -173.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.7 mt -110.11 109.63 58.84 Favored Pre-proline 0 N--CA 1.453 -0.309 0 C-N-CA 124.981 1.313 . . . . 0.0 107.811 -170.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.69 -42.09 58.39 Favored 'Trans proline' 0 CA--C 1.546 1.094 0 C-N-CA 122.353 2.035 . . . . 0.0 114.844 169.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.58 179.25 6.12 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 121.796 1.664 . . . . 0.0 113.824 -175.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -56.41 -13.0 1.92 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 127.714 2.406 . . . . 0.0 113.799 -172.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -55.8 -26.74 47.72 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 121.002 -1.061 . . . . 0.0 112.035 172.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.6 p -84.12 -16.33 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 119.579 1.081 . . . . 0.0 110.337 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.7 p -105.12 16.39 25.9 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.683 0.793 . . . . 0.0 112.477 -169.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -79.13 173.91 12.1 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.608 0.763 . . . . 0.0 109.241 170.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.6 mp0 -58.96 -33.77 71.01 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.343 1.057 . . . . 0.0 113.41 -169.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.2 mt -134.92 136.72 51.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -177.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -143.15 138.76 30.01 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.501 1.12 . . . . 0.0 108.833 175.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -147.23 162.27 39.26 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.367 1.467 . . . . 0.0 107.986 168.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -122.61 97.5 5.48 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.78 1.632 . . . . 0.0 108.805 169.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.45 ' CZ2' ' HB3' ' A' ' 122' ' ' ARG . 43.7 m0 -74.05 97.81 2.95 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.778 0.831 . . . . 0.0 109.619 -178.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -63.05 119.16 8.96 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 169.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 47.6 mt -151.72 151.48 31.48 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.865 1.666 . . . . 0.0 107.581 -169.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -84.08 73.54 10.38 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.153 0.981 . . . . 0.0 111.002 -176.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -19.36 97.39 0.05 OUTLIER Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 128.765 2.826 . . . . 0.0 111.427 177.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -63.7 -7.43 12.84 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.965 2.443 . . . . 0.0 116.708 -169.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -61.62 90.86 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 120.849 1.658 . . . . 0.0 113.501 -172.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.61 12.48 28.35 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.955 1.741 . . . . 0.0 113.387 175.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -91.34 -179.64 5.45 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.035 1.417 . . . . 0.0 112.128 -171.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.6 m -76.14 155.44 34.63 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.43 1.492 . . . . 0.0 109.973 174.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.6 -31.62 68.22 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.793 -0.567 . . . . 0.0 111.748 -178.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.62 -34.61 76.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 118.418 0.554 . . . . 0.0 111.169 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 95.3 t -66.25 -45.78 89.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 172.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.441 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 18.8 m-85 -56.83 -49.46 75.33 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 119.066 -0.493 . . . . 0.0 110.489 175.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -57.84 -43.38 85.81 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.591 1.157 . . . . 0.0 111.799 176.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.7 m -61.03 -49.49 77.18 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 118.875 0.761 . . . . 0.0 109.406 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.57 -44.66 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 117.742 -1.123 . . . . 0.0 110.377 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 44.3 ttp85 -52.81 -47.11 67.88 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 119.984 1.266 . . . . 0.0 109.137 175.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.89 -49.79 65.45 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-O 118.341 -1.255 . . . . 0.0 110.398 -176.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -59.81 -56.5 21.02 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 118.36 1.08 . . . . 0.0 110.269 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 80.3 t -49.46 -53.28 9.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 125.285 1.434 . . . . 0.0 109.897 177.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -60.82 -46.9 88.73 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 121.049 1.75 . . . . 0.0 110.463 -175.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.15 -44.8 88.06 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.996 0.519 . . . . 0.0 110.269 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.45 ' HB3' ' CZ2' ' A' ' 99' ' ' TRP . 79.2 mtt-85 -69.08 -40.97 78.14 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.152 -0.927 . . . . 0.0 110.175 -176.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 70.5 t -55.08 -49.05 74.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 120.446 1.476 . . . . 0.0 109.604 169.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -60.35 -39.0 85.57 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.389 0.995 . . . . 0.0 110.45 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -63.54 -45.85 88.68 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.318 1.047 . . . . 0.0 110.427 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.57 -47.12 79.91 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 123.963 0.905 . . . . 0.0 109.779 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.1 mt -53.88 -42.69 54.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 124.715 1.206 . . . . 0.0 109.968 174.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.15 -28.45 67.93 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.399 1.0 . . . . 0.0 111.67 -171.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -73.29 -20.44 60.82 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.91 1.684 . . . . 0.0 112.465 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.3 pt -124.64 -22.29 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 -168.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.9 m . . . . . 0 C--O 1.251 1.174 0 C-N-CA 125.591 1.557 . . . . 0.0 111.283 170.528 . . . . . . . . 0 0 . 1 stop_ save_